data_1n7t_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1n7t _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 . . . . . 0 CA--C 1.53 0.184 0 CA-C-O 120.802 0.334 . . . . 0.23000000000000001 110.962 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -112.99 159.52 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-O 121.155 0.502 . . . . 0.23000000000000001 112.202 -179.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 11.5 ttp-105 -114.5 155.23 26.81 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 115.605 -0.725 . . . . 0.23000000000000001 110.9 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.9 m -136.65 143.73 34.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.386 -0.37 . . . . 0.23000000000000001 111.217 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.5 mtm180 -108.44 106.85 17.15 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.271 -0.422 . . . . 0.23000000000000001 110.609 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.8 t -110.31 110.39 31.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.306 -0.406 . . . . 0.23000000000000001 110.883 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -88.79 128.76 35.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.308 -0.405 . . . . 0.23000000000000001 110.899 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 10.4 mtmt -80.53 115.04 19.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.08 -0.509 . . . . 0.23000000000000001 110.937 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -166.98 89.06 0.76 Allowed Pre-proline 0 CA--C 1.535 0.39 0 CA-C-N 115.913 -0.585 . . . . 0.23000000000000001 110.634 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -79.72 -24.06 13.07 Favored 'Cis proline' 0 C--N 1.363 1.317 0 CA-C-N 119.36 0.807 . . . . 0.23000000000000001 112.879 0.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 54.4 mm-40 -135.53 -176.8 4.4 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.8 0.333 . . . . 0.23000000000000001 111.451 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.405 ' HB3' ' CE2' ' A' ' 25' ' ' PHE . 3.0 mp -63.47 -59.08 5.13 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.061 -0.518 . . . . 0.23000000000000001 111.02 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 106.75 31.18 4.02 Favored Glycine 0 CA--C 1.521 0.415 0 C-N-CA 120.867 -0.682 . . . . 0.23000000000000001 113.585 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.405 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 28.3 p90 -162.62 155.44 19.52 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 117.066 0.433 . . . . 0.23000000000000001 111.235 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.1 p -108.12 152.98 23.8 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.106 -0.497 . . . . 0.23000000000000001 111.4 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 41.3 pt -120.27 148.71 23.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.059 -0.518 . . . . 0.23000000000000001 110.632 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.5 t -139.45 167.71 21.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.871 0.367 . . . . 0.23000000000000001 111.05 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.46 -146.4 18.19 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.972 -0.632 . . . . 0.23000000000000001 112.382 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 101.54 153.32 25.75 Favored Glycine 0 C--N 1.331 0.255 0 C-N-CA 120.848 -0.692 . . . . 0.23000000000000001 112.491 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 25.9 t -79.53 97.24 2.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.906 0.384 . . . . 0.23000000000000001 111.003 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 98.81 -2.72 58.58 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 120.999 -0.62 . . . . 0.23000000000000001 113.937 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -78.64 -155.75 8.83 Favored Glycine 0 C--N 1.34 0.781 0 CA-C-N 117.842 0.821 . . . . 0.23000000000000001 113.04 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -62.12 -29.41 70.31 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.505 0.193 . . . . 0.23000000000000001 111.341 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 107.94 153.74 17.75 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.969 -0.634 . . . . 0.23000000000000001 112.606 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -112.28 129.85 23.91 Favored Pre-proline 0 N--CA 1.468 0.468 0 CA-C-O 119.886 -0.102 . . . . 0.23000000000000001 110.764 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -92.85 34.9 0.23 Allowed 'Trans proline' 0 C--N 1.357 0.999 0 C-N-CA 122.357 2.038 . . . . 0.23000000000000001 113.129 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -116.12 -49.21 2.7 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.761 0.315 . . . . 0.23000000000000001 110.952 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 32.1 mmt180 -116.36 138.93 24.72 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 116.234 -0.439 . . . . 0.23000000000000001 110.806 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -83.63 -44.31 0.07 OUTLIER 'Trans proline' 0 C--N 1.357 1.023 0 C-N-CA 121.972 1.782 . . . . 0.23000000000000001 112.936 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -92.03 -8.58 45.59 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 112.794 0.664 . . . . 0.23000000000000001 112.794 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -108.22 123.21 48.41 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 118.08 0.4 . . . . 0.23000000000000001 110.885 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.2 p30 -110.04 34.67 3.74 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.265 -0.425 . . . . 0.23000000000000001 111.072 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -78.73 -158.56 12.5 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 120.925 -0.655 . . . . 0.23000000000000001 112.485 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 20.5 mm -108.94 131.04 60.76 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 N-CA-C 110.418 -0.215 . . . . 0.23000000000000001 110.418 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -130.48 146.39 52.02 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.87 0.367 . . . . 0.23000000000000001 111.545 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 22.0 t -90.38 73.95 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 116.149 -0.478 . . . . 0.23000000000000001 110.672 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.2 t -34.47 -54.31 0.53 Allowed 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 114.767 1.395 . . . . 0.23000000000000001 114.767 -178.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 11.0 ptm180 -160.3 170.87 20.19 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.201 0.524 . . . . 0.23000000000000001 112.171 -179.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.2 t -125.23 147.24 29.93 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 CA-C-N 115.485 -0.779 . . . . 0.23000000000000001 110.355 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 8.3 mm-40 -103.91 -68.09 0.04 OUTLIER Pre-proline 0 CA--C 1.535 0.4 0 CA-C-N 116.833 -0.167 . . . . 0.23000000000000001 111.277 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -79.83 119.33 3.97 Favored 'Trans proline' 0 C--N 1.356 0.951 0 C-N-CA 121.694 1.596 . . . . 0.23000000000000001 112.173 179.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -79.59 66.27 5.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.276 0.56 . . . . 0.23000000000000001 110.793 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -143.86 -73.37 0.03 OUTLIER Glycine 0 CA--C 1.526 0.734 0 CA-C-N 115.721 -0.672 . . . . 0.23000000000000001 112.58 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -60.2 -70.03 0.04 OUTLIER 'Trans proline' 0 C--N 1.358 1.03 0 C-N-CA 121.832 1.688 . . . . 0.23000000000000001 112.938 -179.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -99.02 43.4 1.06 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-O 120.99 0.424 . . . . 0.23000000000000001 111.415 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 92.9 p -87.11 -59.41 2.26 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.184 -0.462 . . . . 0.23000000000000001 110.304 179.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -91.12 -4.0 56.6 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.791 -0.641 . . . . 0.23000000000000001 112.244 179.318 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -91.62 -69.52 0.73 Allowed 'General case' 0 C--N 1.341 0.22 0 CA-C-N 118.231 0.469 . . . . 0.23000000000000001 111.606 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.7 mt -96.82 146.31 25.04 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.896 0.379 . . . . 0.23000000000000001 111.921 -179.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -112.61 151.17 43.69 Favored Pre-proline 0 N--CA 1.47 0.574 0 CA-C-N 115.568 -0.742 . . . . 0.23000000000000001 110.478 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -64.22 129.22 23.56 Favored 'Trans proline' 0 C--N 1.355 0.909 0 C-N-CA 121.872 1.714 . . . . 0.23000000000000001 112.588 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 92.71 18.99 38.87 Favored Glycine 0 CA--C 1.523 0.541 0 C-N-CA 120.929 -0.653 . . . . 0.23000000000000001 113.689 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -93.54 151.35 19.76 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 117.306 0.553 . . . . 0.23000000000000001 110.762 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 60.1 tttm -100.1 130.27 46.23 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.348 -0.387 . . . . 0.23000000000000001 111.212 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 28.0 mt -89.85 117.08 32.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 116.163 -0.471 . . . . 0.23000000000000001 110.411 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 22.1 mm -90.48 -43.96 14.63 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 N-CA-C 112.062 0.393 . . . . 0.23000000000000001 112.062 -178.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -145.14 150.79 37.39 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.812 0.339 . . . . 0.23000000000000001 111.652 -178.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -138.32 119.78 14.91 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.136 -0.484 . . . . 0.23000000000000001 111.487 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.4 m120 46.47 29.0 0.81 Allowed 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 113.254 0.835 . . . . 0.23000000000000001 113.254 178.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 101.78 -20.25 46.74 Favored Glycine 0 CA--C 1.521 0.468 0 C-N-CA 120.747 -0.739 . . . . 0.23000000000000001 113.391 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -88.77 126.51 35.37 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 117.212 0.506 . . . . 0.23000000000000001 110.535 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.5 t -72.53 141.71 48.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 0.23000000000000001 110.576 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -111.43 20.57 17.11 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.106 0.41 . . . . 0.23000000000000001 112.106 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 24.7 mm -97.52 137.66 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-O 120.681 0.277 . . . . 0.23000000000000001 111.446 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 65.31 10.69 6.7 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.983 0.734 . . . . 0.23000000000000001 112.983 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 9.5 pt -92.88 163.08 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 N-CA-C 113.375 0.879 . . . . 0.23000000000000001 113.375 -178.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -83.03 144.7 29.76 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.184 -0.916 . . . . 0.23000000000000001 109.79 179.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 8.8 t-160 -52.35 -51.4 59.01 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 112.385 0.513 . . . . 0.23000000000000001 112.385 -178.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -53.95 -28.39 40.14 Favored Glycine 0 C--N 1.335 0.509 0 C-N-CA 121.104 -0.569 . . . . 0.23000000000000001 113.127 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.4 tp-100 -75.77 -37.72 59.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.993 0.425 . . . . 0.23000000000000001 110.309 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.63 -47.92 68.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.931 -0.577 . . . . 0.23000000000000001 111.373 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 20.3 t -62.02 -43.37 97.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.217 -0.447 . . . . 0.23000000000000001 111.271 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 33.2 t -60.77 -38.32 84.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.271 -0.422 . . . . 0.23000000000000001 111.424 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 32.7 mt -67.66 -45.54 74.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.318 -0.401 . . . . 0.23000000000000001 111.454 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.419 ' HA ' ' CD2' ' A' ' 89' ' ' PHE . 15.6 mt -64.21 -36.25 83.44 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.395 0.517 . . . . 0.23000000000000001 112.395 -179.128 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 34.2 mttm -72.19 -37.98 69.17 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.651 0.612 . . . . 0.23000000000000001 112.651 -178.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 9.9 t -70.99 -27.02 63.4 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 113.089 0.774 . . . . 0.23000000000000001 113.089 -178.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.419 ' CD2' ' HA ' ' A' ' 86' ' ' LEU . 13.3 m-85 -49.45 148.01 3.0 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 112.747 0.647 . . . . 0.23000000000000001 112.747 -178.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -65.65 -137.75 0.0 OUTLIER 'General case' 0 CA--C 1.551 0.994 0 CA-C-N 115.487 -0.779 . . . . 0.23000000000000001 111.292 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -81.36 -69.79 0.58 Allowed 'General case' 0 C--N 1.351 0.646 0 CA-C-N 119.488 1.04 . . . . 0.23000000000000001 112.403 -178.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.18 121.36 21.09 Favored 'General case' 0 C--O 1.231 0.08 0 CA-C-O 120.839 0.352 . . . . 0.23000000000000001 111.068 -179.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 19.1 t -112.58 111.89 38.08 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-N 116.124 -0.489 . . . . 0.23000000000000001 111.004 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -93.44 126.08 38.39 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 110.018 -0.364 . . . . 0.23000000000000001 110.018 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 2.0 mt -130.42 159.93 35.55 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.074 0.464 . . . . 0.23000000000000001 111.867 -178.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 48.2 mt -119.17 129.18 75.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.597 -0.729 . . . . 0.23000000000000001 109.984 178.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 33.0 pt -125.55 165.32 23.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-O 120.97 0.414 . . . . 0.23000000000000001 111.878 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 44.3 t -144.61 149.34 17.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 115.73 -0.668 . . . . 0.23000000000000001 111.555 -179.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.51 116.29 28.6 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.639 -0.709 . . . . 0.23000000000000001 109.091 179.002 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 . . . . . 0 N--CA 1.462 0.137 0 CA-C-O 120.936 0.398 . . . . 0.23000000000000001 111.647 -178.953 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.786 0.327 . . . . 0.23000000000000001 110.865 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 305' ' ' THR . . . . . . . . . . . . . 6.9 m -122.78 120.19 32.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.142 -0.481 . . . . 17.879999999999999 110.627 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 306' ' ' TRP . . . . . . . . . . . . . 94.3 m95 -85.03 114.21 22.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.282 -0.417 . . . . 0.23000000000000001 110.945 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 307' ' ' VAL . . . . . . . . . . . . . 25.2 m . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.14 -0.934 . . . . 16.109999999999999 111.168 -179.849 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.229 0 CA-C-O 120.928 0.394 . . . . 0.23000000000000001 111.002 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.2 155.79 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-N 116.008 -0.542 . . . . 0.23000000000000001 112.296 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 24.7 ttm-85 -116.52 152.39 34.19 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.359 -0.837 . . . . 0.23000000000000001 111.11 -179.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.5 m -145.78 147.23 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 N-CA-C 111.623 0.231 . . . . 0.23000000000000001 111.623 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 14.1 ptp180 -112.54 130.59 55.96 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.813 0.34 . . . . 0.23000000000000001 111.274 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.7 t -116.07 120.38 64.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.163 -0.471 . . . . 0.23000000000000001 110.705 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -94.2 119.54 33.15 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.518 -0.31 . . . . 0.23000000000000001 111.831 -179.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.57 113.18 4.02 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.139 -0.482 . . . . 0.23000000000000001 110.833 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -175.29 84.02 0.31 Allowed Pre-proline 0 CA--C 1.537 0.461 0 CA-C-N 116.495 -0.32 . . . . 0.23000000000000001 111.119 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -82.68 -24.84 10.8 Favored 'Cis proline' 0 C--N 1.363 1.297 0 CA-C-N 119.508 0.86 . . . . 0.23000000000000001 112.8 0.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -137.51 -178.06 5.06 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 120.815 0.341 . . . . 0.23000000000000001 111.441 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.408 ' HB3' ' CE2' ' A' ' 25' ' ' PHE . 3.5 mp -61.1 -59.65 5.01 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.151 -0.477 . . . . 0.23000000000000001 111.198 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 104.94 25.53 6.76 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 120.799 -0.715 . . . . 0.23000000000000001 113.48 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.408 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 37.2 p90 -155.25 144.47 20.98 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 117.252 0.526 . . . . 0.23000000000000001 111.051 179.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.3 p -98.91 151.82 20.44 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.189 -0.46 . . . . 0.23000000000000001 111.363 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 22.5 pt -122.34 153.62 26.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.033 -0.53 . . . . 0.23000000000000001 110.914 179.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.8 m -148.06 162.12 40.02 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.383 -0.371 . . . . 0.23000000000000001 110.78 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 106.58 -149.9 16.71 Favored Glycine 0 C--N 1.332 0.355 0 C-N-CA 120.908 -0.663 . . . . 0.23000000000000001 113.186 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 103.98 154.91 23.72 Favored Glycine 0 C--N 1.331 0.267 0 C-N-CA 120.985 -0.626 . . . . 0.23000000000000001 112.178 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 18.7 t -78.75 110.82 14.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 120.934 0.397 . . . . 0.23000000000000001 110.756 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 88.83 3.71 76.59 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 120.939 -0.648 . . . . 0.23000000000000001 113.847 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -82.89 -146.77 6.54 Favored Glycine 0 C--N 1.341 0.825 0 CA-C-N 117.841 0.82 . . . . 0.23000000000000001 112.798 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 48.5 mtt-85 -81.0 -4.36 54.88 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 112.856 0.687 . . . . 0.23000000000000001 112.856 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.03 162.35 37.52 Favored Glycine 0 C--N 1.344 0.991 0 C-N-CA 120.609 -0.805 . . . . 0.23000000000000001 113.099 179.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -105.84 134.87 19.53 Favored Pre-proline 0 CA--C 1.533 0.289 0 CA-C-O 119.899 -0.096 . . . . 0.23000000000000001 110.921 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -92.87 27.06 0.37 Allowed 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 122.309 2.006 . . . . 0.23000000000000001 112.819 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -125.25 -46.03 1.81 Allowed 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.731 0.3 . . . . 0.23000000000000001 110.796 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 64.6 mtt-85 -116.59 150.99 46.56 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 116.18 -0.464 . . . . 0.23000000000000001 110.614 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -92.08 -57.58 0.02 OUTLIER 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 122.153 1.902 . . . . 0.23000000000000001 114.082 -178.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -84.21 -7.18 59.43 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 113.396 0.887 . . . . 0.23000000000000001 113.396 -178.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -101.69 117.08 34.16 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 118.154 0.433 . . . . 0.23000000000000001 111.108 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -106.31 34.03 3.57 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.253 -0.431 . . . . 0.23000000000000001 111.481 -179.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -80.86 -161.56 26.19 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.868 -0.682 . . . . 0.23000000000000001 112.199 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.8 mm -107.27 131.28 57.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-N 116.782 0.291 . . . . 0.23000000000000001 110.298 179.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.435 ' N ' ' CD1' ' A' ' 46' ' ' PHE . 6.0 m-85 -130.5 148.35 52.3 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.882 0.372 . . . . 0.23000000000000001 111.359 -179.332 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 22.0 t -92.2 76.02 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-O 121.158 0.504 . . . . 0.23000000000000001 110.955 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.2 t -35.13 -51.72 0.56 Allowed 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 114.778 1.399 . . . . 0.23000000000000001 114.778 -178.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.6 ptm180 -160.22 176.63 11.52 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.117 0.484 . . . . 0.23000000000000001 112.28 -179.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 18.3 t -130.8 148.47 33.08 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 CA-C-N 115.535 -0.757 . . . . 0.23000000000000001 110.605 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -102.66 -67.89 0.04 OUTLIER Pre-proline 0 CA--C 1.536 0.422 0 CA-C-O 119.753 -0.165 . . . . 0.23000000000000001 111.392 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -79.4 120.8 4.55 Favored 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 121.796 1.664 . . . . 0.23000000000000001 112.052 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -77.76 65.63 3.27 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.94 0.4 . . . . 0.23000000000000001 111.096 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -158.42 -66.54 0.01 OUTLIER Glycine 0 CA--C 1.528 0.85 0 C-N-CA 120.765 -0.731 . . . . 0.23000000000000001 113.362 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -58.26 -76.43 0.02 OUTLIER 'Trans proline' 0 C--N 1.357 0.99 0 C-N-CA 122.142 1.895 . . . . 0.23000000000000001 113.36 -179.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -111.72 49.77 0.88 Allowed 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.196 0.522 . . . . 0.23000000000000001 111.437 -179.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 82.4 p -107.35 -67.25 0.97 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.93 -0.577 . . . . 0.23000000000000001 109.758 179.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.72 -12.13 57.27 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.892 -0.594 . . . . 0.23000000000000001 111.99 178.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.4 mt -93.71 -59.22 2.05 Favored 'General case' 0 C--N 1.342 0.24 0 O-C-N 122.008 -0.433 . . . . 0.23000000000000001 111.405 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 15.2 mt -93.03 149.26 21.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.325 -0.398 . . . . 0.23000000000000001 111.547 -179.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.22 144.53 33.13 Favored Pre-proline 0 N--CA 1.471 0.603 0 CA-C-N 116.09 -0.505 . . . . 0.23000000000000001 109.744 179.2 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.53 133.47 52.05 Favored 'Trans proline' 0 C--N 1.359 1.081 0 C-N-CA 122.165 1.91 . . . . 0.23000000000000001 113.427 -178.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 87.75 21.75 45.77 Favored Glycine 0 C--N 1.334 0.417 0 CA-C-N 115.716 -0.675 . . . . 0.23000000000000001 113.632 178.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -84.62 -169.55 2.68 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 117.092 0.446 . . . . 0.23000000000000001 111.005 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 57.8 tttp -141.55 126.44 18.19 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-O 120.874 0.368 . . . . 0.23000000000000001 111.338 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 27.9 mt -90.31 118.05 34.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.038 -0.528 . . . . 0.23000000000000001 110.233 179.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 50.3 mt -102.14 -31.79 3.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 N-CA-C 112.419 0.525 . . . . 0.23000000000000001 112.419 -178.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.61 144.57 27.31 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.005 0.431 . . . . 0.23000000000000001 111.844 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -146.25 121.48 10.19 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.932 -0.576 . . . . 0.23000000000000001 111.783 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 44.73 41.77 5.3 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 113.483 0.92 . . . . 0.23000000000000001 113.483 178.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 89.21 -17.99 48.07 Favored Glycine 0 CA--C 1.524 0.605 0 C-N-CA 120.856 -0.688 . . . . 0.23000000000000001 113.634 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -100.92 123.27 44.87 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 117.373 0.586 . . . . 0.23000000000000001 110.256 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 30.0 m -72.52 151.87 42.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.23000000000000001 111.284 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -113.09 19.56 17.08 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.952 -0.567 . . . . 0.23000000000000001 111.783 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.406 HG21 HD11 ' A' ' 75' ' ' ILE . 30.7 mm -97.03 133.14 39.69 Favored 'Isoleucine or valine' 0 C--O 1.231 0.111 0 CA-C-O 120.751 0.31 . . . . 0.23000000000000001 110.859 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 61.23 62.36 1.4 Allowed 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 121.185 0.517 . . . . 0.23000000000000001 110.898 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 18.7 pt -144.43 164.67 13.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.084 -0.507 . . . . 0.23000000000000001 111.752 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -82.09 145.53 30.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.652 -0.704 . . . . 0.23000000000000001 110.633 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 -51.2 -53.29 36.37 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 116.167 -0.47 . . . . 0.23000000000000001 112.162 -179.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -54.65 -25.97 37.62 Favored Glycine 0 CA--C 1.523 0.549 0 C-N-CA 121.079 -0.582 . . . . 0.23000000000000001 113.02 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -74.46 -39.69 62.37 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.111 0.481 . . . . 0.23000000000000001 110.404 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -70.5 -37.57 74.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.76 -0.654 . . . . 0.23000000000000001 111.852 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 35.2 t -70.49 -44.53 76.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.972 0.415 . . . . 0.23000000000000001 110.893 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 75.4 m -61.05 -37.32 82.21 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.124 -0.489 . . . . 0.23000000000000001 111.303 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 19.9 mt -65.65 -46.89 77.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.293 -0.412 . . . . 0.23000000000000001 111.599 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.4 ' HA ' ' CD2' ' A' ' 89' ' ' PHE . 34.4 mt -65.7 -38.31 88.87 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.404 -0.362 . . . . 0.23000000000000001 111.897 -178.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 56.1 mttm -71.45 -39.16 71.16 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.55 0.574 . . . . 0.23000000000000001 112.55 -178.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 12.0 t -73.77 -27.28 61.07 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 113.147 0.795 . . . . 0.23000000000000001 113.147 -178.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.4 ' CD2' ' HA ' ' A' ' 86' ' ' LEU . 11.8 m-85 -48.98 172.7 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 112.842 0.682 . . . . 0.23000000000000001 112.842 -178.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -84.31 -143.46 0.08 Allowed 'General case' 0 CA--C 1.552 1.054 0 CA-C-N 115.627 -0.715 . . . . 0.23000000000000001 111.193 -179.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 67.8 m-80 -76.96 -69.95 0.49 Allowed 'General case' 0 C--N 1.349 0.564 0 CA-C-N 119.005 0.821 . . . . 0.23000000000000001 111.552 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.7 p -80.07 125.46 29.82 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.921 0.391 . . . . 0.23000000000000001 110.788 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 18.8 t -113.41 114.56 47.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.943 -0.571 . . . . 0.23000000000000001 110.556 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -87.79 112.97 23.0 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.967 -0.383 . . . . 0.23000000000000001 109.967 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 4.2 mt -115.21 152.64 32.3 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-O 121.224 0.535 . . . . 0.23000000000000001 112.101 -178.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 31.3 mm -112.39 124.6 69.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.386 -0.825 . . . . 0.23000000000000001 109.065 178.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 29.3 pt -127.23 158.34 38.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 120.882 0.372 . . . . 0.23000000000000001 111.208 -178.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 58.3 t -144.24 150.25 16.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.895 -0.593 . . . . 0.23000000000000001 111.241 -179.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.6 mmm180 -112.0 116.8 31.16 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.299 -0.63 . . . . 0.23000000000000001 109.299 178.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 . . . . . 0 C--N 1.328 -0.339 0 CA-C-O 121.058 0.456 . . . . 0.23000000000000001 111.703 -178.844 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.692 0.282 . . . . 0.23000000000000001 110.515 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 305' ' ' THR . . . . . . . . . . . . . 4.7 m -140.42 113.71 8.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.454 -0.339 . . . . 17.879999999999999 111.159 -179.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 306' ' ' TRP . . . . . . . . . . . . . 92.8 m95 -80.77 105.46 12.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 0.23000000000000001 110.707 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 307' ' ' VAL . . . . . . . . . . . . . 16.7 m . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.233 -0.889 . . . . 16.109999999999999 111.134 -179.941 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 . . . . . 0 C--O 1.232 0.17 0 N-CA-C 109.557 -0.534 . . . . 0.23000000000000001 109.557 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 19.8 pt -147.29 159.17 9.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 N-CA-C 112.833 0.679 . . . . 0.23000000000000001 112.833 -178.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 9.7 ttm105 -104.91 153.77 20.96 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.482 -0.781 . . . . 0.23000000000000001 111.718 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.5 m -146.74 132.74 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-N 116.083 -0.508 . . . . 0.23000000000000001 110.547 178.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.2 ttt180 -107.84 119.94 40.88 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.473 -0.33 . . . . 0.23000000000000001 111.202 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.4 t -118.97 119.77 61.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 116.313 -0.403 . . . . 0.23000000000000001 111.062 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -96.79 132.36 42.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.314 -0.403 . . . . 0.23000000000000001 110.681 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 21.5 mttt -80.31 122.98 27.58 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.435 0.636 . . . . 0.23000000000000001 111.856 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -173.97 85.52 0.36 Allowed Pre-proline 0 CA--C 1.537 0.466 0 CA-C-N 115.62 -0.718 . . . . 0.23000000000000001 110.939 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -81.3 -17.52 27.25 Favored 'Cis proline' 0 C--N 1.365 1.401 0 CA-C-N 119.261 0.772 . . . . 0.23000000000000001 113.371 0.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 38.1 mm-40 -136.63 -177.17 4.61 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.79 0.329 . . . . 0.23000000000000001 111.453 -179.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.403 ' HB3' ' CE2' ' A' ' 25' ' ' PHE . 4.5 mp -59.42 -63.08 1.43 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.2 -0.455 . . . . 0.23000000000000001 111.211 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 114.67 28.84 2.83 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 120.877 -0.677 . . . . 0.23000000000000001 113.485 179.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.403 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 49.5 p90 -164.14 148.9 10.15 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 117.156 0.478 . . . . 0.23000000000000001 111.285 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.4 p -102.06 155.1 18.4 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.075 -0.511 . . . . 0.23000000000000001 111.24 -179.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 21.1 pt -125.38 153.47 32.95 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-N 116.122 -0.49 . . . . 0.23000000000000001 110.752 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.4 m -143.28 165.61 26.99 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.821 0.343 . . . . 0.23000000000000001 111.139 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.77 -144.45 17.22 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.898 -0.668 . . . . 0.23000000000000001 112.674 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 102.3 151.52 23.83 Favored Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.933 -0.651 . . . . 0.23000000000000001 112.378 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 30.3 t -79.99 98.7 3.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.849 0.357 . . . . 0.23000000000000001 110.781 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 98.94 -3.61 58.71 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 120.958 -0.639 . . . . 0.23000000000000001 114.07 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -81.17 -150.66 7.53 Favored Glycine 0 C--N 1.342 0.906 0 CA-C-N 117.799 0.8 . . . . 0.23000000000000001 112.904 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 4.9 ptt-85 -87.18 12.23 12.16 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 112.458 0.54 . . . . 0.23000000000000001 112.458 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 51.39 -173.02 0.17 Allowed Glycine 0 C--N 1.342 0.893 0 N-CA-C 114.496 0.559 . . . . 0.23000000000000001 114.496 178.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 22.7 p30 -142.56 161.51 49.32 Favored Pre-proline 0 CA--C 1.536 0.41 0 CA-C-N 115.553 -0.323 . . . . 0.23000000000000001 110.545 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -92.75 25.12 0.44 Allowed 'Trans proline' 0 C--N 1.358 1.052 0 C-N-CA 122.386 2.057 . . . . 0.23000000000000001 113.431 -179.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -103.33 -44.17 5.23 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.699 0.285 . . . . 0.23000000000000001 111.298 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -124.07 136.16 27.22 Favored Pre-proline 0 CA--C 1.535 0.369 0 CA-C-N 116.366 -0.379 . . . . 0.23000000000000001 110.503 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -84.98 -46.89 0.04 OUTLIER 'Trans proline' 0 C--N 1.358 1.04 0 C-N-CA 121.908 1.738 . . . . 0.23000000000000001 113.385 -179.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -97.01 -11.31 24.68 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 112.867 0.691 . . . . 0.23000000000000001 112.867 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -92.33 121.59 33.97 Favored 'General case' 0 N--CA 1.464 0.254 0 O-C-N 122.064 -0.397 . . . . 0.23000000000000001 110.465 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 14.0 p-10 -111.03 47.65 0.98 Allowed 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.04 0.448 . . . . 0.23000000000000001 111.596 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -94.71 -162.83 35.07 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 121.058 -0.592 . . . . 0.23000000000000001 111.69 179.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 14.6 mm -112.45 124.91 69.59 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-N 117.421 0.611 . . . . 0.23000000000000001 110.449 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -126.79 146.51 50.22 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.735 0.302 . . . . 0.23000000000000001 110.959 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 22.7 t -90.99 76.18 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-O 120.89 0.376 . . . . 0.23000000000000001 111.201 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.8 t -33.09 -54.53 0.39 Allowed 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 114.971 1.471 . . . . 0.23000000000000001 114.971 -178.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -160.27 174.17 14.61 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.262 0.553 . . . . 0.23000000000000001 112.45 -179.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 20.7 t -124.79 145.36 32.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-N 115.349 -0.841 . . . . 0.23000000000000001 110.459 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 -102.86 -69.95 0.04 OUTLIER Pre-proline 0 CA--C 1.539 0.54 0 CA-C-O 119.461 -0.304 . . . . 0.23000000000000001 111.413 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -82.57 121.15 3.3 Favored 'Trans proline' 0 C--N 1.359 1.118 0 C-N-CA 121.698 1.599 . . . . 0.23000000000000001 112.601 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -79.8 66.21 5.21 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.303 0.573 . . . . 0.23000000000000001 110.799 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -142.08 -71.08 0.03 OUTLIER Glycine 0 CA--C 1.527 0.834 0 CA-C-N 115.778 -0.646 . . . . 0.23000000000000001 113.152 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -63.47 -58.15 0.31 Allowed 'Trans proline' 0 C--N 1.358 1.058 0 C-N-CA 121.948 1.766 . . . . 0.23000000000000001 113.497 -179.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -118.8 48.56 1.44 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 121.08 0.467 . . . . 0.23000000000000001 111.728 -179.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 82.6 p -79.81 -59.64 2.66 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.082 -0.508 . . . . 0.23000000000000001 110.852 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 17.3 mttt -97.73 9.89 41.44 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 112.522 0.564 . . . . 0.23000000000000001 112.522 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 79.0 mt -92.23 -65.11 1.03 Allowed 'General case' 0 C--N 1.34 0.181 0 O-C-N 122.106 -0.371 . . . . 0.23000000000000001 111.413 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.1 mt -97.12 147.76 23.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.25 -0.432 . . . . 0.23000000000000001 111.509 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -113.4 140.04 23.95 Favored Pre-proline 0 N--CA 1.469 0.481 0 CA-C-N 116.027 -0.533 . . . . 0.23000000000000001 109.67 178.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -53.01 136.04 60.04 Favored 'Trans proline' 0 C--N 1.358 1.068 0 C-N-CA 122.083 1.855 . . . . 0.23000000000000001 113.291 -178.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 82.03 24.78 54.29 Favored Glycine 0 C--N 1.333 0.374 0 CA-C-N 115.767 -0.651 . . . . 0.23000000000000001 113.246 179.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -86.05 -170.58 3.16 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.89 0.345 . . . . 0.23000000000000001 110.857 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 60.8 tttp -139.33 122.86 17.32 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.83 0.348 . . . . 0.23000000000000001 110.891 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 48.8 mt -89.61 121.94 40.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 0.23000000000000001 110.509 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 19.5 mm -96.03 -43.97 12.81 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 N-CA-C 112.581 0.585 . . . . 0.23000000000000001 112.581 -178.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -145.81 150.57 36.44 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 121.073 0.463 . . . . 0.23000000000000001 111.957 -178.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -137.1 119.46 15.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.631 -0.713 . . . . 0.23000000000000001 110.94 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 42.28 32.3 0.32 Allowed 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 113.642 0.978 . . . . 0.23000000000000001 113.642 178.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 97.83 4.2 57.94 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 120.986 -0.626 . . . . 0.23000000000000001 114.083 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -110.09 124.24 51.15 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 117.949 0.875 . . . . 0.23000000000000001 110.565 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 54.8 p -72.78 139.85 47.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.468 -0.333 . . . . 0.23000000000000001 110.484 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -110.5 21.55 16.49 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 112.097 0.406 . . . . 0.23000000000000001 112.097 -179.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 21.1 mm -100.29 139.45 21.72 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 O-C-N 122.214 -0.304 . . . . 0.23000000000000001 111.048 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 19.9 m120 63.81 12.23 6.54 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 112.88 0.696 . . . . 0.23000000000000001 112.88 -179.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 25.3 pt -93.62 158.21 2.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 N-CA-C 112.83 0.678 . . . . 0.23000000000000001 112.83 -178.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -81.63 148.83 28.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.322 -0.854 . . . . 0.23000000000000001 110.479 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 35.4 t60 -47.23 -50.32 21.34 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 113.011 0.745 . . . . 0.23000000000000001 113.011 -179.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -57.59 -26.15 56.65 Favored Glycine 0 C--N 1.335 0.501 0 C-N-CA 120.874 -0.679 . . . . 0.23000000000000001 113.082 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.21 -42.59 45.63 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.897 0.38 . . . . 0.23000000000000001 110.887 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.38 -39.57 81.69 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.14 -0.482 . . . . 0.23000000000000001 111.662 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.4 t -72.57 -43.2 63.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.852 0.358 . . . . 0.23000000000000001 110.666 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 34.7 t -60.53 -39.95 89.75 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.23 -0.441 . . . . 0.23000000000000001 111.296 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 53.2 mt -67.56 -44.0 79.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.898 0.38 . . . . 0.23000000000000001 111.139 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.405 ' HA ' ' CD2' ' A' ' 89' ' ' PHE . 17.5 mt -66.27 -38.57 88.11 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.086 -0.506 . . . . 0.23000000000000001 111.809 -178.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 48.5 mttm -73.31 -38.09 65.96 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.539 0.57 . . . . 0.23000000000000001 112.539 -178.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 9.0 t -70.15 -25.34 63.42 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 112.329 0.492 . . . . 0.23000000000000001 112.329 -178.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.405 ' CD2' ' HA ' ' A' ' 86' ' ' LEU . 14.7 m-85 -53.5 140.49 28.04 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.19 0.519 . . . . 0.23000000000000001 111.842 -179.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -62.59 -131.4 0.0 OUTLIER 'General case' 0 CA--C 1.558 1.258 0 CA-C-N 115.565 -0.743 . . . . 0.23000000000000001 111.948 -178.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -82.59 -72.28 0.45 Allowed 'General case' 0 C--N 1.355 0.806 0 CA-C-N 119.718 1.144 . . . . 0.23000000000000001 112.621 -177.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -74.23 123.11 23.91 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.818 0.342 . . . . 0.23000000000000001 111.011 -179.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.6 t -109.51 116.08 51.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.117 -0.492 . . . . 0.23000000000000001 110.953 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.95 104.62 16.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.078 -0.51 . . . . 0.23000000000000001 110.353 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.8 mp -111.76 158.54 19.23 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.239 0.542 . . . . 0.23000000000000001 112.098 -179.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 26.5 mm -118.72 129.59 74.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-N 115.372 -0.831 . . . . 0.23000000000000001 109.822 178.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 25.8 pt -130.96 167.24 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-O 120.846 0.355 . . . . 0.23000000000000001 111.663 -178.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 19.0 t -148.29 151.65 13.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.146 -0.479 . . . . 0.23000000000000001 111.243 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -115.42 131.05 57.05 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.094 -0.503 . . . . 0.23000000000000001 109.928 179.086 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 . . . . . 0 C--N 1.327 -0.385 0 CA-C-N 116.262 -0.426 . . . . 0.23000000000000001 112.061 -178.985 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.464 0.255 0 CA-C-O 120.953 0.406 . . . . 0.23000000000000001 111.068 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 305' ' ' THR . . . . . . . . . . . . . 4.9 m -144.98 118.86 9.29 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.123 -0.489 . . . . 17.879999999999999 111.047 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 306' ' ' TRP . . . . . . . . . . . . . 91.9 m95 -88.79 106.0 18.09 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.273 -0.421 . . . . 0.23000000000000001 110.664 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 307' ' ' VAL . . . . . . . . . . . . . 25.6 m . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.26 -0.876 . . . . 16.109999999999999 111.16 -179.983 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.465 0.322 0 CA-C-O 120.718 0.294 . . . . 0.23000000000000001 111.147 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 18.4 pt -115.82 158.11 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 N-CA-C 112.815 0.672 . . . . 0.23000000000000001 112.815 -178.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 26.8 ttp180 -116.07 156.19 26.81 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.667 -0.697 . . . . 0.23000000000000001 111.612 -179.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.7 m -149.45 142.83 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.272 -0.422 . . . . 0.23000000000000001 111.302 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.17 132.01 54.55 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.949 0.404 . . . . 0.23000000000000001 111.236 179.565 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.3 t -114.62 120.03 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 CA-C-N 116.237 -0.438 . . . . 0.23000000000000001 111.155 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -89.8 111.59 22.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.267 -0.424 . . . . 0.23000000000000001 111.095 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.87 116.89 7.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.143 -0.481 . . . . 0.23000000000000001 110.971 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -175.1 84.87 0.32 Allowed Pre-proline 0 CA--C 1.54 0.571 0 CA-C-N 116.428 -0.351 . . . . 0.23000000000000001 110.962 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -84.7 -22.2 14.65 Favored 'Cis proline' 0 C--N 1.366 1.475 0 CA-C-N 119.488 0.853 . . . . 0.23000000000000001 113.058 0.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 18.2 mp0 -131.42 -178.28 4.78 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.768 0.318 . . . . 0.23000000000000001 111.142 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.403 HD21 ' CZ ' ' A' ' 25' ' ' PHE . 3.2 mp -63.12 -58.16 8.18 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.254 -0.43 . . . . 0.23000000000000001 110.563 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 109.92 26.89 4.8 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.888 -0.672 . . . . 0.23000000000000001 113.377 179.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.403 ' CZ ' HD21 ' A' ' 23' ' ' LEU . 37.4 p90 -159.84 139.93 11.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 117.133 0.467 . . . . 0.23000000000000001 111.12 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.9 p -94.06 153.59 18.07 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.007 -0.542 . . . . 0.23000000000000001 110.823 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 28.2 pt -122.59 152.77 27.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.279 -0.418 . . . . 0.23000000000000001 111.084 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 50.9 m -146.14 160.93 41.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.285 -0.416 . . . . 0.23000000000000001 110.912 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 104.97 -146.77 16.14 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 120.988 -0.625 . . . . 0.23000000000000001 113.098 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.36 157.62 28.92 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.993 -0.622 . . . . 0.23000000000000001 111.98 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 18.8 t -78.55 109.65 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 CA-C-O 120.806 0.336 . . . . 0.23000000000000001 110.953 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 86.8 3.81 83.05 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 121.039 -0.601 . . . . 0.23000000000000001 113.857 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -82.87 -154.7 16.45 Favored Glycine 0 C--N 1.343 0.954 0 CA-C-N 117.816 0.808 . . . . 0.23000000000000001 112.928 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 7.4 mtt180 -75.71 -2.51 29.96 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 112.973 0.731 . . . . 0.23000000000000001 112.973 -179.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.26 -151.28 25.52 Favored Glycine 0 C--N 1.342 0.911 0 C-N-CA 120.695 -0.764 . . . . 0.23000000000000001 113.037 179.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -173.54 142.3 0.94 Allowed Pre-proline 0 CA--C 1.534 0.346 0 N-CA-C 110.611 -0.144 . . . . 0.23000000000000001 110.611 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -90.42 39.87 0.39 Allowed 'Trans proline' 0 C--N 1.358 1.03 0 C-N-CA 122.274 1.983 . . . . 0.23000000000000001 113.507 -179.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -125.62 -53.44 1.57 Allowed 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.739 0.304 . . . . 0.23000000000000001 110.915 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? -116.16 136.28 22.97 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 116.323 -0.398 . . . . 0.23000000000000001 110.677 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -85.59 -46.37 0.04 OUTLIER 'Trans proline' 0 C--N 1.358 1.05 0 C-N-CA 121.965 1.777 . . . . 0.23000000000000001 113.335 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -93.42 -8.68 41.02 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 112.91 0.707 . . . . 0.23000000000000001 112.91 -179.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -101.03 121.48 41.87 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 118.175 0.443 . . . . 0.23000000000000001 110.537 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -110.72 39.8 2.15 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 120.819 0.342 . . . . 0.23000000000000001 111.874 -178.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -87.44 -158.97 33.48 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 120.895 -0.669 . . . . 0.23000000000000001 112.085 179.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 13.9 mm -109.43 124.58 66.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 116.996 0.398 . . . . 0.23000000000000001 110.83 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.418 ' CD1' ' N ' ' A' ' 46' ' ' PHE . 7.3 m-85 -127.12 150.16 49.62 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.628 0.251 . . . . 0.23000000000000001 110.636 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 22.5 t -95.92 78.98 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 116.439 -0.346 . . . . 0.23000000000000001 111.531 -179.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.9 t -35.58 -53.6 0.69 Allowed 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 114.43 1.27 . . . . 0.23000000000000001 114.43 -178.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 15.4 ptt180 -160.77 163.95 31.87 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.993 0.425 . . . . 0.23000000000000001 111.801 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.8 t -114.29 146.13 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 115.76 -0.655 . . . . 0.23000000000000001 110.42 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.9 mm-40 -97.13 -70.41 0.05 OUTLIER Pre-proline 0 CA--C 1.538 0.496 0 CA-C-O 119.465 -0.302 . . . . 0.23000000000000001 111.316 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -83.05 121.13 3.1 Favored 'Trans proline' 0 C--N 1.36 1.133 0 C-N-CA 121.606 1.538 . . . . 0.23000000000000001 112.292 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -78.62 65.49 3.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.205 0.526 . . . . 0.23000000000000001 110.737 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -148.19 -70.56 0.01 OUTLIER Glycine 0 CA--C 1.527 0.793 0 C-N-CA 120.965 -0.636 . . . . 0.23000000000000001 112.871 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -60.37 -63.3 0.12 Allowed 'Trans proline' 0 C--N 1.358 1.062 0 C-N-CA 121.977 1.784 . . . . 0.23000000000000001 112.893 -179.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -110.02 45.65 1.09 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.16 0.505 . . . . 0.23000000000000001 111.186 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 88.9 p -82.5 -59.06 2.65 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.009 -0.541 . . . . 0.23000000000000001 110.93 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -93.72 5.28 52.17 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.752 0.649 . . . . 0.23000000000000001 112.752 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 80.2 mt -92.04 -72.61 0.58 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 118.144 0.429 . . . . 0.23000000000000001 111.612 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -95.94 143.08 27.44 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.545 0.212 . . . . 0.23000000000000001 110.764 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -114.98 153.6 47.08 Favored Pre-proline 0 N--CA 1.471 0.592 0 CA-C-N 116.334 -0.394 . . . . 0.23000000000000001 110.776 179.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -55.22 123.71 14.49 Favored 'Trans proline' 0 C--N 1.36 1.161 0 C-N-CA 122.335 2.023 . . . . 0.23000000000000001 113.882 -178.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 92.74 16.02 50.29 Favored Glycine 0 CA--C 1.521 0.467 0 CA-C-N 115.687 -0.688 . . . . 0.23000000000000001 114.139 178.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 35.1 p-10 -80.27 -171.7 3.13 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 117.541 0.671 . . . . 0.23000000000000001 111.361 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 32.2 tttp -142.4 125.14 15.94 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 120.774 0.321 . . . . 0.23000000000000001 111.108 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.5 mp -90.87 123.86 43.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-N 116.387 -0.37 . . . . 0.23000000000000001 110.023 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 21.0 mm -94.9 -44.55 13.3 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 112.201 0.445 . . . . 0.23000000000000001 112.201 -179.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -148.62 150.42 33.24 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 120.833 0.349 . . . . 0.23000000000000001 111.668 -178.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -136.7 123.69 21.49 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.021 -0.536 . . . . 0.23000000000000001 111.557 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 28.7 m-20 42.44 35.01 0.59 Allowed 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 113.61 0.966 . . . . 0.23000000000000001 113.61 178.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 99.65 -16.37 58.81 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 120.867 -0.682 . . . . 0.23000000000000001 113.792 179.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -92.99 123.06 35.97 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 117.534 0.667 . . . . 0.23000000000000001 111.016 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 14.9 m -71.12 130.49 41.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.15 -0.477 . . . . 0.23000000000000001 111.077 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -103.16 15.64 28.73 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.263 0.468 . . . . 0.23000000000000001 112.263 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 6.5 tp -89.32 124.24 41.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-O 120.729 0.299 . . . . 0.23000000000000001 110.546 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 62.54 73.78 0.45 Allowed 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.118 0.485 . . . . 0.23000000000000001 111.161 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 11.5 pt -144.29 163.12 14.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.046 -0.524 . . . . 0.23000000000000001 110.886 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -81.12 153.39 27.32 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.265 -0.425 . . . . 0.23000000000000001 111.256 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 21.1 t60 -52.85 -55.7 21.21 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 116.02 -0.537 . . . . 0.23000000000000001 112.186 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -56.29 -26.7 51.27 Favored Glycine 0 C--N 1.334 0.45 0 C-N-CA 121.073 -0.584 . . . . 0.23000000000000001 113.277 -179.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -72.66 -40.56 66.25 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.866 0.365 . . . . 0.23000000000000001 111.008 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.99 -41.0 95.8 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.124 -0.489 . . . . 0.23000000000000001 111.423 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 16.1 t -70.74 -42.0 77.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.384 -0.371 . . . . 0.23000000000000001 111.199 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 72.5 m -60.53 -45.82 92.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 0.23000000000000001 111.588 -179.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 31.7 mt -64.14 -45.52 88.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.412 -0.358 . . . . 0.23000000000000001 111.603 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.408 ' HA ' ' CD2' ' A' ' 89' ' ' PHE . 24.5 mt -65.36 -39.48 92.35 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.287 -0.415 . . . . 0.23000000000000001 111.956 -179.009 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 8.4 mmtp -68.68 -40.02 80.31 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.595 0.591 . . . . 0.23000000000000001 112.595 -178.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 8.8 t -72.22 -27.26 62.42 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.36 0.874 . . . . 0.23000000000000001 113.36 -177.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.408 ' CD2' ' HA ' ' A' ' 86' ' ' LEU . 10.5 m-85 -47.87 172.81 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 113.105 0.779 . . . . 0.23000000000000001 113.105 -177.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -92.5 -138.0 0.18 Allowed 'General case' 0 CA--C 1.554 1.103 0 CA-C-N 115.519 -0.764 . . . . 0.23000000000000001 111.277 -178.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 54.5 m-80 -78.96 -74.97 0.25 Allowed 'General case' 0 C--N 1.35 0.61 0 CA-C-N 119.454 1.025 . . . . 0.23000000000000001 111.955 -178.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.44 123.19 26.21 Favored 'General case' 0 CA--C 1.527 0.081 0 CA-C-O 120.84 0.352 . . . . 0.23000000000000001 110.307 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 20.2 t -111.32 116.69 53.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.944 -0.571 . . . . 0.23000000000000001 110.498 179.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -86.77 112.66 21.91 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.959 0.409 . . . . 0.23000000000000001 110.159 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.3 mt -116.51 147.46 41.75 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.679 -0.692 . . . . 0.23000000000000001 111.896 -178.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.8 mm -107.19 121.71 60.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.673 -0.694 . . . . 0.23000000000000001 109.651 178.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 41.4 pt -126.5 158.64 36.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.855 0.36 . . . . 0.23000000000000001 111.119 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 17.2 t -146.78 153.19 12.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.068 -0.514 . . . . 0.23000000000000001 111.258 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 2.6 mmm180 -109.87 116.9 32.48 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.294 -0.632 . . . . 0.23000000000000001 109.294 178.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 . . . . . 0 N--CA 1.456 -0.158 0 CA-C-O 120.678 0.275 . . . . 0.23000000000000001 110.628 -179.994 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.662 0.268 . . . . 0.23000000000000001 110.721 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 305' ' ' THR . . . . . . . . . . . . . 4.7 m -122.7 114.88 21.17 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.21 -0.45 . . . . 17.879999999999999 110.923 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 306' ' ' TRP . . . . . . . . . . . . . 98.9 m95 -78.75 104.79 9.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.23000000000000001 110.797 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 307' ' ' VAL . . . . . . . . . . . . . 17.0 m . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.264 -0.874 . . . . 16.109999999999999 111.135 -179.964 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.2 tm-20 . . . . . 0 C--O 1.233 0.197 0 CA-C-O 120.783 0.325 . . . . 0.23000000000000001 110.941 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.1 pt -149.61 159.59 5.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-O 120.824 0.345 . . . . 0.23000000000000001 111.8 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 10.2 ttm-85 -116.6 153.32 32.46 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.069 -0.514 . . . . 0.23000000000000001 111.264 -178.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.9 m -141.91 144.04 26.02 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 CA-C-N 116.402 -0.363 . . . . 0.23000000000000001 111.356 179.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 2.4 ttt-85 -108.09 115.58 30.39 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.168 -0.469 . . . . 0.23000000000000001 110.5 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.0 t -109.34 121.52 62.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-O 120.896 0.379 . . . . 0.23000000000000001 111.459 -179.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -96.79 114.7 26.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.14 -0.482 . . . . 0.23000000000000001 110.206 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 19.2 mtmt -75.23 119.97 20.09 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.929 0.395 . . . . 0.23000000000000001 111.262 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -163.59 86.87 1.25 Allowed Pre-proline 0 CA--C 1.536 0.425 0 CA-C-N 115.955 -0.566 . . . . 0.23000000000000001 110.712 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -84.59 -13.43 37.69 Favored 'Cis proline' 0 C--N 1.364 1.345 0 CA-C-N 119.548 0.874 . . . . 0.23000000000000001 113.595 0.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -136.78 -175.95 4.2 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.892 0.377 . . . . 0.23000000000000001 111.176 -179.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.402 ' HB3' ' CE2' ' A' ' 25' ' ' PHE . 1.5 mp -63.44 -52.22 62.39 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.524 -0.307 . . . . 0.23000000000000001 110.3 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 102.88 29.99 5.63 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 120.862 -0.685 . . . . 0.23000000000000001 113.586 179.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.402 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 32.1 p90 -162.15 146.53 12.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 117.053 0.426 . . . . 0.23000000000000001 110.919 179.392 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.402 ' HB3' ' CD2' ' B' ' 306' ' ' TRP . 2.5 p -97.15 155.55 16.78 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.219 -0.446 . . . . 0.23000000000000001 111.367 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 29.0 pt -124.21 154.06 30.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 115.874 -0.603 . . . . 0.23000000000000001 110.306 179.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 48.1 t -145.78 171.94 14.04 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.835 0.35 . . . . 0.23000000000000001 111.165 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 92.14 -137.72 13.87 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.931 -0.652 . . . . 0.23000000000000001 112.584 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.45 155.01 29.98 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.962 -0.637 . . . . 0.23000000000000001 112.25 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.8 t -78.69 97.38 2.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.014 0.435 . . . . 0.23000000000000001 110.705 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 98.86 -1.87 58.16 Favored Glycine 0 CA--C 1.531 1.067 0 CA-C-N 115.844 -0.616 . . . . 0.23000000000000001 113.723 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -72.34 -154.62 2.29 Favored Glycine 0 C--N 1.343 0.932 0 CA-C-N 117.856 0.828 . . . . 0.23000000000000001 113.098 -179.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 4.5 mtt85 -72.7 -29.06 63.07 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 111.656 0.243 . . . . 0.23000000000000001 111.656 -179.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 124.32 -163.49 18.08 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 121.026 -0.607 . . . . 0.23000000000000001 112.908 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -170.74 132.69 0.93 Allowed Pre-proline 0 CA--C 1.536 0.428 0 O-C-N 123.026 -0.102 . . . . 0.23000000000000001 110.744 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -91.52 44.15 0.44 Allowed 'Trans proline' 0 C--N 1.358 1.069 0 C-N-CA 122.178 1.918 . . . . 0.23000000000000001 113.073 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -122.84 -57.77 1.7 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.512 -0.313 . . . . 0.23000000000000001 111.226 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 6.1 mmp_? -113.3 145.25 32.84 Favored Pre-proline 0 N--CA 1.467 0.382 0 CA-C-N 116.385 -0.37 . . . . 0.23000000000000001 110.991 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -88.78 -56.45 0.02 OUTLIER 'Trans proline' 0 C--N 1.36 1.181 0 C-N-CA 122.041 1.827 . . . . 0.23000000000000001 113.125 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -86.51 -7.63 58.23 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 112.877 0.695 . . . . 0.23000000000000001 112.877 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -104.0 121.23 42.73 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 117.967 0.349 . . . . 0.23000000000000001 111.02 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.7 p30 -110.8 40.34 2.03 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 121.042 0.448 . . . . 0.23000000000000001 110.834 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -84.37 -157.19 25.95 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.976 -0.631 . . . . 0.23000000000000001 112.732 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 19.6 mm -110.53 122.4 64.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.522 0.201 . . . . 0.23000000000000001 110.563 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -122.07 144.76 48.72 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 120.899 0.381 . . . . 0.23000000000000001 111.392 -179.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 22.7 t -86.37 75.87 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-N 116.134 -0.484 . . . . 0.23000000000000001 111.161 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.7 t -33.87 -52.88 0.44 Allowed 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 114.694 1.368 . . . . 0.23000000000000001 114.694 -178.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 5.8 ptt85 -160.35 179.09 8.95 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.074 0.464 . . . . 0.23000000000000001 111.737 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 15.8 t -134.48 146.92 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 CA-C-N 115.722 -0.672 . . . . 0.23000000000000001 110.782 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.41 ' HG3' ' CH2' ' B' ' 306' ' ' TRP . 40.1 mt-30 -104.87 -68.17 0.04 OUTLIER Pre-proline 0 CA--C 1.536 0.441 0 CA-C-N 116.704 -0.225 . . . . 0.23000000000000001 111.267 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -78.34 112.62 3.23 Favored 'Trans proline' 0 C--N 1.357 1.023 0 C-N-CA 121.654 1.569 . . . . 0.23000000000000001 112.009 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -72.81 70.92 1.01 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.003 0.43 . . . . 0.23000000000000001 111.298 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -162.27 -65.77 0.02 OUTLIER Glycine 0 CA--C 1.527 0.787 0 C-N-CA 120.79 -0.719 . . . . 0.23000000000000001 113.273 -179.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -57.05 -76.11 0.02 OUTLIER 'Trans proline' 0 C--N 1.357 1.017 0 C-N-CA 122.086 1.857 . . . . 0.23000000000000001 113.098 -179.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -116.38 47.37 1.43 Allowed 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 121.265 0.555 . . . . 0.23000000000000001 111.636 -179.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.7 t -99.73 -63.27 1.14 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.048 -0.524 . . . . 0.23000000000000001 109.922 179.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 44.2 mttp -74.51 -3.91 33.66 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 115.88 -0.6 . . . . 0.23000000000000001 112.1 178.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 9.0 mt -99.13 -50.51 4.13 Favored 'General case' 0 C--N 1.343 0.311 0 CA-C-N 118.265 0.484 . . . . 0.23000000000000001 111.373 -179.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 19.0 mt -102.56 150.34 23.51 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-O 120.818 0.342 . . . . 0.23000000000000001 111.492 -179.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -97.56 140.69 22.14 Favored Pre-proline 0 CA--C 1.535 0.388 0 CA-C-N 116.015 -0.538 . . . . 0.23000000000000001 110.873 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -63.79 79.06 0.15 Allowed 'Trans proline' 0 C--N 1.362 1.243 0 C-N-CA 122.068 1.845 . . . . 0.23000000000000001 112.16 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 129.29 41.32 0.26 Allowed Glycine 0 CA--C 1.525 0.68 0 CA-C-N 115.787 -0.642 . . . . 0.23000000000000001 112.606 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -96.24 -158.25 0.64 Allowed 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 110.306 -0.257 . . . . 0.23000000000000001 110.306 179.25 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 59.5 tttp -144.65 127.53 16.37 Favored 'General case' 0 C--O 1.231 0.081 0 CA-C-O 120.679 0.276 . . . . 0.23000000000000001 110.942 179.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.3 mp -88.9 115.73 29.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 109.515 -0.55 . . . . 0.23000000000000001 109.515 179.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 13.4 mm -91.38 -39.13 11.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.879 -0.6 . . . . 0.23000000000000001 111.558 -179.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -149.55 150.22 31.93 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.06 0.457 . . . . 0.23000000000000001 111.365 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -134.59 115.35 13.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.676 -0.693 . . . . 0.23000000000000001 110.246 179.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 63.3 m-20 46.72 29.27 0.93 Allowed 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 113.031 0.752 . . . . 0.23000000000000001 113.031 179.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 100.08 -7.52 58.77 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 120.892 -0.67 . . . . 0.23000000000000001 113.889 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -95.35 129.22 42.57 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 117.94 0.87 . . . . 0.23000000000000001 110.028 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.27 125.27 28.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.816 0.341 . . . . 0.23000000000000001 111.147 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -100.71 22.53 11.8 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.209 -0.45 . . . . 0.23000000000000001 111.461 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 7.0 tp -102.93 141.4 18.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 O-C-N 122.137 -0.352 . . . . 0.23000000000000001 110.95 -178.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 64.71 11.58 6.92 Favored 'General case' 0 CA--C 1.55 0.947 0 N-CA-C 112.772 0.656 . . . . 0.23000000000000001 112.772 -178.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 18.0 pt -94.2 164.91 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 N-CA-C 112.983 0.734 . . . . 0.23000000000000001 112.983 -177.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -85.69 144.99 27.5 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.013 -0.994 . . . . 0.23000000000000001 110.542 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -48.79 -51.12 30.88 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 112.508 0.558 . . . . 0.23000000000000001 112.508 -179.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -55.98 -26.81 49.52 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 120.837 -0.697 . . . . 0.23000000000000001 113.177 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.7 tp-100 -75.98 -40.97 52.71 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.08 0.467 . . . . 0.23000000000000001 110.866 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.63 -34.93 77.97 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.014 -0.539 . . . . 0.23000000000000001 111.539 -179.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 23.5 t -71.99 -42.54 68.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.927 0.394 . . . . 0.23000000000000001 110.584 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.2 t -61.23 -41.16 96.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.132 -0.485 . . . . 0.23000000000000001 111.28 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 25.5 mt -65.82 -45.97 80.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 0.23000000000000001 111.459 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.413 ' HA ' ' CD2' ' A' ' 89' ' ' PHE . 39.5 mt -64.61 -37.02 86.14 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.112 -0.495 . . . . 0.23000000000000001 112.195 -178.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 34.1 mmtt -71.26 -36.68 71.84 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.3 0.481 . . . . 0.23000000000000001 112.3 -178.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 9.8 t -73.59 -29.08 62.18 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.893 0.701 . . . . 0.23000000000000001 112.893 -178.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.413 ' CD2' ' HA ' ' A' ' 86' ' ' LEU . 16.4 m-85 -50.49 147.22 4.68 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 112.723 0.638 . . . . 0.23000000000000001 112.723 -178.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -66.72 -136.6 0.0 OUTLIER 'General case' 0 CA--C 1.556 1.21 0 CA-C-N 115.442 -0.799 . . . . 0.23000000000000001 111.053 -179.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -80.57 -67.88 0.73 Allowed 'General case' 0 C--N 1.352 0.68 0 CA-C-N 119.586 1.085 . . . . 0.23000000000000001 111.883 -178.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -81.55 135.35 35.58 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.689 0.281 . . . . 0.23000000000000001 110.979 -179.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.5 t -128.01 122.64 58.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.175 -0.466 . . . . 0.23000000000000001 111.151 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -89.66 108.33 19.61 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.747 -0.464 . . . . 0.23000000000000001 109.747 178.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 12.5 mt -110.12 144.23 39.04 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.011 0.434 . . . . 0.23000000000000001 111.679 -179.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.6 mm -106.21 120.8 57.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.711 -0.677 . . . . 0.23000000000000001 109.604 178.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 23.5 pt -126.84 164.14 27.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.818 0.342 . . . . 0.23000000000000001 111.313 -179.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 22.1 t -149.72 151.87 12.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.109 -0.496 . . . . 0.23000000000000001 111.245 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -111.97 121.21 44.37 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.66 -0.7 . . . . 0.23000000000000001 109.268 178.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.973 0.416 . . . . 0.23000000000000001 111.534 -179.262 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 . . . . . 0 C--O 1.232 0.146 0 CA-C-O 121.004 0.431 . . . . 0.23000000000000001 111.284 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 305' ' ' THR . . . . . . . . . . . . . 5.8 m -138.95 128.8 24.94 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.91 -0.586 . . . . 17.879999999999999 110.339 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 306' ' ' TRP . . . . . 0.41 ' CH2' ' HG3' ' A' ' 51' ' ' GLN . 88.7 m95 -94.48 114.63 26.67 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.944 0.402 . . . . 0.23000000000000001 111.224 -179.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 307' ' ' VAL . . . . . . . . . . . . . 15.4 m . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.244 -0.884 . . . . 16.109999999999999 111.074 -179.971 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 . . . . . 0 C--O 1.232 0.182 0 N-CA-C 109.715 -0.476 . . . . 0.23000000000000001 109.715 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.401 HD11 HG22 ' A' ' 13' ' ' ILE . 0.2 OUTLIER -110.81 161.49 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 N-CA-C 113.028 0.751 . . . . 0.23000000000000001 113.028 -178.66 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 12.6 mtm180 -112.23 155.72 23.55 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.1 -0.954 . . . . 0.23000000000000001 110.776 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.9 m -143.82 142.77 24.51 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-O 120.79 0.328 . . . . 0.23000000000000001 110.911 179.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 22.1 ttm180 -107.27 115.02 29.43 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.223 -0.444 . . . . 0.23000000000000001 111.248 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.9 t -114.53 117.7 56.38 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.337 -0.392 . . . . 0.23000000000000001 110.972 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -93.29 122.75 36.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.267 -0.424 . . . . 0.23000000000000001 110.635 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 15.3 mtmt -76.68 120.86 22.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.467 . . . . 0.23000000000000001 111.081 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -171.11 88.22 0.47 Allowed Pre-proline 0 CA--C 1.536 0.408 0 CA-C-N 115.972 -0.558 . . . . 0.23000000000000001 110.726 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -82.69 -18.45 24.91 Favored 'Cis proline' 0 C--N 1.362 1.267 0 CA-C-N 119.477 0.849 . . . . 0.23000000000000001 113.277 0.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -135.31 -178.29 5.04 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.868 0.366 . . . . 0.23000000000000001 111.755 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.0 mp -64.14 -57.27 10.05 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.016 -0.538 . . . . 0.23000000000000001 111.03 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 103.35 32.46 4.57 Favored Glycine 0 CA--C 1.522 0.493 0 C-N-CA 120.797 -0.716 . . . . 0.23000000000000001 113.98 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 38.7 p90 -162.36 147.25 12.4 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 117.363 0.582 . . . . 0.23000000000000001 111.191 179.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.3 p -100.65 151.4 21.68 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.156 -0.474 . . . . 0.23000000000000001 111.474 -179.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 28.9 pt -121.71 151.15 25.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.887 -0.597 . . . . 0.23000000000000001 110.911 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 28.7 t -150.33 164.57 35.46 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.548 0.213 . . . . 0.23000000000000001 111.44 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 115.05 -94.84 0.69 Allowed Glycine 0 C--N 1.338 0.658 0 C-N-CA 120.972 -0.632 . . . . 0.23000000000000001 113.797 178.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 72.18 -134.76 21.82 Favored Glycine 0 CA--C 1.524 0.601 0 C-N-CA 121.24 -0.505 . . . . 0.23000000000000001 112.597 -179.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 23.1 t -148.08 84.55 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 CA-C-O 120.953 0.406 . . . . 0.23000000000000001 109.962 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 92.44 9.34 61.75 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 120.823 -0.703 . . . . 0.23000000000000001 113.44 -179.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -84.2 -140.68 4.66 Favored Glycine 0 C--N 1.342 0.868 0 CA-C-N 117.705 0.753 . . . . 0.23000000000000001 112.487 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.22 -28.35 62.81 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 111.745 0.276 . . . . 0.23000000000000001 111.745 -179.492 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.34 158.87 30.98 Favored Glycine 0 C--N 1.333 0.362 0 C-N-CA 120.914 -0.66 . . . . 0.23000000000000001 112.772 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -124.96 133.35 24.73 Favored Pre-proline 0 CA--C 1.535 0.371 0 N-CA-C 110.744 -0.095 . . . . 0.23000000000000001 110.744 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -91.19 26.61 0.45 Allowed 'Trans proline' 0 C--N 1.358 1.03 0 C-N-CA 122.181 1.921 . . . . 0.23000000000000001 113.451 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -106.62 -53.85 2.56 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.791 0.329 . . . . 0.23000000000000001 110.6 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 1.2 mmm180 -118.63 137.4 24.81 Favored Pre-proline 0 CA--C 1.535 0.399 0 CA-C-N 116.21 -0.45 . . . . 0.23000000000000001 110.566 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -86.33 -48.02 0.04 OUTLIER 'Trans proline' 0 C--N 1.357 0.993 0 C-N-CA 121.954 1.77 . . . . 0.23000000000000001 113.356 -179.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -91.63 -10.9 38.72 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 112.811 0.671 . . . . 0.23000000000000001 112.811 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -96.64 113.63 25.2 Favored 'General case' 0 C--O 1.231 0.083 0 CA-C-N 117.998 0.363 . . . . 0.23000000000000001 110.533 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.5 p-10 -100.03 64.62 1.23 Allowed 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 121.123 0.487 . . . . 0.23000000000000001 111.17 -179.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -116.09 -159.02 11.71 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 121.118 -0.563 . . . . 0.23000000000000001 112.462 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.403 HG22 HD11 ' A' ' 45' ' ' ILE . 20.8 mm -111.44 133.21 57.79 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-O 120.444 0.164 . . . . 0.23000000000000001 110.813 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.433 ' N ' ' CD1' ' A' ' 46' ' ' PHE . 4.2 m-85 -129.78 151.02 50.82 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.684 0.278 . . . . 0.23000000000000001 110.722 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 21.7 t -94.28 77.44 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 CA-C-O 121.01 0.434 . . . . 0.23000000000000001 111.278 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.9 t -36.36 -54.39 0.83 Allowed 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 114.615 1.339 . . . . 0.23000000000000001 114.615 -178.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.9 ptt-85 -160.46 163.22 33.15 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.113 0.482 . . . . 0.23000000000000001 112.242 -179.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 16.8 t -118.35 149.69 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-N 115.559 -0.746 . . . . 0.23000000000000001 110.562 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.2 mm-40 -104.97 -68.45 0.04 OUTLIER Pre-proline 0 CA--C 1.538 0.51 0 CA-C-O 119.67 -0.205 . . . . 0.23000000000000001 111.389 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -78.77 121.47 5.06 Favored 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 121.8 1.667 . . . . 0.23000000000000001 112.242 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -77.22 65.96 2.92 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 120.911 0.386 . . . . 0.23000000000000001 111.096 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -156.1 -68.14 0.01 OUTLIER Glycine 0 CA--C 1.528 0.885 0 C-N-CA 120.69 -0.767 . . . . 0.23000000000000001 113.544 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -58.89 -76.82 0.02 OUTLIER 'Trans proline' 0 C--N 1.356 0.966 0 C-N-CA 122.14 1.893 . . . . 0.23000000000000001 113.435 -178.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -110.14 48.74 0.88 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-O 121.218 0.532 . . . . 0.23000000000000001 111.5 -179.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 34.7 t -105.04 -67.45 0.91 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.941 -0.572 . . . . 0.23000000000000001 109.999 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.85 -12.74 60.22 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.891 -0.595 . . . . 0.23000000000000001 111.962 179.176 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 69.1 mt -95.09 -58.91 2.02 Favored 'General case' 0 C--N 1.342 0.276 0 O-C-N 122.137 -0.352 . . . . 0.23000000000000001 111.506 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 22.2 mt -94.18 148.84 21.8 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.501 -0.318 . . . . 0.23000000000000001 111.706 -179.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.7 pm0 -103.53 150.98 38.61 Favored Pre-proline 0 CA--C 1.538 0.488 0 CA-C-N 116.171 -0.468 . . . . 0.23000000000000001 109.958 178.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -68.8 73.79 0.94 Allowed 'Trans proline' 0 C--N 1.357 1.007 0 C-N-CA 122.247 1.965 . . . . 0.23000000000000001 114.108 -178.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 140.74 39.2 0.08 OUTLIER Glycine 0 C--N 1.338 0.662 0 C-N-CA 120.549 -0.834 . . . . 0.23000000000000001 113.943 178.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -94.33 -163.3 1.03 Allowed 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 117.286 0.543 . . . . 0.23000000000000001 111.277 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 27.0 tttm -132.92 121.91 23.54 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 110.275 -0.268 . . . . 0.23000000000000001 110.275 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.7 mm -87.27 109.08 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-N 116.634 -0.257 . . . . 0.23000000000000001 110.802 -178.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 18.1 mm -88.25 -44.45 15.68 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 N-CA-C 112.058 0.392 . . . . 0.23000000000000001 112.058 -179.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -150.87 152.44 33.69 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 112.634 0.605 . . . . 0.23000000000000001 112.634 -178.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -132.52 118.76 19.65 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 115.222 -0.899 . . . . 0.23000000000000001 110.637 179.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 30.3 m-20 46.47 29.77 0.96 Allowed 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 112.905 0.706 . . . . 0.23000000000000001 112.905 179.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 100.16 -3.26 56.79 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 120.936 -0.649 . . . . 0.23000000000000001 113.925 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -91.23 145.72 24.43 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 117.901 0.851 . . . . 0.23000000000000001 110.369 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 80.3 p -88.38 108.42 19.34 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.371 -0.377 . . . . 0.23000000000000001 111.321 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -92.72 8.29 39.91 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 112.376 0.509 . . . . 0.23000000000000001 112.376 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 6.5 tp -86.49 118.25 32.44 Favored 'Isoleucine or valine' 0 C--N 1.341 0.204 0 CA-C-N 118.124 0.42 . . . . 0.23000000000000001 110.673 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 62.81 75.77 0.39 Allowed 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 121.206 0.527 . . . . 0.23000000000000001 111.057 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 8.4 pt -147.71 153.91 11.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.548 -0.751 . . . . 0.23000000000000001 110.543 179.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -66.21 140.46 58.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.415 -0.357 . . . . 0.23000000000000001 110.512 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -50.3 -51.89 41.29 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 112.342 0.497 . . . . 0.23000000000000001 112.342 -179.215 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -54.6 -25.77 36.53 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 120.978 -0.629 . . . . 0.23000000000000001 112.963 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -77.28 -38.87 49.95 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.916 0.389 . . . . 0.23000000000000001 110.453 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -70.05 -39.04 75.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.926 -0.579 . . . . 0.23000000000000001 111.455 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 29.1 t -70.67 -43.35 77.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.898 0.38 . . . . 0.23000000000000001 110.638 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 43.2 m -61.49 -39.18 89.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.14 -0.482 . . . . 0.23000000000000001 111.221 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 14.3 mt -64.6 -46.51 82.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.349 -0.387 . . . . 0.23000000000000001 111.103 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 31.9 mt -64.29 -39.83 94.72 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.171 -0.468 . . . . 0.23000000000000001 112.085 -178.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 19.7 mmtp -65.42 -39.69 92.45 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 112.335 0.494 . . . . 0.23000000000000001 112.335 -178.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 9.8 t -70.74 -26.24 63.28 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 113.52 0.933 . . . . 0.23000000000000001 113.52 -178.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -46.67 170.85 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 113.425 0.898 . . . . 0.23000000000000001 113.425 -178.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 7.1 mp0 -88.56 -142.23 0.13 Allowed 'General case' 0 CA--C 1.55 0.947 0 CA-C-N 115.424 -0.807 . . . . 0.23000000000000001 110.728 -179.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 60.9 m-80 -80.08 -66.91 0.82 Allowed 'General case' 0 C--N 1.348 0.537 0 CA-C-N 119.076 0.853 . . . . 0.23000000000000001 111.08 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.8 124.1 27.87 Favored 'General case' 0 C--N 1.334 -0.095 0 CA-C-N 116.451 -0.341 . . . . 0.23000000000000001 110.412 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 21.9 t -114.16 112.37 39.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.215 -0.448 . . . . 0.23000000000000001 111.143 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -90.41 111.37 22.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.023 -0.535 . . . . 0.23000000000000001 109.889 179.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 15.8 mt -112.02 153.49 26.77 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 121.071 0.462 . . . . 0.23000000000000001 112.166 -178.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 16.5 mt -118.5 130.52 73.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.554 -0.748 . . . . 0.23000000000000001 109.794 178.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 29.3 pt -136.69 169.66 19.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.997 0.427 . . . . 0.23000000000000001 111.925 -179.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.3 t -143.65 154.94 16.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 115.91 -0.586 . . . . 0.23000000000000001 111.412 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 25.3 mmm180 -116.58 114.33 23.97 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.054 -0.521 . . . . 0.23000000000000001 110.147 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.183 -0.462 . . . . 0.23000000000000001 111.344 -179.346 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.699 0.285 . . . . 0.23000000000000001 110.844 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 305' ' ' THR . . . . . . . . . . . . . 10.0 m -116.59 131.64 56.89 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.312 -0.404 . . . . 17.879999999999999 110.845 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 306' ' ' TRP . . . . . . . . . . . . . 80.3 m95 -91.09 115.52 28.08 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.298 -0.41 . . . . 0.23000000000000001 110.847 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 307' ' ' VAL . . . . . . . . . . . . . 14.1 m . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.229 -0.891 . . . . 16.109999999999999 111.084 179.959 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 . . . . . 0 CA--C 1.533 0.307 0 N-CA-C 112.081 0.4 . . . . 0.23000000000000001 112.081 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 29.6 pt -108.78 166.46 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-O 120.931 0.396 . . . . 0.23000000000000001 111.843 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 6.2 mtm-85 -114.2 164.26 14.12 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.041 -0.527 . . . . 0.23000000000000001 111.575 -179.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.3 m -148.01 164.67 5.68 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 115.9 -0.591 . . . . 0.23000000000000001 110.838 179.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 9.2 ttp180 -132.07 119.43 20.98 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 111.765 0.283 . . . . 0.23000000000000001 111.765 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.0 t -116.26 130.69 70.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-N 116.437 -0.347 . . . . 0.23000000000000001 111.15 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -105.3 123.79 48.45 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.389 -0.369 . . . . 0.23000000000000001 110.923 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 11.3 mmtt -70.6 80.01 0.59 Allowed 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 120.805 0.336 . . . . 0.23000000000000001 111.795 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -137.59 85.68 20.29 Favored Pre-proline 0 CA--C 1.537 0.454 0 CA-C-N 116.485 -0.325 . . . . 0.23000000000000001 111.068 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -83.57 -24.58 10.79 Favored 'Cis proline' 0 C--N 1.366 1.461 0 CA-C-N 119.55 0.875 . . . . 0.23000000000000001 113.034 0.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -137.46 -177.33 4.74 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 120.799 0.333 . . . . 0.23000000000000001 111.125 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.404 ' HB3' ' CE2' ' A' ' 25' ' ' PHE . 4.4 mp -61.94 -57.68 10.81 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.252 -0.431 . . . . 0.23000000000000001 110.991 179.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 99.78 34.25 5.0 Favored Glycine 0 CA--C 1.522 0.513 0 C-N-CA 120.722 -0.751 . . . . 0.23000000000000001 113.87 179.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.404 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 36.3 p90 -160.35 153.06 21.12 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 117.418 0.609 . . . . 0.23000000000000001 111.184 179.096 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.7 p -105.43 147.95 27.69 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.281 -0.418 . . . . 0.23000000000000001 111.221 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 32.4 pt -117.62 148.0 20.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.924 -0.58 . . . . 0.23000000000000001 110.875 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 65.2 p -140.22 156.57 46.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.745 0.307 . . . . 0.23000000000000001 111.188 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 109.11 -159.28 14.15 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 121.058 -0.592 . . . . 0.23000000000000001 112.746 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 108.26 152.75 16.58 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 121.059 -0.591 . . . . 0.23000000000000001 112.384 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 20.1 t -79.73 106.77 11.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.808 0.337 . . . . 0.23000000000000001 110.661 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 88.06 -2.1 85.25 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 120.881 -0.675 . . . . 0.23000000000000001 113.782 -179.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -84.44 -155.94 23.58 Favored Glycine 0 C--N 1.341 0.847 0 CA-C-N 117.869 0.835 . . . . 0.23000000000000001 112.717 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.21 -24.86 65.16 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 111.904 0.335 . . . . 0.23000000000000001 111.904 -179.155 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.61 160.0 35.92 Favored Glycine 0 C--N 1.34 0.793 0 C-N-CA 120.681 -0.771 . . . . 0.23000000000000001 112.504 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 13.7 p30 -119.59 126.37 26.99 Favored Pre-proline 0 N--CA 1.465 0.301 0 N-CA-C 110.619 -0.141 . . . . 0.23000000000000001 110.619 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -88.62 51.87 1.77 Allowed 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 121.901 1.734 . . . . 0.23000000000000001 112.254 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -133.92 -51.37 0.84 Allowed 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.146 -0.479 . . . . 0.23000000000000001 111.124 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -110.52 139.04 21.17 Favored Pre-proline 0 N--CA 1.466 0.33 0 CA-C-N 116.314 -0.403 . . . . 0.23000000000000001 110.879 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -85.58 -46.38 0.04 OUTLIER 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 122.038 1.825 . . . . 0.23000000000000001 113.198 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -94.62 -8.77 37.08 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 112.893 0.701 . . . . 0.23000000000000001 112.893 -179.232 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -103.1 116.53 32.68 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 118.157 0.435 . . . . 0.23000000000000001 110.579 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.7 p30 -104.25 35.3 2.74 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.294 -0.412 . . . . 0.23000000000000001 111.2 -179.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -84.23 -156.77 24.79 Favored Glycine 0 CA--C 1.519 0.316 0 C-N-CA 120.918 -0.658 . . . . 0.23000000000000001 112.29 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 14.4 mm -111.88 142.57 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-O 120.676 0.274 . . . . 0.23000000000000001 110.692 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -140.15 154.1 46.87 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.495 -0.32 . . . . 0.23000000000000001 111.162 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 17.8 t -97.99 75.75 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-O 120.968 0.413 . . . . 0.23000000000000001 111.191 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.0 t -35.66 -51.68 0.66 Allowed 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 114.597 1.332 . . . . 0.23000000000000001 114.597 -178.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 14.5 ptt180 -160.36 175.4 12.85 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.162 0.506 . . . . 0.23000000000000001 112.137 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 20.5 t -131.28 151.21 35.33 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 CA-C-N 115.591 -0.731 . . . . 0.23000000000000001 110.673 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.403 ' HG2' ' CH2' ' B' ' 306' ' ' TRP . 7.5 mm-40 -104.38 -67.82 0.04 OUTLIER Pre-proline 0 CA--C 1.537 0.471 0 CA-C-N 116.634 -0.257 . . . . 0.23000000000000001 111.676 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -77.4 122.46 6.08 Favored 'Trans proline' 0 C--N 1.357 0.977 0 C-N-CA 121.675 1.584 . . . . 0.23000000000000001 112.233 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -80.16 64.21 4.91 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.208 -0.451 . . . . 0.23000000000000001 111.091 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -158.43 -70.56 0.01 OUTLIER Glycine 0 CA--C 1.528 0.886 0 C-N-CA 120.703 -0.76 . . . . 0.23000000000000001 113.564 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.57 -74.45 0.02 OUTLIER 'Trans proline' 0 C--N 1.358 1.06 0 C-N-CA 122.032 1.821 . . . . 0.23000000000000001 113.355 -178.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -106.9 46.76 0.91 Allowed 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 121.083 0.468 . . . . 0.23000000000000001 111.643 -179.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 91.8 p -108.54 -60.39 1.74 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.075 -0.511 . . . . 0.23000000000000001 110.109 179.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 5.7 ttpm? -69.42 -15.52 63.3 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.744 -0.662 . . . . 0.23000000000000001 112.068 179.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 64.2 mt -93.23 -63.35 1.22 Allowed 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.869 0.366 . . . . 0.23000000000000001 111.158 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.9 mt -91.87 144.03 25.9 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.112 -0.495 . . . . 0.23000000000000001 111.44 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 5.1 pp0? -117.35 155.79 49.64 Favored Pre-proline 0 CA--C 1.534 0.355 0 CA-C-N 116.111 -0.495 . . . . 0.23000000000000001 110.449 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -59.19 119.28 6.42 Favored 'Trans proline' 0 C--N 1.357 1.01 0 C-N-CA 121.829 1.686 . . . . 0.23000000000000001 112.49 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 98.68 5.37 56.73 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 121.05 -0.595 . . . . 0.23000000000000001 113.827 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -71.13 140.35 50.56 Favored 'General case' 0 C--N 1.343 0.32 0 CA-C-N 118.102 0.951 . . . . 0.23000000000000001 110.791 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 67.0 tttt -92.61 123.45 35.91 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.039 -0.528 . . . . 0.23000000000000001 110.926 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 20.0 mt -89.15 115.23 28.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.218 -0.447 . . . . 0.23000000000000001 109.841 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 19.9 mm -89.53 -42.16 14.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 112.249 0.462 . . . . 0.23000000000000001 112.249 -178.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 22.4 tt0 -152.53 156.97 40.4 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.933 0.397 . . . . 0.23000000000000001 111.884 -179.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -144.67 125.89 14.69 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.846 -0.616 . . . . 0.23000000000000001 111.194 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 45.72 34.45 1.8 Allowed 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.244 0.831 . . . . 0.23000000000000001 113.244 178.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 95.01 -18.03 58.16 Favored Glycine 0 CA--C 1.523 0.593 0 C-N-CA 120.772 -0.728 . . . . 0.23000000000000001 113.534 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -89.23 126.98 35.72 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 117.353 0.576 . . . . 0.23000000000000001 110.884 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 8.4 t -72.64 124.52 25.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.095 -0.502 . . . . 0.23000000000000001 110.937 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -102.75 12.95 35.57 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 112.421 0.526 . . . . 0.23000000000000001 112.421 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 6.4 tp -91.0 121.74 41.68 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 CA-C-O 120.944 0.402 . . . . 0.23000000000000001 110.703 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 5.4 m120 64.24 74.17 0.41 Allowed 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 121.094 0.474 . . . . 0.23000000000000001 110.721 -179.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 13.9 pt -149.77 164.27 3.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.981 -0.554 . . . . 0.23000000000000001 110.794 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -73.79 144.83 45.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.385 -0.37 . . . . 0.23000000000000001 110.663 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 6.9 t60 -54.3 -54.35 41.43 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.084 -0.507 . . . . 0.23000000000000001 111.804 -179.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -54.78 -27.46 43.65 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 121.163 -0.541 . . . . 0.23000000000000001 112.911 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -71.21 -39.29 71.83 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.093 0.473 . . . . 0.23000000000000001 110.451 179.274 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.19 -52.14 44.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.767 -0.652 . . . . 0.23000000000000001 111.492 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 20.8 t -59.68 -43.89 92.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.364 -0.38 . . . . 0.23000000000000001 111.604 -179.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 57.8 m -59.99 -40.9 90.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.381 -0.372 . . . . 0.23000000000000001 111.534 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 31.2 mt -66.4 -43.93 84.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.414 -0.357 . . . . 0.23000000000000001 111.53 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.4 ' HA ' ' CD2' ' A' ' 89' ' ' PHE . 32.6 mt -66.51 -42.6 87.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.265 -0.425 . . . . 0.23000000000000001 111.796 -179.249 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 42.0 mmtt -65.02 -43.07 93.68 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.432 0.53 . . . . 0.23000000000000001 112.432 -178.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 12.1 t -69.43 -25.89 64.34 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 112.777 0.658 . . . . 0.23000000000000001 112.777 -178.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.4 ' CD2' ' HA ' ' A' ' 86' ' ' LEU . 14.7 m-30 -45.56 170.99 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 113.447 0.906 . . . . 0.23000000000000001 113.447 -179.053 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -84.56 -143.01 0.08 Allowed 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 115.221 -0.9 . . . . 0.23000000000000001 110.973 -179.224 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 35.9 m120 -83.07 -62.21 1.66 Allowed 'General case' 0 C--N 1.348 0.506 0 CA-C-N 118.992 0.814 . . . . 0.23000000000000001 111.779 -178.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -87.5 129.57 35.02 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.587 -0.279 . . . . 0.23000000000000001 110.505 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 19.1 t -125.41 121.02 59.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-N 116.45 -0.341 . . . . 0.23000000000000001 111.139 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -95.37 105.67 17.65 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.333 -0.394 . . . . 0.23000000000000001 110.469 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 12.1 mt -99.11 152.55 19.74 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 121.076 0.465 . . . . 0.23000000000000001 111.673 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 61.1 mt -110.37 126.21 67.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.575 -0.739 . . . . 0.23000000000000001 109.654 178.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 43.6 pt -127.95 168.62 20.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.821 0.343 . . . . 0.23000000000000001 111.622 -178.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.4 t -145.88 151.34 14.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.065 -0.516 . . . . 0.23000000000000001 111.236 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -114.72 109.68 18.57 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.315 -0.402 . . . . 0.23000000000000001 109.95 179.292 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.322 -0.399 . . . . 0.23000000000000001 111.891 -179.107 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.535 0.369 0 N-CA-C 113.284 0.846 . . . . 0.23000000000000001 113.284 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 305' ' ' THR . . . . . . . . . . . . . 21.0 m -154.67 100.31 2.23 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 114.942 -1.026 . . . . 17.879999999999999 109.698 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 306' ' ' TRP . . . . . 0.403 ' CH2' ' HG2' ' A' ' 51' ' ' GLN . 83.4 m95 -60.6 123.0 16.11 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.995 0.426 . . . . 0.23000000000000001 111.684 -179.045 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 307' ' ' VAL . . . . . . . . . . . . . 16.0 m . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.273 -0.87 . . . . 16.109999999999999 111.174 179.944 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.535 0.369 0 CA-C-O 120.637 0.256 . . . . 0.23000000000000001 110.885 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.41 HG22 HD11 ' A' ' 13' ' ' ILE . 0.2 OUTLIER -150.4 163.56 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-O 120.61 0.243 . . . . 0.23000000000000001 111.571 179.89 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 57.9 mtt180 -116.78 164.72 14.23 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.36 -0.382 . . . . 0.23000000000000001 111.879 -179.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.0 m -146.08 161.15 11.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 116.068 -0.515 . . . . 0.23000000000000001 111.027 179.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.39 120.83 23.62 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.556 -0.293 . . . . 0.23000000000000001 111.659 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.7 t -125.71 135.55 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.41 -0.359 . . . . 0.23000000000000001 110.793 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -107.44 127.86 53.97 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.742 0.306 . . . . 0.23000000000000001 111.418 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.46 112.45 6.75 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.317 -0.401 . . . . 0.23000000000000001 111.13 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -173.75 83.45 0.38 Allowed Pre-proline 0 CA--C 1.54 0.566 0 CA-C-N 116.488 -0.323 . . . . 0.23000000000000001 111.31 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -83.84 -23.3 12.93 Favored 'Cis proline' 0 C--N 1.366 1.463 0 CA-C-N 119.359 0.807 . . . . 0.23000000000000001 112.888 0.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -137.41 -177.97 5.01 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.745 0.307 . . . . 0.23000000000000001 110.955 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.2 mp -65.66 -54.35 28.8 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.337 -0.392 . . . . 0.23000000000000001 110.963 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 109.83 32.93 2.74 Favored Glycine 0 C--N 1.334 0.426 0 C-N-CA 120.837 -0.697 . . . . 0.23000000000000001 113.543 179.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -167.21 179.38 5.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 117.008 0.404 . . . . 0.23000000000000001 111.069 179.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.0 p -131.39 162.4 30.24 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.376 -0.374 . . . . 0.23000000000000001 111.205 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 37.4 pt -127.38 154.89 38.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.059 -0.519 . . . . 0.23000000000000001 110.879 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 39.1 t -145.14 166.51 25.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.46 -0.336 . . . . 0.23000000000000001 111.014 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 101.01 -147.52 17.85 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.816 -0.707 . . . . 0.23000000000000001 112.635 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 105.47 152.97 21.2 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.932 -0.652 . . . . 0.23000000000000001 112.446 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 32.2 t -79.81 108.1 12.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.913 0.387 . . . . 0.23000000000000001 110.587 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 90.28 -1.06 79.16 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 120.946 -0.645 . . . . 0.23000000000000001 113.844 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -83.82 -149.45 9.54 Favored Glycine 0 C--N 1.342 0.903 0 CA-C-N 117.866 0.833 . . . . 0.23000000000000001 112.887 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 52.0 mtt85 -81.34 -18.32 46.12 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 112.591 0.589 . . . . 0.23000000000000001 112.591 -179.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.06 -177.89 49.41 Favored Glycine 0 C--N 1.338 0.652 0 C-N-CA 120.706 -0.759 . . . . 0.23000000000000001 112.757 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -136.82 157.78 74.23 Favored Pre-proline 0 CA--C 1.533 0.301 0 O-C-N 123.041 -0.093 . . . . 0.23000000000000001 110.78 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -87.87 17.71 1.65 Allowed 'Trans proline' 0 C--N 1.358 1.068 0 C-N-CA 122.147 1.898 . . . . 0.23000000000000001 113.781 -179.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -101.77 -41.07 6.66 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.87 0.367 . . . . 0.23000000000000001 110.626 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 11.2 mmp_? -129.99 132.06 23.88 Favored Pre-proline 0 CA--C 1.533 0.322 0 CA-C-N 116.1 -0.5 . . . . 0.23000000000000001 110.332 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -83.05 -40.39 0.11 Allowed 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 121.887 1.725 . . . . 0.23000000000000001 113.089 -179.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -99.92 -4.23 30.65 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 113.107 0.78 . . . . 0.23000000000000001 113.107 -179.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -90.63 122.67 33.62 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 118.2 0.455 . . . . 0.23000000000000001 110.912 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -102.18 40.82 1.29 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.224 -0.444 . . . . 0.23000000000000001 111.132 -179.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -98.9 -170.77 31.22 Favored Glycine 0 C--N 1.333 0.387 0 C-N-CA 120.958 -0.639 . . . . 0.23000000000000001 112.507 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 22.0 mm -110.26 127.69 67.03 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-N 116.569 0.184 . . . . 0.23000000000000001 110.51 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.44 ' CD1' ' N ' ' A' ' 46' ' ' PHE . 4.0 m-85 -128.29 146.77 50.65 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.762 0.315 . . . . 0.23000000000000001 111.529 -179.454 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 21.4 t -86.7 79.57 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-O 120.98 0.419 . . . . 0.23000000000000001 111.077 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.5 t -36.24 -55.22 0.8 Allowed 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 114.849 1.426 . . . . 0.23000000000000001 114.849 -178.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -160.07 -179.55 7.87 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.218 0.532 . . . . 0.23000000000000001 112.392 -179.049 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 13.7 t -138.48 145.55 28.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-N 115.577 -0.738 . . . . 0.23000000000000001 110.498 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.405 ' HG3' ' CH2' ' B' ' 306' ' ' TRP . 15.3 mt-30 -104.55 -68.71 0.04 OUTLIER Pre-proline 0 CA--C 1.537 0.459 0 N-CA-C 111.59 0.218 . . . . 0.23000000000000001 111.59 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -81.16 113.84 2.75 Favored 'Trans proline' 0 C--N 1.357 1.005 0 C-N-CA 121.661 1.574 . . . . 0.23000000000000001 112.304 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -77.78 70.36 4.14 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.138 0.494 . . . . 0.23000000000000001 110.936 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -145.37 -71.45 0.02 OUTLIER Glycine 0 CA--C 1.526 0.762 0 CA-C-N 115.719 -0.673 . . . . 0.23000000000000001 112.643 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -58.59 -71.93 0.03 OUTLIER 'Trans proline' 0 C--N 1.357 0.998 0 C-N-CA 122.021 1.814 . . . . 0.23000000000000001 112.796 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -105.87 47.34 0.88 Allowed 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 121.217 0.532 . . . . 0.23000000000000001 111.263 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 98.1 p -83.2 -59.73 2.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.956 -0.565 . . . . 0.23000000000000001 109.965 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 37.2 tptt -88.21 4.42 45.79 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 115.697 -0.683 . . . . 0.23000000000000001 112.016 178.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -92.6 -64.87 1.05 Allowed 'General case' 0 C--N 1.343 0.302 0 CA-C-N 118.16 0.436 . . . . 0.23000000000000001 111.727 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.1 mt -100.9 145.4 28.67 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.159 0.504 . . . . 0.23000000000000001 112.223 -178.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -107.28 142.51 25.25 Favored Pre-proline 0 CA--C 1.534 0.358 0 CA-C-N 115.726 -0.67 . . . . 0.23000000000000001 109.996 179.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.02 131.29 45.52 Favored 'Trans proline' 0 C--N 1.357 1.0 0 C-N-CA 121.899 1.733 . . . . 0.23000000000000001 113.159 -179.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 81.72 32.25 30.65 Favored Glycine 0 C--N 1.33 0.235 0 CA-C-N 115.979 -0.555 . . . . 0.23000000000000001 113.55 179.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -88.28 -169.51 2.59 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 117.027 0.414 . . . . 0.23000000000000001 110.898 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 78.1 tttt -138.44 125.64 21.54 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.381 -0.372 . . . . 0.23000000000000001 110.975 -179.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 34.3 mt -94.36 122.53 45.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.294 -0.412 . . . . 0.23000000000000001 110.501 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 26.0 mm -104.5 -36.82 4.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 N-CA-C 111.982 0.364 . . . . 0.23000000000000001 111.982 -179.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -148.87 149.46 31.31 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.974 0.416 . . . . 0.23000000000000001 111.827 -179.185 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -145.77 122.46 11.17 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 115.812 -0.631 . . . . 0.23000000000000001 111.334 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.3 m120 45.94 38.3 4.44 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 113.086 0.773 . . . . 0.23000000000000001 113.086 179.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 84.42 11.21 78.38 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 121.007 -0.616 . . . . 0.23000000000000001 113.87 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -113.44 121.8 45.38 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 117.69 0.745 . . . . 0.23000000000000001 110.238 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 79.9 p -72.74 135.78 45.39 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.41 -0.359 . . . . 0.23000000000000001 110.661 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -104.59 23.51 13.21 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 112.029 0.381 . . . . 0.23000000000000001 112.029 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 11.4 mm -97.41 139.77 19.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-O 121.032 0.444 . . . . 0.23000000000000001 109.921 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 7.9 m120 61.47 16.69 7.77 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 112.696 0.628 . . . . 0.23000000000000001 112.696 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 25.9 pt -95.29 163.8 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 112.732 0.642 . . . . 0.23000000000000001 112.732 -179.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -91.67 149.69 21.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.141 -0.936 . . . . 0.23000000000000001 111.173 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 15.3 t60 -46.41 -51.89 14.1 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 112.803 0.668 . . . . 0.23000000000000001 112.803 -179.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -56.13 -26.91 50.73 Favored Glycine 0 CA--C 1.523 0.573 0 C-N-CA 120.985 -0.626 . . . . 0.23000000000000001 113.176 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -74.56 -42.97 57.84 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 120.954 0.407 . . . . 0.23000000000000001 110.476 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.25 -42.49 99.18 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.149 -0.478 . . . . 0.23000000000000001 111.374 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 18.0 t -73.71 -40.99 54.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.211 -0.449 . . . . 0.23000000000000001 110.753 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 43.7 t -62.19 -46.76 87.47 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.035 -0.529 . . . . 0.23000000000000001 111.353 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 31.5 mt -61.16 -49.83 75.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.381 -0.372 . . . . 0.23000000000000001 111.72 -179.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 17.3 mt -64.1 -37.68 88.31 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.988 0.366 . . . . 0.23000000000000001 111.988 -178.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 9.2 mmtp -71.04 -39.82 72.06 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.634 0.605 . . . . 0.23000000000000001 112.634 -178.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 11.4 t -71.87 -27.31 62.78 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 113.261 0.837 . . . . 0.23000000000000001 113.261 -178.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -46.74 170.9 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 113.29 0.848 . . . . 0.23000000000000001 113.29 -178.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -83.85 -142.85 0.07 Allowed 'General case' 0 CA--C 1.55 0.968 0 CA-C-N 115.423 -0.808 . . . . 0.23000000000000001 110.834 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -79.48 -70.3 0.52 Allowed 'General case' 0 C--N 1.348 0.523 0 CA-C-N 119.22 0.918 . . . . 0.23000000000000001 111.501 -179.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -75.24 123.45 25.32 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.366 -0.379 . . . . 0.23000000000000001 110.634 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 14.2 t -121.04 120.82 63.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.162 -0.472 . . . . 0.23000000000000001 110.723 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -99.91 107.17 19.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.381 -0.372 . . . . 0.23000000000000001 110.54 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 6.2 mp -107.13 161.76 14.48 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 121.054 0.455 . . . . 0.23000000000000001 111.788 -179.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.5 mt -123.64 132.23 71.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.544 -0.753 . . . . 0.23000000000000001 109.402 178.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 43.9 pt -126.38 175.64 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-O 120.689 0.281 . . . . 0.23000000000000001 111.625 -178.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 17.2 t -150.22 143.96 17.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-O 120.934 0.397 . . . . 0.23000000000000001 112.034 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.01 116.91 30.68 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 109.133 -0.691 . . . . 0.23000000000000001 109.133 178.367 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 . . . . . 0 C--N 1.332 -0.17 0 CA-C-O 121.047 0.451 . . . . 0.23000000000000001 111.811 -178.787 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 . . . . . 0 N--CA 1.461 0.116 0 CA-C-O 120.911 0.386 . . . . 0.23000000000000001 111.082 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 305' ' ' THR . . . . . . . . . . . . . 15.2 m -142.24 132.28 24.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.948 -0.569 . . . . 17.879999999999999 110.368 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 306' ' ' TRP . . . . . 0.405 ' CH2' ' HG3' ' A' ' 51' ' ' GLN . 81.0 m95 -88.39 121.73 31.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.308 -0.406 . . . . 0.23000000000000001 111.335 -179.373 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 307' ' ' VAL . . . . . . . . . . . . . 23.8 m . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.314 -0.851 . . . . 16.109999999999999 111.167 -179.996 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 . . . . . 0 N--CA 1.463 0.211 0 N-CA-C 109.857 -0.423 . . . . 0.23000000000000001 109.857 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.6 pt -148.21 159.14 7.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 112.346 0.499 . . . . 0.23000000000000001 112.346 -178.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 13.3 ttp-105 -119.52 157.01 29.21 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 116.083 -0.508 . . . . 0.23000000000000001 111.639 -179.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 17.6 m -150.93 152.67 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 112.009 0.374 . . . . 0.23000000000000001 112.009 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 2.0 ptp180 -114.92 129.02 56.62 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 116.327 -0.397 . . . . 0.23000000000000001 111.025 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.2 t -113.54 119.57 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 116.264 -0.426 . . . . 0.23000000000000001 110.789 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -93.54 121.48 35.0 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.476 -0.329 . . . . 0.23000000000000001 111.648 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.91 116.07 10.79 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.366 -0.379 . . . . 0.23000000000000001 110.752 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -175.85 81.39 0.29 Allowed Pre-proline 0 CA--C 1.538 0.509 0 CA-C-N 116.513 -0.312 . . . . 0.23000000000000001 110.753 179.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -84.85 -22.97 12.86 Favored 'Cis proline' 0 C--N 1.363 1.294 0 CA-C-N 119.327 0.795 . . . . 0.23000000000000001 113.333 0.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -137.93 -179.18 5.61 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.946 0.403 . . . . 0.23000000000000001 112.06 -179.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.404 HD21 ' CZ ' ' A' ' 25' ' ' PHE . 3.4 mp -61.82 -61.17 2.69 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.877 -0.601 . . . . 0.23000000000000001 111.293 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 109.25 20.55 7.81 Favored Glycine 0 CA--C 1.523 0.568 0 C-N-CA 120.788 -0.72 . . . . 0.23000000000000001 113.796 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.404 ' CZ ' HD21 ' A' ' 23' ' ' LEU . 40.7 p90 -151.0 155.67 39.53 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 117.52 0.66 . . . . 0.23000000000000001 111.393 179.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -110.11 151.94 26.62 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.223 -0.444 . . . . 0.23000000000000001 111.537 -179.187 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 12.1 pt -121.07 151.67 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-N 115.921 -0.582 . . . . 0.23000000000000001 111.465 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.3 m -150.29 163.12 39.1 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.505 -0.316 . . . . 0.23000000000000001 111.345 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 120.75 -89.57 0.45 Allowed Glycine 0 C--N 1.337 0.618 0 C-N-CA 121.034 -0.603 . . . . 0.23000000000000001 113.379 179.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 66.91 -138.45 35.08 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.938 -0.649 . . . . 0.23000000000000001 112.427 -179.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 47.0 t -131.42 57.95 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-O 121.145 0.497 . . . . 0.23000000000000001 111.38 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 92.15 -7.5 78.43 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 115.09 0.796 . . . . 0.23000000000000001 115.09 178.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -97.68 26.88 21.34 Favored Glycine 0 C--N 1.339 0.75 0 CA-C-N 118.092 0.946 . . . . 0.23000000000000001 113.642 -179.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -173.12 -42.22 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 109.603 -0.517 . . . . 0.23000000000000001 109.603 178.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.86 146.66 0.74 Allowed Glycine 0 CA--C 1.521 0.419 0 CA-C-N 115.877 -0.602 . . . . 0.23000000000000001 112.966 179.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -123.94 137.58 29.12 Favored Pre-proline 0 CA--C 1.534 0.332 0 N-CA-C 110.541 -0.17 . . . . 0.23000000000000001 110.541 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -91.47 24.44 0.55 Allowed 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 122.289 1.992 . . . . 0.23000000000000001 113.593 -179.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -107.94 -52.84 2.71 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.759 0.314 . . . . 0.23000000000000001 110.813 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -119.58 133.37 23.82 Favored Pre-proline 0 N--CA 1.466 0.372 0 CA-C-N 116.292 -0.413 . . . . 0.23000000000000001 110.359 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -84.61 -46.59 0.05 OUTLIER 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 121.869 1.713 . . . . 0.23000000000000001 113.086 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 13.1 p-10 -88.06 -9.48 53.21 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 112.78 0.659 . . . . 0.23000000000000001 112.78 -179.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -100.89 118.05 36.16 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 118.056 0.389 . . . . 0.23000000000000001 110.725 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.8 p30 -106.79 66.7 0.69 Allowed 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 121.15 0.5 . . . . 0.23000000000000001 110.912 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -114.98 -143.79 8.21 Favored Glycine 0 CA--C 1.519 0.308 0 CA-C-N 115.924 -0.58 . . . . 0.23000000000000001 112.366 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.425 HD11 HG22 ' A' ' 45' ' ' ILE . 21.5 mm -125.68 128.14 72.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.607 0.241 . . . . 0.23000000000000001 110.735 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -121.6 147.46 45.81 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.542 -0.299 . . . . 0.23000000000000001 111.075 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 21.7 t -92.07 71.89 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 116.104 -0.498 . . . . 0.23000000000000001 111.04 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.1 t -35.78 -54.13 0.73 Allowed 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 115.063 1.505 . . . . 0.23000000000000001 115.063 -178.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.03 168.49 25.47 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.945 0.721 . . . . 0.23000000000000001 112.945 -178.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 17.3 t -124.89 150.98 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-N 115.247 -0.888 . . . . 0.23000000000000001 110.401 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.5 mm-40 -105.54 -68.99 0.03 OUTLIER Pre-proline 0 CA--C 1.539 0.547 0 N-CA-C 112.347 0.499 . . . . 0.23000000000000001 112.347 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -80.93 121.68 4.11 Favored 'Trans proline' 0 C--N 1.359 1.091 0 C-N-CA 121.861 1.707 . . . . 0.23000000000000001 112.818 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -74.84 67.66 1.66 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 120.968 0.413 . . . . 0.23000000000000001 111.328 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -156.81 -67.33 0.01 OUTLIER Glycine 0 CA--C 1.528 0.904 0 C-N-CA 120.803 -0.713 . . . . 0.23000000000000001 113.476 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -58.63 -78.06 0.02 OUTLIER 'Trans proline' 0 C--N 1.357 0.983 0 C-N-CA 122.081 1.854 . . . . 0.23000000000000001 113.499 -179.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -117.06 53.96 0.89 Allowed 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 121.255 0.55 . . . . 0.23000000000000001 111.929 -179.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 77.8 p -108.14 -65.12 1.15 Allowed 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.36 -0.608 . . . . 0.23000000000000001 109.36 178.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.14 -14.43 61.8 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.705 -0.68 . . . . 0.23000000000000001 111.18 178.182 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 65.0 mt -92.66 -57.42 2.67 Favored 'General case' 0 C--N 1.344 0.329 0 O-C-N 122.137 -0.352 . . . . 0.23000000000000001 110.901 179.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 27.9 mt -96.24 146.92 24.29 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.223 -0.444 . . . . 0.23000000000000001 111.291 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -124.75 145.7 50.53 Favored Pre-proline 0 N--CA 1.47 0.567 0 CA-C-N 115.981 -0.554 . . . . 0.23000000000000001 110.97 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_exo -58.32 127.18 23.8 Favored 'Trans proline' 0 C--N 1.362 1.263 0 C-N-CA 122.35 2.034 . . . . 0.23000000000000001 113.689 -178.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 106.65 8.35 32.64 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 120.906 -0.664 . . . . 0.23000000000000001 114.435 178.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -93.71 146.89 23.52 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 117.821 0.81 . . . . 0.23000000000000001 111.575 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 51.5 tttt -98.71 133.08 43.54 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.918 -0.583 . . . . 0.23000000000000001 110.699 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 29.3 mt -89.29 119.74 36.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.394 -0.367 . . . . 0.23000000000000001 110.467 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 20.5 mm -89.83 -38.68 11.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 N-CA-C 112.203 0.446 . . . . 0.23000000000000001 112.203 -178.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -155.36 154.66 32.35 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 121.059 0.457 . . . . 0.23000000000000001 112.033 -179.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -141.93 123.87 15.31 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.805 -0.634 . . . . 0.23000000000000001 110.966 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 42.91 41.69 2.71 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 113.409 0.892 . . . . 0.23000000000000001 113.409 179.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 84.97 -0.48 89.09 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 120.9 -0.666 . . . . 0.23000000000000001 114.152 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -108.4 124.47 50.44 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 117.953 0.877 . . . . 0.23000000000000001 110.914 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 30.6 t -70.9 131.62 44.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.368 -0.378 . . . . 0.23000000000000001 110.694 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -101.7 19.8 17.44 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 112.124 0.416 . . . . 0.23000000000000001 112.124 -179.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 28.7 mm -92.46 121.09 42.77 Favored 'Isoleucine or valine' 0 C--N 1.339 0.12 0 CA-C-O 120.766 0.317 . . . . 0.23000000000000001 110.664 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 57.1 m-20 61.87 74.88 0.43 Allowed 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.209 0.528 . . . . 0.23000000000000001 110.743 -179.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 10.3 pt -146.57 150.27 15.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.876 -0.602 . . . . 0.23000000000000001 110.914 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -68.92 136.54 52.74 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.067 -0.515 . . . . 0.23000000000000001 110.998 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 36.7 t60 -43.47 -45.92 6.6 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 113.16 0.8 . . . . 0.23000000000000001 113.16 -179.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -59.39 -28.69 65.04 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.86 -0.686 . . . . 0.23000000000000001 112.457 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 3.7 tp-100 -72.65 -44.47 61.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.918 0.39 . . . . 0.23000000000000001 110.639 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.87 -37.95 85.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.047 -0.524 . . . . 0.23000000000000001 111.257 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 24.2 t -75.06 -42.48 45.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.946 0.403 . . . . 0.23000000000000001 110.755 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 42.2 t -62.81 -41.65 99.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.11 -0.496 . . . . 0.23000000000000001 111.142 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 27.4 mt -65.27 -46.75 79.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.23000000000000001 111.455 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.412 ' HA ' ' CD2' ' A' ' 89' ' ' PHE . 27.2 mt -65.94 -30.87 71.52 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.147 -0.479 . . . . 0.23000000000000001 112.169 -178.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 30.0 mmtt -77.13 -35.44 56.17 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.039 0.385 . . . . 0.23000000000000001 112.039 -179.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 9.7 t -75.52 -26.68 58.28 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 112.881 0.697 . . . . 0.23000000000000001 112.881 -178.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.412 ' CD2' ' HA ' ' A' ' 86' ' ' LEU . 21.0 m-85 -52.56 149.36 5.97 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.145 0.498 . . . . 0.23000000000000001 112.134 -179.196 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -65.18 -136.65 0.0 OUTLIER 'General case' 0 CA--C 1.555 1.161 0 CA-C-N 115.808 -0.633 . . . . 0.23000000000000001 111.557 -179.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -80.3 -70.36 0.53 Allowed 'General case' 0 C--N 1.351 0.665 0 CA-C-N 119.588 1.086 . . . . 0.23000000000000001 112.613 -179.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.8 p -78.34 127.53 32.35 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.792 0.329 . . . . 0.23000000000000001 111.3 -179.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 21.8 t -117.2 114.08 44.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.967 -0.561 . . . . 0.23000000000000001 110.719 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -89.67 111.86 22.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.255 -0.43 . . . . 0.23000000000000001 110.515 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 4.0 mp -112.96 151.52 30.47 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.982 0.42 . . . . 0.23000000000000001 111.781 -179.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 17.6 mm -107.6 121.93 61.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.638 -0.71 . . . . 0.23000000000000001 109.9 178.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 22.4 pt -129.05 163.1 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-O 120.809 0.338 . . . . 0.23000000000000001 111.881 -179.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 14.3 t -150.76 155.72 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-N 116.223 -0.444 . . . . 0.23000000000000001 111.727 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 32.9 mmm-85 -110.5 122.43 47.73 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.094 -0.503 . . . . 0.23000000000000001 109.767 177.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 . . . . . 0 C--N 1.328 -0.331 0 CA-C-O 120.852 0.358 . . . . 0.23000000000000001 111.156 -179.598 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.763 0.316 . . . . 0.23000000000000001 110.988 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 305' ' ' THR . . . . . . . . . . . . . 80.7 m -123.93 122.5 38.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.039 -0.528 . . . . 17.879999999999999 110.669 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 306' ' ' TRP . . . . . . . . . . . . . 86.1 m95 -78.16 107.84 11.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.294 -0.412 . . . . 0.23000000000000001 110.891 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 307' ' ' VAL . . . . . . . . . . . . . 17.5 m . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.257 -0.878 . . . . 16.109999999999999 111.153 -179.98 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.466 0.331 0 CA-C-O 120.58 0.229 . . . . 0.23000000000000001 111.265 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.9 pt -107.94 162.49 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-N 116.204 -0.453 . . . . 0.23000000000000001 112.164 -179.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 14.5 ttm105 -116.98 152.86 33.7 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.806 -0.634 . . . . 0.23000000000000001 111.987 -179.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.1 m -143.2 144.12 24.1 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 CA-C-N 116.083 -0.508 . . . . 0.23000000000000001 110.668 179.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 11.6 ttp-105 -116.73 130.58 56.81 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.804 0.335 . . . . 0.23000000000000001 111.293 -179.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.0 t -123.49 125.57 71.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.085 -0.507 . . . . 0.23000000000000001 111.07 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -92.21 119.77 32.15 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.892 0.377 . . . . 0.23000000000000001 111.086 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -71.18 119.75 15.77 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.293 -0.412 . . . . 0.23000000000000001 111.091 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -174.65 82.72 0.34 Allowed Pre-proline 0 CA--C 1.539 0.556 0 CA-C-N 116.3 -0.409 . . . . 0.23000000000000001 111.077 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo -86.84 -18.93 19.75 Favored 'Cis proline' 0 C--N 1.365 1.409 0 CA-C-N 119.407 0.824 . . . . 0.23000000000000001 113.228 0.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -133.44 -178.56 5.04 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.829 0.347 . . . . 0.23000000000000001 111.383 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.9 mp -65.63 -56.16 13.69 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.083 -0.508 . . . . 0.23000000000000001 110.707 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 107.66 32.5 3.36 Favored Glycine 0 CA--C 1.52 0.383 0 C-N-CA 120.932 -0.652 . . . . 0.23000000000000001 113.7 179.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -163.74 152.81 14.12 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 117.163 0.482 . . . . 0.23000000000000001 111.175 179.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.9 p -104.25 150.45 24.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 0.23000000000000001 111.456 -179.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 22.5 pt -117.67 144.58 25.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.867 -0.606 . . . . 0.23000000000000001 110.49 179.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 77.8 p -131.52 157.34 43.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.767 0.318 . . . . 0.23000000000000001 110.893 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 107.98 -156.19 15.92 Favored Glycine 0 C--N 1.33 0.234 0 C-N-CA 121.014 -0.613 . . . . 0.23000000000000001 112.453 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 110.85 148.48 11.49 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.995 -0.621 . . . . 0.23000000000000001 112.507 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 41.3 t -80.48 100.28 4.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.956 0.408 . . . . 0.23000000000000001 110.903 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 94.79 2.28 63.01 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 120.99 -0.624 . . . . 0.23000000000000001 114.139 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.97 -154.84 28.09 Favored Glycine 0 C--N 1.341 0.858 0 CA-C-N 117.827 0.813 . . . . 0.23000000000000001 112.981 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 1.9 mtt180 -62.66 -22.85 66.77 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 111.945 0.35 . . . . 0.23000000000000001 111.945 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.79 160.12 35.49 Favored Glycine 0 C--N 1.336 0.537 0 C-N-CA 120.732 -0.747 . . . . 0.23000000000000001 112.843 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -114.62 136.15 22.4 Favored Pre-proline 0 CA--C 1.535 0.392 0 N-CA-C 110.556 -0.164 . . . . 0.23000000000000001 110.556 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -87.91 13.28 2.64 Favored 'Trans proline' 0 C--N 1.357 1.0 0 C-N-CA 122.018 1.812 . . . . 0.23000000000000001 113.98 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -99.64 -41.55 7.27 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.666 0.269 . . . . 0.23000000000000001 111.178 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.76 136.15 27.99 Favored Pre-proline 0 N--CA 1.466 0.374 0 CA-C-N 116.407 -0.36 . . . . 0.23000000000000001 110.714 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -85.63 -44.58 0.05 OUTLIER 'Trans proline' 0 C--N 1.358 1.049 0 C-N-CA 122.052 1.835 . . . . 0.23000000000000001 113.413 -179.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -92.64 -9.0 42.51 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 112.763 0.653 . . . . 0.23000000000000001 112.763 -179.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -95.68 117.93 31.41 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-N 118.097 0.408 . . . . 0.23000000000000001 110.339 179.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -105.09 38.56 1.91 Allowed 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.342 -0.39 . . . . 0.23000000000000001 111.509 -179.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -92.28 -148.67 23.11 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 120.867 -0.683 . . . . 0.23000000000000001 111.846 179.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 20.8 mm -125.52 140.22 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 116.798 0.299 . . . . 0.23000000000000001 110.842 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -137.81 151.01 47.67 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.465 -0.334 . . . . 0.23000000000000001 111.12 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 21.7 t -90.56 73.69 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-O 121.126 0.488 . . . . 0.23000000000000001 111.084 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.7 t -36.24 -53.17 0.82 Allowed 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 114.745 1.387 . . . . 0.23000000000000001 114.745 -178.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 11.8 ptm180 -161.24 172.79 16.06 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.213 0.53 . . . . 0.23000000000000001 112.291 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 19.4 t -127.47 147.19 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 115.458 -0.792 . . . . 0.23000000000000001 110.445 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.416 ' CG ' ' CH2' ' B' ' 306' ' ' TRP . 4.6 mm-40 -102.1 -69.67 0.04 OUTLIER Pre-proline 0 CA--C 1.537 0.446 0 CA-C-O 119.629 -0.224 . . . . 0.23000000000000001 110.983 179.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -80.91 114.93 2.97 Favored 'Trans proline' 0 C--N 1.359 1.112 0 C-N-CA 121.653 1.569 . . . . 0.23000000000000001 112.036 179.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -74.89 68.4 1.76 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 121.025 0.44 . . . . 0.23000000000000001 111.098 -179.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -150.94 -71.15 0.01 OUTLIER Glycine 0 CA--C 1.528 0.872 0 C-N-CA 120.668 -0.777 . . . . 0.23000000000000001 113.714 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -59.7 -77.49 0.02 OUTLIER 'Trans proline' 0 C--N 1.358 1.06 0 C-N-CA 121.928 1.752 . . . . 0.23000000000000001 113.465 -178.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -106.8 49.57 0.8 Allowed 'General case' 0 CA--C 1.529 0.152 0 CA-C-O 121.401 0.619 . . . . 0.23000000000000001 111.194 -179.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.9 t -100.86 -61.41 1.37 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.741 -0.663 . . . . 0.23000000000000001 110.117 179.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.7 ttpt -74.35 -7.68 53.69 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 115.984 -0.553 . . . . 0.23000000000000001 112.106 178.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 20.7 mt -92.69 -59.02 2.17 Favored 'General case' 0 C--N 1.344 0.333 0 CA-C-N 118.219 0.463 . . . . 0.23000000000000001 110.9 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 11.6 mt -93.36 143.29 26.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.001 -0.545 . . . . 0.23000000000000001 111.299 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -112.44 141.27 24.89 Favored Pre-proline 0 CA--C 1.534 0.365 0 CA-C-N 116.046 -0.525 . . . . 0.23000000000000001 110.258 179.498 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -57.62 122.55 11.96 Favored 'Trans proline' 0 C--N 1.358 1.045 0 C-N-CA 121.784 1.656 . . . . 0.23000000000000001 112.777 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.57 16.6 21.84 Favored Glycine 0 CA--C 1.522 0.507 0 C-N-CA 120.971 -0.633 . . . . 0.23000000000000001 113.932 179.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -94.29 147.36 23.27 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 117.559 0.68 . . . . 0.23000000000000001 110.772 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 58.5 tttm -96.74 135.76 38.23 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.361 -0.381 . . . . 0.23000000000000001 111.153 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 29.3 mt -95.67 123.65 47.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.319 -0.401 . . . . 0.23000000000000001 110.591 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 23.7 mm -99.39 -42.22 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-N 116.28 -0.418 . . . . 0.23000000000000001 111.824 -178.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -146.76 151.51 37.29 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 121.173 0.511 . . . . 0.23000000000000001 112.139 -179.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -139.83 122.45 16.3 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.574 -0.739 . . . . 0.23000000000000001 110.943 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 45.62 28.18 0.5 Allowed 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 113.01 0.744 . . . . 0.23000000000000001 113.01 179.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 95.47 14.19 48.5 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 120.966 -0.635 . . . . 0.23000000000000001 113.49 -179.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -116.8 122.15 43.59 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 117.65 0.725 . . . . 0.23000000000000001 110.677 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 63.8 p -68.87 124.11 22.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.48 -0.327 . . . . 0.23000000000000001 110.427 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -94.08 19.98 8.51 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 112.332 0.493 . . . . 0.23000000000000001 112.332 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 8.5 tp -97.84 138.11 23.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-O 120.633 0.254 . . . . 0.23000000000000001 111.418 -179.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 63.18 20.82 12.51 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 112.421 0.526 . . . . 0.23000000000000001 112.421 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 26.2 pt -98.15 164.32 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 113.184 0.809 . . . . 0.23000000000000001 113.184 -178.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -85.67 146.78 26.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.125 -0.943 . . . . 0.23000000000000001 111.254 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 31.1 t60 -47.34 -50.27 22.38 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 115.857 -0.611 . . . . 0.23000000000000001 112.602 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -61.01 -29.04 69.84 Favored Glycine 0 CA--C 1.519 0.282 0 C-N-CA 120.913 -0.66 . . . . 0.23000000000000001 112.174 179.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -65.32 -45.79 82.92 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.918 0.389 . . . . 0.23000000000000001 111.023 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.77 -38.31 86.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.144 -0.48 . . . . 0.23000000000000001 111.361 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.6 t -73.11 -42.97 58.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.34 -0.391 . . . . 0.23000000000000001 110.741 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 35.5 t -63.66 -46.0 87.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 0.23000000000000001 111.087 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 23.8 mt -59.31 -50.97 71.92 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.367 -0.379 . . . . 0.23000000000000001 111.826 -179.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 26.0 mt -62.76 -32.45 73.6 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.334 -0.394 . . . . 0.23000000000000001 111.932 -178.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 44.1 mttm -76.88 -37.62 55.15 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.437 0.532 . . . . 0.23000000000000001 112.437 -178.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 10.2 t -73.92 -29.51 62.08 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 112.749 0.648 . . . . 0.23000000000000001 112.749 -178.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -47.54 171.38 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 112.875 0.694 . . . . 0.23000000000000001 112.875 -179.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -77.53 -145.6 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.98 0 CA-C-N 115.812 -0.631 . . . . 0.23000000000000001 110.659 -179.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 30.5 m120 -79.41 -67.96 0.71 Allowed 'General case' 0 C--N 1.348 0.511 0 CA-C-N 118.831 0.742 . . . . 0.23000000000000001 110.835 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -74.65 120.43 20.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 0.23000000000000001 110.785 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 18.4 t -113.22 115.18 49.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.144 -0.48 . . . . 0.23000000000000001 110.897 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -95.39 107.0 19.11 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.237 -0.438 . . . . 0.23000000000000001 110.454 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 6.2 mp -102.82 150.99 22.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.278 -0.419 . . . . 0.23000000000000001 111.722 -179.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.401 HD11 HG22 ' A' ' 96' ' ' ILE . 17.2 mm -107.38 122.18 61.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.848 -0.615 . . . . 0.23000000000000001 109.74 178.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 41.8 pt -126.03 163.4 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-O 121.148 0.499 . . . . 0.23000000000000001 112.185 -179.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 51.1 t -137.89 144.3 31.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 115.555 -0.748 . . . . 0.23000000000000001 111.185 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 49.5 mmm-85 -111.98 109.8 19.77 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.049 -0.523 . . . . 0.23000000000000001 109.968 179.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 . . . . . 0 C--N 1.329 -0.309 0 CA-C-O 121.024 0.44 . . . . 0.23000000000000001 111.777 -179.08 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 . . . . . 0 N--CA 1.463 0.178 0 CA-C-O 120.799 0.333 . . . . 0.23000000000000001 110.991 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 305' ' ' THR . . . . . . . . . . . . . 6.8 m -124.23 115.89 21.8 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.072 -0.513 . . . . 17.879999999999999 110.453 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 306' ' ' TRP . . . . . 0.416 ' CH2' ' CG ' ' A' ' 51' ' ' GLN . 83.7 m95 -79.16 113.84 17.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.3 -0.409 . . . . 0.23000000000000001 111.031 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 307' ' ' VAL . . . . . . . . . . . . . 16.1 m . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.223 -0.894 . . . . 16.109999999999999 111.142 179.964 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 . . . . . 0 CA--C 1.531 0.242 0 N-CA-C 109.737 -0.468 . . . . 0.23000000000000001 109.737 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.445 HD11 HG22 ' A' ' 13' ' ' ILE . 0.2 OUTLIER -151.08 165.86 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 N-CA-C 112.542 0.571 . . . . 0.23000000000000001 112.542 -179.712 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.48 158.55 22.4 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.636 -0.711 . . . . 0.23000000000000001 110.637 179.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.9 m -144.16 145.51 21.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.445 -0.343 . . . . 0.23000000000000001 110.755 179.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.03 114.19 27.91 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.343 -0.389 . . . . 0.23000000000000001 111.177 -179.517 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.4 t -110.62 119.13 58.76 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 116.336 -0.393 . . . . 0.23000000000000001 110.839 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -100.04 128.56 46.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.219 -0.446 . . . . 0.23000000000000001 110.491 179.581 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 14.0 mtmt -84.02 123.77 30.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.139 0.495 . . . . 0.23000000000000001 111.608 -179.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -172.84 85.7 0.41 Allowed Pre-proline 0 CA--C 1.537 0.448 0 CA-C-N 115.647 -0.706 . . . . 0.23000000000000001 110.797 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -82.48 -20.19 20.35 Favored 'Cis proline' 0 C--N 1.365 1.401 0 CA-C-N 119.357 0.806 . . . . 0.23000000000000001 113.15 0.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -136.4 -178.34 5.12 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 120.854 0.359 . . . . 0.23000000000000001 111.513 -179.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.403 ' HB3' ' CE2' ' A' ' 25' ' ' PHE . 3.4 mp -67.21 -52.41 41.42 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.163 -0.471 . . . . 0.23000000000000001 110.668 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 106.75 26.17 5.94 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.898 -0.668 . . . . 0.23000000000000001 113.833 179.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.403 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 42.1 p90 -156.63 171.14 20.86 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 117.461 0.63 . . . . 0.23000000000000001 111.316 179.429 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.3 p -119.82 153.63 35.48 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.046 -0.524 . . . . 0.23000000000000001 111.09 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 26.4 pt -120.39 148.52 23.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.097 -0.501 . . . . 0.23000000000000001 110.907 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 74.6 p -140.61 158.28 44.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.389 -0.369 . . . . 0.23000000000000001 111.045 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 106.26 -148.01 16.36 Favored Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.968 -0.634 . . . . 0.23000000000000001 112.731 179.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.79 151.77 26.34 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.994 -0.622 . . . . 0.23000000000000001 112.374 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 13.7 t -79.82 99.32 3.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.722 0.296 . . . . 0.23000000000000001 110.463 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 104.28 -7.81 47.88 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 120.922 -0.656 . . . . 0.23000000000000001 113.522 -179.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -73.44 -148.44 1.13 Allowed Glycine 0 C--N 1.344 1.001 0 CA-C-N 117.751 0.776 . . . . 0.23000000000000001 112.248 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 53.1 mtt-85 -89.21 16.96 6.46 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 112.452 0.538 . . . . 0.23000000000000001 112.452 -179.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 63.86 170.72 1.88 Allowed Glycine 0 C--N 1.338 0.693 0 C-N-CA 120.999 -0.62 . . . . 0.23000000000000001 113.42 179.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -139.75 143.8 36.4 Favored Pre-proline 0 CA--C 1.534 0.363 0 N-CA-C 110.518 -0.179 . . . . 0.23000000000000001 110.518 179.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -92.32 27.28 0.38 Allowed 'Trans proline' 0 C--N 1.358 1.042 0 C-N-CA 122.34 2.027 . . . . 0.23000000000000001 113.537 -179.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -103.43 -51.35 3.23 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.754 0.311 . . . . 0.23000000000000001 110.945 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 16.2 mtp180 -120.31 137.33 25.95 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-N 116.372 -0.376 . . . . 0.23000000000000001 110.418 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -85.3 -45.74 0.05 OUTLIER 'Trans proline' 0 C--N 1.358 1.078 0 C-N-CA 121.904 1.736 . . . . 0.23000000000000001 113.59 -179.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -89.62 -13.01 38.04 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 112.858 0.688 . . . . 0.23000000000000001 112.858 -179.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -106.74 122.69 46.87 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 122.001 -0.437 . . . . 0.23000000000000001 110.831 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 19.0 p30 -108.69 36.04 2.99 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 121.01 0.433 . . . . 0.23000000000000001 111.099 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -79.27 -157.93 12.89 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 120.937 -0.649 . . . . 0.23000000000000001 112.361 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.7 mm -110.14 132.06 59.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-O 120.697 0.284 . . . . 0.23000000000000001 111.114 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.435 ' N ' ' CD1' ' A' ' 46' ' ' PHE . 5.4 m-85 -131.39 150.14 52.27 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.287 -0.415 . . . . 0.23000000000000001 110.346 179.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 31.4 t -94.15 75.68 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-O 120.961 0.41 . . . . 0.23000000000000001 111.466 -179.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.2 t -33.89 -52.99 0.45 Allowed 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 114.939 1.459 . . . . 0.23000000000000001 114.939 -178.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -158.13 173.54 16.57 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 112.436 0.532 . . . . 0.23000000000000001 112.436 -179.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 18.3 t -133.81 150.0 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 115.371 -0.831 . . . . 0.23000000000000001 110.464 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.404 ' HG3' ' CH2' ' B' ' 306' ' ' TRP . 8.1 mt-30 -104.99 -67.92 0.04 OUTLIER Pre-proline 0 CA--C 1.539 0.543 0 N-CA-C 111.643 0.238 . . . . 0.23000000000000001 111.643 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -79.07 121.07 4.79 Favored 'Trans proline' 0 C--N 1.358 1.047 0 C-N-CA 121.645 1.563 . . . . 0.23000000000000001 112.522 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -78.61 69.55 4.81 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 121.103 0.478 . . . . 0.23000000000000001 111.016 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -158.37 -68.96 0.01 OUTLIER Glycine 0 CA--C 1.528 0.885 0 C-N-CA 120.794 -0.717 . . . . 0.23000000000000001 113.358 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -60.98 -75.41 0.02 OUTLIER 'Trans proline' 0 C--N 1.358 1.053 0 C-N-CA 121.94 1.76 . . . . 0.23000000000000001 113.429 -178.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -108.15 47.52 0.9 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 121.24 0.543 . . . . 0.23000000000000001 111.964 -178.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.4 t -111.22 -64.19 1.31 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.089 -0.505 . . . . 0.23000000000000001 109.727 178.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.14 -16.11 61.17 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.671 -0.695 . . . . 0.23000000000000001 111.783 178.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 27.7 mt -96.51 -52.67 3.86 Favored 'General case' 0 C--N 1.342 0.262 0 CA-C-O 120.616 0.246 . . . . 0.23000000000000001 111.135 -179.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 8.9 mt -103.76 151.12 23.42 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.884 0.373 . . . . 0.23000000000000001 111.748 -179.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 3.5 pp0? -126.45 149.42 67.57 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-N 115.901 -0.591 . . . . 0.23000000000000001 110.641 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -58.57 130.01 35.19 Favored 'Trans proline' 0 C--N 1.361 1.186 0 C-N-CA 122.342 2.028 . . . . 0.23000000000000001 113.658 -178.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 98.35 9.46 53.28 Favored Glycine 0 CA--C 1.525 0.714 0 CA-C-N 115.673 -0.694 . . . . 0.23000000000000001 114.075 179.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.5 p30 -77.82 -174.48 3.52 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 117.841 0.82 . . . . 0.23000000000000001 111.623 -179.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 25.4 tttm -139.2 124.32 18.95 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.96 -0.563 . . . . 0.23000000000000001 110.008 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 26.5 mt -88.72 115.23 28.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-O 121.106 0.479 . . . . 0.23000000000000001 110.812 -179.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 19.8 mm -89.78 -42.82 14.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 N-CA-C 112.483 0.549 . . . . 0.23000000000000001 112.483 -178.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.11 146.33 26.85 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.102 0.477 . . . . 0.23000000000000001 112.116 -179.006 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -131.06 120.9 24.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.442 -0.799 . . . . 0.23000000000000001 110.919 179.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 42.76 35.46 0.71 Allowed 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 113.551 0.945 . . . . 0.23000000000000001 113.551 178.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 91.51 -12.59 68.88 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 120.819 -0.705 . . . . 0.23000000000000001 113.853 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -88.21 125.46 34.64 Favored 'General case' 0 C--O 1.231 0.082 0 CA-C-N 117.648 0.724 . . . . 0.23000000000000001 109.949 179.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 84.4 p -69.67 115.55 9.04 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.23 -0.441 . . . . 0.23000000000000001 111.754 -179.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -95.25 9.17 40.75 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 116.081 -0.509 . . . . 0.23000000000000001 111.954 178.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 7.6 tp -89.38 126.86 42.33 Favored 'Isoleucine or valine' 0 C--N 1.343 0.288 0 CA-C-N 118.181 0.446 . . . . 0.23000000000000001 110.508 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 57.1 m-80 61.09 70.82 0.59 Allowed 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 121.284 0.564 . . . . 0.23000000000000001 110.786 -179.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 19.9 pt -145.6 168.48 7.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.944 -0.571 . . . . 0.23000000000000001 110.885 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -82.45 148.14 28.34 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.205 -0.452 . . . . 0.23000000000000001 111.18 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 -52.23 -52.5 52.03 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.893 -0.594 . . . . 0.23000000000000001 112.281 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -56.8 -26.05 53.34 Favored Glycine 0 CA--C 1.523 0.552 0 C-N-CA 121.037 -0.601 . . . . 0.23000000000000001 113.171 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -74.32 -40.25 62.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.068 0.461 . . . . 0.23000000000000001 110.641 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.3 -34.47 74.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.855 -0.611 . . . . 0.23000000000000001 111.797 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 24.0 t -75.08 -44.85 43.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.911 0.386 . . . . 0.23000000000000001 110.861 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 23.3 t -59.01 -36.97 75.83 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.2 -0.454 . . . . 0.23000000000000001 111.383 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 35.7 mt -71.0 -42.3 69.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.099 0.476 . . . . 0.23000000000000001 110.588 179.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.4 ' HA ' ' CD2' ' A' ' 89' ' ' PHE . 33.2 mt -77.53 -8.27 57.54 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 113.362 0.875 . . . . 0.23000000000000001 113.362 -179.408 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 15.8 mmtp -98.09 -36.65 10.02 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.247 0.546 . . . . 0.23000000000000001 110.427 178.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 9.1 t -70.19 -21.78 63.01 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.494 -0.775 . . . . 0.23000000000000001 112.142 -178.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.4 ' CD2' ' HA ' ' A' ' 86' ' ' LEU . 12.9 m-85 -55.83 126.8 27.22 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.194 0.521 . . . . 0.23000000000000001 111.06 -179.06 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 23.1 mp0 -60.29 -64.5 0.93 Allowed 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 113.727 1.01 . . . . 0.23000000000000001 113.727 -177.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 32.4 m120 -134.6 -81.95 0.44 Allowed 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.649 0.611 . . . . 0.23000000000000001 112.649 -178.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.76 158.75 35.76 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.033 0.444 . . . . 0.23000000000000001 111.08 -178.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 19.5 t -150.38 113.97 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.9 -0.591 . . . . 0.23000000000000001 110.888 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -89.36 119.33 29.73 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.418 -0.355 . . . . 0.23000000000000001 110.202 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.5 mt -122.71 147.41 46.51 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.166 0.508 . . . . 0.23000000000000001 111.893 -178.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 41.2 mt -112.86 126.46 70.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.536 -0.757 . . . . 0.23000000000000001 109.719 178.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 30.9 pt -126.0 166.48 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-O 120.837 0.351 . . . . 0.23000000000000001 111.296 -179.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 16.1 t -150.01 149.49 14.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.189 -0.46 . . . . 0.23000000000000001 111.574 -179.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.34 115.63 30.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.768 -0.651 . . . . 0.23000000000000001 109.258 178.213 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 . . . . . 0 C--N 1.329 -0.288 0 CA-C-O 120.935 0.398 . . . . 0.23000000000000001 111.7 -178.532 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 . . . . . 0 N--CA 1.466 0.352 0 CA-C-O 120.754 0.311 . . . . 0.23000000000000001 110.716 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 305' ' ' THR . . . . . . . . . . . . . 4.3 m -124.77 130.94 53.38 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.189 -0.46 . . . . 17.879999999999999 110.731 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 306' ' ' TRP . . . . . 0.404 ' CH2' ' HG3' ' A' ' 51' ' ' GLN . 77.2 m95 -91.05 110.84 22.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.253 -0.431 . . . . 0.23000000000000001 110.92 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 307' ' ' VAL . . . . . . . . . . . . . 16.8 m . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.217 -0.897 . . . . 16.109999999999999 111.076 179.863 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 . . . . . 0 N--CA 1.464 0.233 0 N-CA-C 109.901 -0.407 . . . . 0.23000000000000001 109.901 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.4 pt -109.3 158.94 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 N-CA-C 112.372 0.508 . . . . 0.23000000000000001 112.372 -178.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -116.12 148.65 40.08 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.694 -0.684 . . . . 0.23000000000000001 110.975 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 20.1 m -138.85 142.41 34.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.241 -0.436 . . . . 0.23000000000000001 111.011 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 74.9 mtm-85 -105.18 120.31 41.22 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.374 -0.376 . . . . 0.23000000000000001 111.123 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.1 t -111.01 112.91 42.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.337 -0.392 . . . . 0.23000000000000001 110.974 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -89.19 119.55 29.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.354 -0.384 . . . . 0.23000000000000001 110.676 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 20.1 mttt -75.03 118.0 17.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.287 -0.415 . . . . 0.23000000000000001 111.046 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -169.37 86.89 0.61 Allowed Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.943 -0.571 . . . . 0.23000000000000001 110.56 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -81.61 -18.45 24.93 Favored 'Cis proline' 0 C--N 1.363 1.294 0 CA-C-N 119.384 0.816 . . . . 0.23000000000000001 113.408 0.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -136.42 -175.97 4.18 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.695 0.283 . . . . 0.23000000000000001 111.1 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.402 ' HB3' ' CE2' ' A' ' 25' ' ' PHE . 3.7 mp -62.36 -56.96 13.33 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 116.334 -0.394 . . . . 0.23000000000000001 110.685 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 100.9 35.53 4.25 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.762 -0.732 . . . . 0.23000000000000001 114.318 178.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.402 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 36.3 p90 -159.74 153.75 23.27 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 117.283 0.541 . . . . 0.23000000000000001 110.915 179.019 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.41 ' HB3' ' CD2' ' B' ' 306' ' ' TRP . 2.2 p -105.93 145.12 31.7 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.148 0.499 . . . . 0.23000000000000001 112.023 -178.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 31.2 pt -122.59 149.92 26.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.55 -0.75 . . . . 0.23000000000000001 110.357 178.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.7 m -144.67 -176.67 5.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.786 0.326 . . . . 0.23000000000000001 110.93 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.09 -146.47 22.99 Favored Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.908 -0.663 . . . . 0.23000000000000001 113.086 179.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.41 162.46 31.61 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 121.031 -0.604 . . . . 0.23000000000000001 112.102 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 23.6 t -76.54 92.02 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 CA-C-O 121.236 0.541 . . . . 0.23000000000000001 110.479 -179.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 100.4 8.18 50.25 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-N 115.32 -0.854 . . . . 0.23000000000000001 113.487 -179.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -83.51 -161.33 31.4 Favored Glycine 0 C--N 1.343 0.944 0 CA-C-N 117.719 0.76 . . . . 0.23000000000000001 113.248 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 91.4 mtt-85 -64.24 -27.37 69.0 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 112.012 0.375 . . . . 0.23000000000000001 112.012 -179.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.36 167.55 41.97 Favored Glycine 0 C--N 1.337 0.62 0 C-N-CA 120.636 -0.792 . . . . 0.23000000000000001 113.165 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 12.1 m-80 -125.71 144.8 49.41 Favored Pre-proline 0 CA--C 1.536 0.422 0 C-N-CA 122.131 0.173 . . . . 0.23000000000000001 110.712 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -83.69 2.57 8.23 Favored 'Trans proline' 0 C--N 1.356 0.968 0 C-N-CA 121.865 1.71 . . . . 0.23000000000000001 113.615 179.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -99.99 -39.5 8.11 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.017 0.437 . . . . 0.23000000000000001 110.453 179.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 5.1 ppt_? -90.92 128.77 46.64 Favored Pre-proline 0 N--CA 1.469 0.513 0 CA-C-N 115.761 -0.654 . . . . 0.23000000000000001 111.931 -179.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -89.02 -22.24 1.1 Allowed 'Trans proline' 0 C--N 1.359 1.111 0 C-N-CA 122.325 2.017 . . . . 0.23000000000000001 113.408 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -155.41 18.91 0.41 Allowed 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.986 0.735 . . . . 0.23000000000000001 112.986 -179.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -90.24 118.03 29.45 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 122.188 -0.32 . . . . 0.23000000000000001 110.828 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -89.61 40.64 1.0 Allowed 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.725 0.639 . . . . 0.23000000000000001 112.725 -179.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -109.7 -155.63 15.88 Favored Glycine 0 C--N 1.336 0.57 0 C-N-CA 120.998 -0.62 . . . . 0.23000000000000001 112.86 179.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.6 mm -122.13 137.77 54.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 N-CA-C 110.504 -0.184 . . . . 0.23000000000000001 110.504 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -129.88 148.74 51.78 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.68 0.276 . . . . 0.23000000000000001 111.282 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 19.8 t -94.45 77.13 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-O 121.007 0.432 . . . . 0.23000000000000001 110.99 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.4 t -37.85 -53.68 1.29 Allowed 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 114.564 1.32 . . . . 0.23000000000000001 114.564 -178.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -159.11 177.88 10.63 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 118.273 0.488 . . . . 0.23000000000000001 112.235 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.5 t -130.0 148.06 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 115.64 -0.709 . . . . 0.23000000000000001 110.944 -179.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.408 ' HG2' ' CH2' ' B' ' 306' ' ' TRP . 8.3 mm-40 -96.02 -68.07 0.07 OUTLIER Pre-proline 0 CA--C 1.536 0.416 0 C-N-CA 121.366 -0.134 . . . . 0.23000000000000001 111.049 179.536 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -80.39 121.9 4.43 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 121.811 1.674 . . . . 0.23000000000000001 111.955 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -79.6 64.7 4.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.936 0.398 . . . . 0.23000000000000001 111.28 -179.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -157.83 -67.28 0.01 OUTLIER Glycine 0 CA--C 1.529 0.962 0 C-N-CA 120.668 -0.777 . . . . 0.23000000000000001 113.547 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -57.96 -73.74 0.03 OUTLIER 'Trans proline' 0 C--N 1.357 0.975 0 C-N-CA 122.183 1.922 . . . . 0.23000000000000001 113.52 -178.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -112.24 47.95 1.03 Allowed 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.189 0.518 . . . . 0.23000000000000001 111.393 -179.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 95.4 p -107.77 -50.08 3.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.933 -0.576 . . . . 0.23000000000000001 110.515 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.4 mmtm -80.38 -9.96 59.75 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.831 -0.622 . . . . 0.23000000000000001 112.487 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.2 mp -96.23 -56.69 2.55 Favored 'General case' 0 C--N 1.342 0.25 0 CA-C-N 118.106 0.412 . . . . 0.23000000000000001 111.184 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.1 mt -92.66 146.23 23.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.4 -0.364 . . . . 0.23000000000000001 111.326 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -112.49 140.83 24.24 Favored Pre-proline 0 CA--C 1.535 0.373 0 CA-C-N 116.16 -0.473 . . . . 0.23000000000000001 110.52 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -57.07 125.87 20.34 Favored 'Trans proline' 0 C--N 1.356 0.923 0 C-N-CA 121.716 1.61 . . . . 0.23000000000000001 112.242 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 92.45 19.82 37.04 Favored Glycine 0 CA--C 1.523 0.539 0 C-N-CA 120.948 -0.644 . . . . 0.23000000000000001 113.336 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -93.69 155.34 17.31 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-N 117.237 0.518 . . . . 0.23000000000000001 110.047 179.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 58.8 tttp -100.07 125.54 46.16 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.92 0.39 . . . . 0.23000000000000001 111.753 -179.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 44.4 mt -89.81 120.48 38.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.077 -0.51 . . . . 0.23000000000000001 109.973 179.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 19.3 mm -95.86 -41.34 11.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 N-CA-C 112.949 0.722 . . . . 0.23000000000000001 112.949 -178.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -149.48 153.9 37.97 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 112.2 0.445 . . . . 0.23000000000000001 112.2 -178.13 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -142.45 123.27 14.32 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.955 -0.566 . . . . 0.23000000000000001 111.856 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 28.4 m-20 41.55 37.72 0.75 Allowed 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 113.702 1.001 . . . . 0.23000000000000001 113.702 178.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 96.11 -16.73 60.58 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 120.843 -0.694 . . . . 0.23000000000000001 113.643 179.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 53.8 m-85 -91.35 122.62 34.11 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 117.565 0.683 . . . . 0.23000000000000001 110.66 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 8.8 m -71.47 131.43 43.3 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.369 -0.378 . . . . 0.23000000000000001 110.978 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -105.6 14.37 28.57 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 112.292 0.478 . . . . 0.23000000000000001 112.292 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 7.0 tp -92.04 126.13 44.63 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 CA-C-O 120.998 0.428 . . . . 0.23000000000000001 111.096 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 61.46 70.41 0.6 Allowed 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 121.151 0.5 . . . . 0.23000000000000001 110.845 -179.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 7.1 pt -148.66 164.24 4.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.95 -0.568 . . . . 0.23000000000000001 110.984 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -81.35 143.14 32.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.931 -0.577 . . . . 0.23000000000000001 110.458 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -50.99 -52.1 46.14 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 112.367 0.506 . . . . 0.23000000000000001 112.367 -179.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -53.47 -27.92 34.98 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 121.248 -0.501 . . . . 0.23000000000000001 113.05 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 49.7 tp60 -74.37 -38.71 63.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.092 0.473 . . . . 0.23000000000000001 110.124 179.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.43 -53.75 32.05 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.672 -0.695 . . . . 0.23000000000000001 111.597 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 20.0 t -58.5 -43.39 86.82 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-N 116.442 -0.345 . . . . 0.23000000000000001 111.417 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.7 t -60.46 -41.29 93.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.446 . . . . 0.23000000000000001 111.392 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 26.8 mt -65.17 -45.97 82.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.412 -0.358 . . . . 0.23000000000000001 111.518 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.411 ' HA ' ' CD2' ' A' ' 89' ' ' PHE . 32.9 mt -63.15 -38.45 91.23 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.192 -0.458 . . . . 0.23000000000000001 112.012 -179.148 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 19.1 mmtt -66.48 -40.3 89.23 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.451 0.538 . . . . 0.23000000000000001 112.451 -178.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 7.8 t -72.18 -27.88 62.85 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.674 0.99 . . . . 0.23000000000000001 113.674 -177.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.411 ' CD2' ' HA ' ' A' ' 86' ' ' LEU . 12.6 m-85 -49.09 173.66 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 113.107 0.78 . . . . 0.23000000000000001 113.107 -178.416 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -87.84 -140.25 0.11 Allowed 'General case' 0 CA--C 1.552 1.026 0 CA-C-N 115.468 -0.787 . . . . 0.23000000000000001 111.204 -179.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 33.1 m120 -82.58 -61.82 1.78 Allowed 'General case' 0 C--N 1.348 0.538 0 CA-C-N 119.251 0.932 . . . . 0.23000000000000001 111.526 -179.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -84.09 129.03 34.92 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.289 -0.414 . . . . 0.23000000000000001 111.061 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.3 t -123.29 120.26 59.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.001 -0.545 . . . . 0.23000000000000001 110.511 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -92.54 91.71 7.72 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.394 -0.366 . . . . 0.23000000000000001 111.48 -179.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 2.5 mt -92.5 155.15 18.02 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.837 0.351 . . . . 0.23000000000000001 111.419 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 72.9 mt -115.36 127.29 72.99 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-N 115.926 -0.579 . . . . 0.23000000000000001 109.487 178.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 45.3 pt -123.76 162.37 24.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-O 120.902 0.382 . . . . 0.23000000000000001 111.534 -178.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 36.7 t -136.73 139.8 44.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.874 -0.603 . . . . 0.23000000000000001 111.5 -179.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -110.47 106.28 15.54 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.985 -0.552 . . . . 0.23000000000000001 109.665 178.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 . . . . . 0 C--N 1.329 -0.295 0 CA-C-O 120.882 0.373 . . . . 0.23000000000000001 111.578 -178.996 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 . . . . . 0 N--CA 1.466 0.373 0 CA-C-O 121.069 0.461 . . . . 0.23000000000000001 111.346 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 305' ' ' THR . . . . . . . . . . . . . 6.4 m -139.32 119.44 13.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.801 -0.636 . . . . 17.879999999999999 110.372 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 306' ' ' TRP . . . . . 0.41 ' CD2' ' HB3' ' A' ' 26' ' ' SER . 96.5 m95 -85.71 114.6 22.81 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.345 -0.389 . . . . 0.23000000000000001 111.109 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 307' ' ' VAL . . . . . . . . . . . . . 18.0 m . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.285 -0.864 . . . . 16.109999999999999 111.142 -179.945 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 . . . . . 0 N--CA 1.464 0.244 0 CA-C-O 120.806 0.336 . . . . 0.23000000000000001 111.205 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 19.7 pt -117.05 156.15 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-N 116.061 -0.518 . . . . 0.23000000000000001 112.205 -179.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 29.7 mtm180 -90.29 167.47 12.64 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 112.655 0.613 . . . . 0.23000000000000001 112.655 -178.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 77.6 t -147.43 122.97 2.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-N 115.247 -0.888 . . . . 0.23000000000000001 109.977 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 20.8 ttt180 -110.42 112.85 25.05 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.483 -0.326 . . . . 0.23000000000000001 110.66 179.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.2 t -120.21 125.95 74.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 116.509 -0.314 . . . . 0.23000000000000001 111.089 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -102.05 128.51 48.48 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.38 -0.373 . . . . 0.23000000000000001 111.106 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.81 114.6 11.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.406 -0.361 . . . . 0.23000000000000001 110.962 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -174.95 83.35 0.32 Allowed Pre-proline 0 CA--C 1.537 0.471 0 CA-C-N 116.422 -0.354 . . . . 0.23000000000000001 111.087 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -83.38 -23.82 12.29 Favored 'Cis proline' 0 C--N 1.362 1.283 0 CA-C-N 119.445 0.838 . . . . 0.23000000000000001 112.868 0.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.1 mp0 -130.68 -177.4 4.34 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.755 0.312 . . . . 0.23000000000000001 111.405 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.3 mp -62.93 -59.83 4.29 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.206 -0.452 . . . . 0.23000000000000001 110.978 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.7 29.91 2.32 Favored Glycine 0 C--N 1.335 0.499 0 C-N-CA 120.925 -0.655 . . . . 0.23000000000000001 113.771 179.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -169.48 149.21 3.93 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 117.37 0.585 . . . . 0.23000000000000001 111.521 179.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.3 p -100.44 150.44 22.64 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.904 -0.589 . . . . 0.23000000000000001 110.87 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 38.3 pt -120.27 148.76 23.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.24 -0.436 . . . . 0.23000000000000001 111.196 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 78.1 p -142.9 160.25 40.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.253 -0.431 . . . . 0.23000000000000001 110.859 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 108.14 -152.57 16.95 Favored Glycine 0 C--N 1.332 0.338 0 C-N-CA 120.891 -0.671 . . . . 0.23000000000000001 112.94 179.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 104.0 157.01 24.14 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 121.096 -0.573 . . . . 0.23000000000000001 112.264 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.5 t -78.18 100.38 3.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 120.925 0.393 . . . . 0.23000000000000001 110.853 -179.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 93.48 7.68 61.66 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 121.047 -0.597 . . . . 0.23000000000000001 113.709 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -88.63 -156.07 30.68 Favored Glycine 0 C--N 1.34 0.755 0 CA-C-N 117.746 0.773 . . . . 0.23000000000000001 112.958 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 10.4 mmt180 -61.13 -27.52 68.45 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 111.606 0.224 . . . . 0.23000000000000001 111.606 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 103.71 154.4 23.83 Favored Glycine 0 C--N 1.335 0.512 0 C-N-CA 120.881 -0.676 . . . . 0.23000000000000001 113.059 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -112.15 129.96 23.76 Favored Pre-proline 0 N--CA 1.468 0.472 0 C-N-CA 122.074 0.149 . . . . 0.23000000000000001 110.618 179.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -93.42 34.19 0.22 Allowed 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 122.316 2.011 . . . . 0.23000000000000001 113.101 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -110.34 -51.2 2.89 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.786 0.327 . . . . 0.23000000000000001 111.156 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 45.3 mtt-85 -127.13 158.29 69.55 Favored Pre-proline 0 CA--C 1.535 0.366 0 CA-C-N 116.187 -0.46 . . . . 0.23000000000000001 110.741 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -90.71 -57.67 0.02 OUTLIER 'Trans proline' 0 C--N 1.357 1.005 0 C-N-CA 122.219 1.946 . . . . 0.23000000000000001 113.977 -178.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -79.35 -8.07 58.81 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 113.05 0.759 . . . . 0.23000000000000001 113.05 -179.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -101.58 114.1 27.82 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 118.024 0.375 . . . . 0.23000000000000001 110.418 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -105.73 38.81 1.9 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.305 -0.407 . . . . 0.23000000000000001 111.379 -179.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -85.86 -156.3 27.17 Favored Glycine 0 CA--C 1.52 0.36 0 C-N-CA 120.913 -0.66 . . . . 0.23000000000000001 112.505 179.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.5 mm -110.57 130.81 63.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-O 120.531 0.205 . . . . 0.23000000000000001 110.852 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -125.99 150.97 47.66 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 120.827 0.346 . . . . 0.23000000000000001 111.43 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 21.8 t -89.1 81.73 1.97 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-N 116.243 -0.435 . . . . 0.23000000000000001 111.185 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.4 t -43.14 -55.41 3.92 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 114.035 1.124 . . . . 0.23000000000000001 114.035 -178.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 -161.49 156.95 24.22 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 118.425 0.557 . . . . 0.23000000000000001 112.209 -179.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 18.6 t -109.23 146.62 14.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 115.648 -0.705 . . . . 0.23000000000000001 110.576 179.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -102.77 -71.34 0.03 OUTLIER Pre-proline 0 CA--C 1.54 0.573 0 CA-C-O 119.437 -0.316 . . . . 0.23000000000000001 111.311 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -83.45 121.45 3.01 Favored 'Trans proline' 0 C--N 1.36 1.143 0 C-N-CA 121.532 1.488 . . . . 0.23000000000000001 112.104 179.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.74 64.51 3.75 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.165 0.507 . . . . 0.23000000000000001 110.963 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -139.01 -72.07 0.05 OUTLIER Glycine 0 CA--C 1.528 0.862 0 CA-C-N 115.672 -0.694 . . . . 0.23000000000000001 112.84 179.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -63.76 -59.59 0.2 Allowed 'Trans proline' 0 C--N 1.357 1.009 0 C-N-CA 122.119 1.879 . . . . 0.23000000000000001 113.585 -179.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -108.56 45.25 1.04 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.055 0.455 . . . . 0.23000000000000001 111.426 -179.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 89.3 p -84.71 -60.98 1.9 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.069 -0.514 . . . . 0.23000000000000001 111.04 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 13.6 mmmt -90.49 0.54 57.28 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 112.81 0.67 . . . . 0.23000000000000001 112.81 -179.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 60.7 mt -95.48 -65.34 0.98 Allowed 'General case' 0 C--N 1.341 0.214 0 CA-C-N 118.254 0.479 . . . . 0.23000000000000001 111.826 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.4 mt -95.64 139.84 31.31 Favored 'General case' 0 C--O 1.23 0.048 0 N-CA-C 111.845 0.313 . . . . 0.23000000000000001 111.845 -179.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 4.7 pp0? -121.4 151.67 56.68 Favored Pre-proline 0 CA--C 1.535 0.369 0 CA-C-N 115.9 -0.591 . . . . 0.23000000000000001 110.16 178.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -54.43 114.27 1.75 Allowed 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 121.818 1.679 . . . . 0.23000000000000001 112.983 -179.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 118.12 -2.8 16.66 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 121.096 -0.573 . . . . 0.23000000000000001 114.367 179.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -67.77 -177.66 0.82 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 117.831 0.816 . . . . 0.23000000000000001 111.873 -179.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 38.0 tttt -145.22 126.57 14.88 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 115.873 -0.603 . . . . 0.23000000000000001 110.705 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.7 mp -89.63 117.82 33.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-O 120.832 0.349 . . . . 0.23000000000000001 110.202 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 35.4 mt -106.63 -26.52 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 116.048 -0.524 . . . . 0.23000000000000001 111.846 -179.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -154.61 149.43 26.63 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.934 0.397 . . . . 0.23000000000000001 111.77 -179.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -149.33 121.24 8.18 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.004 -0.544 . . . . 0.23000000000000001 111.486 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 48.1 m-20 48.35 35.66 5.99 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.631 0.604 . . . . 0.23000000000000001 112.631 179.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 86.88 10.63 71.95 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 120.973 -0.632 . . . . 0.23000000000000001 113.626 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -112.16 120.91 43.4 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 117.692 0.746 . . . . 0.23000000000000001 109.811 179.533 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 18.8 m -71.53 128.78 36.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.425 -0.352 . . . . 0.23000000000000001 111.418 -179.075 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -106.19 13.89 28.33 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.172 -0.467 . . . . 0.23000000000000001 112.125 179.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 6.4 tp -90.83 124.19 43.3 Favored 'Isoleucine or valine' 0 C--N 1.34 0.169 0 O-C-N 122.047 -0.408 . . . . 0.23000000000000001 110.743 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 63.18 72.75 0.47 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.049 -0.523 . . . . 0.23000000000000001 110.929 -179.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 20.1 pt -146.95 166.06 6.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.914 -0.585 . . . . 0.23000000000000001 110.795 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -81.84 154.78 25.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.4 -0.363 . . . . 0.23000000000000001 110.995 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 16.1 t60 -54.6 -56.8 15.21 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.095 -0.502 . . . . 0.23000000000000001 111.899 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -53.05 -33.2 44.05 Favored Glycine 0 C--N 1.336 0.532 0 C-N-CA 121.257 -0.497 . . . . 0.23000000000000001 113.363 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 -65.95 -38.91 89.84 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.036 0.446 . . . . 0.23000000000000001 110.148 179.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.3 -63.63 1.02 Allowed 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.887 -0.597 . . . . 0.23000000000000001 111.684 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.5 t -55.29 -22.87 12.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 N-CA-C 111.93 0.344 . . . . 0.23000000000000001 111.93 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 18.0 m -77.4 -42.28 36.88 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.747 0.308 . . . . 0.23000000000000001 111.101 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 25.5 mt -65.71 -42.06 91.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.391 -0.368 . . . . 0.23000000000000001 111.665 -179.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.406 ' HA ' ' CD2' ' A' ' 89' ' ' PHE . 53.4 mt -66.73 -47.98 70.6 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.353 -0.385 . . . . 0.23000000000000001 111.638 -179.29 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 70.7 mttt -60.66 -45.9 92.36 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.297 0.48 . . . . 0.23000000000000001 112.297 -179.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 11.6 t -68.82 -27.7 66.08 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.654 0.983 . . . . 0.23000000000000001 113.654 -177.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.406 ' CD2' ' HA ' ' A' ' 86' ' ' LEU . 6.0 m-85 -46.88 174.7 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 113.61 0.967 . . . . 0.23000000000000001 113.61 -178.073 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -85.79 -143.69 0.1 Allowed 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 115.139 -0.937 . . . . 0.23000000000000001 110.79 -179.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -81.15 -70.71 0.51 Allowed 'General case' 0 C--N 1.347 0.471 0 CA-C-N 119.016 0.825 . . . . 0.23000000000000001 111.669 -179.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -79.2 129.26 34.27 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 120.766 0.317 . . . . 0.23000000000000001 110.448 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.7 t -121.63 120.07 60.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.222 -0.444 . . . . 0.23000000000000001 110.976 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -98.08 105.46 17.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.398 -0.365 . . . . 0.23000000000000001 110.934 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 4.9 mp -105.29 164.38 11.89 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.977 0.418 . . . . 0.23000000000000001 111.541 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.1 mp -120.5 131.77 71.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 N-CA-C 109.098 -0.704 . . . . 0.23000000000000001 109.098 179.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.426 HG22 HD11 ' A' ' 97' ' ' ILE . 46.0 pt -126.82 166.45 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-O 120.967 0.413 . . . . 0.23000000000000001 111.809 -178.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 98.9 t -143.07 143.78 24.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-N 115.919 -0.582 . . . . 0.23000000000000001 111.276 -179.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.1 105.06 14.02 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.83 -0.804 . . . . 0.23000000000000001 108.83 178.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 . . . . . 0 C--N 1.33 -0.269 0 N-CA-C 111.937 0.347 . . . . 0.23000000000000001 111.937 -178.459 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 4.0 pm0 . . . . . 0 CA--C 1.529 0.163 0 CA-C-O 120.736 0.303 . . . . 0.23000000000000001 111.343 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 305' ' ' THR . . . . . . . . . . . . . 5.6 m -127.41 121.06 29.87 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.201 -0.454 . . . . 17.879999999999999 110.803 179.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 306' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -85.28 106.91 17.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.45 -0.341 . . . . 0.23000000000000001 110.74 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 307' ' ' VAL . . . . . . . . . . . . . 18.4 m . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.281 -0.866 . . . . 16.109999999999999 111.135 179.985 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 . . . . . 0 N--CA 1.467 0.398 0 N-CA-C 112.132 0.419 . . . . 0.23000000000000001 112.132 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.43 HD11 HG22 ' A' ' 13' ' ' ILE . 0.2 OUTLIER -151.75 164.31 2.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 116.252 -0.431 . . . . 0.23000000000000001 111.577 179.447 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 1.2 ttm180 -118.8 156.82 28.74 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 111.783 0.29 . . . . 0.23000000000000001 111.783 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.4 m -143.51 153.61 16.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 112.004 0.372 . . . . 0.23000000000000001 112.004 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -115.06 118.25 32.87 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 116.365 -0.379 . . . . 0.23000000000000001 111.858 -179.442 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.7 t -114.65 124.24 71.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 116.297 -0.41 . . . . 0.23000000000000001 110.368 178.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -102.83 127.84 49.84 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.03 0.443 . . . . 0.23000000000000001 111.577 -179.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.63 118.23 12.23 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.045 -0.525 . . . . 0.23000000000000001 111.252 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -175.89 78.12 0.29 Allowed Pre-proline 0 CA--C 1.541 0.603 0 CA-C-N 116.437 -0.347 . . . . 0.23000000000000001 110.703 179.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -86.76 -18.67 20.56 Favored 'Cis proline' 0 C--N 1.363 1.311 0 CA-C-N 119.331 0.797 . . . . 0.23000000000000001 113.231 0.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -136.59 -178.0 4.98 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.794 0.33 . . . . 0.23000000000000001 111.592 -179.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.2 mp -63.99 -56.95 11.41 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.2 -0.455 . . . . 0.23000000000000001 110.563 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 107.16 29.38 4.57 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.885 -0.674 . . . . 0.23000000000000001 113.937 178.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -159.03 145.41 16.82 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 117.464 0.632 . . . . 0.23000000000000001 111.21 179.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 8.6 p -96.1 148.9 22.21 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 116.051 -0.522 . . . . 0.23000000000000001 111.647 -179.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 25.1 pt -124.52 150.35 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.109 0 CA-C-N 116.032 -0.531 . . . . 0.23000000000000001 111.348 -179.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 47.9 t -138.38 155.64 48.34 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.27 -0.423 . . . . 0.23000000000000001 110.298 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 158.5 -99.18 0.18 Allowed Glycine 0 C--N 1.334 0.439 0 C-N-CA 120.844 -0.693 . . . . 0.23000000000000001 112.519 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 50.23 110.6 0.01 OUTLIER Glycine 0 CA--C 1.527 0.831 0 N-CA-C 115.38 0.912 . . . . 0.23000000000000001 115.38 178.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 20.4 t -77.8 91.29 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.127 0 O-C-N 122.547 -0.384 . . . . 0.23000000000000001 110.837 179.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 91.69 -4.79 79.54 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 120.821 -0.704 . . . . 0.23000000000000001 114.149 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -111.26 9.51 28.87 Favored Glycine 0 C--N 1.342 0.908 0 CA-C-N 117.932 0.866 . . . . 0.23000000000000001 114.282 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -178.35 -77.29 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 117.736 0.768 . . . . 0.23000000000000001 109.626 178.647 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 113.13 152.81 11.21 Favored Glycine 0 C--N 1.335 0.491 0 CA-C-N 115.919 -0.582 . . . . 0.23000000000000001 113.124 179.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -125.76 136.3 28.19 Favored Pre-proline 0 CA--C 1.535 0.37 0 N-CA-C 110.345 -0.243 . . . . 0.23000000000000001 110.345 179.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -93.75 28.94 0.29 Allowed 'Trans proline' 0 C--N 1.356 0.947 0 C-N-CA 122.422 2.082 . . . . 0.23000000000000001 113.514 -179.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -108.03 -49.75 3.16 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.692 0.282 . . . . 0.23000000000000001 111.203 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 14.2 mmm180 -117.15 135.31 23.07 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-N 116.368 -0.378 . . . . 0.23000000000000001 111.004 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -83.57 -44.56 0.07 OUTLIER 'Trans proline' 0 C--N 1.359 1.104 0 C-N-CA 121.898 1.732 . . . . 0.23000000000000001 112.81 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -93.9 -13.4 27.21 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 112.543 0.571 . . . . 0.23000000000000001 112.543 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -101.35 118.46 37.02 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 117.864 0.302 . . . . 0.23000000000000001 110.318 179.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -108.44 42.39 1.4 Allowed 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 120.978 0.418 . . . . 0.23000000000000001 111.364 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -88.83 -156.32 31.25 Favored Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.889 -0.672 . . . . 0.23000000000000001 112.269 179.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 27.7 mm -109.97 135.44 48.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-N 116.678 0.239 . . . . 0.23000000000000001 110.843 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.429 ' N ' ' CD1' ' A' ' 46' ' ' PHE . 4.5 m-85 -132.7 148.24 52.34 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 120.681 0.277 . . . . 0.23000000000000001 111.42 -179.396 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 16.8 t -92.88 73.37 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 N-CA-C 112.324 0.49 . . . . 0.23000000000000001 112.324 -179.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.9 t -34.31 -53.13 0.5 Allowed 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 114.878 1.436 . . . . 0.23000000000000001 114.878 -178.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -160.31 177.39 10.67 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 121.87 -0.519 . . . . 0.23000000000000001 112.042 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 12.1 t -132.08 151.35 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-N 115.951 -0.568 . . . . 0.23000000000000001 110.991 -179.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -105.31 -68.24 0.04 OUTLIER Pre-proline 0 CA--C 1.538 0.517 0 N-CA-C 111.768 0.285 . . . . 0.23000000000000001 111.768 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -79.02 119.97 4.47 Favored 'Trans proline' 0 C--N 1.357 0.983 0 C-N-CA 121.811 1.674 . . . . 0.23000000000000001 112.557 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.38 66.81 4.03 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.003 0.43 . . . . 0.23000000000000001 111.629 -179.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -162.19 -66.58 0.02 OUTLIER Glycine 0 CA--C 1.528 0.865 0 C-N-CA 120.718 -0.753 . . . . 0.23000000000000001 113.522 -179.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.67 -74.46 0.02 OUTLIER 'Trans proline' 0 C--N 1.357 0.993 0 C-N-CA 122.043 1.828 . . . . 0.23000000000000001 113.469 -178.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -117.21 49.32 1.21 Allowed 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 121.054 0.454 . . . . 0.23000000000000001 112.122 -178.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 16.7 t -109.22 -58.67 2.0 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.748 -0.464 . . . . 0.23000000000000001 109.748 178.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 19.4 tptt -68.35 -10.84 57.76 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.812 -0.631 . . . . 0.23000000000000001 111.743 178.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 54.1 mt -91.24 -65.14 1.04 Allowed 'General case' 0 C--N 1.343 0.304 0 CA-C-N 118.022 0.374 . . . . 0.23000000000000001 110.85 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.5 mp -91.92 148.62 22.08 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.545 -0.298 . . . . 0.23000000000000001 110.958 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.4 pm0 -115.18 151.82 46.13 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-N 116.157 -0.474 . . . . 0.23000000000000001 109.985 178.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -57.37 128.53 29.9 Favored 'Trans proline' 0 C--N 1.356 0.962 0 C-N-CA 121.911 1.74 . . . . 0.23000000000000001 113.041 -179.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 93.86 15.63 48.33 Favored Glycine 0 CA--C 1.524 0.653 0 CA-C-N 115.919 -0.582 . . . . 0.23000000000000001 113.68 179.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -76.91 -174.49 3.11 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 117.518 0.659 . . . . 0.23000000000000001 111.064 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 47.0 tttm -141.89 125.11 16.4 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.984 -0.553 . . . . 0.23000000000000001 110.567 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 60.9 mt -90.54 113.34 26.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.206 -0.452 . . . . 0.23000000000000001 110.186 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 24.2 mm -90.91 -36.88 8.6 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-N 115.936 -0.575 . . . . 0.23000000000000001 112.077 -178.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.28 145.99 27.34 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.065 0.46 . . . . 0.23000000000000001 111.172 -179.245 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -136.97 119.69 16.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.89 -0.596 . . . . 0.23000000000000001 111.015 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.3 m120 45.95 30.04 0.84 Allowed 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 113.098 0.777 . . . . 0.23000000000000001 113.098 179.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 100.78 -14.21 58.99 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 120.693 -0.765 . . . . 0.23000000000000001 113.563 -179.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -88.49 153.7 20.94 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 117.506 0.653 . . . . 0.23000000000000001 110.09 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 12.5 m -101.25 124.62 47.23 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.434 -0.348 . . . . 0.23000000000000001 110.428 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -101.59 17.77 22.0 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 112.38 0.511 . . . . 0.23000000000000001 112.38 -179.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 7.9 tp -92.28 121.17 42.63 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 CA-C-O 120.923 0.392 . . . . 0.23000000000000001 110.61 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 62.17 76.47 0.37 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.103 -0.498 . . . . 0.23000000000000001 111.005 -179.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 23.7 pt -150.01 161.61 4.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.014 -0.539 . . . . 0.23000000000000001 110.802 179.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -81.25 140.72 34.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.967 0.413 . . . . 0.23000000000000001 111.396 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -41.49 -49.96 3.96 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 113.492 0.923 . . . . 0.23000000000000001 113.492 -179.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -57.56 -33.36 66.6 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 120.945 -0.645 . . . . 0.23000000000000001 112.965 -179.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 36.2 tp60 -69.74 -44.73 69.67 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.826 0.346 . . . . 0.23000000000000001 111.196 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.92 -63.37 1.13 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.305 -0.407 . . . . 0.23000000000000001 111.859 -179.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 24.4 t -50.81 -42.27 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 N-CA-C 112.125 0.417 . . . . 0.23000000000000001 112.125 -179.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 37.1 m -62.89 -39.53 94.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.735 0.303 . . . . 0.23000000000000001 111.306 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 16.6 mt -64.75 -49.5 70.56 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.301 -0.408 . . . . 0.23000000000000001 111.861 -179.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 54.4 mt -65.04 -33.16 75.38 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.232 0.456 . . . . 0.23000000000000001 112.232 -178.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 60.3 mttm -76.02 -37.32 58.53 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.188 0.44 . . . . 0.23000000000000001 112.188 -178.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 12.0 t -73.98 -26.12 60.29 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 112.556 0.576 . . . . 0.23000000000000001 112.556 -178.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -54.94 155.19 4.61 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.145 0.498 . . . . 0.23000000000000001 111.911 -178.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -63.29 -139.31 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.128 0 CA-C-N 115.733 -0.667 . . . . 0.23000000000000001 111.489 -178.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -82.01 -66.06 0.93 Allowed 'General case' 0 C--N 1.351 0.658 0 CA-C-N 119.345 0.975 . . . . 0.23000000000000001 112.251 -178.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.67 123.49 26.23 Favored 'General case' 0 CA--C 1.528 0.11 0 CA-C-O 120.939 0.399 . . . . 0.23000000000000001 110.958 -179.308 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 18.0 t -114.22 112.2 39.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.833 -0.621 . . . . 0.23000000000000001 110.634 179.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -89.7 112.26 23.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.359 -0.382 . . . . 0.23000000000000001 110.353 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 4.6 mp -115.06 154.02 29.63 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 121.115 0.483 . . . . 0.23000000000000001 112.044 -178.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 17.9 mm -109.38 122.7 64.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 115.46 -0.791 . . . . 0.23000000000000001 109.809 178.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 24.6 pt -118.11 157.73 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-O 120.685 0.279 . . . . 0.23000000000000001 111.047 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.7 t -142.95 146.82 21.29 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-O 121.06 0.457 . . . . 0.23000000000000001 111.708 -179.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.3 mmm-85 -111.69 110.38 20.74 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 109.113 -0.699 . . . . 0.23000000000000001 109.113 178.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.998 0.428 . . . . 0.23000000000000001 111.568 -179.509 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.869 0.366 . . . . 0.23000000000000001 110.375 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 305' ' ' THR . . . . . . . . . . . . . 7.9 m -97.84 131.13 44.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.108 -0.497 . . . . 17.879999999999999 111.201 -179.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 306' ' ' TRP . . . . . . . . . . . . . 92.4 m95 -89.16 106.4 18.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.127 -0.488 . . . . 0.23000000000000001 110.866 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 307' ' ' VAL . . . . . . . . . . . . . 16.5 m . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.176 -0.916 . . . . 16.109999999999999 111.094 179.987 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.584 0.23 . . . . 0.23000000000000001 110.582 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.91 159.31 36.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-O 121.071 0.462 . . . . 0.23000000000000001 111.703 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 15.4 ttm-85 -109.32 161.67 15.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.606 -0.724 . . . . 0.23000000000000001 111.413 -179.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.4 t -139.76 147.78 23.64 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 CA-C-N 116.335 -0.393 . . . . 0.23000000000000001 110.967 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 7.0 tpp85 -115.75 106.42 13.84 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.203 -0.453 . . . . 0.23000000000000001 110.706 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.1 t -111.68 127.43 68.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-N 116.317 -0.401 . . . . 0.23000000000000001 111.289 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -90.42 156.94 17.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 0.23000000000000001 110.513 179.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.7 74.95 1.1 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.074 0.464 . . . . 0.23000000000000001 110.406 179.637 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -141.38 85.84 11.52 Favored Pre-proline 0 CA--C 1.538 0.511 0 CA-C-N 116.135 -0.484 . . . . 0.23000000000000001 111.593 -179.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -85.83 -21.58 15.05 Favored 'Cis proline' 0 C--N 1.363 1.3 0 CA-C-N 119.638 0.906 . . . . 0.23000000000000001 113.211 0.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -138.04 -176.11 4.33 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.733 0.301 . . . . 0.23000000000000001 111.351 -179.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.9 mp -64.74 -57.87 7.8 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.434 -0.348 . . . . 0.23000000000000001 111.048 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 108.0 32.9 3.15 Favored Glycine 0 C--N 1.337 0.623 0 C-N-CA 120.86 -0.686 . . . . 0.23000000000000001 113.621 179.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -165.69 145.62 6.58 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 117.206 0.503 . . . . 0.23000000000000001 111.044 179.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.5 p -100.71 153.48 19.4 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.152 -0.476 . . . . 0.23000000000000001 111.536 -179.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 25.6 pt -122.26 150.11 25.77 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 115.793 -0.639 . . . . 0.23000000000000001 110.829 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 85.0 p -145.03 161.25 39.86 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 121.222 -0.191 . . . . 0.23000000000000001 111.427 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 119.3 -91.62 0.51 Allowed Glycine 0 C--N 1.34 0.752 0 C-N-CA 120.911 -0.661 . . . . 0.23000000000000001 114.191 178.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 67.32 -133.47 30.69 Favored Glycine 0 CA--C 1.521 0.416 0 C-N-CA 121.093 -0.575 . . . . 0.23000000000000001 112.38 -179.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 23.9 t -151.4 81.38 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 CA-C-O 121.141 0.496 . . . . 0.23000000000000001 109.832 179.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.56 15.15 44.57 Favored Glycine 0 CA--C 1.528 0.901 0 CA-C-N 115.753 -0.658 . . . . 0.23000000000000001 113.161 -178.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -93.98 -143.02 12.79 Favored Glycine 0 C--N 1.338 0.691 0 C-N-CA 120.855 -0.688 . . . . 0.23000000000000001 112.292 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 5.1 mmt85 -54.29 -26.17 27.78 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 112.497 0.554 . . . . 0.23000000000000001 112.497 -179.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.47 160.31 32.94 Favored Glycine 0 C--N 1.336 0.582 0 C-N-CA 120.768 -0.73 . . . . 0.23000000000000001 113.492 179.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -121.51 136.9 26.33 Favored Pre-proline 0 N--CA 1.466 0.333 0 N-CA-C 110.491 -0.189 . . . . 0.23000000000000001 110.491 179.396 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -92.83 26.96 0.37 Allowed 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 122.224 1.949 . . . . 0.23000000000000001 113.127 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -102.24 -49.78 3.81 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.761 0.315 . . . . 0.23000000000000001 111.008 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -124.51 140.37 35.16 Favored Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 116.272 -0.422 . . . . 0.23000000000000001 110.783 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -83.76 -41.95 0.09 OUTLIER 'Trans proline' 0 C--N 1.359 1.092 0 C-N-CA 122.028 1.819 . . . . 0.23000000000000001 113.201 -179.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -93.97 -13.08 27.42 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 112.854 0.687 . . . . 0.23000000000000001 112.854 -179.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -103.54 120.69 41.37 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 117.888 0.313 . . . . 0.23000000000000001 111.358 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -104.35 16.86 25.27 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 112.536 0.569 . . . . 0.23000000000000001 112.536 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -57.77 -167.29 0.12 Allowed Glycine 0 C--N 1.338 0.673 0 C-N-CA 120.637 -0.792 . . . . 0.23000000000000001 113.033 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 20.6 mm -104.28 125.97 59.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 N-CA-C 109.649 -0.5 . . . . 0.23000000000000001 109.649 179.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -122.66 146.52 47.39 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 120.796 0.332 . . . . 0.23000000000000001 111.428 -179.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 34.2 t -89.89 73.02 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-O 121.25 0.548 . . . . 0.23000000000000001 110.252 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.0 t -36.14 -53.59 0.8 Allowed 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 114.674 1.361 . . . . 0.23000000000000001 114.674 -178.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 7.7 ptm180 -158.64 168.77 25.98 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.198 0.523 . . . . 0.23000000000000001 112.321 -179.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.4 t -126.39 148.68 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-N 115.478 -0.783 . . . . 0.23000000000000001 110.372 179.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 7.1 mm-40 -105.25 -68.81 0.03 OUTLIER Pre-proline 0 CA--C 1.538 0.514 0 N-CA-C 111.706 0.261 . . . . 0.23000000000000001 111.706 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -79.26 120.19 4.44 Favored 'Trans proline' 0 C--N 1.357 0.998 0 C-N-CA 121.8 1.667 . . . . 0.23000000000000001 112.487 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -78.5 66.92 4.16 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 121.03 0.443 . . . . 0.23000000000000001 111.064 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -160.91 -65.87 0.02 OUTLIER Glycine 0 CA--C 1.527 0.836 0 C-N-CA 120.721 -0.752 . . . . 0.23000000000000001 113.548 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -56.27 -61.12 0.37 Allowed 'Trans proline' 0 C--N 1.356 0.973 0 C-N-CA 122.229 1.953 . . . . 0.23000000000000001 113.513 -178.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -136.21 58.56 1.74 Allowed 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 121.206 0.527 . . . . 0.23000000000000001 111.933 -178.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.8 t -119.3 -58.23 1.94 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.969 -0.56 . . . . 0.23000000000000001 109.898 179.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 25.3 tptp -64.56 -16.08 62.05 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.698 -0.683 . . . . 0.23000000000000001 111.743 178.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 39.5 mt -98.2 -49.73 4.61 Favored 'General case' 0 C--N 1.341 0.221 0 CA-C-O 120.805 0.336 . . . . 0.23000000000000001 111.441 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 41.9 mt -90.99 148.76 22.18 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.978 0.418 . . . . 0.23000000000000001 111.802 -179.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -116.04 137.25 23.25 Favored Pre-proline 0 CA--C 1.536 0.42 0 CA-C-N 115.877 -0.601 . . . . 0.23000000000000001 110.235 179.107 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -52.4 126.57 21.06 Favored 'Trans proline' 0 C--N 1.356 0.971 0 C-N-CA 122.011 1.808 . . . . 0.23000000000000001 113.044 -179.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 95.33 18.1 34.58 Favored Glycine 0 CA--C 1.521 0.428 0 C-N-CA 121.045 -0.598 . . . . 0.23000000000000001 113.807 179.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -86.18 144.64 27.37 Favored 'General case' 0 C--N 1.339 0.122 0 CA-C-N 117.625 0.713 . . . . 0.23000000000000001 110.679 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -92.89 129.57 38.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.266 -0.425 . . . . 0.23000000000000001 111.566 -179.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.8 mm -88.08 111.95 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 N-CA-C 109.872 -0.418 . . . . 0.23000000000000001 109.872 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 25.9 mm -90.63 -44.62 14.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 N-CA-C 112.385 0.513 . . . . 0.23000000000000001 112.385 -178.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -148.45 150.85 34.18 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.201 0.524 . . . . 0.23000000000000001 112.403 -178.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.406 ' HB2' ' CE1' ' A' ' 74' ' ' PHE . . . -142.46 124.32 15.17 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.398 -0.819 . . . . 0.23000000000000001 111.079 179.53 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.3 m120 45.13 27.64 0.33 Allowed 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 113.447 0.906 . . . . 0.23000000000000001 113.447 178.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 99.78 -8.84 59.97 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 120.808 -0.711 . . . . 0.23000000000000001 114.128 179.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -97.81 122.64 41.15 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 117.797 0.798 . . . . 0.23000000000000001 110.886 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.9 t -69.02 126.25 29.23 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.398 -0.365 . . . . 0.23000000000000001 110.432 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.406 ' CE1' ' HB2' ' A' ' 69' ' ' ALA . 3.1 m-85 -97.58 17.9 16.69 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 112.375 0.509 . . . . 0.23000000000000001 112.375 -179.027 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 30.5 mm -92.5 119.61 40.35 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-O 120.82 0.343 . . . . 0.23000000000000001 110.946 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 61.11 76.86 0.35 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.262 0.553 . . . . 0.23000000000000001 111.143 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 17.4 pt -145.97 150.3 15.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.747 -0.66 . . . . 0.23000000000000001 110.546 179.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -62.27 142.43 57.73 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.357 -0.383 . . . . 0.23000000000000001 111.165 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 12.3 t60 -47.97 -50.81 26.05 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 115.878 -0.601 . . . . 0.23000000000000001 112.597 -179.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -60.17 -27.58 65.33 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 120.864 -0.684 . . . . 0.23000000000000001 112.694 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -69.87 -43.57 71.57 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 120.948 0.404 . . . . 0.23000000000000001 110.878 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.68 -39.88 76.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.204 -0.453 . . . . 0.23000000000000001 111.491 -179.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 26.7 t -71.88 -45.24 65.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.218 -0.446 . . . . 0.23000000000000001 111.125 -179.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 36.1 t -62.61 -36.79 83.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.248 -0.433 . . . . 0.23000000000000001 111.548 -179.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 18.3 mt -68.0 -45.69 73.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.833 0.349 . . . . 0.23000000000000001 111.761 -179.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 18.3 mt -68.17 -32.89 73.46 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.237 0.458 . . . . 0.23000000000000001 112.237 -178.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 3.0 mtmp? -79.6 -37.98 34.99 Favored 'General case' 0 N--CA 1.457 -0.087 0 N-CA-C 112.341 0.497 . . . . 0.23000000000000001 112.341 -178.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 9.0 t -70.77 -23.28 62.37 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 112.239 0.459 . . . . 0.23000000000000001 112.239 -178.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -51.06 176.4 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 121.335 0.588 . . . . 0.23000000000000001 112.398 -178.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 87.0 mm-40 -82.08 -144.0 0.06 Allowed 'General case' 0 CA--C 1.551 0.998 0 CA-C-N 115.476 -0.783 . . . . 0.23000000000000001 111.119 -179.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -79.87 -63.48 1.4 Allowed 'General case' 0 C--N 1.347 0.493 0 CA-C-N 118.94 0.791 . . . . 0.23000000000000001 110.964 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -87.19 138.38 31.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.218 -0.446 . . . . 0.23000000000000001 110.198 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 18.2 t -127.08 121.65 58.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.324 -0.398 . . . . 0.23000000000000001 111.047 -179.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -93.52 101.46 13.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.444 . . . . 0.23000000000000001 110.337 179.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 5.6 mp -104.07 155.69 18.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.043 0.449 . . . . 0.23000000000000001 111.797 -179.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 41.4 mt -116.01 130.76 70.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.589 -0.732 . . . . 0.23000000000000001 109.641 178.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 39.3 pt -126.95 160.66 35.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-O 120.992 0.425 . . . . 0.23000000000000001 111.635 -179.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 71.9 t -143.17 149.42 18.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 115.911 -0.586 . . . . 0.23000000000000001 111.136 -179.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -112.84 117.51 32.35 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.799 -0.637 . . . . 0.23000000000000001 109.928 179.092 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 48.2 mm-40 . . . . . 0 C--N 1.328 -0.335 0 CA-C-O 120.832 0.349 . . . . 0.23000000000000001 111.723 -179.23 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.74 0.305 . . . . 0.23000000000000001 110.696 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 305' ' ' THR . . . . . . . . . . . . . 5.3 m -141.22 119.34 12.02 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.353 -0.385 . . . . 17.879999999999999 110.607 179.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 306' ' ' TRP . . . . . . . . . . . . . 83.6 m95 -84.29 117.32 23.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.23000000000000001 111.046 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 307' ' ' VAL . . . . . . . . . . . . . 16.2 m . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.261 -0.876 . . . . 16.109999999999999 111.159 179.964 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 . . . . . 0 CA--C 1.532 0.281 0 CA-C-O 120.716 0.293 . . . . 0.23000000000000001 110.277 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -113.97 164.16 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 112.665 0.617 . . . . 0.23000000000000001 112.665 -179.191 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 82.3 mtt-85 -100.56 168.49 9.68 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.475 -0.784 . . . . 0.23000000000000001 111.655 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 40.3 t -150.35 139.23 15.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-N 115.898 -0.592 . . . . 0.23000000000000001 111.015 179.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 39.7 mtt85 -113.93 108.09 16.58 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.298 -0.41 . . . . 0.23000000000000001 110.845 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.5 t -111.29 123.66 67.36 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.16 0 CA-C-N 116.527 -0.306 . . . . 0.23000000000000001 110.677 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -86.18 161.16 18.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 0.23000000000000001 111.179 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.3 73.28 0.81 Allowed 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.061 -0.518 . . . . 0.23000000000000001 110.545 179.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -138.68 85.13 17.41 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-N 116.092 -0.503 . . . . 0.23000000000000001 111.168 -179.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -86.03 -19.93 18.54 Favored 'Cis proline' 0 C--N 1.364 1.372 0 CA-C-N 119.507 0.86 . . . . 0.23000000000000001 113.129 0.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -136.46 -177.64 4.81 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 120.746 0.307 . . . . 0.23000000000000001 111.276 -179.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.2 mp -65.3 -55.81 16.21 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.248 -0.433 . . . . 0.23000000000000001 110.263 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 109.48 16.13 11.44 Favored Glycine 0 C--N 1.336 0.528 0 C-N-CA 120.794 -0.717 . . . . 0.23000000000000001 114.215 178.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -145.79 157.02 43.95 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 117.759 0.78 . . . . 0.23000000000000001 111.463 179.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.4 p -108.52 150.59 27.24 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 116.115 -0.493 . . . . 0.23000000000000001 111.171 -179.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 17.7 pt -122.88 151.67 27.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.105 -0.498 . . . . 0.23000000000000001 111.502 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 98.2 p -149.98 164.07 36.43 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.395 -0.366 . . . . 0.23000000000000001 111.207 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 112.48 -96.08 0.82 Allowed Glycine 0 C--N 1.337 0.601 0 C-N-CA 120.898 -0.668 . . . . 0.23000000000000001 113.876 178.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 74.52 -132.82 14.93 Favored Glycine 0 CA--C 1.519 0.309 0 C-N-CA 121.119 -0.562 . . . . 0.23000000000000001 112.401 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 24.1 t -149.75 87.16 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.95 -0.389 . . . . 0.23000000000000001 109.95 179.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 92.89 5.16 64.56 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 120.983 -0.627 . . . . 0.23000000000000001 113.693 -178.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -77.47 -134.62 0.71 Allowed Glycine 0 C--N 1.343 0.963 0 CA-C-N 117.741 0.77 . . . . 0.23000000000000001 112.723 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 1.4 mtt180 -71.17 -19.67 62.38 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.597 0.592 . . . . 0.23000000000000001 112.597 -179.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.92 -156.02 17.0 Favored Glycine 0 C--N 1.342 0.907 0 C-N-CA 120.701 -0.761 . . . . 0.23000000000000001 112.952 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -173.89 132.86 0.57 Allowed Pre-proline 0 CA--C 1.534 0.358 0 N-CA-C 110.539 -0.171 . . . . 0.23000000000000001 110.539 179.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -90.16 25.6 0.55 Allowed 'Trans proline' 0 C--N 1.358 1.048 0 C-N-CA 122.174 1.916 . . . . 0.23000000000000001 113.89 -179.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -110.25 -56.06 2.38 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.734 0.302 . . . . 0.23000000000000001 110.921 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -114.16 135.78 22.18 Favored Pre-proline 0 CA--C 1.535 0.389 0 CA-C-N 116.413 -0.358 . . . . 0.23000000000000001 110.689 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -86.96 -47.58 0.04 OUTLIER 'Trans proline' 0 C--N 1.36 1.14 0 C-N-CA 121.994 1.796 . . . . 0.23000000000000001 113.623 -179.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -95.83 -11.4 26.88 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 112.931 0.715 . . . . 0.23000000000000001 112.931 -179.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -94.48 115.91 28.16 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 117.904 0.32 . . . . 0.23000000000000001 110.27 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.4 p30 -102.3 64.52 0.92 Allowed 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 121.174 0.511 . . . . 0.23000000000000001 111.408 -179.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -116.15 -162.49 13.13 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 121.093 -0.575 . . . . 0.23000000000000001 112.316 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.438 HG22 HD11 ' A' ' 45' ' ' ILE . 15.8 mm -107.53 131.64 57.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 110.348 -0.242 . . . . 0.23000000000000001 110.348 179.537 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -129.55 149.87 51.13 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.77 0.319 . . . . 0.23000000000000001 111.107 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 21.8 t -97.13 73.58 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-N 116.213 -0.448 . . . . 0.23000000000000001 111.331 -179.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.6 t -35.34 -53.54 0.64 Allowed 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 114.527 1.306 . . . . 0.23000000000000001 114.527 -178.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 1.8 ptt-85 -158.53 163.84 36.69 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.059 0.457 . . . . 0.23000000000000001 112.112 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 5.3 t -121.26 154.85 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-N 115.674 -0.694 . . . . 0.23000000000000001 110.56 -179.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 3.6 mm-40 -104.73 -68.3 0.04 OUTLIER Pre-proline 0 CA--C 1.538 0.513 0 N-CA-C 111.575 0.213 . . . . 0.23000000000000001 111.575 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -80.37 120.13 3.96 Favored 'Trans proline' 0 C--N 1.358 1.07 0 C-N-CA 121.836 1.691 . . . . 0.23000000000000001 112.481 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -77.06 69.2 3.32 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 120.992 0.425 . . . . 0.23000000000000001 111.337 -179.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -165.04 -64.33 0.02 OUTLIER Glycine 0 CA--C 1.529 0.937 0 C-N-CA 120.696 -0.764 . . . . 0.23000000000000001 113.719 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.57 -72.52 0.03 OUTLIER 'Trans proline' 0 C--N 1.357 1.002 0 C-N-CA 122.072 1.848 . . . . 0.23000000000000001 113.72 -178.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -102.68 -10.92 18.8 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 113.796 1.036 . . . . 0.23000000000000001 113.796 -178.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.9 t -75.31 -25.93 58.27 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 112.131 0.419 . . . . 0.23000000000000001 112.131 -178.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.9 tppt? -76.81 -20.94 55.81 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 111.925 0.343 . . . . 0.23000000000000001 111.925 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 43.5 mt -123.48 6.43 8.96 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 113.773 1.027 . . . . 0.23000000000000001 113.773 -178.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 91.2 mt -136.03 148.9 48.58 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 118.344 0.52 . . . . 0.23000000000000001 111.729 179.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -104.98 141.49 22.66 Favored Pre-proline 0 CA--C 1.536 0.42 0 CA-C-N 115.744 -0.662 . . . . 0.23000000000000001 110.437 179.317 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -64.15 71.16 0.2 Allowed 'Trans proline' 0 C--N 1.362 1.254 0 C-N-CA 122.297 1.998 . . . . 0.23000000000000001 113.647 -179.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 139.16 40.42 0.09 OUTLIER Glycine 0 CA--C 1.524 0.617 0 C-N-CA 120.903 -0.665 . . . . 0.23000000000000001 113.299 179.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -96.36 -161.67 0.89 Allowed 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 117.034 0.417 . . . . 0.23000000000000001 110.661 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.6 tttm -138.77 122.0 16.98 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 120.718 0.294 . . . . 0.23000000000000001 110.818 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.3 mp -89.45 120.97 39.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-N 116.433 -0.349 . . . . 0.23000000000000001 110.534 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 20.1 mm -92.39 -40.39 12.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 112.65 0.611 . . . . 0.23000000000000001 112.65 -178.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 -150.38 150.86 31.96 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.12 0.486 . . . . 0.23000000000000001 111.981 -178.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -138.23 123.02 18.79 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.638 -0.71 . . . . 0.23000000000000001 111.684 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 62.8 m-20 40.85 33.63 0.22 Allowed 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 113.996 1.11 . . . . 0.23000000000000001 113.996 178.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 99.2 -20.87 48.29 Favored Glycine 0 CA--C 1.522 0.509 0 C-N-CA 120.724 -0.75 . . . . 0.23000000000000001 113.409 179.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -88.46 119.52 28.97 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 117.151 0.475 . . . . 0.23000000000000001 110.281 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 33.3 t -66.25 122.12 16.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.972 -0.558 . . . . 0.23000000000000001 111.005 -179.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -98.07 7.64 45.99 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 113.121 0.786 . . . . 0.23000000000000001 113.121 -178.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 6.5 tp -84.55 120.28 34.94 Favored 'Isoleucine or valine' 0 C--N 1.341 0.201 0 CA-C-N 118.392 0.542 . . . . 0.23000000000000001 110.678 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 62.13 75.93 0.39 Allowed 'General case' 0 C--O 1.232 0.184 0 CA-C-O 121.259 0.552 . . . . 0.23000000000000001 111.023 -179.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 16.0 pt -144.87 152.86 14.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.631 -0.713 . . . . 0.23000000000000001 110.514 179.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -64.61 150.9 46.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.039 0.447 . . . . 0.23000000000000001 110.992 -179.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 11.0 t60 -54.73 -55.11 33.37 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.08 -0.509 . . . . 0.23000000000000001 111.953 -179.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -55.55 -25.3 42.09 Favored Glycine 0 CA--C 1.523 0.544 0 C-N-CA 121.058 -0.592 . . . . 0.23000000000000001 113.309 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.21 -39.85 53.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.056 0.455 . . . . 0.23000000000000001 110.592 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.66 -35.88 67.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.834 -0.621 . . . . 0.23000000000000001 112.207 -179.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.6 t -76.08 -45.85 35.35 Favored 'Isoleucine or valine' 0 C--O 1.231 0.082 0 CA-C-O 120.83 0.348 . . . . 0.23000000000000001 111.022 -179.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 45.1 m -61.63 -35.33 77.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.122 -0.49 . . . . 0.23000000000000001 111.078 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 15.3 mt -70.64 -44.02 68.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.158 -0.474 . . . . 0.23000000000000001 111.171 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.403 ' HA ' ' CD2' ' A' ' 89' ' ' PHE . 13.7 mt -68.45 -31.03 70.05 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.283 0.475 . . . . 0.23000000000000001 112.283 -179.067 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 23.7 mtmt -83.79 -36.35 23.62 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.227 0.454 . . . . 0.23000000000000001 112.227 -179.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 9.0 t -72.26 -24.06 61.3 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 112.209 0.448 . . . . 0.23000000000000001 112.209 -178.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.403 ' CD2' ' HA ' ' A' ' 86' ' ' LEU . 8.3 m-85 -49.74 177.02 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 112.431 0.53 . . . . 0.23000000000000001 112.431 -178.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 50.9 mm-40 -82.17 -144.83 0.06 Allowed 'General case' 0 CA--C 1.549 0.911 0 CA-C-N 115.981 -0.554 . . . . 0.23000000000000001 110.689 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -78.24 -65.05 1.03 Allowed 'General case' 0 C--N 1.347 0.468 0 CA-C-N 118.977 0.808 . . . . 0.23000000000000001 111.021 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -83.58 140.35 32.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.283 -0.417 . . . . 0.23000000000000001 110.356 179.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 19.0 t -124.84 120.68 59.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.393 -0.367 . . . . 0.23000000000000001 111.275 -179.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -89.49 107.31 19.0 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.602 -0.518 . . . . 0.23000000000000001 109.602 179.134 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 15.2 mt -107.95 145.29 34.04 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.99 0.424 . . . . 0.23000000000000001 111.766 -178.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 15.9 mm -108.01 125.91 64.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 108.975 -0.75 . . . . 0.23000000000000001 108.975 178.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 41.6 pt -131.2 167.99 24.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 112.249 0.463 . . . . 0.23000000000000001 112.249 -178.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 18.3 t -149.72 153.94 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 115.925 -0.58 . . . . 0.23000000000000001 111.167 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -115.77 116.01 27.3 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.163 -0.471 . . . . 0.23000000000000001 110.315 179.307 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.344 -0.389 . . . . 0.23000000000000001 111.371 -179.505 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.737 0.303 . . . . 0.23000000000000001 110.796 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 305' ' ' THR . . . . . . . . . . . . . 16.9 m -139.76 120.88 14.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.303 -0.408 . . . . 17.879999999999999 110.953 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 306' ' ' TRP . . . . . . . . . . . . . 92.2 m95 -80.64 111.03 16.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.31 -0.405 . . . . 0.23000000000000001 110.863 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 307' ' ' VAL . . . . . . . . . . . . . 15.5 m . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.253 -0.879 . . . . 16.109999999999999 111.122 179.954 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 . . . . . 0 C--O 1.231 0.126 0 N-CA-C 109.264 -0.643 . . . . 0.23000000000000001 109.264 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.4 pt -117.48 159.24 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 116.105 -0.498 . . . . 0.23000000000000001 112.214 -178.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -112.95 157.58 21.31 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.685 -0.689 . . . . 0.23000000000000001 111.099 -179.361 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.5 m -141.66 139.68 31.43 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 116.136 -0.484 . . . . 0.23000000000000001 110.707 179.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -106.03 114.27 28.31 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.352 -0.386 . . . . 0.23000000000000001 111.605 -179.123 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.0 t -114.13 123.26 69.62 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-N 116.307 -0.406 . . . . 0.23000000000000001 110.997 179.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -98.95 119.08 37.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.321 -0.399 . . . . 0.23000000000000001 110.704 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 16.1 mttt -70.02 118.38 12.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.246 -0.434 . . . . 0.23000000000000001 111.048 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -171.98 85.57 0.45 Allowed Pre-proline 0 CA--C 1.536 0.435 0 CA-C-N 115.996 -0.547 . . . . 0.23000000000000001 110.655 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -84.0 -17.76 26.09 Favored 'Cis proline' 0 C--N 1.363 1.338 0 CA-C-N 119.383 0.815 . . . . 0.23000000000000001 113.42 0.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 51.7 mm-40 -136.79 -177.04 4.56 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 120.913 0.387 . . . . 0.23000000000000001 111.689 -179.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.412 ' HB3' ' CE2' ' A' ' 25' ' ' PHE . 4.5 mp -65.67 -56.1 13.93 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.058 -0.519 . . . . 0.23000000000000001 111.244 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 102.54 39.46 2.77 Favored Glycine 0 CA--C 1.522 0.488 0 C-N-CA 120.754 -0.736 . . . . 0.23000000000000001 113.926 178.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.412 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 43.3 p90 -169.85 156.91 6.5 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 117.155 0.477 . . . . 0.23000000000000001 111.202 179.173 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 9.3 p -113.55 154.64 26.78 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.138 -0.483 . . . . 0.23000000000000001 111.506 -179.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 46.6 pt -121.38 153.35 25.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-N 116.058 -0.519 . . . . 0.23000000000000001 111.799 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 77.6 p -141.21 155.24 46.07 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.311 -0.404 . . . . 0.23000000000000001 110.865 179.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 114.05 -158.26 14.43 Favored Glycine 0 C--N 1.335 0.508 0 C-N-CA 120.934 -0.651 . . . . 0.23000000000000001 113.369 179.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 137.27 -135.51 7.68 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 121.26 -0.495 . . . . 0.23000000000000001 112.234 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 39.5 t -141.88 75.38 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.225 0.536 . . . . 0.23000000000000001 109.877 179.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 93.59 13.56 55.11 Favored Glycine 0 CA--C 1.529 0.943 0 CA-C-N 115.66 -0.7 . . . . 0.23000000000000001 113.154 -178.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -86.74 -146.42 10.05 Favored Glycine 0 C--N 1.342 0.908 0 CA-C-N 117.598 0.699 . . . . 0.23000000000000001 112.695 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 69.6 mtt180 -56.46 -24.56 46.49 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 112.306 0.484 . . . . 0.23000000000000001 112.306 -179.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.24 175.46 48.76 Favored Glycine 0 C--N 1.336 0.536 0 C-N-CA 120.66 -0.781 . . . . 0.23000000000000001 112.629 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -139.53 146.55 48.52 Favored Pre-proline 0 CA--C 1.534 0.337 0 N-CA-C 110.473 -0.195 . . . . 0.23000000000000001 110.473 179.723 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -92.33 30.32 0.31 Allowed 'Trans proline' 0 C--N 1.358 1.039 0 C-N-CA 122.309 2.006 . . . . 0.23000000000000001 113.43 -179.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -107.48 -56.48 2.21 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.778 0.323 . . . . 0.23000000000000001 110.647 179.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -112.46 139.12 22.27 Favored Pre-proline 0 CA--C 1.534 0.33 0 CA-C-N 116.195 -0.457 . . . . 0.23000000000000001 110.376 179.41 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -87.58 -50.3 0.03 OUTLIER 'Trans proline' 0 C--N 1.358 1.044 0 C-N-CA 121.964 1.776 . . . . 0.23000000000000001 113.642 -178.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -95.43 -7.82 37.22 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 113.114 0.783 . . . . 0.23000000000000001 113.114 -179.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -90.9 113.75 26.03 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 118.106 0.412 . . . . 0.23000000000000001 110.766 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 14.1 p30 -98.88 54.82 1.01 Allowed 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 121.1 0.476 . . . . 0.23000000000000001 111.15 -179.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -112.45 -163.75 16.49 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 121.056 -0.592 . . . . 0.23000000000000001 112.577 179.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.419 HD11 HG22 ' A' ' 45' ' ' ILE . 13.1 mm -108.74 133.79 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 116.553 0.177 . . . . 0.23000000000000001 110.591 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.432 ' CD1' ' N ' ' A' ' 46' ' ' PHE . 3.7 m-85 -131.2 151.59 51.32 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 120.542 0.21 . . . . 0.23000000000000001 110.714 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 29.2 t -91.0 79.79 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-O 121.103 0.478 . . . . 0.23000000000000001 110.686 179.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.1 t -36.41 -53.78 0.85 Allowed 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 114.824 1.416 . . . . 0.23000000000000001 114.824 -178.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.48 179.47 8.59 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.236 0.541 . . . . 0.23000000000000001 112.372 -178.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 20.3 t -137.37 148.62 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 115.519 -0.764 . . . . 0.23000000000000001 110.48 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 7.2 mm-40 -105.06 -68.85 0.03 OUTLIER Pre-proline 0 CA--C 1.538 0.488 0 CA-C-O 119.629 -0.224 . . . . 0.23000000000000001 111.389 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -78.12 118.04 4.28 Favored 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 121.676 1.584 . . . . 0.23000000000000001 112.045 179.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.3 pm0 -75.63 66.95 2.04 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.114 0.483 . . . . 0.23000000000000001 111.257 -179.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -156.03 -69.83 0.01 OUTLIER Glycine 0 CA--C 1.528 0.868 0 C-N-CA 120.791 -0.719 . . . . 0.23000000000000001 113.335 -179.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -60.07 -75.81 0.02 OUTLIER 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 121.968 1.779 . . . . 0.23000000000000001 113.365 -179.019 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -104.05 46.06 0.93 Allowed 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 121.073 0.464 . . . . 0.23000000000000001 111.77 -179.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.9 t -114.4 -65.04 1.23 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.086 -0.506 . . . . 0.23000000000000001 110.006 179.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.1 tppm? -62.46 -21.22 65.27 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.705 -0.68 . . . . 0.23000000000000001 111.488 178.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 40.2 mt -97.73 -54.9 2.97 Favored 'General case' 0 C--N 1.339 0.128 0 CA-C-O 120.59 0.233 . . . . 0.23000000000000001 111.558 -179.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 32.6 mt -93.96 146.94 23.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.807 0.337 . . . . 0.23000000000000001 111.563 -179.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -118.84 143.06 32.91 Favored Pre-proline 0 CA--C 1.537 0.472 0 CA-C-N 116.073 -0.512 . . . . 0.23000000000000001 110.333 179.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -62.19 131.69 35.6 Favored 'Trans proline' 0 C--N 1.359 1.092 0 C-N-CA 122.128 1.886 . . . . 0.23000000000000001 113.761 -179.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 93.88 18.7 36.5 Favored Glycine 0 C--N 1.335 0.482 0 CA-C-N 115.934 -0.575 . . . . 0.23000000000000001 113.89 178.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -85.16 -171.71 3.78 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 117.33 0.565 . . . . 0.23000000000000001 111.227 -179.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 43.5 tttm -135.11 122.03 21.16 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.274 -0.421 . . . . 0.23000000000000001 110.773 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 20.6 mt -90.12 117.3 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-N 116.378 -0.374 . . . . 0.23000000000000001 111.017 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 20.2 mm -96.01 -36.77 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 N-CA-C 112.287 0.477 . . . . 0.23000000000000001 112.287 -179.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.02 150.55 30.09 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.136 0.493 . . . . 0.23000000000000001 112.07 -178.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.403 ' HB2' ' CE1' ' A' ' 74' ' ' PHE . . . -137.25 119.94 16.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.611 -0.722 . . . . 0.23000000000000001 110.822 179.315 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.405 ' HB2' ' CZ ' ' A' ' 89' ' ' PHE . 62.8 m-20 42.56 28.87 0.13 Allowed 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 113.775 1.028 . . . . 0.23000000000000001 113.775 179.26 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 99.31 5.69 55.78 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 120.888 -0.672 . . . . 0.23000000000000001 113.98 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -109.32 121.28 44.82 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 117.911 0.856 . . . . 0.23000000000000001 110.084 179.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.3 t -68.03 121.0 15.18 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.798 0.332 . . . . 0.23000000000000001 111.235 -179.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . 0.403 ' CE1' ' HB2' ' A' ' 69' ' ' ALA . 3.9 m-30 -99.63 15.15 27.62 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 116.173 -0.467 . . . . 0.23000000000000001 112.069 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 7.7 tp -92.2 123.41 44.3 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-O 120.785 0.326 . . . . 0.23000000000000001 110.86 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 61.29 73.78 0.47 Allowed 'General case' 0 C--O 1.232 0.167 0 CA-C-O 121.258 0.551 . . . . 0.23000000000000001 110.773 -179.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 11.7 pt -149.21 160.93 5.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.707 -0.679 . . . . 0.23000000000000001 110.646 179.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -73.29 139.47 46.12 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.22 -0.445 . . . . 0.23000000000000001 111.225 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 3.8 t-160 -48.25 -49.74 32.25 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 112.463 0.542 . . . . 0.23000000000000001 112.463 -179.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -56.63 -28.26 56.16 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 121.13 -0.557 . . . . 0.23000000000000001 112.944 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -73.96 -40.91 62.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.888 0.375 . . . . 0.23000000000000001 110.372 179.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.98 -36.41 83.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.053 -0.522 . . . . 0.23000000000000001 111.032 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.1 t -75.04 -41.4 45.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.072 -0.513 . . . . 0.23000000000000001 110.821 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 54.3 p -60.45 -45.66 92.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.955 -0.566 . . . . 0.23000000000000001 111.291 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 54.8 mt -65.84 -44.66 84.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.275 -0.42 . . . . 0.23000000000000001 111.611 -179.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 12.6 mt -66.74 -36.54 82.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.23 -0.441 . . . . 0.23000000000000001 112.105 -178.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 54.9 mttm -75.31 -38.56 60.21 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.632 0.604 . . . . 0.23000000000000001 112.632 -178.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 11.5 t -70.94 -24.85 62.52 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.958 0.725 . . . . 0.23000000000000001 112.958 -178.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.405 ' CZ ' ' HB2' ' A' ' 70' ' ' ASN . 8.5 m-85 -47.82 173.55 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 113.205 0.817 . . . . 0.23000000000000001 113.205 -178.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 6.9 mm-40 -81.38 -145.58 0.06 Allowed 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 115.277 -0.874 . . . . 0.23000000000000001 110.517 -179.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -79.36 -66.78 0.83 Allowed 'General case' 0 C--N 1.345 0.401 0 CA-C-N 118.911 0.778 . . . . 0.23000000000000001 110.721 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -76.91 126.37 30.86 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.27 -0.423 . . . . 0.23000000000000001 110.645 179.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 21.2 t -119.27 123.23 70.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.118 -0.492 . . . . 0.23000000000000001 110.97 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -100.68 106.46 17.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.23000000000000001 110.578 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -100.36 149.92 23.13 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.071 -0.513 . . . . 0.23000000000000001 111.47 -179.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 17.5 mm -108.54 124.87 65.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.82 -0.627 . . . . 0.23000000000000001 109.38 178.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 43.4 pt -129.23 165.17 29.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.735 0.302 . . . . 0.23000000000000001 111.255 -179.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 14.6 t -150.38 154.57 8.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.009 0.433 . . . . 0.23000000000000001 111.689 -179.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -108.49 112.76 25.31 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 108.681 -0.859 . . . . 0.23000000000000001 108.681 177.694 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 . . . . . 0 N--CA 1.462 0.157 0 N-CA-C 112.534 0.568 . . . . 0.23000000000000001 112.534 -178.638 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 4.9 pm0 . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.674 0.273 . . . . 0.23000000000000001 110.492 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 305' ' ' THR . . . . . . . . . . . . . 5.7 m -132.97 121.79 23.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.39 -0.368 . . . . 17.879999999999999 110.888 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 306' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -85.58 118.55 25.16 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.23 -0.441 . . . . 0.23000000000000001 110.99 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 307' ' ' VAL . . . . . . . . . . . . . 18.3 m . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.21 -0.9 . . . . 16.109999999999999 111.139 179.953 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.529 0.156 0 CA-C-O 120.775 0.322 . . . . 0.23000000000000001 111.097 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.419 HG22 HD11 ' A' ' 13' ' ' ILE . 0.2 OUTLIER -139.82 155.29 24.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.958 0.409 . . . . 0.23000000000000001 111.544 -179.893 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.74 167.13 10.08 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.17 -0.468 . . . . 0.23000000000000001 111.448 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 22.4 t -146.82 153.5 12.6 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 115.933 -0.576 . . . . 0.23000000000000001 110.966 179.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.05 118.65 22.88 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.238 -0.437 . . . . 0.23000000000000001 110.278 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.3 t -125.43 130.63 72.78 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-O 120.924 0.392 . . . . 0.23000000000000001 111.453 -179.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -100.02 146.11 27.11 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.912 -0.586 . . . . 0.23000000000000001 110.067 179.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.64 76.59 9.51 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.863 0.363 . . . . 0.23000000000000001 110.492 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -140.8 85.65 12.47 Favored Pre-proline 0 CA--C 1.539 0.528 0 CA-C-N 116.334 -0.393 . . . . 0.23000000000000001 111.706 -179.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -82.15 -30.67 4.76 Favored 'Cis proline' 0 C--N 1.363 1.338 0 CA-C-N 119.409 0.825 . . . . 0.23000000000000001 113.172 0.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -138.19 -178.54 5.32 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.872 0.367 . . . . 0.23000000000000001 111.361 -179.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.2 mp -62.09 -61.89 2.16 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.047 -0.524 . . . . 0.23000000000000001 110.83 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 103.79 34.87 3.65 Favored Glycine 0 CA--C 1.52 0.38 0 C-N-CA 120.825 -0.702 . . . . 0.23000000000000001 113.783 179.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -163.57 145.95 9.73 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 117.254 0.527 . . . . 0.23000000000000001 111.137 179.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.8 p -100.63 150.4 22.76 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.001 -0.545 . . . . 0.23000000000000001 111.056 -179.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 25.4 pt -117.23 147.63 20.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.134 -0.484 . . . . 0.23000000000000001 110.867 179.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 12.9 p -138.35 153.92 48.96 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.77 0.319 . . . . 0.23000000000000001 111.293 -179.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 113.47 -158.92 13.97 Favored Glycine 0 C--N 1.332 0.323 0 C-N-CA 120.977 -0.63 . . . . 0.23000000000000001 113.519 179.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 109.47 153.38 14.91 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 121.234 -0.507 . . . . 0.23000000000000001 112.022 -179.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 17.9 t -76.82 98.39 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-O 121.081 0.467 . . . . 0.23000000000000001 110.522 -179.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 96.0 10.25 56.42 Favored Glycine 0 CA--C 1.528 0.866 0 CA-C-N 115.657 -0.701 . . . . 0.23000000000000001 113.349 -179.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.6 -158.28 32.66 Favored Glycine 0 C--N 1.342 0.865 0 C-N-CA 120.708 -0.758 . . . . 0.23000000000000001 112.712 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -59.61 -27.63 66.48 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 112.327 0.491 . . . . 0.23000000000000001 112.327 -179.067 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 117.57 -167.02 12.66 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 120.743 -0.741 . . . . 0.23000000000000001 112.662 -179.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -145.44 125.92 7.27 Favored Pre-proline 0 CA--C 1.533 0.291 0 O-C-N 122.928 -0.16 . . . . 0.23000000000000001 110.871 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -92.31 24.7 0.48 Allowed 'Trans proline' 0 C--N 1.355 0.913 0 C-N-CA 122.122 1.881 . . . . 0.23000000000000001 112.875 179.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -124.49 -49.63 1.78 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 120.793 0.33 . . . . 0.23000000000000001 110.639 179.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -114.83 130.98 23.69 Favored Pre-proline 0 CA--C 1.533 0.301 0 CA-C-N 116.148 -0.478 . . . . 0.23000000000000001 110.455 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -85.0 -44.85 0.05 OUTLIER 'Trans proline' 0 C--N 1.356 0.927 0 C-N-CA 121.965 1.776 . . . . 0.23000000000000001 113.22 -179.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -89.6 -3.95 58.05 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.06 0.763 . . . . 0.23000000000000001 113.06 -179.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -109.94 125.26 52.66 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 118.156 0.435 . . . . 0.23000000000000001 110.576 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -109.98 31.29 5.97 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.385 -0.37 . . . . 0.23000000000000001 111.647 -179.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -76.49 -146.62 2.04 Favored Glycine 0 CA--C 1.519 0.34 0 C-N-CA 120.811 -0.709 . . . . 0.23000000000000001 111.98 179.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 14.7 mm -124.13 135.36 63.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-N 116.934 0.367 . . . . 0.23000000000000001 110.469 179.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.427 ' CD1' ' N ' ' A' ' 46' ' ' PHE . 7.7 m-85 -132.99 151.98 52.01 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.451 -0.34 . . . . 0.23000000000000001 111.16 -179.586 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 21.8 t -97.34 74.23 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 CA-C-O 121.058 0.456 . . . . 0.23000000000000001 110.797 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.0 t -31.44 -53.23 0.23 Allowed 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 115.057 1.503 . . . . 0.23000000000000001 115.057 -178.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.9 -178.92 7.14 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.155 0.502 . . . . 0.23000000000000001 111.987 -179.457 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.0 t -134.73 150.75 30.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 115.549 -0.75 . . . . 0.23000000000000001 110.61 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -104.86 -68.23 0.04 OUTLIER Pre-proline 0 CA--C 1.538 0.495 0 N-CA-C 111.728 0.269 . . . . 0.23000000000000001 111.728 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -79.25 119.39 4.2 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 121.781 1.654 . . . . 0.23000000000000001 112.275 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -75.15 68.33 1.9 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.931 0.396 . . . . 0.23000000000000001 110.872 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -161.19 -66.64 0.02 OUTLIER Glycine 0 CA--C 1.529 0.936 0 C-N-CA 120.651 -0.785 . . . . 0.23000000000000001 113.821 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -58.32 -76.44 0.02 OUTLIER 'Trans proline' 0 C--N 1.356 0.949 0 C-N-CA 122.166 1.911 . . . . 0.23000000000000001 113.452 -178.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -115.32 50.95 0.95 Allowed 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.289 0.566 . . . . 0.23000000000000001 111.298 -179.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.4 t -112.85 -63.37 1.45 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.823 -0.626 . . . . 0.23000000000000001 110.45 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.82 -13.64 61.78 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.125 -0.489 . . . . 0.23000000000000001 111.569 179.313 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 34.6 mt -96.61 -54.43 3.24 Favored 'General case' 0 C--N 1.345 0.388 0 O-C-N 122.091 -0.381 . . . . 0.23000000000000001 111.101 179.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 56.5 mt -91.93 146.86 23.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.07 -0.513 . . . . 0.23000000000000001 111.453 -179.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -118.25 137.47 24.65 Favored Pre-proline 0 CA--C 1.537 0.48 0 CA-C-N 116.156 -0.474 . . . . 0.23000000000000001 110.016 178.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.82 131.01 43.57 Favored 'Trans proline' 0 C--N 1.361 1.195 0 C-N-CA 122.341 2.027 . . . . 0.23000000000000001 113.931 -178.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 96.73 16.59 35.88 Favored Glycine 0 CA--C 1.523 0.576 0 CA-C-N 115.637 -0.71 . . . . 0.23000000000000001 113.816 178.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -81.65 -169.1 2.16 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 117.379 0.589 . . . . 0.23000000000000001 111.298 -179.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 45.8 tttp -139.31 124.57 19.05 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 116.406 -0.361 . . . . 0.23000000000000001 110.28 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 33.9 mt -89.02 115.16 28.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.382 -0.372 . . . . 0.23000000000000001 110.615 -179.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 23.9 mm -94.19 -38.17 9.01 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 116.097 -0.501 . . . . 0.23000000000000001 112.126 -178.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.08 150.89 31.23 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.178 0.514 . . . . 0.23000000000000001 112.096 -179.025 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -145.56 124.68 12.87 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 115.722 -0.672 . . . . 0.23000000000000001 110.942 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.6 m120 43.95 31.7 0.54 Allowed 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.603 0.964 . . . . 0.23000000000000001 113.603 179.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 97.6 -6.0 62.64 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 120.78 -0.724 . . . . 0.23000000000000001 114.068 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -102.03 123.06 45.27 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 117.83 0.815 . . . . 0.23000000000000001 110.775 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 7.9 m -71.43 126.8 30.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.363 -0.38 . . . . 0.23000000000000001 110.927 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -99.75 6.64 45.46 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 112.697 0.629 . . . . 0.23000000000000001 112.697 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 7.3 tp -83.85 120.06 34.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 118.165 0.438 . . . . 0.23000000000000001 110.896 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 63.3 76.17 0.37 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.032 0.444 . . . . 0.23000000000000001 111.072 -179.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 9.3 pt -150.19 164.77 3.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.917 -0.583 . . . . 0.23000000000000001 110.817 179.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.7 mp0 -78.75 148.52 32.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.139 0.495 . . . . 0.23000000000000001 111.454 -179.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 23.9 t60 -53.47 -54.13 41.44 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.645 -0.707 . . . . 0.23000000000000001 112.282 -179.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -55.33 -27.43 47.15 Favored Glycine 0 CA--C 1.52 0.373 0 C-N-CA 121.147 -0.549 . . . . 0.23000000000000001 113.163 -179.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.4 tp60 -73.57 -39.02 64.98 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.028 0.442 . . . . 0.23000000000000001 110.544 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.11 -55.91 12.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.88 -0.6 . . . . 0.23000000000000001 111.933 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 17.2 t -58.29 -44.0 87.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.436 -0.347 . . . . 0.23000000000000001 111.787 -179.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.6 t -60.39 -39.24 86.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.42 -0.355 . . . . 0.23000000000000001 111.596 -179.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 30.2 mt -67.52 -43.61 80.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.391 -0.368 . . . . 0.23000000000000001 111.825 -179.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.412 ' HA ' ' CD2' ' A' ' 89' ' ' PHE . 22.2 mt -66.66 -42.07 87.18 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.062 0.393 . . . . 0.23000000000000001 112.062 -179.022 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 15.1 mttm -64.48 -41.47 96.47 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.106 0.41 . . . . 0.23000000000000001 112.106 -178.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 9.7 t -64.11 -22.61 67.0 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.548 0.573 . . . . 0.23000000000000001 112.548 -178.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.412 ' CD2' ' HA ' ' A' ' 86' ' ' LEU . 21.4 m-85 -60.81 131.0 49.29 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.951 0.405 . . . . 0.23000000000000001 110.495 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -65.77 -105.34 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.959 0 N-CA-C 112.661 0.615 . . . . 0.23000000000000001 112.661 -178.388 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -88.4 -83.04 0.22 Allowed 'General case' 0 C--N 1.35 0.618 0 CA-C-N 119.422 1.01 . . . . 0.23000000000000001 113.321 -178.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -71.22 162.17 29.87 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 121.128 0.489 . . . . 0.23000000000000001 111.658 -178.652 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 19.9 t -151.41 112.91 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.601 -0.727 . . . . 0.23000000000000001 110.612 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.1 mp0 -89.01 122.51 32.43 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 110.005 -0.369 . . . . 0.23000000000000001 110.005 179.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 14.1 mt -121.56 143.05 49.51 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 112.544 0.572 . . . . 0.23000000000000001 112.544 -178.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 42.4 mt -114.07 129.28 70.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 108.742 -0.836 . . . . 0.23000000000000001 108.742 177.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 43.5 pt -134.71 172.99 15.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 112.424 0.527 . . . . 0.23000000000000001 112.424 -178.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 20.2 t -147.25 151.66 13.63 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 CA-C-N 115.739 -0.664 . . . . 0.23000000000000001 110.731 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -123.2 113.51 19.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.312 -0.403 . . . . 0.23000000000000001 110.53 179.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.144 -0.48 . . . . 0.23000000000000001 111.336 -179.319 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.81 0.338 . . . . 0.23000000000000001 111.128 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 305' ' ' THR . . . . . . . . . . . . . 7.4 m -109.38 134.69 51.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.009 -0.541 . . . . 17.879999999999999 110.613 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 306' ' ' TRP . . . . . . . . . . . . . 83.4 m95 -97.43 131.71 43.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.885 0.374 . . . . 0.23000000000000001 111.058 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 307' ' ' VAL . . . . . . . . . . . . . 24.0 m . . . . . 0 C--O 1.25 1.125 0 CA-C-O 118.271 -0.871 . . . . 16.109999999999999 111.153 -179.876 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 . . . . . 0 N--CA 1.465 0.284 0 CA-C-O 120.802 0.334 . . . . 0.23000000000000001 111.5 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.404 HG22 HD11 ' A' ' 13' ' ' ILE . 0.2 OUTLIER -114.42 154.8 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 CA-C-N 116.029 -0.532 . . . . 0.23000000000000001 111.934 179.934 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 1.1 ttt85 -93.09 165.45 12.83 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.579 -0.737 . . . . 0.23000000000000001 111.628 -179.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 53.9 t -141.1 118.59 8.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 116.18 -0.464 . . . . 0.23000000000000001 111.241 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -105.48 109.29 21.21 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 110.035 -0.357 . . . . 0.23000000000000001 110.035 178.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.0 t -121.37 131.81 72.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-O 120.883 0.373 . . . . 0.23000000000000001 111.517 -179.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -92.04 164.07 13.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.079 -0.51 . . . . 0.23000000000000001 110.162 179.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.32 74.93 1.05 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 121.337 0.589 . . . . 0.23000000000000001 110.949 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -141.61 84.71 12.06 Favored Pre-proline 0 CA--C 1.54 0.593 0 CA-C-N 116.134 -0.485 . . . . 0.23000000000000001 111.419 -179.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -83.73 -23.92 11.87 Favored 'Cis proline' 0 C--N 1.364 1.352 0 CA-C-N 119.444 0.837 . . . . 0.23000000000000001 113.009 0.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -139.14 -169.07 2.57 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 120.692 0.282 . . . . 0.23000000000000001 110.986 -179.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.2 mp -67.47 -49.43 63.61 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-O 120.807 0.337 . . . . 0.23000000000000001 110.228 179.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 106.22 24.32 6.9 Favored Glycine 0 C--N 1.333 0.364 0 C-N-CA 120.972 -0.633 . . . . 0.23000000000000001 113.371 179.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -160.52 153.87 21.99 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 117.14 0.47 . . . . 0.23000000000000001 111.28 179.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.8 p -104.03 156.77 17.59 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.083 -0.508 . . . . 0.23000000000000001 110.977 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 30.9 pt -122.91 149.39 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 116.346 -0.388 . . . . 0.23000000000000001 111.1 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.4 m -151.29 169.74 21.22 Favored 'General case' 0 CA--C 1.53 0.212 0 CA-C-N 116.238 -0.437 . . . . 0.23000000000000001 111.144 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.66 21.49 26.24 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 121.076 -0.583 . . . . 0.23000000000000001 114.164 178.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -60.47 151.96 38.89 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.655 -0.783 . . . . 0.23000000000000001 112.343 179.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 58.5 t -78.37 106.91 9.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.028 0.442 . . . . 0.23000000000000001 110.281 -179.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 94.24 -5.42 71.38 Favored Glycine 0 CA--C 1.53 0.994 0 CA-C-N 115.752 -0.658 . . . . 0.23000000000000001 113.635 -178.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -85.89 -139.87 5.36 Favored Glycine 0 C--N 1.345 1.075 0 CA-C-N 117.804 0.802 . . . . 0.23000000000000001 113.236 -179.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 8.6 mmt180 -75.75 -17.91 59.73 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 112.756 0.65 . . . . 0.23000000000000001 112.756 -178.106 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 99.25 -150.12 19.15 Favored Glycine 0 C--N 1.339 0.749 0 C-N-CA 120.508 -0.853 . . . . 0.23000000000000001 112.477 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -166.57 132.95 1.93 Allowed Pre-proline 0 CA--C 1.535 0.393 0 CA-C-N 116.626 0.213 . . . . 0.23000000000000001 110.99 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -90.41 25.7 0.53 Allowed 'Trans proline' 0 C--N 1.36 1.135 0 C-N-CA 122.193 1.929 . . . . 0.23000000000000001 113.689 -179.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -110.65 -54.69 2.56 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.755 0.312 . . . . 0.23000000000000001 110.785 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.408 ' HG3' ' CE2' ' A' ' 46' ' ' PHE . 4.9 mmp_? -108.41 144.76 30.14 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-N 116.309 -0.405 . . . . 0.23000000000000001 110.311 179.558 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -89.17 -51.9 0.02 OUTLIER 'Trans proline' 0 C--N 1.357 1.026 0 C-N-CA 121.899 1.733 . . . . 0.23000000000000001 113.853 -178.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -99.28 -2.47 36.44 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 113.359 0.874 . . . . 0.23000000000000001 113.359 -178.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -95.07 117.92 31.0 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 118.264 0.484 . . . . 0.23000000000000001 110.601 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -101.08 37.01 1.84 Allowed 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.304 -0.407 . . . . 0.23000000000000001 111.958 -179.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.4 -168.03 38.52 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.798 -0.715 . . . . 0.23000000000000001 112.466 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.2 mm -102.83 129.21 54.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 109.478 -0.564 . . . . 0.23000000000000001 109.478 178.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.413 ' CD1' ' N ' ' A' ' 46' ' ' PHE . 1.2 m-85 -129.99 149.49 51.69 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.839 0.352 . . . . 0.23000000000000001 110.925 -179.154 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 38.8 t -89.77 79.07 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-N 116.212 -0.449 . . . . 0.23000000000000001 111.306 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.9 t -37.82 -53.31 1.3 Allowed 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 114.483 1.29 . . . . 0.23000000000000001 114.483 -178.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.5 ptt-85 -160.3 165.49 31.22 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 118.229 0.468 . . . . 0.23000000000000001 112.111 -179.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 12.1 t -122.98 148.38 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-N 115.717 -0.674 . . . . 0.23000000000000001 110.805 -179.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -100.21 -68.41 0.04 OUTLIER Pre-proline 0 CA--C 1.538 0.487 0 CA-C-O 119.738 -0.172 . . . . 0.23000000000000001 111.129 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -80.78 117.22 3.28 Favored 'Trans proline' 0 C--N 1.358 1.07 0 C-N-CA 121.715 1.61 . . . . 0.23000000000000001 112.581 179.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -75.57 70.55 2.41 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 120.954 0.407 . . . . 0.23000000000000001 110.784 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -162.8 -65.92 0.02 OUTLIER Glycine 0 CA--C 1.529 0.937 0 C-N-CA 120.789 -0.72 . . . . 0.23000000000000001 113.354 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -58.27 -78.26 0.02 OUTLIER 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 122.118 1.878 . . . . 0.23000000000000001 112.924 -179.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -108.19 46.88 0.93 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.47 0.652 . . . . 0.23000000000000001 110.582 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 91.7 p -101.95 -61.43 1.39 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.556 -0.747 . . . . 0.23000000000000001 110.193 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -71.77 -7.12 46.24 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 115.872 -0.604 . . . . 0.23000000000000001 112.206 179.115 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 66.3 mt -95.57 -59.61 1.84 Allowed 'General case' 0 C--N 1.344 0.332 0 CA-C-N 118.244 0.474 . . . . 0.23000000000000001 111.541 -179.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.7 mt -95.63 144.31 26.18 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.654 0.264 . . . . 0.23000000000000001 111.452 -179.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.1 pm0 -112.35 142.73 27.5 Favored Pre-proline 0 CA--C 1.538 0.488 0 CA-C-N 116.284 -0.416 . . . . 0.23000000000000001 110.382 178.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -50.93 130.32 30.92 Favored 'Trans proline' 0 C--N 1.359 1.105 0 C-N-CA 122.206 1.937 . . . . 0.23000000000000001 113.667 -179.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 82.59 24.73 52.85 Favored Glycine 0 C--N 1.333 0.386 0 CA-C-N 115.853 -0.612 . . . . 0.23000000000000001 113.637 178.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 20.6 p30 -86.98 -171.79 3.68 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 117.025 0.413 . . . . 0.23000000000000001 110.793 -179.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 66.5 tttt -140.33 128.83 22.76 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 112.109 0.411 . . . . 0.23000000000000001 112.109 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.0 mp -93.59 118.82 40.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 CA-C-N 115.788 -0.642 . . . . 0.23000000000000001 109.833 179.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 23.7 mm -92.67 -33.97 5.74 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 CA-C-N 116.427 -0.351 . . . . 0.23000000000000001 111.86 -178.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 -146.88 148.85 32.24 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.95 0.405 . . . . 0.23000000000000001 111.456 -179.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -138.5 114.84 10.36 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.986 -0.552 . . . . 0.23000000000000001 111.509 -179.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 49.32 29.11 2.57 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 113.11 0.781 . . . . 0.23000000000000001 113.11 179.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 101.03 -22.65 38.55 Favored Glycine 0 CA--C 1.521 0.458 0 C-N-CA 120.787 -0.721 . . . . 0.23000000000000001 113.178 179.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -89.16 127.95 35.76 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 117.099 0.449 . . . . 0.23000000000000001 110.696 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.2 m -65.93 130.35 42.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 0.23000000000000001 110.974 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -104.65 21.58 16.59 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.231 -0.44 . . . . 0.23000000000000001 111.662 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 6.6 tp -101.68 140.53 20.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 O-C-N 122.249 -0.282 . . . . 0.23000000000000001 110.99 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 34.7 m-20 65.54 10.72 6.89 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 112.905 0.706 . . . . 0.23000000000000001 112.905 -178.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 17.3 pt -89.12 156.09 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 121.334 0.588 . . . . 0.23000000000000001 112.584 -178.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -80.84 153.6 27.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.118 -0.946 . . . . 0.23000000000000001 110.615 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 9.3 t60 -49.8 -55.26 14.78 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 112.284 0.476 . . . . 0.23000000000000001 112.284 -179.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -54.83 -28.0 45.83 Favored Glycine 0 C--N 1.335 0.522 0 C-N-CA 121.039 -0.6 . . . . 0.23000000000000001 113.351 -179.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -72.78 -41.86 64.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.943 0.401 . . . . 0.23000000000000001 110.484 179.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.78 -57.4 8.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.039 -0.528 . . . . 0.23000000000000001 111.742 -179.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 15.4 t -56.7 -43.95 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-O 120.871 0.367 . . . . 0.23000000000000001 111.595 -179.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 38.0 m -60.79 -43.18 98.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.118 -0.492 . . . . 0.23000000000000001 111.438 -179.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 12.8 mt -65.51 -47.39 76.13 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.39 -0.368 . . . . 0.23000000000000001 111.577 -179.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.409 ' HA ' ' CD2' ' A' ' 89' ' ' PHE . 26.5 mt -64.37 -41.77 96.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.44 -0.345 . . . . 0.23000000000000001 111.661 -179.033 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 36.8 mmtt -64.23 -41.71 96.88 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.626 0.602 . . . . 0.23000000000000001 112.626 -178.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 11.3 t -72.02 -25.04 61.66 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 113.459 0.911 . . . . 0.23000000000000001 113.459 -177.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.409 ' CD2' ' HA ' ' A' ' 86' ' ' LEU . 14.8 m-85 -53.81 156.6 2.71 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.53 0.681 . . . . 0.23000000000000001 112.741 -178.476 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -61.72 -145.55 0.0 OUTLIER 'General case' 0 CA--C 1.556 1.179 0 CA-C-N 115.127 -0.942 . . . . 0.23000000000000001 111.672 -178.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -81.25 -59.52 2.61 Favored 'General case' 0 C--N 1.35 0.62 0 CA-C-N 118.859 0.754 . . . . 0.23000000000000001 111.829 -178.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.15 135.19 33.39 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 110.015 -0.365 . . . . 0.23000000000000001 110.015 -179.644 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 12.0 t -127.6 124.82 64.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.865 0.364 . . . . 0.23000000000000001 111.484 -179.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -101.03 114.87 29.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.169 -0.469 . . . . 0.23000000000000001 110.25 179.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 5.7 mp -113.58 160.84 18.11 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.082 0.468 . . . . 0.23000000000000001 111.929 -179.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 22.9 mm -118.67 129.73 74.51 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-N 115.632 -0.713 . . . . 0.23000000000000001 110.263 179.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 7.1 pt -134.14 166.79 27.8 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-O 120.577 0.227 . . . . 0.23000000000000001 111.592 -179.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.3 t -144.88 155.27 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-O 121.203 0.525 . . . . 0.23000000000000001 111.873 -179.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.26 110.15 20.23 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.57 -0.741 . . . . 0.23000000000000001 109.361 178.798 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 . . . . . 0 N--CA 1.464 0.229 0 CA-C-O 121.025 0.441 . . . . 0.23000000000000001 112.164 -178.468 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.853 0.359 . . . . 0.23000000000000001 111.101 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 305' ' ' THR . . . . . . . . . . . . . 11.5 m -119.05 130.66 55.75 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.017 -0.538 . . . . 17.879999999999999 110.611 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 306' ' ' TRP . . . . . . . . . . . . . 82.3 m95 -90.68 105.35 17.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.895 0.378 . . . . 0.23000000000000001 110.904 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 307' ' ' VAL . . . . . . . . . . . . . 15.9 m . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.248 -0.882 . . . . 16.109999999999999 111.138 179.924 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.534 0.345 0 CA-C-O 120.726 0.298 . . . . 0.23000000000000001 111.048 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -105.87 160.64 5.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.956 -0.566 . . . . 0.23000000000000001 111.377 -179.071 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.72 151.07 26.69 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 115.815 -0.629 . . . . 0.23000000000000001 111.129 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.3 t -137.29 137.11 46.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.198 -0.455 . . . . 0.23000000000000001 110.837 179.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.52 111.46 24.18 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.382 -0.372 . . . . 0.23000000000000001 110.783 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.8 t -105.47 116.83 50.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.26 -0.427 . . . . 0.23000000000000001 110.812 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -94.61 116.92 29.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.317 -0.401 . . . . 0.23000000000000001 110.853 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 24.5 mttt -71.57 127.37 32.35 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.479 0.656 . . . . 0.23000000000000001 110.934 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -172.18 83.09 0.45 Allowed Pre-proline 0 CA--C 1.539 0.555 0 CA-C-N 115.89 -0.596 . . . . 0.23000000000000001 110.872 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -85.85 -8.78 48.08 Favored 'Cis proline' 0 C--N 1.366 1.448 0 CA-C-N 119.426 0.831 . . . . 0.23000000000000001 113.786 0.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -137.29 -177.53 4.81 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.789 0.328 . . . . 0.23000000000000001 111.264 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.5 mp -63.03 -57.15 11.64 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.14 -0.482 . . . . 0.23000000000000001 111.105 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 102.29 29.02 6.18 Favored Glycine 0 C--N 1.337 0.631 0 C-N-CA 120.82 -0.705 . . . . 0.23000000000000001 113.675 178.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 36.0 p90 -157.26 145.31 19.18 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 117.131 0.465 . . . . 0.23000000000000001 110.825 179.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.5 p -98.85 149.7 22.64 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.168 -0.469 . . . . 0.23000000000000001 111.608 -179.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 21.0 pt -121.7 147.8 25.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.763 -0.653 . . . . 0.23000000000000001 110.288 179.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 34.1 t -143.68 163.38 33.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.839 0.352 . . . . 0.23000000000000001 111.078 -179.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 103.51 -146.67 16.51 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 121.042 -0.599 . . . . 0.23000000000000001 112.61 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.12 156.57 29.02 Favored Glycine 0 N--CA 1.452 -0.233 0 C-N-CA 120.966 -0.635 . . . . 0.23000000000000001 112.228 -179.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 17.3 t -78.64 101.61 4.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.872 0.368 . . . . 0.23000000000000001 110.773 -179.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 92.85 1.55 67.67 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 120.979 -0.629 . . . . 0.23000000000000001 113.746 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -82.13 -155.38 15.82 Favored Glycine 0 C--N 1.341 0.831 0 CA-C-N 117.965 0.882 . . . . 0.23000000000000001 113.038 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 73.7 mtt180 -63.64 -27.92 69.56 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.638 0.236 . . . . 0.23000000000000001 111.638 -179.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.54 168.32 38.41 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 120.608 -0.805 . . . . 0.23000000000000001 112.794 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -137.11 139.13 27.42 Favored Pre-proline 0 CA--C 1.534 0.359 0 O-C-N 123.004 -0.115 . . . . 0.23000000000000001 110.804 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -92.53 27.3 0.37 Allowed 'Trans proline' 0 C--N 1.358 1.078 0 C-N-CA 122.396 2.064 . . . . 0.23000000000000001 113.291 -179.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -100.77 -54.1 2.9 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.71 0.291 . . . . 0.23000000000000001 110.956 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -114.17 141.45 26.39 Favored Pre-proline 0 CA--C 1.533 0.295 0 CA-C-N 116.356 -0.384 . . . . 0.23000000000000001 110.606 179.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -87.59 -50.32 0.03 OUTLIER 'Trans proline' 0 C--N 1.358 1.049 0 C-N-CA 121.992 1.794 . . . . 0.23000000000000001 113.66 -178.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -87.44 -11.47 49.0 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 112.913 0.709 . . . . 0.23000000000000001 112.913 -179.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -101.31 115.99 31.77 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 117.984 0.356 . . . . 0.23000000000000001 110.793 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 30.9 p-10 -104.42 44.63 1.01 Allowed 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 121.211 0.529 . . . . 0.23000000000000001 110.712 179.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -92.42 -159.45 35.19 Favored Glycine 0 C--N 1.332 0.328 0 CA-C-N 115.826 -0.625 . . . . 0.23000000000000001 112.71 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.1 mm -107.5 131.94 56.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 110.312 -0.255 . . . . 0.23000000000000001 110.312 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -131.58 148.66 52.63 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.816 0.341 . . . . 0.23000000000000001 111.307 -179.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 24.0 t -89.78 73.95 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-O 121.158 0.504 . . . . 0.23000000000000001 111.014 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.6 t -38.4 -52.63 1.55 Allowed 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 114.444 1.276 . . . . 0.23000000000000001 114.444 -178.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -158.02 162.37 38.14 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 121.108 0.48 . . . . 0.23000000000000001 112.116 -179.546 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 15.7 t -120.93 149.55 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 115.605 -0.725 . . . . 0.23000000000000001 110.47 179.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 18.8 mm-40 -104.35 -67.77 0.04 OUTLIER Pre-proline 0 CA--C 1.538 0.513 0 N-CA-C 111.941 0.348 . . . . 0.23000000000000001 111.941 -179.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -76.87 124.5 7.48 Favored 'Trans proline' 0 C--N 1.357 1.004 0 C-N-CA 121.666 1.577 . . . . 0.23000000000000001 112.79 -179.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.85 63.4 3.56 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.21 -0.45 . . . . 0.23000000000000001 111.142 -179.718 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -158.35 -66.97 0.01 OUTLIER Glycine 0 CA--C 1.526 0.774 0 C-N-CA 120.57 -0.824 . . . . 0.23000000000000001 113.643 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -57.58 -77.07 0.02 OUTLIER 'Trans proline' 0 C--N 1.357 1.011 0 C-N-CA 122.195 1.93 . . . . 0.23000000000000001 113.63 -178.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -118.34 51.8 1.06 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 121.267 0.556 . . . . 0.23000000000000001 111.208 -179.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 19.8 t -116.56 -60.17 1.88 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.884 -0.598 . . . . 0.23000000000000001 110.142 179.003 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 40.2 pttt -69.22 -9.99 55.62 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.971 -0.559 . . . . 0.23000000000000001 111.977 179.007 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 69.5 mt -102.5 -52.24 3.15 Favored 'General case' 0 C--N 1.345 0.371 0 CA-C-N 118.237 0.471 . . . . 0.23000000000000001 110.936 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 53.3 mt -91.02 158.42 16.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.23000000000000001 111.36 -179.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -130.65 143.03 47.65 Favored Pre-proline 0 CA--C 1.535 0.377 0 CA-C-N 116.094 -0.503 . . . . 0.23000000000000001 110.429 179.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -50.44 128.1 22.32 Favored 'Trans proline' 0 C--N 1.361 1.219 0 C-N-CA 122.099 1.866 . . . . 0.23000000000000001 113.389 -179.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.06 2.25 48.58 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 120.979 -0.629 . . . . 0.23000000000000001 113.911 179.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -75.95 140.91 42.32 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 118.024 0.912 . . . . 0.23000000000000001 111.151 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 60.7 tttp -97.54 129.1 44.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.889 -0.596 . . . . 0.23000000000000001 110.909 179.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 28.3 mt -89.06 114.07 26.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.534 -0.303 . . . . 0.23000000000000001 110.562 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 21.1 mm -89.72 -44.06 14.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 112.934 0.716 . . . . 0.23000000000000001 112.934 -178.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 9.6 mt-30 -148.23 149.53 32.08 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.348 0.594 . . . . 0.23000000000000001 112.344 -178.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -136.82 121.4 18.39 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 115.398 -0.819 . . . . 0.23000000000000001 111.121 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 48.1 m-20 45.67 28.46 0.54 Allowed 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 113.298 0.851 . . . . 0.23000000000000001 113.298 178.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 101.7 -14.09 57.73 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 120.762 -0.732 . . . . 0.23000000000000001 113.705 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -88.59 127.99 35.57 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-N 117.685 0.742 . . . . 0.23000000000000001 110.432 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 79.4 p -76.27 127.04 32.1 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.254 -0.43 . . . . 0.23000000000000001 110.784 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -101.97 14.2 32.64 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 112.225 0.454 . . . . 0.23000000000000001 112.225 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 31.4 mm -90.65 125.53 43.46 Favored 'Isoleucine or valine' 0 C--N 1.341 0.226 0 O-C-N 122.011 -0.43 . . . . 0.23000000000000001 110.97 179.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 61.64 71.88 0.53 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-O 121.279 0.561 . . . . 0.23000000000000001 110.838 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 12.7 pt -149.01 165.84 3.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.918 -0.583 . . . . 0.23000000000000001 110.792 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -80.97 145.21 31.33 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.95 0.405 . . . . 0.23000000000000001 110.771 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -52.5 -51.73 58.03 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 116.014 -0.539 . . . . 0.23000000000000001 112.05 -179.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -56.58 -27.46 54.62 Favored Glycine 0 C--N 1.334 0.424 0 C-N-CA 121.103 -0.57 . . . . 0.23000000000000001 112.938 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 7.1 tm0? -72.72 -40.2 66.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.957 0.408 . . . . 0.23000000000000001 110.316 179.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.48 -36.13 82.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.994 -0.548 . . . . 0.23000000000000001 111.314 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.4 t -73.4 -44.13 54.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.978 0.418 . . . . 0.23000000000000001 110.572 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 23.0 t -56.49 -38.07 71.23 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.229 -0.441 . . . . 0.23000000000000001 111.135 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 89.6 mt -71.78 -39.54 69.86 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.077 -0.511 . . . . 0.23000000000000001 110.364 179.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 75.2 mt -78.14 -3.0 40.25 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 113.003 0.742 . . . . 0.23000000000000001 113.003 179.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 11.5 mmtp -99.23 -40.78 7.78 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-O 121.302 0.572 . . . . 0.23000000000000001 110.303 178.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 8.9 t -73.86 -24.53 59.76 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 113.251 0.834 . . . . 0.23000000000000001 113.251 -178.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -48.52 171.62 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 113.322 0.86 . . . . 0.23000000000000001 113.322 -178.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -86.99 -142.47 0.11 Allowed 'General case' 0 CA--C 1.554 1.113 0 CA-C-N 115.455 -0.793 . . . . 0.23000000000000001 111.214 -179.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -78.13 -68.32 0.65 Allowed 'General case' 0 C--N 1.349 0.561 0 CA-C-N 119.027 0.83 . . . . 0.23000000000000001 111.017 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.41 134.24 35.52 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.371 -0.377 . . . . 0.23000000000000001 110.572 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 21.3 t -120.84 124.67 72.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.253 -0.43 . . . . 0.23000000000000001 111.138 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -89.78 115.12 26.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 0.23000000000000001 109.982 179.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.0 mt -118.57 148.24 42.87 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.043 0.449 . . . . 0.23000000000000001 112.041 -178.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 48.6 mt -119.56 132.22 69.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 115.614 -0.721 . . . . 0.23000000000000001 109.527 178.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 35.1 pt -130.67 169.03 22.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.864 0.364 . . . . 0.23000000000000001 111.762 -179.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 58.2 t -133.01 143.02 40.67 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 115.931 -0.577 . . . . 0.23000000000000001 111.042 -179.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.49 102.23 10.11 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.12 -0.696 . . . . 0.23000000000000001 109.12 178.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 . . . . . 0 C--N 1.328 -0.346 0 CA-C-O 120.848 0.356 . . . . 0.23000000000000001 111.727 -178.895 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 . . . . . 0 N--CA 1.464 0.245 0 CA-C-O 120.842 0.353 . . . . 0.23000000000000001 110.904 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 305' ' ' THR . . . . . . . . . . . . . 3.5 m -105.1 123.42 47.79 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.109 -0.496 . . . . 17.879999999999999 110.688 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 306' ' ' TRP . . . . . . . . . . . . . 88.5 m95 -89.02 112.2 23.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.26 -0.427 . . . . 0.23000000000000001 110.951 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 307' ' ' VAL . . . . . . . . . . . . . 17.8 m . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.241 -0.885 . . . . 16.109999999999999 111.077 -179.994 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.162 0 N-CA-C 112.489 -0.244 . . . . 0.23000000000000001 112.489 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 75.6 p -158.01 -179.57 8.25 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.862 0.363 . . . . 0.23000000000000001 110.942 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 13.4 t-80 -76.41 134.53 39.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 0.23000000000000001 110.826 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 10.7 mmt -83.77 162.59 20.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.264 -0.425 . . . . 0.23000000000000001 110.895 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -157.49 -78.44 0.02 OUTLIER Glycine 0 CA--C 1.518 0.233 0 C-N-CA 120.825 -0.703 . . . . 0.23000000000000001 112.44 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -89.64 60.0 4.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.263 0.554 . . . . 0.23000000000000001 110.646 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -167.82 177.34 5.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.847 -0.615 . . . . 0.23000000000000001 110.881 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 16.6 tp -72.99 103.84 3.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.461 . . . . 0.23000000000000001 111.065 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -171.0 -171.17 0.95 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.297 -0.41 . . . . 0.23000000000000001 111.374 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 5.2 mtpt -63.88 104.52 0.7 Allowed 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.148 -0.478 . . . . 0.23000000000000001 111.093 -179.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.8 168.66 9.99 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.35 -0.386 . . . . 0.23000000000000001 110.936 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -132.72 95.57 3.62 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.412 -0.358 . . . . 0.23000000000000001 110.962 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -112.99 159.52 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-O 121.155 0.502 . . . . 0.23000000000000001 112.202 -179.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 11.5 ttp-105 -114.5 155.23 26.81 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 115.605 -0.725 . . . . 0.23000000000000001 110.9 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.9 m -136.65 143.73 34.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.386 -0.37 . . . . 0.23000000000000001 111.217 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.5 mtm180 -108.44 106.85 17.15 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.271 -0.422 . . . . 0.23000000000000001 110.609 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.8 t -110.31 110.39 31.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.306 -0.406 . . . . 0.23000000000000001 110.883 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -88.79 128.76 35.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.308 -0.405 . . . . 0.23000000000000001 110.899 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 10.4 mtmt -80.53 115.04 19.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.08 -0.509 . . . . 0.23000000000000001 110.937 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -166.98 89.06 0.76 Allowed Pre-proline 0 CA--C 1.535 0.39 0 CA-C-N 115.913 -0.585 . . . . 0.23000000000000001 110.634 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -79.72 -24.06 13.07 Favored 'Cis proline' 0 C--N 1.363 1.317 0 CA-C-N 119.36 0.807 . . . . 0.23000000000000001 112.879 0.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 54.4 mm-40 -135.53 -176.8 4.4 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.8 0.333 . . . . 0.23000000000000001 111.451 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.405 ' HB3' ' CE2' ' A' ' 25' ' ' PHE . 3.0 mp -63.47 -59.08 5.13 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.061 -0.518 . . . . 0.23000000000000001 111.02 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 106.75 31.18 4.02 Favored Glycine 0 CA--C 1.521 0.415 0 C-N-CA 120.867 -0.682 . . . . 0.23000000000000001 113.585 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.405 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 28.3 p90 -162.62 155.44 19.52 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 117.066 0.433 . . . . 0.23000000000000001 111.235 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.1 p -108.12 152.98 23.8 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.106 -0.497 . . . . 0.23000000000000001 111.4 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 41.3 pt -120.27 148.71 23.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.059 -0.518 . . . . 0.23000000000000001 110.632 179.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.5 t -139.45 167.71 21.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.871 0.367 . . . . 0.23000000000000001 111.05 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.46 -146.4 18.19 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.972 -0.632 . . . . 0.23000000000000001 112.382 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 101.54 153.32 25.75 Favored Glycine 0 C--N 1.331 0.255 0 C-N-CA 120.848 -0.692 . . . . 0.23000000000000001 112.491 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 25.9 t -79.53 97.24 2.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.906 0.384 . . . . 0.23000000000000001 111.003 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 98.81 -2.72 58.58 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 120.999 -0.62 . . . . 0.23000000000000001 113.937 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -78.64 -155.75 8.83 Favored Glycine 0 C--N 1.34 0.781 0 CA-C-N 117.842 0.821 . . . . 0.23000000000000001 113.04 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -62.12 -29.41 70.31 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.505 0.193 . . . . 0.23000000000000001 111.341 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 107.94 153.74 17.75 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.969 -0.634 . . . . 0.23000000000000001 112.606 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -112.28 129.85 23.91 Favored Pre-proline 0 N--CA 1.468 0.468 0 CA-C-O 119.886 -0.102 . . . . 0.23000000000000001 110.764 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -92.85 34.9 0.23 Allowed 'Trans proline' 0 C--N 1.357 0.999 0 C-N-CA 122.357 2.038 . . . . 0.23000000000000001 113.129 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -116.12 -49.21 2.7 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.761 0.315 . . . . 0.23000000000000001 110.952 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 32.1 mmt180 -116.36 138.93 24.72 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 116.234 -0.439 . . . . 0.23000000000000001 110.806 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -83.63 -44.31 0.07 OUTLIER 'Trans proline' 0 C--N 1.357 1.023 0 C-N-CA 121.972 1.782 . . . . 0.23000000000000001 112.936 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -92.03 -8.58 45.59 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 112.794 0.664 . . . . 0.23000000000000001 112.794 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -108.22 123.21 48.41 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 118.08 0.4 . . . . 0.23000000000000001 110.885 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.2 p30 -110.04 34.67 3.74 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.265 -0.425 . . . . 0.23000000000000001 111.072 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -78.73 -158.56 12.5 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 120.925 -0.655 . . . . 0.23000000000000001 112.485 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 20.5 mm -108.94 131.04 60.76 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 N-CA-C 110.418 -0.215 . . . . 0.23000000000000001 110.418 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -130.48 146.39 52.02 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.87 0.367 . . . . 0.23000000000000001 111.545 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 22.0 t -90.38 73.95 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 116.149 -0.478 . . . . 0.23000000000000001 110.672 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.2 t -34.47 -54.31 0.53 Allowed 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 114.767 1.395 . . . . 0.23000000000000001 114.767 -178.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 11.0 ptm180 -160.3 170.87 20.19 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.201 0.524 . . . . 0.23000000000000001 112.171 -179.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.2 t -125.23 147.24 29.93 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 CA-C-N 115.485 -0.779 . . . . 0.23000000000000001 110.355 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 8.3 mm-40 -103.91 -68.09 0.04 OUTLIER Pre-proline 0 CA--C 1.535 0.4 0 CA-C-N 116.833 -0.167 . . . . 0.23000000000000001 111.277 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -79.83 119.33 3.97 Favored 'Trans proline' 0 C--N 1.356 0.951 0 C-N-CA 121.694 1.596 . . . . 0.23000000000000001 112.173 179.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -79.59 66.27 5.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.276 0.56 . . . . 0.23000000000000001 110.793 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -143.86 -73.37 0.03 OUTLIER Glycine 0 CA--C 1.526 0.734 0 CA-C-N 115.721 -0.672 . . . . 0.23000000000000001 112.58 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -60.2 -70.03 0.04 OUTLIER 'Trans proline' 0 C--N 1.358 1.03 0 C-N-CA 121.832 1.688 . . . . 0.23000000000000001 112.938 -179.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -99.02 43.4 1.06 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-O 120.99 0.424 . . . . 0.23000000000000001 111.415 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 92.9 p -87.11 -59.41 2.26 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.184 -0.462 . . . . 0.23000000000000001 110.304 179.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -91.12 -4.0 56.6 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.791 -0.641 . . . . 0.23000000000000001 112.244 179.318 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -91.62 -69.52 0.73 Allowed 'General case' 0 C--N 1.341 0.22 0 CA-C-N 118.231 0.469 . . . . 0.23000000000000001 111.606 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.7 mt -96.82 146.31 25.04 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.896 0.379 . . . . 0.23000000000000001 111.921 -179.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -112.61 151.17 43.69 Favored Pre-proline 0 N--CA 1.47 0.574 0 CA-C-N 115.568 -0.742 . . . . 0.23000000000000001 110.478 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -64.22 129.22 23.56 Favored 'Trans proline' 0 C--N 1.355 0.909 0 C-N-CA 121.872 1.714 . . . . 0.23000000000000001 112.588 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 92.71 18.99 38.87 Favored Glycine 0 CA--C 1.523 0.541 0 C-N-CA 120.929 -0.653 . . . . 0.23000000000000001 113.689 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -93.54 151.35 19.76 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 117.306 0.553 . . . . 0.23000000000000001 110.762 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 60.1 tttm -100.1 130.27 46.23 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.348 -0.387 . . . . 0.23000000000000001 111.212 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 28.0 mt -89.85 117.08 32.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 116.163 -0.471 . . . . 0.23000000000000001 110.411 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 22.1 mm -90.48 -43.96 14.63 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 N-CA-C 112.062 0.393 . . . . 0.23000000000000001 112.062 -178.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -145.14 150.79 37.39 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.812 0.339 . . . . 0.23000000000000001 111.652 -178.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -138.32 119.78 14.91 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.136 -0.484 . . . . 0.23000000000000001 111.487 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.4 m120 46.47 29.0 0.81 Allowed 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 113.254 0.835 . . . . 0.23000000000000001 113.254 178.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 101.78 -20.25 46.74 Favored Glycine 0 CA--C 1.521 0.468 0 C-N-CA 120.747 -0.739 . . . . 0.23000000000000001 113.391 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -88.77 126.51 35.37 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 117.212 0.506 . . . . 0.23000000000000001 110.535 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.5 t -72.53 141.71 48.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 0.23000000000000001 110.576 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -111.43 20.57 17.11 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.106 0.41 . . . . 0.23000000000000001 112.106 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 24.7 mm -97.52 137.66 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-O 120.681 0.277 . . . . 0.23000000000000001 111.446 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 65.31 10.69 6.7 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.983 0.734 . . . . 0.23000000000000001 112.983 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 9.5 pt -92.88 163.08 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 N-CA-C 113.375 0.879 . . . . 0.23000000000000001 113.375 -178.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -83.03 144.7 29.76 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.184 -0.916 . . . . 0.23000000000000001 109.79 179.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 8.8 t-160 -52.35 -51.4 59.01 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 112.385 0.513 . . . . 0.23000000000000001 112.385 -178.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -53.95 -28.39 40.14 Favored Glycine 0 C--N 1.335 0.509 0 C-N-CA 121.104 -0.569 . . . . 0.23000000000000001 113.127 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.4 tp-100 -75.77 -37.72 59.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.993 0.425 . . . . 0.23000000000000001 110.309 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.63 -47.92 68.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.931 -0.577 . . . . 0.23000000000000001 111.373 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 20.3 t -62.02 -43.37 97.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.217 -0.447 . . . . 0.23000000000000001 111.271 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 33.2 t -60.77 -38.32 84.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.271 -0.422 . . . . 0.23000000000000001 111.424 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 32.7 mt -67.66 -45.54 74.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.318 -0.401 . . . . 0.23000000000000001 111.454 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.419 ' HA ' ' CD2' ' A' ' 89' ' ' PHE . 15.6 mt -64.21 -36.25 83.44 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.395 0.517 . . . . 0.23000000000000001 112.395 -179.128 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 34.2 mttm -72.19 -37.98 69.17 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.651 0.612 . . . . 0.23000000000000001 112.651 -178.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 9.9 t -70.99 -27.02 63.4 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 113.089 0.774 . . . . 0.23000000000000001 113.089 -178.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.419 ' CD2' ' HA ' ' A' ' 86' ' ' LEU . 13.3 m-85 -49.45 148.01 3.0 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 112.747 0.647 . . . . 0.23000000000000001 112.747 -178.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -65.65 -137.75 0.0 OUTLIER 'General case' 0 CA--C 1.551 0.994 0 CA-C-N 115.487 -0.779 . . . . 0.23000000000000001 111.292 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -81.36 -69.79 0.58 Allowed 'General case' 0 C--N 1.351 0.646 0 CA-C-N 119.488 1.04 . . . . 0.23000000000000001 112.403 -178.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.18 121.36 21.09 Favored 'General case' 0 C--O 1.231 0.08 0 CA-C-O 120.839 0.352 . . . . 0.23000000000000001 111.068 -179.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 19.1 t -112.58 111.89 38.08 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-N 116.124 -0.489 . . . . 0.23000000000000001 111.004 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -93.44 126.08 38.39 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 110.018 -0.364 . . . . 0.23000000000000001 110.018 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 2.0 mt -130.42 159.93 35.55 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.074 0.464 . . . . 0.23000000000000001 111.867 -178.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 48.2 mt -119.17 129.18 75.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.597 -0.729 . . . . 0.23000000000000001 109.984 178.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 33.0 pt -125.55 165.32 23.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-O 120.97 0.414 . . . . 0.23000000000000001 111.878 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 44.3 t -144.61 149.34 17.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 115.73 -0.668 . . . . 0.23000000000000001 111.555 -179.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.51 116.29 28.6 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.639 -0.709 . . . . 0.23000000000000001 109.091 179.002 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -63.12 166.5 5.93 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 120.936 0.398 . . . . 0.23000000000000001 111.647 -178.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.7 m -149.89 108.52 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.8 -0.637 . . . . 0.23000000000000001 110.973 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 31.5 t -149.45 110.02 4.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.311 -0.404 . . . . 0.23000000000000001 110.922 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 8.3 t . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.234 -0.888 . . . . 0.23000000000000001 110.799 179.995 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 301' ' ' THR . . . . . . . . . . . . . 2.8 m . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.813 0.34 . . . . 0.23000000000000001 111.208 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 302' ' ' GLY . . . . . . . . . . . . . . . 78.12 130.43 0.56 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.914 -0.66 . . . . 0.23000000000000001 112.572 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 303' ' ' TRP . . . . . . . . . . . . . 20.5 p-90 -169.89 -42.25 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.718 0.294 . . . . 0.23000000000000001 111.102 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -71.93 131.06 42.45 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.786 0.327 . . . . 0.23000000000000001 110.865 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 305' ' ' THR . . . . . . . . . . . . . 6.9 m -122.78 120.19 32.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.142 -0.481 . . . . 17.879999999999999 110.627 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 306' ' ' TRP . . . . . . . . . . . . . 94.3 m95 -85.03 114.21 22.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.282 -0.417 . . . . 0.23000000000000001 110.945 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 307' ' ' VAL . . . . . . . . . . . . . 25.2 m . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.14 -0.934 . . . . 16.109999999999999 111.168 -179.849 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.124 0 N-CA-C 112.514 -0.234 . . . . 0.23000000000000001 112.514 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.6 t -162.44 -47.28 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.831 0.348 . . . . 0.23000000000000001 110.948 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 16.0 m80 -70.74 109.14 4.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.23000000000000001 111.093 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 11.9 mmm -103.89 -47.17 4.28 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.167 -0.469 . . . . 0.23000000000000001 110.789 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -178.26 -39.42 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.962 -0.637 . . . . 0.23000000000000001 112.427 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -81.18 99.13 8.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.782 0.325 . . . . 0.23000000000000001 110.658 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -142.43 163.79 31.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.348 -0.387 . . . . 0.23000000000000001 111.024 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -81.07 86.91 6.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.096 -0.502 . . . . 0.23000000000000001 110.663 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -144.48 44.2 1.4 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.111 0.481 . . . . 0.23000000000000001 110.904 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.0 tttt -174.65 -179.27 1.46 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.921 -0.581 . . . . 0.23000000000000001 110.508 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -149.95 138.38 20.62 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-O 120.725 0.298 . . . . 0.23000000000000001 111.345 -179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.6 110.23 12.49 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.142 -0.481 . . . . 0.23000000000000001 111.002 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -126.2 155.79 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-N 116.008 -0.542 . . . . 0.23000000000000001 112.296 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 24.7 ttm-85 -116.52 152.39 34.19 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.359 -0.837 . . . . 0.23000000000000001 111.11 -179.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.5 m -145.78 147.23 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 N-CA-C 111.623 0.231 . . . . 0.23000000000000001 111.623 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 14.1 ptp180 -112.54 130.59 55.96 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.813 0.34 . . . . 0.23000000000000001 111.274 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.7 t -116.07 120.38 64.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.163 -0.471 . . . . 0.23000000000000001 110.705 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -94.2 119.54 33.15 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.518 -0.31 . . . . 0.23000000000000001 111.831 -179.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.57 113.18 4.02 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.139 -0.482 . . . . 0.23000000000000001 110.833 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -175.29 84.02 0.31 Allowed Pre-proline 0 CA--C 1.537 0.461 0 CA-C-N 116.495 -0.32 . . . . 0.23000000000000001 111.119 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -82.68 -24.84 10.8 Favored 'Cis proline' 0 C--N 1.363 1.297 0 CA-C-N 119.508 0.86 . . . . 0.23000000000000001 112.8 0.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -137.51 -178.06 5.06 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 120.815 0.341 . . . . 0.23000000000000001 111.441 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.408 ' HB3' ' CE2' ' A' ' 25' ' ' PHE . 3.5 mp -61.1 -59.65 5.01 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.151 -0.477 . . . . 0.23000000000000001 111.198 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 104.94 25.53 6.76 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 120.799 -0.715 . . . . 0.23000000000000001 113.48 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.408 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 37.2 p90 -155.25 144.47 20.98 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 117.252 0.526 . . . . 0.23000000000000001 111.051 179.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.3 p -98.91 151.82 20.44 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.189 -0.46 . . . . 0.23000000000000001 111.363 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 22.5 pt -122.34 153.62 26.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.033 -0.53 . . . . 0.23000000000000001 110.914 179.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.8 m -148.06 162.12 40.02 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.383 -0.371 . . . . 0.23000000000000001 110.78 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 106.58 -149.9 16.71 Favored Glycine 0 C--N 1.332 0.355 0 C-N-CA 120.908 -0.663 . . . . 0.23000000000000001 113.186 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 103.98 154.91 23.72 Favored Glycine 0 C--N 1.331 0.267 0 C-N-CA 120.985 -0.626 . . . . 0.23000000000000001 112.178 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 18.7 t -78.75 110.82 14.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 120.934 0.397 . . . . 0.23000000000000001 110.756 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 88.83 3.71 76.59 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 120.939 -0.648 . . . . 0.23000000000000001 113.847 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -82.89 -146.77 6.54 Favored Glycine 0 C--N 1.341 0.825 0 CA-C-N 117.841 0.82 . . . . 0.23000000000000001 112.798 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 48.5 mtt-85 -81.0 -4.36 54.88 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 112.856 0.687 . . . . 0.23000000000000001 112.856 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.03 162.35 37.52 Favored Glycine 0 C--N 1.344 0.991 0 C-N-CA 120.609 -0.805 . . . . 0.23000000000000001 113.099 179.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -105.84 134.87 19.53 Favored Pre-proline 0 CA--C 1.533 0.289 0 CA-C-O 119.899 -0.096 . . . . 0.23000000000000001 110.921 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -92.87 27.06 0.37 Allowed 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 122.309 2.006 . . . . 0.23000000000000001 112.819 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -125.25 -46.03 1.81 Allowed 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.731 0.3 . . . . 0.23000000000000001 110.796 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 64.6 mtt-85 -116.59 150.99 46.56 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 116.18 -0.464 . . . . 0.23000000000000001 110.614 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -92.08 -57.58 0.02 OUTLIER 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 122.153 1.902 . . . . 0.23000000000000001 114.082 -178.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -84.21 -7.18 59.43 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 113.396 0.887 . . . . 0.23000000000000001 113.396 -178.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -101.69 117.08 34.16 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 118.154 0.433 . . . . 0.23000000000000001 111.108 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -106.31 34.03 3.57 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.253 -0.431 . . . . 0.23000000000000001 111.481 -179.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -80.86 -161.56 26.19 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.868 -0.682 . . . . 0.23000000000000001 112.199 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.8 mm -107.27 131.28 57.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-N 116.782 0.291 . . . . 0.23000000000000001 110.298 179.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.435 ' N ' ' CD1' ' A' ' 46' ' ' PHE . 6.0 m-85 -130.5 148.35 52.3 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.882 0.372 . . . . 0.23000000000000001 111.359 -179.332 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 22.0 t -92.2 76.02 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-O 121.158 0.504 . . . . 0.23000000000000001 110.955 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.2 t -35.13 -51.72 0.56 Allowed 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 114.778 1.399 . . . . 0.23000000000000001 114.778 -178.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.6 ptm180 -160.22 176.63 11.52 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.117 0.484 . . . . 0.23000000000000001 112.28 -179.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 18.3 t -130.8 148.47 33.08 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 CA-C-N 115.535 -0.757 . . . . 0.23000000000000001 110.605 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -102.66 -67.89 0.04 OUTLIER Pre-proline 0 CA--C 1.536 0.422 0 CA-C-O 119.753 -0.165 . . . . 0.23000000000000001 111.392 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -79.4 120.8 4.55 Favored 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 121.796 1.664 . . . . 0.23000000000000001 112.052 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -77.76 65.63 3.27 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.94 0.4 . . . . 0.23000000000000001 111.096 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -158.42 -66.54 0.01 OUTLIER Glycine 0 CA--C 1.528 0.85 0 C-N-CA 120.765 -0.731 . . . . 0.23000000000000001 113.362 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -58.26 -76.43 0.02 OUTLIER 'Trans proline' 0 C--N 1.357 0.99 0 C-N-CA 122.142 1.895 . . . . 0.23000000000000001 113.36 -179.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -111.72 49.77 0.88 Allowed 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.196 0.522 . . . . 0.23000000000000001 111.437 -179.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 82.4 p -107.35 -67.25 0.97 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.93 -0.577 . . . . 0.23000000000000001 109.758 179.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.72 -12.13 57.27 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.892 -0.594 . . . . 0.23000000000000001 111.99 178.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.4 mt -93.71 -59.22 2.05 Favored 'General case' 0 C--N 1.342 0.24 0 O-C-N 122.008 -0.433 . . . . 0.23000000000000001 111.405 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 15.2 mt -93.03 149.26 21.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.325 -0.398 . . . . 0.23000000000000001 111.547 -179.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.22 144.53 33.13 Favored Pre-proline 0 N--CA 1.471 0.603 0 CA-C-N 116.09 -0.505 . . . . 0.23000000000000001 109.744 179.2 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.53 133.47 52.05 Favored 'Trans proline' 0 C--N 1.359 1.081 0 C-N-CA 122.165 1.91 . . . . 0.23000000000000001 113.427 -178.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 87.75 21.75 45.77 Favored Glycine 0 C--N 1.334 0.417 0 CA-C-N 115.716 -0.675 . . . . 0.23000000000000001 113.632 178.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -84.62 -169.55 2.68 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 117.092 0.446 . . . . 0.23000000000000001 111.005 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 57.8 tttp -141.55 126.44 18.19 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-O 120.874 0.368 . . . . 0.23000000000000001 111.338 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 27.9 mt -90.31 118.05 34.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.038 -0.528 . . . . 0.23000000000000001 110.233 179.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 50.3 mt -102.14 -31.79 3.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 N-CA-C 112.419 0.525 . . . . 0.23000000000000001 112.419 -178.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.61 144.57 27.31 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.005 0.431 . . . . 0.23000000000000001 111.844 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -146.25 121.48 10.19 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.932 -0.576 . . . . 0.23000000000000001 111.783 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 44.73 41.77 5.3 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 113.483 0.92 . . . . 0.23000000000000001 113.483 178.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 89.21 -17.99 48.07 Favored Glycine 0 CA--C 1.524 0.605 0 C-N-CA 120.856 -0.688 . . . . 0.23000000000000001 113.634 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -100.92 123.27 44.87 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 117.373 0.586 . . . . 0.23000000000000001 110.256 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 30.0 m -72.52 151.87 42.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.23000000000000001 111.284 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -113.09 19.56 17.08 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.952 -0.567 . . . . 0.23000000000000001 111.783 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.406 HG21 HD11 ' A' ' 75' ' ' ILE . 30.7 mm -97.03 133.14 39.69 Favored 'Isoleucine or valine' 0 C--O 1.231 0.111 0 CA-C-O 120.751 0.31 . . . . 0.23000000000000001 110.859 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 61.23 62.36 1.4 Allowed 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 121.185 0.517 . . . . 0.23000000000000001 110.898 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 18.7 pt -144.43 164.67 13.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.084 -0.507 . . . . 0.23000000000000001 111.752 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -82.09 145.53 30.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.652 -0.704 . . . . 0.23000000000000001 110.633 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 -51.2 -53.29 36.37 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 116.167 -0.47 . . . . 0.23000000000000001 112.162 -179.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -54.65 -25.97 37.62 Favored Glycine 0 CA--C 1.523 0.549 0 C-N-CA 121.079 -0.582 . . . . 0.23000000000000001 113.02 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -74.46 -39.69 62.37 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.111 0.481 . . . . 0.23000000000000001 110.404 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -70.5 -37.57 74.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.76 -0.654 . . . . 0.23000000000000001 111.852 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 35.2 t -70.49 -44.53 76.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.972 0.415 . . . . 0.23000000000000001 110.893 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 75.4 m -61.05 -37.32 82.21 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.124 -0.489 . . . . 0.23000000000000001 111.303 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 19.9 mt -65.65 -46.89 77.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.293 -0.412 . . . . 0.23000000000000001 111.599 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.4 ' HA ' ' CD2' ' A' ' 89' ' ' PHE . 34.4 mt -65.7 -38.31 88.87 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.404 -0.362 . . . . 0.23000000000000001 111.897 -178.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 56.1 mttm -71.45 -39.16 71.16 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.55 0.574 . . . . 0.23000000000000001 112.55 -178.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 12.0 t -73.77 -27.28 61.07 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 113.147 0.795 . . . . 0.23000000000000001 113.147 -178.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.4 ' CD2' ' HA ' ' A' ' 86' ' ' LEU . 11.8 m-85 -48.98 172.7 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 112.842 0.682 . . . . 0.23000000000000001 112.842 -178.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -84.31 -143.46 0.08 Allowed 'General case' 0 CA--C 1.552 1.054 0 CA-C-N 115.627 -0.715 . . . . 0.23000000000000001 111.193 -179.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 67.8 m-80 -76.96 -69.95 0.49 Allowed 'General case' 0 C--N 1.349 0.564 0 CA-C-N 119.005 0.821 . . . . 0.23000000000000001 111.552 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.7 p -80.07 125.46 29.82 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.921 0.391 . . . . 0.23000000000000001 110.788 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 18.8 t -113.41 114.56 47.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.943 -0.571 . . . . 0.23000000000000001 110.556 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -87.79 112.97 23.0 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.967 -0.383 . . . . 0.23000000000000001 109.967 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 4.2 mt -115.21 152.64 32.3 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-O 121.224 0.535 . . . . 0.23000000000000001 112.101 -178.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 31.3 mm -112.39 124.6 69.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.386 -0.825 . . . . 0.23000000000000001 109.065 178.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 29.3 pt -127.23 158.34 38.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 120.882 0.372 . . . . 0.23000000000000001 111.208 -178.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 58.3 t -144.24 150.25 16.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.895 -0.593 . . . . 0.23000000000000001 111.241 -179.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.6 mmm180 -112.0 116.8 31.16 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.299 -0.63 . . . . 0.23000000000000001 109.299 178.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -67.54 143.97 55.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.058 0.456 . . . . 0.23000000000000001 111.703 -178.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 25.5 t -148.07 102.52 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.572 -0.74 . . . . 0.23000000000000001 110.516 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 69.0 m -151.15 166.04 32.03 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.378 -0.374 . . . . 0.23000000000000001 111.118 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 20.0 t . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.243 -0.884 . . . . 0.23000000000000001 110.814 179.879 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 301' ' ' THR . . . . . . . . . . . . . 47.1 p . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.758 0.313 . . . . 0.23000000000000001 111.231 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 302' ' ' GLY . . . . . . . . . . . . . . . -87.75 147.04 20.26 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.855 -0.688 . . . . 0.23000000000000001 112.455 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 303' ' ' TRP . . . . . . . . . . . . . 26.9 p-90 -74.98 -30.62 61.22 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.657 0.265 . . . . 0.23000000000000001 111.126 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -83.51 164.75 19.63 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.692 0.282 . . . . 0.23000000000000001 110.515 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 305' ' ' THR . . . . . . . . . . . . . 4.7 m -140.42 113.71 8.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.454 -0.339 . . . . 17.879999999999999 111.159 -179.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 306' ' ' TRP . . . . . . . . . . . . . 92.8 m95 -80.77 105.46 12.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 0.23000000000000001 110.707 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 307' ' ' VAL . . . . . . . . . . . . . 16.7 m . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.233 -0.889 . . . . 16.109999999999999 111.134 -179.941 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.176 0 N-CA-C 112.534 -0.226 . . . . 0.23000000000000001 112.534 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.2 t -86.11 174.37 9.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.744 0.307 . . . . 0.23000000000000001 110.954 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 36.8 t60 -89.99 121.1 31.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.29 -0.414 . . . . 0.23000000000000001 110.986 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.64 90.94 2.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.466 . . . . 0.23000000000000001 110.451 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -163.71 32.16 0.27 Allowed Glycine 0 C--N 1.334 0.434 0 C-N-CA 120.838 -0.696 . . . . 0.23000000000000001 112.674 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 37.3 m170 -104.21 162.66 13.0 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.761 0.315 . . . . 0.23000000000000001 110.781 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -86.46 100.06 12.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.282 -0.417 . . . . 0.23000000000000001 110.799 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.8 tp -160.35 148.38 16.51 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 116.37 -0.377 . . . . 0.23000000000000001 111.155 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -102.14 -158.43 0.67 Allowed 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 116.087 -0.506 . . . . 0.23000000000000001 110.788 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.3 mmtm -52.7 124.43 13.82 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 121.159 0.504 . . . . 0.23000000000000001 111.581 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -87.92 94.17 9.69 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.641 -0.709 . . . . 0.23000000000000001 112.873 -178.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -94.8 126.76 40.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.636 -0.711 . . . . 0.23000000000000001 109.557 178.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 19.8 pt -147.29 159.17 9.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 N-CA-C 112.833 0.679 . . . . 0.23000000000000001 112.833 -178.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 9.7 ttm105 -104.91 153.77 20.96 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.482 -0.781 . . . . 0.23000000000000001 111.718 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.5 m -146.74 132.74 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-N 116.083 -0.508 . . . . 0.23000000000000001 110.547 178.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.2 ttt180 -107.84 119.94 40.88 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.473 -0.33 . . . . 0.23000000000000001 111.202 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.4 t -118.97 119.77 61.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 116.313 -0.403 . . . . 0.23000000000000001 111.062 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -96.79 132.36 42.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.314 -0.403 . . . . 0.23000000000000001 110.681 179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 21.5 mttt -80.31 122.98 27.58 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.435 0.636 . . . . 0.23000000000000001 111.856 -179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -173.97 85.52 0.36 Allowed Pre-proline 0 CA--C 1.537 0.466 0 CA-C-N 115.62 -0.718 . . . . 0.23000000000000001 110.939 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -81.3 -17.52 27.25 Favored 'Cis proline' 0 C--N 1.365 1.401 0 CA-C-N 119.261 0.772 . . . . 0.23000000000000001 113.371 0.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 38.1 mm-40 -136.63 -177.17 4.61 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.79 0.329 . . . . 0.23000000000000001 111.453 -179.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.403 ' HB3' ' CE2' ' A' ' 25' ' ' PHE . 4.5 mp -59.42 -63.08 1.43 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.2 -0.455 . . . . 0.23000000000000001 111.211 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 114.67 28.84 2.83 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 120.877 -0.677 . . . . 0.23000000000000001 113.485 179.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.403 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 49.5 p90 -164.14 148.9 10.15 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 117.156 0.478 . . . . 0.23000000000000001 111.285 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.4 p -102.06 155.1 18.4 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.075 -0.511 . . . . 0.23000000000000001 111.24 -179.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 21.1 pt -125.38 153.47 32.95 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-N 116.122 -0.49 . . . . 0.23000000000000001 110.752 179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.4 m -143.28 165.61 26.99 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.821 0.343 . . . . 0.23000000000000001 111.139 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.77 -144.45 17.22 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.898 -0.668 . . . . 0.23000000000000001 112.674 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 102.3 151.52 23.83 Favored Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.933 -0.651 . . . . 0.23000000000000001 112.378 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 30.3 t -79.99 98.7 3.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.849 0.357 . . . . 0.23000000000000001 110.781 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 98.94 -3.61 58.71 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 120.958 -0.639 . . . . 0.23000000000000001 114.07 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -81.17 -150.66 7.53 Favored Glycine 0 C--N 1.342 0.906 0 CA-C-N 117.799 0.8 . . . . 0.23000000000000001 112.904 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 4.9 ptt-85 -87.18 12.23 12.16 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 112.458 0.54 . . . . 0.23000000000000001 112.458 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 51.39 -173.02 0.17 Allowed Glycine 0 C--N 1.342 0.893 0 N-CA-C 114.496 0.559 . . . . 0.23000000000000001 114.496 178.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 22.7 p30 -142.56 161.51 49.32 Favored Pre-proline 0 CA--C 1.536 0.41 0 CA-C-N 115.553 -0.323 . . . . 0.23000000000000001 110.545 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -92.75 25.12 0.44 Allowed 'Trans proline' 0 C--N 1.358 1.052 0 C-N-CA 122.386 2.057 . . . . 0.23000000000000001 113.431 -179.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -103.33 -44.17 5.23 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.699 0.285 . . . . 0.23000000000000001 111.298 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -124.07 136.16 27.22 Favored Pre-proline 0 CA--C 1.535 0.369 0 CA-C-N 116.366 -0.379 . . . . 0.23000000000000001 110.503 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -84.98 -46.89 0.04 OUTLIER 'Trans proline' 0 C--N 1.358 1.04 0 C-N-CA 121.908 1.738 . . . . 0.23000000000000001 113.385 -179.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -97.01 -11.31 24.68 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 112.867 0.691 . . . . 0.23000000000000001 112.867 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -92.33 121.59 33.97 Favored 'General case' 0 N--CA 1.464 0.254 0 O-C-N 122.064 -0.397 . . . . 0.23000000000000001 110.465 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 14.0 p-10 -111.03 47.65 0.98 Allowed 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.04 0.448 . . . . 0.23000000000000001 111.596 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -94.71 -162.83 35.07 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 121.058 -0.592 . . . . 0.23000000000000001 111.69 179.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 14.6 mm -112.45 124.91 69.59 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-N 117.421 0.611 . . . . 0.23000000000000001 110.449 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -126.79 146.51 50.22 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.735 0.302 . . . . 0.23000000000000001 110.959 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 22.7 t -90.99 76.18 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-O 120.89 0.376 . . . . 0.23000000000000001 111.201 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.8 t -33.09 -54.53 0.39 Allowed 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 114.971 1.471 . . . . 0.23000000000000001 114.971 -178.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -160.27 174.17 14.61 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.262 0.553 . . . . 0.23000000000000001 112.45 -179.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 20.7 t -124.79 145.36 32.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-N 115.349 -0.841 . . . . 0.23000000000000001 110.459 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 -102.86 -69.95 0.04 OUTLIER Pre-proline 0 CA--C 1.539 0.54 0 CA-C-O 119.461 -0.304 . . . . 0.23000000000000001 111.413 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -82.57 121.15 3.3 Favored 'Trans proline' 0 C--N 1.359 1.118 0 C-N-CA 121.698 1.599 . . . . 0.23000000000000001 112.601 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -79.8 66.21 5.21 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.303 0.573 . . . . 0.23000000000000001 110.799 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -142.08 -71.08 0.03 OUTLIER Glycine 0 CA--C 1.527 0.834 0 CA-C-N 115.778 -0.646 . . . . 0.23000000000000001 113.152 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -63.47 -58.15 0.31 Allowed 'Trans proline' 0 C--N 1.358 1.058 0 C-N-CA 121.948 1.766 . . . . 0.23000000000000001 113.497 -179.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -118.8 48.56 1.44 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 121.08 0.467 . . . . 0.23000000000000001 111.728 -179.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 82.6 p -79.81 -59.64 2.66 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.082 -0.508 . . . . 0.23000000000000001 110.852 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 17.3 mttt -97.73 9.89 41.44 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 112.522 0.564 . . . . 0.23000000000000001 112.522 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 79.0 mt -92.23 -65.11 1.03 Allowed 'General case' 0 C--N 1.34 0.181 0 O-C-N 122.106 -0.371 . . . . 0.23000000000000001 111.413 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.1 mt -97.12 147.76 23.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.25 -0.432 . . . . 0.23000000000000001 111.509 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -113.4 140.04 23.95 Favored Pre-proline 0 N--CA 1.469 0.481 0 CA-C-N 116.027 -0.533 . . . . 0.23000000000000001 109.67 178.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -53.01 136.04 60.04 Favored 'Trans proline' 0 C--N 1.358 1.068 0 C-N-CA 122.083 1.855 . . . . 0.23000000000000001 113.291 -178.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 82.03 24.78 54.29 Favored Glycine 0 C--N 1.333 0.374 0 CA-C-N 115.767 -0.651 . . . . 0.23000000000000001 113.246 179.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -86.05 -170.58 3.16 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.89 0.345 . . . . 0.23000000000000001 110.857 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 60.8 tttp -139.33 122.86 17.32 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.83 0.348 . . . . 0.23000000000000001 110.891 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 48.8 mt -89.61 121.94 40.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 0.23000000000000001 110.509 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 19.5 mm -96.03 -43.97 12.81 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 N-CA-C 112.581 0.585 . . . . 0.23000000000000001 112.581 -178.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -145.81 150.57 36.44 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 121.073 0.463 . . . . 0.23000000000000001 111.957 -178.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -137.1 119.46 15.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.631 -0.713 . . . . 0.23000000000000001 110.94 179.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 42.28 32.3 0.32 Allowed 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 113.642 0.978 . . . . 0.23000000000000001 113.642 178.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 97.83 4.2 57.94 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 120.986 -0.626 . . . . 0.23000000000000001 114.083 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -110.09 124.24 51.15 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 117.949 0.875 . . . . 0.23000000000000001 110.565 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 54.8 p -72.78 139.85 47.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.468 -0.333 . . . . 0.23000000000000001 110.484 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -110.5 21.55 16.49 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 112.097 0.406 . . . . 0.23000000000000001 112.097 -179.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 21.1 mm -100.29 139.45 21.72 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 O-C-N 122.214 -0.304 . . . . 0.23000000000000001 111.048 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 19.9 m120 63.81 12.23 6.54 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 112.88 0.696 . . . . 0.23000000000000001 112.88 -179.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 25.3 pt -93.62 158.21 2.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 N-CA-C 112.83 0.678 . . . . 0.23000000000000001 112.83 -178.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -81.63 148.83 28.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.322 -0.854 . . . . 0.23000000000000001 110.479 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 35.4 t60 -47.23 -50.32 21.34 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 113.011 0.745 . . . . 0.23000000000000001 113.011 -179.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -57.59 -26.15 56.65 Favored Glycine 0 C--N 1.335 0.501 0 C-N-CA 120.874 -0.679 . . . . 0.23000000000000001 113.082 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.21 -42.59 45.63 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.897 0.38 . . . . 0.23000000000000001 110.887 179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.38 -39.57 81.69 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.14 -0.482 . . . . 0.23000000000000001 111.662 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.4 t -72.57 -43.2 63.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.852 0.358 . . . . 0.23000000000000001 110.666 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 34.7 t -60.53 -39.95 89.75 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.23 -0.441 . . . . 0.23000000000000001 111.296 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 53.2 mt -67.56 -44.0 79.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.898 0.38 . . . . 0.23000000000000001 111.139 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.405 ' HA ' ' CD2' ' A' ' 89' ' ' PHE . 17.5 mt -66.27 -38.57 88.11 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.086 -0.506 . . . . 0.23000000000000001 111.809 -178.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 48.5 mttm -73.31 -38.09 65.96 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.539 0.57 . . . . 0.23000000000000001 112.539 -178.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 9.0 t -70.15 -25.34 63.42 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 112.329 0.492 . . . . 0.23000000000000001 112.329 -178.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.405 ' CD2' ' HA ' ' A' ' 86' ' ' LEU . 14.7 m-85 -53.5 140.49 28.04 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.19 0.519 . . . . 0.23000000000000001 111.842 -179.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -62.59 -131.4 0.0 OUTLIER 'General case' 0 CA--C 1.558 1.258 0 CA-C-N 115.565 -0.743 . . . . 0.23000000000000001 111.948 -178.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -82.59 -72.28 0.45 Allowed 'General case' 0 C--N 1.355 0.806 0 CA-C-N 119.718 1.144 . . . . 0.23000000000000001 112.621 -177.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -74.23 123.11 23.91 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.818 0.342 . . . . 0.23000000000000001 111.011 -179.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.6 t -109.51 116.08 51.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.117 -0.492 . . . . 0.23000000000000001 110.953 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.95 104.62 16.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.078 -0.51 . . . . 0.23000000000000001 110.353 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.8 mp -111.76 158.54 19.23 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.239 0.542 . . . . 0.23000000000000001 112.098 -179.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 26.5 mm -118.72 129.59 74.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-N 115.372 -0.831 . . . . 0.23000000000000001 109.822 178.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 25.8 pt -130.96 167.24 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-O 120.846 0.355 . . . . 0.23000000000000001 111.663 -178.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 19.0 t -148.29 151.65 13.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.146 -0.479 . . . . 0.23000000000000001 111.243 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -115.42 131.05 57.05 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.094 -0.503 . . . . 0.23000000000000001 109.928 179.086 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -64.56 113.72 3.9 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.262 -0.426 . . . . 0.23000000000000001 112.061 -178.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 20.7 t -121.88 124.83 72.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.028 -0.533 . . . . 0.23000000000000001 110.137 178.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 63.6 p -142.11 135.57 29.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.844 0.354 . . . . 0.23000000000000001 111.233 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 62.2 m . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.302 -0.856 . . . . 0.23000000000000001 110.746 179.726 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 301' ' ' THR . . . . . . . . . . . . . 5.9 t . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 121.244 0.545 . . . . 0.23000000000000001 111.079 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 302' ' ' GLY . . . . . . . . . . . . . . . -90.9 121.06 6.12 Favored Glycine 0 C--N 1.333 0.371 0 C-N-CA 120.989 -0.624 . . . . 0.23000000000000001 112.307 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 303' ' ' TRP . . . . . . . . . . . . . 55.3 p-90 -99.94 -17.1 17.73 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 112.334 0.494 . . . . 0.23000000000000001 112.334 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -98.54 173.43 6.94 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.953 0.406 . . . . 0.23000000000000001 111.068 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 305' ' ' THR . . . . . . . . . . . . . 4.9 m -144.98 118.86 9.29 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.123 -0.489 . . . . 17.879999999999999 111.047 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 306' ' ' TRP . . . . . . . . . . . . . 91.9 m95 -88.79 106.0 18.09 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.273 -0.421 . . . . 0.23000000000000001 110.664 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 307' ' ' VAL . . . . . . . . . . . . . 25.6 m . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.26 -0.876 . . . . 16.109999999999999 111.16 -179.983 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.246 0 N-CA-C 112.473 -0.251 . . . . 0.23000000000000001 112.473 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.8 t -93.43 -178.6 4.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.688 0.28 . . . . 0.23000000000000001 110.815 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 15.7 p80 -71.09 115.82 10.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.357 -0.383 . . . . 0.23000000000000001 110.738 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.75 161.97 7.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.968 -0.56 . . . . 0.23000000000000001 111.184 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -176.15 45.37 0.11 Allowed Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.977 -0.63 . . . . 0.23000000000000001 112.507 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 15.6 m170 -90.83 132.8 35.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.713 0.292 . . . . 0.23000000000000001 110.928 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -113.9 66.8 0.67 Allowed 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 121.314 0.578 . . . . 0.23000000000000001 110.754 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -90.31 135.71 33.51 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.903 -0.589 . . . . 0.23000000000000001 110.39 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -102.25 47.88 0.89 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 121.15 0.5 . . . . 0.23000000000000001 111.359 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -64.87 113.76 4.05 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.075 -0.512 . . . . 0.23000000000000001 110.873 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -90.07 112.56 24.05 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.18 -0.463 . . . . 0.23000000000000001 112.021 -179.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -87.83 98.29 11.39 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.087 -0.506 . . . . 0.23000000000000001 111.147 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 18.4 pt -115.82 158.11 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 N-CA-C 112.815 0.672 . . . . 0.23000000000000001 112.815 -178.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 26.8 ttp180 -116.07 156.19 26.81 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.667 -0.697 . . . . 0.23000000000000001 111.612 -179.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.7 m -149.45 142.83 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.272 -0.422 . . . . 0.23000000000000001 111.302 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.17 132.01 54.55 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.949 0.404 . . . . 0.23000000000000001 111.236 179.565 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.3 t -114.62 120.03 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 CA-C-N 116.237 -0.438 . . . . 0.23000000000000001 111.155 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -89.8 111.59 22.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.267 -0.424 . . . . 0.23000000000000001 111.095 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.87 116.89 7.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.143 -0.481 . . . . 0.23000000000000001 110.971 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -175.1 84.87 0.32 Allowed Pre-proline 0 CA--C 1.54 0.571 0 CA-C-N 116.428 -0.351 . . . . 0.23000000000000001 110.962 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -84.7 -22.2 14.65 Favored 'Cis proline' 0 C--N 1.366 1.475 0 CA-C-N 119.488 0.853 . . . . 0.23000000000000001 113.058 0.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 18.2 mp0 -131.42 -178.28 4.78 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.768 0.318 . . . . 0.23000000000000001 111.142 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.403 HD21 ' CZ ' ' A' ' 25' ' ' PHE . 3.2 mp -63.12 -58.16 8.18 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.254 -0.43 . . . . 0.23000000000000001 110.563 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 109.92 26.89 4.8 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.888 -0.672 . . . . 0.23000000000000001 113.377 179.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.403 ' CZ ' HD21 ' A' ' 23' ' ' LEU . 37.4 p90 -159.84 139.93 11.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 117.133 0.467 . . . . 0.23000000000000001 111.12 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.9 p -94.06 153.59 18.07 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.007 -0.542 . . . . 0.23000000000000001 110.823 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 28.2 pt -122.59 152.77 27.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.279 -0.418 . . . . 0.23000000000000001 111.084 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 50.9 m -146.14 160.93 41.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.285 -0.416 . . . . 0.23000000000000001 110.912 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 104.97 -146.77 16.14 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 120.988 -0.625 . . . . 0.23000000000000001 113.098 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.36 157.62 28.92 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.993 -0.622 . . . . 0.23000000000000001 111.98 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 18.8 t -78.55 109.65 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 CA-C-O 120.806 0.336 . . . . 0.23000000000000001 110.953 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 86.8 3.81 83.05 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 121.039 -0.601 . . . . 0.23000000000000001 113.857 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -82.87 -154.7 16.45 Favored Glycine 0 C--N 1.343 0.954 0 CA-C-N 117.816 0.808 . . . . 0.23000000000000001 112.928 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 7.4 mtt180 -75.71 -2.51 29.96 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 112.973 0.731 . . . . 0.23000000000000001 112.973 -179.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.26 -151.28 25.52 Favored Glycine 0 C--N 1.342 0.911 0 C-N-CA 120.695 -0.764 . . . . 0.23000000000000001 113.037 179.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -173.54 142.3 0.94 Allowed Pre-proline 0 CA--C 1.534 0.346 0 N-CA-C 110.611 -0.144 . . . . 0.23000000000000001 110.611 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -90.42 39.87 0.39 Allowed 'Trans proline' 0 C--N 1.358 1.03 0 C-N-CA 122.274 1.983 . . . . 0.23000000000000001 113.507 -179.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -125.62 -53.44 1.57 Allowed 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.739 0.304 . . . . 0.23000000000000001 110.915 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? -116.16 136.28 22.97 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 116.323 -0.398 . . . . 0.23000000000000001 110.677 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -85.59 -46.37 0.04 OUTLIER 'Trans proline' 0 C--N 1.358 1.05 0 C-N-CA 121.965 1.777 . . . . 0.23000000000000001 113.335 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -93.42 -8.68 41.02 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 112.91 0.707 . . . . 0.23000000000000001 112.91 -179.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -101.03 121.48 41.87 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 118.175 0.443 . . . . 0.23000000000000001 110.537 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -110.72 39.8 2.15 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 120.819 0.342 . . . . 0.23000000000000001 111.874 -178.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -87.44 -158.97 33.48 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 120.895 -0.669 . . . . 0.23000000000000001 112.085 179.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 13.9 mm -109.43 124.58 66.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 116.996 0.398 . . . . 0.23000000000000001 110.83 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.418 ' CD1' ' N ' ' A' ' 46' ' ' PHE . 7.3 m-85 -127.12 150.16 49.62 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.628 0.251 . . . . 0.23000000000000001 110.636 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 22.5 t -95.92 78.98 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 116.439 -0.346 . . . . 0.23000000000000001 111.531 -179.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.9 t -35.58 -53.6 0.69 Allowed 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 114.43 1.27 . . . . 0.23000000000000001 114.43 -178.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 15.4 ptt180 -160.77 163.95 31.87 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.993 0.425 . . . . 0.23000000000000001 111.801 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.8 t -114.29 146.13 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 115.76 -0.655 . . . . 0.23000000000000001 110.42 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.9 mm-40 -97.13 -70.41 0.05 OUTLIER Pre-proline 0 CA--C 1.538 0.496 0 CA-C-O 119.465 -0.302 . . . . 0.23000000000000001 111.316 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -83.05 121.13 3.1 Favored 'Trans proline' 0 C--N 1.36 1.133 0 C-N-CA 121.606 1.538 . . . . 0.23000000000000001 112.292 179.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -78.62 65.49 3.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.205 0.526 . . . . 0.23000000000000001 110.737 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -148.19 -70.56 0.01 OUTLIER Glycine 0 CA--C 1.527 0.793 0 C-N-CA 120.965 -0.636 . . . . 0.23000000000000001 112.871 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -60.37 -63.3 0.12 Allowed 'Trans proline' 0 C--N 1.358 1.062 0 C-N-CA 121.977 1.784 . . . . 0.23000000000000001 112.893 -179.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -110.02 45.65 1.09 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.16 0.505 . . . . 0.23000000000000001 111.186 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 88.9 p -82.5 -59.06 2.65 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.009 -0.541 . . . . 0.23000000000000001 110.93 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -93.72 5.28 52.17 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.752 0.649 . . . . 0.23000000000000001 112.752 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 80.2 mt -92.04 -72.61 0.58 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 118.144 0.429 . . . . 0.23000000000000001 111.612 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -95.94 143.08 27.44 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.545 0.212 . . . . 0.23000000000000001 110.764 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -114.98 153.6 47.08 Favored Pre-proline 0 N--CA 1.471 0.592 0 CA-C-N 116.334 -0.394 . . . . 0.23000000000000001 110.776 179.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -55.22 123.71 14.49 Favored 'Trans proline' 0 C--N 1.36 1.161 0 C-N-CA 122.335 2.023 . . . . 0.23000000000000001 113.882 -178.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 92.74 16.02 50.29 Favored Glycine 0 CA--C 1.521 0.467 0 CA-C-N 115.687 -0.688 . . . . 0.23000000000000001 114.139 178.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 35.1 p-10 -80.27 -171.7 3.13 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 117.541 0.671 . . . . 0.23000000000000001 111.361 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 32.2 tttp -142.4 125.14 15.94 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 120.774 0.321 . . . . 0.23000000000000001 111.108 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.5 mp -90.87 123.86 43.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-N 116.387 -0.37 . . . . 0.23000000000000001 110.023 179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 21.0 mm -94.9 -44.55 13.3 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 112.201 0.445 . . . . 0.23000000000000001 112.201 -179.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -148.62 150.42 33.24 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 120.833 0.349 . . . . 0.23000000000000001 111.668 -178.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -136.7 123.69 21.49 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.021 -0.536 . . . . 0.23000000000000001 111.557 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 28.7 m-20 42.44 35.01 0.59 Allowed 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 113.61 0.966 . . . . 0.23000000000000001 113.61 178.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 99.65 -16.37 58.81 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 120.867 -0.682 . . . . 0.23000000000000001 113.792 179.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -92.99 123.06 35.97 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 117.534 0.667 . . . . 0.23000000000000001 111.016 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 14.9 m -71.12 130.49 41.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.15 -0.477 . . . . 0.23000000000000001 111.077 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -103.16 15.64 28.73 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.263 0.468 . . . . 0.23000000000000001 112.263 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 6.5 tp -89.32 124.24 41.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-O 120.729 0.299 . . . . 0.23000000000000001 110.546 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 62.54 73.78 0.45 Allowed 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.118 0.485 . . . . 0.23000000000000001 111.161 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 11.5 pt -144.29 163.12 14.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.046 -0.524 . . . . 0.23000000000000001 110.886 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -81.12 153.39 27.32 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.265 -0.425 . . . . 0.23000000000000001 111.256 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 21.1 t60 -52.85 -55.7 21.21 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 116.02 -0.537 . . . . 0.23000000000000001 112.186 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -56.29 -26.7 51.27 Favored Glycine 0 C--N 1.334 0.45 0 C-N-CA 121.073 -0.584 . . . . 0.23000000000000001 113.277 -179.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -72.66 -40.56 66.25 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.866 0.365 . . . . 0.23000000000000001 111.008 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.99 -41.0 95.8 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.124 -0.489 . . . . 0.23000000000000001 111.423 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 16.1 t -70.74 -42.0 77.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.384 -0.371 . . . . 0.23000000000000001 111.199 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 72.5 m -60.53 -45.82 92.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 0.23000000000000001 111.588 -179.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 31.7 mt -64.14 -45.52 88.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.412 -0.358 . . . . 0.23000000000000001 111.603 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.408 ' HA ' ' CD2' ' A' ' 89' ' ' PHE . 24.5 mt -65.36 -39.48 92.35 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.287 -0.415 . . . . 0.23000000000000001 111.956 -179.009 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 8.4 mmtp -68.68 -40.02 80.31 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.595 0.591 . . . . 0.23000000000000001 112.595 -178.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 8.8 t -72.22 -27.26 62.42 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.36 0.874 . . . . 0.23000000000000001 113.36 -177.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.408 ' CD2' ' HA ' ' A' ' 86' ' ' LEU . 10.5 m-85 -47.87 172.81 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 113.105 0.779 . . . . 0.23000000000000001 113.105 -177.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -92.5 -138.0 0.18 Allowed 'General case' 0 CA--C 1.554 1.103 0 CA-C-N 115.519 -0.764 . . . . 0.23000000000000001 111.277 -178.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 54.5 m-80 -78.96 -74.97 0.25 Allowed 'General case' 0 C--N 1.35 0.61 0 CA-C-N 119.454 1.025 . . . . 0.23000000000000001 111.955 -178.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.44 123.19 26.21 Favored 'General case' 0 CA--C 1.527 0.081 0 CA-C-O 120.84 0.352 . . . . 0.23000000000000001 110.307 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 20.2 t -111.32 116.69 53.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.944 -0.571 . . . . 0.23000000000000001 110.498 179.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -86.77 112.66 21.91 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.959 0.409 . . . . 0.23000000000000001 110.159 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.3 mt -116.51 147.46 41.75 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.679 -0.692 . . . . 0.23000000000000001 111.896 -178.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 18.8 mm -107.19 121.71 60.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.673 -0.694 . . . . 0.23000000000000001 109.651 178.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 41.4 pt -126.5 158.64 36.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.855 0.36 . . . . 0.23000000000000001 111.119 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 17.2 t -146.78 153.19 12.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.068 -0.514 . . . . 0.23000000000000001 111.258 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 2.6 mmm180 -109.87 116.9 32.48 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.294 -0.632 . . . . 0.23000000000000001 109.294 178.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -69.83 143.08 52.99 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 120.678 0.275 . . . . 0.23000000000000001 110.628 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -119.14 150.74 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-N 116.322 -0.399 . . . . 0.23000000000000001 110.212 -179.155 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -153.02 -171.5 3.95 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.809 0.338 . . . . 0.23000000000000001 110.867 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 5.3 m . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.324 -0.846 . . . . 0.23000000000000001 110.869 -179.939 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 301' ' ' THR . . . . . . . . . . . . . 40.5 p . . . . . 0 N--CA 1.487 1.396 0 CA-C-O 120.757 0.313 . . . . 0.23000000000000001 111.279 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 302' ' ' GLY . . . . . . . . . . . . . . . 78.47 81.41 0.68 Allowed Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.877 -0.677 . . . . 0.23000000000000001 112.304 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 303' ' ' TRP . . . . . 0.407 ' CZ3' ' HB3' ' B' ' 304' ' ' GLU . 51.4 p-90 -69.13 -28.78 66.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.534 0.207 . . . . 0.23000000000000001 111.437 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 304' ' ' GLU . . . . . 0.407 ' HB3' ' CZ3' ' B' ' 303' ' ' TRP . 9.4 pt-20 -97.45 132.81 42.8 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.662 0.268 . . . . 0.23000000000000001 110.721 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 305' ' ' THR . . . . . . . . . . . . . 4.7 m -122.7 114.88 21.17 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.21 -0.45 . . . . 17.879999999999999 110.923 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 306' ' ' TRP . . . . . . . . . . . . . 98.9 m95 -78.75 104.79 9.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.23000000000000001 110.797 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 307' ' ' VAL . . . . . . . . . . . . . 17.0 m . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.264 -0.874 . . . . 16.109999999999999 111.135 -179.964 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.175 0 N-CA-C 112.502 -0.239 . . . . 0.23000000000000001 112.502 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.3 t -117.29 146.79 43.09 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.857 0.361 . . . . 0.23000000000000001 110.798 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 9.0 t60 -92.45 161.81 14.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.146 -0.479 . . . . 0.23000000000000001 110.776 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 20.9 tpp -71.29 132.78 45.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.306 -0.406 . . . . 0.23000000000000001 110.612 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 97.66 62.07 0.9 Allowed Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.907 -0.663 . . . . 0.23000000000000001 112.064 -179.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 2.5 t-160 -98.0 -28.81 13.62 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 111.554 0.205 . . . . 0.23000000000000001 111.554 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -59.57 118.94 6.66 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.678 0.275 . . . . 0.23000000000000001 111.202 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 42.1 tp -106.79 -84.74 0.51 Allowed 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.486 -0.325 . . . . 0.23000000000000001 111.2 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -174.96 35.58 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 O-C-N 122.132 -0.355 . . . . 0.23000000000000001 111.843 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 36.7 mttp -91.92 -178.46 5.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.651 0.262 . . . . 0.23000000000000001 111.071 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.55 93.43 3.14 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.473 -0.33 . . . . 0.23000000000000001 111.362 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.2 tm-20 -95.95 129.8 43.11 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.271 -0.422 . . . . 0.23000000000000001 110.941 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.1 pt -149.61 159.59 5.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-O 120.824 0.345 . . . . 0.23000000000000001 111.8 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 10.2 ttm-85 -116.6 153.32 32.46 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.069 -0.514 . . . . 0.23000000000000001 111.264 -178.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.9 m -141.91 144.04 26.02 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 CA-C-N 116.402 -0.363 . . . . 0.23000000000000001 111.356 179.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 2.4 ttt-85 -108.09 115.58 30.39 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.168 -0.469 . . . . 0.23000000000000001 110.5 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.0 t -109.34 121.52 62.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-O 120.896 0.379 . . . . 0.23000000000000001 111.459 -179.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -96.79 114.7 26.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.14 -0.482 . . . . 0.23000000000000001 110.206 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 19.2 mtmt -75.23 119.97 20.09 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.929 0.395 . . . . 0.23000000000000001 111.262 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -163.59 86.87 1.25 Allowed Pre-proline 0 CA--C 1.536 0.425 0 CA-C-N 115.955 -0.566 . . . . 0.23000000000000001 110.712 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -84.59 -13.43 37.69 Favored 'Cis proline' 0 C--N 1.364 1.345 0 CA-C-N 119.548 0.874 . . . . 0.23000000000000001 113.595 0.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -136.78 -175.95 4.2 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.892 0.377 . . . . 0.23000000000000001 111.176 -179.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.402 ' HB3' ' CE2' ' A' ' 25' ' ' PHE . 1.5 mp -63.44 -52.22 62.39 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.524 -0.307 . . . . 0.23000000000000001 110.3 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 102.88 29.99 5.63 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 120.862 -0.685 . . . . 0.23000000000000001 113.586 179.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.402 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 32.1 p90 -162.15 146.53 12.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 117.053 0.426 . . . . 0.23000000000000001 110.919 179.392 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.402 ' HB3' ' CD2' ' B' ' 306' ' ' TRP . 2.5 p -97.15 155.55 16.78 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.219 -0.446 . . . . 0.23000000000000001 111.367 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 29.0 pt -124.21 154.06 30.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 115.874 -0.603 . . . . 0.23000000000000001 110.306 179.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 48.1 t -145.78 171.94 14.04 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.835 0.35 . . . . 0.23000000000000001 111.165 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 92.14 -137.72 13.87 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.931 -0.652 . . . . 0.23000000000000001 112.584 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.45 155.01 29.98 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.962 -0.637 . . . . 0.23000000000000001 112.25 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 34.8 t -78.69 97.38 2.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.014 0.435 . . . . 0.23000000000000001 110.705 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 98.86 -1.87 58.16 Favored Glycine 0 CA--C 1.531 1.067 0 CA-C-N 115.844 -0.616 . . . . 0.23000000000000001 113.723 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -72.34 -154.62 2.29 Favored Glycine 0 C--N 1.343 0.932 0 CA-C-N 117.856 0.828 . . . . 0.23000000000000001 113.098 -179.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 4.5 mtt85 -72.7 -29.06 63.07 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 111.656 0.243 . . . . 0.23000000000000001 111.656 -179.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 124.32 -163.49 18.08 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 121.026 -0.607 . . . . 0.23000000000000001 112.908 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -170.74 132.69 0.93 Allowed Pre-proline 0 CA--C 1.536 0.428 0 O-C-N 123.026 -0.102 . . . . 0.23000000000000001 110.744 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -91.52 44.15 0.44 Allowed 'Trans proline' 0 C--N 1.358 1.069 0 C-N-CA 122.178 1.918 . . . . 0.23000000000000001 113.073 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -122.84 -57.77 1.7 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.512 -0.313 . . . . 0.23000000000000001 111.226 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 6.1 mmp_? -113.3 145.25 32.84 Favored Pre-proline 0 N--CA 1.467 0.382 0 CA-C-N 116.385 -0.37 . . . . 0.23000000000000001 110.991 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -88.78 -56.45 0.02 OUTLIER 'Trans proline' 0 C--N 1.36 1.181 0 C-N-CA 122.041 1.827 . . . . 0.23000000000000001 113.125 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -86.51 -7.63 58.23 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 112.877 0.695 . . . . 0.23000000000000001 112.877 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -104.0 121.23 42.73 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 117.967 0.349 . . . . 0.23000000000000001 111.02 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.7 p30 -110.8 40.34 2.03 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 121.042 0.448 . . . . 0.23000000000000001 110.834 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -84.37 -157.19 25.95 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.976 -0.631 . . . . 0.23000000000000001 112.732 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 19.6 mm -110.53 122.4 64.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.522 0.201 . . . . 0.23000000000000001 110.563 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -122.07 144.76 48.72 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 120.899 0.381 . . . . 0.23000000000000001 111.392 -179.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 22.7 t -86.37 75.87 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-N 116.134 -0.484 . . . . 0.23000000000000001 111.161 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.7 t -33.87 -52.88 0.44 Allowed 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 114.694 1.368 . . . . 0.23000000000000001 114.694 -178.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 5.8 ptt85 -160.35 179.09 8.95 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.074 0.464 . . . . 0.23000000000000001 111.737 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 15.8 t -134.48 146.92 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 CA-C-N 115.722 -0.672 . . . . 0.23000000000000001 110.782 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.41 ' HG3' ' CH2' ' B' ' 306' ' ' TRP . 40.1 mt-30 -104.87 -68.17 0.04 OUTLIER Pre-proline 0 CA--C 1.536 0.441 0 CA-C-N 116.704 -0.225 . . . . 0.23000000000000001 111.267 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -78.34 112.62 3.23 Favored 'Trans proline' 0 C--N 1.357 1.023 0 C-N-CA 121.654 1.569 . . . . 0.23000000000000001 112.009 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -72.81 70.92 1.01 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.003 0.43 . . . . 0.23000000000000001 111.298 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -162.27 -65.77 0.02 OUTLIER Glycine 0 CA--C 1.527 0.787 0 C-N-CA 120.79 -0.719 . . . . 0.23000000000000001 113.273 -179.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -57.05 -76.11 0.02 OUTLIER 'Trans proline' 0 C--N 1.357 1.017 0 C-N-CA 122.086 1.857 . . . . 0.23000000000000001 113.098 -179.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -116.38 47.37 1.43 Allowed 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 121.265 0.555 . . . . 0.23000000000000001 111.636 -179.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.7 t -99.73 -63.27 1.14 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.048 -0.524 . . . . 0.23000000000000001 109.922 179.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 44.2 mttp -74.51 -3.91 33.66 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 115.88 -0.6 . . . . 0.23000000000000001 112.1 178.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 9.0 mt -99.13 -50.51 4.13 Favored 'General case' 0 C--N 1.343 0.311 0 CA-C-N 118.265 0.484 . . . . 0.23000000000000001 111.373 -179.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 19.0 mt -102.56 150.34 23.51 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-O 120.818 0.342 . . . . 0.23000000000000001 111.492 -179.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -97.56 140.69 22.14 Favored Pre-proline 0 CA--C 1.535 0.388 0 CA-C-N 116.015 -0.538 . . . . 0.23000000000000001 110.873 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -63.79 79.06 0.15 Allowed 'Trans proline' 0 C--N 1.362 1.243 0 C-N-CA 122.068 1.845 . . . . 0.23000000000000001 112.16 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 129.29 41.32 0.26 Allowed Glycine 0 CA--C 1.525 0.68 0 CA-C-N 115.787 -0.642 . . . . 0.23000000000000001 112.606 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -96.24 -158.25 0.64 Allowed 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 110.306 -0.257 . . . . 0.23000000000000001 110.306 179.25 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 59.5 tttp -144.65 127.53 16.37 Favored 'General case' 0 C--O 1.231 0.081 0 CA-C-O 120.679 0.276 . . . . 0.23000000000000001 110.942 179.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.3 mp -88.9 115.73 29.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 109.515 -0.55 . . . . 0.23000000000000001 109.515 179.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 13.4 mm -91.38 -39.13 11.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.879 -0.6 . . . . 0.23000000000000001 111.558 -179.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -149.55 150.22 31.93 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.06 0.457 . . . . 0.23000000000000001 111.365 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -134.59 115.35 13.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.676 -0.693 . . . . 0.23000000000000001 110.246 179.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 63.3 m-20 46.72 29.27 0.93 Allowed 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 113.031 0.752 . . . . 0.23000000000000001 113.031 179.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 100.08 -7.52 58.77 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 120.892 -0.67 . . . . 0.23000000000000001 113.889 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -95.35 129.22 42.57 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 117.94 0.87 . . . . 0.23000000000000001 110.028 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.27 125.27 28.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.816 0.341 . . . . 0.23000000000000001 111.147 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -100.71 22.53 11.8 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.209 -0.45 . . . . 0.23000000000000001 111.461 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 7.0 tp -102.93 141.4 18.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 O-C-N 122.137 -0.352 . . . . 0.23000000000000001 110.95 -178.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 64.71 11.58 6.92 Favored 'General case' 0 CA--C 1.55 0.947 0 N-CA-C 112.772 0.656 . . . . 0.23000000000000001 112.772 -178.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 18.0 pt -94.2 164.91 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 N-CA-C 112.983 0.734 . . . . 0.23000000000000001 112.983 -177.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -85.69 144.99 27.5 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.013 -0.994 . . . . 0.23000000000000001 110.542 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -48.79 -51.12 30.88 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 112.508 0.558 . . . . 0.23000000000000001 112.508 -179.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -55.98 -26.81 49.52 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 120.837 -0.697 . . . . 0.23000000000000001 113.177 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.7 tp-100 -75.98 -40.97 52.71 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.08 0.467 . . . . 0.23000000000000001 110.866 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.63 -34.93 77.97 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.014 -0.539 . . . . 0.23000000000000001 111.539 -179.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 23.5 t -71.99 -42.54 68.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.927 0.394 . . . . 0.23000000000000001 110.584 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.2 t -61.23 -41.16 96.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.132 -0.485 . . . . 0.23000000000000001 111.28 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 25.5 mt -65.82 -45.97 80.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 0.23000000000000001 111.459 -179.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.413 ' HA ' ' CD2' ' A' ' 89' ' ' PHE . 39.5 mt -64.61 -37.02 86.14 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.112 -0.495 . . . . 0.23000000000000001 112.195 -178.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 34.1 mmtt -71.26 -36.68 71.84 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.3 0.481 . . . . 0.23000000000000001 112.3 -178.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 9.8 t -73.59 -29.08 62.18 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.893 0.701 . . . . 0.23000000000000001 112.893 -178.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.413 ' CD2' ' HA ' ' A' ' 86' ' ' LEU . 16.4 m-85 -50.49 147.22 4.68 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 112.723 0.638 . . . . 0.23000000000000001 112.723 -178.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -66.72 -136.6 0.0 OUTLIER 'General case' 0 CA--C 1.556 1.21 0 CA-C-N 115.442 -0.799 . . . . 0.23000000000000001 111.053 -179.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -80.57 -67.88 0.73 Allowed 'General case' 0 C--N 1.352 0.68 0 CA-C-N 119.586 1.085 . . . . 0.23000000000000001 111.883 -178.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -81.55 135.35 35.58 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.689 0.281 . . . . 0.23000000000000001 110.979 -179.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.5 t -128.01 122.64 58.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.175 -0.466 . . . . 0.23000000000000001 111.151 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -89.66 108.33 19.61 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.747 -0.464 . . . . 0.23000000000000001 109.747 178.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 12.5 mt -110.12 144.23 39.04 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.011 0.434 . . . . 0.23000000000000001 111.679 -179.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.6 mm -106.21 120.8 57.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.711 -0.677 . . . . 0.23000000000000001 109.604 178.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 23.5 pt -126.84 164.14 27.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.818 0.342 . . . . 0.23000000000000001 111.313 -179.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 22.1 t -149.72 151.87 12.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.109 -0.496 . . . . 0.23000000000000001 111.245 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -111.97 121.21 44.37 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.66 -0.7 . . . . 0.23000000000000001 109.268 178.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -61.59 118.01 6.51 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.973 0.416 . . . . 0.23000000000000001 111.534 -179.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 30.2 t -104.91 96.79 4.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.869 -0.605 . . . . 0.23000000000000001 110.415 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 24.4 m -113.1 160.97 17.64 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.902 0.382 . . . . 0.23000000000000001 111.153 -179.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 43.2 m . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.21 -0.9 . . . . 0.23000000000000001 110.779 179.941 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 301' ' ' THR . . . . . . . . . . . . . 41.8 p . . . . . 0 N--CA 1.488 1.43 0 CA-C-O 120.822 0.344 . . . . 0.23000000000000001 111.225 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 302' ' ' GLY . . . . . . . . . . . . . . . 160.33 -159.22 30.63 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.956 -0.64 . . . . 0.23000000000000001 112.265 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 303' ' ' TRP . . . . . . . . . . . . . 23.1 p-90 -123.26 -40.16 2.41 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.561 0.219 . . . . 0.23000000000000001 111.531 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -73.73 153.38 40.07 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.004 0.431 . . . . 0.23000000000000001 111.284 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 305' ' ' THR . . . . . . . . . . . . . 5.8 m -138.95 128.8 24.94 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.91 -0.586 . . . . 17.879999999999999 110.339 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 306' ' ' TRP . . . . . 0.41 ' CH2' ' HG3' ' A' ' 51' ' ' GLN . 88.7 m95 -94.48 114.63 26.67 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.944 0.402 . . . . 0.23000000000000001 111.224 -179.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 307' ' ' VAL . . . . . . . . . . . . . 15.4 m . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.244 -0.884 . . . . 16.109999999999999 111.074 -179.971 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.17 0 N-CA-C 112.459 -0.256 . . . . 0.23000000000000001 112.459 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.7 t -111.83 -57.93 2.19 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.901 0.381 . . . . 0.23000000000000001 110.824 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 44.5 t60 -92.65 115.78 28.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.106 -0.497 . . . . 0.23000000000000001 110.874 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 14.2 ttt -92.61 -56.14 3.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 0.23000000000000001 110.949 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -162.0 -139.57 2.67 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.763 -0.732 . . . . 0.23000000000000001 112.67 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 -153.92 100.2 2.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.591 0.234 . . . . 0.23000000000000001 110.649 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.2 mp0 -122.77 32.3 5.78 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.373 -0.376 . . . . 0.23000000000000001 111.099 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.9 mp -128.17 146.33 50.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.387 -0.37 . . . . 0.23000000000000001 110.867 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -97.64 89.53 4.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.455 . . . . 0.23000000000000001 111.21 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -92.98 125.35 37.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.3 -0.409 . . . . 0.23000000000000001 110.717 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -89.72 89.66 7.88 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.117 -0.492 . . . . 0.23000000000000001 112.145 -178.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -88.95 92.14 9.11 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.715 -0.476 . . . . 0.23000000000000001 109.715 178.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.401 HD11 HG22 ' A' ' 13' ' ' ILE . 0.2 OUTLIER -110.81 161.49 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 N-CA-C 113.028 0.751 . . . . 0.23000000000000001 113.028 -178.66 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 12.6 mtm180 -112.23 155.72 23.55 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.1 -0.954 . . . . 0.23000000000000001 110.776 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.9 m -143.82 142.77 24.51 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-O 120.79 0.328 . . . . 0.23000000000000001 110.911 179.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 22.1 ttm180 -107.27 115.02 29.43 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.223 -0.444 . . . . 0.23000000000000001 111.248 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.9 t -114.53 117.7 56.38 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.337 -0.392 . . . . 0.23000000000000001 110.972 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -93.29 122.75 36.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.267 -0.424 . . . . 0.23000000000000001 110.635 179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 15.3 mtmt -76.68 120.86 22.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.467 . . . . 0.23000000000000001 111.081 -179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -171.11 88.22 0.47 Allowed Pre-proline 0 CA--C 1.536 0.408 0 CA-C-N 115.972 -0.558 . . . . 0.23000000000000001 110.726 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -82.69 -18.45 24.91 Favored 'Cis proline' 0 C--N 1.362 1.267 0 CA-C-N 119.477 0.849 . . . . 0.23000000000000001 113.277 0.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -135.31 -178.29 5.04 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.868 0.366 . . . . 0.23000000000000001 111.755 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.0 mp -64.14 -57.27 10.05 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.016 -0.538 . . . . 0.23000000000000001 111.03 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 103.35 32.46 4.57 Favored Glycine 0 CA--C 1.522 0.493 0 C-N-CA 120.797 -0.716 . . . . 0.23000000000000001 113.98 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 38.7 p90 -162.36 147.25 12.4 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 117.363 0.582 . . . . 0.23000000000000001 111.191 179.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.3 p -100.65 151.4 21.68 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.156 -0.474 . . . . 0.23000000000000001 111.474 -179.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 28.9 pt -121.71 151.15 25.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.887 -0.597 . . . . 0.23000000000000001 110.911 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 28.7 t -150.33 164.57 35.46 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.548 0.213 . . . . 0.23000000000000001 111.44 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 115.05 -94.84 0.69 Allowed Glycine 0 C--N 1.338 0.658 0 C-N-CA 120.972 -0.632 . . . . 0.23000000000000001 113.797 178.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 72.18 -134.76 21.82 Favored Glycine 0 CA--C 1.524 0.601 0 C-N-CA 121.24 -0.505 . . . . 0.23000000000000001 112.597 -179.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 23.1 t -148.08 84.55 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 CA-C-O 120.953 0.406 . . . . 0.23000000000000001 109.962 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 92.44 9.34 61.75 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 120.823 -0.703 . . . . 0.23000000000000001 113.44 -179.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -84.2 -140.68 4.66 Favored Glycine 0 C--N 1.342 0.868 0 CA-C-N 117.705 0.753 . . . . 0.23000000000000001 112.487 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.22 -28.35 62.81 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 111.745 0.276 . . . . 0.23000000000000001 111.745 -179.492 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.34 158.87 30.98 Favored Glycine 0 C--N 1.333 0.362 0 C-N-CA 120.914 -0.66 . . . . 0.23000000000000001 112.772 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -124.96 133.35 24.73 Favored Pre-proline 0 CA--C 1.535 0.371 0 N-CA-C 110.744 -0.095 . . . . 0.23000000000000001 110.744 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -91.19 26.61 0.45 Allowed 'Trans proline' 0 C--N 1.358 1.03 0 C-N-CA 122.181 1.921 . . . . 0.23000000000000001 113.451 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -106.62 -53.85 2.56 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.791 0.329 . . . . 0.23000000000000001 110.6 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 1.2 mmm180 -118.63 137.4 24.81 Favored Pre-proline 0 CA--C 1.535 0.399 0 CA-C-N 116.21 -0.45 . . . . 0.23000000000000001 110.566 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -86.33 -48.02 0.04 OUTLIER 'Trans proline' 0 C--N 1.357 0.993 0 C-N-CA 121.954 1.77 . . . . 0.23000000000000001 113.356 -179.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -91.63 -10.9 38.72 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 112.811 0.671 . . . . 0.23000000000000001 112.811 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -96.64 113.63 25.2 Favored 'General case' 0 C--O 1.231 0.083 0 CA-C-N 117.998 0.363 . . . . 0.23000000000000001 110.533 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.5 p-10 -100.03 64.62 1.23 Allowed 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 121.123 0.487 . . . . 0.23000000000000001 111.17 -179.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -116.09 -159.02 11.71 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 121.118 -0.563 . . . . 0.23000000000000001 112.462 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.403 HG22 HD11 ' A' ' 45' ' ' ILE . 20.8 mm -111.44 133.21 57.79 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-O 120.444 0.164 . . . . 0.23000000000000001 110.813 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.433 ' N ' ' CD1' ' A' ' 46' ' ' PHE . 4.2 m-85 -129.78 151.02 50.82 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.684 0.278 . . . . 0.23000000000000001 110.722 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 21.7 t -94.28 77.44 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 CA-C-O 121.01 0.434 . . . . 0.23000000000000001 111.278 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.9 t -36.36 -54.39 0.83 Allowed 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 114.615 1.339 . . . . 0.23000000000000001 114.615 -178.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.9 ptt-85 -160.46 163.22 33.15 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.113 0.482 . . . . 0.23000000000000001 112.242 -179.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 16.8 t -118.35 149.69 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-N 115.559 -0.746 . . . . 0.23000000000000001 110.562 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.2 mm-40 -104.97 -68.45 0.04 OUTLIER Pre-proline 0 CA--C 1.538 0.51 0 CA-C-O 119.67 -0.205 . . . . 0.23000000000000001 111.389 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -78.77 121.47 5.06 Favored 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 121.8 1.667 . . . . 0.23000000000000001 112.242 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -77.22 65.96 2.92 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 120.911 0.386 . . . . 0.23000000000000001 111.096 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -156.1 -68.14 0.01 OUTLIER Glycine 0 CA--C 1.528 0.885 0 C-N-CA 120.69 -0.767 . . . . 0.23000000000000001 113.544 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -58.89 -76.82 0.02 OUTLIER 'Trans proline' 0 C--N 1.356 0.966 0 C-N-CA 122.14 1.893 . . . . 0.23000000000000001 113.435 -178.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -110.14 48.74 0.88 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-O 121.218 0.532 . . . . 0.23000000000000001 111.5 -179.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 34.7 t -105.04 -67.45 0.91 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.941 -0.572 . . . . 0.23000000000000001 109.999 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.85 -12.74 60.22 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.891 -0.595 . . . . 0.23000000000000001 111.962 179.176 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 69.1 mt -95.09 -58.91 2.02 Favored 'General case' 0 C--N 1.342 0.276 0 O-C-N 122.137 -0.352 . . . . 0.23000000000000001 111.506 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 22.2 mt -94.18 148.84 21.8 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.501 -0.318 . . . . 0.23000000000000001 111.706 -179.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.7 pm0 -103.53 150.98 38.61 Favored Pre-proline 0 CA--C 1.538 0.488 0 CA-C-N 116.171 -0.468 . . . . 0.23000000000000001 109.958 178.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -68.8 73.79 0.94 Allowed 'Trans proline' 0 C--N 1.357 1.007 0 C-N-CA 122.247 1.965 . . . . 0.23000000000000001 114.108 -178.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 140.74 39.2 0.08 OUTLIER Glycine 0 C--N 1.338 0.662 0 C-N-CA 120.549 -0.834 . . . . 0.23000000000000001 113.943 178.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -94.33 -163.3 1.03 Allowed 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 117.286 0.543 . . . . 0.23000000000000001 111.277 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 27.0 tttm -132.92 121.91 23.54 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 110.275 -0.268 . . . . 0.23000000000000001 110.275 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.7 mm -87.27 109.08 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-N 116.634 -0.257 . . . . 0.23000000000000001 110.802 -178.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 18.1 mm -88.25 -44.45 15.68 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 N-CA-C 112.058 0.392 . . . . 0.23000000000000001 112.058 -179.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -150.87 152.44 33.69 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 112.634 0.605 . . . . 0.23000000000000001 112.634 -178.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -132.52 118.76 19.65 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 115.222 -0.899 . . . . 0.23000000000000001 110.637 179.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 30.3 m-20 46.47 29.77 0.96 Allowed 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 112.905 0.706 . . . . 0.23000000000000001 112.905 179.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 100.16 -3.26 56.79 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 120.936 -0.649 . . . . 0.23000000000000001 113.925 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -91.23 145.72 24.43 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 117.901 0.851 . . . . 0.23000000000000001 110.369 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 80.3 p -88.38 108.42 19.34 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.371 -0.377 . . . . 0.23000000000000001 111.321 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -92.72 8.29 39.91 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 112.376 0.509 . . . . 0.23000000000000001 112.376 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 6.5 tp -86.49 118.25 32.44 Favored 'Isoleucine or valine' 0 C--N 1.341 0.204 0 CA-C-N 118.124 0.42 . . . . 0.23000000000000001 110.673 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 62.81 75.77 0.39 Allowed 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 121.206 0.527 . . . . 0.23000000000000001 111.057 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 8.4 pt -147.71 153.91 11.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.548 -0.751 . . . . 0.23000000000000001 110.543 179.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -66.21 140.46 58.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.415 -0.357 . . . . 0.23000000000000001 110.512 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -50.3 -51.89 41.29 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 112.342 0.497 . . . . 0.23000000000000001 112.342 -179.215 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -54.6 -25.77 36.53 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 120.978 -0.629 . . . . 0.23000000000000001 112.963 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -77.28 -38.87 49.95 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.916 0.389 . . . . 0.23000000000000001 110.453 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -70.05 -39.04 75.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.926 -0.579 . . . . 0.23000000000000001 111.455 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 29.1 t -70.67 -43.35 77.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.898 0.38 . . . . 0.23000000000000001 110.638 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 43.2 m -61.49 -39.18 89.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.14 -0.482 . . . . 0.23000000000000001 111.221 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 14.3 mt -64.6 -46.51 82.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.349 -0.387 . . . . 0.23000000000000001 111.103 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 31.9 mt -64.29 -39.83 94.72 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.171 -0.468 . . . . 0.23000000000000001 112.085 -178.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 19.7 mmtp -65.42 -39.69 92.45 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 112.335 0.494 . . . . 0.23000000000000001 112.335 -178.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 9.8 t -70.74 -26.24 63.28 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 113.52 0.933 . . . . 0.23000000000000001 113.52 -178.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -46.67 170.85 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 113.425 0.898 . . . . 0.23000000000000001 113.425 -178.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 7.1 mp0 -88.56 -142.23 0.13 Allowed 'General case' 0 CA--C 1.55 0.947 0 CA-C-N 115.424 -0.807 . . . . 0.23000000000000001 110.728 -179.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 60.9 m-80 -80.08 -66.91 0.82 Allowed 'General case' 0 C--N 1.348 0.537 0 CA-C-N 119.076 0.853 . . . . 0.23000000000000001 111.08 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.8 124.1 27.87 Favored 'General case' 0 C--N 1.334 -0.095 0 CA-C-N 116.451 -0.341 . . . . 0.23000000000000001 110.412 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 21.9 t -114.16 112.37 39.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.215 -0.448 . . . . 0.23000000000000001 111.143 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -90.41 111.37 22.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.023 -0.535 . . . . 0.23000000000000001 109.889 179.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 15.8 mt -112.02 153.49 26.77 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 121.071 0.462 . . . . 0.23000000000000001 112.166 -178.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 16.5 mt -118.5 130.52 73.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.554 -0.748 . . . . 0.23000000000000001 109.794 178.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 29.3 pt -136.69 169.66 19.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.997 0.427 . . . . 0.23000000000000001 111.925 -179.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.3 t -143.65 154.94 16.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 115.91 -0.586 . . . . 0.23000000000000001 111.412 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 25.3 mmm180 -116.58 114.33 23.97 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.054 -0.521 . . . . 0.23000000000000001 110.147 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -63.47 121.47 13.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.183 -0.462 . . . . 0.23000000000000001 111.344 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.7 m -105.72 93.94 2.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.088 -0.505 . . . . 0.23000000000000001 111.037 179.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 29.5 p -98.87 115.11 28.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.218 -0.446 . . . . 0.23000000000000001 110.952 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 79.5 p . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.24 -0.886 . . . . 0.23000000000000001 110.79 179.952 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 301' ' ' THR . . . . . . . . . . . . . 5.2 m . . . . . 0 N--CA 1.488 1.458 0 N-CA-C 112.307 0.484 . . . . 0.23000000000000001 112.307 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 302' ' ' GLY . . . . . . . . . . . . . . . 94.0 68.08 1.06 Allowed Glycine 0 C--N 1.338 0.657 0 C-N-CA 120.717 -0.754 . . . . 0.23000000000000001 113.29 179.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 303' ' ' TRP . . . . . . . . . . . . . 50.8 p-90 -161.68 -43.94 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.767 0.283 . . . . 0.23000000000000001 111.22 179.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -71.86 132.73 44.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.699 0.285 . . . . 0.23000000000000001 110.844 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 305' ' ' THR . . . . . . . . . . . . . 10.0 m -116.59 131.64 56.89 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.312 -0.404 . . . . 17.879999999999999 110.845 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 306' ' ' TRP . . . . . . . . . . . . . 80.3 m95 -91.09 115.52 28.08 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.298 -0.41 . . . . 0.23000000000000001 110.847 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 307' ' ' VAL . . . . . . . . . . . . . 14.1 m . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.229 -0.891 . . . . 16.109999999999999 111.084 179.959 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.205 0 N-CA-C 112.484 -0.246 . . . . 0.23000000000000001 112.484 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.4 m -87.01 103.43 15.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.793 0.33 . . . . 0.23000000000000001 110.862 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 7.6 p80 -100.28 176.89 5.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.242 -0.435 . . . . 0.23000000000000001 110.852 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 3.6 ttt -74.72 -45.8 41.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.137 -0.483 . . . . 0.23000000000000001 110.9 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 94.49 126.39 4.63 Favored Glycine 0 C--N 1.331 0.286 0 C-N-CA 120.952 -0.642 . . . . 0.23000000000000001 112.41 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 41.9 m-70 -111.93 -61.54 1.7 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.816 0.341 . . . . 0.23000000000000001 111.041 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -95.57 166.71 11.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.254 -0.43 . . . . 0.23000000000000001 111.202 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 15.6 mt -97.39 -63.1 1.16 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.095 -0.502 . . . . 0.23000000000000001 110.894 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -168.42 150.34 5.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.169 -0.469 . . . . 0.23000000000000001 110.913 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.4 tppp? -172.78 117.86 0.33 Allowed 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.55 -0.295 . . . . 0.23000000000000001 111.575 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -107.49 114.04 27.77 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.341 -0.39 . . . . 0.23000000000000001 111.452 -179.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -96.08 106.18 18.32 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.236 -0.438 . . . . 0.23000000000000001 112.081 -179.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 29.6 pt -108.78 166.46 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-O 120.931 0.396 . . . . 0.23000000000000001 111.843 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 6.2 mtm-85 -114.2 164.26 14.12 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.041 -0.527 . . . . 0.23000000000000001 111.575 -179.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.3 m -148.01 164.67 5.68 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 115.9 -0.591 . . . . 0.23000000000000001 110.838 179.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 9.2 ttp180 -132.07 119.43 20.98 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 111.765 0.283 . . . . 0.23000000000000001 111.765 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.0 t -116.26 130.69 70.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-N 116.437 -0.347 . . . . 0.23000000000000001 111.15 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -105.3 123.79 48.45 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.389 -0.369 . . . . 0.23000000000000001 110.923 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 11.3 mmtt -70.6 80.01 0.59 Allowed 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 120.805 0.336 . . . . 0.23000000000000001 111.795 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -137.59 85.68 20.29 Favored Pre-proline 0 CA--C 1.537 0.454 0 CA-C-N 116.485 -0.325 . . . . 0.23000000000000001 111.068 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -83.57 -24.58 10.79 Favored 'Cis proline' 0 C--N 1.366 1.461 0 CA-C-N 119.55 0.875 . . . . 0.23000000000000001 113.034 0.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -137.46 -177.33 4.74 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 120.799 0.333 . . . . 0.23000000000000001 111.125 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.404 ' HB3' ' CE2' ' A' ' 25' ' ' PHE . 4.4 mp -61.94 -57.68 10.81 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.252 -0.431 . . . . 0.23000000000000001 110.991 179.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 99.78 34.25 5.0 Favored Glycine 0 CA--C 1.522 0.513 0 C-N-CA 120.722 -0.751 . . . . 0.23000000000000001 113.87 179.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.404 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 36.3 p90 -160.35 153.06 21.12 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 117.418 0.609 . . . . 0.23000000000000001 111.184 179.096 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.7 p -105.43 147.95 27.69 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.281 -0.418 . . . . 0.23000000000000001 111.221 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 32.4 pt -117.62 148.0 20.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.924 -0.58 . . . . 0.23000000000000001 110.875 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 65.2 p -140.22 156.57 46.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.745 0.307 . . . . 0.23000000000000001 111.188 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 109.11 -159.28 14.15 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 121.058 -0.592 . . . . 0.23000000000000001 112.746 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 108.26 152.75 16.58 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 121.059 -0.591 . . . . 0.23000000000000001 112.384 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 20.1 t -79.73 106.77 11.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.808 0.337 . . . . 0.23000000000000001 110.661 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 88.06 -2.1 85.25 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 120.881 -0.675 . . . . 0.23000000000000001 113.782 -179.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -84.44 -155.94 23.58 Favored Glycine 0 C--N 1.341 0.847 0 CA-C-N 117.869 0.835 . . . . 0.23000000000000001 112.717 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.21 -24.86 65.16 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 111.904 0.335 . . . . 0.23000000000000001 111.904 -179.155 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.61 160.0 35.92 Favored Glycine 0 C--N 1.34 0.793 0 C-N-CA 120.681 -0.771 . . . . 0.23000000000000001 112.504 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 13.7 p30 -119.59 126.37 26.99 Favored Pre-proline 0 N--CA 1.465 0.301 0 N-CA-C 110.619 -0.141 . . . . 0.23000000000000001 110.619 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.41 ' CG ' ' CH2' ' B' ' 303' ' ' TRP . 45.9 Cg_endo -88.62 51.87 1.77 Allowed 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 121.901 1.734 . . . . 0.23000000000000001 112.254 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -133.92 -51.37 0.84 Allowed 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.146 -0.479 . . . . 0.23000000000000001 111.124 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -110.52 139.04 21.17 Favored Pre-proline 0 N--CA 1.466 0.33 0 CA-C-N 116.314 -0.403 . . . . 0.23000000000000001 110.879 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -85.58 -46.38 0.04 OUTLIER 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 122.038 1.825 . . . . 0.23000000000000001 113.198 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -94.62 -8.77 37.08 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 112.893 0.701 . . . . 0.23000000000000001 112.893 -179.232 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -103.1 116.53 32.68 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 118.157 0.435 . . . . 0.23000000000000001 110.579 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.7 p30 -104.25 35.3 2.74 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.294 -0.412 . . . . 0.23000000000000001 111.2 -179.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -84.23 -156.77 24.79 Favored Glycine 0 CA--C 1.519 0.316 0 C-N-CA 120.918 -0.658 . . . . 0.23000000000000001 112.29 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 14.4 mm -111.88 142.57 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-O 120.676 0.274 . . . . 0.23000000000000001 110.692 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -140.15 154.1 46.87 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.495 -0.32 . . . . 0.23000000000000001 111.162 -179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 17.8 t -97.99 75.75 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-O 120.968 0.413 . . . . 0.23000000000000001 111.191 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.0 t -35.66 -51.68 0.66 Allowed 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 114.597 1.332 . . . . 0.23000000000000001 114.597 -178.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 14.5 ptt180 -160.36 175.4 12.85 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.162 0.506 . . . . 0.23000000000000001 112.137 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 20.5 t -131.28 151.21 35.33 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 CA-C-N 115.591 -0.731 . . . . 0.23000000000000001 110.673 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.403 ' HG2' ' CH2' ' B' ' 306' ' ' TRP . 7.5 mm-40 -104.38 -67.82 0.04 OUTLIER Pre-proline 0 CA--C 1.537 0.471 0 CA-C-N 116.634 -0.257 . . . . 0.23000000000000001 111.676 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -77.4 122.46 6.08 Favored 'Trans proline' 0 C--N 1.357 0.977 0 C-N-CA 121.675 1.584 . . . . 0.23000000000000001 112.233 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -80.16 64.21 4.91 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.208 -0.451 . . . . 0.23000000000000001 111.091 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -158.43 -70.56 0.01 OUTLIER Glycine 0 CA--C 1.528 0.886 0 C-N-CA 120.703 -0.76 . . . . 0.23000000000000001 113.564 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.57 -74.45 0.02 OUTLIER 'Trans proline' 0 C--N 1.358 1.06 0 C-N-CA 122.032 1.821 . . . . 0.23000000000000001 113.355 -178.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -106.9 46.76 0.91 Allowed 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 121.083 0.468 . . . . 0.23000000000000001 111.643 -179.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 91.8 p -108.54 -60.39 1.74 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.075 -0.511 . . . . 0.23000000000000001 110.109 179.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 5.7 ttpm? -69.42 -15.52 63.3 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.744 -0.662 . . . . 0.23000000000000001 112.068 179.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 64.2 mt -93.23 -63.35 1.22 Allowed 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.869 0.366 . . . . 0.23000000000000001 111.158 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.9 mt -91.87 144.03 25.9 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.112 -0.495 . . . . 0.23000000000000001 111.44 -179.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 5.1 pp0? -117.35 155.79 49.64 Favored Pre-proline 0 CA--C 1.534 0.355 0 CA-C-N 116.111 -0.495 . . . . 0.23000000000000001 110.449 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -59.19 119.28 6.42 Favored 'Trans proline' 0 C--N 1.357 1.01 0 C-N-CA 121.829 1.686 . . . . 0.23000000000000001 112.49 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 98.68 5.37 56.73 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 121.05 -0.595 . . . . 0.23000000000000001 113.827 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -71.13 140.35 50.56 Favored 'General case' 0 C--N 1.343 0.32 0 CA-C-N 118.102 0.951 . . . . 0.23000000000000001 110.791 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 67.0 tttt -92.61 123.45 35.91 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.039 -0.528 . . . . 0.23000000000000001 110.926 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 20.0 mt -89.15 115.23 28.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.218 -0.447 . . . . 0.23000000000000001 109.841 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 19.9 mm -89.53 -42.16 14.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 112.249 0.462 . . . . 0.23000000000000001 112.249 -178.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 22.4 tt0 -152.53 156.97 40.4 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.933 0.397 . . . . 0.23000000000000001 111.884 -179.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -144.67 125.89 14.69 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.846 -0.616 . . . . 0.23000000000000001 111.194 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 45.72 34.45 1.8 Allowed 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.244 0.831 . . . . 0.23000000000000001 113.244 178.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 95.01 -18.03 58.16 Favored Glycine 0 CA--C 1.523 0.593 0 C-N-CA 120.772 -0.728 . . . . 0.23000000000000001 113.534 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -89.23 126.98 35.72 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 117.353 0.576 . . . . 0.23000000000000001 110.884 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 8.4 t -72.64 124.52 25.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.095 -0.502 . . . . 0.23000000000000001 110.937 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -102.75 12.95 35.57 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 112.421 0.526 . . . . 0.23000000000000001 112.421 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 6.4 tp -91.0 121.74 41.68 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 CA-C-O 120.944 0.402 . . . . 0.23000000000000001 110.703 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 5.4 m120 64.24 74.17 0.41 Allowed 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 121.094 0.474 . . . . 0.23000000000000001 110.721 -179.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 13.9 pt -149.77 164.27 3.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.981 -0.554 . . . . 0.23000000000000001 110.794 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -73.79 144.83 45.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.385 -0.37 . . . . 0.23000000000000001 110.663 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 6.9 t60 -54.3 -54.35 41.43 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.084 -0.507 . . . . 0.23000000000000001 111.804 -179.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -54.78 -27.46 43.65 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 121.163 -0.541 . . . . 0.23000000000000001 112.911 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -71.21 -39.29 71.83 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.093 0.473 . . . . 0.23000000000000001 110.451 179.274 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.19 -52.14 44.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.767 -0.652 . . . . 0.23000000000000001 111.492 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 20.8 t -59.68 -43.89 92.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.364 -0.38 . . . . 0.23000000000000001 111.604 -179.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 57.8 m -59.99 -40.9 90.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.381 -0.372 . . . . 0.23000000000000001 111.534 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 31.2 mt -66.4 -43.93 84.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.414 -0.357 . . . . 0.23000000000000001 111.53 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.4 ' HA ' ' CD2' ' A' ' 89' ' ' PHE . 32.6 mt -66.51 -42.6 87.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.265 -0.425 . . . . 0.23000000000000001 111.796 -179.249 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 42.0 mmtt -65.02 -43.07 93.68 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.432 0.53 . . . . 0.23000000000000001 112.432 -178.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 12.1 t -69.43 -25.89 64.34 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 112.777 0.658 . . . . 0.23000000000000001 112.777 -178.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.4 ' CD2' ' HA ' ' A' ' 86' ' ' LEU . 14.7 m-30 -45.56 170.99 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 113.447 0.906 . . . . 0.23000000000000001 113.447 -179.053 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -84.56 -143.01 0.08 Allowed 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 115.221 -0.9 . . . . 0.23000000000000001 110.973 -179.224 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 35.9 m120 -83.07 -62.21 1.66 Allowed 'General case' 0 C--N 1.348 0.506 0 CA-C-N 118.992 0.814 . . . . 0.23000000000000001 111.779 -178.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -87.5 129.57 35.02 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.587 -0.279 . . . . 0.23000000000000001 110.505 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 19.1 t -125.41 121.02 59.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-N 116.45 -0.341 . . . . 0.23000000000000001 111.139 -179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -95.37 105.67 17.65 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.333 -0.394 . . . . 0.23000000000000001 110.469 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 12.1 mt -99.11 152.55 19.74 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 121.076 0.465 . . . . 0.23000000000000001 111.673 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 61.1 mt -110.37 126.21 67.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.575 -0.739 . . . . 0.23000000000000001 109.654 178.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 43.6 pt -127.95 168.62 20.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.821 0.343 . . . . 0.23000000000000001 111.622 -178.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.4 t -145.88 151.34 14.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.065 -0.516 . . . . 0.23000000000000001 111.236 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -114.72 109.68 18.57 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.315 -0.402 . . . . 0.23000000000000001 109.95 179.292 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -58.56 124.69 20.49 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.322 -0.399 . . . . 0.23000000000000001 111.891 -179.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.4 t -101.96 153.75 5.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.042 -0.526 . . . . 0.23000000000000001 110.496 179.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 71.3 m -160.07 176.5 11.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.892 0.377 . . . . 0.23000000000000001 111.136 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 22.7 t . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.309 -0.853 . . . . 0.23000000000000001 110.796 179.912 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 301' ' ' THR . . . . . . . . . . . . . 10.3 t . . . . . 0 N--CA 1.489 1.489 0 N-CA-C 111.81 0.3 . . . . 0.23000000000000001 111.81 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 302' ' ' GLY . . . . . . . . . . . . . . . -72.25 98.34 0.81 Allowed Glycine 0 CA--C 1.52 0.401 0 C-N-CA 120.904 -0.665 . . . . 0.23000000000000001 113.111 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 303' ' ' TRP . . . . . 0.41 ' CH2' ' CG ' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -162.52 -158.97 0.54 Allowed 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 116.804 0.302 . . . . 0.23000000000000001 111.327 -179.952 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.54 -179.64 1.78 Allowed 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 113.284 0.846 . . . . 0.23000000000000001 113.284 -177.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 305' ' ' THR . . . . . . . . . . . . . 21.0 m -154.67 100.31 2.23 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 114.942 -1.026 . . . . 17.879999999999999 109.698 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 306' ' ' TRP . . . . . 0.403 ' CH2' ' HG2' ' A' ' 51' ' ' GLN . 83.4 m95 -60.6 123.0 16.11 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.995 0.426 . . . . 0.23000000000000001 111.684 -179.045 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 307' ' ' VAL . . . . . . . . . . . . . 16.0 m . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.273 -0.87 . . . . 16.109999999999999 111.174 179.944 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.185 0 N-CA-C 112.612 -0.195 . . . . 0.23000000000000001 112.612 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.4 m -84.82 -175.22 5.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.581 0.229 . . . . 0.23000000000000001 110.755 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -57.79 108.22 0.55 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.069 0.461 . . . . 0.23000000000000001 111.366 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 5.2 tpt -79.59 -22.5 43.64 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.034 -0.53 . . . . 0.23000000000000001 112.163 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -55.7 -169.68 0.08 OUTLIER Glycine 0 C--N 1.338 0.677 0 C-N-CA 120.983 -0.627 . . . . 0.23000000000000001 113.466 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 13.2 m80 -75.92 166.03 24.11 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.002 0.429 . . . . 0.23000000000000001 111.405 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -125.56 -159.21 0.88 Allowed 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.733 -0.667 . . . . 0.23000000000000001 109.907 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.42 109.97 0.7 Allowed 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.986 0.422 . . . . 0.23000000000000001 111.581 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -151.92 -144.28 0.15 Allowed 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 116.033 -0.531 . . . . 0.23000000000000001 110.053 -179.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -43.88 108.05 0.1 Allowed 'General case' 0 N--CA 1.486 1.345 0 CA-C-N 119.223 0.92 . . . . 0.23000000000000001 112.471 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.47 121.48 29.08 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.858 -0.61 . . . . 0.23000000000000001 112.612 -177.373 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -100.86 131.36 46.78 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.536 -0.756 . . . . 0.23000000000000001 110.885 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.41 HG22 HD11 ' A' ' 13' ' ' ILE . 0.2 OUTLIER -150.4 163.56 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-O 120.61 0.243 . . . . 0.23000000000000001 111.571 179.89 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 57.9 mtt180 -116.78 164.72 14.23 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.36 -0.382 . . . . 0.23000000000000001 111.879 -179.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.0 m -146.08 161.15 11.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 116.068 -0.515 . . . . 0.23000000000000001 111.027 179.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.39 120.83 23.62 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.556 -0.293 . . . . 0.23000000000000001 111.659 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.7 t -125.71 135.55 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.41 -0.359 . . . . 0.23000000000000001 110.793 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -107.44 127.86 53.97 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.742 0.306 . . . . 0.23000000000000001 111.418 -179.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.46 112.45 6.75 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.317 -0.401 . . . . 0.23000000000000001 111.13 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -173.75 83.45 0.38 Allowed Pre-proline 0 CA--C 1.54 0.566 0 CA-C-N 116.488 -0.323 . . . . 0.23000000000000001 111.31 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -83.84 -23.3 12.93 Favored 'Cis proline' 0 C--N 1.366 1.463 0 CA-C-N 119.359 0.807 . . . . 0.23000000000000001 112.888 0.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -137.41 -177.97 5.01 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.745 0.307 . . . . 0.23000000000000001 110.955 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.2 mp -65.66 -54.35 28.8 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.337 -0.392 . . . . 0.23000000000000001 110.963 179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 109.83 32.93 2.74 Favored Glycine 0 C--N 1.334 0.426 0 C-N-CA 120.837 -0.697 . . . . 0.23000000000000001 113.543 179.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -167.21 179.38 5.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 117.008 0.404 . . . . 0.23000000000000001 111.069 179.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.0 p -131.39 162.4 30.24 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.376 -0.374 . . . . 0.23000000000000001 111.205 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 37.4 pt -127.38 154.89 38.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.059 -0.519 . . . . 0.23000000000000001 110.879 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 39.1 t -145.14 166.51 25.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.46 -0.336 . . . . 0.23000000000000001 111.014 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 101.01 -147.52 17.85 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.816 -0.707 . . . . 0.23000000000000001 112.635 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 105.47 152.97 21.2 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.932 -0.652 . . . . 0.23000000000000001 112.446 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 32.2 t -79.81 108.1 12.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.913 0.387 . . . . 0.23000000000000001 110.587 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 90.28 -1.06 79.16 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 120.946 -0.645 . . . . 0.23000000000000001 113.844 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -83.82 -149.45 9.54 Favored Glycine 0 C--N 1.342 0.903 0 CA-C-N 117.866 0.833 . . . . 0.23000000000000001 112.887 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 52.0 mtt85 -81.34 -18.32 46.12 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 112.591 0.589 . . . . 0.23000000000000001 112.591 -179.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.06 -177.89 49.41 Favored Glycine 0 C--N 1.338 0.652 0 C-N-CA 120.706 -0.759 . . . . 0.23000000000000001 112.757 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -136.82 157.78 74.23 Favored Pre-proline 0 CA--C 1.533 0.301 0 O-C-N 123.041 -0.093 . . . . 0.23000000000000001 110.78 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -87.87 17.71 1.65 Allowed 'Trans proline' 0 C--N 1.358 1.068 0 C-N-CA 122.147 1.898 . . . . 0.23000000000000001 113.781 -179.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -101.77 -41.07 6.66 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.87 0.367 . . . . 0.23000000000000001 110.626 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 11.2 mmp_? -129.99 132.06 23.88 Favored Pre-proline 0 CA--C 1.533 0.322 0 CA-C-N 116.1 -0.5 . . . . 0.23000000000000001 110.332 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -83.05 -40.39 0.11 Allowed 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 121.887 1.725 . . . . 0.23000000000000001 113.089 -179.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -99.92 -4.23 30.65 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 113.107 0.78 . . . . 0.23000000000000001 113.107 -179.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -90.63 122.67 33.62 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 118.2 0.455 . . . . 0.23000000000000001 110.912 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -102.18 40.82 1.29 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.224 -0.444 . . . . 0.23000000000000001 111.132 -179.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -98.9 -170.77 31.22 Favored Glycine 0 C--N 1.333 0.387 0 C-N-CA 120.958 -0.639 . . . . 0.23000000000000001 112.507 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 22.0 mm -110.26 127.69 67.03 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-N 116.569 0.184 . . . . 0.23000000000000001 110.51 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.44 ' CD1' ' N ' ' A' ' 46' ' ' PHE . 4.0 m-85 -128.29 146.77 50.65 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.762 0.315 . . . . 0.23000000000000001 111.529 -179.454 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 21.4 t -86.7 79.57 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-O 120.98 0.419 . . . . 0.23000000000000001 111.077 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.5 t -36.24 -55.22 0.8 Allowed 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 114.849 1.426 . . . . 0.23000000000000001 114.849 -178.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -160.07 -179.55 7.87 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.218 0.532 . . . . 0.23000000000000001 112.392 -179.049 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 13.7 t -138.48 145.55 28.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-N 115.577 -0.738 . . . . 0.23000000000000001 110.498 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.405 ' HG3' ' CH2' ' B' ' 306' ' ' TRP . 15.3 mt-30 -104.55 -68.71 0.04 OUTLIER Pre-proline 0 CA--C 1.537 0.459 0 N-CA-C 111.59 0.218 . . . . 0.23000000000000001 111.59 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -81.16 113.84 2.75 Favored 'Trans proline' 0 C--N 1.357 1.005 0 C-N-CA 121.661 1.574 . . . . 0.23000000000000001 112.304 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -77.78 70.36 4.14 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.138 0.494 . . . . 0.23000000000000001 110.936 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -145.37 -71.45 0.02 OUTLIER Glycine 0 CA--C 1.526 0.762 0 CA-C-N 115.719 -0.673 . . . . 0.23000000000000001 112.643 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -58.59 -71.93 0.03 OUTLIER 'Trans proline' 0 C--N 1.357 0.998 0 C-N-CA 122.021 1.814 . . . . 0.23000000000000001 112.796 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -105.87 47.34 0.88 Allowed 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 121.217 0.532 . . . . 0.23000000000000001 111.263 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 98.1 p -83.2 -59.73 2.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.956 -0.565 . . . . 0.23000000000000001 109.965 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 37.2 tptt -88.21 4.42 45.79 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 115.697 -0.683 . . . . 0.23000000000000001 112.016 178.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -92.6 -64.87 1.05 Allowed 'General case' 0 C--N 1.343 0.302 0 CA-C-N 118.16 0.436 . . . . 0.23000000000000001 111.727 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.1 mt -100.9 145.4 28.67 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.159 0.504 . . . . 0.23000000000000001 112.223 -178.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -107.28 142.51 25.25 Favored Pre-proline 0 CA--C 1.534 0.358 0 CA-C-N 115.726 -0.67 . . . . 0.23000000000000001 109.996 179.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.02 131.29 45.52 Favored 'Trans proline' 0 C--N 1.357 1.0 0 C-N-CA 121.899 1.733 . . . . 0.23000000000000001 113.159 -179.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 81.72 32.25 30.65 Favored Glycine 0 C--N 1.33 0.235 0 CA-C-N 115.979 -0.555 . . . . 0.23000000000000001 113.55 179.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -88.28 -169.51 2.59 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 117.027 0.414 . . . . 0.23000000000000001 110.898 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 78.1 tttt -138.44 125.64 21.54 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.381 -0.372 . . . . 0.23000000000000001 110.975 -179.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 34.3 mt -94.36 122.53 45.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.294 -0.412 . . . . 0.23000000000000001 110.501 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 26.0 mm -104.5 -36.82 4.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 N-CA-C 111.982 0.364 . . . . 0.23000000000000001 111.982 -179.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -148.87 149.46 31.31 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.974 0.416 . . . . 0.23000000000000001 111.827 -179.185 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -145.77 122.46 11.17 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 115.812 -0.631 . . . . 0.23000000000000001 111.334 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.3 m120 45.94 38.3 4.44 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 113.086 0.773 . . . . 0.23000000000000001 113.086 179.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 84.42 11.21 78.38 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 121.007 -0.616 . . . . 0.23000000000000001 113.87 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -113.44 121.8 45.38 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 117.69 0.745 . . . . 0.23000000000000001 110.238 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 79.9 p -72.74 135.78 45.39 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.41 -0.359 . . . . 0.23000000000000001 110.661 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 -104.59 23.51 13.21 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 112.029 0.381 . . . . 0.23000000000000001 112.029 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 11.4 mm -97.41 139.77 19.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-O 121.032 0.444 . . . . 0.23000000000000001 109.921 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 7.9 m120 61.47 16.69 7.77 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 112.696 0.628 . . . . 0.23000000000000001 112.696 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 25.9 pt -95.29 163.8 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 112.732 0.642 . . . . 0.23000000000000001 112.732 -179.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -91.67 149.69 21.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.141 -0.936 . . . . 0.23000000000000001 111.173 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 15.3 t60 -46.41 -51.89 14.1 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 112.803 0.668 . . . . 0.23000000000000001 112.803 -179.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -56.13 -26.91 50.73 Favored Glycine 0 CA--C 1.523 0.573 0 C-N-CA 120.985 -0.626 . . . . 0.23000000000000001 113.176 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -74.56 -42.97 57.84 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 120.954 0.407 . . . . 0.23000000000000001 110.476 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.25 -42.49 99.18 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.149 -0.478 . . . . 0.23000000000000001 111.374 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 18.0 t -73.71 -40.99 54.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.211 -0.449 . . . . 0.23000000000000001 110.753 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 43.7 t -62.19 -46.76 87.47 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.035 -0.529 . . . . 0.23000000000000001 111.353 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 31.5 mt -61.16 -49.83 75.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.381 -0.372 . . . . 0.23000000000000001 111.72 -179.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 17.3 mt -64.1 -37.68 88.31 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.988 0.366 . . . . 0.23000000000000001 111.988 -178.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 9.2 mmtp -71.04 -39.82 72.06 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.634 0.605 . . . . 0.23000000000000001 112.634 -178.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 11.4 t -71.87 -27.31 62.78 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 113.261 0.837 . . . . 0.23000000000000001 113.261 -178.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -46.74 170.9 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 113.29 0.848 . . . . 0.23000000000000001 113.29 -178.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -83.85 -142.85 0.07 Allowed 'General case' 0 CA--C 1.55 0.968 0 CA-C-N 115.423 -0.808 . . . . 0.23000000000000001 110.834 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -79.48 -70.3 0.52 Allowed 'General case' 0 C--N 1.348 0.523 0 CA-C-N 119.22 0.918 . . . . 0.23000000000000001 111.501 -179.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -75.24 123.45 25.32 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.366 -0.379 . . . . 0.23000000000000001 110.634 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 14.2 t -121.04 120.82 63.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.162 -0.472 . . . . 0.23000000000000001 110.723 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -99.91 107.17 19.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.381 -0.372 . . . . 0.23000000000000001 110.54 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 6.2 mp -107.13 161.76 14.48 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 121.054 0.455 . . . . 0.23000000000000001 111.788 -179.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 21.5 mt -123.64 132.23 71.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.544 -0.753 . . . . 0.23000000000000001 109.402 178.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 43.9 pt -126.38 175.64 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-O 120.689 0.281 . . . . 0.23000000000000001 111.625 -178.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 17.2 t -150.22 143.96 17.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-O 120.934 0.397 . . . . 0.23000000000000001 112.034 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.01 116.91 30.68 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 109.133 -0.691 . . . . 0.23000000000000001 109.133 178.367 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -65.77 154.65 38.45 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.047 0.451 . . . . 0.23000000000000001 111.811 -178.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 8.3 m -115.49 148.6 18.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.607 -0.724 . . . . 0.23000000000000001 110.683 179.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 59.3 p -77.67 124.17 27.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.495 -0.32 . . . . 0.23000000000000001 111.106 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 39.2 m . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.142 -0.932 . . . . 0.23000000000000001 110.815 179.88 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 301' ' ' THR . . . . . . . . . . . . . 6.5 m . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.677 0.275 . . . . 0.23000000000000001 111.237 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 302' ' ' GLY . . . . . . . . . . . . . . . 172.06 -60.88 0.16 Allowed Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.703 -0.761 . . . . 0.23000000000000001 112.946 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 303' ' ' TRP . . . . . 0.406 ' CZ3' ' HB3' ' B' ' 304' ' ' GLU . 4.1 p-90 -85.77 -21.56 28.14 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 111.906 0.336 . . . . 0.23000000000000001 111.906 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 304' ' ' GLU . . . . . 0.406 ' HB3' ' CZ3' ' B' ' 303' ' ' TRP . 7.9 pt-20 -99.41 162.1 13.23 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-O 120.911 0.386 . . . . 0.23000000000000001 111.082 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 305' ' ' THR . . . . . . . . . . . . . 15.2 m -142.24 132.28 24.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.948 -0.569 . . . . 17.879999999999999 110.368 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 306' ' ' TRP . . . . . 0.405 ' CH2' ' HG3' ' A' ' 51' ' ' GLN . 81.0 m95 -88.39 121.73 31.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.308 -0.406 . . . . 0.23000000000000001 111.335 -179.373 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 307' ' ' VAL . . . . . . . . . . . . . 23.8 m . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.314 -0.851 . . . . 16.109999999999999 111.167 -179.996 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.163 0 N-CA-C 112.486 -0.245 . . . . 0.23000000000000001 112.486 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 75.2 m -113.61 47.78 1.13 Allowed 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 121.231 0.539 . . . . 0.23000000000000001 110.758 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -76.38 147.71 37.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.926 -0.579 . . . . 0.23000000000000001 110.749 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.6 ptp -135.77 156.79 48.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.294 -0.412 . . . . 0.23000000000000001 110.795 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 157.56 -140.43 7.07 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.73 -0.748 . . . . 0.23000000000000001 112.715 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 13.1 t-160 -113.45 -28.05 7.68 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 111.711 0.263 . . . . 0.23000000000000001 111.711 -179.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.42 177.77 0.35 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.978 0.418 . . . . 0.23000000000000001 111.53 -179.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.8 mt -87.32 146.45 25.92 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.908 -0.587 . . . . 0.23000000000000001 111.047 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -103.34 61.8 0.78 Allowed 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 121.33 0.586 . . . . 0.23000000000000001 110.325 179.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 8.9 mmmt -153.48 124.08 7.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.625 -0.716 . . . . 0.23000000000000001 109.977 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -89.64 88.58 7.46 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 111.916 0.339 . . . . 0.23000000000000001 111.916 -179.333 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -90.91 124.99 35.62 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.857 -0.423 . . . . 0.23000000000000001 109.857 179.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.6 pt -148.21 159.14 7.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 112.346 0.499 . . . . 0.23000000000000001 112.346 -178.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 13.3 ttp-105 -119.52 157.01 29.21 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 116.083 -0.508 . . . . 0.23000000000000001 111.639 -179.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 17.6 m -150.93 152.67 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 112.009 0.374 . . . . 0.23000000000000001 112.009 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 2.0 ptp180 -114.92 129.02 56.62 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 116.327 -0.397 . . . . 0.23000000000000001 111.025 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.2 t -113.54 119.57 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 116.264 -0.426 . . . . 0.23000000000000001 110.789 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -93.54 121.48 35.0 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.476 -0.329 . . . . 0.23000000000000001 111.648 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.91 116.07 10.79 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.366 -0.379 . . . . 0.23000000000000001 110.752 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -175.85 81.39 0.29 Allowed Pre-proline 0 CA--C 1.538 0.509 0 CA-C-N 116.513 -0.312 . . . . 0.23000000000000001 110.753 179.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -84.85 -22.97 12.86 Favored 'Cis proline' 0 C--N 1.363 1.294 0 CA-C-N 119.327 0.795 . . . . 0.23000000000000001 113.333 0.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -137.93 -179.18 5.61 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.946 0.403 . . . . 0.23000000000000001 112.06 -179.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.404 HD21 ' CZ ' ' A' ' 25' ' ' PHE . 3.4 mp -61.82 -61.17 2.69 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.877 -0.601 . . . . 0.23000000000000001 111.293 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 109.25 20.55 7.81 Favored Glycine 0 CA--C 1.523 0.568 0 C-N-CA 120.788 -0.72 . . . . 0.23000000000000001 113.796 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.404 ' CZ ' HD21 ' A' ' 23' ' ' LEU . 40.7 p90 -151.0 155.67 39.53 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 117.52 0.66 . . . . 0.23000000000000001 111.393 179.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -110.11 151.94 26.62 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.223 -0.444 . . . . 0.23000000000000001 111.537 -179.187 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 12.1 pt -121.07 151.67 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-N 115.921 -0.582 . . . . 0.23000000000000001 111.465 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.3 m -150.29 163.12 39.1 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.505 -0.316 . . . . 0.23000000000000001 111.345 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 120.75 -89.57 0.45 Allowed Glycine 0 C--N 1.337 0.618 0 C-N-CA 121.034 -0.603 . . . . 0.23000000000000001 113.379 179.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 66.91 -138.45 35.08 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.938 -0.649 . . . . 0.23000000000000001 112.427 -179.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 47.0 t -131.42 57.95 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-O 121.145 0.497 . . . . 0.23000000000000001 111.38 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 92.15 -7.5 78.43 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 115.09 0.796 . . . . 0.23000000000000001 115.09 178.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -97.68 26.88 21.34 Favored Glycine 0 C--N 1.339 0.75 0 CA-C-N 118.092 0.946 . . . . 0.23000000000000001 113.642 -179.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -173.12 -42.22 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 109.603 -0.517 . . . . 0.23000000000000001 109.603 178.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.86 146.66 0.74 Allowed Glycine 0 CA--C 1.521 0.419 0 CA-C-N 115.877 -0.602 . . . . 0.23000000000000001 112.966 179.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -123.94 137.58 29.12 Favored Pre-proline 0 CA--C 1.534 0.332 0 N-CA-C 110.541 -0.17 . . . . 0.23000000000000001 110.541 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -91.47 24.44 0.55 Allowed 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 122.289 1.992 . . . . 0.23000000000000001 113.593 -179.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -107.94 -52.84 2.71 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.759 0.314 . . . . 0.23000000000000001 110.813 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -119.58 133.37 23.82 Favored Pre-proline 0 N--CA 1.466 0.372 0 CA-C-N 116.292 -0.413 . . . . 0.23000000000000001 110.359 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -84.61 -46.59 0.05 OUTLIER 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 121.869 1.713 . . . . 0.23000000000000001 113.086 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 13.1 p-10 -88.06 -9.48 53.21 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 112.78 0.659 . . . . 0.23000000000000001 112.78 -179.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -100.89 118.05 36.16 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 118.056 0.389 . . . . 0.23000000000000001 110.725 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.8 p30 -106.79 66.7 0.69 Allowed 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 121.15 0.5 . . . . 0.23000000000000001 110.912 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -114.98 -143.79 8.21 Favored Glycine 0 CA--C 1.519 0.308 0 CA-C-N 115.924 -0.58 . . . . 0.23000000000000001 112.366 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.425 HD11 HG22 ' A' ' 45' ' ' ILE . 21.5 mm -125.68 128.14 72.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.607 0.241 . . . . 0.23000000000000001 110.735 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -121.6 147.46 45.81 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.542 -0.299 . . . . 0.23000000000000001 111.075 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 21.7 t -92.07 71.89 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 116.104 -0.498 . . . . 0.23000000000000001 111.04 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 10.1 t -35.78 -54.13 0.73 Allowed 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 115.063 1.505 . . . . 0.23000000000000001 115.063 -178.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.03 168.49 25.47 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.945 0.721 . . . . 0.23000000000000001 112.945 -178.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 17.3 t -124.89 150.98 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-N 115.247 -0.888 . . . . 0.23000000000000001 110.401 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.5 mm-40 -105.54 -68.99 0.03 OUTLIER Pre-proline 0 CA--C 1.539 0.547 0 N-CA-C 112.347 0.499 . . . . 0.23000000000000001 112.347 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -80.93 121.68 4.11 Favored 'Trans proline' 0 C--N 1.359 1.091 0 C-N-CA 121.861 1.707 . . . . 0.23000000000000001 112.818 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -74.84 67.66 1.66 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 120.968 0.413 . . . . 0.23000000000000001 111.328 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -156.81 -67.33 0.01 OUTLIER Glycine 0 CA--C 1.528 0.904 0 C-N-CA 120.803 -0.713 . . . . 0.23000000000000001 113.476 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -58.63 -78.06 0.02 OUTLIER 'Trans proline' 0 C--N 1.357 0.983 0 C-N-CA 122.081 1.854 . . . . 0.23000000000000001 113.499 -179.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -117.06 53.96 0.89 Allowed 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 121.255 0.55 . . . . 0.23000000000000001 111.929 -179.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 77.8 p -108.14 -65.12 1.15 Allowed 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.36 -0.608 . . . . 0.23000000000000001 109.36 178.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.14 -14.43 61.8 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.705 -0.68 . . . . 0.23000000000000001 111.18 178.182 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 65.0 mt -92.66 -57.42 2.67 Favored 'General case' 0 C--N 1.344 0.329 0 O-C-N 122.137 -0.352 . . . . 0.23000000000000001 110.901 179.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 27.9 mt -96.24 146.92 24.29 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.223 -0.444 . . . . 0.23000000000000001 111.291 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -124.75 145.7 50.53 Favored Pre-proline 0 N--CA 1.47 0.567 0 CA-C-N 115.981 -0.554 . . . . 0.23000000000000001 110.97 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_exo -58.32 127.18 23.8 Favored 'Trans proline' 0 C--N 1.362 1.263 0 C-N-CA 122.35 2.034 . . . . 0.23000000000000001 113.689 -178.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 106.65 8.35 32.64 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 120.906 -0.664 . . . . 0.23000000000000001 114.435 178.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -93.71 146.89 23.52 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 117.821 0.81 . . . . 0.23000000000000001 111.575 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 51.5 tttt -98.71 133.08 43.54 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.918 -0.583 . . . . 0.23000000000000001 110.699 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 29.3 mt -89.29 119.74 36.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.394 -0.367 . . . . 0.23000000000000001 110.467 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 20.5 mm -89.83 -38.68 11.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 N-CA-C 112.203 0.446 . . . . 0.23000000000000001 112.203 -178.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -155.36 154.66 32.35 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 121.059 0.457 . . . . 0.23000000000000001 112.033 -179.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -141.93 123.87 15.31 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.805 -0.634 . . . . 0.23000000000000001 110.966 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 42.91 41.69 2.71 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 113.409 0.892 . . . . 0.23000000000000001 113.409 179.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 84.97 -0.48 89.09 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 120.9 -0.666 . . . . 0.23000000000000001 114.152 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -108.4 124.47 50.44 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 117.953 0.877 . . . . 0.23000000000000001 110.914 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 30.6 t -70.9 131.62 44.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.368 -0.378 . . . . 0.23000000000000001 110.694 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -101.7 19.8 17.44 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 112.124 0.416 . . . . 0.23000000000000001 112.124 -179.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 28.7 mm -92.46 121.09 42.77 Favored 'Isoleucine or valine' 0 C--N 1.339 0.12 0 CA-C-O 120.766 0.317 . . . . 0.23000000000000001 110.664 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 57.1 m-20 61.87 74.88 0.43 Allowed 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.209 0.528 . . . . 0.23000000000000001 110.743 -179.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 10.3 pt -146.57 150.27 15.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.876 -0.602 . . . . 0.23000000000000001 110.914 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -68.92 136.54 52.74 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.067 -0.515 . . . . 0.23000000000000001 110.998 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 36.7 t60 -43.47 -45.92 6.6 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 113.16 0.8 . . . . 0.23000000000000001 113.16 -179.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -59.39 -28.69 65.04 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.86 -0.686 . . . . 0.23000000000000001 112.457 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 3.7 tp-100 -72.65 -44.47 61.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.918 0.39 . . . . 0.23000000000000001 110.639 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.87 -37.95 85.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.047 -0.524 . . . . 0.23000000000000001 111.257 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 24.2 t -75.06 -42.48 45.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.946 0.403 . . . . 0.23000000000000001 110.755 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 42.2 t -62.81 -41.65 99.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.11 -0.496 . . . . 0.23000000000000001 111.142 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 27.4 mt -65.27 -46.75 79.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.23000000000000001 111.455 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.412 ' HA ' ' CD2' ' A' ' 89' ' ' PHE . 27.2 mt -65.94 -30.87 71.52 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.147 -0.479 . . . . 0.23000000000000001 112.169 -178.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 30.0 mmtt -77.13 -35.44 56.17 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.039 0.385 . . . . 0.23000000000000001 112.039 -179.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 9.7 t -75.52 -26.68 58.28 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 112.881 0.697 . . . . 0.23000000000000001 112.881 -178.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.412 ' CD2' ' HA ' ' A' ' 86' ' ' LEU . 21.0 m-85 -52.56 149.36 5.97 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.145 0.498 . . . . 0.23000000000000001 112.134 -179.196 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -65.18 -136.65 0.0 OUTLIER 'General case' 0 CA--C 1.555 1.161 0 CA-C-N 115.808 -0.633 . . . . 0.23000000000000001 111.557 -179.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -80.3 -70.36 0.53 Allowed 'General case' 0 C--N 1.351 0.665 0 CA-C-N 119.588 1.086 . . . . 0.23000000000000001 112.613 -179.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.8 p -78.34 127.53 32.35 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.792 0.329 . . . . 0.23000000000000001 111.3 -179.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 21.8 t -117.2 114.08 44.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.967 -0.561 . . . . 0.23000000000000001 110.719 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -89.67 111.86 22.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.255 -0.43 . . . . 0.23000000000000001 110.515 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 4.0 mp -112.96 151.52 30.47 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.982 0.42 . . . . 0.23000000000000001 111.781 -179.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 17.6 mm -107.6 121.93 61.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.638 -0.71 . . . . 0.23000000000000001 109.9 178.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 22.4 pt -129.05 163.1 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-O 120.809 0.338 . . . . 0.23000000000000001 111.881 -179.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 14.3 t -150.76 155.72 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-N 116.223 -0.444 . . . . 0.23000000000000001 111.727 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 32.9 mmm-85 -110.5 122.43 47.73 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.094 -0.503 . . . . 0.23000000000000001 109.767 177.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -70.45 104.31 2.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.852 0.358 . . . . 0.23000000000000001 111.156 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 22.9 t -118.61 123.99 72.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.982 -0.554 . . . . 0.23000000000000001 110.733 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 17.6 t -113.82 128.11 56.28 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.817 0.342 . . . . 0.23000000000000001 111.087 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 76.8 p . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.325 -0.845 . . . . 0.23000000000000001 110.868 179.744 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 301' ' ' THR . . . . . . . . . . . . . 8.2 m . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 121.143 0.497 . . . . 0.23000000000000001 111.026 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 302' ' ' GLY . . . . . . . . . . . . . . . -179.51 61.28 0.08 OUTLIER Glycine 0 CA--C 1.521 0.427 0 C-N-CA 120.882 -0.675 . . . . 0.23000000000000001 112.862 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 303' ' ' TRP . . . . . . . . . . . . . 45.0 p-90 -124.8 16.63 8.68 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 112.043 0.386 . . . . 0.23000000000000001 112.043 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -139.47 135.26 33.36 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 120.763 0.316 . . . . 0.23000000000000001 110.988 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 305' ' ' THR . . . . . . . . . . . . . 80.7 m -123.93 122.5 38.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.039 -0.528 . . . . 17.879999999999999 110.669 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 306' ' ' TRP . . . . . . . . . . . . . 86.1 m95 -78.16 107.84 11.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.294 -0.412 . . . . 0.23000000000000001 110.891 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 307' ' ' VAL . . . . . . . . . . . . . 17.5 m . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.257 -0.878 . . . . 16.109999999999999 111.153 -179.98 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.142 0 N-CA-C 112.509 -0.236 . . . . 0.23000000000000001 112.509 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 62.0 m -152.04 -63.32 0.17 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.784 0.326 . . . . 0.23000000000000001 110.957 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -124.33 141.35 52.14 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.27 -0.423 . . . . 0.23000000000000001 111.006 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 6.5 ptp -141.17 -47.55 0.4 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.26 -0.427 . . . . 0.23000000000000001 110.899 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 139.67 120.34 1.75 Allowed Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.952 -0.642 . . . . 0.23000000000000001 112.527 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 4.8 m80 -157.99 -48.35 0.06 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.802 0.334 . . . . 0.23000000000000001 110.84 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -86.07 116.24 24.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.301 -0.409 . . . . 0.23000000000000001 111.089 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.8 mp -124.08 106.68 10.56 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.083 -0.508 . . . . 0.23000000000000001 110.55 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -169.29 -161.34 0.3 Allowed 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 116.455 -0.338 . . . . 0.23000000000000001 111.228 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 35.9 mttt -50.97 115.37 1.49 Allowed 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 112.418 0.525 . . . . 0.23000000000000001 112.418 -179.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.28 175.57 5.45 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.036 -0.529 . . . . 0.23000000000000001 110.856 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.43 102.83 4.15 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.688 -0.233 . . . . 0.23000000000000001 111.265 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.9 pt -107.94 162.49 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-N 116.204 -0.453 . . . . 0.23000000000000001 112.164 -179.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 14.5 ttm105 -116.98 152.86 33.7 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.806 -0.634 . . . . 0.23000000000000001 111.987 -179.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.1 m -143.2 144.12 24.1 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 CA-C-N 116.083 -0.508 . . . . 0.23000000000000001 110.668 179.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 11.6 ttp-105 -116.73 130.58 56.81 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.804 0.335 . . . . 0.23000000000000001 111.293 -179.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.0 t -123.49 125.57 71.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.085 -0.507 . . . . 0.23000000000000001 111.07 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -92.21 119.77 32.15 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.892 0.377 . . . . 0.23000000000000001 111.086 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -71.18 119.75 15.77 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.293 -0.412 . . . . 0.23000000000000001 111.091 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -174.65 82.72 0.34 Allowed Pre-proline 0 CA--C 1.539 0.556 0 CA-C-N 116.3 -0.409 . . . . 0.23000000000000001 111.077 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo -86.84 -18.93 19.75 Favored 'Cis proline' 0 C--N 1.365 1.409 0 CA-C-N 119.407 0.824 . . . . 0.23000000000000001 113.228 0.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -133.44 -178.56 5.04 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.829 0.347 . . . . 0.23000000000000001 111.383 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.9 mp -65.63 -56.16 13.69 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.083 -0.508 . . . . 0.23000000000000001 110.707 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 107.66 32.5 3.36 Favored Glycine 0 CA--C 1.52 0.383 0 C-N-CA 120.932 -0.652 . . . . 0.23000000000000001 113.7 179.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -163.74 152.81 14.12 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 117.163 0.482 . . . . 0.23000000000000001 111.175 179.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.9 p -104.25 150.45 24.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 0.23000000000000001 111.456 -179.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 22.5 pt -117.67 144.58 25.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.867 -0.606 . . . . 0.23000000000000001 110.49 179.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 77.8 p -131.52 157.34 43.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.767 0.318 . . . . 0.23000000000000001 110.893 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 107.98 -156.19 15.92 Favored Glycine 0 C--N 1.33 0.234 0 C-N-CA 121.014 -0.613 . . . . 0.23000000000000001 112.453 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 110.85 148.48 11.49 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.995 -0.621 . . . . 0.23000000000000001 112.507 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 41.3 t -80.48 100.28 4.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.956 0.408 . . . . 0.23000000000000001 110.903 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 94.79 2.28 63.01 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 120.99 -0.624 . . . . 0.23000000000000001 114.139 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.97 -154.84 28.09 Favored Glycine 0 C--N 1.341 0.858 0 CA-C-N 117.827 0.813 . . . . 0.23000000000000001 112.981 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 1.9 mtt180 -62.66 -22.85 66.77 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 111.945 0.35 . . . . 0.23000000000000001 111.945 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.79 160.12 35.49 Favored Glycine 0 C--N 1.336 0.537 0 C-N-CA 120.732 -0.747 . . . . 0.23000000000000001 112.843 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -114.62 136.15 22.4 Favored Pre-proline 0 CA--C 1.535 0.392 0 N-CA-C 110.556 -0.164 . . . . 0.23000000000000001 110.556 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -87.91 13.28 2.64 Favored 'Trans proline' 0 C--N 1.357 1.0 0 C-N-CA 122.018 1.812 . . . . 0.23000000000000001 113.98 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -99.64 -41.55 7.27 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.666 0.269 . . . . 0.23000000000000001 111.178 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.76 136.15 27.99 Favored Pre-proline 0 N--CA 1.466 0.374 0 CA-C-N 116.407 -0.36 . . . . 0.23000000000000001 110.714 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -85.63 -44.58 0.05 OUTLIER 'Trans proline' 0 C--N 1.358 1.049 0 C-N-CA 122.052 1.835 . . . . 0.23000000000000001 113.413 -179.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -92.64 -9.0 42.51 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 112.763 0.653 . . . . 0.23000000000000001 112.763 -179.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -95.68 117.93 31.41 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-N 118.097 0.408 . . . . 0.23000000000000001 110.339 179.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -105.09 38.56 1.91 Allowed 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.342 -0.39 . . . . 0.23000000000000001 111.509 -179.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -92.28 -148.67 23.11 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 120.867 -0.683 . . . . 0.23000000000000001 111.846 179.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 20.8 mm -125.52 140.22 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 116.798 0.299 . . . . 0.23000000000000001 110.842 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -137.81 151.01 47.67 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.465 -0.334 . . . . 0.23000000000000001 111.12 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 21.7 t -90.56 73.69 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-O 121.126 0.488 . . . . 0.23000000000000001 111.084 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.7 t -36.24 -53.17 0.82 Allowed 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 114.745 1.387 . . . . 0.23000000000000001 114.745 -178.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 11.8 ptm180 -161.24 172.79 16.06 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.213 0.53 . . . . 0.23000000000000001 112.291 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 19.4 t -127.47 147.19 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 115.458 -0.792 . . . . 0.23000000000000001 110.445 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.416 ' CG ' ' CH2' ' B' ' 306' ' ' TRP . 4.6 mm-40 -102.1 -69.67 0.04 OUTLIER Pre-proline 0 CA--C 1.537 0.446 0 CA-C-O 119.629 -0.224 . . . . 0.23000000000000001 110.983 179.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -80.91 114.93 2.97 Favored 'Trans proline' 0 C--N 1.359 1.112 0 C-N-CA 121.653 1.569 . . . . 0.23000000000000001 112.036 179.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -74.89 68.4 1.76 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 121.025 0.44 . . . . 0.23000000000000001 111.098 -179.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -150.94 -71.15 0.01 OUTLIER Glycine 0 CA--C 1.528 0.872 0 C-N-CA 120.668 -0.777 . . . . 0.23000000000000001 113.714 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -59.7 -77.49 0.02 OUTLIER 'Trans proline' 0 C--N 1.358 1.06 0 C-N-CA 121.928 1.752 . . . . 0.23000000000000001 113.465 -178.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -106.8 49.57 0.8 Allowed 'General case' 0 CA--C 1.529 0.152 0 CA-C-O 121.401 0.619 . . . . 0.23000000000000001 111.194 -179.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.9 t -100.86 -61.41 1.37 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.741 -0.663 . . . . 0.23000000000000001 110.117 179.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.7 ttpt -74.35 -7.68 53.69 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 115.984 -0.553 . . . . 0.23000000000000001 112.106 178.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 20.7 mt -92.69 -59.02 2.17 Favored 'General case' 0 C--N 1.344 0.333 0 CA-C-N 118.219 0.463 . . . . 0.23000000000000001 110.9 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 11.6 mt -93.36 143.29 26.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.001 -0.545 . . . . 0.23000000000000001 111.299 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -112.44 141.27 24.89 Favored Pre-proline 0 CA--C 1.534 0.365 0 CA-C-N 116.046 -0.525 . . . . 0.23000000000000001 110.258 179.498 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -57.62 122.55 11.96 Favored 'Trans proline' 0 C--N 1.358 1.045 0 C-N-CA 121.784 1.656 . . . . 0.23000000000000001 112.777 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.57 16.6 21.84 Favored Glycine 0 CA--C 1.522 0.507 0 C-N-CA 120.971 -0.633 . . . . 0.23000000000000001 113.932 179.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -94.29 147.36 23.27 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 117.559 0.68 . . . . 0.23000000000000001 110.772 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 58.5 tttm -96.74 135.76 38.23 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.361 -0.381 . . . . 0.23000000000000001 111.153 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 29.3 mt -95.67 123.65 47.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.319 -0.401 . . . . 0.23000000000000001 110.591 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 23.7 mm -99.39 -42.22 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-N 116.28 -0.418 . . . . 0.23000000000000001 111.824 -178.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -146.76 151.51 37.29 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 121.173 0.511 . . . . 0.23000000000000001 112.139 -179.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -139.83 122.45 16.3 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.574 -0.739 . . . . 0.23000000000000001 110.943 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 45.62 28.18 0.5 Allowed 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 113.01 0.744 . . . . 0.23000000000000001 113.01 179.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 95.47 14.19 48.5 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 120.966 -0.635 . . . . 0.23000000000000001 113.49 -179.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -116.8 122.15 43.59 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 117.65 0.725 . . . . 0.23000000000000001 110.677 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 63.8 p -68.87 124.11 22.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.48 -0.327 . . . . 0.23000000000000001 110.427 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -94.08 19.98 8.51 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 112.332 0.493 . . . . 0.23000000000000001 112.332 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 8.5 tp -97.84 138.11 23.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-O 120.633 0.254 . . . . 0.23000000000000001 111.418 -179.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 63.18 20.82 12.51 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 112.421 0.526 . . . . 0.23000000000000001 112.421 -179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 26.2 pt -98.15 164.32 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 113.184 0.809 . . . . 0.23000000000000001 113.184 -178.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -85.67 146.78 26.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.125 -0.943 . . . . 0.23000000000000001 111.254 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 31.1 t60 -47.34 -50.27 22.38 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 115.857 -0.611 . . . . 0.23000000000000001 112.602 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -61.01 -29.04 69.84 Favored Glycine 0 CA--C 1.519 0.282 0 C-N-CA 120.913 -0.66 . . . . 0.23000000000000001 112.174 179.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -65.32 -45.79 82.92 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.918 0.389 . . . . 0.23000000000000001 111.023 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.77 -38.31 86.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.144 -0.48 . . . . 0.23000000000000001 111.361 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.6 t -73.11 -42.97 58.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.34 -0.391 . . . . 0.23000000000000001 110.741 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 35.5 t -63.66 -46.0 87.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 0.23000000000000001 111.087 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 23.8 mt -59.31 -50.97 71.92 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.367 -0.379 . . . . 0.23000000000000001 111.826 -179.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 26.0 mt -62.76 -32.45 73.6 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.334 -0.394 . . . . 0.23000000000000001 111.932 -178.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 44.1 mttm -76.88 -37.62 55.15 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.437 0.532 . . . . 0.23000000000000001 112.437 -178.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 10.2 t -73.92 -29.51 62.08 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 112.749 0.648 . . . . 0.23000000000000001 112.749 -178.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 15.3 m-85 -47.54 171.38 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 112.875 0.694 . . . . 0.23000000000000001 112.875 -179.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -77.53 -145.6 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.98 0 CA-C-N 115.812 -0.631 . . . . 0.23000000000000001 110.659 -179.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 30.5 m120 -79.41 -67.96 0.71 Allowed 'General case' 0 C--N 1.348 0.511 0 CA-C-N 118.831 0.742 . . . . 0.23000000000000001 110.835 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -74.65 120.43 20.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 0.23000000000000001 110.785 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 18.4 t -113.22 115.18 49.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.144 -0.48 . . . . 0.23000000000000001 110.897 -179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -95.39 107.0 19.11 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.237 -0.438 . . . . 0.23000000000000001 110.454 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 6.2 mp -102.82 150.99 22.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.278 -0.419 . . . . 0.23000000000000001 111.722 -179.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.401 HD11 HG22 ' A' ' 96' ' ' ILE . 17.2 mm -107.38 122.18 61.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.848 -0.615 . . . . 0.23000000000000001 109.74 178.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 41.8 pt -126.03 163.4 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-O 121.148 0.499 . . . . 0.23000000000000001 112.185 -179.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 51.1 t -137.89 144.3 31.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 115.555 -0.748 . . . . 0.23000000000000001 111.185 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 49.5 mmm-85 -111.98 109.8 19.77 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.049 -0.523 . . . . 0.23000000000000001 109.968 179.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -59.25 145.9 41.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.024 0.44 . . . . 0.23000000000000001 111.777 -179.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.3 m -107.51 108.71 25.9 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-N 115.784 -0.644 . . . . 0.23000000000000001 110.605 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 40.0 t -105.88 35.11 3.01 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.237 -0.438 . . . . 0.23000000000000001 111.401 -179.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 28.3 t . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.196 -0.907 . . . . 0.23000000000000001 110.761 179.781 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 301' ' ' THR . . . . . . . . . . . . . 64.3 p . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.747 0.308 . . . . 0.23000000000000001 111.165 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 302' ' ' GLY . . . . . . . . . . . . . . . 170.38 121.34 0.58 Allowed Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.861 -0.685 . . . . 0.23000000000000001 112.754 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 303' ' ' TRP . . . . . . . . . . . . . 2.3 p-90 -100.43 -18.33 16.76 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 111.839 0.311 . . . . 0.23000000000000001 111.839 179.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -89.55 162.4 15.7 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.799 0.333 . . . . 0.23000000000000001 110.991 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 305' ' ' THR . . . . . . . . . . . . . 6.8 m -124.23 115.89 21.8 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.072 -0.513 . . . . 17.879999999999999 110.453 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 306' ' ' TRP . . . . . 0.416 ' CH2' ' CG ' ' A' ' 51' ' ' GLN . 83.7 m95 -79.16 113.84 17.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.3 -0.409 . . . . 0.23000000000000001 111.031 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 307' ' ' VAL . . . . . . . . . . . . . 16.1 m . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.223 -0.894 . . . . 16.109999999999999 111.142 179.964 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.21 0 N-CA-C 112.515 -0.234 . . . . 0.23000000000000001 112.515 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 57.4 p -148.86 33.31 0.76 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.897 0.38 . . . . 0.23000000000000001 110.842 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -82.08 142.68 32.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.273 -0.421 . . . . 0.23000000000000001 110.633 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -141.56 105.93 4.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.123 -0.489 . . . . 0.23000000000000001 110.678 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -82.64 -176.56 51.49 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.964 -0.636 . . . . 0.23000000000000001 112.752 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -86.62 -36.39 18.85 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.794 0.331 . . . . 0.23000000000000001 110.969 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -68.8 -174.24 0.56 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.446 . . . . 0.23000000000000001 111.034 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 16.6 tp -63.76 159.16 19.96 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.173 -0.467 . . . . 0.23000000000000001 110.811 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.31 127.29 32.55 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.172 -0.467 . . . . 0.23000000000000001 111.711 -179.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.5 tppt? -174.89 125.46 0.27 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.853 -0.612 . . . . 0.23000000000000001 110.381 179.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -88.67 92.15 9.09 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 112.797 0.665 . . . . 0.23000000000000001 112.797 -177.22 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -96.15 123.8 39.91 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.696 -0.684 . . . . 0.23000000000000001 109.737 179.092 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.445 HD11 HG22 ' A' ' 13' ' ' ILE . 0.2 OUTLIER -151.08 165.86 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 N-CA-C 112.542 0.571 . . . . 0.23000000000000001 112.542 -179.712 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.48 158.55 22.4 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.636 -0.711 . . . . 0.23000000000000001 110.637 179.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.9 m -144.16 145.51 21.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.445 -0.343 . . . . 0.23000000000000001 110.755 179.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.03 114.19 27.91 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.343 -0.389 . . . . 0.23000000000000001 111.177 -179.517 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.4 t -110.62 119.13 58.76 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 116.336 -0.393 . . . . 0.23000000000000001 110.839 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -100.04 128.56 46.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.219 -0.446 . . . . 0.23000000000000001 110.491 179.581 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 14.0 mtmt -84.02 123.77 30.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.139 0.495 . . . . 0.23000000000000001 111.608 -179.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -172.84 85.7 0.41 Allowed Pre-proline 0 CA--C 1.537 0.448 0 CA-C-N 115.647 -0.706 . . . . 0.23000000000000001 110.797 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -82.48 -20.19 20.35 Favored 'Cis proline' 0 C--N 1.365 1.401 0 CA-C-N 119.357 0.806 . . . . 0.23000000000000001 113.15 0.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -136.4 -178.34 5.12 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 120.854 0.359 . . . . 0.23000000000000001 111.513 -179.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.403 ' HB3' ' CE2' ' A' ' 25' ' ' PHE . 3.4 mp -67.21 -52.41 41.42 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.163 -0.471 . . . . 0.23000000000000001 110.668 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 106.75 26.17 5.94 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.898 -0.668 . . . . 0.23000000000000001 113.833 179.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.403 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 42.1 p90 -156.63 171.14 20.86 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 117.461 0.63 . . . . 0.23000000000000001 111.316 179.429 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.3 p -119.82 153.63 35.48 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.046 -0.524 . . . . 0.23000000000000001 111.09 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 26.4 pt -120.39 148.52 23.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.097 -0.501 . . . . 0.23000000000000001 110.907 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 74.6 p -140.61 158.28 44.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.389 -0.369 . . . . 0.23000000000000001 111.045 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 106.26 -148.01 16.36 Favored Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.968 -0.634 . . . . 0.23000000000000001 112.731 179.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.79 151.77 26.34 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.994 -0.622 . . . . 0.23000000000000001 112.374 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 13.7 t -79.82 99.32 3.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.722 0.296 . . . . 0.23000000000000001 110.463 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 104.28 -7.81 47.88 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 120.922 -0.656 . . . . 0.23000000000000001 113.522 -179.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -73.44 -148.44 1.13 Allowed Glycine 0 C--N 1.344 1.001 0 CA-C-N 117.751 0.776 . . . . 0.23000000000000001 112.248 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 53.1 mtt-85 -89.21 16.96 6.46 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 112.452 0.538 . . . . 0.23000000000000001 112.452 -179.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 63.86 170.72 1.88 Allowed Glycine 0 C--N 1.338 0.693 0 C-N-CA 120.999 -0.62 . . . . 0.23000000000000001 113.42 179.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -139.75 143.8 36.4 Favored Pre-proline 0 CA--C 1.534 0.363 0 N-CA-C 110.518 -0.179 . . . . 0.23000000000000001 110.518 179.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -92.32 27.28 0.38 Allowed 'Trans proline' 0 C--N 1.358 1.042 0 C-N-CA 122.34 2.027 . . . . 0.23000000000000001 113.537 -179.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -103.43 -51.35 3.23 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.754 0.311 . . . . 0.23000000000000001 110.945 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 16.2 mtp180 -120.31 137.33 25.95 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-N 116.372 -0.376 . . . . 0.23000000000000001 110.418 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -85.3 -45.74 0.05 OUTLIER 'Trans proline' 0 C--N 1.358 1.078 0 C-N-CA 121.904 1.736 . . . . 0.23000000000000001 113.59 -179.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -89.62 -13.01 38.04 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 112.858 0.688 . . . . 0.23000000000000001 112.858 -179.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -106.74 122.69 46.87 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 122.001 -0.437 . . . . 0.23000000000000001 110.831 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 19.0 p30 -108.69 36.04 2.99 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 121.01 0.433 . . . . 0.23000000000000001 111.099 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -79.27 -157.93 12.89 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 120.937 -0.649 . . . . 0.23000000000000001 112.361 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.7 mm -110.14 132.06 59.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-O 120.697 0.284 . . . . 0.23000000000000001 111.114 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.435 ' N ' ' CD1' ' A' ' 46' ' ' PHE . 5.4 m-85 -131.39 150.14 52.27 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.287 -0.415 . . . . 0.23000000000000001 110.346 179.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 31.4 t -94.15 75.68 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-O 120.961 0.41 . . . . 0.23000000000000001 111.466 -179.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.2 t -33.89 -52.99 0.45 Allowed 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 114.939 1.459 . . . . 0.23000000000000001 114.939 -178.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -158.13 173.54 16.57 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 112.436 0.532 . . . . 0.23000000000000001 112.436 -179.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 18.3 t -133.81 150.0 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 115.371 -0.831 . . . . 0.23000000000000001 110.464 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.404 ' HG3' ' CH2' ' B' ' 306' ' ' TRP . 8.1 mt-30 -104.99 -67.92 0.04 OUTLIER Pre-proline 0 CA--C 1.539 0.543 0 N-CA-C 111.643 0.238 . . . . 0.23000000000000001 111.643 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -79.07 121.07 4.79 Favored 'Trans proline' 0 C--N 1.358 1.047 0 C-N-CA 121.645 1.563 . . . . 0.23000000000000001 112.522 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -78.61 69.55 4.81 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 121.103 0.478 . . . . 0.23000000000000001 111.016 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -158.37 -68.96 0.01 OUTLIER Glycine 0 CA--C 1.528 0.885 0 C-N-CA 120.794 -0.717 . . . . 0.23000000000000001 113.358 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -60.98 -75.41 0.02 OUTLIER 'Trans proline' 0 C--N 1.358 1.053 0 C-N-CA 121.94 1.76 . . . . 0.23000000000000001 113.429 -178.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -108.15 47.52 0.9 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 121.24 0.543 . . . . 0.23000000000000001 111.964 -178.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.4 t -111.22 -64.19 1.31 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.089 -0.505 . . . . 0.23000000000000001 109.727 178.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.14 -16.11 61.17 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.671 -0.695 . . . . 0.23000000000000001 111.783 178.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 27.7 mt -96.51 -52.67 3.86 Favored 'General case' 0 C--N 1.342 0.262 0 CA-C-O 120.616 0.246 . . . . 0.23000000000000001 111.135 -179.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 8.9 mt -103.76 151.12 23.42 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.884 0.373 . . . . 0.23000000000000001 111.748 -179.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 3.5 pp0? -126.45 149.42 67.57 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-N 115.901 -0.591 . . . . 0.23000000000000001 110.641 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -58.57 130.01 35.19 Favored 'Trans proline' 0 C--N 1.361 1.186 0 C-N-CA 122.342 2.028 . . . . 0.23000000000000001 113.658 -178.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 98.35 9.46 53.28 Favored Glycine 0 CA--C 1.525 0.714 0 CA-C-N 115.673 -0.694 . . . . 0.23000000000000001 114.075 179.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.5 p30 -77.82 -174.48 3.52 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 117.841 0.82 . . . . 0.23000000000000001 111.623 -179.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 25.4 tttm -139.2 124.32 18.95 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.96 -0.563 . . . . 0.23000000000000001 110.008 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 26.5 mt -88.72 115.23 28.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-O 121.106 0.479 . . . . 0.23000000000000001 110.812 -179.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 19.8 mm -89.78 -42.82 14.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 N-CA-C 112.483 0.549 . . . . 0.23000000000000001 112.483 -178.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.11 146.33 26.85 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.102 0.477 . . . . 0.23000000000000001 112.116 -179.006 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -131.06 120.9 24.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.442 -0.799 . . . . 0.23000000000000001 110.919 179.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 42.76 35.46 0.71 Allowed 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 113.551 0.945 . . . . 0.23000000000000001 113.551 178.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 91.51 -12.59 68.88 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 120.819 -0.705 . . . . 0.23000000000000001 113.853 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -88.21 125.46 34.64 Favored 'General case' 0 C--O 1.231 0.082 0 CA-C-N 117.648 0.724 . . . . 0.23000000000000001 109.949 179.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 84.4 p -69.67 115.55 9.04 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.23 -0.441 . . . . 0.23000000000000001 111.754 -179.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -95.25 9.17 40.75 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 116.081 -0.509 . . . . 0.23000000000000001 111.954 178.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 7.6 tp -89.38 126.86 42.33 Favored 'Isoleucine or valine' 0 C--N 1.343 0.288 0 CA-C-N 118.181 0.446 . . . . 0.23000000000000001 110.508 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 57.1 m-80 61.09 70.82 0.59 Allowed 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 121.284 0.564 . . . . 0.23000000000000001 110.786 -179.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 19.9 pt -145.6 168.48 7.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.944 -0.571 . . . . 0.23000000000000001 110.885 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -82.45 148.14 28.34 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.205 -0.452 . . . . 0.23000000000000001 111.18 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 1.3 t-160 -52.23 -52.5 52.03 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.893 -0.594 . . . . 0.23000000000000001 112.281 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -56.8 -26.05 53.34 Favored Glycine 0 CA--C 1.523 0.552 0 C-N-CA 121.037 -0.601 . . . . 0.23000000000000001 113.171 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -74.32 -40.25 62.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.068 0.461 . . . . 0.23000000000000001 110.641 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.3 -34.47 74.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.855 -0.611 . . . . 0.23000000000000001 111.797 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 24.0 t -75.08 -44.85 43.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.911 0.386 . . . . 0.23000000000000001 110.861 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 23.3 t -59.01 -36.97 75.83 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.2 -0.454 . . . . 0.23000000000000001 111.383 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 35.7 mt -71.0 -42.3 69.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.099 0.476 . . . . 0.23000000000000001 110.588 179.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.4 ' HA ' ' CD2' ' A' ' 89' ' ' PHE . 33.2 mt -77.53 -8.27 57.54 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 113.362 0.875 . . . . 0.23000000000000001 113.362 -179.408 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 15.8 mmtp -98.09 -36.65 10.02 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.247 0.546 . . . . 0.23000000000000001 110.427 178.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 9.1 t -70.19 -21.78 63.01 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.494 -0.775 . . . . 0.23000000000000001 112.142 -178.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.4 ' CD2' ' HA ' ' A' ' 86' ' ' LEU . 12.9 m-85 -55.83 126.8 27.22 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.194 0.521 . . . . 0.23000000000000001 111.06 -179.06 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 23.1 mp0 -60.29 -64.5 0.93 Allowed 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 113.727 1.01 . . . . 0.23000000000000001 113.727 -177.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 32.4 m120 -134.6 -81.95 0.44 Allowed 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.649 0.611 . . . . 0.23000000000000001 112.649 -178.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.76 158.75 35.76 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.033 0.444 . . . . 0.23000000000000001 111.08 -178.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 19.5 t -150.38 113.97 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.9 -0.591 . . . . 0.23000000000000001 110.888 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -89.36 119.33 29.73 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.418 -0.355 . . . . 0.23000000000000001 110.202 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.5 mt -122.71 147.41 46.51 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.166 0.508 . . . . 0.23000000000000001 111.893 -178.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 41.2 mt -112.86 126.46 70.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.536 -0.757 . . . . 0.23000000000000001 109.719 178.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 30.9 pt -126.0 166.48 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-O 120.837 0.351 . . . . 0.23000000000000001 111.296 -179.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 16.1 t -150.01 149.49 14.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.189 -0.46 . . . . 0.23000000000000001 111.574 -179.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.34 115.63 30.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.768 -0.651 . . . . 0.23000000000000001 109.258 178.213 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -73.17 133.27 44.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.935 0.398 . . . . 0.23000000000000001 111.7 -178.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 15.8 m -90.87 145.98 6.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.019 -0.537 . . . . 0.23000000000000001 110.801 179.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 22.7 t -134.46 33.97 3.26 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.338 -0.392 . . . . 0.23000000000000001 110.976 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 56.8 p . . . . . 0 C--O 1.248 0.99 0 CA-C-O 118.282 -0.866 . . . . 0.23000000000000001 110.836 179.886 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 301' ' ' THR . . . . . . . . . . . . . 4.0 m . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.742 0.306 . . . . 0.23000000000000001 111.178 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 302' ' ' GLY . . . . . . . . . . . . . . . -165.37 112.23 0.49 Allowed Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.909 -0.662 . . . . 0.23000000000000001 112.447 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 303' ' ' TRP . . . . . 0.4 ' CZ3' ' HB3' ' B' ' 304' ' ' GLU . 13.2 p-90 -73.29 -5.44 39.57 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 112.836 0.68 . . . . 0.23000000000000001 112.836 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 304' ' ' GLU . . . . . 0.4 ' HB3' ' CZ3' ' B' ' 303' ' ' TRP . 1.5 pm0 -107.54 158.5 17.17 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 118.336 0.516 . . . . 0.23000000000000001 110.716 179.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 305' ' ' THR . . . . . . . . . . . . . 4.3 m -124.77 130.94 53.38 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.189 -0.46 . . . . 17.879999999999999 110.731 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 306' ' ' TRP . . . . . 0.404 ' CH2' ' HG3' ' A' ' 51' ' ' GLN . 77.2 m95 -91.05 110.84 22.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.253 -0.431 . . . . 0.23000000000000001 110.92 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 307' ' ' VAL . . . . . . . . . . . . . 16.8 m . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.217 -0.897 . . . . 16.109999999999999 111.076 179.863 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.204 0 N-CA-C 112.47 -0.252 . . . . 0.23000000000000001 112.47 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.5 t -156.79 94.33 1.44 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.795 0.331 . . . . 0.23000000000000001 110.804 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -92.72 167.73 11.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.277 -0.42 . . . . 0.23000000000000001 110.789 179.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.01 -41.16 2.46 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.218 -0.446 . . . . 0.23000000000000001 111.142 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 152.56 104.8 0.26 Allowed Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.751 -0.737 . . . . 0.23000000000000001 112.828 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 17.9 t-80 -124.85 147.18 48.91 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.695 0.284 . . . . 0.23000000000000001 110.568 179.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -100.33 147.7 25.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.349 -0.387 . . . . 0.23000000000000001 111.204 -179.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -144.63 35.73 1.17 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.159 -0.473 . . . . 0.23000000000000001 110.6 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -88.98 -146.09 0.16 Allowed 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 115.878 -0.601 . . . . 0.23000000000000001 110.562 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 42.3 mmtm -44.2 107.79 0.1 Allowed 'General case' 0 N--CA 1.485 1.301 0 CA-C-N 118.957 0.799 . . . . 0.23000000000000001 112.819 -179.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -96.62 162.1 13.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.097 -0.501 . . . . 0.23000000000000001 111.627 -179.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -132.43 97.78 4.19 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.096 -0.502 . . . . 0.23000000000000001 109.901 179.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.4 pt -109.3 158.94 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 N-CA-C 112.372 0.508 . . . . 0.23000000000000001 112.372 -178.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -116.12 148.65 40.08 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.694 -0.684 . . . . 0.23000000000000001 110.975 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 20.1 m -138.85 142.41 34.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.241 -0.436 . . . . 0.23000000000000001 111.011 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 74.9 mtm-85 -105.18 120.31 41.22 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.374 -0.376 . . . . 0.23000000000000001 111.123 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.1 t -111.01 112.91 42.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.337 -0.392 . . . . 0.23000000000000001 110.974 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -89.19 119.55 29.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.354 -0.384 . . . . 0.23000000000000001 110.676 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 20.1 mttt -75.03 118.0 17.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.287 -0.415 . . . . 0.23000000000000001 111.046 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -169.37 86.89 0.61 Allowed Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.943 -0.571 . . . . 0.23000000000000001 110.56 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -81.61 -18.45 24.93 Favored 'Cis proline' 0 C--N 1.363 1.294 0 CA-C-N 119.384 0.816 . . . . 0.23000000000000001 113.408 0.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -136.42 -175.97 4.18 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.695 0.283 . . . . 0.23000000000000001 111.1 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.402 ' HB3' ' CE2' ' A' ' 25' ' ' PHE . 3.7 mp -62.36 -56.96 13.33 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 116.334 -0.394 . . . . 0.23000000000000001 110.685 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 100.9 35.53 4.25 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.762 -0.732 . . . . 0.23000000000000001 114.318 178.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.402 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 36.3 p90 -159.74 153.75 23.27 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 117.283 0.541 . . . . 0.23000000000000001 110.915 179.019 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.41 ' HB3' ' CD2' ' B' ' 306' ' ' TRP . 2.2 p -105.93 145.12 31.7 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.148 0.499 . . . . 0.23000000000000001 112.023 -178.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 31.2 pt -122.59 149.92 26.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.55 -0.75 . . . . 0.23000000000000001 110.357 178.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.7 m -144.67 -176.67 5.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.786 0.326 . . . . 0.23000000000000001 110.93 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.09 -146.47 22.99 Favored Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.908 -0.663 . . . . 0.23000000000000001 113.086 179.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.41 162.46 31.61 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 121.031 -0.604 . . . . 0.23000000000000001 112.102 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 23.6 t -76.54 92.02 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 CA-C-O 121.236 0.541 . . . . 0.23000000000000001 110.479 -179.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 100.4 8.18 50.25 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-N 115.32 -0.854 . . . . 0.23000000000000001 113.487 -179.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -83.51 -161.33 31.4 Favored Glycine 0 C--N 1.343 0.944 0 CA-C-N 117.719 0.76 . . . . 0.23000000000000001 113.248 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 91.4 mtt-85 -64.24 -27.37 69.0 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 112.012 0.375 . . . . 0.23000000000000001 112.012 -179.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.36 167.55 41.97 Favored Glycine 0 C--N 1.337 0.62 0 C-N-CA 120.636 -0.792 . . . . 0.23000000000000001 113.165 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 12.1 m-80 -125.71 144.8 49.41 Favored Pre-proline 0 CA--C 1.536 0.422 0 C-N-CA 122.131 0.173 . . . . 0.23000000000000001 110.712 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -83.69 2.57 8.23 Favored 'Trans proline' 0 C--N 1.356 0.968 0 C-N-CA 121.865 1.71 . . . . 0.23000000000000001 113.615 179.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -99.99 -39.5 8.11 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.017 0.437 . . . . 0.23000000000000001 110.453 179.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 5.1 ppt_? -90.92 128.77 46.64 Favored Pre-proline 0 N--CA 1.469 0.513 0 CA-C-N 115.761 -0.654 . . . . 0.23000000000000001 111.931 -179.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -89.02 -22.24 1.1 Allowed 'Trans proline' 0 C--N 1.359 1.111 0 C-N-CA 122.325 2.017 . . . . 0.23000000000000001 113.408 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -155.41 18.91 0.41 Allowed 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.986 0.735 . . . . 0.23000000000000001 112.986 -179.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -90.24 118.03 29.45 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 122.188 -0.32 . . . . 0.23000000000000001 110.828 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -89.61 40.64 1.0 Allowed 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.725 0.639 . . . . 0.23000000000000001 112.725 -179.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -109.7 -155.63 15.88 Favored Glycine 0 C--N 1.336 0.57 0 C-N-CA 120.998 -0.62 . . . . 0.23000000000000001 112.86 179.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.6 mm -122.13 137.77 54.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 N-CA-C 110.504 -0.184 . . . . 0.23000000000000001 110.504 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -129.88 148.74 51.78 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.68 0.276 . . . . 0.23000000000000001 111.282 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 19.8 t -94.45 77.13 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-O 121.007 0.432 . . . . 0.23000000000000001 110.99 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.4 t -37.85 -53.68 1.29 Allowed 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 114.564 1.32 . . . . 0.23000000000000001 114.564 -178.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -159.11 177.88 10.63 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 118.273 0.488 . . . . 0.23000000000000001 112.235 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.5 t -130.0 148.06 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 115.64 -0.709 . . . . 0.23000000000000001 110.944 -179.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.408 ' HG2' ' CH2' ' B' ' 306' ' ' TRP . 8.3 mm-40 -96.02 -68.07 0.07 OUTLIER Pre-proline 0 CA--C 1.536 0.416 0 C-N-CA 121.366 -0.134 . . . . 0.23000000000000001 111.049 179.536 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -80.39 121.9 4.43 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 121.811 1.674 . . . . 0.23000000000000001 111.955 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -79.6 64.7 4.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.936 0.398 . . . . 0.23000000000000001 111.28 -179.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -157.83 -67.28 0.01 OUTLIER Glycine 0 CA--C 1.529 0.962 0 C-N-CA 120.668 -0.777 . . . . 0.23000000000000001 113.547 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -57.96 -73.74 0.03 OUTLIER 'Trans proline' 0 C--N 1.357 0.975 0 C-N-CA 122.183 1.922 . . . . 0.23000000000000001 113.52 -178.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -112.24 47.95 1.03 Allowed 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.189 0.518 . . . . 0.23000000000000001 111.393 -179.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 95.4 p -107.77 -50.08 3.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.933 -0.576 . . . . 0.23000000000000001 110.515 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.4 mmtm -80.38 -9.96 59.75 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.831 -0.622 . . . . 0.23000000000000001 112.487 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.2 mp -96.23 -56.69 2.55 Favored 'General case' 0 C--N 1.342 0.25 0 CA-C-N 118.106 0.412 . . . . 0.23000000000000001 111.184 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.1 mt -92.66 146.23 23.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.4 -0.364 . . . . 0.23000000000000001 111.326 -179.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -112.49 140.83 24.24 Favored Pre-proline 0 CA--C 1.535 0.373 0 CA-C-N 116.16 -0.473 . . . . 0.23000000000000001 110.52 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -57.07 125.87 20.34 Favored 'Trans proline' 0 C--N 1.356 0.923 0 C-N-CA 121.716 1.61 . . . . 0.23000000000000001 112.242 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 92.45 19.82 37.04 Favored Glycine 0 CA--C 1.523 0.539 0 C-N-CA 120.948 -0.644 . . . . 0.23000000000000001 113.336 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -93.69 155.34 17.31 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-N 117.237 0.518 . . . . 0.23000000000000001 110.047 179.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 58.8 tttp -100.07 125.54 46.16 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.92 0.39 . . . . 0.23000000000000001 111.753 -179.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 44.4 mt -89.81 120.48 38.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.077 -0.51 . . . . 0.23000000000000001 109.973 179.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 19.3 mm -95.86 -41.34 11.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 N-CA-C 112.949 0.722 . . . . 0.23000000000000001 112.949 -178.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -149.48 153.9 37.97 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 112.2 0.445 . . . . 0.23000000000000001 112.2 -178.13 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -142.45 123.27 14.32 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.955 -0.566 . . . . 0.23000000000000001 111.856 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 28.4 m-20 41.55 37.72 0.75 Allowed 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 113.702 1.001 . . . . 0.23000000000000001 113.702 178.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 96.11 -16.73 60.58 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 120.843 -0.694 . . . . 0.23000000000000001 113.643 179.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 53.8 m-85 -91.35 122.62 34.11 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 117.565 0.683 . . . . 0.23000000000000001 110.66 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 8.8 m -71.47 131.43 43.3 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.369 -0.378 . . . . 0.23000000000000001 110.978 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -105.6 14.37 28.57 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 112.292 0.478 . . . . 0.23000000000000001 112.292 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 7.0 tp -92.04 126.13 44.63 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 CA-C-O 120.998 0.428 . . . . 0.23000000000000001 111.096 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 61.46 70.41 0.6 Allowed 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 121.151 0.5 . . . . 0.23000000000000001 110.845 -179.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 7.1 pt -148.66 164.24 4.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.95 -0.568 . . . . 0.23000000000000001 110.984 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -81.35 143.14 32.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.931 -0.577 . . . . 0.23000000000000001 110.458 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -50.99 -52.1 46.14 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 112.367 0.506 . . . . 0.23000000000000001 112.367 -179.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -53.47 -27.92 34.98 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 121.248 -0.501 . . . . 0.23000000000000001 113.05 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 49.7 tp60 -74.37 -38.71 63.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.092 0.473 . . . . 0.23000000000000001 110.124 179.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.43 -53.75 32.05 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.672 -0.695 . . . . 0.23000000000000001 111.597 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 20.0 t -58.5 -43.39 86.82 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-N 116.442 -0.345 . . . . 0.23000000000000001 111.417 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.7 t -60.46 -41.29 93.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.446 . . . . 0.23000000000000001 111.392 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 26.8 mt -65.17 -45.97 82.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.412 -0.358 . . . . 0.23000000000000001 111.518 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.411 ' HA ' ' CD2' ' A' ' 89' ' ' PHE . 32.9 mt -63.15 -38.45 91.23 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.192 -0.458 . . . . 0.23000000000000001 112.012 -179.148 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 19.1 mmtt -66.48 -40.3 89.23 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.451 0.538 . . . . 0.23000000000000001 112.451 -178.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 7.8 t -72.18 -27.88 62.85 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.674 0.99 . . . . 0.23000000000000001 113.674 -177.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.411 ' CD2' ' HA ' ' A' ' 86' ' ' LEU . 12.6 m-85 -49.09 173.66 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 113.107 0.78 . . . . 0.23000000000000001 113.107 -178.416 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -87.84 -140.25 0.11 Allowed 'General case' 0 CA--C 1.552 1.026 0 CA-C-N 115.468 -0.787 . . . . 0.23000000000000001 111.204 -179.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 33.1 m120 -82.58 -61.82 1.78 Allowed 'General case' 0 C--N 1.348 0.538 0 CA-C-N 119.251 0.932 . . . . 0.23000000000000001 111.526 -179.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -84.09 129.03 34.92 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.289 -0.414 . . . . 0.23000000000000001 111.061 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.3 t -123.29 120.26 59.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.001 -0.545 . . . . 0.23000000000000001 110.511 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -92.54 91.71 7.72 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.394 -0.366 . . . . 0.23000000000000001 111.48 -179.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 2.5 mt -92.5 155.15 18.02 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.837 0.351 . . . . 0.23000000000000001 111.419 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 72.9 mt -115.36 127.29 72.99 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-N 115.926 -0.579 . . . . 0.23000000000000001 109.487 178.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 45.3 pt -123.76 162.37 24.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-O 120.902 0.382 . . . . 0.23000000000000001 111.534 -178.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 36.7 t -136.73 139.8 44.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.874 -0.603 . . . . 0.23000000000000001 111.5 -179.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -110.47 106.28 15.54 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.985 -0.552 . . . . 0.23000000000000001 109.665 178.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -60.18 130.08 44.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.882 0.373 . . . . 0.23000000000000001 111.578 -178.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 14.9 m -97.47 156.94 3.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.051 -0.522 . . . . 0.23000000000000001 110.995 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 56.7 p -162.42 102.01 1.07 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.328 -0.396 . . . . 0.23000000000000001 110.948 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 24.0 t . . . . . 0 C--O 1.248 0.993 0 CA-C-O 118.284 -0.865 . . . . 0.23000000000000001 110.903 179.964 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 301' ' ' THR . . . . . . . . . . . . . 12.8 p . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.748 0.309 . . . . 0.23000000000000001 111.165 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 302' ' ' GLY . . . . . . . . . . . . . . . -100.67 -70.51 0.91 Allowed Glycine 0 CA--C 1.518 0.254 0 C-N-CA 120.92 -0.657 . . . . 0.23000000000000001 112.884 -179.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 303' ' ' TRP . . . . . . . . . . . . . 11.8 p-90 -147.67 20.73 1.16 Allowed 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.2 0.444 . . . . 0.23000000000000001 112.2 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -123.26 172.54 8.55 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.069 0.461 . . . . 0.23000000000000001 111.346 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 305' ' ' THR . . . . . . . . . . . . . 6.4 m -139.32 119.44 13.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.801 -0.636 . . . . 17.879999999999999 110.372 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 306' ' ' TRP . . . . . 0.41 ' CD2' ' HB3' ' A' ' 26' ' ' SER . 96.5 m95 -85.71 114.6 22.81 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.345 -0.389 . . . . 0.23000000000000001 111.109 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 307' ' ' VAL . . . . . . . . . . . . . 18.0 m . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.285 -0.864 . . . . 16.109999999999999 111.142 -179.945 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.198 0 N-CA-C 112.544 -0.222 . . . . 0.23000000000000001 112.544 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.0 p -114.07 33.29 5.33 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.853 0.359 . . . . 0.23000000000000001 110.951 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 74.0 m80 -99.68 123.09 43.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.457 . . . . 0.23000000000000001 110.821 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.11 177.1 5.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.235 -0.438 . . . . 0.23000000000000001 110.797 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 158.85 -149.05 18.93 Favored Glycine 0 C--N 1.331 0.304 0 C-N-CA 120.972 -0.632 . . . . 0.23000000000000001 112.486 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 10.6 m-70 -147.77 -72.33 0.21 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.74 0.305 . . . . 0.23000000000000001 110.887 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -109.72 154.09 23.39 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.322 -0.399 . . . . 0.23000000000000001 110.939 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 53.5 mt -143.31 163.56 32.66 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.369 -0.378 . . . . 0.23000000000000001 111.089 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -130.84 82.18 2.04 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.041 -0.527 . . . . 0.23000000000000001 110.968 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -162.61 177.8 9.1 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.127 -0.488 . . . . 0.23000000000000001 110.588 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -152.33 143.61 23.27 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.596 -0.275 . . . . 0.23000000000000001 111.249 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -133.34 105.14 6.79 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.806 0.336 . . . . 0.23000000000000001 111.205 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 19.7 pt -117.05 156.15 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-N 116.061 -0.518 . . . . 0.23000000000000001 112.205 -179.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 29.7 mtm180 -90.29 167.47 12.64 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 112.655 0.613 . . . . 0.23000000000000001 112.655 -178.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 77.6 t -147.43 122.97 2.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-N 115.247 -0.888 . . . . 0.23000000000000001 109.977 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 20.8 ttt180 -110.42 112.85 25.05 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.483 -0.326 . . . . 0.23000000000000001 110.66 179.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.2 t -120.21 125.95 74.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 116.509 -0.314 . . . . 0.23000000000000001 111.089 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -102.05 128.51 48.48 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.38 -0.373 . . . . 0.23000000000000001 111.106 -179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.81 114.6 11.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.406 -0.361 . . . . 0.23000000000000001 110.962 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -174.95 83.35 0.32 Allowed Pre-proline 0 CA--C 1.537 0.471 0 CA-C-N 116.422 -0.354 . . . . 0.23000000000000001 111.087 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -83.38 -23.82 12.29 Favored 'Cis proline' 0 C--N 1.362 1.283 0 CA-C-N 119.445 0.838 . . . . 0.23000000000000001 112.868 0.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.1 mp0 -130.68 -177.4 4.34 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.755 0.312 . . . . 0.23000000000000001 111.405 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.3 mp -62.93 -59.83 4.29 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.206 -0.452 . . . . 0.23000000000000001 110.978 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 115.7 29.91 2.32 Favored Glycine 0 C--N 1.335 0.499 0 C-N-CA 120.925 -0.655 . . . . 0.23000000000000001 113.771 179.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -169.48 149.21 3.93 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 117.37 0.585 . . . . 0.23000000000000001 111.521 179.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.3 p -100.44 150.44 22.64 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.904 -0.589 . . . . 0.23000000000000001 110.87 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 38.3 pt -120.27 148.76 23.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.24 -0.436 . . . . 0.23000000000000001 111.196 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 78.1 p -142.9 160.25 40.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.253 -0.431 . . . . 0.23000000000000001 110.859 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 108.14 -152.57 16.95 Favored Glycine 0 C--N 1.332 0.338 0 C-N-CA 120.891 -0.671 . . . . 0.23000000000000001 112.94 179.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 104.0 157.01 24.14 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 121.096 -0.573 . . . . 0.23000000000000001 112.264 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.5 t -78.18 100.38 3.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 120.925 0.393 . . . . 0.23000000000000001 110.853 -179.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 93.48 7.68 61.66 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 121.047 -0.597 . . . . 0.23000000000000001 113.709 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -88.63 -156.07 30.68 Favored Glycine 0 C--N 1.34 0.755 0 CA-C-N 117.746 0.773 . . . . 0.23000000000000001 112.958 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 10.4 mmt180 -61.13 -27.52 68.45 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 111.606 0.224 . . . . 0.23000000000000001 111.606 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 103.71 154.4 23.83 Favored Glycine 0 C--N 1.335 0.512 0 C-N-CA 120.881 -0.676 . . . . 0.23000000000000001 113.059 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -112.15 129.96 23.76 Favored Pre-proline 0 N--CA 1.468 0.472 0 C-N-CA 122.074 0.149 . . . . 0.23000000000000001 110.618 179.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -93.42 34.19 0.22 Allowed 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 122.316 2.011 . . . . 0.23000000000000001 113.101 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -110.34 -51.2 2.89 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.786 0.327 . . . . 0.23000000000000001 111.156 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 45.3 mtt-85 -127.13 158.29 69.55 Favored Pre-proline 0 CA--C 1.535 0.366 0 CA-C-N 116.187 -0.46 . . . . 0.23000000000000001 110.741 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -90.71 -57.67 0.02 OUTLIER 'Trans proline' 0 C--N 1.357 1.005 0 C-N-CA 122.219 1.946 . . . . 0.23000000000000001 113.977 -178.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -79.35 -8.07 58.81 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 113.05 0.759 . . . . 0.23000000000000001 113.05 -179.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -101.58 114.1 27.82 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 118.024 0.375 . . . . 0.23000000000000001 110.418 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -105.73 38.81 1.9 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.305 -0.407 . . . . 0.23000000000000001 111.379 -179.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -85.86 -156.3 27.17 Favored Glycine 0 CA--C 1.52 0.36 0 C-N-CA 120.913 -0.66 . . . . 0.23000000000000001 112.505 179.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.5 mm -110.57 130.81 63.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-O 120.531 0.205 . . . . 0.23000000000000001 110.852 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -125.99 150.97 47.66 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 120.827 0.346 . . . . 0.23000000000000001 111.43 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 21.8 t -89.1 81.73 1.97 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-N 116.243 -0.435 . . . . 0.23000000000000001 111.185 179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.4 t -43.14 -55.41 3.92 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 114.035 1.124 . . . . 0.23000000000000001 114.035 -178.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 11.6 ptm180 -161.49 156.95 24.22 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 118.425 0.557 . . . . 0.23000000000000001 112.209 -179.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 18.6 t -109.23 146.62 14.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 115.648 -0.705 . . . . 0.23000000000000001 110.576 179.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -102.77 -71.34 0.03 OUTLIER Pre-proline 0 CA--C 1.54 0.573 0 CA-C-O 119.437 -0.316 . . . . 0.23000000000000001 111.311 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -83.45 121.45 3.01 Favored 'Trans proline' 0 C--N 1.36 1.143 0 C-N-CA 121.532 1.488 . . . . 0.23000000000000001 112.104 179.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.74 64.51 3.75 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.165 0.507 . . . . 0.23000000000000001 110.963 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -139.01 -72.07 0.05 OUTLIER Glycine 0 CA--C 1.528 0.862 0 CA-C-N 115.672 -0.694 . . . . 0.23000000000000001 112.84 179.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -63.76 -59.59 0.2 Allowed 'Trans proline' 0 C--N 1.357 1.009 0 C-N-CA 122.119 1.879 . . . . 0.23000000000000001 113.585 -179.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -108.56 45.25 1.04 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.055 0.455 . . . . 0.23000000000000001 111.426 -179.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 89.3 p -84.71 -60.98 1.9 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.069 -0.514 . . . . 0.23000000000000001 111.04 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 13.6 mmmt -90.49 0.54 57.28 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 112.81 0.67 . . . . 0.23000000000000001 112.81 -179.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 60.7 mt -95.48 -65.34 0.98 Allowed 'General case' 0 C--N 1.341 0.214 0 CA-C-N 118.254 0.479 . . . . 0.23000000000000001 111.826 -179.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.4 mt -95.64 139.84 31.31 Favored 'General case' 0 C--O 1.23 0.048 0 N-CA-C 111.845 0.313 . . . . 0.23000000000000001 111.845 -179.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 4.7 pp0? -121.4 151.67 56.68 Favored Pre-proline 0 CA--C 1.535 0.369 0 CA-C-N 115.9 -0.591 . . . . 0.23000000000000001 110.16 178.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -54.43 114.27 1.75 Allowed 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 121.818 1.679 . . . . 0.23000000000000001 112.983 -179.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 118.12 -2.8 16.66 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 121.096 -0.573 . . . . 0.23000000000000001 114.367 179.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -67.77 -177.66 0.82 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 117.831 0.816 . . . . 0.23000000000000001 111.873 -179.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 38.0 tttt -145.22 126.57 14.88 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 115.873 -0.603 . . . . 0.23000000000000001 110.705 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 3.7 mp -89.63 117.82 33.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-O 120.832 0.349 . . . . 0.23000000000000001 110.202 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 35.4 mt -106.63 -26.52 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 116.048 -0.524 . . . . 0.23000000000000001 111.846 -179.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -154.61 149.43 26.63 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.934 0.397 . . . . 0.23000000000000001 111.77 -179.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -149.33 121.24 8.18 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.004 -0.544 . . . . 0.23000000000000001 111.486 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 48.1 m-20 48.35 35.66 5.99 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.631 0.604 . . . . 0.23000000000000001 112.631 179.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 86.88 10.63 71.95 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 120.973 -0.632 . . . . 0.23000000000000001 113.626 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -112.16 120.91 43.4 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 117.692 0.746 . . . . 0.23000000000000001 109.811 179.533 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 18.8 m -71.53 128.78 36.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.425 -0.352 . . . . 0.23000000000000001 111.418 -179.075 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -106.19 13.89 28.33 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.172 -0.467 . . . . 0.23000000000000001 112.125 179.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 6.4 tp -90.83 124.19 43.3 Favored 'Isoleucine or valine' 0 C--N 1.34 0.169 0 O-C-N 122.047 -0.408 . . . . 0.23000000000000001 110.743 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 63.18 72.75 0.47 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.049 -0.523 . . . . 0.23000000000000001 110.929 -179.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 20.1 pt -146.95 166.06 6.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.914 -0.585 . . . . 0.23000000000000001 110.795 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -81.84 154.78 25.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.4 -0.363 . . . . 0.23000000000000001 110.995 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 16.1 t60 -54.6 -56.8 15.21 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.095 -0.502 . . . . 0.23000000000000001 111.899 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -53.05 -33.2 44.05 Favored Glycine 0 C--N 1.336 0.532 0 C-N-CA 121.257 -0.497 . . . . 0.23000000000000001 113.363 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 -65.95 -38.91 89.84 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.036 0.446 . . . . 0.23000000000000001 110.148 179.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.3 -63.63 1.02 Allowed 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.887 -0.597 . . . . 0.23000000000000001 111.684 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.5 t -55.29 -22.87 12.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 N-CA-C 111.93 0.344 . . . . 0.23000000000000001 111.93 -179.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 18.0 m -77.4 -42.28 36.88 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.747 0.308 . . . . 0.23000000000000001 111.101 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 25.5 mt -65.71 -42.06 91.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.391 -0.368 . . . . 0.23000000000000001 111.665 -179.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.406 ' HA ' ' CD2' ' A' ' 89' ' ' PHE . 53.4 mt -66.73 -47.98 70.6 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.353 -0.385 . . . . 0.23000000000000001 111.638 -179.29 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 70.7 mttt -60.66 -45.9 92.36 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.297 0.48 . . . . 0.23000000000000001 112.297 -179.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 11.6 t -68.82 -27.7 66.08 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.654 0.983 . . . . 0.23000000000000001 113.654 -177.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.406 ' CD2' ' HA ' ' A' ' 86' ' ' LEU . 6.0 m-85 -46.88 174.7 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 113.61 0.967 . . . . 0.23000000000000001 113.61 -178.073 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -85.79 -143.69 0.1 Allowed 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 115.139 -0.937 . . . . 0.23000000000000001 110.79 -179.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -81.15 -70.71 0.51 Allowed 'General case' 0 C--N 1.347 0.471 0 CA-C-N 119.016 0.825 . . . . 0.23000000000000001 111.669 -179.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -79.2 129.26 34.27 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 120.766 0.317 . . . . 0.23000000000000001 110.448 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.7 t -121.63 120.07 60.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.222 -0.444 . . . . 0.23000000000000001 110.976 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -98.08 105.46 17.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.398 -0.365 . . . . 0.23000000000000001 110.934 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 4.9 mp -105.29 164.38 11.89 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.977 0.418 . . . . 0.23000000000000001 111.541 -179.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 3.1 mp -120.5 131.77 71.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 N-CA-C 109.098 -0.704 . . . . 0.23000000000000001 109.098 179.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.426 HG22 HD11 ' A' ' 97' ' ' ILE . 46.0 pt -126.82 166.45 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-O 120.967 0.413 . . . . 0.23000000000000001 111.809 -178.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 98.9 t -143.07 143.78 24.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-N 115.919 -0.582 . . . . 0.23000000000000001 111.276 -179.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.1 105.06 14.02 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.83 -0.804 . . . . 0.23000000000000001 108.83 178.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -59.19 119.01 6.56 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 111.937 0.347 . . . . 0.23000000000000001 111.937 -178.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 19.4 t -97.9 112.16 29.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.012 -0.54 . . . . 0.23000000000000001 110.75 179.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 69.9 p -92.99 83.52 4.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.433 -0.349 . . . . 0.23000000000000001 110.863 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 51.3 p . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.319 -0.848 . . . . 0.23000000000000001 110.869 179.994 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 301' ' ' THR . . . . . . . . . . . . . 3.4 m . . . . . 0 N--CA 1.489 1.484 0 N-CA-C 111.688 0.255 . . . . 0.23000000000000001 111.688 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 302' ' ' GLY . . . . . . . . . . . . . . . 162.56 -108.79 0.36 Allowed Glycine 0 C--N 1.333 0.406 0 C-N-CA 120.854 -0.689 . . . . 0.23000000000000001 112.417 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 303' ' ' TRP . . . . . . . . . . . . . 20.7 p-90 -165.28 -42.04 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 111.649 0.24 . . . . 0.23000000000000001 111.649 179.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 4.0 pm0 -61.9 148.91 41.98 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.736 0.303 . . . . 0.23000000000000001 111.343 -179.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 305' ' ' THR . . . . . . . . . . . . . 5.6 m -127.41 121.06 29.87 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.201 -0.454 . . . . 17.879999999999999 110.803 179.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 306' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -85.28 106.91 17.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.45 -0.341 . . . . 0.23000000000000001 110.74 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 307' ' ' VAL . . . . . . . . . . . . . 18.4 m . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.281 -0.866 . . . . 16.109999999999999 111.135 179.985 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.159 0 N-CA-C 112.525 -0.23 . . . . 0.23000000000000001 112.525 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.7 t -148.68 120.96 8.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.83 0.348 . . . . 0.23000000000000001 110.815 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 24.0 m80 -93.69 140.22 29.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.209 -0.451 . . . . 0.23000000000000001 110.936 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -111.98 177.48 4.63 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.2 -0.455 . . . . 0.23000000000000001 110.893 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -65.28 176.13 13.62 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.917 -0.659 . . . . 0.23000000000000001 112.426 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 51.6 p-80 -87.8 77.44 8.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.969 0.414 . . . . 0.23000000000000001 110.892 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -141.78 28.6 1.76 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.06 -0.518 . . . . 0.23000000000000001 111.149 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 11.1 mt -102.17 -44.26 5.49 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.061 0.458 . . . . 0.23000000000000001 110.152 179.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -87.63 92.89 9.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.768 -0.651 . . . . 0.23000000000000001 110.263 179.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -170.99 172.27 5.54 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.223 -0.444 . . . . 0.23000000000000001 110.681 -179.18 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -145.33 96.33 2.82 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.706 0.288 . . . . 0.23000000000000001 110.934 -179.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -98.63 131.75 44.58 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.132 0.419 . . . . 0.23000000000000001 112.132 -179.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.43 HD11 HG22 ' A' ' 13' ' ' ILE . 0.2 OUTLIER -151.75 164.31 2.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 116.252 -0.431 . . . . 0.23000000000000001 111.577 179.447 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 1.2 ttm180 -118.8 156.82 28.74 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 111.783 0.29 . . . . 0.23000000000000001 111.783 -179.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.4 m -143.51 153.61 16.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 112.004 0.372 . . . . 0.23000000000000001 112.004 -179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -115.06 118.25 32.87 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 116.365 -0.379 . . . . 0.23000000000000001 111.858 -179.442 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.7 t -114.65 124.24 71.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 116.297 -0.41 . . . . 0.23000000000000001 110.368 178.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -102.83 127.84 49.84 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.03 0.443 . . . . 0.23000000000000001 111.577 -179.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.63 118.23 12.23 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.045 -0.525 . . . . 0.23000000000000001 111.252 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -175.89 78.12 0.29 Allowed Pre-proline 0 CA--C 1.541 0.603 0 CA-C-N 116.437 -0.347 . . . . 0.23000000000000001 110.703 179.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -86.76 -18.67 20.56 Favored 'Cis proline' 0 C--N 1.363 1.311 0 CA-C-N 119.331 0.797 . . . . 0.23000000000000001 113.231 0.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -136.59 -178.0 4.98 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.794 0.33 . . . . 0.23000000000000001 111.592 -179.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 4.2 mp -63.99 -56.95 11.41 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.2 -0.455 . . . . 0.23000000000000001 110.563 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 107.16 29.38 4.57 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.885 -0.674 . . . . 0.23000000000000001 113.937 178.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -159.03 145.41 16.82 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 117.464 0.632 . . . . 0.23000000000000001 111.21 179.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 8.6 p -96.1 148.9 22.21 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 116.051 -0.522 . . . . 0.23000000000000001 111.647 -179.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 25.1 pt -124.52 150.35 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.109 0 CA-C-N 116.032 -0.531 . . . . 0.23000000000000001 111.348 -179.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 47.9 t -138.38 155.64 48.34 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.27 -0.423 . . . . 0.23000000000000001 110.298 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 158.5 -99.18 0.18 Allowed Glycine 0 C--N 1.334 0.439 0 C-N-CA 120.844 -0.693 . . . . 0.23000000000000001 112.519 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 50.23 110.6 0.01 OUTLIER Glycine 0 CA--C 1.527 0.831 0 N-CA-C 115.38 0.912 . . . . 0.23000000000000001 115.38 178.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 20.4 t -77.8 91.29 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.127 0 O-C-N 122.547 -0.384 . . . . 0.23000000000000001 110.837 179.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 91.69 -4.79 79.54 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 120.821 -0.704 . . . . 0.23000000000000001 114.149 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -111.26 9.51 28.87 Favored Glycine 0 C--N 1.342 0.908 0 CA-C-N 117.932 0.866 . . . . 0.23000000000000001 114.282 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -178.35 -77.29 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 117.736 0.768 . . . . 0.23000000000000001 109.626 178.647 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 113.13 152.81 11.21 Favored Glycine 0 C--N 1.335 0.491 0 CA-C-N 115.919 -0.582 . . . . 0.23000000000000001 113.124 179.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -125.76 136.3 28.19 Favored Pre-proline 0 CA--C 1.535 0.37 0 N-CA-C 110.345 -0.243 . . . . 0.23000000000000001 110.345 179.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -93.75 28.94 0.29 Allowed 'Trans proline' 0 C--N 1.356 0.947 0 C-N-CA 122.422 2.082 . . . . 0.23000000000000001 113.514 -179.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -108.03 -49.75 3.16 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.692 0.282 . . . . 0.23000000000000001 111.203 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 14.2 mmm180 -117.15 135.31 23.07 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-N 116.368 -0.378 . . . . 0.23000000000000001 111.004 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -83.57 -44.56 0.07 OUTLIER 'Trans proline' 0 C--N 1.359 1.104 0 C-N-CA 121.898 1.732 . . . . 0.23000000000000001 112.81 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -93.9 -13.4 27.21 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 112.543 0.571 . . . . 0.23000000000000001 112.543 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -101.35 118.46 37.02 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 117.864 0.302 . . . . 0.23000000000000001 110.318 179.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -108.44 42.39 1.4 Allowed 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 120.978 0.418 . . . . 0.23000000000000001 111.364 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -88.83 -156.32 31.25 Favored Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.889 -0.672 . . . . 0.23000000000000001 112.269 179.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 27.7 mm -109.97 135.44 48.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-N 116.678 0.239 . . . . 0.23000000000000001 110.843 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.429 ' N ' ' CD1' ' A' ' 46' ' ' PHE . 4.5 m-85 -132.7 148.24 52.34 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 120.681 0.277 . . . . 0.23000000000000001 111.42 -179.396 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 16.8 t -92.88 73.37 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 N-CA-C 112.324 0.49 . . . . 0.23000000000000001 112.324 -179.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.9 t -34.31 -53.13 0.5 Allowed 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 114.878 1.436 . . . . 0.23000000000000001 114.878 -178.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -160.31 177.39 10.67 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 121.87 -0.519 . . . . 0.23000000000000001 112.042 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 12.1 t -132.08 151.35 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-N 115.951 -0.568 . . . . 0.23000000000000001 110.991 -179.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -105.31 -68.24 0.04 OUTLIER Pre-proline 0 CA--C 1.538 0.517 0 N-CA-C 111.768 0.285 . . . . 0.23000000000000001 111.768 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -79.02 119.97 4.47 Favored 'Trans proline' 0 C--N 1.357 0.983 0 C-N-CA 121.811 1.674 . . . . 0.23000000000000001 112.557 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.38 66.81 4.03 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.003 0.43 . . . . 0.23000000000000001 111.629 -179.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -162.19 -66.58 0.02 OUTLIER Glycine 0 CA--C 1.528 0.865 0 C-N-CA 120.718 -0.753 . . . . 0.23000000000000001 113.522 -179.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.67 -74.46 0.02 OUTLIER 'Trans proline' 0 C--N 1.357 0.993 0 C-N-CA 122.043 1.828 . . . . 0.23000000000000001 113.469 -178.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -117.21 49.32 1.21 Allowed 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 121.054 0.454 . . . . 0.23000000000000001 112.122 -178.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 16.7 t -109.22 -58.67 2.0 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.748 -0.464 . . . . 0.23000000000000001 109.748 178.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 19.4 tptt -68.35 -10.84 57.76 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.812 -0.631 . . . . 0.23000000000000001 111.743 178.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 54.1 mt -91.24 -65.14 1.04 Allowed 'General case' 0 C--N 1.343 0.304 0 CA-C-N 118.022 0.374 . . . . 0.23000000000000001 110.85 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.5 mp -91.92 148.62 22.08 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.545 -0.298 . . . . 0.23000000000000001 110.958 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.4 pm0 -115.18 151.82 46.13 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-N 116.157 -0.474 . . . . 0.23000000000000001 109.985 178.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -57.37 128.53 29.9 Favored 'Trans proline' 0 C--N 1.356 0.962 0 C-N-CA 121.911 1.74 . . . . 0.23000000000000001 113.041 -179.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 93.86 15.63 48.33 Favored Glycine 0 CA--C 1.524 0.653 0 CA-C-N 115.919 -0.582 . . . . 0.23000000000000001 113.68 179.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -76.91 -174.49 3.11 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 117.518 0.659 . . . . 0.23000000000000001 111.064 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 47.0 tttm -141.89 125.11 16.4 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.984 -0.553 . . . . 0.23000000000000001 110.567 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 60.9 mt -90.54 113.34 26.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.206 -0.452 . . . . 0.23000000000000001 110.186 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 24.2 mm -90.91 -36.88 8.6 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-N 115.936 -0.575 . . . . 0.23000000000000001 112.077 -178.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.28 145.99 27.34 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.065 0.46 . . . . 0.23000000000000001 111.172 -179.245 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -136.97 119.69 16.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.89 -0.596 . . . . 0.23000000000000001 111.015 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.3 m120 45.95 30.04 0.84 Allowed 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 113.098 0.777 . . . . 0.23000000000000001 113.098 179.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 100.78 -14.21 58.99 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 120.693 -0.765 . . . . 0.23000000000000001 113.563 -179.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -88.49 153.7 20.94 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 117.506 0.653 . . . . 0.23000000000000001 110.09 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 12.5 m -101.25 124.62 47.23 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.434 -0.348 . . . . 0.23000000000000001 110.428 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -101.59 17.77 22.0 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 112.38 0.511 . . . . 0.23000000000000001 112.38 -179.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 7.9 tp -92.28 121.17 42.63 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 CA-C-O 120.923 0.392 . . . . 0.23000000000000001 110.61 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 62.17 76.47 0.37 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.103 -0.498 . . . . 0.23000000000000001 111.005 -179.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 23.7 pt -150.01 161.61 4.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.014 -0.539 . . . . 0.23000000000000001 110.802 179.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -81.25 140.72 34.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.967 0.413 . . . . 0.23000000000000001 111.396 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -41.49 -49.96 3.96 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 113.492 0.923 . . . . 0.23000000000000001 113.492 -179.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -57.56 -33.36 66.6 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 120.945 -0.645 . . . . 0.23000000000000001 112.965 -179.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 36.2 tp60 -69.74 -44.73 69.67 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.826 0.346 . . . . 0.23000000000000001 111.196 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.92 -63.37 1.13 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.305 -0.407 . . . . 0.23000000000000001 111.859 -179.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 24.4 t -50.81 -42.27 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 N-CA-C 112.125 0.417 . . . . 0.23000000000000001 112.125 -179.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 37.1 m -62.89 -39.53 94.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.735 0.303 . . . . 0.23000000000000001 111.306 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 16.6 mt -64.75 -49.5 70.56 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.301 -0.408 . . . . 0.23000000000000001 111.861 -179.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 54.4 mt -65.04 -33.16 75.38 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.232 0.456 . . . . 0.23000000000000001 112.232 -178.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 60.3 mttm -76.02 -37.32 58.53 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.188 0.44 . . . . 0.23000000000000001 112.188 -178.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 12.0 t -73.98 -26.12 60.29 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 112.556 0.576 . . . . 0.23000000000000001 112.556 -178.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -54.94 155.19 4.61 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.145 0.498 . . . . 0.23000000000000001 111.911 -178.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -63.29 -139.31 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.128 0 CA-C-N 115.733 -0.667 . . . . 0.23000000000000001 111.489 -178.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -82.01 -66.06 0.93 Allowed 'General case' 0 C--N 1.351 0.658 0 CA-C-N 119.345 0.975 . . . . 0.23000000000000001 112.251 -178.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.67 123.49 26.23 Favored 'General case' 0 CA--C 1.528 0.11 0 CA-C-O 120.939 0.399 . . . . 0.23000000000000001 110.958 -179.308 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 18.0 t -114.22 112.2 39.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.833 -0.621 . . . . 0.23000000000000001 110.634 179.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -89.7 112.26 23.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.359 -0.382 . . . . 0.23000000000000001 110.353 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 4.6 mp -115.06 154.02 29.63 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 121.115 0.483 . . . . 0.23000000000000001 112.044 -178.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 17.9 mm -109.38 122.7 64.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 115.46 -0.791 . . . . 0.23000000000000001 109.809 178.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 24.6 pt -118.11 157.73 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-O 120.685 0.279 . . . . 0.23000000000000001 111.047 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.7 t -142.95 146.82 21.29 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-O 121.06 0.457 . . . . 0.23000000000000001 111.708 -179.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.3 mmm-85 -111.69 110.38 20.74 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 109.113 -0.699 . . . . 0.23000000000000001 109.113 178.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -67.05 129.41 39.81 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 120.998 0.428 . . . . 0.23000000000000001 111.568 -179.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 17.1 m -146.39 164.69 8.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.907 -0.588 . . . . 0.23000000000000001 110.896 179.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 78.0 p -138.2 52.32 1.84 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.314 0.578 . . . . 0.23000000000000001 110.81 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 17.1 m . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.207 -0.901 . . . . 0.23000000000000001 110.911 179.986 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 301' ' ' THR . . . . . . . . . . . . . 4.7 m . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.68 0.276 . . . . 0.23000000000000001 111.247 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 302' ' ' GLY . . . . . . . . . . . . . . . 173.39 -64.63 0.12 Allowed Glycine 0 C--N 1.333 0.403 0 C-N-CA 120.814 -0.708 . . . . 0.23000000000000001 112.692 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 303' ' ' TRP . . . . . . . . . . . . . 47.0 p-90 -76.22 -28.92 57.38 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.49 0.186 . . . . 0.23000000000000001 111.125 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -91.16 105.53 17.87 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.869 0.366 . . . . 0.23000000000000001 110.375 179.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 305' ' ' THR . . . . . . . . . . . . . 7.9 m -97.84 131.13 44.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.108 -0.497 . . . . 17.879999999999999 111.201 -179.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 306' ' ' TRP . . . . . . . . . . . . . 92.4 m95 -89.16 106.4 18.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.127 -0.488 . . . . 0.23000000000000001 110.866 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 307' ' ' VAL . . . . . . . . . . . . . 16.5 m . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.176 -0.916 . . . . 16.109999999999999 111.094 179.987 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.253 0 N-CA-C 112.56 -0.216 . . . . 0.23000000000000001 112.56 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.4 t -88.52 -34.32 17.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.781 0.324 . . . . 0.23000000000000001 110.904 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -68.08 169.46 10.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.223 -0.444 . . . . 0.23000000000000001 110.581 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 55.9 mtm -90.0 -62.89 1.37 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.312 -0.404 . . . . 0.23000000000000001 110.943 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 92.77 -91.47 1.55 Allowed Glycine 0 C--N 1.331 0.272 0 C-N-CA 120.936 -0.65 . . . . 0.23000000000000001 112.304 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 24.2 m80 -83.82 173.8 10.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.728 0.299 . . . . 0.23000000000000001 110.674 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.5 mp0 -82.04 123.26 28.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.306 -0.406 . . . . 0.23000000000000001 110.808 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -74.77 100.74 4.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 0.23000000000000001 111.071 -179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -93.92 69.01 3.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.272 0.558 . . . . 0.23000000000000001 110.812 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -165.64 171.42 13.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.856 -0.611 . . . . 0.23000000000000001 110.528 -179.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -142.77 130.3 21.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.596 -0.275 . . . . 0.23000000000000001 111.127 -179.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -124.2 102.21 7.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.528 -0.305 . . . . 0.23000000000000001 110.582 179.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -126.91 159.31 36.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-O 121.071 0.462 . . . . 0.23000000000000001 111.703 -179.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 15.4 ttm-85 -109.32 161.67 15.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.606 -0.724 . . . . 0.23000000000000001 111.413 -179.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.4 t -139.76 147.78 23.64 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 CA-C-N 116.335 -0.393 . . . . 0.23000000000000001 110.967 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 7.0 tpp85 -115.75 106.42 13.84 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.203 -0.453 . . . . 0.23000000000000001 110.706 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.1 t -111.68 127.43 68.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-N 116.317 -0.401 . . . . 0.23000000000000001 111.289 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -90.42 156.94 17.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 0.23000000000000001 110.513 179.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.7 74.95 1.1 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.074 0.464 . . . . 0.23000000000000001 110.406 179.637 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -141.38 85.84 11.52 Favored Pre-proline 0 CA--C 1.538 0.511 0 CA-C-N 116.135 -0.484 . . . . 0.23000000000000001 111.593 -179.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -85.83 -21.58 15.05 Favored 'Cis proline' 0 C--N 1.363 1.3 0 CA-C-N 119.638 0.906 . . . . 0.23000000000000001 113.211 0.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -138.04 -176.11 4.33 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.733 0.301 . . . . 0.23000000000000001 111.351 -179.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.9 mp -64.74 -57.87 7.8 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.434 -0.348 . . . . 0.23000000000000001 111.048 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 108.0 32.9 3.15 Favored Glycine 0 C--N 1.337 0.623 0 C-N-CA 120.86 -0.686 . . . . 0.23000000000000001 113.621 179.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -165.69 145.62 6.58 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 117.206 0.503 . . . . 0.23000000000000001 111.044 179.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.5 p -100.71 153.48 19.4 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.152 -0.476 . . . . 0.23000000000000001 111.536 -179.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 25.6 pt -122.26 150.11 25.77 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 115.793 -0.639 . . . . 0.23000000000000001 110.829 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 85.0 p -145.03 161.25 39.86 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 121.222 -0.191 . . . . 0.23000000000000001 111.427 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 119.3 -91.62 0.51 Allowed Glycine 0 C--N 1.34 0.752 0 C-N-CA 120.911 -0.661 . . . . 0.23000000000000001 114.191 178.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 67.32 -133.47 30.69 Favored Glycine 0 CA--C 1.521 0.416 0 C-N-CA 121.093 -0.575 . . . . 0.23000000000000001 112.38 -179.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 23.9 t -151.4 81.38 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 CA-C-O 121.141 0.496 . . . . 0.23000000000000001 109.832 179.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.56 15.15 44.57 Favored Glycine 0 CA--C 1.528 0.901 0 CA-C-N 115.753 -0.658 . . . . 0.23000000000000001 113.161 -178.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -93.98 -143.02 12.79 Favored Glycine 0 C--N 1.338 0.691 0 C-N-CA 120.855 -0.688 . . . . 0.23000000000000001 112.292 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 5.1 mmt85 -54.29 -26.17 27.78 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 112.497 0.554 . . . . 0.23000000000000001 112.497 -179.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.47 160.31 32.94 Favored Glycine 0 C--N 1.336 0.582 0 C-N-CA 120.768 -0.73 . . . . 0.23000000000000001 113.492 179.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -121.51 136.9 26.33 Favored Pre-proline 0 N--CA 1.466 0.333 0 N-CA-C 110.491 -0.189 . . . . 0.23000000000000001 110.491 179.396 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -92.83 26.96 0.37 Allowed 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 122.224 1.949 . . . . 0.23000000000000001 113.127 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -102.24 -49.78 3.81 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.761 0.315 . . . . 0.23000000000000001 111.008 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -124.51 140.37 35.16 Favored Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 116.272 -0.422 . . . . 0.23000000000000001 110.783 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -83.76 -41.95 0.09 OUTLIER 'Trans proline' 0 C--N 1.359 1.092 0 C-N-CA 122.028 1.819 . . . . 0.23000000000000001 113.201 -179.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -93.97 -13.08 27.42 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 112.854 0.687 . . . . 0.23000000000000001 112.854 -179.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -103.54 120.69 41.37 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 117.888 0.313 . . . . 0.23000000000000001 111.358 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -104.35 16.86 25.27 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 112.536 0.569 . . . . 0.23000000000000001 112.536 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -57.77 -167.29 0.12 Allowed Glycine 0 C--N 1.338 0.673 0 C-N-CA 120.637 -0.792 . . . . 0.23000000000000001 113.033 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 20.6 mm -104.28 125.97 59.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 N-CA-C 109.649 -0.5 . . . . 0.23000000000000001 109.649 179.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -122.66 146.52 47.39 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 120.796 0.332 . . . . 0.23000000000000001 111.428 -179.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 34.2 t -89.89 73.02 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-O 121.25 0.548 . . . . 0.23000000000000001 110.252 179.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.0 t -36.14 -53.59 0.8 Allowed 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 114.674 1.361 . . . . 0.23000000000000001 114.674 -178.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 7.7 ptm180 -158.64 168.77 25.98 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.198 0.523 . . . . 0.23000000000000001 112.321 -179.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.4 t -126.39 148.68 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-N 115.478 -0.783 . . . . 0.23000000000000001 110.372 179.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 7.1 mm-40 -105.25 -68.81 0.03 OUTLIER Pre-proline 0 CA--C 1.538 0.514 0 N-CA-C 111.706 0.261 . . . . 0.23000000000000001 111.706 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -79.26 120.19 4.44 Favored 'Trans proline' 0 C--N 1.357 0.998 0 C-N-CA 121.8 1.667 . . . . 0.23000000000000001 112.487 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -78.5 66.92 4.16 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 121.03 0.443 . . . . 0.23000000000000001 111.064 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -160.91 -65.87 0.02 OUTLIER Glycine 0 CA--C 1.527 0.836 0 C-N-CA 120.721 -0.752 . . . . 0.23000000000000001 113.548 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -56.27 -61.12 0.37 Allowed 'Trans proline' 0 C--N 1.356 0.973 0 C-N-CA 122.229 1.953 . . . . 0.23000000000000001 113.513 -178.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -136.21 58.56 1.74 Allowed 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 121.206 0.527 . . . . 0.23000000000000001 111.933 -178.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.8 t -119.3 -58.23 1.94 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.969 -0.56 . . . . 0.23000000000000001 109.898 179.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 25.3 tptp -64.56 -16.08 62.05 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.698 -0.683 . . . . 0.23000000000000001 111.743 178.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 39.5 mt -98.2 -49.73 4.61 Favored 'General case' 0 C--N 1.341 0.221 0 CA-C-O 120.805 0.336 . . . . 0.23000000000000001 111.441 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 41.9 mt -90.99 148.76 22.18 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.978 0.418 . . . . 0.23000000000000001 111.802 -179.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -116.04 137.25 23.25 Favored Pre-proline 0 CA--C 1.536 0.42 0 CA-C-N 115.877 -0.601 . . . . 0.23000000000000001 110.235 179.107 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -52.4 126.57 21.06 Favored 'Trans proline' 0 C--N 1.356 0.971 0 C-N-CA 122.011 1.808 . . . . 0.23000000000000001 113.044 -179.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 95.33 18.1 34.58 Favored Glycine 0 CA--C 1.521 0.428 0 C-N-CA 121.045 -0.598 . . . . 0.23000000000000001 113.807 179.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -86.18 144.64 27.37 Favored 'General case' 0 C--N 1.339 0.122 0 CA-C-N 117.625 0.713 . . . . 0.23000000000000001 110.679 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -92.89 129.57 38.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.266 -0.425 . . . . 0.23000000000000001 111.566 -179.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 2.8 mm -88.08 111.95 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 N-CA-C 109.872 -0.418 . . . . 0.23000000000000001 109.872 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 25.9 mm -90.63 -44.62 14.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 N-CA-C 112.385 0.513 . . . . 0.23000000000000001 112.385 -178.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -148.45 150.85 34.18 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.201 0.524 . . . . 0.23000000000000001 112.403 -178.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.406 ' HB2' ' CE1' ' A' ' 74' ' ' PHE . . . -142.46 124.32 15.17 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.398 -0.819 . . . . 0.23000000000000001 111.079 179.53 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.3 m120 45.13 27.64 0.33 Allowed 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 113.447 0.906 . . . . 0.23000000000000001 113.447 178.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 99.78 -8.84 59.97 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 120.808 -0.711 . . . . 0.23000000000000001 114.128 179.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -97.81 122.64 41.15 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 117.797 0.798 . . . . 0.23000000000000001 110.886 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.9 t -69.02 126.25 29.23 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.398 -0.365 . . . . 0.23000000000000001 110.432 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.406 ' CE1' ' HB2' ' A' ' 69' ' ' ALA . 3.1 m-85 -97.58 17.9 16.69 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 112.375 0.509 . . . . 0.23000000000000001 112.375 -179.027 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 30.5 mm -92.5 119.61 40.35 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-O 120.82 0.343 . . . . 0.23000000000000001 110.946 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 61.11 76.86 0.35 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.262 0.553 . . . . 0.23000000000000001 111.143 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 17.4 pt -145.97 150.3 15.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.747 -0.66 . . . . 0.23000000000000001 110.546 179.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -62.27 142.43 57.73 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.357 -0.383 . . . . 0.23000000000000001 111.165 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 12.3 t60 -47.97 -50.81 26.05 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 115.878 -0.601 . . . . 0.23000000000000001 112.597 -179.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -60.17 -27.58 65.33 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 120.864 -0.684 . . . . 0.23000000000000001 112.694 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -69.87 -43.57 71.57 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 120.948 0.404 . . . . 0.23000000000000001 110.878 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.68 -39.88 76.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.204 -0.453 . . . . 0.23000000000000001 111.491 -179.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 26.7 t -71.88 -45.24 65.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.218 -0.446 . . . . 0.23000000000000001 111.125 -179.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 36.1 t -62.61 -36.79 83.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.248 -0.433 . . . . 0.23000000000000001 111.548 -179.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 18.3 mt -68.0 -45.69 73.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.833 0.349 . . . . 0.23000000000000001 111.761 -179.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 18.3 mt -68.17 -32.89 73.46 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.237 0.458 . . . . 0.23000000000000001 112.237 -178.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 3.0 mtmp? -79.6 -37.98 34.99 Favored 'General case' 0 N--CA 1.457 -0.087 0 N-CA-C 112.341 0.497 . . . . 0.23000000000000001 112.341 -178.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 9.0 t -70.77 -23.28 62.37 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 112.239 0.459 . . . . 0.23000000000000001 112.239 -178.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -51.06 176.4 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 121.335 0.588 . . . . 0.23000000000000001 112.398 -178.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 87.0 mm-40 -82.08 -144.0 0.06 Allowed 'General case' 0 CA--C 1.551 0.998 0 CA-C-N 115.476 -0.783 . . . . 0.23000000000000001 111.119 -179.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -79.87 -63.48 1.4 Allowed 'General case' 0 C--N 1.347 0.493 0 CA-C-N 118.94 0.791 . . . . 0.23000000000000001 110.964 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -87.19 138.38 31.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.218 -0.446 . . . . 0.23000000000000001 110.198 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 18.2 t -127.08 121.65 58.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.324 -0.398 . . . . 0.23000000000000001 111.047 -179.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -93.52 101.46 13.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.444 . . . . 0.23000000000000001 110.337 179.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 5.6 mp -104.07 155.69 18.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.043 0.449 . . . . 0.23000000000000001 111.797 -179.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 41.4 mt -116.01 130.76 70.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.589 -0.732 . . . . 0.23000000000000001 109.641 178.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 39.3 pt -126.95 160.66 35.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-O 120.992 0.425 . . . . 0.23000000000000001 111.635 -179.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 71.9 t -143.17 149.42 18.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 115.911 -0.586 . . . . 0.23000000000000001 111.136 -179.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -112.84 117.51 32.35 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.799 -0.637 . . . . 0.23000000000000001 109.928 179.092 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 48.2 mm-40 -62.02 127.6 32.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.832 0.349 . . . . 0.23000000000000001 111.723 -179.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 14.6 t -140.78 100.79 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.064 -0.516 . . . . 0.23000000000000001 110.658 179.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 11.6 t -155.25 180.0 8.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.903 0.382 . . . . 0.23000000000000001 111.161 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 79.7 p . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.25 -0.881 . . . . 0.23000000000000001 110.846 179.951 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 301' ' ' THR . . . . . . . . . . . . . 41.6 p . . . . . 0 N--CA 1.487 1.413 0 CA-C-O 120.79 0.329 . . . . 0.23000000000000001 111.135 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 302' ' ' GLY . . . . . . . . . . . . . . . 95.24 163.21 34.56 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.773 -0.727 . . . . 0.23000000000000001 112.571 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 303' ' ' TRP . . . . . . . . . . . . . 18.5 p-90 -104.34 -28.99 11.04 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.616 0.246 . . . . 0.23000000000000001 111.281 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -70.83 175.44 5.04 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.74 0.305 . . . . 0.23000000000000001 110.696 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 305' ' ' THR . . . . . . . . . . . . . 5.3 m -141.22 119.34 12.02 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.353 -0.385 . . . . 17.879999999999999 110.607 179.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 306' ' ' TRP . . . . . . . . . . . . . 83.6 m95 -84.29 117.32 23.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.23000000000000001 111.046 -179.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 307' ' ' VAL . . . . . . . . . . . . . 16.2 m . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.261 -0.876 . . . . 16.109999999999999 111.159 179.964 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.146 0 N-CA-C 112.565 -0.214 . . . . 0.23000000000000001 112.565 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.1 t -91.97 116.66 29.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.884 0.374 . . . . 0.23000000000000001 110.991 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -84.34 141.94 30.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.129 -0.487 . . . . 0.23000000000000001 110.375 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.53 97.37 5.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.391 -0.368 . . . . 0.23000000000000001 110.629 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 154.18 -33.63 0.72 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 121.0 -0.619 . . . . 0.23000000000000001 112.309 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -123.3 86.68 2.62 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.873 0.368 . . . . 0.23000000000000001 110.587 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -91.0 157.66 17.15 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.181 -0.463 . . . . 0.23000000000000001 110.968 -179.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -170.83 -41.71 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.35 -0.386 . . . . 0.23000000000000001 111.572 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.17 -160.05 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 116.418 -0.355 . . . . 0.23000000000000001 111.632 -179.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -51.46 102.86 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.672 0.619 . . . . 0.23000000000000001 112.672 -179.178 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -89.73 107.56 19.17 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 112.204 0.446 . . . . 0.23000000000000001 112.204 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -89.34 95.19 10.18 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.309 -0.405 . . . . 0.23000000000000001 110.277 179.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -113.97 164.16 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 112.665 0.617 . . . . 0.23000000000000001 112.665 -179.191 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 82.3 mtt-85 -100.56 168.49 9.68 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.475 -0.784 . . . . 0.23000000000000001 111.655 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 40.3 t -150.35 139.23 15.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-N 115.898 -0.592 . . . . 0.23000000000000001 111.015 179.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 39.7 mtt85 -113.93 108.09 16.58 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.298 -0.41 . . . . 0.23000000000000001 110.845 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.5 t -111.29 123.66 67.36 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.16 0 CA-C-N 116.527 -0.306 . . . . 0.23000000000000001 110.677 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -86.18 161.16 18.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 0.23000000000000001 111.179 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.3 73.28 0.81 Allowed 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.061 -0.518 . . . . 0.23000000000000001 110.545 179.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -138.68 85.13 17.41 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-N 116.092 -0.503 . . . . 0.23000000000000001 111.168 -179.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -86.03 -19.93 18.54 Favored 'Cis proline' 0 C--N 1.364 1.372 0 CA-C-N 119.507 0.86 . . . . 0.23000000000000001 113.129 0.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -136.46 -177.64 4.81 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 120.746 0.307 . . . . 0.23000000000000001 111.276 -179.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.2 mp -65.3 -55.81 16.21 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.248 -0.433 . . . . 0.23000000000000001 110.263 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 109.48 16.13 11.44 Favored Glycine 0 C--N 1.336 0.528 0 C-N-CA 120.794 -0.717 . . . . 0.23000000000000001 114.215 178.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -145.79 157.02 43.95 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 117.759 0.78 . . . . 0.23000000000000001 111.463 179.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.4 p -108.52 150.59 27.24 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 116.115 -0.493 . . . . 0.23000000000000001 111.171 -179.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 17.7 pt -122.88 151.67 27.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.105 -0.498 . . . . 0.23000000000000001 111.502 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 98.2 p -149.98 164.07 36.43 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.395 -0.366 . . . . 0.23000000000000001 111.207 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 112.48 -96.08 0.82 Allowed Glycine 0 C--N 1.337 0.601 0 C-N-CA 120.898 -0.668 . . . . 0.23000000000000001 113.876 178.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 74.52 -132.82 14.93 Favored Glycine 0 CA--C 1.519 0.309 0 C-N-CA 121.119 -0.562 . . . . 0.23000000000000001 112.401 -179.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 24.1 t -149.75 87.16 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.95 -0.389 . . . . 0.23000000000000001 109.95 179.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 92.89 5.16 64.56 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 120.983 -0.627 . . . . 0.23000000000000001 113.693 -178.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -77.47 -134.62 0.71 Allowed Glycine 0 C--N 1.343 0.963 0 CA-C-N 117.741 0.77 . . . . 0.23000000000000001 112.723 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 1.4 mtt180 -71.17 -19.67 62.38 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.597 0.592 . . . . 0.23000000000000001 112.597 -179.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.92 -156.02 17.0 Favored Glycine 0 C--N 1.342 0.907 0 C-N-CA 120.701 -0.761 . . . . 0.23000000000000001 112.952 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -173.89 132.86 0.57 Allowed Pre-proline 0 CA--C 1.534 0.358 0 N-CA-C 110.539 -0.171 . . . . 0.23000000000000001 110.539 179.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -90.16 25.6 0.55 Allowed 'Trans proline' 0 C--N 1.358 1.048 0 C-N-CA 122.174 1.916 . . . . 0.23000000000000001 113.89 -179.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -110.25 -56.06 2.38 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.734 0.302 . . . . 0.23000000000000001 110.921 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -114.16 135.78 22.18 Favored Pre-proline 0 CA--C 1.535 0.389 0 CA-C-N 116.413 -0.358 . . . . 0.23000000000000001 110.689 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -86.96 -47.58 0.04 OUTLIER 'Trans proline' 0 C--N 1.36 1.14 0 C-N-CA 121.994 1.796 . . . . 0.23000000000000001 113.623 -179.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -95.83 -11.4 26.88 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 112.931 0.715 . . . . 0.23000000000000001 112.931 -179.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -94.48 115.91 28.16 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 117.904 0.32 . . . . 0.23000000000000001 110.27 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.4 p30 -102.3 64.52 0.92 Allowed 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 121.174 0.511 . . . . 0.23000000000000001 111.408 -179.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -116.15 -162.49 13.13 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 121.093 -0.575 . . . . 0.23000000000000001 112.316 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.438 HG22 HD11 ' A' ' 45' ' ' ILE . 15.8 mm -107.53 131.64 57.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 110.348 -0.242 . . . . 0.23000000000000001 110.348 179.537 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -129.55 149.87 51.13 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.77 0.319 . . . . 0.23000000000000001 111.107 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 21.8 t -97.13 73.58 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-N 116.213 -0.448 . . . . 0.23000000000000001 111.331 -179.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.6 t -35.34 -53.54 0.64 Allowed 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 114.527 1.306 . . . . 0.23000000000000001 114.527 -178.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 1.8 ptt-85 -158.53 163.84 36.69 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.059 0.457 . . . . 0.23000000000000001 112.112 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 5.3 t -121.26 154.85 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-N 115.674 -0.694 . . . . 0.23000000000000001 110.56 -179.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 3.6 mm-40 -104.73 -68.3 0.04 OUTLIER Pre-proline 0 CA--C 1.538 0.513 0 N-CA-C 111.575 0.213 . . . . 0.23000000000000001 111.575 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -80.37 120.13 3.96 Favored 'Trans proline' 0 C--N 1.358 1.07 0 C-N-CA 121.836 1.691 . . . . 0.23000000000000001 112.481 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -77.06 69.2 3.32 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 120.992 0.425 . . . . 0.23000000000000001 111.337 -179.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -165.04 -64.33 0.02 OUTLIER Glycine 0 CA--C 1.529 0.937 0 C-N-CA 120.696 -0.764 . . . . 0.23000000000000001 113.719 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.57 -72.52 0.03 OUTLIER 'Trans proline' 0 C--N 1.357 1.002 0 C-N-CA 122.072 1.848 . . . . 0.23000000000000001 113.72 -178.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -102.68 -10.92 18.8 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 113.796 1.036 . . . . 0.23000000000000001 113.796 -178.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.9 t -75.31 -25.93 58.27 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 112.131 0.419 . . . . 0.23000000000000001 112.131 -178.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.9 tppt? -76.81 -20.94 55.81 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 111.925 0.343 . . . . 0.23000000000000001 111.925 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 43.5 mt -123.48 6.43 8.96 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 113.773 1.027 . . . . 0.23000000000000001 113.773 -178.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 91.2 mt -136.03 148.9 48.58 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 118.344 0.52 . . . . 0.23000000000000001 111.729 179.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -104.98 141.49 22.66 Favored Pre-proline 0 CA--C 1.536 0.42 0 CA-C-N 115.744 -0.662 . . . . 0.23000000000000001 110.437 179.317 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -64.15 71.16 0.2 Allowed 'Trans proline' 0 C--N 1.362 1.254 0 C-N-CA 122.297 1.998 . . . . 0.23000000000000001 113.647 -179.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 139.16 40.42 0.09 OUTLIER Glycine 0 CA--C 1.524 0.617 0 C-N-CA 120.903 -0.665 . . . . 0.23000000000000001 113.299 179.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -96.36 -161.67 0.89 Allowed 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 117.034 0.417 . . . . 0.23000000000000001 110.661 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.6 tttm -138.77 122.0 16.98 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 120.718 0.294 . . . . 0.23000000000000001 110.818 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.3 mp -89.45 120.97 39.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-N 116.433 -0.349 . . . . 0.23000000000000001 110.534 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 20.1 mm -92.39 -40.39 12.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 112.65 0.611 . . . . 0.23000000000000001 112.65 -178.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 -150.38 150.86 31.96 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.12 0.486 . . . . 0.23000000000000001 111.981 -178.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -138.23 123.02 18.79 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.638 -0.71 . . . . 0.23000000000000001 111.684 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 62.8 m-20 40.85 33.63 0.22 Allowed 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 113.996 1.11 . . . . 0.23000000000000001 113.996 178.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 99.2 -20.87 48.29 Favored Glycine 0 CA--C 1.522 0.509 0 C-N-CA 120.724 -0.75 . . . . 0.23000000000000001 113.409 179.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -88.46 119.52 28.97 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 117.151 0.475 . . . . 0.23000000000000001 110.281 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 33.3 t -66.25 122.12 16.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.972 -0.558 . . . . 0.23000000000000001 111.005 -179.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -98.07 7.64 45.99 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 113.121 0.786 . . . . 0.23000000000000001 113.121 -178.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 6.5 tp -84.55 120.28 34.94 Favored 'Isoleucine or valine' 0 C--N 1.341 0.201 0 CA-C-N 118.392 0.542 . . . . 0.23000000000000001 110.678 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 62.13 75.93 0.39 Allowed 'General case' 0 C--O 1.232 0.184 0 CA-C-O 121.259 0.552 . . . . 0.23000000000000001 111.023 -179.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 16.0 pt -144.87 152.86 14.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.631 -0.713 . . . . 0.23000000000000001 110.514 179.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -64.61 150.9 46.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.039 0.447 . . . . 0.23000000000000001 110.992 -179.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 11.0 t60 -54.73 -55.11 33.37 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.08 -0.509 . . . . 0.23000000000000001 111.953 -179.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -55.55 -25.3 42.09 Favored Glycine 0 CA--C 1.523 0.544 0 C-N-CA 121.058 -0.592 . . . . 0.23000000000000001 113.309 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.21 -39.85 53.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.056 0.455 . . . . 0.23000000000000001 110.592 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.66 -35.88 67.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.834 -0.621 . . . . 0.23000000000000001 112.207 -179.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.6 t -76.08 -45.85 35.35 Favored 'Isoleucine or valine' 0 C--O 1.231 0.082 0 CA-C-O 120.83 0.348 . . . . 0.23000000000000001 111.022 -179.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 45.1 m -61.63 -35.33 77.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.122 -0.49 . . . . 0.23000000000000001 111.078 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 15.3 mt -70.64 -44.02 68.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.158 -0.474 . . . . 0.23000000000000001 111.171 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.403 ' HA ' ' CD2' ' A' ' 89' ' ' PHE . 13.7 mt -68.45 -31.03 70.05 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.283 0.475 . . . . 0.23000000000000001 112.283 -179.067 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 23.7 mtmt -83.79 -36.35 23.62 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.227 0.454 . . . . 0.23000000000000001 112.227 -179.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 9.0 t -72.26 -24.06 61.3 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 112.209 0.448 . . . . 0.23000000000000001 112.209 -178.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.403 ' CD2' ' HA ' ' A' ' 86' ' ' LEU . 8.3 m-85 -49.74 177.02 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 112.431 0.53 . . . . 0.23000000000000001 112.431 -178.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 50.9 mm-40 -82.17 -144.83 0.06 Allowed 'General case' 0 CA--C 1.549 0.911 0 CA-C-N 115.981 -0.554 . . . . 0.23000000000000001 110.689 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -78.24 -65.05 1.03 Allowed 'General case' 0 C--N 1.347 0.468 0 CA-C-N 118.977 0.808 . . . . 0.23000000000000001 111.021 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -83.58 140.35 32.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.283 -0.417 . . . . 0.23000000000000001 110.356 179.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 19.0 t -124.84 120.68 59.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.393 -0.367 . . . . 0.23000000000000001 111.275 -179.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -89.49 107.31 19.0 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.602 -0.518 . . . . 0.23000000000000001 109.602 179.134 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 15.2 mt -107.95 145.29 34.04 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.99 0.424 . . . . 0.23000000000000001 111.766 -178.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 15.9 mm -108.01 125.91 64.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 108.975 -0.75 . . . . 0.23000000000000001 108.975 178.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 41.6 pt -131.2 167.99 24.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 112.249 0.463 . . . . 0.23000000000000001 112.249 -178.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 18.3 t -149.72 153.94 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 115.925 -0.58 . . . . 0.23000000000000001 111.167 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -115.77 116.01 27.3 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.163 -0.471 . . . . 0.23000000000000001 110.315 179.307 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -67.57 127.52 33.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.344 -0.389 . . . . 0.23000000000000001 111.371 -179.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 13.3 m -108.82 175.56 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.08 -0.509 . . . . 0.23000000000000001 110.795 179.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 21.2 m -79.54 144.46 33.9 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.379 -0.373 . . . . 0.23000000000000001 110.99 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 77.7 p . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.289 -0.863 . . . . 0.23000000000000001 110.865 179.962 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 301' ' ' THR . . . . . . . . . . . . . 1.7 m . . . . . 0 N--CA 1.487 1.407 0 CA-C-O 121.191 0.52 . . . . 0.23000000000000001 111.028 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 302' ' ' GLY . . . . . . . . . . . . . . . -84.03 177.77 52.04 Favored Glycine 0 C--N 1.333 0.364 0 C-N-CA 120.983 -0.627 . . . . 0.23000000000000001 112.488 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 303' ' ' TRP . . . . . 0.4 ' CZ3' ' HB3' ' B' ' 304' ' ' GLU . 34.7 p-90 -76.33 -28.52 56.91 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.519 0.2 . . . . 0.23000000000000001 111.377 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 304' ' ' GLU . . . . . 0.4 ' HB3' ' CZ3' ' B' ' 303' ' ' TRP . 7.4 pt-20 -86.69 153.53 21.67 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.737 0.303 . . . . 0.23000000000000001 110.796 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 305' ' ' THR . . . . . . . . . . . . . 16.9 m -139.76 120.88 14.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.303 -0.408 . . . . 17.879999999999999 110.953 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 306' ' ' TRP . . . . . . . . . . . . . 92.2 m95 -80.64 111.03 16.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.31 -0.405 . . . . 0.23000000000000001 110.863 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 307' ' ' VAL . . . . . . . . . . . . . 15.5 m . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.253 -0.879 . . . . 16.109999999999999 111.122 179.954 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.253 0 N-CA-C 112.473 -0.251 . . . . 0.23000000000000001 112.473 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.8 m -90.85 138.48 31.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.776 0.322 . . . . 0.23000000000000001 110.845 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 22.9 m-70 -83.12 156.49 23.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 0.23000000000000001 110.882 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -103.9 -31.84 9.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.263 -0.426 . . . . 0.23000000000000001 110.922 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 114.6 48.86 0.53 Allowed Glycine 0 C--N 1.332 0.325 0 C-N-CA 121.076 -0.583 . . . . 0.23000000000000001 112.622 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -100.22 117.98 35.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.764 0.316 . . . . 0.23000000000000001 110.646 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -70.12 -178.97 1.77 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.279 -0.419 . . . . 0.23000000000000001 111.004 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.6 mp -64.43 135.55 56.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.249 -0.432 . . . . 0.23000000000000001 110.937 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -110.82 46.06 1.1 Allowed 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.137 -0.483 . . . . 0.23000000000000001 111.103 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.3 mmmm -64.74 127.79 33.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.043 -0.526 . . . . 0.23000000000000001 110.875 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -88.98 90.27 8.34 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.994 -0.548 . . . . 0.23000000000000001 111.979 -178.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -84.97 99.09 10.76 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.264 -0.643 . . . . 0.23000000000000001 109.264 178.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.4 pt -117.48 159.24 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 116.105 -0.498 . . . . 0.23000000000000001 112.214 -178.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -112.95 157.58 21.31 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.685 -0.689 . . . . 0.23000000000000001 111.099 -179.361 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.5 m -141.66 139.68 31.43 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 116.136 -0.484 . . . . 0.23000000000000001 110.707 179.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -106.03 114.27 28.31 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.352 -0.386 . . . . 0.23000000000000001 111.605 -179.123 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.0 t -114.13 123.26 69.62 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-N 116.307 -0.406 . . . . 0.23000000000000001 110.997 179.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 4.8 mp0 -98.95 119.08 37.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.321 -0.399 . . . . 0.23000000000000001 110.704 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 16.1 mttt -70.02 118.38 12.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.246 -0.434 . . . . 0.23000000000000001 111.048 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -171.98 85.57 0.45 Allowed Pre-proline 0 CA--C 1.536 0.435 0 CA-C-N 115.996 -0.547 . . . . 0.23000000000000001 110.655 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -84.0 -17.76 26.09 Favored 'Cis proline' 0 C--N 1.363 1.338 0 CA-C-N 119.383 0.815 . . . . 0.23000000000000001 113.42 0.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 51.7 mm-40 -136.79 -177.04 4.56 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 120.913 0.387 . . . . 0.23000000000000001 111.689 -179.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.412 ' HB3' ' CE2' ' A' ' 25' ' ' PHE . 4.5 mp -65.67 -56.1 13.93 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.058 -0.519 . . . . 0.23000000000000001 111.244 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 102.54 39.46 2.77 Favored Glycine 0 CA--C 1.522 0.488 0 C-N-CA 120.754 -0.736 . . . . 0.23000000000000001 113.926 178.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.412 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 43.3 p90 -169.85 156.91 6.5 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 117.155 0.477 . . . . 0.23000000000000001 111.202 179.173 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 9.3 p -113.55 154.64 26.78 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.138 -0.483 . . . . 0.23000000000000001 111.506 -179.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 46.6 pt -121.38 153.35 25.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-N 116.058 -0.519 . . . . 0.23000000000000001 111.799 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 77.6 p -141.21 155.24 46.07 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.311 -0.404 . . . . 0.23000000000000001 110.865 179.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 114.05 -158.26 14.43 Favored Glycine 0 C--N 1.335 0.508 0 C-N-CA 120.934 -0.651 . . . . 0.23000000000000001 113.369 179.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 137.27 -135.51 7.68 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 121.26 -0.495 . . . . 0.23000000000000001 112.234 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 39.5 t -141.88 75.38 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.225 0.536 . . . . 0.23000000000000001 109.877 179.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 93.59 13.56 55.11 Favored Glycine 0 CA--C 1.529 0.943 0 CA-C-N 115.66 -0.7 . . . . 0.23000000000000001 113.154 -178.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -86.74 -146.42 10.05 Favored Glycine 0 C--N 1.342 0.908 0 CA-C-N 117.598 0.699 . . . . 0.23000000000000001 112.695 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 69.6 mtt180 -56.46 -24.56 46.49 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 112.306 0.484 . . . . 0.23000000000000001 112.306 -179.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.24 175.46 48.76 Favored Glycine 0 C--N 1.336 0.536 0 C-N-CA 120.66 -0.781 . . . . 0.23000000000000001 112.629 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -139.53 146.55 48.52 Favored Pre-proline 0 CA--C 1.534 0.337 0 N-CA-C 110.473 -0.195 . . . . 0.23000000000000001 110.473 179.723 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -92.33 30.32 0.31 Allowed 'Trans proline' 0 C--N 1.358 1.039 0 C-N-CA 122.309 2.006 . . . . 0.23000000000000001 113.43 -179.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -107.48 -56.48 2.21 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.778 0.323 . . . . 0.23000000000000001 110.647 179.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -112.46 139.12 22.27 Favored Pre-proline 0 CA--C 1.534 0.33 0 CA-C-N 116.195 -0.457 . . . . 0.23000000000000001 110.376 179.41 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -87.58 -50.3 0.03 OUTLIER 'Trans proline' 0 C--N 1.358 1.044 0 C-N-CA 121.964 1.776 . . . . 0.23000000000000001 113.642 -178.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -95.43 -7.82 37.22 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 113.114 0.783 . . . . 0.23000000000000001 113.114 -179.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -90.9 113.75 26.03 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 118.106 0.412 . . . . 0.23000000000000001 110.766 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 14.1 p30 -98.88 54.82 1.01 Allowed 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 121.1 0.476 . . . . 0.23000000000000001 111.15 -179.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -112.45 -163.75 16.49 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 121.056 -0.592 . . . . 0.23000000000000001 112.577 179.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.419 HD11 HG22 ' A' ' 45' ' ' ILE . 13.1 mm -108.74 133.79 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 116.553 0.177 . . . . 0.23000000000000001 110.591 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.432 ' CD1' ' N ' ' A' ' 46' ' ' PHE . 3.7 m-85 -131.2 151.59 51.32 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 120.542 0.21 . . . . 0.23000000000000001 110.714 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 29.2 t -91.0 79.79 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-O 121.103 0.478 . . . . 0.23000000000000001 110.686 179.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.1 t -36.41 -53.78 0.85 Allowed 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 114.824 1.416 . . . . 0.23000000000000001 114.824 -178.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.48 179.47 8.59 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.236 0.541 . . . . 0.23000000000000001 112.372 -178.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 20.3 t -137.37 148.62 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 115.519 -0.764 . . . . 0.23000000000000001 110.48 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 7.2 mm-40 -105.06 -68.85 0.03 OUTLIER Pre-proline 0 CA--C 1.538 0.488 0 CA-C-O 119.629 -0.224 . . . . 0.23000000000000001 111.389 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -78.12 118.04 4.28 Favored 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 121.676 1.584 . . . . 0.23000000000000001 112.045 179.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.3 pm0 -75.63 66.95 2.04 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.114 0.483 . . . . 0.23000000000000001 111.257 -179.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -156.03 -69.83 0.01 OUTLIER Glycine 0 CA--C 1.528 0.868 0 C-N-CA 120.791 -0.719 . . . . 0.23000000000000001 113.335 -179.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -60.07 -75.81 0.02 OUTLIER 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 121.968 1.779 . . . . 0.23000000000000001 113.365 -179.019 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -104.05 46.06 0.93 Allowed 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 121.073 0.464 . . . . 0.23000000000000001 111.77 -179.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.9 t -114.4 -65.04 1.23 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.086 -0.506 . . . . 0.23000000000000001 110.006 179.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.1 tppm? -62.46 -21.22 65.27 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.705 -0.68 . . . . 0.23000000000000001 111.488 178.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 40.2 mt -97.73 -54.9 2.97 Favored 'General case' 0 C--N 1.339 0.128 0 CA-C-O 120.59 0.233 . . . . 0.23000000000000001 111.558 -179.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 32.6 mt -93.96 146.94 23.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.807 0.337 . . . . 0.23000000000000001 111.563 -179.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -118.84 143.06 32.91 Favored Pre-proline 0 CA--C 1.537 0.472 0 CA-C-N 116.073 -0.512 . . . . 0.23000000000000001 110.333 179.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -62.19 131.69 35.6 Favored 'Trans proline' 0 C--N 1.359 1.092 0 C-N-CA 122.128 1.886 . . . . 0.23000000000000001 113.761 -179.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 93.88 18.7 36.5 Favored Glycine 0 C--N 1.335 0.482 0 CA-C-N 115.934 -0.575 . . . . 0.23000000000000001 113.89 178.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -85.16 -171.71 3.78 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 117.33 0.565 . . . . 0.23000000000000001 111.227 -179.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 43.5 tttm -135.11 122.03 21.16 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.274 -0.421 . . . . 0.23000000000000001 110.773 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 20.6 mt -90.12 117.3 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-N 116.378 -0.374 . . . . 0.23000000000000001 111.017 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 20.2 mm -96.01 -36.77 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 N-CA-C 112.287 0.477 . . . . 0.23000000000000001 112.287 -179.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.02 150.55 30.09 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.136 0.493 . . . . 0.23000000000000001 112.07 -178.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.403 ' HB2' ' CE1' ' A' ' 74' ' ' PHE . . . -137.25 119.94 16.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.611 -0.722 . . . . 0.23000000000000001 110.822 179.315 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.405 ' HB2' ' CZ ' ' A' ' 89' ' ' PHE . 62.8 m-20 42.56 28.87 0.13 Allowed 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 113.775 1.028 . . . . 0.23000000000000001 113.775 179.26 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 99.31 5.69 55.78 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 120.888 -0.672 . . . . 0.23000000000000001 113.98 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -109.32 121.28 44.82 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 117.911 0.856 . . . . 0.23000000000000001 110.084 179.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.3 t -68.03 121.0 15.18 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.798 0.332 . . . . 0.23000000000000001 111.235 -179.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . 0.403 ' CE1' ' HB2' ' A' ' 69' ' ' ALA . 3.9 m-30 -99.63 15.15 27.62 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 116.173 -0.467 . . . . 0.23000000000000001 112.069 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 7.7 tp -92.2 123.41 44.3 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-O 120.785 0.326 . . . . 0.23000000000000001 110.86 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 61.29 73.78 0.47 Allowed 'General case' 0 C--O 1.232 0.167 0 CA-C-O 121.258 0.551 . . . . 0.23000000000000001 110.773 -179.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 11.7 pt -149.21 160.93 5.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.707 -0.679 . . . . 0.23000000000000001 110.646 179.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -73.29 139.47 46.12 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.22 -0.445 . . . . 0.23000000000000001 111.225 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 3.8 t-160 -48.25 -49.74 32.25 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 112.463 0.542 . . . . 0.23000000000000001 112.463 -179.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -56.63 -28.26 56.16 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 121.13 -0.557 . . . . 0.23000000000000001 112.944 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -73.96 -40.91 62.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.888 0.375 . . . . 0.23000000000000001 110.372 179.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.98 -36.41 83.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.053 -0.522 . . . . 0.23000000000000001 111.032 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.1 t -75.04 -41.4 45.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.072 -0.513 . . . . 0.23000000000000001 110.821 179.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 54.3 p -60.45 -45.66 92.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.955 -0.566 . . . . 0.23000000000000001 111.291 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 54.8 mt -65.84 -44.66 84.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.275 -0.42 . . . . 0.23000000000000001 111.611 -179.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 12.6 mt -66.74 -36.54 82.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.23 -0.441 . . . . 0.23000000000000001 112.105 -178.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 54.9 mttm -75.31 -38.56 60.21 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.632 0.604 . . . . 0.23000000000000001 112.632 -178.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 11.5 t -70.94 -24.85 62.52 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.958 0.725 . . . . 0.23000000000000001 112.958 -178.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.405 ' CZ ' ' HB2' ' A' ' 70' ' ' ASN . 8.5 m-85 -47.82 173.55 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 113.205 0.817 . . . . 0.23000000000000001 113.205 -178.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 6.9 mm-40 -81.38 -145.58 0.06 Allowed 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 115.277 -0.874 . . . . 0.23000000000000001 110.517 -179.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -79.36 -66.78 0.83 Allowed 'General case' 0 C--N 1.345 0.401 0 CA-C-N 118.911 0.778 . . . . 0.23000000000000001 110.721 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -76.91 126.37 30.86 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.27 -0.423 . . . . 0.23000000000000001 110.645 179.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 21.2 t -119.27 123.23 70.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.118 -0.492 . . . . 0.23000000000000001 110.97 -179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -100.68 106.46 17.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.23000000000000001 110.578 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -100.36 149.92 23.13 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.071 -0.513 . . . . 0.23000000000000001 111.47 -179.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 17.5 mm -108.54 124.87 65.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.82 -0.627 . . . . 0.23000000000000001 109.38 178.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 43.4 pt -129.23 165.17 29.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.735 0.302 . . . . 0.23000000000000001 111.255 -179.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 14.6 t -150.38 154.57 8.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.009 0.433 . . . . 0.23000000000000001 111.689 -179.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -108.49 112.76 25.31 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 108.681 -0.859 . . . . 0.23000000000000001 108.681 177.694 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -55.41 135.89 49.94 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 112.534 0.568 . . . . 0.23000000000000001 112.534 -178.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 16.4 m -146.74 114.83 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 CA-C-N 115.658 -0.701 . . . . 0.23000000000000001 111.016 179.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.9 m -100.2 85.06 2.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.867 0.365 . . . . 0.23000000000000001 110.852 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 57.3 p . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.211 -0.9 . . . . 0.23000000000000001 110.906 179.981 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 301' ' ' THR . . . . . . . . . . . . . 12.6 m . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 120.886 0.374 . . . . 0.23000000000000001 111.269 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 302' ' ' GLY . . . . . . . . . . . . . . . 69.02 46.69 58.13 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.96 -0.638 . . . . 0.23000000000000001 112.847 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 303' ' ' TRP . . . . . . . . . . . . . 27.1 p-90 -90.7 -27.91 18.67 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 121.211 -0.196 . . . . 0.23000000000000001 111.071 179.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 4.9 pm0 -77.53 158.82 29.7 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.674 0.273 . . . . 0.23000000000000001 110.492 179.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 305' ' ' THR . . . . . . . . . . . . . 5.7 m -132.97 121.79 23.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.39 -0.368 . . . . 17.879999999999999 110.888 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 306' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -85.58 118.55 25.16 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.23 -0.441 . . . . 0.23000000000000001 110.99 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 307' ' ' VAL . . . . . . . . . . . . . 18.3 m . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.21 -0.9 . . . . 16.109999999999999 111.139 179.953 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.226 0 N-CA-C 112.423 -0.271 . . . . 0.23000000000000001 112.423 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.3 t -160.44 33.08 0.16 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.871 0.367 . . . . 0.23000000000000001 110.889 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 60.6 m80 -93.56 145.19 24.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 0.23000000000000001 110.791 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.9 ptp -94.97 150.27 20.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.285 -0.416 . . . . 0.23000000000000001 111.009 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 70.99 79.37 0.38 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.964 -0.636 . . . . 0.23000000000000001 112.818 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -165.56 33.7 0.05 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.937 0.399 . . . . 0.23000000000000001 110.874 179.7 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.6 mp0 -98.65 61.53 1.35 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.269 0.557 . . . . 0.23000000000000001 110.405 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.6 mt -148.88 136.07 20.09 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.815 -0.63 . . . . 0.23000000000000001 110.792 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -92.1 75.72 5.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 0.23000000000000001 110.655 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 60.5 mmtt -143.83 -178.8 6.1 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.022 -0.535 . . . . 0.23000000000000001 110.697 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -148.69 100.44 3.1 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.297 -0.411 . . . . 0.23000000000000001 110.914 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -90.15 118.54 29.76 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.155 -0.475 . . . . 0.23000000000000001 111.097 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.419 HG22 HD11 ' A' ' 13' ' ' ILE . 0.2 OUTLIER -139.82 155.29 24.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.958 0.409 . . . . 0.23000000000000001 111.544 -179.893 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.74 167.13 10.08 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.17 -0.468 . . . . 0.23000000000000001 111.448 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 22.4 t -146.82 153.5 12.6 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 115.933 -0.576 . . . . 0.23000000000000001 110.966 179.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.05 118.65 22.88 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.238 -0.437 . . . . 0.23000000000000001 110.278 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.3 t -125.43 130.63 72.78 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-O 120.924 0.392 . . . . 0.23000000000000001 111.453 -179.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -100.02 146.11 27.11 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.912 -0.586 . . . . 0.23000000000000001 110.067 179.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.64 76.59 9.51 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.863 0.363 . . . . 0.23000000000000001 110.492 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -140.8 85.65 12.47 Favored Pre-proline 0 CA--C 1.539 0.528 0 CA-C-N 116.334 -0.393 . . . . 0.23000000000000001 111.706 -179.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -82.15 -30.67 4.76 Favored 'Cis proline' 0 C--N 1.363 1.338 0 CA-C-N 119.409 0.825 . . . . 0.23000000000000001 113.172 0.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -138.19 -178.54 5.32 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.872 0.367 . . . . 0.23000000000000001 111.361 -179.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.2 mp -62.09 -61.89 2.16 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.047 -0.524 . . . . 0.23000000000000001 110.83 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 103.79 34.87 3.65 Favored Glycine 0 CA--C 1.52 0.38 0 C-N-CA 120.825 -0.702 . . . . 0.23000000000000001 113.783 179.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -163.57 145.95 9.73 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 117.254 0.527 . . . . 0.23000000000000001 111.137 179.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.8 p -100.63 150.4 22.76 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.001 -0.545 . . . . 0.23000000000000001 111.056 -179.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 25.4 pt -117.23 147.63 20.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.134 -0.484 . . . . 0.23000000000000001 110.867 179.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 12.9 p -138.35 153.92 48.96 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.77 0.319 . . . . 0.23000000000000001 111.293 -179.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 113.47 -158.92 13.97 Favored Glycine 0 C--N 1.332 0.323 0 C-N-CA 120.977 -0.63 . . . . 0.23000000000000001 113.519 179.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 109.47 153.38 14.91 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 121.234 -0.507 . . . . 0.23000000000000001 112.022 -179.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 17.9 t -76.82 98.39 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-O 121.081 0.467 . . . . 0.23000000000000001 110.522 -179.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 96.0 10.25 56.42 Favored Glycine 0 CA--C 1.528 0.866 0 CA-C-N 115.657 -0.701 . . . . 0.23000000000000001 113.349 -179.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.6 -158.28 32.66 Favored Glycine 0 C--N 1.342 0.865 0 C-N-CA 120.708 -0.758 . . . . 0.23000000000000001 112.712 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -59.61 -27.63 66.48 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 112.327 0.491 . . . . 0.23000000000000001 112.327 -179.067 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 117.57 -167.02 12.66 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 120.743 -0.741 . . . . 0.23000000000000001 112.662 -179.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -145.44 125.92 7.27 Favored Pre-proline 0 CA--C 1.533 0.291 0 O-C-N 122.928 -0.16 . . . . 0.23000000000000001 110.871 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -92.31 24.7 0.48 Allowed 'Trans proline' 0 C--N 1.355 0.913 0 C-N-CA 122.122 1.881 . . . . 0.23000000000000001 112.875 179.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -124.49 -49.63 1.78 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 120.793 0.33 . . . . 0.23000000000000001 110.639 179.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -114.83 130.98 23.69 Favored Pre-proline 0 CA--C 1.533 0.301 0 CA-C-N 116.148 -0.478 . . . . 0.23000000000000001 110.455 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -85.0 -44.85 0.05 OUTLIER 'Trans proline' 0 C--N 1.356 0.927 0 C-N-CA 121.965 1.776 . . . . 0.23000000000000001 113.22 -179.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -89.6 -3.95 58.05 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.06 0.763 . . . . 0.23000000000000001 113.06 -179.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -109.94 125.26 52.66 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 118.156 0.435 . . . . 0.23000000000000001 110.576 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -109.98 31.29 5.97 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.385 -0.37 . . . . 0.23000000000000001 111.647 -179.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -76.49 -146.62 2.04 Favored Glycine 0 CA--C 1.519 0.34 0 C-N-CA 120.811 -0.709 . . . . 0.23000000000000001 111.98 179.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 14.7 mm -124.13 135.36 63.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-N 116.934 0.367 . . . . 0.23000000000000001 110.469 179.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.427 ' CD1' ' N ' ' A' ' 46' ' ' PHE . 7.7 m-85 -132.99 151.98 52.01 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.451 -0.34 . . . . 0.23000000000000001 111.16 -179.586 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 21.8 t -97.34 74.23 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 CA-C-O 121.058 0.456 . . . . 0.23000000000000001 110.797 180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 8.0 t -31.44 -53.23 0.23 Allowed 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 115.057 1.503 . . . . 0.23000000000000001 115.057 -178.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.9 -178.92 7.14 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.155 0.502 . . . . 0.23000000000000001 111.987 -179.457 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.0 t -134.73 150.75 30.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 115.549 -0.75 . . . . 0.23000000000000001 110.61 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -104.86 -68.23 0.04 OUTLIER Pre-proline 0 CA--C 1.538 0.495 0 N-CA-C 111.728 0.269 . . . . 0.23000000000000001 111.728 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -79.25 119.39 4.2 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 121.781 1.654 . . . . 0.23000000000000001 112.275 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -75.15 68.33 1.9 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.931 0.396 . . . . 0.23000000000000001 110.872 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -161.19 -66.64 0.02 OUTLIER Glycine 0 CA--C 1.529 0.936 0 C-N-CA 120.651 -0.785 . . . . 0.23000000000000001 113.821 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -58.32 -76.44 0.02 OUTLIER 'Trans proline' 0 C--N 1.356 0.949 0 C-N-CA 122.166 1.911 . . . . 0.23000000000000001 113.452 -178.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -115.32 50.95 0.95 Allowed 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.289 0.566 . . . . 0.23000000000000001 111.298 -179.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.4 t -112.85 -63.37 1.45 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.823 -0.626 . . . . 0.23000000000000001 110.45 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.82 -13.64 61.78 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.125 -0.489 . . . . 0.23000000000000001 111.569 179.313 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 34.6 mt -96.61 -54.43 3.24 Favored 'General case' 0 C--N 1.345 0.388 0 O-C-N 122.091 -0.381 . . . . 0.23000000000000001 111.101 179.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 56.5 mt -91.93 146.86 23.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.07 -0.513 . . . . 0.23000000000000001 111.453 -179.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -118.25 137.47 24.65 Favored Pre-proline 0 CA--C 1.537 0.48 0 CA-C-N 116.156 -0.474 . . . . 0.23000000000000001 110.016 178.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.82 131.01 43.57 Favored 'Trans proline' 0 C--N 1.361 1.195 0 C-N-CA 122.341 2.027 . . . . 0.23000000000000001 113.931 -178.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 96.73 16.59 35.88 Favored Glycine 0 CA--C 1.523 0.576 0 CA-C-N 115.637 -0.71 . . . . 0.23000000000000001 113.816 178.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -81.65 -169.1 2.16 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 117.379 0.589 . . . . 0.23000000000000001 111.298 -179.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 45.8 tttp -139.31 124.57 19.05 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 116.406 -0.361 . . . . 0.23000000000000001 110.28 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 33.9 mt -89.02 115.16 28.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.382 -0.372 . . . . 0.23000000000000001 110.615 -179.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 23.9 mm -94.19 -38.17 9.01 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 116.097 -0.501 . . . . 0.23000000000000001 112.126 -178.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.08 150.89 31.23 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.178 0.514 . . . . 0.23000000000000001 112.096 -179.025 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -145.56 124.68 12.87 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 115.722 -0.672 . . . . 0.23000000000000001 110.942 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.6 m120 43.95 31.7 0.54 Allowed 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.603 0.964 . . . . 0.23000000000000001 113.603 179.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 97.6 -6.0 62.64 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 120.78 -0.724 . . . . 0.23000000000000001 114.068 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -102.03 123.06 45.27 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 117.83 0.815 . . . . 0.23000000000000001 110.775 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 7.9 m -71.43 126.8 30.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.363 -0.38 . . . . 0.23000000000000001 110.927 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -99.75 6.64 45.46 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 112.697 0.629 . . . . 0.23000000000000001 112.697 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 7.3 tp -83.85 120.06 34.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 118.165 0.438 . . . . 0.23000000000000001 110.896 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 63.3 76.17 0.37 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.032 0.444 . . . . 0.23000000000000001 111.072 -179.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 9.3 pt -150.19 164.77 3.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.917 -0.583 . . . . 0.23000000000000001 110.817 179.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.7 mp0 -78.75 148.52 32.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.139 0.495 . . . . 0.23000000000000001 111.454 -179.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 23.9 t60 -53.47 -54.13 41.44 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.645 -0.707 . . . . 0.23000000000000001 112.282 -179.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -55.33 -27.43 47.15 Favored Glycine 0 CA--C 1.52 0.373 0 C-N-CA 121.147 -0.549 . . . . 0.23000000000000001 113.163 -179.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.4 tp60 -73.57 -39.02 64.98 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.028 0.442 . . . . 0.23000000000000001 110.544 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.11 -55.91 12.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.88 -0.6 . . . . 0.23000000000000001 111.933 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 17.2 t -58.29 -44.0 87.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.436 -0.347 . . . . 0.23000000000000001 111.787 -179.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.6 t -60.39 -39.24 86.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.42 -0.355 . . . . 0.23000000000000001 111.596 -179.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 30.2 mt -67.52 -43.61 80.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.391 -0.368 . . . . 0.23000000000000001 111.825 -179.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.412 ' HA ' ' CD2' ' A' ' 89' ' ' PHE . 22.2 mt -66.66 -42.07 87.18 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.062 0.393 . . . . 0.23000000000000001 112.062 -179.022 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 15.1 mttm -64.48 -41.47 96.47 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.106 0.41 . . . . 0.23000000000000001 112.106 -178.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 9.7 t -64.11 -22.61 67.0 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.548 0.573 . . . . 0.23000000000000001 112.548 -178.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.412 ' CD2' ' HA ' ' A' ' 86' ' ' LEU . 21.4 m-85 -60.81 131.0 49.29 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.951 0.405 . . . . 0.23000000000000001 110.495 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -65.77 -105.34 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.959 0 N-CA-C 112.661 0.615 . . . . 0.23000000000000001 112.661 -178.388 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -88.4 -83.04 0.22 Allowed 'General case' 0 C--N 1.35 0.618 0 CA-C-N 119.422 1.01 . . . . 0.23000000000000001 113.321 -178.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -71.22 162.17 29.87 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 121.128 0.489 . . . . 0.23000000000000001 111.658 -178.652 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 19.9 t -151.41 112.91 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.601 -0.727 . . . . 0.23000000000000001 110.612 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.1 mp0 -89.01 122.51 32.43 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 110.005 -0.369 . . . . 0.23000000000000001 110.005 179.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 14.1 mt -121.56 143.05 49.51 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 112.544 0.572 . . . . 0.23000000000000001 112.544 -178.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 42.4 mt -114.07 129.28 70.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 108.742 -0.836 . . . . 0.23000000000000001 108.742 177.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 43.5 pt -134.71 172.99 15.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 112.424 0.527 . . . . 0.23000000000000001 112.424 -178.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 20.2 t -147.25 151.66 13.63 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 CA-C-N 115.739 -0.664 . . . . 0.23000000000000001 110.731 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -123.2 113.51 19.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.312 -0.403 . . . . 0.23000000000000001 110.53 179.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -66.16 117.9 9.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.144 -0.48 . . . . 0.23000000000000001 111.336 -179.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 22.1 t -108.69 117.96 55.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.046 -0.524 . . . . 0.23000000000000001 110.487 179.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 10.5 t -90.73 120.72 32.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.346 -0.388 . . . . 0.23000000000000001 111.051 -179.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 20.2 m . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.182 -0.913 . . . . 0.23000000000000001 110.761 179.912 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 301' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.394 0 CA-C-O 120.808 0.337 . . . . 0.23000000000000001 111.071 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 302' ' ' GLY . . . . . . . . . . . . . . . 106.25 86.62 1.9 Allowed Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.996 -0.621 . . . . 0.23000000000000001 112.255 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 303' ' ' TRP . . . . . . . . . . . . . 61.1 p-90 -94.11 -30.49 14.62 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.662 0.267 . . . . 0.23000000000000001 111.33 -179.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -90.41 132.32 35.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.81 0.338 . . . . 0.23000000000000001 111.128 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 305' ' ' THR . . . . . . . . . . . . . 7.4 m -109.38 134.69 51.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.009 -0.541 . . . . 17.879999999999999 110.613 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 306' ' ' TRP . . . . . . . . . . . . . 83.4 m95 -97.43 131.71 43.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.885 0.374 . . . . 0.23000000000000001 111.058 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 307' ' ' VAL . . . . . . . . . . . . . 24.0 m . . . . . 0 C--O 1.25 1.125 0 CA-C-O 118.271 -0.871 . . . . 16.109999999999999 111.153 -179.876 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.162 0 N-CA-C 112.517 -0.233 . . . . 0.23000000000000001 112.517 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.3 m -133.31 48.51 2.38 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.395 0.617 . . . . 0.23000000000000001 110.644 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 13.7 m-70 -92.64 149.5 21.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.913 -0.585 . . . . 0.23000000000000001 110.987 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 8.8 ptm -165.37 123.26 1.58 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.364 -0.38 . . . . 0.23000000000000001 111.063 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 106.02 -32.01 7.8 Favored Glycine 0 C--N 1.333 0.369 0 C-N-CA 121.001 -0.618 . . . . 0.23000000000000001 112.883 179.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -69.75 -30.64 68.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.596 0.236 . . . . 0.23000000000000001 111.229 -179.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -115.02 72.29 0.79 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 121.117 0.484 . . . . 0.23000000000000001 110.732 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 14.0 tp -152.85 141.03 20.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.059 -0.519 . . . . 0.23000000000000001 110.829 -179.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -167.29 37.85 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 120.93 0.395 . . . . 0.23000000000000001 111.63 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 16.9 mtpt -75.29 116.22 15.78 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.349 -0.387 . . . . 0.23000000000000001 110.886 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.65 108.22 20.49 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.915 0.388 . . . . 0.23000000000000001 111.962 -179.258 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -88.05 107.43 18.74 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.063 -0.517 . . . . 0.23000000000000001 111.5 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.404 HG22 HD11 ' A' ' 13' ' ' ILE . 0.2 OUTLIER -114.42 154.8 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 CA-C-N 116.029 -0.532 . . . . 0.23000000000000001 111.934 179.934 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 1.1 ttt85 -93.09 165.45 12.83 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.579 -0.737 . . . . 0.23000000000000001 111.628 -179.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 53.9 t -141.1 118.59 8.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 116.18 -0.464 . . . . 0.23000000000000001 111.241 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -105.48 109.29 21.21 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 110.035 -0.357 . . . . 0.23000000000000001 110.035 178.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.0 t -121.37 131.81 72.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-O 120.883 0.373 . . . . 0.23000000000000001 111.517 -179.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -92.04 164.07 13.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.079 -0.51 . . . . 0.23000000000000001 110.162 179.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.32 74.93 1.05 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 121.337 0.589 . . . . 0.23000000000000001 110.949 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -141.61 84.71 12.06 Favored Pre-proline 0 CA--C 1.54 0.593 0 CA-C-N 116.134 -0.485 . . . . 0.23000000000000001 111.419 -179.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -83.73 -23.92 11.87 Favored 'Cis proline' 0 C--N 1.364 1.352 0 CA-C-N 119.444 0.837 . . . . 0.23000000000000001 113.009 0.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -139.14 -169.07 2.57 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 120.692 0.282 . . . . 0.23000000000000001 110.986 -179.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 5.2 mp -67.47 -49.43 63.61 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-O 120.807 0.337 . . . . 0.23000000000000001 110.228 179.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 106.22 24.32 6.9 Favored Glycine 0 C--N 1.333 0.364 0 C-N-CA 120.972 -0.633 . . . . 0.23000000000000001 113.371 179.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -160.52 153.87 21.99 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 117.14 0.47 . . . . 0.23000000000000001 111.28 179.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.8 p -104.03 156.77 17.59 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.083 -0.508 . . . . 0.23000000000000001 110.977 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 30.9 pt -122.91 149.39 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 116.346 -0.388 . . . . 0.23000000000000001 111.1 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.4 m -151.29 169.74 21.22 Favored 'General case' 0 CA--C 1.53 0.212 0 CA-C-N 116.238 -0.437 . . . . 0.23000000000000001 111.144 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.66 21.49 26.24 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 121.076 -0.583 . . . . 0.23000000000000001 114.164 178.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -60.47 151.96 38.89 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.655 -0.783 . . . . 0.23000000000000001 112.343 179.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 58.5 t -78.37 106.91 9.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.028 0.442 . . . . 0.23000000000000001 110.281 -179.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 94.24 -5.42 71.38 Favored Glycine 0 CA--C 1.53 0.994 0 CA-C-N 115.752 -0.658 . . . . 0.23000000000000001 113.635 -178.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -85.89 -139.87 5.36 Favored Glycine 0 C--N 1.345 1.075 0 CA-C-N 117.804 0.802 . . . . 0.23000000000000001 113.236 -179.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 8.6 mmt180 -75.75 -17.91 59.73 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 112.756 0.65 . . . . 0.23000000000000001 112.756 -178.106 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 99.25 -150.12 19.15 Favored Glycine 0 C--N 1.339 0.749 0 C-N-CA 120.508 -0.853 . . . . 0.23000000000000001 112.477 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -166.57 132.95 1.93 Allowed Pre-proline 0 CA--C 1.535 0.393 0 CA-C-N 116.626 0.213 . . . . 0.23000000000000001 110.99 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -90.41 25.7 0.53 Allowed 'Trans proline' 0 C--N 1.36 1.135 0 C-N-CA 122.193 1.929 . . . . 0.23000000000000001 113.689 -179.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -110.65 -54.69 2.56 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.755 0.312 . . . . 0.23000000000000001 110.785 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.408 ' HG3' ' CE2' ' A' ' 46' ' ' PHE . 4.9 mmp_? -108.41 144.76 30.14 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-N 116.309 -0.405 . . . . 0.23000000000000001 110.311 179.558 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -89.17 -51.9 0.02 OUTLIER 'Trans proline' 0 C--N 1.357 1.026 0 C-N-CA 121.899 1.733 . . . . 0.23000000000000001 113.853 -178.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -99.28 -2.47 36.44 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 113.359 0.874 . . . . 0.23000000000000001 113.359 -178.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -95.07 117.92 31.0 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 118.264 0.484 . . . . 0.23000000000000001 110.601 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -101.08 37.01 1.84 Allowed 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.304 -0.407 . . . . 0.23000000000000001 111.958 -179.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.4 -168.03 38.52 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.798 -0.715 . . . . 0.23000000000000001 112.466 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.2 mm -102.83 129.21 54.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 109.478 -0.564 . . . . 0.23000000000000001 109.478 178.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.413 ' CD1' ' N ' ' A' ' 46' ' ' PHE . 1.2 m-85 -129.99 149.49 51.69 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.839 0.352 . . . . 0.23000000000000001 110.925 -179.154 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 38.8 t -89.77 79.07 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-N 116.212 -0.449 . . . . 0.23000000000000001 111.306 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 9.9 t -37.82 -53.31 1.3 Allowed 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 114.483 1.29 . . . . 0.23000000000000001 114.483 -178.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.5 ptt-85 -160.3 165.49 31.22 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 118.229 0.468 . . . . 0.23000000000000001 112.111 -179.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 12.1 t -122.98 148.38 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-N 115.717 -0.674 . . . . 0.23000000000000001 110.805 -179.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -100.21 -68.41 0.04 OUTLIER Pre-proline 0 CA--C 1.538 0.487 0 CA-C-O 119.738 -0.172 . . . . 0.23000000000000001 111.129 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -80.78 117.22 3.28 Favored 'Trans proline' 0 C--N 1.358 1.07 0 C-N-CA 121.715 1.61 . . . . 0.23000000000000001 112.581 179.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -75.57 70.55 2.41 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 120.954 0.407 . . . . 0.23000000000000001 110.784 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -162.8 -65.92 0.02 OUTLIER Glycine 0 CA--C 1.529 0.937 0 C-N-CA 120.789 -0.72 . . . . 0.23000000000000001 113.354 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -58.27 -78.26 0.02 OUTLIER 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 122.118 1.878 . . . . 0.23000000000000001 112.924 -179.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -108.19 46.88 0.93 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.47 0.652 . . . . 0.23000000000000001 110.582 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 91.7 p -101.95 -61.43 1.39 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.556 -0.747 . . . . 0.23000000000000001 110.193 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -71.77 -7.12 46.24 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 115.872 -0.604 . . . . 0.23000000000000001 112.206 179.115 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 66.3 mt -95.57 -59.61 1.84 Allowed 'General case' 0 C--N 1.344 0.332 0 CA-C-N 118.244 0.474 . . . . 0.23000000000000001 111.541 -179.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 2.7 mt -95.63 144.31 26.18 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.654 0.264 . . . . 0.23000000000000001 111.452 -179.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.1 pm0 -112.35 142.73 27.5 Favored Pre-proline 0 CA--C 1.538 0.488 0 CA-C-N 116.284 -0.416 . . . . 0.23000000000000001 110.382 178.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -50.93 130.32 30.92 Favored 'Trans proline' 0 C--N 1.359 1.105 0 C-N-CA 122.206 1.937 . . . . 0.23000000000000001 113.667 -179.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 82.59 24.73 52.85 Favored Glycine 0 C--N 1.333 0.386 0 CA-C-N 115.853 -0.612 . . . . 0.23000000000000001 113.637 178.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 20.6 p30 -86.98 -171.79 3.68 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 117.025 0.413 . . . . 0.23000000000000001 110.793 -179.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 66.5 tttt -140.33 128.83 22.76 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 112.109 0.411 . . . . 0.23000000000000001 112.109 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 4.0 mp -93.59 118.82 40.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 CA-C-N 115.788 -0.642 . . . . 0.23000000000000001 109.833 179.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 23.7 mm -92.67 -33.97 5.74 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 CA-C-N 116.427 -0.351 . . . . 0.23000000000000001 111.86 -178.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 -146.88 148.85 32.24 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.95 0.405 . . . . 0.23000000000000001 111.456 -179.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -138.5 114.84 10.36 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.986 -0.552 . . . . 0.23000000000000001 111.509 -179.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 49.32 29.11 2.57 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 113.11 0.781 . . . . 0.23000000000000001 113.11 179.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 101.03 -22.65 38.55 Favored Glycine 0 CA--C 1.521 0.458 0 C-N-CA 120.787 -0.721 . . . . 0.23000000000000001 113.178 179.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -89.16 127.95 35.76 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 117.099 0.449 . . . . 0.23000000000000001 110.696 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.2 m -65.93 130.35 42.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 0.23000000000000001 110.974 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -104.65 21.58 16.59 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.231 -0.44 . . . . 0.23000000000000001 111.662 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 6.6 tp -101.68 140.53 20.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 O-C-N 122.249 -0.282 . . . . 0.23000000000000001 110.99 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 34.7 m-20 65.54 10.72 6.89 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 112.905 0.706 . . . . 0.23000000000000001 112.905 -178.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 17.3 pt -89.12 156.09 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 121.334 0.588 . . . . 0.23000000000000001 112.584 -178.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -80.84 153.6 27.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.118 -0.946 . . . . 0.23000000000000001 110.615 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 9.3 t60 -49.8 -55.26 14.78 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 112.284 0.476 . . . . 0.23000000000000001 112.284 -179.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -54.83 -28.0 45.83 Favored Glycine 0 C--N 1.335 0.522 0 C-N-CA 121.039 -0.6 . . . . 0.23000000000000001 113.351 -179.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -72.78 -41.86 64.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.943 0.401 . . . . 0.23000000000000001 110.484 179.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.78 -57.4 8.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.039 -0.528 . . . . 0.23000000000000001 111.742 -179.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 15.4 t -56.7 -43.95 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-O 120.871 0.367 . . . . 0.23000000000000001 111.595 -179.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 38.0 m -60.79 -43.18 98.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.118 -0.492 . . . . 0.23000000000000001 111.438 -179.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 12.8 mt -65.51 -47.39 76.13 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.39 -0.368 . . . . 0.23000000000000001 111.577 -179.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.409 ' HA ' ' CD2' ' A' ' 89' ' ' PHE . 26.5 mt -64.37 -41.77 96.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.44 -0.345 . . . . 0.23000000000000001 111.661 -179.033 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 36.8 mmtt -64.23 -41.71 96.88 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.626 0.602 . . . . 0.23000000000000001 112.626 -178.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 11.3 t -72.02 -25.04 61.66 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 113.459 0.911 . . . . 0.23000000000000001 113.459 -177.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.409 ' CD2' ' HA ' ' A' ' 86' ' ' LEU . 14.8 m-85 -53.81 156.6 2.71 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.53 0.681 . . . . 0.23000000000000001 112.741 -178.476 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -61.72 -145.55 0.0 OUTLIER 'General case' 0 CA--C 1.556 1.179 0 CA-C-N 115.127 -0.942 . . . . 0.23000000000000001 111.672 -178.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -81.25 -59.52 2.61 Favored 'General case' 0 C--N 1.35 0.62 0 CA-C-N 118.859 0.754 . . . . 0.23000000000000001 111.829 -178.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.15 135.19 33.39 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 110.015 -0.365 . . . . 0.23000000000000001 110.015 -179.644 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 12.0 t -127.6 124.82 64.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.865 0.364 . . . . 0.23000000000000001 111.484 -179.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -101.03 114.87 29.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.169 -0.469 . . . . 0.23000000000000001 110.25 179.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 5.7 mp -113.58 160.84 18.11 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.082 0.468 . . . . 0.23000000000000001 111.929 -179.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 22.9 mm -118.67 129.73 74.51 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-N 115.632 -0.713 . . . . 0.23000000000000001 110.263 179.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 7.1 pt -134.14 166.79 27.8 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-O 120.577 0.227 . . . . 0.23000000000000001 111.592 -179.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.3 t -144.88 155.27 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-O 121.203 0.525 . . . . 0.23000000000000001 111.873 -179.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.26 110.15 20.23 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.57 -0.741 . . . . 0.23000000000000001 109.361 178.798 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -70.54 143.18 51.69 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.025 0.441 . . . . 0.23000000000000001 112.164 -178.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 17.8 m -150.71 108.09 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.748 -0.66 . . . . 0.23000000000000001 110.955 179.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 22.9 t -156.4 135.6 12.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.871 0.367 . . . . 0.23000000000000001 111.089 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 19.9 m . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.174 -0.917 . . . . 0.23000000000000001 110.856 179.874 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 301' ' ' THR . . . . . . . . . . . . . 1.8 p . . . . . 0 N--CA 1.487 1.4 0 CA-C-O 120.746 0.308 . . . . 0.23000000000000001 111.222 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 302' ' ' GLY . . . . . . . . . . . . . . . 147.98 -76.63 0.25 Allowed Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.834 -0.698 . . . . 0.23000000000000001 112.646 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 303' ' ' TRP . . . . . . . . . . . . . 11.7 p-90 -115.21 -53.09 2.65 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.719 0.295 . . . . 0.23000000000000001 111.143 -179.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.79 143.49 41.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.853 0.359 . . . . 0.23000000000000001 111.101 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 305' ' ' THR . . . . . . . . . . . . . 11.5 m -119.05 130.66 55.75 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.017 -0.538 . . . . 17.879999999999999 110.611 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 306' ' ' TRP . . . . . . . . . . . . . 82.3 m95 -90.68 105.35 17.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.895 0.378 . . . . 0.23000000000000001 110.904 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 307' ' ' VAL . . . . . . . . . . . . . 15.9 m . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.248 -0.882 . . . . 16.109999999999999 111.138 179.924 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.201 0 N-CA-C 112.504 -0.238 . . . . 0.23000000000000001 112.504 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.2 m -96.29 167.1 11.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.757 0.313 . . . . 0.23000000000000001 110.864 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 22.3 m80 -79.92 130.67 35.48 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.272 -0.422 . . . . 0.23000000000000001 110.781 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 6.2 mtt -85.91 111.06 19.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.227 -0.442 . . . . 0.23000000000000001 110.975 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -110.87 -108.56 3.08 Favored Glycine 0 C--N 1.33 0.242 0 C-N-CA 121.066 -0.588 . . . . 0.23000000000000001 112.437 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 40.8 m80 -149.58 142.5 24.79 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.678 0.275 . . . . 0.23000000000000001 110.784 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -110.46 36.38 3.1 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.23 -0.441 . . . . 0.23000000000000001 110.814 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.2 mp -129.34 176.99 7.5 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.102 -0.499 . . . . 0.23000000000000001 110.656 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -107.71 49.74 0.8 Allowed 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 121.218 0.533 . . . . 0.23000000000000001 111.619 -179.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -98.97 106.06 18.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.459 . . . . 0.23000000000000001 109.977 179.316 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.38 179.58 4.15 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.344 -0.389 . . . . 0.23000000000000001 111.511 -178.747 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.59 110.6 5.21 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.376 -0.375 . . . . 0.23000000000000001 111.048 179.579 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -105.87 160.64 5.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.956 -0.566 . . . . 0.23000000000000001 111.377 -179.071 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.72 151.07 26.69 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 115.815 -0.629 . . . . 0.23000000000000001 111.129 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.3 t -137.29 137.11 46.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.198 -0.455 . . . . 0.23000000000000001 110.837 179.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.52 111.46 24.18 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.382 -0.372 . . . . 0.23000000000000001 110.783 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.8 t -105.47 116.83 50.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.26 -0.427 . . . . 0.23000000000000001 110.812 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -94.61 116.92 29.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.317 -0.401 . . . . 0.23000000000000001 110.853 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 24.5 mttt -71.57 127.37 32.35 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.479 0.656 . . . . 0.23000000000000001 110.934 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -172.18 83.09 0.45 Allowed Pre-proline 0 CA--C 1.539 0.555 0 CA-C-N 115.89 -0.596 . . . . 0.23000000000000001 110.872 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -85.85 -8.78 48.08 Favored 'Cis proline' 0 C--N 1.366 1.448 0 CA-C-N 119.426 0.831 . . . . 0.23000000000000001 113.786 0.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -137.29 -177.53 4.81 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.789 0.328 . . . . 0.23000000000000001 111.264 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.5 mp -63.03 -57.15 11.64 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.14 -0.482 . . . . 0.23000000000000001 111.105 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 102.29 29.02 6.18 Favored Glycine 0 C--N 1.337 0.631 0 C-N-CA 120.82 -0.705 . . . . 0.23000000000000001 113.675 178.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 36.0 p90 -157.26 145.31 19.18 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 117.131 0.465 . . . . 0.23000000000000001 110.825 179.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.5 p -98.85 149.7 22.64 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.168 -0.469 . . . . 0.23000000000000001 111.608 -179.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 21.0 pt -121.7 147.8 25.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.763 -0.653 . . . . 0.23000000000000001 110.288 179.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 34.1 t -143.68 163.38 33.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.839 0.352 . . . . 0.23000000000000001 111.078 -179.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 103.51 -146.67 16.51 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 121.042 -0.599 . . . . 0.23000000000000001 112.61 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.12 156.57 29.02 Favored Glycine 0 N--CA 1.452 -0.233 0 C-N-CA 120.966 -0.635 . . . . 0.23000000000000001 112.228 -179.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 17.3 t -78.64 101.61 4.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.872 0.368 . . . . 0.23000000000000001 110.773 -179.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 92.85 1.55 67.67 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 120.979 -0.629 . . . . 0.23000000000000001 113.746 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -82.13 -155.38 15.82 Favored Glycine 0 C--N 1.341 0.831 0 CA-C-N 117.965 0.882 . . . . 0.23000000000000001 113.038 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 73.7 mtt180 -63.64 -27.92 69.56 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.638 0.236 . . . . 0.23000000000000001 111.638 -179.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.54 168.32 38.41 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 120.608 -0.805 . . . . 0.23000000000000001 112.794 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -137.11 139.13 27.42 Favored Pre-proline 0 CA--C 1.534 0.359 0 O-C-N 123.004 -0.115 . . . . 0.23000000000000001 110.804 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -92.53 27.3 0.37 Allowed 'Trans proline' 0 C--N 1.358 1.078 0 C-N-CA 122.396 2.064 . . . . 0.23000000000000001 113.291 -179.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -100.77 -54.1 2.9 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.71 0.291 . . . . 0.23000000000000001 110.956 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -114.17 141.45 26.39 Favored Pre-proline 0 CA--C 1.533 0.295 0 CA-C-N 116.356 -0.384 . . . . 0.23000000000000001 110.606 179.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -87.59 -50.32 0.03 OUTLIER 'Trans proline' 0 C--N 1.358 1.049 0 C-N-CA 121.992 1.794 . . . . 0.23000000000000001 113.66 -178.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -87.44 -11.47 49.0 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 112.913 0.709 . . . . 0.23000000000000001 112.913 -179.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -101.31 115.99 31.77 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 117.984 0.356 . . . . 0.23000000000000001 110.793 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 30.9 p-10 -104.42 44.63 1.01 Allowed 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 121.211 0.529 . . . . 0.23000000000000001 110.712 179.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -92.42 -159.45 35.19 Favored Glycine 0 C--N 1.332 0.328 0 CA-C-N 115.826 -0.625 . . . . 0.23000000000000001 112.71 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.1 mm -107.5 131.94 56.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 110.312 -0.255 . . . . 0.23000000000000001 110.312 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -131.58 148.66 52.63 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.816 0.341 . . . . 0.23000000000000001 111.307 -179.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 24.0 t -89.78 73.95 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-O 121.158 0.504 . . . . 0.23000000000000001 111.014 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.6 t -38.4 -52.63 1.55 Allowed 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 114.444 1.276 . . . . 0.23000000000000001 114.444 -178.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -158.02 162.37 38.14 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 121.108 0.48 . . . . 0.23000000000000001 112.116 -179.546 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 15.7 t -120.93 149.55 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 115.605 -0.725 . . . . 0.23000000000000001 110.47 179.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 18.8 mm-40 -104.35 -67.77 0.04 OUTLIER Pre-proline 0 CA--C 1.538 0.513 0 N-CA-C 111.941 0.348 . . . . 0.23000000000000001 111.941 -179.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -76.87 124.5 7.48 Favored 'Trans proline' 0 C--N 1.357 1.004 0 C-N-CA 121.666 1.577 . . . . 0.23000000000000001 112.79 -179.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.85 63.4 3.56 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.21 -0.45 . . . . 0.23000000000000001 111.142 -179.718 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -158.35 -66.97 0.01 OUTLIER Glycine 0 CA--C 1.526 0.774 0 C-N-CA 120.57 -0.824 . . . . 0.23000000000000001 113.643 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -57.58 -77.07 0.02 OUTLIER 'Trans proline' 0 C--N 1.357 1.011 0 C-N-CA 122.195 1.93 . . . . 0.23000000000000001 113.63 -178.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -118.34 51.8 1.06 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 121.267 0.556 . . . . 0.23000000000000001 111.208 -179.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 19.8 t -116.56 -60.17 1.88 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.884 -0.598 . . . . 0.23000000000000001 110.142 179.003 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 40.2 pttt -69.22 -9.99 55.62 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.971 -0.559 . . . . 0.23000000000000001 111.977 179.007 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 69.5 mt -102.5 -52.24 3.15 Favored 'General case' 0 C--N 1.345 0.371 0 CA-C-N 118.237 0.471 . . . . 0.23000000000000001 110.936 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 53.3 mt -91.02 158.42 16.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.23000000000000001 111.36 -179.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -130.65 143.03 47.65 Favored Pre-proline 0 CA--C 1.535 0.377 0 CA-C-N 116.094 -0.503 . . . . 0.23000000000000001 110.429 179.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -50.44 128.1 22.32 Favored 'Trans proline' 0 C--N 1.361 1.219 0 C-N-CA 122.099 1.866 . . . . 0.23000000000000001 113.389 -179.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.06 2.25 48.58 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 120.979 -0.629 . . . . 0.23000000000000001 113.911 179.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -75.95 140.91 42.32 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 118.024 0.912 . . . . 0.23000000000000001 111.151 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 60.7 tttp -97.54 129.1 44.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.889 -0.596 . . . . 0.23000000000000001 110.909 179.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 28.3 mt -89.06 114.07 26.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.534 -0.303 . . . . 0.23000000000000001 110.562 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 21.1 mm -89.72 -44.06 14.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 112.934 0.716 . . . . 0.23000000000000001 112.934 -178.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 9.6 mt-30 -148.23 149.53 32.08 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.348 0.594 . . . . 0.23000000000000001 112.344 -178.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -136.82 121.4 18.39 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 115.398 -0.819 . . . . 0.23000000000000001 111.121 179.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 48.1 m-20 45.67 28.46 0.54 Allowed 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 113.298 0.851 . . . . 0.23000000000000001 113.298 178.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 101.7 -14.09 57.73 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 120.762 -0.732 . . . . 0.23000000000000001 113.705 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -88.59 127.99 35.57 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-N 117.685 0.742 . . . . 0.23000000000000001 110.432 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 79.4 p -76.27 127.04 32.1 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.254 -0.43 . . . . 0.23000000000000001 110.784 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -101.97 14.2 32.64 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 112.225 0.454 . . . . 0.23000000000000001 112.225 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 31.4 mm -90.65 125.53 43.46 Favored 'Isoleucine or valine' 0 C--N 1.341 0.226 0 O-C-N 122.011 -0.43 . . . . 0.23000000000000001 110.97 179.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 61.64 71.88 0.53 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-O 121.279 0.561 . . . . 0.23000000000000001 110.838 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 12.7 pt -149.01 165.84 3.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.918 -0.583 . . . . 0.23000000000000001 110.792 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -80.97 145.21 31.33 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.95 0.405 . . . . 0.23000000000000001 110.771 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -52.5 -51.73 58.03 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 116.014 -0.539 . . . . 0.23000000000000001 112.05 -179.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -56.58 -27.46 54.62 Favored Glycine 0 C--N 1.334 0.424 0 C-N-CA 121.103 -0.57 . . . . 0.23000000000000001 112.938 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 7.1 tm0? -72.72 -40.2 66.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.957 0.408 . . . . 0.23000000000000001 110.316 179.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.48 -36.13 82.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.994 -0.548 . . . . 0.23000000000000001 111.314 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 25.4 t -73.4 -44.13 54.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.978 0.418 . . . . 0.23000000000000001 110.572 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 23.0 t -56.49 -38.07 71.23 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.229 -0.441 . . . . 0.23000000000000001 111.135 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 89.6 mt -71.78 -39.54 69.86 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.077 -0.511 . . . . 0.23000000000000001 110.364 179.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 75.2 mt -78.14 -3.0 40.25 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 113.003 0.742 . . . . 0.23000000000000001 113.003 179.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 11.5 mmtp -99.23 -40.78 7.78 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-O 121.302 0.572 . . . . 0.23000000000000001 110.303 178.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 8.9 t -73.86 -24.53 59.76 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 113.251 0.834 . . . . 0.23000000000000001 113.251 -178.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -48.52 171.62 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 113.322 0.86 . . . . 0.23000000000000001 113.322 -178.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -86.99 -142.47 0.11 Allowed 'General case' 0 CA--C 1.554 1.113 0 CA-C-N 115.455 -0.793 . . . . 0.23000000000000001 111.214 -179.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -78.13 -68.32 0.65 Allowed 'General case' 0 C--N 1.349 0.561 0 CA-C-N 119.027 0.83 . . . . 0.23000000000000001 111.017 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.41 134.24 35.52 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.371 -0.377 . . . . 0.23000000000000001 110.572 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 21.3 t -120.84 124.67 72.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.253 -0.43 . . . . 0.23000000000000001 111.138 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -89.78 115.12 26.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 0.23000000000000001 109.982 179.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.0 mt -118.57 148.24 42.87 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.043 0.449 . . . . 0.23000000000000001 112.041 -178.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 48.6 mt -119.56 132.22 69.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 115.614 -0.721 . . . . 0.23000000000000001 109.527 178.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 35.1 pt -130.67 169.03 22.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.864 0.364 . . . . 0.23000000000000001 111.762 -179.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 58.2 t -133.01 143.02 40.67 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 115.931 -0.577 . . . . 0.23000000000000001 111.042 -179.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.49 102.23 10.11 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.12 -0.696 . . . . 0.23000000000000001 109.12 178.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -81.71 133.53 35.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.848 0.356 . . . . 0.23000000000000001 111.727 -178.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 9.2 m -95.51 179.77 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.985 -0.552 . . . . 0.23000000000000001 110.628 179.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 16.7 t -61.05 112.58 2.15 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.82 0.343 . . . . 0.23000000000000001 111.149 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 38.6 t . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.237 -0.887 . . . . 0.23000000000000001 110.816 179.946 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 301' ' ' THR . . . . . . . . . . . . . 4.3 m . . . . . 0 N--CA 1.487 1.424 0 CA-C-O 120.689 0.281 . . . . 0.23000000000000001 111.466 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 302' ' ' GLY . . . . . . . . . . . . . . . -83.17 60.65 4.87 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.935 -0.65 . . . . 0.23000000000000001 112.853 -179.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 303' ' ' TRP . . . . . . . . . . . . . 9.5 p-90 -145.98 16.54 1.39 Allowed 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 112.221 0.452 . . . . 0.23000000000000001 112.221 179.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -115.58 134.76 54.75 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.842 0.353 . . . . 0.23000000000000001 110.904 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 305' ' ' THR . . . . . . . . . . . . . 3.5 m -105.1 123.42 47.79 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.109 -0.496 . . . . 17.879999999999999 110.688 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 306' ' ' TRP . . . . . . . . . . . . . 88.5 m95 -89.02 112.2 23.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.26 -0.427 . . . . 0.23000000000000001 110.951 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 307' ' ' VAL . . . . . . . . . . . . . 17.8 m . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.241 -0.885 . . . . 16.109999999999999 111.077 -179.994 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 . . . . . 0 CA--C 1.53 0.184 0 CA-C-O 120.802 0.334 . . . . 0.0 110.962 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.564 ' H ' HD13 ' A' ' 13' ' ' ILE . 0.2 OUTLIER -112.99 159.52 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-O 121.155 0.502 . . . . 0.0 112.202 -179.657 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 11.5 ttp-105 -114.5 155.23 26.81 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.9 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.536 HG21 HD21 ' A' ' 60' ' ' LEU . 15.9 m -136.65 143.73 34.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.217 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.5 mtm180 -108.44 106.85 17.15 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.609 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.8 t -110.31 110.39 31.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.883 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.711 ' HG3' HG23 ' A' ' 92' ' ' THR . 0.9 OUTLIER -88.79 128.76 35.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.899 -179.975 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.494 ' HD3' HD12 ' A' ' 23' ' ' LEU . 10.4 mtmt -80.53 115.04 19.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.937 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -166.98 89.06 0.76 Allowed Pre-proline 0 CA--C 1.535 0.39 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.634 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -79.72 -24.06 13.07 Favored 'Cis proline' 0 C--N 1.363 1.317 0 CA-C-N 119.36 0.807 . . . . 0.0 112.879 0.509 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 54.4 mm-40 -135.53 -176.8 4.4 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.8 0.333 . . . . 0.0 111.451 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.494 HD12 ' HD3' ' A' ' 19' ' ' LYS . 3.0 mp -63.47 -59.08 5.13 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.02 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.437 ' O ' HG13 ' A' ' 50' ' ' VAL . . . 106.75 31.18 4.02 Favored Glycine 0 CA--C 1.521 0.415 0 C-N-CA 120.867 -0.682 . . . . 0.0 113.585 179.157 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.418 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 28.3 p90 -162.62 155.44 19.52 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 117.066 0.433 . . . . 0.0 111.235 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.1 p -108.12 152.98 23.8 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.4 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.744 HD11 HG22 ' A' ' 83' ' ' VAL . 41.3 pt -120.27 148.71 23.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.632 179.339 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.5 t -139.45 167.71 21.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.871 0.367 . . . . 0.0 111.05 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.46 -146.4 18.19 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.972 -0.632 . . . . 0.0 112.382 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 101.54 153.32 25.75 Favored Glycine 0 C--N 1.331 0.255 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.491 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 25.9 t -79.53 97.24 2.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.906 0.384 . . . . 0.0 111.003 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 98.81 -2.72 58.58 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 120.999 -0.62 . . . . 0.0 113.937 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -78.64 -155.75 8.83 Favored Glycine 0 C--N 1.34 0.781 0 CA-C-N 117.842 0.821 . . . . 0.0 113.04 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -62.12 -29.41 70.31 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.505 0.193 . . . . 0.0 111.341 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 107.94 153.74 17.75 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.606 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -112.28 129.85 23.91 Favored Pre-proline 0 N--CA 1.468 0.468 0 CA-C-O 119.886 -0.102 . . . . 0.0 110.764 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -92.85 34.9 0.23 Allowed 'Trans proline' 0 C--N 1.357 0.999 0 C-N-CA 122.357 2.038 . . . . 0.0 113.129 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -116.12 -49.21 2.7 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.761 0.315 . . . . 0.0 110.952 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 32.1 mmt180 -116.36 138.93 24.72 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.806 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -83.63 -44.31 0.07 OUTLIER 'Trans proline' 0 C--N 1.357 1.023 0 C-N-CA 121.972 1.782 . . . . 0.0 112.936 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -92.03 -8.58 45.59 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -108.22 123.21 48.41 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 118.08 0.4 . . . . 0.0 110.885 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.2 p30 -110.04 34.67 3.74 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.072 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -78.73 -158.56 12.5 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.485 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 20.5 mm -108.94 131.04 60.76 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 N-CA-C 110.418 -0.215 . . . . 0.0 110.418 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -130.48 146.39 52.02 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.87 0.367 . . . . 0.0 111.545 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 22.0 t -90.38 73.95 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.672 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.2 t -34.47 -54.31 0.53 Allowed 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 114.767 1.395 . . . . 0.0 114.767 -178.412 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 11.0 ptm180 -160.3 170.87 20.19 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.201 0.524 . . . . 0.0 112.171 -179.249 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.437 HG13 ' O ' ' A' ' 24' ' ' GLY . 21.2 t -125.23 147.24 29.93 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.355 179.566 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 8.3 mm-40 -103.91 -68.09 0.04 OUTLIER Pre-proline 0 CA--C 1.535 0.4 0 CA-C-N 116.833 -0.167 . . . . 0.0 111.277 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -79.83 119.33 3.97 Favored 'Trans proline' 0 C--N 1.356 0.951 0 C-N-CA 121.694 1.596 . . . . 0.0 112.173 179.487 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -79.59 66.27 5.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.276 0.56 . . . . 0.0 110.793 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -143.86 -73.37 0.03 OUTLIER Glycine 0 CA--C 1.526 0.734 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.58 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -60.2 -70.03 0.04 OUTLIER 'Trans proline' 0 C--N 1.358 1.03 0 C-N-CA 121.832 1.688 . . . . 0.0 112.938 -179.561 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -99.02 43.4 1.06 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-O 120.99 0.424 . . . . 0.0 111.415 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 92.9 p -87.11 -59.41 2.26 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.304 179.455 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -91.12 -4.0 56.6 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.791 -0.641 . . . . 0.0 112.244 179.318 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -91.62 -69.52 0.73 Allowed 'General case' 0 C--N 1.341 0.22 0 CA-C-N 118.231 0.469 . . . . 0.0 111.606 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.536 HD21 HG21 ' A' ' 15' ' ' VAL . 5.7 mt -96.82 146.31 25.04 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.896 0.379 . . . . 0.0 111.921 -179.315 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -112.61 151.17 43.69 Favored Pre-proline 0 N--CA 1.47 0.574 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.478 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -64.22 129.22 23.56 Favored 'Trans proline' 0 C--N 1.355 0.909 0 C-N-CA 121.872 1.714 . . . . 0.0 112.588 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 92.71 18.99 38.87 Favored Glycine 0 CA--C 1.523 0.541 0 C-N-CA 120.929 -0.653 . . . . 0.0 113.689 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -93.54 151.35 19.76 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 117.306 0.553 . . . . 0.0 110.762 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 60.1 tttm -100.1 130.27 46.23 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.212 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 28.0 mt -89.85 117.08 32.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.411 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 22.1 mm -90.48 -43.96 14.63 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -178.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.619 ' HB3' HD12 ' A' ' 96' ' ' ILE . 3.4 tt0 -145.14 150.79 37.39 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.812 0.339 . . . . 0.0 111.652 -178.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.553 ' HB3' ' CE1' ' A' ' 74' ' ' PHE . . . -138.32 119.78 14.91 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.487 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.401 ' HB2' ' CZ ' ' A' ' 89' ' ' PHE . 2.4 m120 46.47 29.0 0.81 Allowed 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 178.878 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 101.78 -20.25 46.74 Favored Glycine 0 CA--C 1.521 0.468 0 C-N-CA 120.747 -0.739 . . . . 0.0 113.391 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -88.77 126.51 35.37 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 117.212 0.506 . . . . 0.0 110.535 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.5 t -72.53 141.71 48.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.576 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.553 ' CE1' ' HB3' ' A' ' 69' ' ' ALA . 3.7 m-85 -111.43 20.57 17.11 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -179.621 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 24.7 mm -97.52 137.66 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-O 120.681 0.277 . . . . 0.0 111.446 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 33.5 m120 65.31 10.69 6.7 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 9.5 pt -92.88 163.08 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 N-CA-C 113.375 0.879 . . . . 0.0 113.375 -178.249 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -83.03 144.7 29.76 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.79 179.027 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 8.8 t-160 -52.35 -51.4 59.01 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -178.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -53.95 -28.39 40.14 Favored Glycine 0 C--N 1.335 0.509 0 C-N-CA 121.104 -0.569 . . . . 0.0 113.127 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.4 tp-100 -75.77 -37.72 59.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.993 0.425 . . . . 0.0 110.309 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.63 -47.92 68.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.373 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.744 HG22 HD11 ' A' ' 27' ' ' ILE . 20.3 t -62.02 -43.37 97.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.271 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 33.2 t -60.77 -38.32 84.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.424 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.45 ' O ' HG22 ' A' ' 88' ' ' THR . 32.7 mt -67.66 -45.54 74.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.454 -179.64 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.441 ' HA ' ' CD2' ' A' ' 89' ' ' PHE . 15.6 mt -64.21 -36.25 83.44 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -179.128 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 34.2 mttm -72.19 -37.98 69.17 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 -178.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.45 HG22 ' O ' ' A' ' 85' ' ' LEU . 9.9 t -70.99 -27.02 63.4 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -178.394 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.441 ' CD2' ' HA ' ' A' ' 86' ' ' LEU . 13.3 m-85 -49.45 148.01 3.0 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -178.579 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -65.65 -137.75 0.0 OUTLIER 'General case' 0 CA--C 1.551 0.994 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.292 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -81.36 -69.79 0.58 Allowed 'General case' 0 C--N 1.351 0.646 0 CA-C-N 119.488 1.04 . . . . 0.0 112.403 -178.722 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.711 HG23 ' HG3' ' A' ' 18' ' ' GLU . 0.2 OUTLIER -74.18 121.36 21.09 Favored 'General case' 0 C--O 1.231 0.08 0 CA-C-O 120.839 0.352 . . . . 0.0 111.068 -179.278 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 19.1 t -112.58 111.89 38.08 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.004 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -93.44 126.08 38.39 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 2.0 mt -130.42 159.93 35.55 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.074 0.464 . . . . 0.0 111.867 -178.708 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.619 HD12 ' HB3' ' A' ' 68' ' ' GLN . 48.2 mt -119.17 129.18 75.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.984 178.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.514 HD13 HD23 ' A' ' 60' ' ' LEU . 33.0 pt -125.55 165.32 23.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-O 120.97 0.414 . . . . 0.0 111.878 -179.298 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 44.3 t -144.61 149.34 17.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.555 -179.36 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.51 116.29 28.6 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.091 179.002 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 . . . . . 0 N--CA 1.462 0.137 0 CA-C-O 120.936 0.398 . . . . 0.0 111.647 -178.953 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.786 0.327 . . . . 0.0 110.865 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 305' ' ' THR . . . . . . . . . . . . . 6.9 m -122.78 120.19 32.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.142 -0.481 . . . . 17.879999999999999 110.627 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 306' ' ' TRP . . . . . . . . . . . . . 94.3 m95 -85.03 114.21 22.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.945 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 307' ' ' VAL . . . . . . . . . . . . . 25.2 m . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.14 -0.934 . . . . 16.109999999999999 111.168 -179.849 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.229 0 CA-C-O 120.928 0.394 . . . . 0.0 111.002 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.615 ' H ' HD13 ' A' ' 13' ' ' ILE . 0.2 OUTLIER -126.2 155.79 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.296 179.867 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.642 ' HG3' HD13 ' A' ' 96' ' ' ILE . 24.7 ttm-85 -116.52 152.39 34.19 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.11 -179.013 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.405 ' HB ' HD22 ' A' ' 59' ' ' LEU . 18.5 m -145.78 147.23 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 N-CA-C 111.623 0.231 . . . . 0.0 111.623 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 14.1 ptp180 -112.54 130.59 55.96 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.813 0.34 . . . . 0.0 111.274 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.7 t -116.07 120.38 64.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.705 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.729 ' HG3' HG22 ' A' ' 92' ' ' THR . 3.5 mp0 -94.2 119.54 33.15 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.831 -179.283 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.57 113.18 4.02 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.833 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -175.29 84.02 0.31 Allowed Pre-proline 0 CA--C 1.537 0.461 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.119 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -82.68 -24.84 10.8 Favored 'Cis proline' 0 C--N 1.363 1.297 0 CA-C-N 119.508 0.86 . . . . 0.0 112.8 0.424 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -137.51 -178.06 5.06 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 120.815 0.341 . . . . 0.0 111.441 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.42 ' HB3' ' CE2' ' A' ' 25' ' ' PHE . 3.5 mp -61.1 -59.65 5.01 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.198 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.411 ' O ' HG13 ' A' ' 50' ' ' VAL . . . 104.94 25.53 6.76 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 120.799 -0.715 . . . . 0.0 113.48 179.52 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.498 ' O ' HG22 ' B' ' 307' ' ' VAL . 37.2 p90 -155.25 144.47 20.98 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 117.252 0.526 . . . . 0.0 111.051 179.492 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.3 p -98.91 151.82 20.44 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.363 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.872 HD11 HG22 ' A' ' 83' ' ' VAL . 22.5 pt -122.34 153.62 26.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.914 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.8 m -148.06 162.12 40.02 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.78 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 106.58 -149.9 16.71 Favored Glycine 0 C--N 1.332 0.355 0 C-N-CA 120.908 -0.663 . . . . 0.0 113.186 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 103.98 154.91 23.72 Favored Glycine 0 C--N 1.331 0.267 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.178 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 18.7 t -78.75 110.82 14.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 120.934 0.397 . . . . 0.0 110.756 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 88.83 3.71 76.59 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 120.939 -0.648 . . . . 0.0 113.847 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -82.89 -146.77 6.54 Favored Glycine 0 C--N 1.341 0.825 0 CA-C-N 117.841 0.82 . . . . 0.0 112.798 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 48.5 mtt-85 -81.0 -4.36 54.88 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.03 162.35 37.52 Favored Glycine 0 C--N 1.344 0.991 0 C-N-CA 120.609 -0.805 . . . . 0.0 113.099 179.602 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -105.84 134.87 19.53 Favored Pre-proline 0 CA--C 1.533 0.289 0 CA-C-O 119.899 -0.096 . . . . 0.0 110.921 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -92.87 27.06 0.37 Allowed 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 122.309 2.006 . . . . 0.0 112.819 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -125.25 -46.03 1.81 Allowed 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.731 0.3 . . . . 0.0 110.796 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 64.6 mtt-85 -116.59 150.99 46.56 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.614 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -92.08 -57.58 0.02 OUTLIER 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 122.153 1.902 . . . . 0.0 114.082 -178.753 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -84.21 -7.18 59.43 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 -178.557 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -101.69 117.08 34.16 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 118.154 0.433 . . . . 0.0 111.108 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -106.31 34.03 3.57 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.481 -179.498 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -80.86 -161.56 26.19 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.199 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.8 mm -107.27 131.28 57.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-N 116.782 0.291 . . . . 0.0 110.298 179.398 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.435 ' N ' ' CD1' ' A' ' 46' ' ' PHE . 6.0 m-85 -130.5 148.35 52.3 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.882 0.372 . . . . 0.0 111.359 -179.332 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.538 HG23 ' OD1' ' A' ' 64' ' ' ASP . 22.0 t -92.2 76.02 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-O 121.158 0.504 . . . . 0.0 110.955 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.424 HG23 ' N ' ' A' ' 49' ' ' ARG . 8.2 t -35.13 -51.72 0.56 Allowed 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 -178.62 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.424 ' N ' HG23 ' A' ' 48' ' ' THR . 3.6 ptm180 -160.22 176.63 11.52 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.117 0.484 . . . . 0.0 112.28 -179.254 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.411 HG13 ' O ' ' A' ' 24' ' ' GLY . 18.3 t -130.8 148.47 33.08 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.605 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -102.66 -67.89 0.04 OUTLIER Pre-proline 0 CA--C 1.536 0.422 0 CA-C-O 119.753 -0.165 . . . . 0.0 111.392 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -79.4 120.8 4.55 Favored 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 121.796 1.664 . . . . 0.0 112.052 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -77.76 65.63 3.27 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.94 0.4 . . . . 0.0 111.096 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -158.42 -66.54 0.01 OUTLIER Glycine 0 CA--C 1.528 0.85 0 C-N-CA 120.765 -0.731 . . . . 0.0 113.362 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -58.26 -76.43 0.02 OUTLIER 'Trans proline' 0 C--N 1.357 0.99 0 C-N-CA 122.142 1.895 . . . . 0.0 113.36 -179.04 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.858 ' HB1' HD12 ' A' ' 60' ' ' LEU . . . -111.72 49.77 0.88 Allowed 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.196 0.522 . . . . 0.0 111.437 -179.412 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 82.4 p -107.35 -67.25 0.97 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.758 179.3 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.72 -12.13 57.27 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.99 178.872 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.405 HD22 ' HB ' ' A' ' 15' ' ' VAL . 4.4 mt -93.71 -59.22 2.05 Favored 'General case' 0 C--N 1.342 0.24 0 O-C-N 122.008 -0.433 . . . . 0.0 111.405 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.858 HD12 ' HB1' ' A' ' 56' ' ' ALA . 15.2 mt -93.03 149.26 21.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.547 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.22 144.53 33.13 Favored Pre-proline 0 N--CA 1.471 0.603 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.744 179.2 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.53 133.47 52.05 Favored 'Trans proline' 0 C--N 1.359 1.081 0 C-N-CA 122.165 1.91 . . . . 0.0 113.427 -178.851 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 87.75 21.75 45.77 Favored Glycine 0 C--N 1.334 0.417 0 CA-C-N 115.716 -0.675 . . . . 0.0 113.632 178.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.538 ' OD1' HG23 ' A' ' 47' ' ' VAL . 2.9 p30 -84.62 -169.55 2.68 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 117.092 0.446 . . . . 0.0 111.005 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 57.8 tttp -141.55 126.44 18.19 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-O 120.874 0.368 . . . . 0.0 111.338 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 27.9 mt -90.31 118.05 34.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.233 179.366 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.512 HD12 ' CG2' ' A' ' 98' ' ' VAL . 50.3 mt -102.14 -31.79 3.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 N-CA-C 112.419 0.525 . . . . 0.0 112.419 -178.45 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.61 144.57 27.31 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.005 0.431 . . . . 0.0 111.844 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.47 ' HB3' ' CE1' ' A' ' 74' ' ' PHE . . . -146.25 121.48 10.19 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.783 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 44.73 41.77 5.3 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 178.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 89.21 -17.99 48.07 Favored Glycine 0 CA--C 1.524 0.605 0 C-N-CA 120.856 -0.688 . . . . 0.0 113.634 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -100.92 123.27 44.87 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 117.373 0.586 . . . . 0.0 110.256 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 30.0 m -72.52 151.87 42.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.284 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.47 ' CE1' ' HB3' ' A' ' 69' ' ' ALA . 3.7 m-85 -113.09 19.56 17.08 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.783 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.431 HD11 HG23 ' A' ' 67' ' ' ILE . 30.7 mm -97.03 133.14 39.69 Favored 'Isoleucine or valine' 0 C--O 1.231 0.111 0 CA-C-O 120.751 0.31 . . . . 0.0 110.859 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 61.23 62.36 1.4 Allowed 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 121.185 0.517 . . . . 0.0 110.898 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 18.7 pt -144.43 164.67 13.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.752 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -82.09 145.53 30.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.633 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 -51.2 -53.29 36.37 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 116.167 -0.47 . . . . 0.0 112.162 -179.546 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -54.65 -25.97 37.62 Favored Glycine 0 CA--C 1.523 0.549 0 C-N-CA 121.079 -0.582 . . . . 0.0 113.02 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -74.46 -39.69 62.37 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.111 0.481 . . . . 0.0 110.404 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -70.5 -37.57 74.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.852 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.872 HG22 HD11 ' A' ' 27' ' ' ILE . 35.2 t -70.49 -44.53 76.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.972 0.415 . . . . 0.0 110.893 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 75.4 m -61.05 -37.32 82.21 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.303 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 19.9 mt -65.65 -46.89 77.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.599 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.415 ' HA ' ' CD2' ' A' ' 89' ' ' PHE . 34.4 mt -65.7 -38.31 88.87 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.897 -178.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 56.1 mttm -71.45 -39.16 71.16 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -178.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 12.0 t -73.77 -27.28 61.07 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -178.084 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.415 ' CD2' ' HA ' ' A' ' 86' ' ' LEU . 11.8 m-85 -48.98 172.7 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -178.618 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -84.31 -143.46 0.08 Allowed 'General case' 0 CA--C 1.552 1.054 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.193 -179.123 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 67.8 m-80 -76.96 -69.95 0.49 Allowed 'General case' 0 C--N 1.349 0.564 0 CA-C-N 119.005 0.821 . . . . 0.0 111.552 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.729 HG22 ' HG3' ' A' ' 18' ' ' GLU . 4.7 p -80.07 125.46 29.82 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.921 0.391 . . . . 0.0 110.788 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 18.8 t -113.41 114.56 47.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.556 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -87.79 112.97 23.0 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 4.2 mt -115.21 152.64 32.3 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-O 121.224 0.535 . . . . 0.0 112.101 -178.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.642 HD13 ' HG3' ' A' ' 14' ' ' ARG . 31.3 mm -112.39 124.6 69.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.065 178.109 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.535 HD13 HD23 ' A' ' 60' ' ' LEU . 29.3 pt -127.23 158.34 38.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 120.882 0.372 . . . . 0.0 111.208 -178.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.512 ' CG2' HD12 ' A' ' 67' ' ' ILE . 58.3 t -144.24 150.25 16.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.241 -179.133 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.6 mmm180 -112.0 116.8 31.16 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 . . . . . 0 C--N 1.328 -0.339 0 CA-C-O 121.058 0.456 . . . . 0.0 111.703 -178.844 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.692 0.282 . . . . 0.0 110.515 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 305' ' ' THR . . . . . . . . . . . . . 4.7 m -140.42 113.71 8.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.454 -0.339 . . . . 17.879999999999999 111.159 -179.702 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 306' ' ' TRP . . . . . . . . . . . . . 92.8 m95 -80.77 105.46 12.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.707 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 307' ' ' VAL . . . . . 0.498 HG22 ' O ' ' A' ' 25' ' ' PHE . 16.7 m . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.233 -0.889 . . . . 16.109999999999999 111.134 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 . . . . . 0 C--O 1.232 0.17 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 19.8 pt -147.29 159.17 9.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -178.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 9.7 ttm105 -104.91 153.77 20.96 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.718 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.5 m -146.74 132.74 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.547 178.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.2 ttt180 -107.84 119.94 40.88 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.202 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.4 t -118.97 119.77 61.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.062 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.711 ' CG ' HG23 ' A' ' 92' ' ' THR . 40.0 mt-10 -96.79 132.36 42.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.681 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.484 ' HE2' HD11 ' A' ' 23' ' ' LEU . 21.5 mttt -80.31 122.98 27.58 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.435 0.636 . . . . 0.0 111.856 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -173.97 85.52 0.36 Allowed Pre-proline 0 CA--C 1.537 0.466 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.939 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -81.3 -17.52 27.25 Favored 'Cis proline' 0 C--N 1.365 1.401 0 CA-C-N 119.261 0.772 . . . . 0.0 113.371 0.458 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 38.1 mm-40 -136.63 -177.17 4.61 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.79 0.329 . . . . 0.0 111.453 -179.535 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.484 HD11 ' HE2' ' A' ' 19' ' ' LYS . 4.5 mp -59.42 -63.08 1.43 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.211 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.507 ' O ' HG13 ' A' ' 50' ' ' VAL . . . 114.67 28.84 2.83 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 120.877 -0.677 . . . . 0.0 113.485 179.559 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.444 ' O ' HG22 ' B' ' 307' ' ' VAL . 49.5 p90 -164.14 148.9 10.15 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 117.156 0.478 . . . . 0.0 111.285 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.4 p -102.06 155.1 18.4 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.24 -179.67 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.837 HD11 HG22 ' A' ' 83' ' ' VAL . 21.1 pt -125.38 153.47 32.95 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.752 179.759 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.4 m -143.28 165.61 26.99 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.821 0.343 . . . . 0.0 111.139 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.77 -144.45 17.22 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.674 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 102.3 151.52 23.83 Favored Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.378 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.574 HG22 ' OD2' ' A' ' 43' ' ' ASP . 30.3 t -79.99 98.7 3.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.849 0.357 . . . . 0.0 110.781 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 98.94 -3.61 58.71 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 120.958 -0.639 . . . . 0.0 114.07 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -81.17 -150.66 7.53 Favored Glycine 0 C--N 1.342 0.906 0 CA-C-N 117.799 0.8 . . . . 0.0 112.904 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 4.9 ptt-85 -87.18 12.23 12.16 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 51.39 -173.02 0.17 Allowed Glycine 0 C--N 1.342 0.893 0 N-CA-C 114.496 0.559 . . . . 0.0 114.496 178.543 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 22.7 p30 -142.56 161.51 49.32 Favored Pre-proline 0 CA--C 1.536 0.41 0 CA-C-N 115.553 -0.323 . . . . 0.0 110.545 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -92.75 25.12 0.44 Allowed 'Trans proline' 0 C--N 1.358 1.052 0 C-N-CA 122.386 2.057 . . . . 0.0 113.431 -179.334 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -103.33 -44.17 5.23 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.699 0.285 . . . . 0.0 111.298 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -124.07 136.16 27.22 Favored Pre-proline 0 CA--C 1.535 0.369 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.503 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -84.98 -46.89 0.04 OUTLIER 'Trans proline' 0 C--N 1.358 1.04 0 C-N-CA 121.908 1.738 . . . . 0.0 113.385 -179.343 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -97.01 -11.31 24.68 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 112.867 0.691 . . . . 0.0 112.867 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -92.33 121.59 33.97 Favored 'General case' 0 N--CA 1.464 0.254 0 O-C-N 122.064 -0.397 . . . . 0.0 110.465 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.574 ' OD2' HG22 ' A' ' 31' ' ' VAL . 14.0 p-10 -111.03 47.65 0.98 Allowed 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.04 0.448 . . . . 0.0 111.596 -179.55 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -94.71 -162.83 35.07 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 121.058 -0.592 . . . . 0.0 111.69 179.009 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 14.6 mm -112.45 124.91 69.59 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-N 117.421 0.611 . . . . 0.0 110.449 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -126.79 146.51 50.22 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.735 0.302 . . . . 0.0 110.959 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.572 HG23 ' OD1' ' A' ' 64' ' ' ASP . 22.7 t -90.99 76.18 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-O 120.89 0.376 . . . . 0.0 111.201 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.402 HG23 ' N ' ' A' ' 49' ' ' ARG . 4.8 t -33.09 -54.53 0.39 Allowed 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 -178.289 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.402 ' N ' HG23 ' A' ' 48' ' ' THR . 0.6 OUTLIER -160.27 174.17 14.61 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.262 0.553 . . . . 0.0 112.45 -179.271 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.507 HG13 ' O ' ' A' ' 24' ' ' GLY . 20.7 t -124.79 145.36 32.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.459 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.403 ' CB ' ' HD3' ' A' ' 52' ' ' PRO . 1.9 mm-40 -102.86 -69.95 0.04 OUTLIER Pre-proline 0 CA--C 1.539 0.54 0 CA-C-O 119.461 -0.304 . . . . 0.0 111.413 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.403 ' HD3' ' CB ' ' A' ' 51' ' ' GLN . 61.0 Cg_endo -82.57 121.15 3.3 Favored 'Trans proline' 0 C--N 1.359 1.118 0 C-N-CA 121.698 1.599 . . . . 0.0 112.601 179.605 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -79.8 66.21 5.21 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.303 0.573 . . . . 0.0 110.799 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -142.08 -71.08 0.03 OUTLIER Glycine 0 CA--C 1.527 0.834 0 CA-C-N 115.778 -0.646 . . . . 0.0 113.152 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -63.47 -58.15 0.31 Allowed 'Trans proline' 0 C--N 1.358 1.058 0 C-N-CA 121.948 1.766 . . . . 0.0 113.497 -179.153 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.494 ' HB1' HD12 ' A' ' 60' ' ' LEU . . . -118.8 48.56 1.44 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 121.08 0.467 . . . . 0.0 111.728 -179.292 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 82.6 p -79.81 -59.64 2.66 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.852 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 17.3 mttt -97.73 9.89 41.44 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 79.0 mt -92.23 -65.11 1.03 Allowed 'General case' 0 C--N 1.34 0.181 0 O-C-N 122.106 -0.371 . . . . 0.0 111.413 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.515 HD23 HG21 ' A' ' 97' ' ' ILE . 1.1 mt -97.12 147.76 23.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.509 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -113.4 140.04 23.95 Favored Pre-proline 0 N--CA 1.469 0.481 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.67 178.785 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -53.01 136.04 60.04 Favored 'Trans proline' 0 C--N 1.358 1.068 0 C-N-CA 122.083 1.855 . . . . 0.0 113.291 -178.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 82.03 24.78 54.29 Favored Glycine 0 C--N 1.333 0.374 0 CA-C-N 115.767 -0.651 . . . . 0.0 113.246 179.212 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.572 ' OD1' HG23 ' A' ' 47' ' ' VAL . 3.0 p30 -86.05 -170.58 3.16 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.89 0.345 . . . . 0.0 110.857 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 60.8 tttp -139.33 122.86 17.32 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.83 0.348 . . . . 0.0 110.891 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 48.8 mt -89.61 121.94 40.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.509 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 19.5 mm -96.03 -43.97 12.81 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 N-CA-C 112.581 0.585 . . . . 0.0 112.581 -178.441 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -145.81 150.57 36.44 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 121.073 0.463 . . . . 0.0 111.957 -178.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.404 ' HB3' ' CE1' ' A' ' 74' ' ' PHE . . . -137.1 119.46 15.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.94 179.446 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 42.28 32.3 0.32 Allowed 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 113.642 0.978 . . . . 0.0 113.642 178.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 97.83 4.2 57.94 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 120.986 -0.626 . . . . 0.0 114.083 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -110.09 124.24 51.15 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 117.949 0.875 . . . . 0.0 110.565 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 54.8 p -72.78 139.85 47.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.484 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.412 ' HA ' HD13 ' A' ' 77' ' ' ILE . 4.7 m-85 -110.5 21.55 16.49 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -179.371 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.439 HG22 ' OD1' ' A' ' 76' ' ' ASN . 21.1 mm -100.29 139.45 21.72 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 O-C-N 122.214 -0.304 . . . . 0.0 111.048 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.504 ' HA ' HG21 ' A' ' 31' ' ' VAL . 19.9 m120 63.81 12.23 6.54 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -179.407 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.412 HD13 ' HA ' ' A' ' 74' ' ' PHE . 25.3 pt -93.62 158.21 2.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -178.445 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -81.63 148.83 28.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.479 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.453 ' O ' HG23 ' A' ' 83' ' ' VAL . 35.4 t60 -47.23 -50.32 21.34 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -179.324 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -57.59 -26.15 56.65 Favored Glycine 0 C--N 1.335 0.501 0 C-N-CA 120.874 -0.679 . . . . 0.0 113.082 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.419 ' OE1' HD11 ' A' ' 85' ' ' LEU . 0.0 OUTLIER -76.21 -42.59 45.63 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.897 0.38 . . . . 0.0 110.887 179.839 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.38 -39.57 81.69 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.662 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.837 HG22 HD11 ' A' ' 27' ' ' ILE . 25.4 t -72.57 -43.2 63.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.852 0.358 . . . . 0.0 110.666 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 34.7 t -60.53 -39.95 89.75 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.296 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.419 HD11 ' OE1' ' A' ' 81' ' ' GLN . 53.2 mt -67.56 -44.0 79.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.898 0.38 . . . . 0.0 111.139 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.422 ' HA ' ' CD2' ' A' ' 89' ' ' PHE . 17.5 mt -66.27 -38.57 88.11 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.809 -178.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 48.5 mttm -73.31 -38.09 65.96 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -178.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 9.0 t -70.15 -25.34 63.42 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -178.716 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.422 ' CD2' ' HA ' ' A' ' 86' ' ' LEU . 14.7 m-85 -53.5 140.49 28.04 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.19 0.519 . . . . 0.0 111.842 -179.348 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -62.59 -131.4 0.0 OUTLIER 'General case' 0 CA--C 1.558 1.258 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.948 -178.067 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -82.59 -72.28 0.45 Allowed 'General case' 0 C--N 1.355 0.806 0 CA-C-N 119.718 1.144 . . . . 0.0 112.621 -177.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.711 HG23 ' CG ' ' A' ' 18' ' ' GLU . 0.3 OUTLIER -74.23 123.11 23.91 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.818 0.342 . . . . 0.0 111.011 -179.367 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.49 ' CG1' HD11 ' A' ' 95' ' ' LEU . 16.6 t -109.51 116.08 51.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.953 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.95 104.62 16.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.353 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.49 HD11 ' CG1' ' A' ' 93' ' ' VAL . 3.8 mp -111.76 158.54 19.23 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.239 0.542 . . . . 0.0 112.098 -179.118 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 26.5 mm -118.72 129.59 74.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.822 178.786 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.515 HG21 HD23 ' A' ' 60' ' ' LEU . 25.8 pt -130.96 167.24 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-O 120.846 0.355 . . . . 0.0 111.663 -178.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 19.0 t -148.29 151.65 13.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.243 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -115.42 131.05 57.05 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.928 179.086 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 . . . . . 0 C--N 1.327 -0.385 0 CA-C-N 116.262 -0.426 . . . . 0.0 112.061 -178.985 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.464 0.255 0 CA-C-O 120.953 0.406 . . . . 0.0 111.068 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 305' ' ' THR . . . . . . . . . . . . . 4.9 m -144.98 118.86 9.29 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.123 -0.489 . . . . 17.879999999999999 111.047 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 306' ' ' TRP . . . . . . . . . . . . . 91.9 m95 -88.79 106.0 18.09 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.664 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 307' ' ' VAL . . . . . 0.444 HG22 ' O ' ' A' ' 25' ' ' PHE . 25.6 m . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.26 -0.876 . . . . 16.109999999999999 111.16 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.465 0.322 0 CA-C-O 120.718 0.294 . . . . 0.0 111.147 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 18.4 pt -115.82 158.11 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -178.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.683 ' HG3' HD13 ' A' ' 96' ' ' ILE . 26.8 ttp180 -116.07 156.19 26.81 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.612 -179.313 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.7 m -149.45 142.83 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.302 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.17 132.01 54.55 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.949 0.404 . . . . 0.0 111.236 179.565 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.3 t -114.62 120.03 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.155 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.495 ' HG2' HG23 ' A' ' 92' ' ' THR . 3.0 mm-40 -89.8 111.59 22.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.095 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.526 ' HD2' HD12 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -65.87 116.89 7.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.971 179.87 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -175.1 84.87 0.32 Allowed Pre-proline 0 CA--C 1.54 0.571 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.962 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -84.7 -22.2 14.65 Favored 'Cis proline' 0 C--N 1.366 1.475 0 CA-C-N 119.488 0.853 . . . . 0.0 113.058 0.371 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 18.2 mp0 -131.42 -178.28 4.78 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.768 0.318 . . . . 0.0 111.142 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.526 HD12 ' HD2' ' A' ' 19' ' ' LYS . 3.2 mp -63.12 -58.16 8.18 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.563 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.612 ' O ' HG13 ' A' ' 50' ' ' VAL . . . 109.92 26.89 4.8 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.888 -0.672 . . . . 0.0 113.377 179.362 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.447 ' O ' HG22 ' B' ' 307' ' ' VAL . 37.4 p90 -159.84 139.93 11.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 117.133 0.467 . . . . 0.0 111.12 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.9 p -94.06 153.59 18.07 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.823 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.407 HD11 HG22 ' A' ' 83' ' ' VAL . 28.2 pt -122.59 152.77 27.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.084 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 50.9 m -146.14 160.93 41.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.912 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 104.97 -146.77 16.14 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 120.988 -0.625 . . . . 0.0 113.098 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.36 157.62 28.92 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.993 -0.622 . . . . 0.0 111.98 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 18.8 t -78.55 109.65 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 CA-C-O 120.806 0.336 . . . . 0.0 110.953 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 86.8 3.81 83.05 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 121.039 -0.601 . . . . 0.0 113.857 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -82.87 -154.7 16.45 Favored Glycine 0 C--N 1.343 0.954 0 CA-C-N 117.816 0.808 . . . . 0.0 112.928 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 7.4 mtt180 -75.71 -2.51 29.96 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -179.482 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.26 -151.28 25.52 Favored Glycine 0 C--N 1.342 0.911 0 C-N-CA 120.695 -0.764 . . . . 0.0 113.037 179.671 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -173.54 142.3 0.94 Allowed Pre-proline 0 CA--C 1.534 0.346 0 N-CA-C 110.611 -0.144 . . . . 0.0 110.611 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -90.42 39.87 0.39 Allowed 'Trans proline' 0 C--N 1.358 1.03 0 C-N-CA 122.274 1.983 . . . . 0.0 113.507 -179.436 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -125.62 -53.44 1.57 Allowed 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.739 0.304 . . . . 0.0 110.915 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? -116.16 136.28 22.97 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.677 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -85.59 -46.37 0.04 OUTLIER 'Trans proline' 0 C--N 1.358 1.05 0 C-N-CA 121.965 1.777 . . . . 0.0 113.335 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -93.42 -8.68 41.02 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 -179.427 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -101.03 121.48 41.87 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 118.175 0.443 . . . . 0.0 110.537 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -110.72 39.8 2.15 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 120.819 0.342 . . . . 0.0 111.874 -178.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -87.44 -158.97 33.48 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.085 179.336 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 13.9 mm -109.43 124.58 66.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 116.996 0.398 . . . . 0.0 110.83 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.418 ' CD1' ' N ' ' A' ' 46' ' ' PHE . 7.3 m-85 -127.12 150.16 49.62 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.628 0.251 . . . . 0.0 110.636 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.457 ' CG2' HD11 ' A' ' 66' ' ' ILE . 22.5 t -95.92 78.98 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.531 -179.202 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.9 t -35.58 -53.6 0.69 Allowed 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 -178.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.402 ' HG3' ' CH2' ' B' ' 306' ' ' TRP . 15.4 ptt180 -160.77 163.95 31.87 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.993 0.425 . . . . 0.0 111.801 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.612 HG13 ' O ' ' A' ' 24' ' ' GLY . 11.8 t -114.29 146.13 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.42 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.404 ' CB ' ' HD3' ' A' ' 52' ' ' PRO . 4.9 mm-40 -97.13 -70.41 0.05 OUTLIER Pre-proline 0 CA--C 1.538 0.496 0 CA-C-O 119.465 -0.302 . . . . 0.0 111.316 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.404 ' HD3' ' CB ' ' A' ' 51' ' ' GLN . 60.2 Cg_endo -83.05 121.13 3.1 Favored 'Trans proline' 0 C--N 1.36 1.133 0 C-N-CA 121.606 1.538 . . . . 0.0 112.292 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -78.62 65.49 3.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.205 0.526 . . . . 0.0 110.737 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -148.19 -70.56 0.01 OUTLIER Glycine 0 CA--C 1.527 0.793 0 C-N-CA 120.965 -0.636 . . . . 0.0 112.871 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -60.37 -63.3 0.12 Allowed 'Trans proline' 0 C--N 1.358 1.062 0 C-N-CA 121.977 1.784 . . . . 0.0 112.893 -179.567 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.429 ' HB1' HD12 ' A' ' 60' ' ' LEU . . . -110.02 45.65 1.09 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.16 0.505 . . . . 0.0 111.186 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 88.9 p -82.5 -59.06 2.65 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.93 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -93.72 5.28 52.17 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 80.2 mt -92.04 -72.61 0.58 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 118.144 0.429 . . . . 0.0 111.612 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.701 HD23 HG21 ' A' ' 97' ' ' ILE . 1.0 OUTLIER -95.94 143.08 27.44 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.545 0.212 . . . . 0.0 110.764 179.852 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -114.98 153.6 47.08 Favored Pre-proline 0 N--CA 1.471 0.592 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.776 179.093 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -55.22 123.71 14.49 Favored 'Trans proline' 0 C--N 1.36 1.161 0 C-N-CA 122.335 2.023 . . . . 0.0 113.882 -178.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 92.74 16.02 50.29 Favored Glycine 0 CA--C 1.521 0.467 0 CA-C-N 115.687 -0.688 . . . . 0.0 114.139 178.486 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.429 ' OD1' HG23 ' A' ' 47' ' ' VAL . 35.1 p-10 -80.27 -171.7 3.13 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 117.541 0.671 . . . . 0.0 111.361 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 32.2 tttp -142.4 125.14 15.94 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 120.774 0.321 . . . . 0.0 111.108 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.559 ' N ' HD12 ' A' ' 66' ' ' ILE . 3.5 mp -90.87 123.86 43.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.023 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 21.0 mm -94.9 -44.55 13.3 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -179.038 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -148.62 150.42 33.24 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 120.833 0.349 . . . . 0.0 111.668 -178.661 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.507 ' HB3' ' CE1' ' A' ' 74' ' ' PHE . . . -136.7 123.69 21.49 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.557 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 28.7 m-20 42.44 35.01 0.59 Allowed 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 113.61 0.966 . . . . 0.0 113.61 178.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 99.65 -16.37 58.81 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 120.867 -0.682 . . . . 0.0 113.792 179.177 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -92.99 123.06 35.97 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 117.534 0.667 . . . . 0.0 111.016 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 14.9 m -71.12 130.49 41.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.077 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.507 ' CE1' ' HB3' ' A' ' 69' ' ' ALA . 5.6 m-85 -103.16 15.64 28.73 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 6.5 tp -89.32 124.24 41.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-O 120.729 0.299 . . . . 0.0 110.546 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 62.54 73.78 0.45 Allowed 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.118 0.485 . . . . 0.0 111.161 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 11.5 pt -144.29 163.12 14.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.886 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -81.12 153.39 27.32 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.256 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 21.1 t60 -52.85 -55.7 21.21 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 116.02 -0.537 . . . . 0.0 112.186 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -56.29 -26.7 51.27 Favored Glycine 0 C--N 1.334 0.45 0 C-N-CA 121.073 -0.584 . . . . 0.0 113.277 -179.625 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -72.66 -40.56 66.25 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.866 0.365 . . . . 0.0 111.008 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.99 -41.0 95.8 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.423 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.407 HG22 HD11 ' A' ' 27' ' ' ILE . 16.1 t -70.74 -42.0 77.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.199 -179.646 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 72.5 m -60.53 -45.82 92.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.588 -179.479 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 31.7 mt -64.14 -45.52 88.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.603 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.426 ' HA ' ' CD2' ' A' ' 89' ' ' PHE . 24.5 mt -65.36 -39.48 92.35 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.956 -179.009 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 8.4 mmtp -68.68 -40.02 80.31 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -178.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 8.8 t -72.22 -27.26 62.42 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -177.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.426 ' CD2' ' HA ' ' A' ' 86' ' ' LEU . 10.5 m-85 -47.87 172.81 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 113.105 0.779 . . . . 0.0 113.105 -177.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -92.5 -138.0 0.18 Allowed 'General case' 0 CA--C 1.554 1.103 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.277 -178.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 54.5 m-80 -78.96 -74.97 0.25 Allowed 'General case' 0 C--N 1.35 0.61 0 CA-C-N 119.454 1.025 . . . . 0.0 111.955 -178.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.495 HG23 ' HG2' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -77.44 123.19 26.21 Favored 'General case' 0 CA--C 1.527 0.081 0 CA-C-O 120.84 0.352 . . . . 0.0 110.307 -179.832 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 20.2 t -111.32 116.69 53.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.498 179.584 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -86.77 112.66 21.91 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.959 0.409 . . . . 0.0 110.159 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.3 mt -116.51 147.46 41.75 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.679 -0.692 . . . . 0.0 111.896 -178.649 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.683 HD13 ' HG3' ' A' ' 14' ' ' ARG . 18.8 mm -107.19 121.71 60.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.651 178.379 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.701 HG21 HD23 ' A' ' 60' ' ' LEU . 41.4 pt -126.5 158.64 36.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.855 0.36 . . . . 0.0 111.119 -179.44 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 17.2 t -146.78 153.19 12.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.258 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 2.6 mmm180 -109.87 116.9 32.48 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.47 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 . . . . . 0 N--CA 1.456 -0.158 0 CA-C-O 120.678 0.275 . . . . 0.0 110.628 -179.994 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.662 0.268 . . . . 0.0 110.721 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 305' ' ' THR . . . . . . . . . . . . . 4.7 m -122.7 114.88 21.17 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.21 -0.45 . . . . 17.879999999999999 110.923 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 306' ' ' TRP . . . . . 0.402 ' CH2' ' HG3' ' A' ' 49' ' ' ARG . 98.9 m95 -78.75 104.79 9.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.797 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 307' ' ' VAL . . . . . 0.447 HG22 ' O ' ' A' ' 25' ' ' PHE . 17.0 m . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.264 -0.874 . . . . 16.109999999999999 111.135 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.2 tm-20 . . . . . 0 C--O 1.233 0.197 0 CA-C-O 120.783 0.325 . . . . 0.0 110.941 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.1 pt -149.61 159.59 5.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-O 120.824 0.345 . . . . 0.0 111.8 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.434 ' HG3' HD13 ' A' ' 96' ' ' ILE . 10.2 ttm-85 -116.6 153.32 32.46 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.264 -178.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.406 ' HB ' HD22 ' A' ' 59' ' ' LEU . 14.9 m -141.91 144.04 26.02 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.356 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 2.4 ttt-85 -108.09 115.58 30.39 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.5 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.0 t -109.34 121.52 62.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-O 120.896 0.379 . . . . 0.0 111.459 -179.435 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.555 ' HG3' HG22 ' A' ' 92' ' ' THR . 5.3 mp0 -96.79 114.7 26.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.206 179.252 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.5 ' HD3' HD12 ' A' ' 23' ' ' LEU . 19.2 mtmt -75.23 119.97 20.09 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.929 0.395 . . . . 0.0 111.262 -179.473 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -163.59 86.87 1.25 Allowed Pre-proline 0 CA--C 1.536 0.425 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.712 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -84.59 -13.43 37.69 Favored 'Cis proline' 0 C--N 1.364 1.345 0 CA-C-N 119.548 0.874 . . . . 0.0 113.595 0.471 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -136.78 -175.95 4.2 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.892 0.377 . . . . 0.0 111.176 -179.287 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.5 HD12 ' HD3' ' A' ' 19' ' ' LYS . 1.5 mp -63.44 -52.22 62.39 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.3 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 102.88 29.99 5.63 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 120.862 -0.685 . . . . 0.0 113.586 179.082 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.418 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 32.1 p90 -162.15 146.53 12.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 117.053 0.426 . . . . 0.0 110.919 179.392 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.5 p -97.15 155.55 16.78 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.367 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.772 HD11 HG22 ' A' ' 83' ' ' VAL . 29.0 pt -124.21 154.06 30.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.306 179.196 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 48.1 t -145.78 171.94 14.04 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.835 0.35 . . . . 0.0 111.165 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 92.14 -137.72 13.87 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.584 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.45 155.01 29.98 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.25 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.495 HG21 ' HA ' ' A' ' 76' ' ' ASN . 34.8 t -78.69 97.38 2.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.014 0.435 . . . . 0.0 110.705 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 98.86 -1.87 58.16 Favored Glycine 0 CA--C 1.531 1.067 0 CA-C-N 115.844 -0.616 . . . . 0.0 113.723 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -72.34 -154.62 2.29 Favored Glycine 0 C--N 1.343 0.932 0 CA-C-N 117.856 0.828 . . . . 0.0 113.098 -179.475 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 4.5 mtt85 -72.7 -29.06 63.07 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 111.656 0.243 . . . . 0.0 111.656 -179.397 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 124.32 -163.49 18.08 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.908 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -170.74 132.69 0.93 Allowed Pre-proline 0 CA--C 1.536 0.428 0 O-C-N 123.026 -0.102 . . . . 0.0 110.744 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -91.52 44.15 0.44 Allowed 'Trans proline' 0 C--N 1.358 1.069 0 C-N-CA 122.178 1.918 . . . . 0.0 113.073 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -122.84 -57.77 1.7 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.226 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 6.1 mmp_? -113.3 145.25 32.84 Favored Pre-proline 0 N--CA 1.467 0.382 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.991 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -88.78 -56.45 0.02 OUTLIER 'Trans proline' 0 C--N 1.36 1.181 0 C-N-CA 122.041 1.827 . . . . 0.0 113.125 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -86.51 -7.63 58.23 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -104.0 121.23 42.73 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 117.967 0.349 . . . . 0.0 111.02 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.7 p30 -110.8 40.34 2.03 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 121.042 0.448 . . . . 0.0 110.834 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -84.37 -157.19 25.95 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.976 -0.631 . . . . 0.0 112.732 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 19.6 mm -110.53 122.4 64.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.522 0.201 . . . . 0.0 110.563 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -122.07 144.76 48.72 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 120.899 0.381 . . . . 0.0 111.392 -179.381 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 22.7 t -86.37 75.87 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.161 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.408 HG23 ' N ' ' A' ' 49' ' ' ARG . 4.7 t -33.87 -52.88 0.44 Allowed 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 -178.799 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.408 ' N ' HG23 ' A' ' 48' ' ' THR . 5.8 ptt85 -160.35 179.09 8.95 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.074 0.464 . . . . 0.0 111.737 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 15.8 t -134.48 146.92 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.782 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -104.87 -68.17 0.04 OUTLIER Pre-proline 0 CA--C 1.536 0.441 0 CA-C-N 116.704 -0.225 . . . . 0.0 111.267 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -78.34 112.62 3.23 Favored 'Trans proline' 0 C--N 1.357 1.023 0 C-N-CA 121.654 1.569 . . . . 0.0 112.009 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -72.81 70.92 1.01 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.003 0.43 . . . . 0.0 111.298 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -162.27 -65.77 0.02 OUTLIER Glycine 0 CA--C 1.527 0.787 0 C-N-CA 120.79 -0.719 . . . . 0.0 113.273 -179.461 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -57.05 -76.11 0.02 OUTLIER 'Trans proline' 0 C--N 1.357 1.017 0 C-N-CA 122.086 1.857 . . . . 0.0 113.098 -179.162 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.885 ' HB1' HD12 ' A' ' 60' ' ' LEU . . . -116.38 47.37 1.43 Allowed 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 121.265 0.555 . . . . 0.0 111.636 -179.098 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.7 t -99.73 -63.27 1.14 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.922 179.146 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 44.2 mttp -74.51 -3.91 33.66 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.1 178.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.406 HD22 ' HB ' ' A' ' 15' ' ' VAL . 9.0 mt -99.13 -50.51 4.13 Favored 'General case' 0 C--N 1.343 0.311 0 CA-C-N 118.265 0.484 . . . . 0.0 111.373 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.885 HD12 ' HB1' ' A' ' 56' ' ' ALA . 19.0 mt -102.56 150.34 23.51 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-O 120.818 0.342 . . . . 0.0 111.492 -179.342 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -97.56 140.69 22.14 Favored Pre-proline 0 CA--C 1.535 0.388 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.873 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -63.79 79.06 0.15 Allowed 'Trans proline' 0 C--N 1.362 1.243 0 C-N-CA 122.068 1.845 . . . . 0.0 112.16 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 129.29 41.32 0.26 Allowed Glycine 0 CA--C 1.525 0.68 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.606 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -96.24 -158.25 0.64 Allowed 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 179.25 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 59.5 tttp -144.65 127.53 16.37 Favored 'General case' 0 C--O 1.231 0.081 0 CA-C-O 120.679 0.276 . . . . 0.0 110.942 179.218 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.606 ' N ' HD12 ' A' ' 66' ' ' ILE . 3.3 mp -88.9 115.73 29.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.458 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 13.4 mm -91.38 -39.13 11.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.558 -179.011 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -149.55 150.22 31.93 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.06 0.457 . . . . 0.0 111.365 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.422 ' HB3' ' CE1' ' A' ' 74' ' ' PHE . . . -134.59 115.35 13.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.246 179.254 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 63.3 m-20 46.72 29.27 0.93 Allowed 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 179.304 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 100.08 -7.52 58.77 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 120.892 -0.67 . . . . 0.0 113.889 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -95.35 129.22 42.57 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 117.94 0.87 . . . . 0.0 110.028 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.27 125.27 28.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.816 0.341 . . . . 0.0 111.147 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.422 ' CE1' ' HB3' ' A' ' 69' ' ' ALA . 3.4 m-85 -100.71 22.53 11.8 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.461 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 7.0 tp -102.93 141.4 18.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 O-C-N 122.137 -0.352 . . . . 0.0 110.95 -178.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.495 ' HA ' HG21 ' A' ' 31' ' ' VAL . 2.6 m-20 64.71 11.58 6.92 Favored 'General case' 0 CA--C 1.55 0.947 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -178.841 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 18.0 pt -94.2 164.91 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -177.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -85.69 144.99 27.5 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.542 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.494 ' O ' HG23 ' A' ' 83' ' ' VAL . 1.8 t-160 -48.79 -51.12 30.88 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -179.138 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -55.98 -26.81 49.52 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 120.837 -0.697 . . . . 0.0 113.177 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.7 tp-100 -75.98 -40.97 52.71 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.08 0.467 . . . . 0.0 110.866 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.63 -34.93 77.97 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.539 -179.625 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.772 HG22 HD11 ' A' ' 27' ' ' ILE . 23.5 t -71.99 -42.54 68.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.927 0.394 . . . . 0.0 110.584 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.2 t -61.23 -41.16 96.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.28 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.432 ' O ' HG22 ' A' ' 88' ' ' THR . 25.5 mt -65.82 -45.97 80.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.459 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.433 ' HA ' ' CD2' ' A' ' 89' ' ' PHE . 39.5 mt -64.61 -37.02 86.14 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.112 -0.495 . . . . 0.0 112.195 -178.801 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 34.1 mmtt -71.26 -36.68 71.84 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -178.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.432 HG22 ' O ' ' A' ' 85' ' ' LEU . 9.8 t -73.59 -29.08 62.18 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 -178.377 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.433 ' CD2' ' HA ' ' A' ' 86' ' ' LEU . 16.4 m-85 -50.49 147.22 4.68 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -178.749 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -66.72 -136.6 0.0 OUTLIER 'General case' 0 CA--C 1.556 1.21 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.053 -179.078 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -80.57 -67.88 0.73 Allowed 'General case' 0 C--N 1.352 0.68 0 CA-C-N 119.586 1.085 . . . . 0.0 111.883 -178.586 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.555 HG22 ' HG3' ' A' ' 18' ' ' GLU . 0.9 OUTLIER -81.55 135.35 35.58 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.689 0.281 . . . . 0.0 110.979 -179.553 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.5 t -128.01 122.64 58.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.151 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -89.66 108.33 19.61 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 178.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 12.5 mt -110.12 144.23 39.04 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.011 0.434 . . . . 0.0 111.679 -179.005 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.434 HD13 ' HG3' ' A' ' 14' ' ' ARG . 21.6 mm -106.21 120.8 57.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.604 178.594 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.721 HD13 HD23 ' A' ' 60' ' ' LEU . 23.5 pt -126.84 164.14 27.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.818 0.342 . . . . 0.0 111.313 -179.311 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 22.1 t -149.72 151.87 12.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.245 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -111.97 121.21 44.37 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.268 178.527 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.973 0.416 . . . . 0.0 111.534 -179.262 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 . . . . . 0 C--O 1.232 0.146 0 CA-C-O 121.004 0.431 . . . . 0.0 111.284 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 305' ' ' THR . . . . . . . . . . . . . 5.8 m -138.95 128.8 24.94 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.91 -0.586 . . . . 17.879999999999999 110.339 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 306' ' ' TRP . . . . . . . . . . . . . 88.7 m95 -94.48 114.63 26.67 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.944 0.402 . . . . 0.0 111.224 -179.582 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 307' ' ' VAL . . . . . . . . . . . . . 15.4 m . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.244 -0.884 . . . . 16.109999999999999 111.074 -179.971 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 . . . . . 0 C--O 1.232 0.182 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.558 ' H ' HD13 ' A' ' 13' ' ' ILE . 0.2 OUTLIER -110.81 161.49 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -178.66 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 12.6 mtm180 -112.23 155.72 23.55 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.1 -0.954 . . . . 0.0 110.776 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.441 HG21 HD21 ' A' ' 60' ' ' LEU . 15.9 m -143.82 142.77 24.51 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-O 120.79 0.328 . . . . 0.0 110.911 179.284 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 22.1 ttm180 -107.27 115.02 29.43 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.248 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.9 t -114.53 117.7 56.38 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.972 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.762 ' HG3' HG23 ' A' ' 92' ' ' THR . 1.6 mp0 -93.29 122.75 36.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.635 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.437 ' HD3' HD12 ' A' ' 23' ' ' LEU . 15.3 mtmt -76.68 120.86 22.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.081 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -171.11 88.22 0.47 Allowed Pre-proline 0 CA--C 1.536 0.408 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.726 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -82.69 -18.45 24.91 Favored 'Cis proline' 0 C--N 1.362 1.267 0 CA-C-N 119.477 0.849 . . . . 0.0 113.277 0.506 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -135.31 -178.29 5.04 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.868 0.366 . . . . 0.0 111.755 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.437 HD12 ' HD3' ' A' ' 19' ' ' LYS . 3.0 mp -64.14 -57.27 10.05 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.03 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 103.35 32.46 4.57 Favored Glycine 0 CA--C 1.522 0.493 0 C-N-CA 120.797 -0.716 . . . . 0.0 113.98 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.546 ' O ' HG22 ' B' ' 307' ' ' VAL . 38.7 p90 -162.36 147.25 12.4 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 117.363 0.582 . . . . 0.0 111.191 179.223 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.3 p -100.65 151.4 21.68 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.474 -179.358 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.541 HD11 HG22 ' A' ' 83' ' ' VAL . 28.9 pt -121.71 151.15 25.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.911 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 28.7 t -150.33 164.57 35.46 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.548 0.213 . . . . 0.0 111.44 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 115.05 -94.84 0.69 Allowed Glycine 0 C--N 1.338 0.658 0 C-N-CA 120.972 -0.632 . . . . 0.0 113.797 178.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.515 ' H ' HD13 ' A' ' 45' ' ' ILE . . . 72.18 -134.76 21.82 Favored Glycine 0 CA--C 1.524 0.601 0 C-N-CA 121.24 -0.505 . . . . 0.0 112.597 -179.51 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 23.1 t -148.08 84.55 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 CA-C-O 120.953 0.406 . . . . 0.0 109.962 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 92.44 9.34 61.75 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 120.823 -0.703 . . . . 0.0 113.44 -179.036 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -84.2 -140.68 4.66 Favored Glycine 0 C--N 1.342 0.868 0 CA-C-N 117.705 0.753 . . . . 0.0 112.487 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.22 -28.35 62.81 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 111.745 0.276 . . . . 0.0 111.745 -179.492 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.34 158.87 30.98 Favored Glycine 0 C--N 1.333 0.362 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.772 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -124.96 133.35 24.73 Favored Pre-proline 0 CA--C 1.535 0.371 0 N-CA-C 110.744 -0.095 . . . . 0.0 110.744 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -91.19 26.61 0.45 Allowed 'Trans proline' 0 C--N 1.358 1.03 0 C-N-CA 122.181 1.921 . . . . 0.0 113.451 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -106.62 -53.85 2.56 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.791 0.329 . . . . 0.0 110.6 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 1.2 mmm180 -118.63 137.4 24.81 Favored Pre-proline 0 CA--C 1.535 0.399 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.566 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -86.33 -48.02 0.04 OUTLIER 'Trans proline' 0 C--N 1.357 0.993 0 C-N-CA 121.954 1.77 . . . . 0.0 113.356 -179.198 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -91.63 -10.9 38.72 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -96.64 113.63 25.2 Favored 'General case' 0 C--O 1.231 0.083 0 CA-C-N 117.998 0.363 . . . . 0.0 110.533 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.5 p-10 -100.03 64.62 1.23 Allowed 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 121.123 0.487 . . . . 0.0 111.17 -179.534 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -116.09 -159.02 11.71 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 121.118 -0.563 . . . . 0.0 112.462 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.515 HD13 ' H ' ' A' ' 30' ' ' GLY . 20.8 mm -111.44 133.21 57.79 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-O 120.444 0.164 . . . . 0.0 110.813 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.433 ' N ' ' CD1' ' A' ' 46' ' ' PHE . 4.2 m-85 -129.78 151.02 50.82 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.684 0.278 . . . . 0.0 110.722 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.572 ' CG2' HD11 ' A' ' 66' ' ' ILE . 21.7 t -94.28 77.44 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 CA-C-O 121.01 0.434 . . . . 0.0 111.278 -179.562 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.404 HG23 ' N ' ' A' ' 49' ' ' ARG . 4.9 t -36.36 -54.39 0.83 Allowed 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 -178.748 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.404 ' N ' HG23 ' A' ' 48' ' ' THR . 3.9 ptt-85 -160.46 163.22 33.15 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.113 0.482 . . . . 0.0 112.242 -179.402 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 16.8 t -118.35 149.69 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.562 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.2 mm-40 -104.97 -68.45 0.04 OUTLIER Pre-proline 0 CA--C 1.538 0.51 0 CA-C-O 119.67 -0.205 . . . . 0.0 111.389 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -78.77 121.47 5.06 Favored 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 121.8 1.667 . . . . 0.0 112.242 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -77.22 65.96 2.92 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 120.911 0.386 . . . . 0.0 111.096 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -156.1 -68.14 0.01 OUTLIER Glycine 0 CA--C 1.528 0.885 0 C-N-CA 120.69 -0.767 . . . . 0.0 113.544 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -58.89 -76.82 0.02 OUTLIER 'Trans proline' 0 C--N 1.356 0.966 0 C-N-CA 122.14 1.893 . . . . 0.0 113.435 -178.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.859 ' HB1' HD12 ' A' ' 60' ' ' LEU . . . -110.14 48.74 0.88 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-O 121.218 0.532 . . . . 0.0 111.5 -179.21 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 34.7 t -105.04 -67.45 0.91 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.999 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.85 -12.74 60.22 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.962 179.176 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 69.1 mt -95.09 -58.91 2.02 Favored 'General case' 0 C--N 1.342 0.276 0 O-C-N 122.137 -0.352 . . . . 0.0 111.506 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.859 HD12 ' HB1' ' A' ' 56' ' ' ALA . 22.2 mt -94.18 148.84 21.8 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.706 -179.519 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.7 pm0 -103.53 150.98 38.61 Favored Pre-proline 0 CA--C 1.538 0.488 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.958 178.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -68.8 73.79 0.94 Allowed 'Trans proline' 0 C--N 1.357 1.007 0 C-N-CA 122.247 1.965 . . . . 0.0 114.108 -178.516 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 140.74 39.2 0.08 OUTLIER Glycine 0 C--N 1.338 0.662 0 C-N-CA 120.549 -0.834 . . . . 0.0 113.943 178.392 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -94.33 -163.3 1.03 Allowed 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 117.286 0.543 . . . . 0.0 111.277 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 27.0 tttm -132.92 121.91 23.54 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 110.275 -0.268 . . . . 0.0 110.275 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.572 HD11 ' CG2' ' A' ' 47' ' ' VAL . 3.7 mm -87.27 109.08 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.802 -178.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 18.1 mm -88.25 -44.45 15.68 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -179.066 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.697 ' HB2' HD12 ' A' ' 96' ' ' ILE . 5.7 mt-30 -150.87 152.44 33.69 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -178.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.427 ' HB3' ' CE1' ' A' ' 74' ' ' PHE . . . -132.52 118.76 19.65 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.637 179.259 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 30.3 m-20 46.47 29.77 0.96 Allowed 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 179.272 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 100.16 -3.26 56.79 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 120.936 -0.649 . . . . 0.0 113.925 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -91.23 145.72 24.43 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 117.901 0.851 . . . . 0.0 110.369 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 80.3 p -88.38 108.42 19.34 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.321 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.427 ' CE1' ' HB3' ' A' ' 69' ' ' ALA . 5.2 m-85 -92.72 8.29 39.91 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 112.376 0.509 . . . . 0.0 112.376 179.621 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.433 HG23 ' O ' ' A' ' 75' ' ' ILE . 6.5 tp -86.49 118.25 32.44 Favored 'Isoleucine or valine' 0 C--N 1.341 0.204 0 CA-C-N 118.124 0.42 . . . . 0.0 110.673 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 62.81 75.77 0.39 Allowed 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 121.206 0.527 . . . . 0.0 111.057 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 8.4 pt -147.71 153.91 11.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.543 179.31 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -66.21 140.46 58.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.512 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -50.3 -51.89 41.29 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -179.215 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -54.6 -25.77 36.53 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 120.978 -0.629 . . . . 0.0 112.963 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -77.28 -38.87 49.95 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.916 0.389 . . . . 0.0 110.453 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -70.05 -39.04 75.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.455 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.541 HG22 HD11 ' A' ' 27' ' ' ILE . 29.1 t -70.67 -43.35 77.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.898 0.38 . . . . 0.0 110.638 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 43.2 m -61.49 -39.18 89.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.221 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.541 ' O ' HG22 ' A' ' 88' ' ' THR . 14.3 mt -64.6 -46.51 82.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.103 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.416 ' HA ' ' CD2' ' A' ' 89' ' ' PHE . 31.9 mt -64.29 -39.83 94.72 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.171 -0.468 . . . . 0.0 112.085 -178.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 19.7 mmtp -65.42 -39.69 92.45 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -178.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.541 HG22 ' O ' ' A' ' 85' ' ' LEU . 9.8 t -70.74 -26.24 63.28 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 -178.058 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.416 ' CD2' ' HA ' ' A' ' 86' ' ' LEU . 6.7 m-85 -46.67 170.85 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -178.471 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 7.1 mp0 -88.56 -142.23 0.13 Allowed 'General case' 0 CA--C 1.55 0.947 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.728 -179.332 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 60.9 m-80 -80.08 -66.91 0.82 Allowed 'General case' 0 C--N 1.348 0.537 0 CA-C-N 119.076 0.853 . . . . 0.0 111.08 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.762 HG23 ' HG3' ' A' ' 18' ' ' GLU . 0.2 OUTLIER -78.8 124.1 27.87 Favored 'General case' 0 C--N 1.334 -0.095 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.412 179.804 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 21.9 t -114.16 112.37 39.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.143 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -90.41 111.37 22.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.889 179.487 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 15.8 mt -112.02 153.49 26.77 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 121.071 0.462 . . . . 0.0 112.166 -178.705 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.697 HD12 ' HB2' ' A' ' 68' ' ' GLN . 16.5 mt -118.5 130.52 73.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.794 178.681 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.771 HD13 HD23 ' A' ' 60' ' ' LEU . 29.3 pt -136.69 169.66 19.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.997 0.427 . . . . 0.0 111.925 -179.014 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.404 HG12 ' N ' ' A' ' 99' ' ' ARG . 21.3 t -143.65 154.94 16.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.412 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.404 ' N ' HG12 ' A' ' 98' ' ' VAL . 25.3 mmm180 -116.58 114.33 23.97 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.147 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.344 -179.346 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.699 0.285 . . . . 0.0 110.844 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 305' ' ' THR . . . . . . . . . . . . . 10.0 m -116.59 131.64 56.89 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.312 -0.404 . . . . 17.879999999999999 110.845 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 306' ' ' TRP . . . . . . . . . . . . . 80.3 m95 -91.09 115.52 28.08 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.847 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 307' ' ' VAL . . . . . 0.546 HG22 ' O ' ' A' ' 25' ' ' PHE . 14.1 m . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.229 -0.891 . . . . 16.109999999999999 111.084 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 . . . . . 0 CA--C 1.533 0.307 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 29.6 pt -108.78 166.46 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-O 120.931 0.396 . . . . 0.0 111.843 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 6.2 mtm-85 -114.2 164.26 14.12 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.575 -179.326 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.3 m -148.01 164.67 5.68 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.838 179.111 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 9.2 ttp180 -132.07 119.43 20.98 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.0 t -116.26 130.69 70.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.15 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.83 ' HG2' HG23 ' A' ' 92' ' ' THR . 2.6 mm-40 -105.3 123.79 48.45 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.923 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.538 ' HE2' HD11 ' A' ' 23' ' ' LEU . 11.3 mmtt -70.6 80.01 0.59 Allowed 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 120.805 0.336 . . . . 0.0 111.795 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -137.59 85.68 20.29 Favored Pre-proline 0 CA--C 1.537 0.454 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.068 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -83.57 -24.58 10.79 Favored 'Cis proline' 0 C--N 1.366 1.461 0 CA-C-N 119.55 0.875 . . . . 0.0 113.034 0.421 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -137.46 -177.33 4.74 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 120.799 0.333 . . . . 0.0 111.125 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.538 HD11 ' HE2' ' A' ' 19' ' ' LYS . 4.4 mp -61.94 -57.68 10.81 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.991 179.602 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 99.78 34.25 5.0 Favored Glycine 0 CA--C 1.522 0.513 0 C-N-CA 120.722 -0.751 . . . . 0.0 113.87 179.428 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.419 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 36.3 p90 -160.35 153.06 21.12 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 117.418 0.609 . . . . 0.0 111.184 179.096 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.7 p -105.43 147.95 27.69 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.221 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.659 HD11 HG22 ' A' ' 83' ' ' VAL . 32.4 pt -117.62 148.0 20.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.875 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 65.2 p -140.22 156.57 46.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.745 0.307 . . . . 0.0 111.188 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 109.11 -159.28 14.15 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 121.058 -0.592 . . . . 0.0 112.746 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 108.26 152.75 16.58 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 121.059 -0.591 . . . . 0.0 112.384 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 20.1 t -79.73 106.77 11.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.808 0.337 . . . . 0.0 110.661 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 88.06 -2.1 85.25 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 120.881 -0.675 . . . . 0.0 113.782 -179.525 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -84.44 -155.94 23.58 Favored Glycine 0 C--N 1.341 0.847 0 CA-C-N 117.869 0.835 . . . . 0.0 112.717 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.21 -24.86 65.16 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -179.155 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.61 160.0 35.92 Favored Glycine 0 C--N 1.34 0.793 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.504 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 13.7 p30 -119.59 126.37 26.99 Favored Pre-proline 0 N--CA 1.465 0.301 0 N-CA-C 110.619 -0.141 . . . . 0.0 110.619 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -88.62 51.87 1.77 Allowed 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 121.901 1.734 . . . . 0.0 112.254 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -133.92 -51.37 0.84 Allowed 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.124 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.403 ' HG3' ' CZ ' ' A' ' 46' ' ' PHE . 1.5 mmp_? -110.52 139.04 21.17 Favored Pre-proline 0 N--CA 1.466 0.33 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.879 -179.541 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -85.58 -46.38 0.04 OUTLIER 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 122.038 1.825 . . . . 0.0 113.198 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -94.62 -8.77 37.08 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 -179.232 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -103.1 116.53 32.68 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 118.157 0.435 . . . . 0.0 110.579 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.7 p30 -104.25 35.3 2.74 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.2 -179.453 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -84.23 -156.77 24.79 Favored Glycine 0 CA--C 1.519 0.316 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.29 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 14.4 mm -111.88 142.57 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-O 120.676 0.274 . . . . 0.0 110.692 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.403 ' CZ ' ' HG3' ' A' ' 39' ' ' ARG . 55.0 m-85 -140.15 154.1 46.87 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.162 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.45 HG21 HD22 ' A' ' 60' ' ' LEU . 17.8 t -97.99 75.75 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-O 120.968 0.413 . . . . 0.0 111.191 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.429 HG23 ' N ' ' A' ' 49' ' ' ARG . 10.0 t -35.66 -51.68 0.66 Allowed 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 -178.554 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.429 ' N ' HG23 ' A' ' 48' ' ' THR . 14.5 ptt180 -160.36 175.4 12.85 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.162 0.506 . . . . 0.0 112.137 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 20.5 t -131.28 151.21 35.33 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.673 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.425 ' HG2' ' CH2' ' B' ' 306' ' ' TRP . 7.5 mm-40 -104.38 -67.82 0.04 OUTLIER Pre-proline 0 CA--C 1.537 0.471 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.676 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -77.4 122.46 6.08 Favored 'Trans proline' 0 C--N 1.357 0.977 0 C-N-CA 121.675 1.584 . . . . 0.0 112.233 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -80.16 64.21 4.91 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.091 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -158.43 -70.56 0.01 OUTLIER Glycine 0 CA--C 1.528 0.886 0 C-N-CA 120.703 -0.76 . . . . 0.0 113.564 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.57 -74.45 0.02 OUTLIER 'Trans proline' 0 C--N 1.358 1.06 0 C-N-CA 122.032 1.821 . . . . 0.0 113.355 -178.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.475 ' HB1' HD12 ' A' ' 60' ' ' LEU . . . -106.9 46.76 0.91 Allowed 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 121.083 0.468 . . . . 0.0 111.643 -179.248 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 91.8 p -108.54 -60.39 1.74 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.109 179.526 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 5.7 ttpm? -69.42 -15.52 63.3 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.068 179.246 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 64.2 mt -93.23 -63.35 1.22 Allowed 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.869 0.366 . . . . 0.0 111.158 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.612 HD23 HG21 ' A' ' 97' ' ' ILE . 2.9 mt -91.87 144.03 25.9 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.44 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 5.1 pp0? -117.35 155.79 49.64 Favored Pre-proline 0 CA--C 1.534 0.355 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.449 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -59.19 119.28 6.42 Favored 'Trans proline' 0 C--N 1.357 1.01 0 C-N-CA 121.829 1.686 . . . . 0.0 112.49 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 98.68 5.37 56.73 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 121.05 -0.595 . . . . 0.0 113.827 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -71.13 140.35 50.56 Favored 'General case' 0 C--N 1.343 0.32 0 CA-C-N 118.102 0.951 . . . . 0.0 110.791 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 67.0 tttt -92.61 123.45 35.91 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.926 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 20.0 mt -89.15 115.23 28.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.218 -0.447 . . . . 0.0 109.841 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 19.9 mm -89.53 -42.16 14.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 112.249 0.462 . . . . 0.0 112.249 -178.583 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.879 ' HB3' HD12 ' A' ' 96' ' ' ILE . 22.4 tt0 -152.53 156.97 40.4 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.933 0.397 . . . . 0.0 111.884 -179.148 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -144.67 125.89 14.69 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.194 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.54 ' OD1' HG13 ' A' ' 93' ' ' VAL . 4.3 m-20 45.72 34.45 1.8 Allowed 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 178.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 95.01 -18.03 58.16 Favored Glycine 0 CA--C 1.523 0.593 0 C-N-CA 120.772 -0.728 . . . . 0.0 113.534 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -89.23 126.98 35.72 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 117.353 0.576 . . . . 0.0 110.884 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 8.4 t -72.64 124.52 25.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.937 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -102.75 12.95 35.57 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 6.4 tp -91.0 121.74 41.68 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 CA-C-O 120.944 0.402 . . . . 0.0 110.703 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 5.4 m120 64.24 74.17 0.41 Allowed 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 121.094 0.474 . . . . 0.0 110.721 -179.439 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 13.9 pt -149.77 164.27 3.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.794 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -73.79 144.83 45.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.663 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 6.9 t60 -54.3 -54.35 41.43 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.804 -179.354 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -54.78 -27.46 43.65 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 121.163 -0.541 . . . . 0.0 112.911 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -71.21 -39.29 71.83 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.093 0.473 . . . . 0.0 110.451 179.274 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.19 -52.14 44.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.492 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.659 HG22 HD11 ' A' ' 27' ' ' ILE . 20.8 t -59.68 -43.89 92.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.604 -179.482 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 57.8 m -59.99 -40.9 90.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.534 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 31.2 mt -66.4 -43.93 84.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.53 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.419 HD23 ' CE2' ' A' ' 89' ' ' PHE . 32.6 mt -66.51 -42.6 87.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.796 -179.249 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 42.0 mmtt -65.02 -43.07 93.68 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -178.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 12.1 t -69.43 -25.89 64.34 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -178.39 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.419 ' CE2' HD23 ' A' ' 86' ' ' LEU . 14.7 m-30 -45.56 170.99 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -179.053 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -84.56 -143.01 0.08 Allowed 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.973 -179.224 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 35.9 m120 -83.07 -62.21 1.66 Allowed 'General case' 0 C--N 1.348 0.506 0 CA-C-N 118.992 0.814 . . . . 0.0 111.779 -178.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.83 HG23 ' HG2' ' A' ' 18' ' ' GLU . 0.3 OUTLIER -87.5 129.57 35.02 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.505 -179.65 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.54 HG13 ' OD1' ' A' ' 70' ' ' ASN . 19.1 t -125.41 121.02 59.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.139 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -95.37 105.67 17.65 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.469 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 12.1 mt -99.11 152.55 19.74 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 121.076 0.465 . . . . 0.0 111.673 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.879 HD12 ' HB3' ' A' ' 68' ' ' GLN . 61.1 mt -110.37 126.21 67.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.654 178.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.612 HG21 HD23 ' A' ' 60' ' ' LEU . 43.6 pt -127.95 168.62 20.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.821 0.343 . . . . 0.0 111.622 -178.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.4 t -145.88 151.34 14.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.236 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -114.72 109.68 18.57 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.315 -0.402 . . . . 0.0 109.95 179.292 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.891 -179.107 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.535 0.369 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 305' ' ' THR . . . . . . . . . . . . . 21.0 m -154.67 100.31 2.23 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 114.942 -1.026 . . . . 17.879999999999999 109.698 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 306' ' ' TRP . . . . . 0.425 ' CH2' ' HG2' ' A' ' 51' ' ' GLN . 83.4 m95 -60.6 123.0 16.11 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.995 0.426 . . . . 0.0 111.684 -179.045 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 307' ' ' VAL . . . . . 0.531 HG12 HG13 ' A' ' 83' ' ' VAL . 16.0 m . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.273 -0.87 . . . . 16.109999999999999 111.174 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.535 0.369 0 CA-C-O 120.637 0.256 . . . . 0.0 110.885 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.604 HD13 ' N ' ' A' ' 13' ' ' ILE . 0.2 OUTLIER -150.4 163.56 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-O 120.61 0.243 . . . . 0.0 111.571 179.89 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 57.9 mtt180 -116.78 164.72 14.23 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.879 -179.536 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.424 HG21 HD21 ' A' ' 60' ' ' LEU . 15.0 m -146.08 161.15 11.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.027 179.307 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.39 120.83 23.62 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.659 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.7 t -125.71 135.55 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.793 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.406 ' HG3' HG23 ' A' ' 92' ' ' THR . 2.9 mp0 -107.44 127.86 53.97 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.742 0.306 . . . . 0.0 111.418 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.46 112.45 6.75 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.13 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -173.75 83.45 0.38 Allowed Pre-proline 0 CA--C 1.54 0.566 0 CA-C-N 116.488 -0.323 . . . . 0.0 111.31 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -83.84 -23.3 12.93 Favored 'Cis proline' 0 C--N 1.366 1.463 0 CA-C-N 119.359 0.807 . . . . 0.0 112.888 0.24 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -137.41 -177.97 5.01 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.745 0.307 . . . . 0.0 110.955 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.612 HD13 HG23 ' B' ' 307' ' ' VAL . 3.2 mp -65.66 -54.35 28.8 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.963 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.592 ' O ' HG13 ' A' ' 50' ' ' VAL . . . 109.83 32.93 2.74 Favored Glycine 0 C--N 1.334 0.426 0 C-N-CA 120.837 -0.697 . . . . 0.0 113.543 179.17 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.409 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 35.8 p90 -167.21 179.38 5.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 117.008 0.404 . . . . 0.0 111.069 179.478 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.0 p -131.39 162.4 30.24 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.205 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.693 HD11 HG22 ' A' ' 83' ' ' VAL . 37.4 pt -127.38 154.89 38.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.879 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 39.1 t -145.14 166.51 25.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.014 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 101.01 -147.52 17.85 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.635 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 105.47 152.97 21.2 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.932 -0.652 . . . . 0.0 112.446 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.46 HG21 ' HA ' ' A' ' 76' ' ' ASN . 32.2 t -79.81 108.1 12.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.913 0.387 . . . . 0.0 110.587 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 90.28 -1.06 79.16 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 120.946 -0.645 . . . . 0.0 113.844 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -83.82 -149.45 9.54 Favored Glycine 0 C--N 1.342 0.903 0 CA-C-N 117.866 0.833 . . . . 0.0 112.887 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 52.0 mtt85 -81.34 -18.32 46.12 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -179.397 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.06 -177.89 49.41 Favored Glycine 0 C--N 1.338 0.652 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.757 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -136.82 157.78 74.23 Favored Pre-proline 0 CA--C 1.533 0.301 0 O-C-N 123.041 -0.093 . . . . 0.0 110.78 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -87.87 17.71 1.65 Allowed 'Trans proline' 0 C--N 1.358 1.068 0 C-N-CA 122.147 1.898 . . . . 0.0 113.781 -179.409 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -101.77 -41.07 6.66 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.87 0.367 . . . . 0.0 110.626 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 11.2 mmp_? -129.99 132.06 23.88 Favored Pre-proline 0 CA--C 1.533 0.322 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.332 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -83.05 -40.39 0.11 Allowed 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 121.887 1.725 . . . . 0.0 113.089 -179.378 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -99.92 -4.23 30.65 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -179.405 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -90.63 122.67 33.62 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 118.2 0.455 . . . . 0.0 110.912 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -102.18 40.82 1.29 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.132 -179.615 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -98.9 -170.77 31.22 Favored Glycine 0 C--N 1.333 0.387 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.507 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 22.0 mm -110.26 127.69 67.03 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-N 116.569 0.184 . . . . 0.0 110.51 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.44 ' CD1' ' N ' ' A' ' 46' ' ' PHE . 4.0 m-85 -128.29 146.77 50.65 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.762 0.315 . . . . 0.0 111.529 -179.454 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 21.4 t -86.7 79.57 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-O 120.98 0.419 . . . . 0.0 111.077 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.5 t -36.24 -55.22 0.8 Allowed 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 114.849 1.426 . . . . 0.0 114.849 -178.601 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -160.07 -179.55 7.87 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.218 0.532 . . . . 0.0 112.392 -179.049 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.592 HG13 ' O ' ' A' ' 24' ' ' GLY . 13.7 t -138.48 145.55 28.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.498 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.403 ' HG3' ' CH2' ' B' ' 306' ' ' TRP . 15.3 mt-30 -104.55 -68.71 0.04 OUTLIER Pre-proline 0 CA--C 1.537 0.459 0 N-CA-C 111.59 0.218 . . . . 0.0 111.59 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.401 ' HD3' ' CB ' ' A' ' 51' ' ' GLN . 81.4 Cg_endo -81.16 113.84 2.75 Favored 'Trans proline' 0 C--N 1.357 1.005 0 C-N-CA 121.661 1.574 . . . . 0.0 112.304 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -77.78 70.36 4.14 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.138 0.494 . . . . 0.0 110.936 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -145.37 -71.45 0.02 OUTLIER Glycine 0 CA--C 1.526 0.762 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.643 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -58.59 -71.93 0.03 OUTLIER 'Trans proline' 0 C--N 1.357 0.998 0 C-N-CA 122.021 1.814 . . . . 0.0 112.796 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.559 ' HB1' HD12 ' A' ' 60' ' ' LEU . . . -105.87 47.34 0.88 Allowed 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 121.217 0.532 . . . . 0.0 111.263 -179.517 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 98.1 p -83.2 -59.73 2.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.965 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 37.2 tptt -88.21 4.42 45.79 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.016 178.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.475 ' N ' HD22 ' A' ' 59' ' ' LEU . 3.6 mm? -92.6 -64.87 1.05 Allowed 'General case' 0 C--N 1.343 0.302 0 CA-C-N 118.16 0.436 . . . . 0.0 111.727 -179.619 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.559 HD12 ' HB1' ' A' ' 56' ' ' ALA . 3.1 mt -100.9 145.4 28.67 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.159 0.504 . . . . 0.0 112.223 -178.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -107.28 142.51 25.25 Favored Pre-proline 0 CA--C 1.534 0.358 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.996 179.194 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.02 131.29 45.52 Favored 'Trans proline' 0 C--N 1.357 1.0 0 C-N-CA 121.899 1.733 . . . . 0.0 113.159 -179.18 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 81.72 32.25 30.65 Favored Glycine 0 C--N 1.33 0.235 0 CA-C-N 115.979 -0.555 . . . . 0.0 113.55 179.082 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -88.28 -169.51 2.59 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 117.027 0.414 . . . . 0.0 110.898 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 78.1 tttt -138.44 125.64 21.54 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.975 -179.745 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 34.3 mt -94.36 122.53 45.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.501 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 26.0 mm -104.5 -36.82 4.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -179.054 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.575 ' HB3' HD12 ' A' ' 96' ' ' ILE . 0.1 OUTLIER -148.87 149.46 31.31 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.974 0.416 . . . . 0.0 111.827 -179.185 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.462 ' HB3' ' CE1' ' A' ' 74' ' ' PHE . . . -145.77 122.46 11.17 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.334 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.3 m120 45.94 38.3 4.44 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 179.059 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 84.42 11.21 78.38 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 121.007 -0.616 . . . . 0.0 113.87 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -113.44 121.8 45.38 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 117.69 0.745 . . . . 0.0 110.238 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 79.9 p -72.74 135.78 45.39 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.661 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.462 ' CE1' ' HB3' ' A' ' 69' ' ' ALA . 5.1 m-85 -104.59 23.51 13.21 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.423 HD13 ' HA ' ' A' ' 75' ' ' ILE . 11.4 mm -97.41 139.77 19.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-O 121.032 0.444 . . . . 0.0 109.921 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.46 ' HA ' HG21 ' A' ' 31' ' ' VAL . 7.9 m120 61.47 16.69 7.77 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.446 HD13 ' HA ' ' A' ' 74' ' ' PHE . 25.9 pt -95.29 163.8 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -179.065 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -91.67 149.69 21.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.173 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 15.3 t60 -46.41 -51.89 14.1 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -179.308 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -56.13 -26.91 50.73 Favored Glycine 0 CA--C 1.523 0.573 0 C-N-CA 120.985 -0.626 . . . . 0.0 113.176 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -74.56 -42.97 57.84 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 120.954 0.407 . . . . 0.0 110.476 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.25 -42.49 99.18 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.374 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.693 HG22 HD11 ' A' ' 27' ' ' ILE . 18.0 t -73.71 -40.99 54.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.753 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 43.7 t -62.19 -46.76 87.47 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.353 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 31.5 mt -61.16 -49.83 75.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.72 -179.456 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.739 HD21 HD21 ' A' ' 95' ' ' LEU . 17.3 mt -64.1 -37.68 88.31 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -178.844 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 9.2 mmtp -71.04 -39.82 72.06 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -178.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 11.4 t -71.87 -27.31 62.78 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 -178.007 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.411 ' CD2' ' HA ' ' A' ' 86' ' ' LEU . 9.6 m-85 -46.74 170.9 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -178.659 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -83.85 -142.85 0.07 Allowed 'General case' 0 CA--C 1.55 0.968 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.834 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -79.48 -70.3 0.52 Allowed 'General case' 0 C--N 1.348 0.523 0 CA-C-N 119.22 0.918 . . . . 0.0 111.501 -179.501 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.406 HG23 ' HG3' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -75.24 123.45 25.32 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.634 -179.687 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.503 HG12 ' CD1' ' A' ' 95' ' ' LEU . 14.2 t -121.04 120.82 63.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.723 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -99.91 107.17 19.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.54 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.739 HD21 HD21 ' A' ' 86' ' ' LEU . 6.2 mp -107.13 161.76 14.48 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 121.054 0.455 . . . . 0.0 111.788 -179.411 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.575 HD12 ' HB3' ' A' ' 68' ' ' GLN . 21.5 mt -123.64 132.23 71.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.402 178.491 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.421 HD13 HD23 ' A' ' 60' ' ' LEU . 43.9 pt -126.38 175.64 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-O 120.689 0.281 . . . . 0.0 111.625 -178.605 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 17.2 t -150.22 143.96 17.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-O 120.934 0.397 . . . . 0.0 112.034 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.01 116.91 30.68 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 178.367 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 . . . . . 0 C--N 1.332 -0.17 0 CA-C-O 121.047 0.451 . . . . 0.0 111.811 -178.787 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 . . . . . 0 N--CA 1.461 0.116 0 CA-C-O 120.911 0.386 . . . . 0.0 111.082 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 305' ' ' THR . . . . . . . . . . . . . 15.2 m -142.24 132.28 24.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.948 -0.569 . . . . 17.879999999999999 110.368 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 306' ' ' TRP . . . . . 0.403 ' CH2' ' HG3' ' A' ' 51' ' ' GLN . 81.0 m95 -88.39 121.73 31.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.335 -179.373 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 307' ' ' VAL . . . . . 0.612 HG23 HD13 ' A' ' 23' ' ' LEU . 23.8 m . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.314 -0.851 . . . . 16.109999999999999 111.167 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 . . . . . 0 N--CA 1.463 0.211 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.6 pt -148.21 159.14 7.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -178.019 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.737 ' HG3' HD13 ' A' ' 96' ' ' ILE . 13.3 ttp-105 -119.52 157.01 29.21 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.639 -179.436 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 17.6 m -150.93 152.67 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 2.0 ptp180 -114.92 129.02 56.62 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.025 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.2 t -113.54 119.57 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.789 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -93.54 121.48 35.0 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.648 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.91 116.07 10.79 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.752 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -175.85 81.39 0.29 Allowed Pre-proline 0 CA--C 1.538 0.509 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.753 179.515 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -84.85 -22.97 12.86 Favored 'Cis proline' 0 C--N 1.363 1.294 0 CA-C-N 119.327 0.795 . . . . 0.0 113.333 0.542 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -137.93 -179.18 5.61 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.946 0.403 . . . . 0.0 112.06 -179.364 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.4 mp -61.82 -61.17 2.69 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.293 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.417 ' O ' HG13 ' A' ' 50' ' ' VAL . . . 109.25 20.55 7.81 Favored Glycine 0 CA--C 1.523 0.568 0 C-N-CA 120.788 -0.72 . . . . 0.0 113.796 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -151.0 155.67 39.53 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 117.52 0.66 . . . . 0.0 111.393 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -110.11 151.94 26.62 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.537 -179.187 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.619 HD11 HG22 ' A' ' 83' ' ' VAL . 12.1 pt -121.07 151.67 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.465 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.3 m -150.29 163.12 39.1 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.345 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 120.75 -89.57 0.45 Allowed Glycine 0 C--N 1.337 0.618 0 C-N-CA 121.034 -0.603 . . . . 0.0 113.379 179.127 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.432 ' H ' HD13 ' A' ' 45' ' ' ILE . . . 66.91 -138.45 35.08 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.938 -0.649 . . . . 0.0 112.427 -179.49 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.49 HG12 ' O ' ' A' ' 31' ' ' VAL . 47.0 t -131.42 57.95 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-O 121.145 0.497 . . . . 0.0 111.38 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 92.15 -7.5 78.43 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 115.09 0.796 . . . . 0.0 115.09 178.236 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -97.68 26.88 21.34 Favored Glycine 0 C--N 1.339 0.75 0 CA-C-N 118.092 0.946 . . . . 0.0 113.642 -179.258 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -173.12 -42.22 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 178.585 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.86 146.66 0.74 Allowed Glycine 0 CA--C 1.521 0.419 0 CA-C-N 115.877 -0.602 . . . . 0.0 112.966 179.663 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -123.94 137.58 29.12 Favored Pre-proline 0 CA--C 1.534 0.332 0 N-CA-C 110.541 -0.17 . . . . 0.0 110.541 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -91.47 24.44 0.55 Allowed 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 122.289 1.992 . . . . 0.0 113.593 -179.108 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -107.94 -52.84 2.71 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.759 0.314 . . . . 0.0 110.813 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -119.58 133.37 23.82 Favored Pre-proline 0 N--CA 1.466 0.372 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.359 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -84.61 -46.59 0.05 OUTLIER 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 121.869 1.713 . . . . 0.0 113.086 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 13.1 p-10 -88.06 -9.48 53.21 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -179.559 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -100.89 118.05 36.16 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 118.056 0.389 . . . . 0.0 110.725 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.8 p30 -106.79 66.7 0.69 Allowed 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 121.15 0.5 . . . . 0.0 110.912 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.478 ' O ' HD13 ' A' ' 45' ' ' ILE . . . -114.98 -143.79 8.21 Favored Glycine 0 CA--C 1.519 0.308 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.366 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.478 HD13 ' O ' ' A' ' 44' ' ' GLY . 21.5 mm -125.68 128.14 72.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.607 0.241 . . . . 0.0 110.735 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -121.6 147.46 45.81 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.075 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 21.7 t -92.07 71.89 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.04 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.421 HG23 ' N ' ' A' ' 49' ' ' ARG . 10.1 t -35.78 -54.13 0.73 Allowed 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 -178.415 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.421 ' N ' HG23 ' A' ' 48' ' ' THR . 0.0 OUTLIER -160.03 168.49 25.47 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.945 0.721 . . . . 0.0 112.945 -178.969 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.417 HG13 ' O ' ' A' ' 24' ' ' GLY . 17.3 t -124.89 150.98 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.401 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.4 ' CB ' ' HD3' ' A' ' 52' ' ' PRO . 4.5 mm-40 -105.54 -68.99 0.03 OUTLIER Pre-proline 0 CA--C 1.539 0.547 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.4 ' HD3' ' CB ' ' A' ' 51' ' ' GLN . 87.8 Cg_endo -80.93 121.68 4.11 Favored 'Trans proline' 0 C--N 1.359 1.091 0 C-N-CA 121.861 1.707 . . . . 0.0 112.818 -179.57 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -74.84 67.66 1.66 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 120.968 0.413 . . . . 0.0 111.328 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -156.81 -67.33 0.01 OUTLIER Glycine 0 CA--C 1.528 0.904 0 C-N-CA 120.803 -0.713 . . . . 0.0 113.476 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -58.63 -78.06 0.02 OUTLIER 'Trans proline' 0 C--N 1.357 0.983 0 C-N-CA 122.081 1.854 . . . . 0.0 113.499 -179.046 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.888 ' HB1' HD12 ' A' ' 60' ' ' LEU . . . -117.06 53.96 0.89 Allowed 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 121.255 0.55 . . . . 0.0 111.929 -179.167 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 77.8 p -108.14 -65.12 1.15 Allowed 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 178.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.14 -14.43 61.8 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.18 178.182 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 65.0 mt -92.66 -57.42 2.67 Favored 'General case' 0 C--N 1.344 0.329 0 O-C-N 122.137 -0.352 . . . . 0.0 110.901 179.429 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.888 HD12 ' HB1' ' A' ' 56' ' ' ALA . 27.9 mt -96.24 146.92 24.29 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.291 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.75 145.7 50.53 Favored Pre-proline 0 N--CA 1.47 0.567 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.97 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_exo -58.32 127.18 23.8 Favored 'Trans proline' 0 C--N 1.362 1.263 0 C-N-CA 122.35 2.034 . . . . 0.0 113.689 -178.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 106.65 8.35 32.64 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 120.906 -0.664 . . . . 0.0 114.435 178.603 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -93.71 146.89 23.52 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 117.821 0.81 . . . . 0.0 111.575 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 51.5 tttt -98.71 133.08 43.54 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.699 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 29.3 mt -89.29 119.74 36.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.467 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 20.5 mm -89.83 -38.68 11.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -178.781 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -155.36 154.66 32.35 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 121.059 0.457 . . . . 0.0 112.033 -179.246 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -141.93 123.87 15.31 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.966 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 42.91 41.69 2.71 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 179.008 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 84.97 -0.48 89.09 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 120.9 -0.666 . . . . 0.0 114.152 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -108.4 124.47 50.44 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 117.953 0.877 . . . . 0.0 110.914 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 30.6 t -70.9 131.62 44.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.694 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -101.7 19.8 17.44 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -179.135 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 28.7 mm -92.46 121.09 42.77 Favored 'Isoleucine or valine' 0 C--N 1.339 0.12 0 CA-C-O 120.766 0.317 . . . . 0.0 110.664 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 57.1 m-20 61.87 74.88 0.43 Allowed 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.209 0.528 . . . . 0.0 110.743 -179.435 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 10.3 pt -146.57 150.27 15.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.914 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -68.92 136.54 52.74 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.998 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.587 ' O ' HG23 ' A' ' 83' ' ' VAL . 36.7 t60 -43.47 -45.92 6.6 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -179.112 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -59.39 -28.69 65.04 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.457 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 3.7 tp-100 -72.65 -44.47 61.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.918 0.39 . . . . 0.0 110.639 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.87 -37.95 85.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.257 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.619 HG22 HD11 ' A' ' 27' ' ' ILE . 24.2 t -75.06 -42.48 45.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.946 0.403 . . . . 0.0 110.755 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 42.2 t -62.81 -41.65 99.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.142 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' A' ' 85' ' ' LEU . 27.4 mt -65.27 -46.75 79.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.455 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.429 ' HA ' ' CD2' ' A' ' 89' ' ' PHE . 27.2 mt -65.94 -30.87 71.52 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.147 -0.479 . . . . 0.0 112.169 -178.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 30.0 mmtt -77.13 -35.44 56.17 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -179.174 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 9.7 t -75.52 -26.68 58.28 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -178.374 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.429 ' CD2' ' HA ' ' A' ' 86' ' ' LEU . 21.0 m-85 -52.56 149.36 5.97 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.145 0.498 . . . . 0.0 112.134 -179.196 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -65.18 -136.65 0.0 OUTLIER 'General case' 0 CA--C 1.555 1.161 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.557 -179.149 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -80.3 -70.36 0.53 Allowed 'General case' 0 C--N 1.351 0.665 0 CA-C-N 119.588 1.086 . . . . 0.0 112.613 -179.045 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.8 p -78.34 127.53 32.35 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.792 0.329 . . . . 0.0 111.3 -179.038 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.466 ' O ' HD12 ' A' ' 95' ' ' LEU . 21.8 t -117.2 114.08 44.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.719 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -89.67 111.86 22.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.515 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.466 HD12 ' O ' ' A' ' 93' ' ' VAL . 4.0 mp -112.96 151.52 30.47 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.982 0.42 . . . . 0.0 111.781 -179.345 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.737 HD13 ' HG3' ' A' ' 14' ' ' ARG . 17.6 mm -107.6 121.93 61.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.9 178.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.459 HD13 HD23 ' A' ' 60' ' ' LEU . 22.4 pt -129.05 163.1 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-O 120.809 0.338 . . . . 0.0 111.881 -179.147 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.431 HG12 ' N ' ' A' ' 99' ' ' ARG . 14.3 t -150.76 155.72 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.727 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.431 ' N ' HG12 ' A' ' 98' ' ' VAL . 32.9 mmm-85 -110.5 122.43 47.73 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.767 177.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 . . . . . 0 C--N 1.328 -0.331 0 CA-C-O 120.852 0.358 . . . . 0.0 111.156 -179.598 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.763 0.316 . . . . 0.0 110.988 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 305' ' ' THR . . . . . . . . . . . . . 80.7 m -123.93 122.5 38.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.039 -0.528 . . . . 17.879999999999999 110.669 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 306' ' ' TRP . . . . . . . . . . . . . 86.1 m95 -78.16 107.84 11.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.891 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 307' ' ' VAL . . . . . 0.414 HG12 HG13 ' A' ' 83' ' ' VAL . 17.5 m . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.257 -0.878 . . . . 16.109999999999999 111.153 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.466 0.331 0 CA-C-O 120.58 0.229 . . . . 0.0 111.265 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.9 pt -107.94 162.49 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-N 116.204 -0.453 . . . . 0.0 112.164 -179.324 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.513 ' HG3' HD13 ' A' ' 96' ' ' ILE . 14.5 ttm105 -116.98 152.86 33.7 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.987 -179.278 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.1 m -143.2 144.12 24.1 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.668 179.106 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 11.6 ttp-105 -116.73 130.58 56.81 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.804 0.335 . . . . 0.0 111.293 -179.455 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.0 t -123.49 125.57 71.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.07 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.516 ' HG3' HG22 ' A' ' 92' ' ' THR . 6.1 mp0 -92.21 119.77 32.15 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.892 0.377 . . . . 0.0 111.086 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -71.18 119.75 15.77 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.091 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -174.65 82.72 0.34 Allowed Pre-proline 0 CA--C 1.539 0.556 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.077 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo -86.84 -18.93 19.75 Favored 'Cis proline' 0 C--N 1.365 1.409 0 CA-C-N 119.407 0.824 . . . . 0.0 113.228 0.412 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -133.44 -178.56 5.04 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.829 0.347 . . . . 0.0 111.383 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.417 ' HB3' ' CE2' ' A' ' 25' ' ' PHE . 2.9 mp -65.63 -56.16 13.69 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.707 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.453 ' O ' HG13 ' A' ' 50' ' ' VAL . . . 107.66 32.5 3.36 Favored Glycine 0 CA--C 1.52 0.383 0 C-N-CA 120.932 -0.652 . . . . 0.0 113.7 179.138 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.417 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 42.1 p90 -163.74 152.81 14.12 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 117.163 0.482 . . . . 0.0 111.175 179.232 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.9 p -104.25 150.45 24.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.456 -179.377 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.783 HD11 HG22 ' A' ' 83' ' ' VAL . 22.5 pt -117.67 144.58 25.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.49 179.349 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 77.8 p -131.52 157.34 43.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.767 0.318 . . . . 0.0 110.893 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 107.98 -156.19 15.92 Favored Glycine 0 C--N 1.33 0.234 0 C-N-CA 121.014 -0.613 . . . . 0.0 112.453 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 110.85 148.48 11.49 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.995 -0.621 . . . . 0.0 112.507 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.432 HG21 ' HA ' ' A' ' 76' ' ' ASN . 41.3 t -80.48 100.28 4.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.956 0.408 . . . . 0.0 110.903 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 94.79 2.28 63.01 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 120.99 -0.624 . . . . 0.0 114.139 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.97 -154.84 28.09 Favored Glycine 0 C--N 1.341 0.858 0 CA-C-N 117.827 0.813 . . . . 0.0 112.981 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 1.9 mtt180 -62.66 -22.85 66.77 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.79 160.12 35.49 Favored Glycine 0 C--N 1.336 0.537 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.843 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -114.62 136.15 22.4 Favored Pre-proline 0 CA--C 1.535 0.392 0 N-CA-C 110.556 -0.164 . . . . 0.0 110.556 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -87.91 13.28 2.64 Favored 'Trans proline' 0 C--N 1.357 1.0 0 C-N-CA 122.018 1.812 . . . . 0.0 113.98 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -99.64 -41.55 7.27 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.666 0.269 . . . . 0.0 111.178 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.76 136.15 27.99 Favored Pre-proline 0 N--CA 1.466 0.374 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.714 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -85.63 -44.58 0.05 OUTLIER 'Trans proline' 0 C--N 1.358 1.049 0 C-N-CA 122.052 1.835 . . . . 0.0 113.413 -179.215 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -92.64 -9.0 42.51 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -179.535 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -95.68 117.93 31.41 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-N 118.097 0.408 . . . . 0.0 110.339 179.469 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -105.09 38.56 1.91 Allowed 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.509 -179.177 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.52 ' O ' HD13 ' A' ' 45' ' ' ILE . . . -92.28 -148.67 23.11 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 120.867 -0.683 . . . . 0.0 111.846 179.198 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.52 HD13 ' O ' ' A' ' 44' ' ' GLY . 20.8 mm -125.52 140.22 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 116.798 0.299 . . . . 0.0 110.842 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -137.81 151.01 47.67 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.12 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 21.7 t -90.56 73.69 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-O 121.126 0.488 . . . . 0.0 111.084 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.43 HG23 ' N ' ' A' ' 49' ' ' ARG . 9.7 t -36.24 -53.17 0.82 Allowed 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 114.745 1.387 . . . . 0.0 114.745 -178.476 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.43 ' N ' HG23 ' A' ' 48' ' ' THR . 11.8 ptm180 -161.24 172.79 16.06 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.213 0.53 . . . . 0.0 112.291 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.453 HG13 ' O ' ' A' ' 24' ' ' GLY . 19.4 t -127.47 147.19 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.445 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.416 ' CG ' ' CH2' ' B' ' 306' ' ' TRP . 4.6 mm-40 -102.1 -69.67 0.04 OUTLIER Pre-proline 0 CA--C 1.537 0.446 0 CA-C-O 119.629 -0.224 . . . . 0.0 110.983 179.509 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.402 ' HD3' ' CB ' ' A' ' 51' ' ' GLN . 95.0 Cg_endo -80.91 114.93 2.97 Favored 'Trans proline' 0 C--N 1.359 1.112 0 C-N-CA 121.653 1.569 . . . . 0.0 112.036 179.389 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -74.89 68.4 1.76 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 121.025 0.44 . . . . 0.0 111.098 -179.611 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -150.94 -71.15 0.01 OUTLIER Glycine 0 CA--C 1.528 0.872 0 C-N-CA 120.668 -0.777 . . . . 0.0 113.714 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -59.7 -77.49 0.02 OUTLIER 'Trans proline' 0 C--N 1.358 1.06 0 C-N-CA 121.928 1.752 . . . . 0.0 113.465 -178.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.797 ' HB1' HD12 ' A' ' 60' ' ' LEU . . . -106.8 49.57 0.8 Allowed 'General case' 0 CA--C 1.529 0.152 0 CA-C-O 121.401 0.619 . . . . 0.0 111.194 -179.39 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.9 t -100.86 -61.41 1.37 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.117 179.514 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.7 ttpt -74.35 -7.68 53.69 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.106 178.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 20.7 mt -92.69 -59.02 2.17 Favored 'General case' 0 C--N 1.344 0.333 0 CA-C-N 118.219 0.463 . . . . 0.0 110.9 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.797 HD12 ' HB1' ' A' ' 56' ' ' ALA . 11.6 mt -93.36 143.29 26.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.299 -179.693 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -112.44 141.27 24.89 Favored Pre-proline 0 CA--C 1.534 0.365 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.258 179.498 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -57.62 122.55 11.96 Favored 'Trans proline' 0 C--N 1.358 1.045 0 C-N-CA 121.784 1.656 . . . . 0.0 112.777 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.57 16.6 21.84 Favored Glycine 0 CA--C 1.522 0.507 0 C-N-CA 120.971 -0.633 . . . . 0.0 113.932 179.068 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -94.29 147.36 23.27 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 117.559 0.68 . . . . 0.0 110.772 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 58.5 tttm -96.74 135.76 38.23 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.153 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 29.3 mt -95.67 123.65 47.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.591 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 23.7 mm -99.39 -42.22 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.824 -178.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -146.76 151.51 37.29 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 121.173 0.511 . . . . 0.0 112.139 -179.058 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.62 ' HB3' ' CE1' ' A' ' 74' ' ' PHE . . . -139.83 122.45 16.3 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.943 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 45.62 28.18 0.5 Allowed 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 179.203 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 95.47 14.19 48.5 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 120.966 -0.635 . . . . 0.0 113.49 -179.613 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -116.8 122.15 43.59 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 117.65 0.725 . . . . 0.0 110.677 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 63.8 p -68.87 124.11 22.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.427 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.62 ' CE1' ' HB3' ' A' ' 69' ' ' ALA . 3.4 m-85 -94.08 19.98 8.51 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 8.5 tp -97.84 138.11 23.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-O 120.633 0.254 . . . . 0.0 111.418 -179.144 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.432 ' HA ' HG21 ' A' ' 31' ' ' VAL . 77.2 m-20 63.18 20.82 12.51 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -179.538 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.487 HD13 ' HA ' ' A' ' 74' ' ' PHE . 26.2 pt -98.15 164.32 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -178.488 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -85.67 146.78 26.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.254 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.47 ' O ' HG23 ' A' ' 83' ' ' VAL . 31.1 t60 -47.34 -50.27 22.38 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 115.857 -0.611 . . . . 0.0 112.602 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -61.01 -29.04 69.84 Favored Glycine 0 CA--C 1.519 0.282 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.174 179.437 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -65.32 -45.79 82.92 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.918 0.389 . . . . 0.0 111.023 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.77 -38.31 86.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.361 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.783 HG22 HD11 ' A' ' 27' ' ' ILE . 25.6 t -73.11 -42.97 58.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.741 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 35.5 t -63.66 -46.0 87.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.087 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 23.8 mt -59.31 -50.97 71.92 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.826 -179.401 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.412 ' HA ' ' CD2' ' A' ' 89' ' ' PHE . 26.0 mt -62.76 -32.45 73.6 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.932 -178.86 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 44.1 mttm -76.88 -37.62 55.15 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -178.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 10.2 t -73.92 -29.51 62.08 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -178.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.412 ' CD2' ' HA ' ' A' ' 86' ' ' LEU . 15.3 m-85 -47.54 171.38 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -179.07 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -77.53 -145.6 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.98 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.659 -179.194 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 30.5 m120 -79.41 -67.96 0.71 Allowed 'General case' 0 C--N 1.348 0.511 0 CA-C-N 118.831 0.742 . . . . 0.0 110.835 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.516 HG22 ' HG3' ' A' ' 18' ' ' GLU . 0.8 OUTLIER -74.65 120.43 20.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.785 -179.865 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.438 HG12 ' CD1' ' A' ' 95' ' ' LEU . 18.4 t -113.22 115.18 49.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.897 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -95.39 107.0 19.11 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.454 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.438 ' CD1' HG12 ' A' ' 93' ' ' VAL . 6.2 mp -102.82 150.99 22.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.722 -179.351 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.513 HD13 ' HG3' ' A' ' 14' ' ' ARG . 17.2 mm -107.38 122.18 61.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.74 178.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.411 HD13 HD23 ' A' ' 60' ' ' LEU . 41.8 pt -126.03 163.4 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-O 121.148 0.499 . . . . 0.0 112.185 -179.15 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 51.1 t -137.89 144.3 31.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.185 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 49.5 mmm-85 -111.98 109.8 19.77 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.968 179.071 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 . . . . . 0 C--N 1.329 -0.309 0 CA-C-O 121.024 0.44 . . . . 0.0 111.777 -179.08 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 . . . . . 0 N--CA 1.463 0.178 0 CA-C-O 120.799 0.333 . . . . 0.0 110.991 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 305' ' ' THR . . . . . . . . . . . . . 6.8 m -124.23 115.89 21.8 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.072 -0.513 . . . . 17.879999999999999 110.453 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 306' ' ' TRP . . . . . 0.416 ' CH2' ' CG ' ' A' ' 51' ' ' GLN . 83.7 m95 -79.16 113.84 17.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.031 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 307' ' ' VAL . . . . . 0.425 HG12 HG13 ' A' ' 83' ' ' VAL . 16.1 m . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.223 -0.894 . . . . 16.109999999999999 111.142 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 . . . . . 0 CA--C 1.531 0.242 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.606 HD13 ' N ' ' A' ' 13' ' ' ILE . 0.2 OUTLIER -151.08 165.86 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -179.712 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.48 158.55 22.4 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.637 179.747 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.9 m -144.16 145.51 21.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.755 179.301 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.03 114.19 27.91 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.177 -179.517 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.4 t -110.62 119.13 58.76 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.839 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.556 ' HG3' HG23 ' A' ' 92' ' ' THR . 1.0 OUTLIER -100.04 128.56 46.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.491 179.581 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.496 ' HD3' HD12 ' A' ' 23' ' ' LEU . 14.0 mtmt -84.02 123.77 30.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.139 0.495 . . . . 0.0 111.608 -179.462 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -172.84 85.7 0.41 Allowed Pre-proline 0 CA--C 1.537 0.448 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.797 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -82.48 -20.19 20.35 Favored 'Cis proline' 0 C--N 1.365 1.401 0 CA-C-N 119.357 0.806 . . . . 0.0 113.15 0.65 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -136.4 -178.34 5.12 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 120.854 0.359 . . . . 0.0 111.513 -179.479 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.496 HD12 ' HD3' ' A' ' 19' ' ' LYS . 3.4 mp -67.21 -52.41 41.42 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.668 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.423 ' O ' HG13 ' A' ' 50' ' ' VAL . . . 106.75 26.17 5.94 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.898 -0.668 . . . . 0.0 113.833 179.096 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.419 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 42.1 p90 -156.63 171.14 20.86 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 117.461 0.63 . . . . 0.0 111.316 179.429 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.3 p -119.82 153.63 35.48 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.09 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.78 HD11 HG22 ' A' ' 83' ' ' VAL . 26.4 pt -120.39 148.52 23.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.907 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 74.6 p -140.61 158.28 44.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.045 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 106.26 -148.01 16.36 Favored Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.731 179.62 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.79 151.77 26.34 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.374 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 13.7 t -79.82 99.32 3.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.722 0.296 . . . . 0.0 110.463 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 104.28 -7.81 47.88 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 120.922 -0.656 . . . . 0.0 113.522 -179.435 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -73.44 -148.44 1.13 Allowed Glycine 0 C--N 1.344 1.001 0 CA-C-N 117.751 0.776 . . . . 0.0 112.248 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 53.1 mtt-85 -89.21 16.96 6.46 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -179.168 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 63.86 170.72 1.88 Allowed Glycine 0 C--N 1.338 0.693 0 C-N-CA 120.999 -0.62 . . . . 0.0 113.42 179.041 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -139.75 143.8 36.4 Favored Pre-proline 0 CA--C 1.534 0.363 0 N-CA-C 110.518 -0.179 . . . . 0.0 110.518 179.783 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -92.32 27.28 0.38 Allowed 'Trans proline' 0 C--N 1.358 1.042 0 C-N-CA 122.34 2.027 . . . . 0.0 113.537 -179.143 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -103.43 -51.35 3.23 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.754 0.311 . . . . 0.0 110.945 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 16.2 mtp180 -120.31 137.33 25.95 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.418 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -85.3 -45.74 0.05 OUTLIER 'Trans proline' 0 C--N 1.358 1.078 0 C-N-CA 121.904 1.736 . . . . 0.0 113.59 -179.07 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -89.62 -13.01 38.04 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -179.304 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -106.74 122.69 46.87 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 122.001 -0.437 . . . . 0.0 110.831 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 19.0 p30 -108.69 36.04 2.99 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 121.01 0.433 . . . . 0.0 111.099 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -79.27 -157.93 12.89 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.361 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.7 mm -110.14 132.06 59.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-O 120.697 0.284 . . . . 0.0 111.114 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.435 ' N ' ' CD1' ' A' ' 46' ' ' PHE . 5.4 m-85 -131.39 150.14 52.27 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.346 179.732 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.607 HG23 ' OD1' ' A' ' 64' ' ' ASP . 31.4 t -94.15 75.68 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-O 120.961 0.41 . . . . 0.0 111.466 -179.532 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.406 HG23 ' N ' ' A' ' 49' ' ' ARG . 5.2 t -33.89 -52.99 0.45 Allowed 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 114.939 1.459 . . . . 0.0 114.939 -178.672 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.406 ' N ' HG23 ' A' ' 48' ' ' THR . 13.0 ptm180 -158.13 173.54 16.57 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -179.257 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.423 HG13 ' O ' ' A' ' 24' ' ' GLY . 18.3 t -133.81 150.0 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.464 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.407 ' HG3' ' CH2' ' B' ' 306' ' ' TRP . 8.1 mt-30 -104.99 -67.92 0.04 OUTLIER Pre-proline 0 CA--C 1.539 0.543 0 N-CA-C 111.643 0.238 . . . . 0.0 111.643 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -79.07 121.07 4.79 Favored 'Trans proline' 0 C--N 1.358 1.047 0 C-N-CA 121.645 1.563 . . . . 0.0 112.522 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -78.61 69.55 4.81 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 121.103 0.478 . . . . 0.0 111.016 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -158.37 -68.96 0.01 OUTLIER Glycine 0 CA--C 1.528 0.885 0 C-N-CA 120.794 -0.717 . . . . 0.0 113.358 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -60.98 -75.41 0.02 OUTLIER 'Trans proline' 0 C--N 1.358 1.053 0 C-N-CA 121.94 1.76 . . . . 0.0 113.429 -178.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.742 ' HB1' HD12 ' A' ' 60' ' ' LEU . . . -108.15 47.52 0.9 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 121.24 0.543 . . . . 0.0 111.964 -178.798 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.4 t -111.22 -64.19 1.31 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.727 178.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.14 -16.11 61.17 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.783 178.557 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 27.7 mt -96.51 -52.67 3.86 Favored 'General case' 0 C--N 1.342 0.262 0 CA-C-O 120.616 0.246 . . . . 0.0 111.135 -179.141 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.742 HD12 ' HB1' ' A' ' 56' ' ' ALA . 8.9 mt -103.76 151.12 23.42 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.884 0.373 . . . . 0.0 111.748 -179.474 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 3.5 pp0? -126.45 149.42 67.57 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.641 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -58.57 130.01 35.19 Favored 'Trans proline' 0 C--N 1.361 1.186 0 C-N-CA 122.342 2.028 . . . . 0.0 113.658 -178.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 98.35 9.46 53.28 Favored Glycine 0 CA--C 1.525 0.714 0 CA-C-N 115.673 -0.694 . . . . 0.0 114.075 179.054 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.607 ' OD1' HG23 ' A' ' 47' ' ' VAL . 10.5 p30 -77.82 -174.48 3.52 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 117.841 0.82 . . . . 0.0 111.623 -179.272 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 25.4 tttm -139.2 124.32 18.95 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.008 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 26.5 mt -88.72 115.23 28.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-O 121.106 0.479 . . . . 0.0 110.812 -179.157 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 19.8 mm -89.78 -42.82 14.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -178.22 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.784 ' HB2' HD12 ' A' ' 96' ' ' ILE . 0.0 OUTLIER -150.11 146.33 26.85 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.102 0.477 . . . . 0.0 112.116 -179.006 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.587 ' HB3' ' CE1' ' A' ' 74' ' ' PHE . . . -131.06 120.9 24.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.919 179.464 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 42.76 35.46 0.71 Allowed 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 178.624 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 91.51 -12.59 68.88 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 120.819 -0.705 . . . . 0.0 113.853 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -88.21 125.46 34.64 Favored 'General case' 0 C--O 1.231 0.082 0 CA-C-N 117.648 0.724 . . . . 0.0 109.949 179.518 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 84.4 p -69.67 115.55 9.04 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.754 -179.038 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.587 ' CE1' ' HB3' ' A' ' 69' ' ' ALA . 4.4 m-85 -95.25 9.17 40.75 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.954 178.866 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 7.6 tp -89.38 126.86 42.33 Favored 'Isoleucine or valine' 0 C--N 1.343 0.288 0 CA-C-N 118.181 0.446 . . . . 0.0 110.508 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 57.1 m-80 61.09 70.82 0.59 Allowed 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 121.284 0.564 . . . . 0.0 110.786 -179.634 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.404 HD13 ' HA ' ' A' ' 74' ' ' PHE . 19.9 pt -145.6 168.48 7.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.885 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -82.45 148.14 28.34 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.18 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.423 ' O ' HG23 ' A' ' 83' ' ' VAL . 1.3 t-160 -52.23 -52.5 52.03 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.281 -179.633 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -56.8 -26.05 53.34 Favored Glycine 0 CA--C 1.523 0.552 0 C-N-CA 121.037 -0.601 . . . . 0.0 113.171 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -74.32 -40.25 62.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.068 0.461 . . . . 0.0 110.641 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.3 -34.47 74.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.797 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.78 HG22 HD11 ' A' ' 27' ' ' ILE . 24.0 t -75.08 -44.85 43.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.911 0.386 . . . . 0.0 110.861 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 23.3 t -59.01 -36.97 75.83 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.383 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 85' ' ' LEU . 35.7 mt -71.0 -42.3 69.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.099 0.476 . . . . 0.0 110.588 179.575 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.425 ' HA ' ' CD2' ' A' ' 89' ' ' PHE . 33.2 mt -77.53 -8.27 57.54 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -179.408 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 15.8 mmtp -98.09 -36.65 10.02 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.247 0.546 . . . . 0.0 110.427 178.427 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 9.1 t -70.19 -21.78 63.01 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.494 -0.775 . . . . 0.0 112.142 -178.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.425 ' CD2' ' HA ' ' A' ' 86' ' ' LEU . 12.9 m-85 -55.83 126.8 27.22 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.194 0.521 . . . . 0.0 111.06 -179.06 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 23.1 mp0 -60.29 -64.5 0.93 Allowed 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -177.781 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 32.4 m120 -134.6 -81.95 0.44 Allowed 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -178.659 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.556 HG23 ' HG3' ' A' ' 18' ' ' GLU . 0.2 OUTLIER -70.76 158.75 35.76 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.033 0.444 . . . . 0.0 111.08 -178.718 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 19.5 t -150.38 113.97 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.888 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -89.36 119.33 29.73 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.202 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.5 mt -122.71 147.41 46.51 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.166 0.508 . . . . 0.0 111.893 -178.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.784 HD12 ' HB2' ' A' ' 68' ' ' GLN . 41.2 mt -112.86 126.46 70.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.536 -0.757 . . . . 0.0 109.719 178.638 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.454 HD13 HD23 ' A' ' 60' ' ' LEU . 30.9 pt -126.0 166.48 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-O 120.837 0.351 . . . . 0.0 111.296 -179.051 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 16.1 t -150.01 149.49 14.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.574 -179.531 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.34 115.63 30.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.258 178.213 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 . . . . . 0 C--N 1.329 -0.288 0 CA-C-O 120.935 0.398 . . . . 0.0 111.7 -178.532 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 . . . . . 0 N--CA 1.466 0.352 0 CA-C-O 120.754 0.311 . . . . 0.0 110.716 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 305' ' ' THR . . . . . . . . . . . . . 4.3 m -124.77 130.94 53.38 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.189 -0.46 . . . . 17.879999999999999 110.731 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 306' ' ' TRP . . . . . 0.407 ' CH2' ' HG3' ' A' ' 51' ' ' GLN . 77.2 m95 -91.05 110.84 22.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.92 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 307' ' ' VAL . . . . . 0.461 HG12 HG13 ' A' ' 83' ' ' VAL . 16.8 m . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.217 -0.897 . . . . 16.109999999999999 111.076 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 . . . . . 0 N--CA 1.464 0.233 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.4 pt -109.3 158.94 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -178.714 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -116.12 148.65 40.08 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.975 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 20.1 m -138.85 142.41 34.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.011 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 74.9 mtm-85 -105.18 120.31 41.22 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.123 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.1 t -111.01 112.91 42.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.974 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -89.19 119.55 29.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.676 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.47 ' HE2' HD11 ' A' ' 23' ' ' LEU . 20.1 mttt -75.03 118.0 17.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.046 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -169.37 86.89 0.61 Allowed Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.56 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -81.61 -18.45 24.93 Favored 'Cis proline' 0 C--N 1.363 1.294 0 CA-C-N 119.384 0.816 . . . . 0.0 113.408 0.681 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -136.42 -175.97 4.18 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.695 0.283 . . . . 0.0 111.1 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.47 HD11 ' HE2' ' A' ' 19' ' ' LYS . 3.7 mp -62.36 -56.96 13.33 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.685 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.562 ' O ' HG13 ' A' ' 50' ' ' VAL . . . 100.9 35.53 4.25 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.762 -0.732 . . . . 0.0 114.318 178.566 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.468 ' O ' HG22 ' B' ' 307' ' ' VAL . 36.3 p90 -159.74 153.75 23.27 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 117.283 0.541 . . . . 0.0 110.915 179.019 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.405 ' HB3' ' CD2' ' B' ' 306' ' ' TRP . 2.2 p -105.93 145.12 31.7 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.148 0.499 . . . . 0.0 112.023 -178.802 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.602 HD11 HG22 ' A' ' 83' ' ' VAL . 31.2 pt -122.59 149.92 26.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.357 178.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.7 m -144.67 -176.67 5.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.786 0.326 . . . . 0.0 110.93 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.09 -146.47 22.99 Favored Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.908 -0.663 . . . . 0.0 113.086 179.407 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.41 162.46 31.61 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.102 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.46 HG22 ' HB2' ' A' ' 43' ' ' ASP . 23.6 t -76.54 92.02 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 CA-C-O 121.236 0.541 . . . . 0.0 110.479 -179.208 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 100.4 8.18 50.25 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-N 115.32 -0.854 . . . . 0.0 113.487 -179.24 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -83.51 -161.33 31.4 Favored Glycine 0 C--N 1.343 0.944 0 CA-C-N 117.719 0.76 . . . . 0.0 113.248 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 91.4 mtt-85 -64.24 -27.37 69.0 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -179.28 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.36 167.55 41.97 Favored Glycine 0 C--N 1.337 0.62 0 C-N-CA 120.636 -0.792 . . . . 0.0 113.165 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 12.1 m-80 -125.71 144.8 49.41 Favored Pre-proline 0 CA--C 1.536 0.422 0 C-N-CA 122.131 0.173 . . . . 0.0 110.712 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -83.69 2.57 8.23 Favored 'Trans proline' 0 C--N 1.356 0.968 0 C-N-CA 121.865 1.71 . . . . 0.0 113.615 179.679 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -99.99 -39.5 8.11 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.017 0.437 . . . . 0.0 110.453 179.463 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 5.1 ppt_? -90.92 128.77 46.64 Favored Pre-proline 0 N--CA 1.469 0.513 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.931 -179.115 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -89.02 -22.24 1.1 Allowed 'Trans proline' 0 C--N 1.359 1.111 0 C-N-CA 122.325 2.017 . . . . 0.0 113.408 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -155.41 18.91 0.41 Allowed 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.986 0.735 . . . . 0.0 112.986 -179.323 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -90.24 118.03 29.45 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 122.188 -0.32 . . . . 0.0 110.828 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.46 ' HB2' HG22 ' A' ' 31' ' ' VAL . 3.1 p30 -89.61 40.64 1.0 Allowed 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -179.08 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -109.7 -155.63 15.88 Favored Glycine 0 C--N 1.336 0.57 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.86 179.555 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.6 mm -122.13 137.77 54.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 N-CA-C 110.504 -0.184 . . . . 0.0 110.504 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -129.88 148.74 51.78 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.68 0.276 . . . . 0.0 111.282 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.673 HG22 HD11 ' A' ' 66' ' ' ILE . 19.8 t -94.45 77.13 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-O 121.007 0.432 . . . . 0.0 110.99 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.419 HG23 ' N ' ' A' ' 49' ' ' ARG . 9.4 t -37.85 -53.68 1.29 Allowed 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 -178.5 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.419 ' N ' HG23 ' A' ' 48' ' ' THR . 0.3 OUTLIER -159.11 177.88 10.63 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 118.273 0.488 . . . . 0.0 112.235 -179.826 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.562 HG13 ' O ' ' A' ' 24' ' ' GLY . 7.5 t -130.0 148.06 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.944 -179.412 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.428 ' HG2' ' CH2' ' B' ' 306' ' ' TRP . 8.3 mm-40 -96.02 -68.07 0.07 OUTLIER Pre-proline 0 CA--C 1.536 0.416 0 C-N-CA 121.366 -0.134 . . . . 0.0 111.049 179.536 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -80.39 121.9 4.43 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 121.811 1.674 . . . . 0.0 111.955 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -79.6 64.7 4.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.936 0.398 . . . . 0.0 111.28 -179.611 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -157.83 -67.28 0.01 OUTLIER Glycine 0 CA--C 1.529 0.962 0 C-N-CA 120.668 -0.777 . . . . 0.0 113.547 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -57.96 -73.74 0.03 OUTLIER 'Trans proline' 0 C--N 1.357 0.975 0 C-N-CA 122.183 1.922 . . . . 0.0 113.52 -178.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -112.24 47.95 1.03 Allowed 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.189 0.518 . . . . 0.0 111.393 -179.351 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 95.4 p -107.77 -50.08 3.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.515 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.4 mmtm -80.38 -9.96 59.75 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.487 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.2 mp -96.23 -56.69 2.55 Favored 'General case' 0 C--N 1.342 0.25 0 CA-C-N 118.106 0.412 . . . . 0.0 111.184 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.735 HD23 HG21 ' A' ' 97' ' ' ILE . 1.1 mt -92.66 146.23 23.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.326 -179.702 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -112.49 140.83 24.24 Favored Pre-proline 0 CA--C 1.535 0.373 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.52 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -57.07 125.87 20.34 Favored 'Trans proline' 0 C--N 1.356 0.923 0 C-N-CA 121.716 1.61 . . . . 0.0 112.242 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 92.45 19.82 37.04 Favored Glycine 0 CA--C 1.523 0.539 0 C-N-CA 120.948 -0.644 . . . . 0.0 113.336 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -93.69 155.34 17.31 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-N 117.237 0.518 . . . . 0.0 110.047 179.457 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 58.8 tttp -100.07 125.54 46.16 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.92 0.39 . . . . 0.0 111.753 -179.066 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.673 HD11 HG22 ' A' ' 47' ' ' VAL . 44.4 mt -89.81 120.48 38.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.973 179.325 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 19.3 mm -95.86 -41.34 11.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -178.323 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.751 ' HB3' HD12 ' A' ' 96' ' ' ILE . 0.2 OUTLIER -149.48 153.9 37.97 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 112.2 0.445 . . . . 0.0 112.2 -178.13 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.484 ' HB3' ' CE1' ' A' ' 74' ' ' PHE . . . -142.45 123.27 14.32 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.856 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.419 ' HB2' ' CZ ' ' A' ' 89' ' ' PHE . 28.4 m-20 41.55 37.72 0.75 Allowed 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 178.663 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 96.11 -16.73 60.58 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 120.843 -0.694 . . . . 0.0 113.643 179.152 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 53.8 m-85 -91.35 122.62 34.11 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 117.565 0.683 . . . . 0.0 110.66 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 8.8 m -71.47 131.43 43.3 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.978 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.484 ' CE1' ' HB3' ' A' ' 69' ' ' ALA . 4.6 m-85 -105.6 14.37 28.57 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 112.292 0.478 . . . . 0.0 112.292 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 7.0 tp -92.04 126.13 44.63 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 CA-C-O 120.998 0.428 . . . . 0.0 111.096 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 61.46 70.41 0.6 Allowed 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 121.151 0.5 . . . . 0.0 110.845 -179.279 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 7.1 pt -148.66 164.24 4.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.984 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -81.35 143.14 32.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.458 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -50.99 -52.1 46.14 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -179.438 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -53.47 -27.92 34.98 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 121.248 -0.501 . . . . 0.0 113.05 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 49.7 tp60 -74.37 -38.71 63.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.092 0.473 . . . . 0.0 110.124 179.119 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.43 -53.75 32.05 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.597 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.602 HG22 HD11 ' A' ' 27' ' ' ILE . 20.0 t -58.5 -43.39 86.82 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.417 -179.647 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.7 t -60.46 -41.29 93.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.392 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.468 ' O ' HG22 ' A' ' 88' ' ' THR . 26.8 mt -65.17 -45.97 82.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.518 -179.595 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.514 HD12 HD13 ' A' ' 27' ' ' ILE . 32.9 mt -63.15 -38.45 91.23 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.192 -0.458 . . . . 0.0 112.012 -179.148 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 19.1 mmtt -66.48 -40.3 89.23 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.451 0.538 . . . . 0.0 112.451 -178.845 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.468 HG22 ' O ' ' A' ' 85' ' ' LEU . 7.8 t -72.18 -27.88 62.85 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -177.895 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.43 ' CD2' ' HA ' ' A' ' 86' ' ' LEU . 12.6 m-85 -49.09 173.66 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -178.416 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -87.84 -140.25 0.11 Allowed 'General case' 0 CA--C 1.552 1.026 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.204 -179.268 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 33.1 m120 -82.58 -61.82 1.78 Allowed 'General case' 0 C--N 1.348 0.538 0 CA-C-N 119.251 0.932 . . . . 0.0 111.526 -179.358 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -84.09 129.03 34.92 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.061 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.3 t -123.29 120.26 59.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.511 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -92.54 91.71 7.72 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.48 -179.503 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 2.5 mt -92.5 155.15 18.02 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.837 0.351 . . . . 0.0 111.419 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.751 HD12 ' HB3' ' A' ' 68' ' ' GLN . 72.9 mt -115.36 127.29 72.99 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.487 178.395 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.735 HG21 HD23 ' A' ' 60' ' ' LEU . 45.3 pt -123.76 162.37 24.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-O 120.902 0.382 . . . . 0.0 111.534 -178.845 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 36.7 t -136.73 139.8 44.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.5 -179.287 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -110.47 106.28 15.54 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.665 178.77 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 . . . . . 0 C--N 1.329 -0.295 0 CA-C-O 120.882 0.373 . . . . 0.0 111.578 -178.996 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 . . . . . 0 N--CA 1.466 0.373 0 CA-C-O 121.069 0.461 . . . . 0.0 111.346 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 305' ' ' THR . . . . . . . . . . . . . 6.4 m -139.32 119.44 13.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.801 -0.636 . . . . 17.879999999999999 110.372 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 306' ' ' TRP . . . . . 0.428 ' CH2' ' HG2' ' A' ' 51' ' ' GLN . 96.5 m95 -85.71 114.6 22.81 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.109 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 307' ' ' VAL . . . . . 0.468 HG22 ' O ' ' A' ' 25' ' ' PHE . 18.0 m . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.285 -0.864 . . . . 16.109999999999999 111.142 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 . . . . . 0 N--CA 1.464 0.244 0 CA-C-O 120.806 0.336 . . . . 0.0 111.205 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 19.7 pt -117.05 156.15 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-N 116.061 -0.518 . . . . 0.0 112.205 -179.6 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 29.7 mtm180 -90.29 167.47 12.64 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -178.529 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.475 HG13 ' HB3' ' A' ' 59' ' ' LEU . 77.6 t -147.43 122.97 2.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.977 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.414 ' HG2' HG22 ' A' ' 92' ' ' THR . 20.8 ttt180 -110.42 112.85 25.05 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.66 179.663 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.2 t -120.21 125.95 74.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.089 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.805 ' CG ' HG23 ' A' ' 92' ' ' THR . 28.9 mt-10 -102.05 128.51 48.48 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.106 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.426 ' HD2' HD12 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -72.81 114.6 11.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.962 179.919 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -174.95 83.35 0.32 Allowed Pre-proline 0 CA--C 1.537 0.471 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.087 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -83.38 -23.82 12.29 Favored 'Cis proline' 0 C--N 1.362 1.283 0 CA-C-N 119.445 0.838 . . . . 0.0 112.868 0.453 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.1 mp0 -130.68 -177.4 4.34 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.755 0.312 . . . . 0.0 111.405 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.426 HD12 ' HD2' ' A' ' 19' ' ' LYS . 3.3 mp -62.93 -59.83 4.29 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.978 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.464 ' O ' HG13 ' A' ' 50' ' ' VAL . . . 115.7 29.91 2.32 Favored Glycine 0 C--N 1.335 0.499 0 C-N-CA 120.925 -0.655 . . . . 0.0 113.771 179.365 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.443 ' O ' HG22 ' B' ' 307' ' ' VAL . 51.2 p90 -169.48 149.21 3.93 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 117.37 0.585 . . . . 0.0 111.521 179.452 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.3 p -100.44 150.44 22.64 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.87 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.681 HD11 HG22 ' A' ' 83' ' ' VAL . 38.3 pt -120.27 148.76 23.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.196 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 78.1 p -142.9 160.25 40.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.859 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 108.14 -152.57 16.95 Favored Glycine 0 C--N 1.332 0.338 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.94 179.617 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 104.0 157.01 24.14 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 121.096 -0.573 . . . . 0.0 112.264 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.5 t -78.18 100.38 3.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 120.925 0.393 . . . . 0.0 110.853 -179.606 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 93.48 7.68 61.66 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 121.047 -0.597 . . . . 0.0 113.709 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -88.63 -156.07 30.68 Favored Glycine 0 C--N 1.34 0.755 0 CA-C-N 117.746 0.773 . . . . 0.0 112.958 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 10.4 mmt180 -61.13 -27.52 68.45 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 111.606 0.224 . . . . 0.0 111.606 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 103.71 154.4 23.83 Favored Glycine 0 C--N 1.335 0.512 0 C-N-CA 120.881 -0.676 . . . . 0.0 113.059 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -112.15 129.96 23.76 Favored Pre-proline 0 N--CA 1.468 0.472 0 C-N-CA 122.074 0.149 . . . . 0.0 110.618 179.738 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -93.42 34.19 0.22 Allowed 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 122.316 2.011 . . . . 0.0 113.101 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -110.34 -51.2 2.89 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.786 0.327 . . . . 0.0 111.156 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 45.3 mtt-85 -127.13 158.29 69.55 Favored Pre-proline 0 CA--C 1.535 0.366 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.741 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -90.71 -57.67 0.02 OUTLIER 'Trans proline' 0 C--N 1.357 1.005 0 C-N-CA 122.219 1.946 . . . . 0.0 113.977 -178.828 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -79.35 -8.07 58.81 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -179.078 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -101.58 114.1 27.82 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 118.024 0.375 . . . . 0.0 110.418 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -105.73 38.81 1.9 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.379 -179.295 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -85.86 -156.3 27.17 Favored Glycine 0 CA--C 1.52 0.36 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.505 179.687 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.5 mm -110.57 130.81 63.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-O 120.531 0.205 . . . . 0.0 110.852 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -125.99 150.97 47.66 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 120.827 0.346 . . . . 0.0 111.43 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.447 HG21 HD22 ' A' ' 60' ' ' LEU . 21.8 t -89.1 81.73 1.97 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.185 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.422 HG23 ' N ' ' A' ' 49' ' ' ARG . 9.4 t -43.14 -55.41 3.92 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -178.268 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.422 ' N ' HG23 ' A' ' 48' ' ' THR . 11.6 ptm180 -161.49 156.95 24.22 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 118.425 0.557 . . . . 0.0 112.209 -179.588 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.464 HG13 ' O ' ' A' ' 24' ' ' GLY . 18.6 t -109.23 146.62 14.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.576 179.51 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.411 ' CB ' ' HD3' ' A' ' 52' ' ' PRO . 0.8 OUTLIER -102.77 -71.34 0.03 OUTLIER Pre-proline 0 CA--C 1.54 0.573 0 CA-C-O 119.437 -0.316 . . . . 0.0 111.311 179.9 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.411 ' HD3' ' CB ' ' A' ' 51' ' ' GLN . 53.9 Cg_endo -83.45 121.45 3.01 Favored 'Trans proline' 0 C--N 1.36 1.143 0 C-N-CA 121.532 1.488 . . . . 0.0 112.104 179.294 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.74 64.51 3.75 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.165 0.507 . . . . 0.0 110.963 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -139.01 -72.07 0.05 OUTLIER Glycine 0 CA--C 1.528 0.862 0 CA-C-N 115.672 -0.694 . . . . 0.0 112.84 179.616 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -63.76 -59.59 0.2 Allowed 'Trans proline' 0 C--N 1.357 1.009 0 C-N-CA 122.119 1.879 . . . . 0.0 113.585 -179.243 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.468 ' HB1' HD12 ' A' ' 60' ' ' LEU . . . -108.56 45.25 1.04 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.055 0.455 . . . . 0.0 111.426 -179.159 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 89.3 p -84.71 -60.98 1.9 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.04 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 13.6 mmmt -90.49 0.54 57.28 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -179.471 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.475 ' HB3' HG13 ' A' ' 15' ' ' VAL . 60.7 mt -95.48 -65.34 0.98 Allowed 'General case' 0 C--N 1.341 0.214 0 CA-C-N 118.254 0.479 . . . . 0.0 111.826 -179.691 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.569 HD23 HG21 ' A' ' 97' ' ' ILE . 3.4 mt -95.64 139.84 31.31 Favored 'General case' 0 C--O 1.23 0.048 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 -179.473 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 4.7 pp0? -121.4 151.67 56.68 Favored Pre-proline 0 CA--C 1.535 0.369 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.16 178.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -54.43 114.27 1.75 Allowed 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 121.818 1.679 . . . . 0.0 112.983 -179.404 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 118.12 -2.8 16.66 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 121.096 -0.573 . . . . 0.0 114.367 179.434 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -67.77 -177.66 0.82 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 117.831 0.816 . . . . 0.0 111.873 -179.544 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 38.0 tttt -145.22 126.57 14.88 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.705 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.604 ' N ' HD12 ' A' ' 66' ' ' ILE . 3.7 mp -89.63 117.82 33.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-O 120.832 0.349 . . . . 0.0 110.202 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 35.4 mt -106.63 -26.52 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.846 -179.042 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.678 ' HB3' HD13 ' A' ' 96' ' ' ILE . 17.2 tt0 -154.61 149.43 26.63 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.934 0.397 . . . . 0.0 111.77 -179.652 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -149.33 121.24 8.18 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.486 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 48.1 m-20 48.35 35.66 5.99 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 179.204 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 86.88 10.63 71.95 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 120.973 -0.632 . . . . 0.0 113.626 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -112.16 120.91 43.4 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 117.692 0.746 . . . . 0.0 109.811 179.533 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 18.8 m -71.53 128.78 36.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.418 -179.075 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -106.19 13.89 28.33 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.172 -0.467 . . . . 0.0 112.125 179.61 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 6.4 tp -90.83 124.19 43.3 Favored 'Isoleucine or valine' 0 C--N 1.34 0.169 0 O-C-N 122.047 -0.408 . . . . 0.0 110.743 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 63.18 72.75 0.47 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.929 -179.217 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 20.1 pt -146.95 166.06 6.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.795 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -81.84 154.78 25.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.995 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 16.1 t60 -54.6 -56.8 15.21 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.899 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -53.05 -33.2 44.05 Favored Glycine 0 C--N 1.336 0.532 0 C-N-CA 121.257 -0.497 . . . . 0.0 113.363 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 -65.95 -38.91 89.84 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.036 0.446 . . . . 0.0 110.148 179.286 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.3 -63.63 1.02 Allowed 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.684 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.681 HG22 HD11 ' A' ' 27' ' ' ILE . 11.5 t -55.29 -22.87 12.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 N-CA-C 111.93 0.344 . . . . 0.0 111.93 -179.781 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.461 ' O ' HG22 ' A' ' 88' ' ' THR . 18.0 m -77.4 -42.28 36.88 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.747 0.308 . . . . 0.0 111.101 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 25.5 mt -65.71 -42.06 91.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.665 -179.339 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.422 ' HA ' ' CD2' ' A' ' 89' ' ' PHE . 53.4 mt -66.73 -47.98 70.6 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.638 -179.29 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.412 ' HD2' HG12 ' A' ' 83' ' ' VAL . 70.7 mttt -60.66 -45.9 92.36 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -179.199 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.461 HG22 ' O ' ' A' ' 84' ' ' SER . 11.6 t -68.82 -27.7 66.08 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -177.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.422 ' CD2' ' HA ' ' A' ' 86' ' ' LEU . 6.0 m-85 -46.88 174.7 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -178.073 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -85.79 -143.69 0.1 Allowed 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.79 -179.527 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -81.15 -70.71 0.51 Allowed 'General case' 0 C--N 1.347 0.471 0 CA-C-N 119.016 0.825 . . . . 0.0 111.669 -179.201 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.805 HG23 ' CG ' ' A' ' 18' ' ' GLU . 0.3 OUTLIER -79.2 129.26 34.27 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 120.766 0.317 . . . . 0.0 110.448 -179.874 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.7 t -121.63 120.07 60.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.976 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -98.08 105.46 17.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.934 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.574 ' C ' HD12 ' A' ' 96' ' ' ILE . 4.9 mp -105.29 164.38 11.89 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.977 0.418 . . . . 0.0 111.541 -179.701 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.678 HD13 ' HB3' ' A' ' 68' ' ' GLN . 3.1 mp -120.5 131.77 71.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.089 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.569 HG21 HD23 ' A' ' 60' ' ' LEU . 46.0 pt -126.82 166.45 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-O 120.967 0.413 . . . . 0.0 111.809 -178.835 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 98.9 t -143.07 143.78 24.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.276 -179.043 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.1 105.06 14.02 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.566 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 . . . . . 0 C--N 1.33 -0.269 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -178.459 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 4.0 pm0 . . . . . 0 CA--C 1.529 0.163 0 CA-C-O 120.736 0.303 . . . . 0.0 111.343 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 305' ' ' THR . . . . . . . . . . . . . 5.6 m -127.41 121.06 29.87 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.201 -0.454 . . . . 17.879999999999999 110.803 179.737 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 306' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -85.28 106.91 17.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.74 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 307' ' ' VAL . . . . . 0.594 HG12 HG13 ' A' ' 83' ' ' VAL . 18.4 m . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.281 -0.866 . . . . 16.109999999999999 111.135 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 . . . . . 0 N--CA 1.467 0.398 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.629 ' N ' HD13 ' A' ' 13' ' ' ILE . 0.2 OUTLIER -151.75 164.31 2.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.577 179.447 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.75 ' HG3' HD13 ' A' ' 96' ' ' ILE . 1.2 ttm180 -118.8 156.82 28.74 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 111.783 0.29 . . . . 0.0 111.783 -179.548 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.464 HG11 ' HB3' ' A' ' 59' ' ' LEU . 29.4 m -143.51 153.61 16.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -115.06 118.25 32.87 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.858 -179.442 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.7 t -114.65 124.24 71.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.368 178.691 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.675 ' HG2' HG23 ' A' ' 92' ' ' THR . 43.3 mt-10 -102.83 127.84 49.84 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.03 0.443 . . . . 0.0 111.577 -179.367 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.63 118.23 12.23 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.252 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -175.89 78.12 0.29 Allowed Pre-proline 0 CA--C 1.541 0.603 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.703 179.261 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -86.76 -18.67 20.56 Favored 'Cis proline' 0 C--N 1.363 1.311 0 CA-C-N 119.331 0.797 . . . . 0.0 113.231 0.503 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -136.59 -178.0 4.98 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.794 0.33 . . . . 0.0 111.592 -179.467 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.412 ' HB3' ' CE2' ' A' ' 25' ' ' PHE . 4.2 mp -63.99 -56.95 11.41 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.563 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 107.16 29.38 4.57 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.885 -0.674 . . . . 0.0 113.937 178.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.412 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 45.2 p90 -159.03 145.41 16.82 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 117.464 0.632 . . . . 0.0 111.21 179.259 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 8.6 p -96.1 148.9 22.21 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.647 -179.264 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.591 HD11 HG22 ' A' ' 83' ' ' VAL . 25.1 pt -124.52 150.35 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.109 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.348 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 47.9 t -138.38 155.64 48.34 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.298 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 158.5 -99.18 0.18 Allowed Glycine 0 C--N 1.334 0.439 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.519 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 50.23 110.6 0.01 OUTLIER Glycine 0 CA--C 1.527 0.831 0 N-CA-C 115.38 0.912 . . . . 0.0 115.38 178.118 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 20.4 t -77.8 91.29 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.127 0 O-C-N 122.547 -0.384 . . . . 0.0 110.837 179.089 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 91.69 -4.79 79.54 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 120.821 -0.704 . . . . 0.0 114.149 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -111.26 9.51 28.87 Favored Glycine 0 C--N 1.342 0.908 0 CA-C-N 117.932 0.866 . . . . 0.0 114.282 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -178.35 -77.29 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 117.736 0.768 . . . . 0.0 109.626 178.647 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 113.13 152.81 11.21 Favored Glycine 0 C--N 1.335 0.491 0 CA-C-N 115.919 -0.582 . . . . 0.0 113.124 179.218 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -125.76 136.3 28.19 Favored Pre-proline 0 CA--C 1.535 0.37 0 N-CA-C 110.345 -0.243 . . . . 0.0 110.345 179.551 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -93.75 28.94 0.29 Allowed 'Trans proline' 0 C--N 1.356 0.947 0 C-N-CA 122.422 2.082 . . . . 0.0 113.514 -179.1 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -108.03 -49.75 3.16 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.692 0.282 . . . . 0.0 111.203 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 14.2 mmm180 -117.15 135.31 23.07 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.004 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -83.57 -44.56 0.07 OUTLIER 'Trans proline' 0 C--N 1.359 1.104 0 C-N-CA 121.898 1.732 . . . . 0.0 112.81 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -93.9 -13.4 27.21 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -101.35 118.46 37.02 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 117.864 0.302 . . . . 0.0 110.318 179.553 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -108.44 42.39 1.4 Allowed 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 120.978 0.418 . . . . 0.0 111.364 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -88.83 -156.32 31.25 Favored Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.269 179.57 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 27.7 mm -109.97 135.44 48.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-N 116.678 0.239 . . . . 0.0 110.843 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.429 ' N ' ' CD1' ' A' ' 46' ' ' PHE . 4.5 m-85 -132.7 148.24 52.34 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 120.681 0.277 . . . . 0.0 111.42 -179.396 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.539 HG21 HD22 ' A' ' 60' ' ' LEU . 16.8 t -92.88 73.37 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -179.314 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.439 HG23 ' N ' ' A' ' 49' ' ' ARG . 8.9 t -34.31 -53.13 0.5 Allowed 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -178.706 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.439 ' N ' HG23 ' A' ' 48' ' ' THR . 0.5 OUTLIER -160.31 177.39 10.67 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 121.87 -0.519 . . . . 0.0 112.042 -179.636 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 12.1 t -132.08 151.35 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.991 -179.5 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -105.31 -68.24 0.04 OUTLIER Pre-proline 0 CA--C 1.538 0.517 0 N-CA-C 111.768 0.285 . . . . 0.0 111.768 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -79.02 119.97 4.47 Favored 'Trans proline' 0 C--N 1.357 0.983 0 C-N-CA 121.811 1.674 . . . . 0.0 112.557 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.38 66.81 4.03 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.003 0.43 . . . . 0.0 111.629 -179.672 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -162.19 -66.58 0.02 OUTLIER Glycine 0 CA--C 1.528 0.865 0 C-N-CA 120.718 -0.753 . . . . 0.0 113.522 -179.653 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.67 -74.46 0.02 OUTLIER 'Trans proline' 0 C--N 1.357 0.993 0 C-N-CA 122.043 1.828 . . . . 0.0 113.469 -178.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -117.21 49.32 1.21 Allowed 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 121.054 0.454 . . . . 0.0 112.122 -178.86 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 16.7 t -109.22 -58.67 2.0 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 178.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 19.4 tptt -68.35 -10.84 57.76 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.743 178.506 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.464 ' HB3' HG11 ' A' ' 15' ' ' VAL . 54.1 mt -91.24 -65.14 1.04 Allowed 'General case' 0 C--N 1.343 0.304 0 CA-C-N 118.022 0.374 . . . . 0.0 110.85 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.762 HD23 HG21 ' A' ' 97' ' ' ILE . 1.5 mp -91.92 148.62 22.08 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.958 179.69 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.4 pm0 -115.18 151.82 46.13 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.985 178.85 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -57.37 128.53 29.9 Favored 'Trans proline' 0 C--N 1.356 0.962 0 C-N-CA 121.911 1.74 . . . . 0.0 113.041 -179.185 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 93.86 15.63 48.33 Favored Glycine 0 CA--C 1.524 0.653 0 CA-C-N 115.919 -0.582 . . . . 0.0 113.68 179.395 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -76.91 -174.49 3.11 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 117.518 0.659 . . . . 0.0 111.064 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 47.0 tttm -141.89 125.11 16.4 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.567 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 60.9 mt -90.54 113.34 26.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.186 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 24.2 mm -90.91 -36.88 8.6 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-N 115.936 -0.575 . . . . 0.0 112.077 -178.303 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.28 145.99 27.34 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.065 0.46 . . . . 0.0 111.172 -179.245 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.416 ' HB3' ' CE1' ' A' ' 74' ' ' PHE . . . -136.97 119.69 16.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.015 179.732 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.3 m120 45.95 30.04 0.84 Allowed 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 179.156 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 100.78 -14.21 58.99 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 120.693 -0.765 . . . . 0.0 113.563 -179.714 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -88.49 153.7 20.94 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 117.506 0.653 . . . . 0.0 110.09 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 12.5 m -101.25 124.62 47.23 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.428 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.416 ' CE1' ' HB3' ' A' ' 69' ' ' ALA . 3.6 m-85 -101.59 17.77 22.0 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 7.9 tp -92.28 121.17 42.63 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 CA-C-O 120.923 0.392 . . . . 0.0 110.61 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 21.7 m120 62.17 76.47 0.37 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.005 -179.415 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 23.7 pt -150.01 161.61 4.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.802 179.645 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -81.25 140.72 34.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.967 0.413 . . . . 0.0 111.396 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -41.49 -49.96 3.96 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -179.207 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -57.56 -33.36 66.6 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.965 -179.563 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 36.2 tp60 -69.74 -44.73 69.67 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.826 0.346 . . . . 0.0 111.196 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.92 -63.37 1.13 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.859 -179.64 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.591 HG22 HD11 ' A' ' 27' ' ' ILE . 24.4 t -50.81 -42.27 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -179.416 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 37.1 m -62.89 -39.53 94.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.735 0.303 . . . . 0.0 111.306 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 16.6 mt -64.75 -49.5 70.56 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.861 -179.509 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 54.4 mt -65.04 -33.16 75.38 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -178.715 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 60.3 mttm -76.02 -37.32 58.53 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -178.734 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 12.0 t -73.98 -26.12 60.29 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -178.613 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -54.94 155.19 4.61 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.145 0.498 . . . . 0.0 111.911 -178.688 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -63.29 -139.31 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.128 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.489 -178.86 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -82.01 -66.06 0.93 Allowed 'General case' 0 C--N 1.351 0.658 0 CA-C-N 119.345 0.975 . . . . 0.0 112.251 -178.761 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.675 HG23 ' HG2' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -76.67 123.49 26.23 Favored 'General case' 0 CA--C 1.528 0.11 0 CA-C-O 120.939 0.399 . . . . 0.0 110.958 -179.308 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.528 ' O ' HD12 ' A' ' 95' ' ' LEU . 18.0 t -114.22 112.2 39.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.634 179.342 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -89.7 112.26 23.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.353 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.528 HD12 ' O ' ' A' ' 93' ' ' VAL . 4.6 mp -115.06 154.02 29.63 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 121.115 0.483 . . . . 0.0 112.044 -178.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.75 HD13 ' HG3' ' A' ' 14' ' ' ARG . 17.9 mm -109.38 122.7 64.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.809 178.394 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.762 HG21 HD23 ' A' ' 60' ' ' LEU . 24.6 pt -118.11 157.73 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-O 120.685 0.279 . . . . 0.0 111.047 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.7 t -142.95 146.82 21.29 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-O 121.06 0.457 . . . . 0.0 111.708 -179.296 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.3 mmm-85 -111.69 110.38 20.74 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 178.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.998 0.428 . . . . 0.0 111.568 -179.509 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.869 0.366 . . . . 0.0 110.375 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 305' ' ' THR . . . . . . . . . . . . . 7.9 m -97.84 131.13 44.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.108 -0.497 . . . . 17.879999999999999 111.201 -179.411 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 306' ' ' TRP . . . . . . . . . . . . . 92.4 m95 -89.16 106.4 18.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.866 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 307' ' ' VAL . . . . . 0.508 HG12 HG13 ' A' ' 83' ' ' VAL . 16.5 m . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.176 -0.916 . . . . 16.109999999999999 111.094 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.584 0.23 . . . . 0.0 110.582 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.606 ' N ' HD13 ' A' ' 13' ' ' ILE . 0.1 OUTLIER -126.91 159.31 36.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-O 121.071 0.462 . . . . 0.0 111.703 -179.888 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 15.4 ttm-85 -109.32 161.67 15.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.413 -179.335 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.55 HG13 HD13 ' A' ' 59' ' ' LEU . 21.4 t -139.76 147.78 23.64 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.967 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 7.0 tpp85 -115.75 106.42 13.84 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.706 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.1 t -111.68 127.43 68.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.289 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.469 ' HG3' HG23 ' A' ' 92' ' ' THR . 3.9 mp0 -90.42 156.94 17.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.513 179.594 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.7 74.95 1.1 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.074 0.464 . . . . 0.0 110.406 179.637 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -141.38 85.84 11.52 Favored Pre-proline 0 CA--C 1.538 0.511 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.593 -179.502 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -85.83 -21.58 15.05 Favored 'Cis proline' 0 C--N 1.363 1.3 0 CA-C-N 119.638 0.906 . . . . 0.0 113.211 0.411 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -138.04 -176.11 4.33 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.733 0.301 . . . . 0.0 111.351 -179.609 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.9 mp -64.74 -57.87 7.8 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.048 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.4 ' O ' HG13 ' A' ' 50' ' ' VAL . . . 108.0 32.9 3.15 Favored Glycine 0 C--N 1.337 0.623 0 C-N-CA 120.86 -0.686 . . . . 0.0 113.621 179.087 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -165.69 145.62 6.58 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 117.206 0.503 . . . . 0.0 111.044 179.353 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.5 p -100.71 153.48 19.4 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.536 -179.224 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 25.6 pt -122.26 150.11 25.77 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.829 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 85.0 p -145.03 161.25 39.86 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 121.222 -0.191 . . . . 0.0 111.427 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 119.3 -91.62 0.51 Allowed Glycine 0 C--N 1.34 0.752 0 C-N-CA 120.911 -0.661 . . . . 0.0 114.191 178.552 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.469 ' H ' HD13 ' A' ' 45' ' ' ILE . . . 67.32 -133.47 30.69 Favored Glycine 0 CA--C 1.521 0.416 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.38 -179.308 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 23.9 t -151.4 81.38 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 CA-C-O 121.141 0.496 . . . . 0.0 109.832 179.298 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.56 15.15 44.57 Favored Glycine 0 CA--C 1.528 0.901 0 CA-C-N 115.753 -0.658 . . . . 0.0 113.161 -178.72 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -93.98 -143.02 12.79 Favored Glycine 0 C--N 1.338 0.691 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.292 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 5.1 mmt85 -54.29 -26.17 27.78 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -179.125 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.47 160.31 32.94 Favored Glycine 0 C--N 1.336 0.582 0 C-N-CA 120.768 -0.73 . . . . 0.0 113.492 179.341 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -121.51 136.9 26.33 Favored Pre-proline 0 N--CA 1.466 0.333 0 N-CA-C 110.491 -0.189 . . . . 0.0 110.491 179.396 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -92.83 26.96 0.37 Allowed 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 122.224 1.949 . . . . 0.0 113.127 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -102.24 -49.78 3.81 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.761 0.315 . . . . 0.0 111.008 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -124.51 140.37 35.16 Favored Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.783 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -83.76 -41.95 0.09 OUTLIER 'Trans proline' 0 C--N 1.359 1.092 0 C-N-CA 122.028 1.819 . . . . 0.0 113.201 -179.466 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -93.97 -13.08 27.42 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -179.239 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -103.54 120.69 41.37 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 117.888 0.313 . . . . 0.0 111.358 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -104.35 16.86 25.27 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -57.77 -167.29 0.12 Allowed Glycine 0 C--N 1.338 0.673 0 C-N-CA 120.637 -0.792 . . . . 0.0 113.033 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.469 HD13 ' H ' ' A' ' 30' ' ' GLY . 20.6 mm -104.28 125.97 59.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 179.043 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -122.66 146.52 47.39 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 120.796 0.332 . . . . 0.0 111.428 -179.38 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.646 ' CG2' HD11 ' A' ' 66' ' ' ILE . 34.2 t -89.89 73.02 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-O 121.25 0.548 . . . . 0.0 110.252 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.0 t -36.14 -53.59 0.8 Allowed 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -178.373 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 7.7 ptm180 -158.64 168.77 25.98 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.198 0.523 . . . . 0.0 112.321 -179.345 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.4 HG13 ' O ' ' A' ' 24' ' ' GLY . 14.4 t -126.39 148.68 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.372 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.419 ' HG2' ' CH2' ' B' ' 306' ' ' TRP . 7.1 mm-40 -105.25 -68.81 0.03 OUTLIER Pre-proline 0 CA--C 1.538 0.514 0 N-CA-C 111.706 0.261 . . . . 0.0 111.706 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -79.26 120.19 4.44 Favored 'Trans proline' 0 C--N 1.357 0.998 0 C-N-CA 121.8 1.667 . . . . 0.0 112.487 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -78.5 66.92 4.16 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 121.03 0.443 . . . . 0.0 111.064 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -160.91 -65.87 0.02 OUTLIER Glycine 0 CA--C 1.527 0.836 0 C-N-CA 120.721 -0.752 . . . . 0.0 113.548 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -56.27 -61.12 0.37 Allowed 'Trans proline' 0 C--N 1.356 0.973 0 C-N-CA 122.229 1.953 . . . . 0.0 113.513 -178.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.842 ' HB1' HD12 ' A' ' 60' ' ' LEU . . . -136.21 58.56 1.74 Allowed 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 121.206 0.527 . . . . 0.0 111.933 -178.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.8 t -119.3 -58.23 1.94 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.898 179.001 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 25.3 tptp -64.56 -16.08 62.05 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.743 178.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.55 HD13 HG13 ' A' ' 15' ' ' VAL . 39.5 mt -98.2 -49.73 4.61 Favored 'General case' 0 C--N 1.341 0.221 0 CA-C-O 120.805 0.336 . . . . 0.0 111.441 -179.729 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.842 HD12 ' HB1' ' A' ' 56' ' ' ALA . 41.9 mt -90.99 148.76 22.18 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.978 0.418 . . . . 0.0 111.802 -179.316 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -116.04 137.25 23.25 Favored Pre-proline 0 CA--C 1.536 0.42 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.235 179.107 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -52.4 126.57 21.06 Favored 'Trans proline' 0 C--N 1.356 0.971 0 C-N-CA 122.011 1.808 . . . . 0.0 113.044 -179.315 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 95.33 18.1 34.58 Favored Glycine 0 CA--C 1.521 0.428 0 C-N-CA 121.045 -0.598 . . . . 0.0 113.807 179.031 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -86.18 144.64 27.37 Favored 'General case' 0 C--N 1.339 0.122 0 CA-C-N 117.625 0.713 . . . . 0.0 110.679 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -92.89 129.57 38.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.566 -179.35 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.646 HD11 ' CG2' ' A' ' 47' ' ' VAL . 2.8 mm -88.08 111.95 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 25.9 mm -90.63 -44.62 14.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -178.787 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.815 ' HB3' HD12 ' A' ' 96' ' ' ILE . 20.4 tt0 -148.45 150.85 34.18 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.201 0.524 . . . . 0.0 112.403 -178.769 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.526 ' HB3' ' CE1' ' A' ' 74' ' ' PHE . . . -142.46 124.32 15.17 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.079 179.53 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.3 m120 45.13 27.64 0.33 Allowed 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 178.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 99.78 -8.84 59.97 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 120.808 -0.711 . . . . 0.0 114.128 179.759 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -97.81 122.64 41.15 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 117.797 0.798 . . . . 0.0 110.886 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.9 t -69.02 126.25 29.23 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.432 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.526 ' CE1' ' HB3' ' A' ' 69' ' ' ALA . 3.1 m-85 -97.58 17.9 16.69 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -179.027 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 30.5 mm -92.5 119.61 40.35 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-O 120.82 0.343 . . . . 0.0 110.946 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 61.11 76.86 0.35 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.262 0.553 . . . . 0.0 111.143 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 17.4 pt -145.97 150.3 15.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.546 179.575 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -62.27 142.43 57.73 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.165 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.487 ' O ' HG23 ' A' ' 83' ' ' VAL . 12.3 t60 -47.97 -50.81 26.05 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.597 -179.151 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -60.17 -27.58 65.33 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.694 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -69.87 -43.57 71.57 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 120.948 0.404 . . . . 0.0 110.878 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.68 -39.88 76.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.491 -179.477 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 79' ' ' HIS . 26.7 t -71.88 -45.24 65.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.125 -179.669 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.507 ' O ' HG22 ' A' ' 88' ' ' THR . 36.1 t -62.61 -36.79 83.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.548 -179.436 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.438 HD23 ' HA ' ' A' ' 85' ' ' LEU . 18.3 mt -68.0 -45.69 73.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.833 0.349 . . . . 0.0 111.761 -179.402 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.428 HD21 HD21 ' A' ' 95' ' ' LEU . 18.3 mt -68.17 -32.89 73.46 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -178.838 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 3.0 mtmp? -79.6 -37.98 34.99 Favored 'General case' 0 N--CA 1.457 -0.087 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -178.731 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.507 HG22 ' O ' ' A' ' 84' ' ' SER . 9.0 t -70.77 -23.28 62.37 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -178.902 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -51.06 176.4 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 121.335 0.588 . . . . 0.0 112.398 -178.702 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 87.0 mm-40 -82.08 -144.0 0.06 Allowed 'General case' 0 CA--C 1.551 0.998 0 CA-C-N 115.476 -0.783 . . . . 0.0 111.119 -179.064 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -79.87 -63.48 1.4 Allowed 'General case' 0 C--N 1.347 0.493 0 CA-C-N 118.94 0.791 . . . . 0.0 110.964 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.469 HG23 ' HG3' ' A' ' 18' ' ' GLU . 0.5 OUTLIER -87.19 138.38 31.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.198 179.797 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 18.2 t -127.08 121.65 58.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.047 -179.586 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -93.52 101.46 13.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.337 179.541 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.428 HD21 HD21 ' A' ' 86' ' ' LEU . 5.6 mp -104.07 155.69 18.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.043 0.449 . . . . 0.0 111.797 -179.307 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.815 HD12 ' HB3' ' A' ' 68' ' ' GLN . 41.4 mt -116.01 130.76 70.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.641 178.87 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.568 HD13 HD23 ' A' ' 60' ' ' LEU . 39.3 pt -126.95 160.66 35.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-O 120.992 0.425 . . . . 0.0 111.635 -179.137 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 71.9 t -143.17 149.42 18.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.136 -179.172 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -112.84 117.51 32.35 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.928 179.092 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 48.2 mm-40 . . . . . 0 C--N 1.328 -0.335 0 CA-C-O 120.832 0.349 . . . . 0.0 111.723 -179.23 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.74 0.305 . . . . 0.0 110.696 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 305' ' ' THR . . . . . . . . . . . . . 5.3 m -141.22 119.34 12.02 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.353 -0.385 . . . . 17.879999999999999 110.607 179.73 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 306' ' ' TRP . . . . . 0.419 ' CH2' ' HG2' ' A' ' 51' ' ' GLN . 83.6 m95 -84.29 117.32 23.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.046 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 307' ' ' VAL . . . . . 0.454 HG12 HG13 ' A' ' 83' ' ' VAL . 16.2 m . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.261 -0.876 . . . . 16.109999999999999 111.159 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 . . . . . 0 CA--C 1.532 0.281 0 CA-C-O 120.716 0.293 . . . . 0.0 110.277 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.522 ' H ' HD13 ' A' ' 13' ' ' ILE . 0.1 OUTLIER -113.97 164.16 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -179.191 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 82.3 mtt-85 -100.56 168.49 9.68 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.655 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.799 HG13 ' CB ' ' A' ' 59' ' ' LEU . 40.3 t -150.35 139.23 15.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.015 179.518 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 39.7 mtt85 -113.93 108.09 16.58 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.845 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.5 t -111.29 123.66 67.36 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.16 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.677 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -86.18 161.16 18.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.179 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.3 73.28 0.81 Allowed 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.545 179.736 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -138.68 85.13 17.41 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.168 -179.727 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -86.03 -19.93 18.54 Favored 'Cis proline' 0 C--N 1.364 1.372 0 CA-C-N 119.507 0.86 . . . . 0.0 113.129 0.428 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -136.46 -177.64 4.81 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 120.746 0.307 . . . . 0.0 111.276 -179.407 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.415 ' HB3' ' CE1' ' A' ' 25' ' ' PHE . 3.2 mp -65.3 -55.81 16.21 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.263 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 109.48 16.13 11.44 Favored Glycine 0 C--N 1.336 0.528 0 C-N-CA 120.794 -0.717 . . . . 0.0 114.215 178.708 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.494 ' O ' HG22 ' B' ' 307' ' ' VAL . 51.0 p90 -145.79 157.02 43.95 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 117.759 0.78 . . . . 0.0 111.463 179.671 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.4 p -108.52 150.59 27.24 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.171 -179.618 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.55 HD11 HG22 ' A' ' 83' ' ' VAL . 17.7 pt -122.88 151.67 27.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.502 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 98.2 p -149.98 164.07 36.43 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.207 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 112.48 -96.08 0.82 Allowed Glycine 0 C--N 1.337 0.601 0 C-N-CA 120.898 -0.668 . . . . 0.0 113.876 178.81 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.498 ' H ' HD13 ' A' ' 45' ' ' ILE . . . 74.52 -132.82 14.93 Favored Glycine 0 CA--C 1.519 0.309 0 C-N-CA 121.119 -0.562 . . . . 0.0 112.401 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 24.1 t -149.75 87.16 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.342 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 92.89 5.16 64.56 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 120.983 -0.627 . . . . 0.0 113.693 -178.81 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -77.47 -134.62 0.71 Allowed Glycine 0 C--N 1.343 0.963 0 CA-C-N 117.741 0.77 . . . . 0.0 112.723 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 1.4 mtt180 -71.17 -19.67 62.38 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.597 0.592 . . . . 0.0 112.597 -179.29 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.92 -156.02 17.0 Favored Glycine 0 C--N 1.342 0.907 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.952 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -173.89 132.86 0.57 Allowed Pre-proline 0 CA--C 1.534 0.358 0 N-CA-C 110.539 -0.171 . . . . 0.0 110.539 179.657 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -90.16 25.6 0.55 Allowed 'Trans proline' 0 C--N 1.358 1.048 0 C-N-CA 122.174 1.916 . . . . 0.0 113.89 -179.155 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -110.25 -56.06 2.38 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.734 0.302 . . . . 0.0 110.921 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -114.16 135.78 22.18 Favored Pre-proline 0 CA--C 1.535 0.389 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.689 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -86.96 -47.58 0.04 OUTLIER 'Trans proline' 0 C--N 1.36 1.14 0 C-N-CA 121.994 1.796 . . . . 0.0 113.623 -179.289 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -95.83 -11.4 26.88 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -179.331 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -94.48 115.91 28.16 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 117.904 0.32 . . . . 0.0 110.27 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.4 p30 -102.3 64.52 0.92 Allowed 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 121.174 0.511 . . . . 0.0 111.408 -179.266 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -116.15 -162.49 13.13 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.316 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.498 HD13 ' H ' ' A' ' 30' ' ' GLY . 15.8 mm -107.53 131.64 57.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 110.348 -0.242 . . . . 0.0 110.348 179.537 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -129.55 149.87 51.13 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.77 0.319 . . . . 0.0 111.107 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.571 HG23 HD11 ' A' ' 66' ' ' ILE . 21.8 t -97.13 73.58 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.331 -179.126 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.6 t -35.34 -53.54 0.64 Allowed 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 114.527 1.306 . . . . 0.0 114.527 -178.691 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 1.8 ptt-85 -158.53 163.84 36.69 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.059 0.457 . . . . 0.0 112.112 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 5.3 t -121.26 154.85 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.56 -179.489 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 3.6 mm-40 -104.73 -68.3 0.04 OUTLIER Pre-proline 0 CA--C 1.538 0.513 0 N-CA-C 111.575 0.213 . . . . 0.0 111.575 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -80.37 120.13 3.96 Favored 'Trans proline' 0 C--N 1.358 1.07 0 C-N-CA 121.836 1.691 . . . . 0.0 112.481 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -77.06 69.2 3.32 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 120.992 0.425 . . . . 0.0 111.337 -179.476 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -165.04 -64.33 0.02 OUTLIER Glycine 0 CA--C 1.529 0.937 0 C-N-CA 120.696 -0.764 . . . . 0.0 113.719 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.57 -72.52 0.03 OUTLIER 'Trans proline' 0 C--N 1.357 1.002 0 C-N-CA 122.072 1.848 . . . . 0.0 113.72 -178.789 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.784 ' HB1' HD12 ' A' ' 60' ' ' LEU . . . -102.68 -10.92 18.8 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 -178.092 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.9 t -75.31 -25.93 58.27 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -178.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.9 tppt? -76.81 -20.94 55.81 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.799 ' CB ' HG13 ' A' ' 15' ' ' VAL . 43.5 mt -123.48 6.43 8.96 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -178.137 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.784 HD12 ' HB1' ' A' ' 56' ' ' ALA . 91.2 mt -136.03 148.9 48.58 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 118.344 0.52 . . . . 0.0 111.729 179.649 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -104.98 141.49 22.66 Favored Pre-proline 0 CA--C 1.536 0.42 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.437 179.317 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -64.15 71.16 0.2 Allowed 'Trans proline' 0 C--N 1.362 1.254 0 C-N-CA 122.297 1.998 . . . . 0.0 113.647 -179.127 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 139.16 40.42 0.09 OUTLIER Glycine 0 CA--C 1.524 0.617 0 C-N-CA 120.903 -0.665 . . . . 0.0 113.299 179.221 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -96.36 -161.67 0.89 Allowed 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 117.034 0.417 . . . . 0.0 110.661 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.6 tttm -138.77 122.0 16.98 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 120.718 0.294 . . . . 0.0 110.818 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.571 HD11 HG23 ' A' ' 47' ' ' VAL . 4.3 mp -89.45 120.97 39.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.534 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 20.1 mm -92.39 -40.39 12.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -178.403 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 -150.38 150.86 31.96 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.12 0.486 . . . . 0.0 111.981 -178.728 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.422 ' HB3' ' CE1' ' A' ' 74' ' ' PHE . . . -138.23 123.02 18.79 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.684 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 17.0 m120 40.85 33.63 0.22 Allowed 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 178.468 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 99.2 -20.87 48.29 Favored Glycine 0 CA--C 1.522 0.509 0 C-N-CA 120.724 -0.75 . . . . 0.0 113.409 179.576 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -88.46 119.52 28.97 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 117.151 0.475 . . . . 0.0 110.281 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 33.3 t -66.25 122.12 16.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.005 -179.642 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.422 ' CE1' ' HB3' ' A' ' 69' ' ' ALA . 2.9 m-85 -98.07 7.64 45.99 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -178.902 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.403 ' O ' HG23 ' A' ' 75' ' ' ILE . 6.5 tp -84.55 120.28 34.94 Favored 'Isoleucine or valine' 0 C--N 1.341 0.201 0 CA-C-N 118.392 0.542 . . . . 0.0 110.678 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 62.13 75.93 0.39 Allowed 'General case' 0 C--O 1.232 0.184 0 CA-C-O 121.259 0.552 . . . . 0.0 111.023 -179.439 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 16.0 pt -144.87 152.86 14.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.514 179.479 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -64.61 150.9 46.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.039 0.447 . . . . 0.0 110.992 -179.607 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.408 ' O ' HG23 ' A' ' 83' ' ' VAL . 11.0 t60 -54.73 -55.11 33.37 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.953 -179.301 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -55.55 -25.3 42.09 Favored Glycine 0 CA--C 1.523 0.544 0 C-N-CA 121.058 -0.592 . . . . 0.0 113.309 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.21 -39.85 53.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.056 0.455 . . . . 0.0 110.592 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.66 -35.88 67.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.207 -179.387 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.55 HG22 HD11 ' A' ' 27' ' ' ILE . 22.6 t -76.08 -45.85 35.35 Favored 'Isoleucine or valine' 0 C--O 1.231 0.082 0 CA-C-O 120.83 0.348 . . . . 0.0 111.022 -179.557 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.585 ' O ' HG22 ' A' ' 88' ' ' THR . 45.1 m -61.63 -35.33 77.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.078 -179.712 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.439 HD23 ' HA ' ' A' ' 85' ' ' LEU . 15.3 mt -70.64 -44.02 68.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.171 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.425 ' HA ' ' CD2' ' A' ' 89' ' ' PHE . 13.7 mt -68.45 -31.03 70.05 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -179.067 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 23.7 mtmt -83.79 -36.35 23.62 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 -179.3 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.585 HG22 ' O ' ' A' ' 84' ' ' SER . 9.0 t -72.26 -24.06 61.3 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -178.872 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.425 ' CD2' ' HA ' ' A' ' 86' ' ' LEU . 8.3 m-85 -49.74 177.02 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -178.81 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 50.9 mm-40 -82.17 -144.83 0.06 Allowed 'General case' 0 CA--C 1.549 0.911 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.689 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -78.24 -65.05 1.03 Allowed 'General case' 0 C--N 1.347 0.468 0 CA-C-N 118.977 0.808 . . . . 0.0 111.021 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -83.58 140.35 32.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.356 179.631 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 19.0 t -124.84 120.68 59.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.275 -179.606 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -89.49 107.31 19.0 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.134 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 15.2 mt -107.95 145.29 34.04 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.99 0.424 . . . . 0.0 111.766 -178.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 15.9 mm -108.01 125.91 64.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.174 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.43 HD13 HD23 ' A' ' 60' ' ' LEU . 41.6 pt -131.2 167.99 24.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -178.468 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 18.3 t -149.72 153.94 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.167 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -115.77 116.01 27.3 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.315 179.307 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.371 -179.505 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.737 0.303 . . . . 0.0 110.796 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 305' ' ' THR . . . . . . . . . . . . . 16.9 m -139.76 120.88 14.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.303 -0.408 . . . . 17.879999999999999 110.953 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 306' ' ' TRP . . . . . . . . . . . . . 92.2 m95 -80.64 111.03 16.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.863 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 307' ' ' VAL . . . . . 0.494 HG22 ' O ' ' A' ' 25' ' ' PHE . 15.5 m . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.253 -0.879 . . . . 16.109999999999999 111.122 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 . . . . . 0 C--O 1.231 0.126 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.4 pt -117.48 159.24 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.214 -178.265 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ARG . . . . . 0.715 ' HG2' HD13 ' A' ' 96' ' ' ILE . 0.1 OUTLIER -112.95 157.58 21.31 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.099 -179.361 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.5 m -141.66 139.68 31.43 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.707 179.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -106.03 114.27 28.31 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.605 -179.123 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.0 t -114.13 123.26 69.62 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.997 179.544 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.558 ' HG3' HG22 ' A' ' 92' ' ' THR . 4.8 mp0 -98.95 119.08 37.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.704 179.767 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.469 ' HE2' HD11 ' A' ' 23' ' ' LEU . 16.1 mttt -70.02 118.38 12.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.048 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -171.98 85.57 0.45 Allowed Pre-proline 0 CA--C 1.536 0.435 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.655 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -84.0 -17.76 26.09 Favored 'Cis proline' 0 C--N 1.363 1.338 0 CA-C-N 119.383 0.815 . . . . 0.0 113.42 0.624 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 51.7 mm-40 -136.79 -177.04 4.56 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 120.913 0.387 . . . . 0.0 111.689 -179.444 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.469 HD11 ' HE2' ' A' ' 19' ' ' LYS . 4.5 mp -65.67 -56.1 13.93 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.244 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 102.54 39.46 2.77 Favored Glycine 0 CA--C 1.522 0.488 0 C-N-CA 120.754 -0.736 . . . . 0.0 113.926 178.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.426 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 43.3 p90 -169.85 156.91 6.5 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 117.155 0.477 . . . . 0.0 111.202 179.173 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 9.3 p -113.55 154.64 26.78 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.506 -179.414 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.464 HD11 HG22 ' A' ' 83' ' ' VAL . 46.6 pt -121.38 153.35 25.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.799 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 77.6 p -141.21 155.24 46.07 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.865 179.573 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 114.05 -158.26 14.43 Favored Glycine 0 C--N 1.335 0.508 0 C-N-CA 120.934 -0.651 . . . . 0.0 113.369 179.502 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 137.27 -135.51 7.68 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 121.26 -0.495 . . . . 0.0 112.234 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 39.5 t -141.88 75.38 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.225 0.536 . . . . 0.0 109.877 179.345 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 93.59 13.56 55.11 Favored Glycine 0 CA--C 1.529 0.943 0 CA-C-N 115.66 -0.7 . . . . 0.0 113.154 -178.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -86.74 -146.42 10.05 Favored Glycine 0 C--N 1.342 0.908 0 CA-C-N 117.598 0.699 . . . . 0.0 112.695 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 69.6 mtt180 -56.46 -24.56 46.49 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -179.238 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.24 175.46 48.76 Favored Glycine 0 C--N 1.336 0.536 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.629 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -139.53 146.55 48.52 Favored Pre-proline 0 CA--C 1.534 0.337 0 N-CA-C 110.473 -0.195 . . . . 0.0 110.473 179.723 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -92.33 30.32 0.31 Allowed 'Trans proline' 0 C--N 1.358 1.039 0 C-N-CA 122.309 2.006 . . . . 0.0 113.43 -179.315 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -107.48 -56.48 2.21 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.778 0.323 . . . . 0.0 110.647 179.574 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -112.46 139.12 22.27 Favored Pre-proline 0 CA--C 1.534 0.33 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.376 179.41 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -87.58 -50.3 0.03 OUTLIER 'Trans proline' 0 C--N 1.358 1.044 0 C-N-CA 121.964 1.776 . . . . 0.0 113.642 -178.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -95.43 -7.82 37.22 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -179.196 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -90.9 113.75 26.03 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 118.106 0.412 . . . . 0.0 110.766 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 14.1 p30 -98.88 54.82 1.01 Allowed 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 121.1 0.476 . . . . 0.0 111.15 -179.547 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -112.45 -163.75 16.49 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 121.056 -0.592 . . . . 0.0 112.577 179.695 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 13.1 mm -108.74 133.79 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 116.553 0.177 . . . . 0.0 110.591 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.432 ' CD1' ' N ' ' A' ' 46' ' ' PHE . 3.7 m-85 -131.2 151.59 51.32 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 120.542 0.21 . . . . 0.0 110.714 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.582 HG23 ' OD1' ' A' ' 64' ' ' ASP . 29.2 t -91.0 79.79 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-O 121.103 0.478 . . . . 0.0 110.686 179.763 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.408 HG23 ' N ' ' A' ' 49' ' ' ARG . 5.1 t -36.41 -53.78 0.85 Allowed 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 114.824 1.416 . . . . 0.0 114.824 -178.533 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.408 ' N ' HG23 ' A' ' 48' ' ' THR . 0.0 OUTLIER -160.48 179.47 8.59 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.236 0.541 . . . . 0.0 112.372 -178.988 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 20.3 t -137.37 148.62 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.48 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 7.2 mm-40 -105.06 -68.85 0.03 OUTLIER Pre-proline 0 CA--C 1.538 0.488 0 CA-C-O 119.629 -0.224 . . . . 0.0 111.389 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -78.12 118.04 4.28 Favored 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 121.676 1.584 . . . . 0.0 112.045 179.508 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.3 pm0 -75.63 66.95 2.04 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.114 0.483 . . . . 0.0 111.257 -179.434 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -156.03 -69.83 0.01 OUTLIER Glycine 0 CA--C 1.528 0.868 0 C-N-CA 120.791 -0.719 . . . . 0.0 113.335 -179.474 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -60.07 -75.81 0.02 OUTLIER 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 121.968 1.779 . . . . 0.0 113.365 -179.019 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.544 ' HB1' HD12 ' A' ' 60' ' ' LEU . . . -104.05 46.06 0.93 Allowed 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 121.073 0.464 . . . . 0.0 111.77 -179.103 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.9 t -114.4 -65.04 1.23 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.006 179.233 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.1 tppm? -62.46 -21.22 65.27 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.488 178.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 40.2 mt -97.73 -54.9 2.97 Favored 'General case' 0 C--N 1.339 0.128 0 CA-C-O 120.59 0.233 . . . . 0.0 111.558 -179.231 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.551 HD23 HD13 ' A' ' 97' ' ' ILE . 32.6 mt -93.96 146.94 23.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.807 0.337 . . . . 0.0 111.563 -179.478 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -118.84 143.06 32.91 Favored Pre-proline 0 CA--C 1.537 0.472 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.333 179.408 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -62.19 131.69 35.6 Favored 'Trans proline' 0 C--N 1.359 1.092 0 C-N-CA 122.128 1.886 . . . . 0.0 113.761 -179.011 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 93.88 18.7 36.5 Favored Glycine 0 C--N 1.335 0.482 0 CA-C-N 115.934 -0.575 . . . . 0.0 113.89 178.558 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.582 ' OD1' HG23 ' A' ' 47' ' ' VAL . 2.8 p30 -85.16 -171.71 3.78 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 117.33 0.565 . . . . 0.0 111.227 -179.44 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 43.5 tttm -135.11 122.03 21.16 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.773 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.456 ' CG2' HD12 ' A' ' 95' ' ' LEU . 20.6 mt -90.12 117.3 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.017 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 20.2 mm -96.01 -36.77 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -179.179 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.02 150.55 30.09 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.136 0.493 . . . . 0.0 112.07 -178.873 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.619 ' HB3' ' CE1' ' A' ' 74' ' ' PHE . . . -137.25 119.94 16.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.822 179.315 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.414 ' HB2' ' CZ ' ' A' ' 89' ' ' PHE . 62.8 m-20 42.56 28.87 0.13 Allowed 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 179.26 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 99.31 5.69 55.78 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 120.888 -0.672 . . . . 0.0 113.98 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -109.32 121.28 44.82 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 117.911 0.856 . . . . 0.0 110.084 179.437 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.3 t -68.03 121.0 15.18 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.798 0.332 . . . . 0.0 111.235 -179.121 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.619 ' CE1' ' HB3' ' A' ' 69' ' ' ALA . 3.9 m-30 -99.63 15.15 27.62 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 116.173 -0.467 . . . . 0.0 112.069 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 7.7 tp -92.2 123.41 44.3 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-O 120.785 0.326 . . . . 0.0 110.86 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 61.29 73.78 0.47 Allowed 'General case' 0 C--O 1.232 0.167 0 CA-C-O 121.258 0.551 . . . . 0.0 110.773 -179.475 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 11.7 pt -149.21 160.93 5.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.646 179.703 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -73.29 139.47 46.12 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.225 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.418 ' O ' HG23 ' A' ' 83' ' ' VAL . 3.8 t-160 -48.25 -49.74 32.25 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -179.513 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -56.63 -28.26 56.16 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 121.13 -0.557 . . . . 0.0 112.944 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -73.96 -40.91 62.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.888 0.375 . . . . 0.0 110.372 179.652 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.98 -36.41 83.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.032 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.528 HG13 HG12 ' B' ' 307' ' ' VAL . 22.1 t -75.04 -41.4 45.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.821 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 54.3 p -60.45 -45.66 92.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.291 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 54.8 mt -65.84 -44.66 84.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.611 -179.558 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.42 ' HA ' ' CD2' ' A' ' 89' ' ' PHE . 12.6 mt -66.74 -36.54 82.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.23 -0.441 . . . . 0.0 112.105 -178.841 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 54.9 mttm -75.31 -38.56 60.21 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 -178.65 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 11.5 t -70.94 -24.85 62.52 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -178.383 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.42 ' CD2' ' HA ' ' A' ' 86' ' ' LEU . 8.5 m-85 -47.82 173.55 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -178.855 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 6.9 mm-40 -81.38 -145.58 0.06 Allowed 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.517 -179.513 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -79.36 -66.78 0.83 Allowed 'General case' 0 C--N 1.345 0.401 0 CA-C-N 118.911 0.778 . . . . 0.0 110.721 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.558 HG22 ' HG3' ' A' ' 18' ' ' GLU . 0.6 OUTLIER -76.91 126.37 30.86 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.645 179.629 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.693 HG12 ' CD2' ' A' ' 95' ' ' LEU . 21.2 t -119.27 123.23 70.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.97 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -100.68 106.46 17.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.578 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.693 ' CD2' HG12 ' A' ' 93' ' ' VAL . 4.3 mm? -100.36 149.92 23.13 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.47 -179.591 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.715 HD13 ' HG2' ' A' ' 14' ' ' ARG . 17.5 mm -108.54 124.87 65.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.38 178.377 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.551 HD13 HD23 ' A' ' 60' ' ' LEU . 43.4 pt -129.23 165.17 29.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.735 0.302 . . . . 0.0 111.255 -179.161 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.41 HG12 ' N ' ' A' ' 99' ' ' ARG . 14.6 t -150.38 154.57 8.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.009 0.433 . . . . 0.0 111.689 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.41 ' N ' HG12 ' A' ' 98' ' ' VAL . 0.1 OUTLIER -108.49 112.76 25.31 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 177.694 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 . . . . . 0 N--CA 1.462 0.157 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.638 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 4.9 pm0 . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.674 0.273 . . . . 0.0 110.492 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 305' ' ' THR . . . . . . . . . . . . . 5.7 m -132.97 121.79 23.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.39 -0.368 . . . . 17.879999999999999 110.888 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 306' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -85.58 118.55 25.16 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.99 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 307' ' ' VAL . . . . . 0.528 HG12 HG13 ' A' ' 83' ' ' VAL . 18.3 m . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.21 -0.9 . . . . 16.109999999999999 111.139 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.529 0.156 0 CA-C-O 120.775 0.322 . . . . 0.0 111.097 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.616 ' N ' HD13 ' A' ' 13' ' ' ILE . 0.2 OUTLIER -139.82 155.29 24.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.958 0.409 . . . . 0.0 111.544 -179.893 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.74 167.13 10.08 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.448 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.63 HG13 ' HB3' ' A' ' 59' ' ' LEU . 22.4 t -146.82 153.5 12.6 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.966 179.437 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.497 ' CD ' HG22 ' A' ' 92' ' ' THR . 0.0 OUTLIER -129.05 118.65 22.88 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.278 179.77 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.3 t -125.43 130.63 72.78 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-O 120.924 0.392 . . . . 0.0 111.453 -179.472 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -100.02 146.11 27.11 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.067 179.221 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.64 76.59 9.51 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.863 0.363 . . . . 0.0 110.492 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -140.8 85.65 12.47 Favored Pre-proline 0 CA--C 1.539 0.528 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.706 -179.448 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -82.15 -30.67 4.76 Favored 'Cis proline' 0 C--N 1.363 1.338 0 CA-C-N 119.409 0.825 . . . . 0.0 113.172 0.31 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -138.19 -178.54 5.32 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.872 0.367 . . . . 0.0 111.361 -179.66 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.411 ' HB3' ' CE2' ' A' ' 25' ' ' PHE . 3.2 mp -62.09 -61.89 2.16 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.83 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 103.79 34.87 3.65 Favored Glycine 0 CA--C 1.52 0.38 0 C-N-CA 120.825 -0.702 . . . . 0.0 113.783 179.013 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.411 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 31.1 p90 -163.57 145.95 9.73 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 117.254 0.527 . . . . 0.0 111.137 179.321 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.8 p -100.63 150.4 22.76 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.056 -179.656 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.66 HD11 HG22 ' A' ' 83' ' ' VAL . 25.4 pt -117.23 147.63 20.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.867 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 12.9 p -138.35 153.92 48.96 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.77 0.319 . . . . 0.0 111.293 -179.523 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 113.47 -158.92 13.97 Favored Glycine 0 C--N 1.332 0.323 0 C-N-CA 120.977 -0.63 . . . . 0.0 113.519 179.119 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 109.47 153.38 14.91 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 121.234 -0.507 . . . . 0.0 112.022 -179.437 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 17.9 t -76.82 98.39 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-O 121.081 0.467 . . . . 0.0 110.522 -179.542 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 96.0 10.25 56.42 Favored Glycine 0 CA--C 1.528 0.866 0 CA-C-N 115.657 -0.701 . . . . 0.0 113.349 -179.215 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.6 -158.28 32.66 Favored Glycine 0 C--N 1.342 0.865 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.712 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -59.61 -27.63 66.48 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -179.067 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 117.57 -167.02 12.66 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.662 -179.686 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -145.44 125.92 7.27 Favored Pre-proline 0 CA--C 1.533 0.291 0 O-C-N 122.928 -0.16 . . . . 0.0 110.871 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -92.31 24.7 0.48 Allowed 'Trans proline' 0 C--N 1.355 0.913 0 C-N-CA 122.122 1.881 . . . . 0.0 112.875 179.745 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -124.49 -49.63 1.78 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 120.793 0.33 . . . . 0.0 110.639 179.704 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -114.83 130.98 23.69 Favored Pre-proline 0 CA--C 1.533 0.301 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.455 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -85.0 -44.85 0.05 OUTLIER 'Trans proline' 0 C--N 1.356 0.927 0 C-N-CA 121.965 1.776 . . . . 0.0 113.22 -179.452 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -89.6 -3.95 58.05 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -179.353 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -109.94 125.26 52.66 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 118.156 0.435 . . . . 0.0 110.576 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -109.98 31.29 5.97 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.647 -179.23 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.422 ' O ' HD13 ' A' ' 45' ' ' ILE . . . -76.49 -146.62 2.04 Favored Glycine 0 CA--C 1.519 0.34 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.98 179.401 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.422 HD13 ' O ' ' A' ' 44' ' ' GLY . 14.7 mm -124.13 135.36 63.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-N 116.934 0.367 . . . . 0.0 110.469 179.269 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.427 ' CD1' ' N ' ' A' ' 46' ' ' PHE . 7.7 m-85 -132.99 151.98 52.01 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.16 -179.586 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.528 HG23 ' OD1' ' A' ' 64' ' ' ASP . 21.8 t -97.34 74.23 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 CA-C-O 121.058 0.456 . . . . 0.0 110.797 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.419 HG23 ' N ' ' A' ' 49' ' ' ARG . 8.0 t -31.44 -53.23 0.23 Allowed 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 -178.71 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.419 ' N ' HG23 ' A' ' 48' ' ' THR . 0.0 OUTLIER -160.9 -178.92 7.14 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.155 0.502 . . . . 0.0 111.987 -179.457 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.0 t -134.73 150.75 30.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.61 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -104.86 -68.23 0.04 OUTLIER Pre-proline 0 CA--C 1.538 0.495 0 N-CA-C 111.728 0.269 . . . . 0.0 111.728 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -79.25 119.39 4.2 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 121.781 1.654 . . . . 0.0 112.275 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -75.15 68.33 1.9 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.931 0.396 . . . . 0.0 110.872 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -161.19 -66.64 0.02 OUTLIER Glycine 0 CA--C 1.529 0.936 0 C-N-CA 120.651 -0.785 . . . . 0.0 113.821 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -58.32 -76.44 0.02 OUTLIER 'Trans proline' 0 C--N 1.356 0.949 0 C-N-CA 122.166 1.911 . . . . 0.0 113.452 -178.825 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.919 ' HB1' HD12 ' A' ' 60' ' ' LEU . . . -115.32 50.95 0.95 Allowed 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.289 0.566 . . . . 0.0 111.298 -179.399 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.4 t -112.85 -63.37 1.45 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.45 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.82 -13.64 61.78 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.569 179.313 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.63 ' HB3' HG13 ' A' ' 15' ' ' VAL . 34.6 mt -96.61 -54.43 3.24 Favored 'General case' 0 C--N 1.345 0.388 0 O-C-N 122.091 -0.381 . . . . 0.0 111.101 179.562 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.919 HD12 ' HB1' ' A' ' 56' ' ' ALA . 56.5 mt -91.93 146.86 23.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.453 -179.681 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -118.25 137.47 24.65 Favored Pre-proline 0 CA--C 1.537 0.48 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.016 178.759 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.82 131.01 43.57 Favored 'Trans proline' 0 C--N 1.361 1.195 0 C-N-CA 122.341 2.027 . . . . 0.0 113.931 -178.665 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 96.73 16.59 35.88 Favored Glycine 0 CA--C 1.523 0.576 0 CA-C-N 115.637 -0.71 . . . . 0.0 113.816 178.858 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.528 ' OD1' HG23 ' A' ' 47' ' ' VAL . 2.7 p30 -81.65 -169.1 2.16 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 117.379 0.589 . . . . 0.0 111.298 -179.482 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 45.8 tttp -139.31 124.57 19.05 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.28 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 33.9 mt -89.02 115.16 28.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.615 -179.686 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 23.9 mm -94.19 -38.17 9.01 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 116.097 -0.501 . . . . 0.0 112.126 -178.809 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.729 ' HB3' HD12 ' A' ' 96' ' ' ILE . 1.2 tt0 -151.08 150.89 31.23 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.178 0.514 . . . . 0.0 112.096 -179.025 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -145.56 124.68 12.87 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.942 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.6 m120 43.95 31.7 0.54 Allowed 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 179.097 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 97.6 -6.0 62.64 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 120.78 -0.724 . . . . 0.0 114.068 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -102.03 123.06 45.27 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 117.83 0.815 . . . . 0.0 110.775 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 7.9 m -71.43 126.8 30.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.927 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -99.75 6.64 45.46 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.413 ' O ' HG23 ' A' ' 75' ' ' ILE . 7.3 tp -83.85 120.06 34.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 118.165 0.438 . . . . 0.0 110.896 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.1 m120 63.3 76.17 0.37 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.032 0.444 . . . . 0.0 111.072 -179.353 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 9.3 pt -150.19 164.77 3.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.817 179.608 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.7 mp0 -78.75 148.52 32.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.139 0.495 . . . . 0.0 111.454 -179.67 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 23.9 t60 -53.47 -54.13 41.44 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.282 -179.507 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -55.33 -27.43 47.15 Favored Glycine 0 CA--C 1.52 0.373 0 C-N-CA 121.147 -0.549 . . . . 0.0 113.163 -179.481 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.4 tp60 -73.57 -39.02 64.98 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.028 0.442 . . . . 0.0 110.544 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.11 -55.91 12.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.933 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.66 HG22 HD11 ' A' ' 27' ' ' ILE . 17.2 t -58.29 -44.0 87.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.787 -179.29 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.6 t -60.39 -39.24 86.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.596 -179.408 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.544 ' O ' HG22 ' A' ' 88' ' ' THR . 30.2 mt -67.52 -43.61 80.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.825 -179.439 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.43 ' HA ' ' CD2' ' A' ' 89' ' ' PHE . 22.2 mt -66.66 -42.07 87.18 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -179.022 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 15.1 mttm -64.48 -41.47 96.47 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -178.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.544 HG22 ' O ' ' A' ' 85' ' ' LEU . 9.7 t -64.11 -22.61 67.0 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -178.788 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.43 ' CD2' ' HA ' ' A' ' 86' ' ' LEU . 21.4 m-85 -60.81 131.0 49.29 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.951 0.405 . . . . 0.0 110.495 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -65.77 -105.34 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.959 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -178.388 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -88.4 -83.04 0.22 Allowed 'General case' 0 C--N 1.35 0.618 0 CA-C-N 119.422 1.01 . . . . 0.0 113.321 -178.044 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.497 HG22 ' CD ' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -71.22 162.17 29.87 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 121.128 0.489 . . . . 0.0 111.658 -178.652 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 19.9 t -151.41 112.91 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.612 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.1 mp0 -89.01 122.51 32.43 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 179.576 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 14.1 mt -121.56 143.05 49.51 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -178.46 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.729 HD12 ' HB3' ' A' ' 68' ' ' GLN . 42.4 mt -114.07 129.28 70.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 177.765 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.436 HD13 HD23 ' A' ' 60' ' ' LEU . 43.5 pt -134.71 172.99 15.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -178.156 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 20.2 t -147.25 151.66 13.63 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.731 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -123.2 113.51 19.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.53 179.716 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.336 -179.319 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.81 0.338 . . . . 0.0 111.128 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 305' ' ' THR . . . . . . . . . . . . . 7.4 m -109.38 134.69 51.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.009 -0.541 . . . . 17.879999999999999 110.613 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 306' ' ' TRP . . . . . . . . . . . . . 83.4 m95 -97.43 131.71 43.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.885 0.374 . . . . 0.0 111.058 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 307' ' ' VAL . . . . . . . . . . . . . 24.0 m . . . . . 0 C--O 1.25 1.125 0 CA-C-O 118.271 -0.871 . . . . 16.109999999999999 111.153 -179.876 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 . . . . . 0 N--CA 1.465 0.284 0 CA-C-O 120.802 0.334 . . . . 0.0 111.5 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.589 ' H ' HD13 ' A' ' 13' ' ' ILE . 0.2 OUTLIER -114.42 154.8 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.934 179.934 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 1.1 ttt85 -93.09 165.45 12.83 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.628 -179.167 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.463 HG11 HD11 ' A' ' 60' ' ' LEU . 53.9 t -141.1 118.59 8.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.241 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -105.48 109.29 21.21 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 178.782 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.451 HG23 HG12 ' A' ' 15' ' ' VAL . 14.0 t -121.37 131.81 72.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-O 120.883 0.373 . . . . 0.0 111.517 -179.245 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.435 ' CG ' HG23 ' A' ' 92' ' ' THR . 34.4 mt-10 -92.04 164.07 13.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.162 179.16 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.32 74.93 1.05 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 121.337 0.589 . . . . 0.0 110.949 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -141.61 84.71 12.06 Favored Pre-proline 0 CA--C 1.54 0.593 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.419 -179.471 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -83.73 -23.92 11.87 Favored 'Cis proline' 0 C--N 1.364 1.352 0 CA-C-N 119.444 0.837 . . . . 0.0 113.009 0.229 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -139.14 -169.07 2.57 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 120.692 0.282 . . . . 0.0 110.986 -179.483 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.509 HD13 HG23 ' B' ' 307' ' ' VAL . 5.2 mp -67.47 -49.43 63.61 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-O 120.807 0.337 . . . . 0.0 110.228 179.43 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.505 ' O ' HG13 ' A' ' 50' ' ' VAL . . . 106.22 24.32 6.9 Favored Glycine 0 C--N 1.333 0.364 0 C-N-CA 120.972 -0.633 . . . . 0.0 113.371 179.205 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.41 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 45.1 p90 -160.52 153.87 21.99 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 117.14 0.47 . . . . 0.0 111.28 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.8 p -104.03 156.77 17.59 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.977 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.47 HD11 HG22 ' A' ' 83' ' ' VAL . 30.9 pt -122.91 149.39 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.1 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.4 m -151.29 169.74 21.22 Favored 'General case' 0 CA--C 1.53 0.212 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.144 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.66 21.49 26.24 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 121.076 -0.583 . . . . 0.0 114.164 178.202 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -60.47 151.96 38.89 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.343 179.328 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 58.5 t -78.37 106.91 9.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.028 0.442 . . . . 0.0 110.281 -179.508 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 94.24 -5.42 71.38 Favored Glycine 0 CA--C 1.53 0.994 0 CA-C-N 115.752 -0.658 . . . . 0.0 113.635 -178.837 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -85.89 -139.87 5.36 Favored Glycine 0 C--N 1.345 1.075 0 CA-C-N 117.804 0.802 . . . . 0.0 113.236 -179.541 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 8.6 mmt180 -75.75 -17.91 59.73 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -178.106 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 99.25 -150.12 19.15 Favored Glycine 0 C--N 1.339 0.749 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.477 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -166.57 132.95 1.93 Allowed Pre-proline 0 CA--C 1.535 0.393 0 CA-C-N 116.626 0.213 . . . . 0.0 110.99 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -90.41 25.7 0.53 Allowed 'Trans proline' 0 C--N 1.36 1.135 0 C-N-CA 122.193 1.929 . . . . 0.0 113.689 -179.554 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -110.65 -54.69 2.56 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.755 0.312 . . . . 0.0 110.785 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.426 ' HG3' ' CE2' ' A' ' 46' ' ' PHE . 4.9 mmp_? -108.41 144.76 30.14 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.311 179.558 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -89.17 -51.9 0.02 OUTLIER 'Trans proline' 0 C--N 1.357 1.026 0 C-N-CA 121.899 1.733 . . . . 0.0 113.853 -178.895 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -99.28 -2.47 36.44 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 -178.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -95.07 117.92 31.0 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 118.264 0.484 . . . . 0.0 110.601 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -101.08 37.01 1.84 Allowed 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.958 -179.051 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.4 -168.03 38.52 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.466 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.2 mm -102.83 129.21 54.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 178.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.426 ' CE2' ' HG3' ' A' ' 39' ' ' ARG . 1.2 m-85 -129.99 149.49 51.69 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.839 0.352 . . . . 0.0 110.925 -179.154 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.553 HG23 ' OD1' ' A' ' 64' ' ' ASP . 38.8 t -89.77 79.07 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.306 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.417 HG23 ' N ' ' A' ' 49' ' ' ARG . 9.9 t -37.82 -53.31 1.3 Allowed 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 -178.564 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.417 ' N ' HG23 ' A' ' 48' ' ' THR . 3.5 ptt-85 -160.3 165.49 31.22 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 118.229 0.468 . . . . 0.0 112.111 -179.691 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.505 HG13 ' O ' ' A' ' 24' ' ' GLY . 12.1 t -122.98 148.38 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.805 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.4 ' HG3' ' CH2' ' B' ' 306' ' ' TRP . 8.5 mt-30 -100.21 -68.41 0.04 OUTLIER Pre-proline 0 CA--C 1.538 0.487 0 CA-C-O 119.738 -0.172 . . . . 0.0 111.129 179.687 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -80.78 117.22 3.28 Favored 'Trans proline' 0 C--N 1.358 1.07 0 C-N-CA 121.715 1.61 . . . . 0.0 112.581 179.673 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -75.57 70.55 2.41 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 120.954 0.407 . . . . 0.0 110.784 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -162.8 -65.92 0.02 OUTLIER Glycine 0 CA--C 1.529 0.937 0 C-N-CA 120.789 -0.72 . . . . 0.0 113.354 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -58.27 -78.26 0.02 OUTLIER 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 122.118 1.878 . . . . 0.0 112.924 -179.15 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.687 ' HB1' HD12 ' A' ' 60' ' ' LEU . . . -108.19 46.88 0.93 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.47 0.652 . . . . 0.0 110.582 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 91.7 p -101.95 -61.43 1.39 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.193 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -71.77 -7.12 46.24 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.206 179.115 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.461 ' HB3' HG13 ' A' ' 15' ' ' VAL . 66.3 mt -95.57 -59.61 1.84 Allowed 'General case' 0 C--N 1.344 0.332 0 CA-C-N 118.244 0.474 . . . . 0.0 111.541 -179.516 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.687 HD12 ' HB1' ' A' ' 56' ' ' ALA . 2.7 mt -95.63 144.31 26.18 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.654 0.264 . . . . 0.0 111.452 -179.375 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.1 pm0 -112.35 142.73 27.5 Favored Pre-proline 0 CA--C 1.538 0.488 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.382 178.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -50.93 130.32 30.92 Favored 'Trans proline' 0 C--N 1.359 1.105 0 C-N-CA 122.206 1.937 . . . . 0.0 113.667 -179.089 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 82.59 24.73 52.85 Favored Glycine 0 C--N 1.333 0.386 0 CA-C-N 115.853 -0.612 . . . . 0.0 113.637 178.625 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.553 ' OD1' HG23 ' A' ' 47' ' ' VAL . 20.6 p30 -86.98 -171.79 3.68 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 117.025 0.413 . . . . 0.0 110.793 -179.618 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 66.5 tttt -140.33 128.83 22.76 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ILE . . . . . 0.565 ' N ' HD12 ' A' ' 66' ' ' ILE . 4.0 mp -93.59 118.82 40.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.833 179.308 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 23.7 mm -92.67 -33.97 5.74 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.86 -178.896 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 -146.88 148.85 32.24 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.95 0.405 . . . . 0.0 111.456 -179.471 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -138.5 114.84 10.36 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.509 -179.614 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 49.32 29.11 2.57 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 179.159 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 101.03 -22.65 38.55 Favored Glycine 0 CA--C 1.521 0.458 0 C-N-CA 120.787 -0.721 . . . . 0.0 113.178 179.711 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -89.16 127.95 35.76 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 117.099 0.449 . . . . 0.0 110.696 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.2 m -65.93 130.35 42.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.974 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -104.65 21.58 16.59 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.662 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 6.6 tp -101.68 140.53 20.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 O-C-N 122.249 -0.282 . . . . 0.0 110.99 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 34.7 m-20 65.54 10.72 6.89 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -178.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 17.3 pt -89.12 156.09 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 121.334 0.588 . . . . 0.0 112.584 -178.287 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -80.84 153.6 27.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.615 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 9.3 t60 -49.8 -55.26 14.78 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 -179.262 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -54.83 -28.0 45.83 Favored Glycine 0 C--N 1.335 0.522 0 C-N-CA 121.039 -0.6 . . . . 0.0 113.351 -179.141 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -72.78 -41.86 64.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.943 0.401 . . . . 0.0 110.484 179.591 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.78 -57.4 8.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.742 -179.319 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.47 HG22 HD11 ' A' ' 27' ' ' ILE . 15.4 t -56.7 -43.95 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-O 120.871 0.367 . . . . 0.0 111.595 -179.377 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 38.0 m -60.79 -43.18 98.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.438 -179.193 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.453 HD23 ' HA ' ' A' ' 85' ' ' LEU . 12.8 mt -65.51 -47.39 76.13 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.577 -179.415 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.425 ' HA ' ' CD2' ' A' ' 89' ' ' PHE . 26.5 mt -64.37 -41.77 96.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.661 -179.033 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 36.8 mmtt -64.23 -41.71 96.88 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -178.548 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 11.3 t -72.02 -25.04 61.66 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -177.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.425 ' CD2' ' HA ' ' A' ' 86' ' ' LEU . 14.8 m-85 -53.81 156.6 2.71 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.53 0.681 . . . . 0.0 112.741 -178.476 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -61.72 -145.55 0.0 OUTLIER 'General case' 0 CA--C 1.556 1.179 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.672 -178.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -81.25 -59.52 2.61 Favored 'General case' 0 C--N 1.35 0.62 0 CA-C-N 118.859 0.754 . . . . 0.0 111.829 -178.876 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.435 HG23 ' CG ' ' A' ' 18' ' ' GLU . 0.2 OUTLIER -87.15 135.19 33.39 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 -179.644 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 12.0 t -127.6 124.82 64.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.865 0.364 . . . . 0.0 111.484 -179.011 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -101.03 114.87 29.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.25 179.224 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.445 ' N ' HD12 ' A' ' 95' ' ' LEU . 5.7 mp -113.58 160.84 18.11 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.082 0.468 . . . . 0.0 111.929 -179.083 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 22.9 mm -118.67 129.73 74.51 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.263 179.3 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.497 HG21 ' CD2' ' A' ' 60' ' ' LEU . 7.1 pt -134.14 166.79 27.8 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-O 120.577 0.227 . . . . 0.0 111.592 -179.509 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.408 HG12 ' N ' ' A' ' 99' ' ' ARG . 21.3 t -144.88 155.27 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-O 121.203 0.525 . . . . 0.0 111.873 -179.336 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.408 ' N ' HG12 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -112.26 110.15 20.23 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.361 178.798 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 . . . . . 0 N--CA 1.464 0.229 0 CA-C-O 121.025 0.441 . . . . 0.0 112.164 -178.468 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.853 0.359 . . . . 0.0 111.101 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 305' ' ' THR . . . . . . . . . . . . . 11.5 m -119.05 130.66 55.75 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.017 -0.538 . . . . 17.879999999999999 110.611 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 306' ' ' TRP . . . . . 0.4 ' CH2' ' HG3' ' A' ' 51' ' ' GLN . 82.3 m95 -90.68 105.35 17.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.895 0.378 . . . . 0.0 110.904 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 307' ' ' VAL . . . . . 0.509 HG23 HD13 ' A' ' 23' ' ' LEU . 15.9 m . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.248 -0.882 . . . . 16.109999999999999 111.138 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.534 0.345 0 CA-C-O 120.726 0.298 . . . . 0.0 111.048 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.547 ' H ' HD13 ' A' ' 13' ' ' ILE . 0.1 OUTLIER -105.87 160.64 5.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.377 -179.071 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.72 151.07 26.69 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.129 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.421 HG13 HD13 ' A' ' 59' ' ' LEU . 21.3 t -137.29 137.11 46.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.837 179.433 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.52 111.46 24.18 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.783 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.8 t -105.47 116.83 50.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.812 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.57 ' CG ' HG23 ' A' ' 92' ' ' THR . 34.6 mt-10 -94.61 116.92 29.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.853 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 24.5 mttt -71.57 127.37 32.35 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.479 0.656 . . . . 0.0 110.934 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -172.18 83.09 0.45 Allowed Pre-proline 0 CA--C 1.539 0.555 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.872 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -85.85 -8.78 48.08 Favored 'Cis proline' 0 C--N 1.366 1.448 0 CA-C-N 119.426 0.831 . . . . 0.0 113.786 0.192 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -137.29 -177.53 4.81 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.789 0.328 . . . . 0.0 111.264 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.415 ' HB3' ' CE2' ' A' ' 25' ' ' PHE . 3.5 mp -63.03 -57.15 11.64 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.105 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 102.29 29.02 6.18 Favored Glycine 0 C--N 1.337 0.631 0 C-N-CA 120.82 -0.705 . . . . 0.0 113.675 178.874 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.415 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 36.0 p90 -157.26 145.31 19.18 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 117.131 0.465 . . . . 0.0 110.825 179.225 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.5 p -98.85 149.7 22.64 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.608 -179.363 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.73 HD11 HG22 ' A' ' 83' ' ' VAL . 21.0 pt -121.7 147.8 25.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.288 179.116 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 34.1 t -143.68 163.38 33.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.839 0.352 . . . . 0.0 111.078 -179.595 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 103.51 -146.67 16.51 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.61 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.12 156.57 29.02 Favored Glycine 0 N--CA 1.452 -0.233 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.228 -179.718 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 17.3 t -78.64 101.61 4.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.872 0.368 . . . . 0.0 110.773 -179.602 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 92.85 1.55 67.67 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 120.979 -0.629 . . . . 0.0 113.746 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -82.13 -155.38 15.82 Favored Glycine 0 C--N 1.341 0.831 0 CA-C-N 117.965 0.882 . . . . 0.0 113.038 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 73.7 mtt180 -63.64 -27.92 69.56 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.638 0.236 . . . . 0.0 111.638 -179.548 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.54 168.32 38.41 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 120.608 -0.805 . . . . 0.0 112.794 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -137.11 139.13 27.42 Favored Pre-proline 0 CA--C 1.534 0.359 0 O-C-N 123.004 -0.115 . . . . 0.0 110.804 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -92.53 27.3 0.37 Allowed 'Trans proline' 0 C--N 1.358 1.078 0 C-N-CA 122.396 2.064 . . . . 0.0 113.291 -179.437 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -100.77 -54.1 2.9 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.71 0.291 . . . . 0.0 110.956 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -114.17 141.45 26.39 Favored Pre-proline 0 CA--C 1.533 0.295 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.606 179.73 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -87.59 -50.32 0.03 OUTLIER 'Trans proline' 0 C--N 1.358 1.049 0 C-N-CA 121.992 1.794 . . . . 0.0 113.66 -178.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -87.44 -11.47 49.0 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 -179.21 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -101.31 115.99 31.77 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 117.984 0.356 . . . . 0.0 110.793 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 30.9 p-10 -104.42 44.63 1.01 Allowed 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 121.211 0.529 . . . . 0.0 110.712 179.347 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -92.42 -159.45 35.19 Favored Glycine 0 C--N 1.332 0.328 0 CA-C-N 115.826 -0.625 . . . . 0.0 112.71 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.1 mm -107.5 131.94 56.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -131.58 148.66 52.63 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.816 0.341 . . . . 0.0 111.307 -179.32 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 24.0 t -89.78 73.95 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-O 121.158 0.504 . . . . 0.0 111.014 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.6 t -38.4 -52.63 1.55 Allowed 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 114.444 1.276 . . . . 0.0 114.444 -178.489 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -158.02 162.37 38.14 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 121.108 0.48 . . . . 0.0 112.116 -179.546 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 15.7 t -120.93 149.55 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.47 179.727 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 18.8 mm-40 -104.35 -67.77 0.04 OUTLIER Pre-proline 0 CA--C 1.538 0.513 0 N-CA-C 111.941 0.348 . . . . 0.0 111.941 -179.53 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -76.87 124.5 7.48 Favored 'Trans proline' 0 C--N 1.357 1.004 0 C-N-CA 121.666 1.577 . . . . 0.0 112.79 -179.694 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.85 63.4 3.56 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.142 -179.718 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -158.35 -66.97 0.01 OUTLIER Glycine 0 CA--C 1.526 0.774 0 C-N-CA 120.57 -0.824 . . . . 0.0 113.643 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -57.58 -77.07 0.02 OUTLIER 'Trans proline' 0 C--N 1.357 1.011 0 C-N-CA 122.195 1.93 . . . . 0.0 113.63 -178.8 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.883 ' HB1' HD12 ' A' ' 60' ' ' LEU . . . -118.34 51.8 1.06 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 121.267 0.556 . . . . 0.0 111.208 -179.036 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 19.8 t -116.56 -60.17 1.88 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.142 179.003 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 40.2 pttt -69.22 -9.99 55.62 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.977 179.007 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.421 HD13 HG13 ' A' ' 15' ' ' VAL . 69.5 mt -102.5 -52.24 3.15 Favored 'General case' 0 C--N 1.345 0.371 0 CA-C-N 118.237 0.471 . . . . 0.0 110.936 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.883 HD12 ' HB1' ' A' ' 56' ' ' ALA . 53.3 mt -91.02 158.42 16.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.36 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -130.65 143.03 47.65 Favored Pre-proline 0 CA--C 1.535 0.377 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.429 179.472 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -50.44 128.1 22.32 Favored 'Trans proline' 0 C--N 1.361 1.219 0 C-N-CA 122.099 1.866 . . . . 0.0 113.389 -179.51 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.06 2.25 48.58 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 120.979 -0.629 . . . . 0.0 113.911 179.617 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -75.95 140.91 42.32 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 118.024 0.912 . . . . 0.0 111.151 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 60.7 tttp -97.54 129.1 44.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.909 179.679 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 28.3 mt -89.06 114.07 26.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.562 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.574 HG23 HD11 ' A' ' 75' ' ' ILE . 21.1 mm -89.72 -44.06 14.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -178.601 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.493 ' HB2' HD12 ' A' ' 96' ' ' ILE . 9.6 mt-30 -148.23 149.53 32.08 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.348 0.594 . . . . 0.0 112.344 -178.573 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.578 ' HB3' ' CE1' ' A' ' 74' ' ' PHE . . . -136.82 121.4 18.39 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.121 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 48.1 m-20 45.67 28.46 0.54 Allowed 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 178.6 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 101.7 -14.09 57.73 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 120.762 -0.732 . . . . 0.0 113.705 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -88.59 127.99 35.57 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-N 117.685 0.742 . . . . 0.0 110.432 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 79.4 p -76.27 127.04 32.1 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.784 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' PHE . . . . . 0.578 ' CE1' ' HB3' ' A' ' 69' ' ' ALA . 6.3 m-85 -101.97 14.2 32.64 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.574 HD11 HG23 ' A' ' 67' ' ' ILE . 31.4 mm -90.65 125.53 43.46 Favored 'Isoleucine or valine' 0 C--N 1.341 0.226 0 O-C-N 122.011 -0.43 . . . . 0.0 110.97 179.386 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 61.64 71.88 0.53 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-O 121.279 0.561 . . . . 0.0 110.838 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 12.7 pt -149.01 165.84 3.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.792 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -80.97 145.21 31.33 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.95 0.405 . . . . 0.0 110.771 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -52.5 -51.73 58.03 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.05 -179.034 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -56.58 -27.46 54.62 Favored Glycine 0 C--N 1.334 0.424 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.938 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 7.1 tm0? -72.72 -40.2 66.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.957 0.408 . . . . 0.0 110.316 179.44 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.48 -36.13 82.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.314 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.73 HG22 HD11 ' A' ' 27' ' ' ILE . 25.4 t -73.4 -44.13 54.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.978 0.418 . . . . 0.0 110.572 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 23.0 t -56.49 -38.07 71.23 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.135 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 89.6 mt -71.78 -39.54 69.86 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.364 179.15 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.421 ' HA ' ' CD2' ' A' ' 89' ' ' PHE . 75.2 mt -78.14 -3.0 40.25 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 179.32 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 11.5 mmtp -99.23 -40.78 7.78 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-O 121.302 0.572 . . . . 0.0 110.303 178.377 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 8.9 t -73.86 -24.53 59.76 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -178.021 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.421 ' CD2' ' HA ' ' A' ' 86' ' ' LEU . 10.2 m-85 -48.52 171.62 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -178.534 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -86.99 -142.47 0.11 Allowed 'General case' 0 CA--C 1.554 1.113 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.214 -179.097 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -78.13 -68.32 0.65 Allowed 'General case' 0 C--N 1.349 0.561 0 CA-C-N 119.027 0.83 . . . . 0.0 111.017 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.57 HG23 ' CG ' ' A' ' 18' ' ' GLU . 0.2 OUTLIER -81.41 134.24 35.52 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.572 179.954 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 21.3 t -120.84 124.67 72.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.138 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -89.78 115.12 26.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.982 179.376 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.0 mt -118.57 148.24 42.87 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.043 0.449 . . . . 0.0 112.041 -178.799 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.493 HD12 ' HB2' ' A' ' 68' ' ' GLN . 48.6 mt -119.56 132.22 69.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.527 178.451 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.478 HD13 ' CD2' ' A' ' 60' ' ' LEU . 35.1 pt -130.67 169.03 22.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.864 0.364 . . . . 0.0 111.762 -179.207 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.467 HG23 ' CG1' ' A' ' 67' ' ' ILE . 58.2 t -133.01 143.02 40.67 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.042 -179.186 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.49 102.23 10.11 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.756 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 . . . . . 0 C--N 1.328 -0.346 0 CA-C-O 120.848 0.356 . . . . 0.0 111.727 -178.895 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 . . . . . 0 N--CA 1.464 0.245 0 CA-C-O 120.842 0.353 . . . . 0.0 110.904 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 305' ' ' THR . . . . . . . . . . . . . 3.5 m -105.1 123.42 47.79 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.109 -0.496 . . . . 17.879999999999999 110.688 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 306' ' ' TRP . . . . . . . . . . . . . 88.5 m95 -89.02 112.2 23.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.951 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 307' ' ' VAL . . . . . 0.488 HG12 HG13 ' A' ' 83' ' ' VAL . 17.8 m . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.241 -0.885 . . . . 16.109999999999999 111.077 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.162 0 N-CA-C 112.489 -0.244 . . . . 0.0 112.489 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 75.6 p -158.01 -179.57 8.25 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.862 0.363 . . . . 0.0 110.942 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 13.4 t-80 -76.41 134.53 39.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.826 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 10.7 mmt -83.77 162.59 20.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.895 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -157.49 -78.44 0.02 OUTLIER Glycine 0 CA--C 1.518 0.233 0 C-N-CA 120.825 -0.703 . . . . 0.0 112.44 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -89.64 60.0 4.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.263 0.554 . . . . 0.0 110.646 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -167.82 177.34 5.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.881 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 16.6 tp -72.99 103.84 3.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.065 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.625 ' HA ' HG21 ' A' ' 101' ' ' VAL . . . -171.0 -171.17 0.95 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.374 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 5.2 mtpt -63.88 104.52 0.7 Allowed 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.093 -179.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.711 ' O ' HG13 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -98.8 168.66 9.99 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.936 179.928 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -132.72 95.57 3.62 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.962 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.564 ' H ' HD13 ' A' ' 13' ' ' ILE . 0.2 OUTLIER -112.99 159.52 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-O 121.155 0.502 . . . . 0.0 112.202 -179.657 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 11.5 ttp-105 -114.5 155.23 26.81 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.9 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.536 HG21 HD21 ' A' ' 60' ' ' LEU . 15.9 m -136.65 143.73 34.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.217 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.5 mtm180 -108.44 106.85 17.15 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.609 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.8 t -110.31 110.39 31.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.883 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.711 ' HG3' HG23 ' A' ' 92' ' ' THR . 0.9 OUTLIER -88.79 128.76 35.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.899 -179.975 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.494 ' HD3' HD12 ' A' ' 23' ' ' LEU . 10.4 mtmt -80.53 115.04 19.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.937 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -166.98 89.06 0.76 Allowed Pre-proline 0 CA--C 1.535 0.39 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.634 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -79.72 -24.06 13.07 Favored 'Cis proline' 0 C--N 1.363 1.317 0 CA-C-N 119.36 0.807 . . . . 0.0 112.879 0.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 54.4 mm-40 -135.53 -176.8 4.4 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.8 0.333 . . . . 0.0 111.451 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.494 HD12 ' HD3' ' A' ' 19' ' ' LYS . 3.0 mp -63.47 -59.08 5.13 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.02 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.437 ' O ' HG13 ' A' ' 50' ' ' VAL . . . 106.75 31.18 4.02 Favored Glycine 0 CA--C 1.521 0.415 0 C-N-CA 120.867 -0.682 . . . . 0.0 113.585 179.157 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.418 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 28.3 p90 -162.62 155.44 19.52 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 117.066 0.433 . . . . 0.0 111.235 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.1 p -108.12 152.98 23.8 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.4 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.744 HD11 HG22 ' A' ' 83' ' ' VAL . 41.3 pt -120.27 148.71 23.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.632 179.339 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.5 t -139.45 167.71 21.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.871 0.367 . . . . 0.0 111.05 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.46 -146.4 18.19 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.972 -0.632 . . . . 0.0 112.382 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 101.54 153.32 25.75 Favored Glycine 0 C--N 1.331 0.255 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.491 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 25.9 t -79.53 97.24 2.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.906 0.384 . . . . 0.0 111.003 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 98.81 -2.72 58.58 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 120.999 -0.62 . . . . 0.0 113.937 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -78.64 -155.75 8.83 Favored Glycine 0 C--N 1.34 0.781 0 CA-C-N 117.842 0.821 . . . . 0.0 113.04 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -62.12 -29.41 70.31 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.505 0.193 . . . . 0.0 111.341 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 107.94 153.74 17.75 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.606 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -112.28 129.85 23.91 Favored Pre-proline 0 N--CA 1.468 0.468 0 CA-C-O 119.886 -0.102 . . . . 0.0 110.764 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -92.85 34.9 0.23 Allowed 'Trans proline' 0 C--N 1.357 0.999 0 C-N-CA 122.357 2.038 . . . . 0.0 113.129 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -116.12 -49.21 2.7 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.761 0.315 . . . . 0.0 110.952 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 32.1 mmt180 -116.36 138.93 24.72 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.806 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -83.63 -44.31 0.07 OUTLIER 'Trans proline' 0 C--N 1.357 1.023 0 C-N-CA 121.972 1.782 . . . . 0.0 112.936 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -92.03 -8.58 45.59 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -108.22 123.21 48.41 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 118.08 0.4 . . . . 0.0 110.885 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.2 p30 -110.04 34.67 3.74 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.072 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -78.73 -158.56 12.5 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.485 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 20.5 mm -108.94 131.04 60.76 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 N-CA-C 110.418 -0.215 . . . . 0.0 110.418 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -130.48 146.39 52.02 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.87 0.367 . . . . 0.0 111.545 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 22.0 t -90.38 73.95 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.672 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.2 t -34.47 -54.31 0.53 Allowed 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 114.767 1.395 . . . . 0.0 114.767 -178.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 11.0 ptm180 -160.3 170.87 20.19 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.201 0.524 . . . . 0.0 112.171 -179.249 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.437 HG13 ' O ' ' A' ' 24' ' ' GLY . 21.2 t -125.23 147.24 29.93 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.355 179.566 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 8.3 mm-40 -103.91 -68.09 0.04 OUTLIER Pre-proline 0 CA--C 1.535 0.4 0 CA-C-N 116.833 -0.167 . . . . 0.0 111.277 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -79.83 119.33 3.97 Favored 'Trans proline' 0 C--N 1.356 0.951 0 C-N-CA 121.694 1.596 . . . . 0.0 112.173 179.487 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -79.59 66.27 5.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.276 0.56 . . . . 0.0 110.793 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -143.86 -73.37 0.03 OUTLIER Glycine 0 CA--C 1.526 0.734 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.58 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -60.2 -70.03 0.04 OUTLIER 'Trans proline' 0 C--N 1.358 1.03 0 C-N-CA 121.832 1.688 . . . . 0.0 112.938 -179.561 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -99.02 43.4 1.06 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-O 120.99 0.424 . . . . 0.0 111.415 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 92.9 p -87.11 -59.41 2.26 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.304 179.455 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -91.12 -4.0 56.6 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.791 -0.641 . . . . 0.0 112.244 179.318 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -91.62 -69.52 0.73 Allowed 'General case' 0 C--N 1.341 0.22 0 CA-C-N 118.231 0.469 . . . . 0.0 111.606 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.536 HD21 HG21 ' A' ' 15' ' ' VAL . 5.7 mt -96.82 146.31 25.04 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.896 0.379 . . . . 0.0 111.921 -179.315 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -112.61 151.17 43.69 Favored Pre-proline 0 N--CA 1.47 0.574 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.478 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -64.22 129.22 23.56 Favored 'Trans proline' 0 C--N 1.355 0.909 0 C-N-CA 121.872 1.714 . . . . 0.0 112.588 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 92.71 18.99 38.87 Favored Glycine 0 CA--C 1.523 0.541 0 C-N-CA 120.929 -0.653 . . . . 0.0 113.689 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -93.54 151.35 19.76 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 117.306 0.553 . . . . 0.0 110.762 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 60.1 tttm -100.1 130.27 46.23 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.212 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 28.0 mt -89.85 117.08 32.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.411 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 22.1 mm -90.48 -43.96 14.63 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -178.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.619 ' HB3' HD12 ' A' ' 96' ' ' ILE . 3.4 tt0 -145.14 150.79 37.39 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.812 0.339 . . . . 0.0 111.652 -178.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.553 ' HB3' ' CE1' ' A' ' 74' ' ' PHE . . . -138.32 119.78 14.91 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.487 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.401 ' HB2' ' CZ ' ' A' ' 89' ' ' PHE . 2.4 m120 46.47 29.0 0.81 Allowed 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 178.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 101.78 -20.25 46.74 Favored Glycine 0 CA--C 1.521 0.468 0 C-N-CA 120.747 -0.739 . . . . 0.0 113.391 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -88.77 126.51 35.37 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 117.212 0.506 . . . . 0.0 110.535 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.5 t -72.53 141.71 48.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.576 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.553 ' CE1' ' HB3' ' A' ' 69' ' ' ALA . 3.7 m-85 -111.43 20.57 17.11 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -179.621 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 24.7 mm -97.52 137.66 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-O 120.681 0.277 . . . . 0.0 111.446 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 33.5 m120 65.31 10.69 6.7 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 9.5 pt -92.88 163.08 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 N-CA-C 113.375 0.879 . . . . 0.0 113.375 -178.249 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -83.03 144.7 29.76 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.79 179.027 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 8.8 t-160 -52.35 -51.4 59.01 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -178.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -53.95 -28.39 40.14 Favored Glycine 0 C--N 1.335 0.509 0 C-N-CA 121.104 -0.569 . . . . 0.0 113.127 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.4 tp-100 -75.77 -37.72 59.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.993 0.425 . . . . 0.0 110.309 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.63 -47.92 68.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.373 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.744 HG22 HD11 ' A' ' 27' ' ' ILE . 20.3 t -62.02 -43.37 97.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.271 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 33.2 t -60.77 -38.32 84.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.424 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.45 ' O ' HG22 ' A' ' 88' ' ' THR . 32.7 mt -67.66 -45.54 74.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.454 -179.64 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.441 ' HA ' ' CD2' ' A' ' 89' ' ' PHE . 15.6 mt -64.21 -36.25 83.44 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -179.128 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 34.2 mttm -72.19 -37.98 69.17 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 -178.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.45 HG22 ' O ' ' A' ' 85' ' ' LEU . 9.9 t -70.99 -27.02 63.4 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -178.394 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.441 ' CD2' ' HA ' ' A' ' 86' ' ' LEU . 13.3 m-85 -49.45 148.01 3.0 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -178.579 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -65.65 -137.75 0.0 OUTLIER 'General case' 0 CA--C 1.551 0.994 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.292 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -81.36 -69.79 0.58 Allowed 'General case' 0 C--N 1.351 0.646 0 CA-C-N 119.488 1.04 . . . . 0.0 112.403 -178.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.711 HG23 ' HG3' ' A' ' 18' ' ' GLU . 0.2 OUTLIER -74.18 121.36 21.09 Favored 'General case' 0 C--O 1.231 0.08 0 CA-C-O 120.839 0.352 . . . . 0.0 111.068 -179.278 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 19.1 t -112.58 111.89 38.08 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.004 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -93.44 126.08 38.39 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 2.0 mt -130.42 159.93 35.55 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.074 0.464 . . . . 0.0 111.867 -178.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.619 HD12 ' HB3' ' A' ' 68' ' ' GLN . 48.2 mt -119.17 129.18 75.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.984 178.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.514 HD13 HD23 ' A' ' 60' ' ' LEU . 33.0 pt -125.55 165.32 23.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-O 120.97 0.414 . . . . 0.0 111.878 -179.298 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.711 HG13 ' O ' ' A' ' 11' ' ' GLN . 44.3 t -144.61 149.34 17.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.555 -179.36 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.51 116.29 28.6 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.091 179.002 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -63.12 166.5 5.93 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 120.936 0.398 . . . . 0.0 111.647 -178.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.625 HG21 ' HA ' ' A' ' 9' ' ' ALA . 3.7 m -149.89 108.52 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.973 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 31.5 t -149.45 110.02 4.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.922 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 8.3 t . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.234 -0.888 . . . . 0.0 110.799 179.995 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 301' ' ' THR . . . . . . . . . . . . . 2.8 m . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.813 0.34 . . . . 0.0 111.208 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 302' ' ' GLY . . . . . . . . . . . . . . . 78.12 130.43 0.56 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.572 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 303' ' ' TRP . . . . . . . . . . . . . 20.5 p-90 -169.89 -42.25 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.718 0.294 . . . . 0.0 111.102 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -71.93 131.06 42.45 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.786 0.327 . . . . 0.0 110.865 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 305' ' ' THR . . . . . . . . . . . . . 6.9 m -122.78 120.19 32.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.142 -0.481 . . . . 17.879999999999999 110.627 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 306' ' ' TRP . . . . . . . . . . . . . 94.3 m95 -85.03 114.21 22.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.945 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 307' ' ' VAL . . . . . . . . . . . . . 25.2 m . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.14 -0.934 . . . . 16.109999999999999 111.168 -179.849 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.124 0 N-CA-C 112.514 -0.234 . . . . 0.0 112.514 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.6 t -162.44 -47.28 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.831 0.348 . . . . 0.0 110.948 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 16.0 m80 -70.74 109.14 4.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.093 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 11.9 mmm -103.89 -47.17 4.28 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.789 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -178.26 -39.42 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.427 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -81.18 99.13 8.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.782 0.325 . . . . 0.0 110.658 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -142.43 163.79 31.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.024 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -81.07 86.91 6.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.663 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -144.48 44.2 1.4 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.111 0.481 . . . . 0.0 110.904 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.0 tttt -174.65 -179.27 1.46 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.508 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.424 ' O ' HG13 ' A' ' 98' ' ' VAL . 5.2 pt20 -149.95 138.38 20.62 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-O 120.725 0.298 . . . . 0.0 111.345 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.6 110.23 12.49 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.002 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.615 ' H ' HD13 ' A' ' 13' ' ' ILE . 0.2 OUTLIER -126.2 155.79 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.296 179.867 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.642 ' HG3' HD13 ' A' ' 96' ' ' ILE . 24.7 ttm-85 -116.52 152.39 34.19 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.11 -179.013 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.405 ' HB ' HD22 ' A' ' 59' ' ' LEU . 18.5 m -145.78 147.23 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 N-CA-C 111.623 0.231 . . . . 0.0 111.623 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 14.1 ptp180 -112.54 130.59 55.96 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.813 0.34 . . . . 0.0 111.274 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.7 t -116.07 120.38 64.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.705 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.729 ' HG3' HG22 ' A' ' 92' ' ' THR . 3.5 mp0 -94.2 119.54 33.15 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.831 -179.283 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.57 113.18 4.02 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.833 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -175.29 84.02 0.31 Allowed Pre-proline 0 CA--C 1.537 0.461 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.119 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -82.68 -24.84 10.8 Favored 'Cis proline' 0 C--N 1.363 1.297 0 CA-C-N 119.508 0.86 . . . . 0.0 112.8 0.424 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -137.51 -178.06 5.06 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 120.815 0.341 . . . . 0.0 111.441 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.42 ' HB3' ' CE2' ' A' ' 25' ' ' PHE . 3.5 mp -61.1 -59.65 5.01 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.198 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.411 ' O ' HG13 ' A' ' 50' ' ' VAL . . . 104.94 25.53 6.76 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 120.799 -0.715 . . . . 0.0 113.48 179.52 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.498 ' O ' HG22 ' B' ' 307' ' ' VAL . 37.2 p90 -155.25 144.47 20.98 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 117.252 0.526 . . . . 0.0 111.051 179.492 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.3 p -98.91 151.82 20.44 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.363 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.872 HD11 HG22 ' A' ' 83' ' ' VAL . 22.5 pt -122.34 153.62 26.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.914 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.8 m -148.06 162.12 40.02 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.78 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 106.58 -149.9 16.71 Favored Glycine 0 C--N 1.332 0.355 0 C-N-CA 120.908 -0.663 . . . . 0.0 113.186 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 103.98 154.91 23.72 Favored Glycine 0 C--N 1.331 0.267 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.178 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 18.7 t -78.75 110.82 14.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 120.934 0.397 . . . . 0.0 110.756 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 88.83 3.71 76.59 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 120.939 -0.648 . . . . 0.0 113.847 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -82.89 -146.77 6.54 Favored Glycine 0 C--N 1.341 0.825 0 CA-C-N 117.841 0.82 . . . . 0.0 112.798 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 48.5 mtt-85 -81.0 -4.36 54.88 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.03 162.35 37.52 Favored Glycine 0 C--N 1.344 0.991 0 C-N-CA 120.609 -0.805 . . . . 0.0 113.099 179.602 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -105.84 134.87 19.53 Favored Pre-proline 0 CA--C 1.533 0.289 0 CA-C-O 119.899 -0.096 . . . . 0.0 110.921 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -92.87 27.06 0.37 Allowed 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 122.309 2.006 . . . . 0.0 112.819 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -125.25 -46.03 1.81 Allowed 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.731 0.3 . . . . 0.0 110.796 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 64.6 mtt-85 -116.59 150.99 46.56 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.614 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -92.08 -57.58 0.02 OUTLIER 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 122.153 1.902 . . . . 0.0 114.082 -178.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -84.21 -7.18 59.43 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 -178.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -101.69 117.08 34.16 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 118.154 0.433 . . . . 0.0 111.108 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -106.31 34.03 3.57 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.481 -179.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -80.86 -161.56 26.19 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.199 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.8 mm -107.27 131.28 57.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-N 116.782 0.291 . . . . 0.0 110.298 179.398 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.435 ' N ' ' CD1' ' A' ' 46' ' ' PHE . 6.0 m-85 -130.5 148.35 52.3 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.882 0.372 . . . . 0.0 111.359 -179.332 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.538 HG23 ' OD1' ' A' ' 64' ' ' ASP . 22.0 t -92.2 76.02 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-O 121.158 0.504 . . . . 0.0 110.955 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.424 HG23 ' N ' ' A' ' 49' ' ' ARG . 8.2 t -35.13 -51.72 0.56 Allowed 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 -178.62 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.424 ' N ' HG23 ' A' ' 48' ' ' THR . 3.6 ptm180 -160.22 176.63 11.52 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.117 0.484 . . . . 0.0 112.28 -179.254 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.411 HG13 ' O ' ' A' ' 24' ' ' GLY . 18.3 t -130.8 148.47 33.08 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.605 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -102.66 -67.89 0.04 OUTLIER Pre-proline 0 CA--C 1.536 0.422 0 CA-C-O 119.753 -0.165 . . . . 0.0 111.392 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -79.4 120.8 4.55 Favored 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 121.796 1.664 . . . . 0.0 112.052 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -77.76 65.63 3.27 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.94 0.4 . . . . 0.0 111.096 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -158.42 -66.54 0.01 OUTLIER Glycine 0 CA--C 1.528 0.85 0 C-N-CA 120.765 -0.731 . . . . 0.0 113.362 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -58.26 -76.43 0.02 OUTLIER 'Trans proline' 0 C--N 1.357 0.99 0 C-N-CA 122.142 1.895 . . . . 0.0 113.36 -179.04 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.858 ' HB1' HD12 ' A' ' 60' ' ' LEU . . . -111.72 49.77 0.88 Allowed 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.196 0.522 . . . . 0.0 111.437 -179.412 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 82.4 p -107.35 -67.25 0.97 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.758 179.3 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.72 -12.13 57.27 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.99 178.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.405 HD22 ' HB ' ' A' ' 15' ' ' VAL . 4.4 mt -93.71 -59.22 2.05 Favored 'General case' 0 C--N 1.342 0.24 0 O-C-N 122.008 -0.433 . . . . 0.0 111.405 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.858 HD12 ' HB1' ' A' ' 56' ' ' ALA . 15.2 mt -93.03 149.26 21.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.547 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.22 144.53 33.13 Favored Pre-proline 0 N--CA 1.471 0.603 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.744 179.2 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.53 133.47 52.05 Favored 'Trans proline' 0 C--N 1.359 1.081 0 C-N-CA 122.165 1.91 . . . . 0.0 113.427 -178.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 87.75 21.75 45.77 Favored Glycine 0 C--N 1.334 0.417 0 CA-C-N 115.716 -0.675 . . . . 0.0 113.632 178.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.538 ' OD1' HG23 ' A' ' 47' ' ' VAL . 2.9 p30 -84.62 -169.55 2.68 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 117.092 0.446 . . . . 0.0 111.005 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 57.8 tttp -141.55 126.44 18.19 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-O 120.874 0.368 . . . . 0.0 111.338 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 27.9 mt -90.31 118.05 34.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.233 179.366 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.512 HD12 ' CG2' ' A' ' 98' ' ' VAL . 50.3 mt -102.14 -31.79 3.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 N-CA-C 112.419 0.525 . . . . 0.0 112.419 -178.45 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.61 144.57 27.31 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.005 0.431 . . . . 0.0 111.844 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.47 ' HB3' ' CE1' ' A' ' 74' ' ' PHE . . . -146.25 121.48 10.19 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.783 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 44.73 41.77 5.3 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 178.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 89.21 -17.99 48.07 Favored Glycine 0 CA--C 1.524 0.605 0 C-N-CA 120.856 -0.688 . . . . 0.0 113.634 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -100.92 123.27 44.87 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 117.373 0.586 . . . . 0.0 110.256 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 30.0 m -72.52 151.87 42.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.284 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.47 ' CE1' ' HB3' ' A' ' 69' ' ' ALA . 3.7 m-85 -113.09 19.56 17.08 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.783 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.431 HD11 HG23 ' A' ' 67' ' ' ILE . 30.7 mm -97.03 133.14 39.69 Favored 'Isoleucine or valine' 0 C--O 1.231 0.111 0 CA-C-O 120.751 0.31 . . . . 0.0 110.859 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 61.23 62.36 1.4 Allowed 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 121.185 0.517 . . . . 0.0 110.898 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 18.7 pt -144.43 164.67 13.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.752 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -82.09 145.53 30.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.633 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 -51.2 -53.29 36.37 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 116.167 -0.47 . . . . 0.0 112.162 -179.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -54.65 -25.97 37.62 Favored Glycine 0 CA--C 1.523 0.549 0 C-N-CA 121.079 -0.582 . . . . 0.0 113.02 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -74.46 -39.69 62.37 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.111 0.481 . . . . 0.0 110.404 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -70.5 -37.57 74.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.852 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.872 HG22 HD11 ' A' ' 27' ' ' ILE . 35.2 t -70.49 -44.53 76.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.972 0.415 . . . . 0.0 110.893 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 75.4 m -61.05 -37.32 82.21 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.303 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 19.9 mt -65.65 -46.89 77.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.599 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.415 ' HA ' ' CD2' ' A' ' 89' ' ' PHE . 34.4 mt -65.7 -38.31 88.87 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.897 -178.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 56.1 mttm -71.45 -39.16 71.16 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -178.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 12.0 t -73.77 -27.28 61.07 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -178.084 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.415 ' CD2' ' HA ' ' A' ' 86' ' ' LEU . 11.8 m-85 -48.98 172.7 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -178.618 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -84.31 -143.46 0.08 Allowed 'General case' 0 CA--C 1.552 1.054 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.193 -179.123 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 67.8 m-80 -76.96 -69.95 0.49 Allowed 'General case' 0 C--N 1.349 0.564 0 CA-C-N 119.005 0.821 . . . . 0.0 111.552 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.729 HG22 ' HG3' ' A' ' 18' ' ' GLU . 4.7 p -80.07 125.46 29.82 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.921 0.391 . . . . 0.0 110.788 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 18.8 t -113.41 114.56 47.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.556 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -87.79 112.97 23.0 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 4.2 mt -115.21 152.64 32.3 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-O 121.224 0.535 . . . . 0.0 112.101 -178.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.642 HD13 ' HG3' ' A' ' 14' ' ' ARG . 31.3 mm -112.39 124.6 69.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.065 178.109 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.535 HD13 HD23 ' A' ' 60' ' ' LEU . 29.3 pt -127.23 158.34 38.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 120.882 0.372 . . . . 0.0 111.208 -178.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.512 ' CG2' HD12 ' A' ' 67' ' ' ILE . 58.3 t -144.24 150.25 16.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.241 -179.133 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.6 mmm180 -112.0 116.8 31.16 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -67.54 143.97 55.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.058 0.456 . . . . 0.0 111.703 -178.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 25.5 t -148.07 102.52 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.516 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 69.0 m -151.15 166.04 32.03 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.118 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 20.0 t . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.814 179.879 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 301' ' ' THR . . . . . . . . . . . . . 47.1 p . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.758 0.313 . . . . 0.0 111.231 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 302' ' ' GLY . . . . . . . . . . . . . . . -87.75 147.04 20.26 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.455 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 303' ' ' TRP . . . . . . . . . . . . . 26.9 p-90 -74.98 -30.62 61.22 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.657 0.265 . . . . 0.0 111.126 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -83.51 164.75 19.63 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.692 0.282 . . . . 0.0 110.515 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 305' ' ' THR . . . . . . . . . . . . . 4.7 m -140.42 113.71 8.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.454 -0.339 . . . . 17.879999999999999 111.159 -179.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 306' ' ' TRP . . . . . . . . . . . . . 92.8 m95 -80.77 105.46 12.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.707 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 307' ' ' VAL . . . . . 0.498 HG22 ' O ' ' A' ' 25' ' ' PHE . 16.7 m . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.233 -0.889 . . . . 16.109999999999999 111.134 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.176 0 N-CA-C 112.534 -0.226 . . . . 0.0 112.534 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.2 t -86.11 174.37 9.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.744 0.307 . . . . 0.0 110.954 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 36.8 t60 -89.99 121.1 31.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.986 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.64 90.94 2.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.451 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -163.71 32.16 0.27 Allowed Glycine 0 C--N 1.334 0.434 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.674 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 37.3 m170 -104.21 162.66 13.0 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.761 0.315 . . . . 0.0 110.781 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -86.46 100.06 12.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.799 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.8 tp -160.35 148.38 16.51 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.155 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -102.14 -158.43 0.67 Allowed 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.788 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.3 mmtm -52.7 124.43 13.82 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 121.159 0.504 . . . . 0.0 111.581 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -87.92 94.17 9.69 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.641 -0.709 . . . . 0.0 112.873 -178.123 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -94.8 126.76 40.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.557 178.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 19.8 pt -147.29 159.17 9.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -178.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 9.7 ttm105 -104.91 153.77 20.96 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.718 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.5 m -146.74 132.74 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.547 178.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.2 ttt180 -107.84 119.94 40.88 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.202 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.4 t -118.97 119.77 61.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.062 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.711 ' CG ' HG23 ' A' ' 92' ' ' THR . 40.0 mt-10 -96.79 132.36 42.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.681 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.484 ' HE2' HD11 ' A' ' 23' ' ' LEU . 21.5 mttt -80.31 122.98 27.58 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.435 0.636 . . . . 0.0 111.856 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -173.97 85.52 0.36 Allowed Pre-proline 0 CA--C 1.537 0.466 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.939 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -81.3 -17.52 27.25 Favored 'Cis proline' 0 C--N 1.365 1.401 0 CA-C-N 119.261 0.772 . . . . 0.0 113.371 0.458 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 38.1 mm-40 -136.63 -177.17 4.61 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.79 0.329 . . . . 0.0 111.453 -179.535 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.484 HD11 ' HE2' ' A' ' 19' ' ' LYS . 4.5 mp -59.42 -63.08 1.43 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.211 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.507 ' O ' HG13 ' A' ' 50' ' ' VAL . . . 114.67 28.84 2.83 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 120.877 -0.677 . . . . 0.0 113.485 179.559 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.444 ' O ' HG22 ' B' ' 307' ' ' VAL . 49.5 p90 -164.14 148.9 10.15 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 117.156 0.478 . . . . 0.0 111.285 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.4 p -102.06 155.1 18.4 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.24 -179.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.837 HD11 HG22 ' A' ' 83' ' ' VAL . 21.1 pt -125.38 153.47 32.95 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.752 179.759 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.4 m -143.28 165.61 26.99 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.821 0.343 . . . . 0.0 111.139 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.77 -144.45 17.22 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.674 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 102.3 151.52 23.83 Favored Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.378 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.574 HG22 ' OD2' ' A' ' 43' ' ' ASP . 30.3 t -79.99 98.7 3.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.849 0.357 . . . . 0.0 110.781 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 98.94 -3.61 58.71 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 120.958 -0.639 . . . . 0.0 114.07 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -81.17 -150.66 7.53 Favored Glycine 0 C--N 1.342 0.906 0 CA-C-N 117.799 0.8 . . . . 0.0 112.904 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 4.9 ptt-85 -87.18 12.23 12.16 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 51.39 -173.02 0.17 Allowed Glycine 0 C--N 1.342 0.893 0 N-CA-C 114.496 0.559 . . . . 0.0 114.496 178.543 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 22.7 p30 -142.56 161.51 49.32 Favored Pre-proline 0 CA--C 1.536 0.41 0 CA-C-N 115.553 -0.323 . . . . 0.0 110.545 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -92.75 25.12 0.44 Allowed 'Trans proline' 0 C--N 1.358 1.052 0 C-N-CA 122.386 2.057 . . . . 0.0 113.431 -179.334 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -103.33 -44.17 5.23 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.699 0.285 . . . . 0.0 111.298 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -124.07 136.16 27.22 Favored Pre-proline 0 CA--C 1.535 0.369 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.503 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -84.98 -46.89 0.04 OUTLIER 'Trans proline' 0 C--N 1.358 1.04 0 C-N-CA 121.908 1.738 . . . . 0.0 113.385 -179.343 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -97.01 -11.31 24.68 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 112.867 0.691 . . . . 0.0 112.867 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -92.33 121.59 33.97 Favored 'General case' 0 N--CA 1.464 0.254 0 O-C-N 122.064 -0.397 . . . . 0.0 110.465 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.574 ' OD2' HG22 ' A' ' 31' ' ' VAL . 14.0 p-10 -111.03 47.65 0.98 Allowed 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.04 0.448 . . . . 0.0 111.596 -179.55 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -94.71 -162.83 35.07 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 121.058 -0.592 . . . . 0.0 111.69 179.009 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 14.6 mm -112.45 124.91 69.59 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-N 117.421 0.611 . . . . 0.0 110.449 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -126.79 146.51 50.22 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.735 0.302 . . . . 0.0 110.959 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.572 HG23 ' OD1' ' A' ' 64' ' ' ASP . 22.7 t -90.99 76.18 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-O 120.89 0.376 . . . . 0.0 111.201 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.402 HG23 ' N ' ' A' ' 49' ' ' ARG . 4.8 t -33.09 -54.53 0.39 Allowed 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 -178.289 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.402 ' N ' HG23 ' A' ' 48' ' ' THR . 0.6 OUTLIER -160.27 174.17 14.61 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.262 0.553 . . . . 0.0 112.45 -179.271 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.507 HG13 ' O ' ' A' ' 24' ' ' GLY . 20.7 t -124.79 145.36 32.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.459 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.403 ' CB ' ' HD3' ' A' ' 52' ' ' PRO . 1.9 mm-40 -102.86 -69.95 0.04 OUTLIER Pre-proline 0 CA--C 1.539 0.54 0 CA-C-O 119.461 -0.304 . . . . 0.0 111.413 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.403 ' HD3' ' CB ' ' A' ' 51' ' ' GLN . 61.0 Cg_endo -82.57 121.15 3.3 Favored 'Trans proline' 0 C--N 1.359 1.118 0 C-N-CA 121.698 1.599 . . . . 0.0 112.601 179.605 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -79.8 66.21 5.21 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.303 0.573 . . . . 0.0 110.799 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -142.08 -71.08 0.03 OUTLIER Glycine 0 CA--C 1.527 0.834 0 CA-C-N 115.778 -0.646 . . . . 0.0 113.152 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -63.47 -58.15 0.31 Allowed 'Trans proline' 0 C--N 1.358 1.058 0 C-N-CA 121.948 1.766 . . . . 0.0 113.497 -179.153 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.494 ' HB1' HD12 ' A' ' 60' ' ' LEU . . . -118.8 48.56 1.44 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 121.08 0.467 . . . . 0.0 111.728 -179.292 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 82.6 p -79.81 -59.64 2.66 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.852 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 17.3 mttt -97.73 9.89 41.44 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 79.0 mt -92.23 -65.11 1.03 Allowed 'General case' 0 C--N 1.34 0.181 0 O-C-N 122.106 -0.371 . . . . 0.0 111.413 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.515 HD23 HG21 ' A' ' 97' ' ' ILE . 1.1 mt -97.12 147.76 23.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.509 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -113.4 140.04 23.95 Favored Pre-proline 0 N--CA 1.469 0.481 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.67 178.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -53.01 136.04 60.04 Favored 'Trans proline' 0 C--N 1.358 1.068 0 C-N-CA 122.083 1.855 . . . . 0.0 113.291 -178.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 82.03 24.78 54.29 Favored Glycine 0 C--N 1.333 0.374 0 CA-C-N 115.767 -0.651 . . . . 0.0 113.246 179.212 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.572 ' OD1' HG23 ' A' ' 47' ' ' VAL . 3.0 p30 -86.05 -170.58 3.16 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.89 0.345 . . . . 0.0 110.857 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 60.8 tttp -139.33 122.86 17.32 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.83 0.348 . . . . 0.0 110.891 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 48.8 mt -89.61 121.94 40.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.509 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 19.5 mm -96.03 -43.97 12.81 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 N-CA-C 112.581 0.585 . . . . 0.0 112.581 -178.441 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -145.81 150.57 36.44 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 121.073 0.463 . . . . 0.0 111.957 -178.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.404 ' HB3' ' CE1' ' A' ' 74' ' ' PHE . . . -137.1 119.46 15.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.94 179.446 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 42.28 32.3 0.32 Allowed 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 113.642 0.978 . . . . 0.0 113.642 178.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 97.83 4.2 57.94 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 120.986 -0.626 . . . . 0.0 114.083 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -110.09 124.24 51.15 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 117.949 0.875 . . . . 0.0 110.565 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 54.8 p -72.78 139.85 47.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.484 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.412 ' HA ' HD13 ' A' ' 77' ' ' ILE . 4.7 m-85 -110.5 21.55 16.49 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -179.371 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.439 HG22 ' OD1' ' A' ' 76' ' ' ASN . 21.1 mm -100.29 139.45 21.72 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 O-C-N 122.214 -0.304 . . . . 0.0 111.048 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.504 ' HA ' HG21 ' A' ' 31' ' ' VAL . 19.9 m120 63.81 12.23 6.54 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -179.407 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.412 HD13 ' HA ' ' A' ' 74' ' ' PHE . 25.3 pt -93.62 158.21 2.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -178.445 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -81.63 148.83 28.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.479 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.453 ' O ' HG23 ' A' ' 83' ' ' VAL . 35.4 t60 -47.23 -50.32 21.34 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -179.324 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -57.59 -26.15 56.65 Favored Glycine 0 C--N 1.335 0.501 0 C-N-CA 120.874 -0.679 . . . . 0.0 113.082 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.419 ' OE1' HD11 ' A' ' 85' ' ' LEU . 0.0 OUTLIER -76.21 -42.59 45.63 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.897 0.38 . . . . 0.0 110.887 179.839 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.38 -39.57 81.69 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.662 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.837 HG22 HD11 ' A' ' 27' ' ' ILE . 25.4 t -72.57 -43.2 63.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.852 0.358 . . . . 0.0 110.666 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 34.7 t -60.53 -39.95 89.75 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.296 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.419 HD11 ' OE1' ' A' ' 81' ' ' GLN . 53.2 mt -67.56 -44.0 79.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.898 0.38 . . . . 0.0 111.139 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.422 ' HA ' ' CD2' ' A' ' 89' ' ' PHE . 17.5 mt -66.27 -38.57 88.11 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.809 -178.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 48.5 mttm -73.31 -38.09 65.96 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -178.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 9.0 t -70.15 -25.34 63.42 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -178.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.422 ' CD2' ' HA ' ' A' ' 86' ' ' LEU . 14.7 m-85 -53.5 140.49 28.04 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.19 0.519 . . . . 0.0 111.842 -179.348 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -62.59 -131.4 0.0 OUTLIER 'General case' 0 CA--C 1.558 1.258 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.948 -178.067 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -82.59 -72.28 0.45 Allowed 'General case' 0 C--N 1.355 0.806 0 CA-C-N 119.718 1.144 . . . . 0.0 112.621 -177.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.711 HG23 ' CG ' ' A' ' 18' ' ' GLU . 0.3 OUTLIER -74.23 123.11 23.91 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.818 0.342 . . . . 0.0 111.011 -179.367 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.49 ' CG1' HD11 ' A' ' 95' ' ' LEU . 16.6 t -109.51 116.08 51.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.953 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.95 104.62 16.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.353 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.49 HD11 ' CG1' ' A' ' 93' ' ' VAL . 3.8 mp -111.76 158.54 19.23 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.239 0.542 . . . . 0.0 112.098 -179.118 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 26.5 mm -118.72 129.59 74.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.822 178.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.515 HG21 HD23 ' A' ' 60' ' ' LEU . 25.8 pt -130.96 167.24 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-O 120.846 0.355 . . . . 0.0 111.663 -178.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 19.0 t -148.29 151.65 13.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.243 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -115.42 131.05 57.05 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.928 179.086 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -64.56 113.72 3.9 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.262 -0.426 . . . . 0.0 112.061 -178.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 20.7 t -121.88 124.83 72.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.137 178.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 63.6 p -142.11 135.57 29.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.844 0.354 . . . . 0.0 111.233 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 62.2 m . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.302 -0.856 . . . . 0.0 110.746 179.726 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 301' ' ' THR . . . . . . . . . . . . . 5.9 t . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 121.244 0.545 . . . . 0.0 111.079 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 302' ' ' GLY . . . . . . . . . . . . . . . -90.9 121.06 6.12 Favored Glycine 0 C--N 1.333 0.371 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.307 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 303' ' ' TRP . . . . . . . . . . . . . 55.3 p-90 -99.94 -17.1 17.73 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -98.54 173.43 6.94 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.953 0.406 . . . . 0.0 111.068 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 305' ' ' THR . . . . . . . . . . . . . 4.9 m -144.98 118.86 9.29 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.123 -0.489 . . . . 17.879999999999999 111.047 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 306' ' ' TRP . . . . . . . . . . . . . 91.9 m95 -88.79 106.0 18.09 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.664 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 307' ' ' VAL . . . . . 0.444 HG22 ' O ' ' A' ' 25' ' ' PHE . 25.6 m . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.26 -0.876 . . . . 16.109999999999999 111.16 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.246 0 N-CA-C 112.473 -0.251 . . . . 0.0 112.473 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.8 t -93.43 -178.6 4.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.688 0.28 . . . . 0.0 110.815 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 15.7 p80 -71.09 115.82 10.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.738 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.75 161.97 7.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.184 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -176.15 45.37 0.11 Allowed Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.507 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 15.6 m170 -90.83 132.8 35.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.713 0.292 . . . . 0.0 110.928 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -113.9 66.8 0.67 Allowed 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 121.314 0.578 . . . . 0.0 110.754 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -90.31 135.71 33.51 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.39 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -102.25 47.88 0.89 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 121.15 0.5 . . . . 0.0 111.359 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -64.87 113.76 4.05 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.873 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -90.07 112.56 24.05 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.18 -0.463 . . . . 0.0 112.021 -179.273 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -87.83 98.29 11.39 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.147 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 18.4 pt -115.82 158.11 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -178.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.683 ' HG3' HD13 ' A' ' 96' ' ' ILE . 26.8 ttp180 -116.07 156.19 26.81 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.612 -179.313 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.7 m -149.45 142.83 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.302 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.17 132.01 54.55 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.949 0.404 . . . . 0.0 111.236 179.565 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.3 t -114.62 120.03 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.155 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.495 ' HG2' HG23 ' A' ' 92' ' ' THR . 3.0 mm-40 -89.8 111.59 22.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.095 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.526 ' HD2' HD12 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -65.87 116.89 7.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.971 179.87 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -175.1 84.87 0.32 Allowed Pre-proline 0 CA--C 1.54 0.571 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.962 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -84.7 -22.2 14.65 Favored 'Cis proline' 0 C--N 1.366 1.475 0 CA-C-N 119.488 0.853 . . . . 0.0 113.058 0.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 18.2 mp0 -131.42 -178.28 4.78 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.768 0.318 . . . . 0.0 111.142 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.526 HD12 ' HD2' ' A' ' 19' ' ' LYS . 3.2 mp -63.12 -58.16 8.18 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.563 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.612 ' O ' HG13 ' A' ' 50' ' ' VAL . . . 109.92 26.89 4.8 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.888 -0.672 . . . . 0.0 113.377 179.362 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.447 ' O ' HG22 ' B' ' 307' ' ' VAL . 37.4 p90 -159.84 139.93 11.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 117.133 0.467 . . . . 0.0 111.12 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.9 p -94.06 153.59 18.07 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.823 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.407 HD11 HG22 ' A' ' 83' ' ' VAL . 28.2 pt -122.59 152.77 27.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.084 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 50.9 m -146.14 160.93 41.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.912 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 104.97 -146.77 16.14 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 120.988 -0.625 . . . . 0.0 113.098 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.36 157.62 28.92 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.993 -0.622 . . . . 0.0 111.98 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 18.8 t -78.55 109.65 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 CA-C-O 120.806 0.336 . . . . 0.0 110.953 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 86.8 3.81 83.05 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 121.039 -0.601 . . . . 0.0 113.857 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -82.87 -154.7 16.45 Favored Glycine 0 C--N 1.343 0.954 0 CA-C-N 117.816 0.808 . . . . 0.0 112.928 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 7.4 mtt180 -75.71 -2.51 29.96 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -179.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.26 -151.28 25.52 Favored Glycine 0 C--N 1.342 0.911 0 C-N-CA 120.695 -0.764 . . . . 0.0 113.037 179.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -173.54 142.3 0.94 Allowed Pre-proline 0 CA--C 1.534 0.346 0 N-CA-C 110.611 -0.144 . . . . 0.0 110.611 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -90.42 39.87 0.39 Allowed 'Trans proline' 0 C--N 1.358 1.03 0 C-N-CA 122.274 1.983 . . . . 0.0 113.507 -179.436 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -125.62 -53.44 1.57 Allowed 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.739 0.304 . . . . 0.0 110.915 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? -116.16 136.28 22.97 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.677 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -85.59 -46.37 0.04 OUTLIER 'Trans proline' 0 C--N 1.358 1.05 0 C-N-CA 121.965 1.777 . . . . 0.0 113.335 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -93.42 -8.68 41.02 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 -179.427 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -101.03 121.48 41.87 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 118.175 0.443 . . . . 0.0 110.537 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -110.72 39.8 2.15 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 120.819 0.342 . . . . 0.0 111.874 -178.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -87.44 -158.97 33.48 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.085 179.336 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 13.9 mm -109.43 124.58 66.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 116.996 0.398 . . . . 0.0 110.83 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.418 ' CD1' ' N ' ' A' ' 46' ' ' PHE . 7.3 m-85 -127.12 150.16 49.62 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.628 0.251 . . . . 0.0 110.636 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.457 ' CG2' HD11 ' A' ' 66' ' ' ILE . 22.5 t -95.92 78.98 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.531 -179.202 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.9 t -35.58 -53.6 0.69 Allowed 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 -178.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.402 ' HG3' ' CH2' ' B' ' 306' ' ' TRP . 15.4 ptt180 -160.77 163.95 31.87 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.993 0.425 . . . . 0.0 111.801 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.612 HG13 ' O ' ' A' ' 24' ' ' GLY . 11.8 t -114.29 146.13 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.42 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.404 ' CB ' ' HD3' ' A' ' 52' ' ' PRO . 4.9 mm-40 -97.13 -70.41 0.05 OUTLIER Pre-proline 0 CA--C 1.538 0.496 0 CA-C-O 119.465 -0.302 . . . . 0.0 111.316 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.404 ' HD3' ' CB ' ' A' ' 51' ' ' GLN . 60.2 Cg_endo -83.05 121.13 3.1 Favored 'Trans proline' 0 C--N 1.36 1.133 0 C-N-CA 121.606 1.538 . . . . 0.0 112.292 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -78.62 65.49 3.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.205 0.526 . . . . 0.0 110.737 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -148.19 -70.56 0.01 OUTLIER Glycine 0 CA--C 1.527 0.793 0 C-N-CA 120.965 -0.636 . . . . 0.0 112.871 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -60.37 -63.3 0.12 Allowed 'Trans proline' 0 C--N 1.358 1.062 0 C-N-CA 121.977 1.784 . . . . 0.0 112.893 -179.567 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.429 ' HB1' HD12 ' A' ' 60' ' ' LEU . . . -110.02 45.65 1.09 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.16 0.505 . . . . 0.0 111.186 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 88.9 p -82.5 -59.06 2.65 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.93 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -93.72 5.28 52.17 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 80.2 mt -92.04 -72.61 0.58 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 118.144 0.429 . . . . 0.0 111.612 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.701 HD23 HG21 ' A' ' 97' ' ' ILE . 1.0 OUTLIER -95.94 143.08 27.44 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.545 0.212 . . . . 0.0 110.764 179.852 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -114.98 153.6 47.08 Favored Pre-proline 0 N--CA 1.471 0.592 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.776 179.093 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -55.22 123.71 14.49 Favored 'Trans proline' 0 C--N 1.36 1.161 0 C-N-CA 122.335 2.023 . . . . 0.0 113.882 -178.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 92.74 16.02 50.29 Favored Glycine 0 CA--C 1.521 0.467 0 CA-C-N 115.687 -0.688 . . . . 0.0 114.139 178.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.429 ' OD1' HG23 ' A' ' 47' ' ' VAL . 35.1 p-10 -80.27 -171.7 3.13 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 117.541 0.671 . . . . 0.0 111.361 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 32.2 tttp -142.4 125.14 15.94 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 120.774 0.321 . . . . 0.0 111.108 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.559 ' N ' HD12 ' A' ' 66' ' ' ILE . 3.5 mp -90.87 123.86 43.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.023 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 21.0 mm -94.9 -44.55 13.3 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -179.038 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -148.62 150.42 33.24 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 120.833 0.349 . . . . 0.0 111.668 -178.661 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.507 ' HB3' ' CE1' ' A' ' 74' ' ' PHE . . . -136.7 123.69 21.49 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.557 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 28.7 m-20 42.44 35.01 0.59 Allowed 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 113.61 0.966 . . . . 0.0 113.61 178.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 99.65 -16.37 58.81 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 120.867 -0.682 . . . . 0.0 113.792 179.177 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -92.99 123.06 35.97 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 117.534 0.667 . . . . 0.0 111.016 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 14.9 m -71.12 130.49 41.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.077 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.507 ' CE1' ' HB3' ' A' ' 69' ' ' ALA . 5.6 m-85 -103.16 15.64 28.73 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 6.5 tp -89.32 124.24 41.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-O 120.729 0.299 . . . . 0.0 110.546 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 62.54 73.78 0.45 Allowed 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.118 0.485 . . . . 0.0 111.161 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 11.5 pt -144.29 163.12 14.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.886 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -81.12 153.39 27.32 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.256 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 21.1 t60 -52.85 -55.7 21.21 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 116.02 -0.537 . . . . 0.0 112.186 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -56.29 -26.7 51.27 Favored Glycine 0 C--N 1.334 0.45 0 C-N-CA 121.073 -0.584 . . . . 0.0 113.277 -179.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -72.66 -40.56 66.25 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.866 0.365 . . . . 0.0 111.008 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.99 -41.0 95.8 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.423 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.407 HG22 HD11 ' A' ' 27' ' ' ILE . 16.1 t -70.74 -42.0 77.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.199 -179.646 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 72.5 m -60.53 -45.82 92.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.588 -179.479 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 31.7 mt -64.14 -45.52 88.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.603 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.426 ' HA ' ' CD2' ' A' ' 89' ' ' PHE . 24.5 mt -65.36 -39.48 92.35 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.956 -179.009 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 8.4 mmtp -68.68 -40.02 80.31 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -178.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 8.8 t -72.22 -27.26 62.42 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -177.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.426 ' CD2' ' HA ' ' A' ' 86' ' ' LEU . 10.5 m-85 -47.87 172.81 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 113.105 0.779 . . . . 0.0 113.105 -177.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -92.5 -138.0 0.18 Allowed 'General case' 0 CA--C 1.554 1.103 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.277 -178.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 54.5 m-80 -78.96 -74.97 0.25 Allowed 'General case' 0 C--N 1.35 0.61 0 CA-C-N 119.454 1.025 . . . . 0.0 111.955 -178.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.495 HG23 ' HG2' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -77.44 123.19 26.21 Favored 'General case' 0 CA--C 1.527 0.081 0 CA-C-O 120.84 0.352 . . . . 0.0 110.307 -179.832 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 20.2 t -111.32 116.69 53.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.498 179.584 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -86.77 112.66 21.91 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.959 0.409 . . . . 0.0 110.159 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.3 mt -116.51 147.46 41.75 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.679 -0.692 . . . . 0.0 111.896 -178.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.683 HD13 ' HG3' ' A' ' 14' ' ' ARG . 18.8 mm -107.19 121.71 60.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.651 178.379 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.701 HG21 HD23 ' A' ' 60' ' ' LEU . 41.4 pt -126.5 158.64 36.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.855 0.36 . . . . 0.0 111.119 -179.44 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 17.2 t -146.78 153.19 12.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.258 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 2.6 mmm180 -109.87 116.9 32.48 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -69.83 143.08 52.99 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 120.678 0.275 . . . . 0.0 110.628 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -119.14 150.74 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.212 -179.155 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -153.02 -171.5 3.95 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.809 0.338 . . . . 0.0 110.867 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 5.3 m . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.324 -0.846 . . . . 0.0 110.869 -179.939 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 301' ' ' THR . . . . . . . . . . . . . 40.5 p . . . . . 0 N--CA 1.487 1.396 0 CA-C-O 120.757 0.313 . . . . 0.0 111.279 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 302' ' ' GLY . . . . . . . . . . . . . . . 78.47 81.41 0.68 Allowed Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.877 -0.677 . . . . 0.0 112.304 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 303' ' ' TRP . . . . . 0.412 ' CZ3' ' HB3' ' B' ' 304' ' ' GLU . 51.4 p-90 -69.13 -28.78 66.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.534 0.207 . . . . 0.0 111.437 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 304' ' ' GLU . . . . . 0.412 ' HB3' ' CZ3' ' B' ' 303' ' ' TRP . 9.4 pt-20 -97.45 132.81 42.8 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.662 0.268 . . . . 0.0 110.721 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 305' ' ' THR . . . . . . . . . . . . . 4.7 m -122.7 114.88 21.17 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.21 -0.45 . . . . 17.879999999999999 110.923 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 306' ' ' TRP . . . . . 0.402 ' CH2' ' HG3' ' A' ' 49' ' ' ARG . 98.9 m95 -78.75 104.79 9.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.797 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 307' ' ' VAL . . . . . 0.447 HG22 ' O ' ' A' ' 25' ' ' PHE . 17.0 m . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.264 -0.874 . . . . 16.109999999999999 111.135 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.175 0 N-CA-C 112.502 -0.239 . . . . 0.0 112.502 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.3 t -117.29 146.79 43.09 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.857 0.361 . . . . 0.0 110.798 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 9.0 t60 -92.45 161.81 14.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.776 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 20.9 tpp -71.29 132.78 45.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.612 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 97.66 62.07 0.9 Allowed Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.064 -179.625 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 2.5 t-160 -98.0 -28.81 13.62 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 111.554 0.205 . . . . 0.0 111.554 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -59.57 118.94 6.66 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.678 0.275 . . . . 0.0 111.202 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 42.1 tp -106.79 -84.74 0.51 Allowed 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.2 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -174.96 35.58 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 O-C-N 122.132 -0.355 . . . . 0.0 111.843 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 36.7 mttp -91.92 -178.46 5.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.651 0.262 . . . . 0.0 111.071 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.55 93.43 3.14 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.362 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.2 tm-20 -95.95 129.8 43.11 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.941 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.1 pt -149.61 159.59 5.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-O 120.824 0.345 . . . . 0.0 111.8 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.434 ' HG3' HD13 ' A' ' 96' ' ' ILE . 10.2 ttm-85 -116.6 153.32 32.46 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.264 -178.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.406 ' HB ' HD22 ' A' ' 59' ' ' LEU . 14.9 m -141.91 144.04 26.02 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.356 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 2.4 ttt-85 -108.09 115.58 30.39 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.5 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.0 t -109.34 121.52 62.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-O 120.896 0.379 . . . . 0.0 111.459 -179.435 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.555 ' HG3' HG22 ' A' ' 92' ' ' THR . 5.3 mp0 -96.79 114.7 26.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.206 179.252 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.5 ' HD3' HD12 ' A' ' 23' ' ' LEU . 19.2 mtmt -75.23 119.97 20.09 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.929 0.395 . . . . 0.0 111.262 -179.473 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -163.59 86.87 1.25 Allowed Pre-proline 0 CA--C 1.536 0.425 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.712 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -84.59 -13.43 37.69 Favored 'Cis proline' 0 C--N 1.364 1.345 0 CA-C-N 119.548 0.874 . . . . 0.0 113.595 0.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -136.78 -175.95 4.2 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.892 0.377 . . . . 0.0 111.176 -179.287 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.5 HD12 ' HD3' ' A' ' 19' ' ' LYS . 1.5 mp -63.44 -52.22 62.39 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.3 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 102.88 29.99 5.63 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 120.862 -0.685 . . . . 0.0 113.586 179.082 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.418 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 32.1 p90 -162.15 146.53 12.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 117.053 0.426 . . . . 0.0 110.919 179.392 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.5 p -97.15 155.55 16.78 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.367 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.772 HD11 HG22 ' A' ' 83' ' ' VAL . 29.0 pt -124.21 154.06 30.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.306 179.196 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 48.1 t -145.78 171.94 14.04 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.835 0.35 . . . . 0.0 111.165 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 92.14 -137.72 13.87 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.584 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.45 155.01 29.98 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.25 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.495 HG21 ' HA ' ' A' ' 76' ' ' ASN . 34.8 t -78.69 97.38 2.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.014 0.435 . . . . 0.0 110.705 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 98.86 -1.87 58.16 Favored Glycine 0 CA--C 1.531 1.067 0 CA-C-N 115.844 -0.616 . . . . 0.0 113.723 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -72.34 -154.62 2.29 Favored Glycine 0 C--N 1.343 0.932 0 CA-C-N 117.856 0.828 . . . . 0.0 113.098 -179.475 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 4.5 mtt85 -72.7 -29.06 63.07 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 111.656 0.243 . . . . 0.0 111.656 -179.397 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 124.32 -163.49 18.08 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.908 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -170.74 132.69 0.93 Allowed Pre-proline 0 CA--C 1.536 0.428 0 O-C-N 123.026 -0.102 . . . . 0.0 110.744 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -91.52 44.15 0.44 Allowed 'Trans proline' 0 C--N 1.358 1.069 0 C-N-CA 122.178 1.918 . . . . 0.0 113.073 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -122.84 -57.77 1.7 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.226 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 6.1 mmp_? -113.3 145.25 32.84 Favored Pre-proline 0 N--CA 1.467 0.382 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.991 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -88.78 -56.45 0.02 OUTLIER 'Trans proline' 0 C--N 1.36 1.181 0 C-N-CA 122.041 1.827 . . . . 0.0 113.125 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -86.51 -7.63 58.23 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -104.0 121.23 42.73 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 117.967 0.349 . . . . 0.0 111.02 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.7 p30 -110.8 40.34 2.03 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 121.042 0.448 . . . . 0.0 110.834 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -84.37 -157.19 25.95 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.976 -0.631 . . . . 0.0 112.732 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 19.6 mm -110.53 122.4 64.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.522 0.201 . . . . 0.0 110.563 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -122.07 144.76 48.72 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 120.899 0.381 . . . . 0.0 111.392 -179.381 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 22.7 t -86.37 75.87 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.161 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.408 HG23 ' N ' ' A' ' 49' ' ' ARG . 4.7 t -33.87 -52.88 0.44 Allowed 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 -178.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.408 ' N ' HG23 ' A' ' 48' ' ' THR . 5.8 ptt85 -160.35 179.09 8.95 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.074 0.464 . . . . 0.0 111.737 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 15.8 t -134.48 146.92 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.782 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -104.87 -68.17 0.04 OUTLIER Pre-proline 0 CA--C 1.536 0.441 0 CA-C-N 116.704 -0.225 . . . . 0.0 111.267 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -78.34 112.62 3.23 Favored 'Trans proline' 0 C--N 1.357 1.023 0 C-N-CA 121.654 1.569 . . . . 0.0 112.009 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -72.81 70.92 1.01 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.003 0.43 . . . . 0.0 111.298 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -162.27 -65.77 0.02 OUTLIER Glycine 0 CA--C 1.527 0.787 0 C-N-CA 120.79 -0.719 . . . . 0.0 113.273 -179.461 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -57.05 -76.11 0.02 OUTLIER 'Trans proline' 0 C--N 1.357 1.017 0 C-N-CA 122.086 1.857 . . . . 0.0 113.098 -179.162 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.885 ' HB1' HD12 ' A' ' 60' ' ' LEU . . . -116.38 47.37 1.43 Allowed 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 121.265 0.555 . . . . 0.0 111.636 -179.098 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.7 t -99.73 -63.27 1.14 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.922 179.146 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 44.2 mttp -74.51 -3.91 33.66 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.1 178.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.406 HD22 ' HB ' ' A' ' 15' ' ' VAL . 9.0 mt -99.13 -50.51 4.13 Favored 'General case' 0 C--N 1.343 0.311 0 CA-C-N 118.265 0.484 . . . . 0.0 111.373 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.885 HD12 ' HB1' ' A' ' 56' ' ' ALA . 19.0 mt -102.56 150.34 23.51 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-O 120.818 0.342 . . . . 0.0 111.492 -179.342 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -97.56 140.69 22.14 Favored Pre-proline 0 CA--C 1.535 0.388 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.873 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -63.79 79.06 0.15 Allowed 'Trans proline' 0 C--N 1.362 1.243 0 C-N-CA 122.068 1.845 . . . . 0.0 112.16 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 129.29 41.32 0.26 Allowed Glycine 0 CA--C 1.525 0.68 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.606 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -96.24 -158.25 0.64 Allowed 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 179.25 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 59.5 tttp -144.65 127.53 16.37 Favored 'General case' 0 C--O 1.231 0.081 0 CA-C-O 120.679 0.276 . . . . 0.0 110.942 179.218 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.606 ' N ' HD12 ' A' ' 66' ' ' ILE . 3.3 mp -88.9 115.73 29.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.458 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 13.4 mm -91.38 -39.13 11.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.558 -179.011 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -149.55 150.22 31.93 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.06 0.457 . . . . 0.0 111.365 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.422 ' HB3' ' CE1' ' A' ' 74' ' ' PHE . . . -134.59 115.35 13.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.246 179.254 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 63.3 m-20 46.72 29.27 0.93 Allowed 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 179.304 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 100.08 -7.52 58.77 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 120.892 -0.67 . . . . 0.0 113.889 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -95.35 129.22 42.57 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 117.94 0.87 . . . . 0.0 110.028 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.27 125.27 28.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.816 0.341 . . . . 0.0 111.147 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.422 ' CE1' ' HB3' ' A' ' 69' ' ' ALA . 3.4 m-85 -100.71 22.53 11.8 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.461 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 7.0 tp -102.93 141.4 18.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 O-C-N 122.137 -0.352 . . . . 0.0 110.95 -178.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.495 ' HA ' HG21 ' A' ' 31' ' ' VAL . 2.6 m-20 64.71 11.58 6.92 Favored 'General case' 0 CA--C 1.55 0.947 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -178.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 18.0 pt -94.2 164.91 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -177.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -85.69 144.99 27.5 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.542 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.494 ' O ' HG23 ' A' ' 83' ' ' VAL . 1.8 t-160 -48.79 -51.12 30.88 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -179.138 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -55.98 -26.81 49.52 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 120.837 -0.697 . . . . 0.0 113.177 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.7 tp-100 -75.98 -40.97 52.71 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.08 0.467 . . . . 0.0 110.866 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.63 -34.93 77.97 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.539 -179.625 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.772 HG22 HD11 ' A' ' 27' ' ' ILE . 23.5 t -71.99 -42.54 68.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.927 0.394 . . . . 0.0 110.584 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.2 t -61.23 -41.16 96.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.28 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.432 ' O ' HG22 ' A' ' 88' ' ' THR . 25.5 mt -65.82 -45.97 80.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.459 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.433 ' HA ' ' CD2' ' A' ' 89' ' ' PHE . 39.5 mt -64.61 -37.02 86.14 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.112 -0.495 . . . . 0.0 112.195 -178.801 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 34.1 mmtt -71.26 -36.68 71.84 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -178.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.432 HG22 ' O ' ' A' ' 85' ' ' LEU . 9.8 t -73.59 -29.08 62.18 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 -178.377 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.433 ' CD2' ' HA ' ' A' ' 86' ' ' LEU . 16.4 m-85 -50.49 147.22 4.68 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -178.749 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -66.72 -136.6 0.0 OUTLIER 'General case' 0 CA--C 1.556 1.21 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.053 -179.078 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -80.57 -67.88 0.73 Allowed 'General case' 0 C--N 1.352 0.68 0 CA-C-N 119.586 1.085 . . . . 0.0 111.883 -178.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.555 HG22 ' HG3' ' A' ' 18' ' ' GLU . 0.9 OUTLIER -81.55 135.35 35.58 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.689 0.281 . . . . 0.0 110.979 -179.553 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.5 t -128.01 122.64 58.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.151 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -89.66 108.33 19.61 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 178.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 12.5 mt -110.12 144.23 39.04 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.011 0.434 . . . . 0.0 111.679 -179.005 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.434 HD13 ' HG3' ' A' ' 14' ' ' ARG . 21.6 mm -106.21 120.8 57.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.604 178.594 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.721 HD13 HD23 ' A' ' 60' ' ' LEU . 23.5 pt -126.84 164.14 27.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.818 0.342 . . . . 0.0 111.313 -179.311 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 22.1 t -149.72 151.87 12.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.245 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -111.97 121.21 44.37 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.268 178.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -61.59 118.01 6.51 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.973 0.416 . . . . 0.0 111.534 -179.262 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 30.2 t -104.91 96.79 4.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.415 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 24.4 m -113.1 160.97 17.64 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.902 0.382 . . . . 0.0 111.153 -179.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 43.2 m . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.21 -0.9 . . . . 0.0 110.779 179.941 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 301' ' ' THR . . . . . . . . . . . . . 41.8 p . . . . . 0 N--CA 1.488 1.43 0 CA-C-O 120.822 0.344 . . . . 0.0 111.225 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 302' ' ' GLY . . . . . . . . . . . . . . . 160.33 -159.22 30.63 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.265 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 303' ' ' TRP . . . . . . . . . . . . . 23.1 p-90 -123.26 -40.16 2.41 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.561 0.219 . . . . 0.0 111.531 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -73.73 153.38 40.07 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.004 0.431 . . . . 0.0 111.284 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 305' ' ' THR . . . . . . . . . . . . . 5.8 m -138.95 128.8 24.94 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.91 -0.586 . . . . 17.879999999999999 110.339 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 306' ' ' TRP . . . . . . . . . . . . . 88.7 m95 -94.48 114.63 26.67 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.944 0.402 . . . . 0.0 111.224 -179.582 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 307' ' ' VAL . . . . . . . . . . . . . 15.4 m . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.244 -0.884 . . . . 16.109999999999999 111.074 -179.971 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.17 0 N-CA-C 112.459 -0.256 . . . . 0.0 112.459 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.7 t -111.83 -57.93 2.19 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.901 0.381 . . . . 0.0 110.824 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 44.5 t60 -92.65 115.78 28.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.874 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 14.2 ttt -92.61 -56.14 3.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.949 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -162.0 -139.57 2.67 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.67 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 -153.92 100.2 2.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.591 0.234 . . . . 0.0 110.649 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.2 mp0 -122.77 32.3 5.78 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.099 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.9 mp -128.17 146.33 50.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.867 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.632 ' O ' HG21 ' A' ' 101' ' ' VAL . . . -97.64 89.53 4.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.21 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -92.98 125.35 37.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.717 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.439 ' O ' HD13 ' A' ' 13' ' ' ILE . 34.2 mt-30 -89.72 89.66 7.88 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.117 -0.492 . . . . 0.0 112.145 -178.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -88.95 92.14 9.11 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 178.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.558 ' H ' HD13 ' A' ' 13' ' ' ILE . 0.2 OUTLIER -110.81 161.49 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -178.66 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 12.6 mtm180 -112.23 155.72 23.55 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.1 -0.954 . . . . 0.0 110.776 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.441 HG21 HD21 ' A' ' 60' ' ' LEU . 15.9 m -143.82 142.77 24.51 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-O 120.79 0.328 . . . . 0.0 110.911 179.284 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 22.1 ttm180 -107.27 115.02 29.43 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.248 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.9 t -114.53 117.7 56.38 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.972 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.762 ' HG3' HG23 ' A' ' 92' ' ' THR . 1.6 mp0 -93.29 122.75 36.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.635 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.437 ' HD3' HD12 ' A' ' 23' ' ' LEU . 15.3 mtmt -76.68 120.86 22.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.081 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -171.11 88.22 0.47 Allowed Pre-proline 0 CA--C 1.536 0.408 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.726 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -82.69 -18.45 24.91 Favored 'Cis proline' 0 C--N 1.362 1.267 0 CA-C-N 119.477 0.849 . . . . 0.0 113.277 0.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -135.31 -178.29 5.04 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.868 0.366 . . . . 0.0 111.755 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.437 HD12 ' HD3' ' A' ' 19' ' ' LYS . 3.0 mp -64.14 -57.27 10.05 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.03 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 103.35 32.46 4.57 Favored Glycine 0 CA--C 1.522 0.493 0 C-N-CA 120.797 -0.716 . . . . 0.0 113.98 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.546 ' O ' HG22 ' B' ' 307' ' ' VAL . 38.7 p90 -162.36 147.25 12.4 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 117.363 0.582 . . . . 0.0 111.191 179.223 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.3 p -100.65 151.4 21.68 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.474 -179.358 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.541 HD11 HG22 ' A' ' 83' ' ' VAL . 28.9 pt -121.71 151.15 25.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.911 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 28.7 t -150.33 164.57 35.46 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.548 0.213 . . . . 0.0 111.44 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 115.05 -94.84 0.69 Allowed Glycine 0 C--N 1.338 0.658 0 C-N-CA 120.972 -0.632 . . . . 0.0 113.797 178.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.515 ' H ' HD13 ' A' ' 45' ' ' ILE . . . 72.18 -134.76 21.82 Favored Glycine 0 CA--C 1.524 0.601 0 C-N-CA 121.24 -0.505 . . . . 0.0 112.597 -179.51 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 23.1 t -148.08 84.55 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 CA-C-O 120.953 0.406 . . . . 0.0 109.962 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 92.44 9.34 61.75 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 120.823 -0.703 . . . . 0.0 113.44 -179.036 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -84.2 -140.68 4.66 Favored Glycine 0 C--N 1.342 0.868 0 CA-C-N 117.705 0.753 . . . . 0.0 112.487 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.22 -28.35 62.81 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 111.745 0.276 . . . . 0.0 111.745 -179.492 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.34 158.87 30.98 Favored Glycine 0 C--N 1.333 0.362 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.772 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -124.96 133.35 24.73 Favored Pre-proline 0 CA--C 1.535 0.371 0 N-CA-C 110.744 -0.095 . . . . 0.0 110.744 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -91.19 26.61 0.45 Allowed 'Trans proline' 0 C--N 1.358 1.03 0 C-N-CA 122.181 1.921 . . . . 0.0 113.451 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -106.62 -53.85 2.56 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.791 0.329 . . . . 0.0 110.6 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 1.2 mmm180 -118.63 137.4 24.81 Favored Pre-proline 0 CA--C 1.535 0.399 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.566 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -86.33 -48.02 0.04 OUTLIER 'Trans proline' 0 C--N 1.357 0.993 0 C-N-CA 121.954 1.77 . . . . 0.0 113.356 -179.198 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -91.63 -10.9 38.72 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -96.64 113.63 25.2 Favored 'General case' 0 C--O 1.231 0.083 0 CA-C-N 117.998 0.363 . . . . 0.0 110.533 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.5 p-10 -100.03 64.62 1.23 Allowed 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 121.123 0.487 . . . . 0.0 111.17 -179.534 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -116.09 -159.02 11.71 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 121.118 -0.563 . . . . 0.0 112.462 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.515 HD13 ' H ' ' A' ' 30' ' ' GLY . 20.8 mm -111.44 133.21 57.79 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-O 120.444 0.164 . . . . 0.0 110.813 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.433 ' N ' ' CD1' ' A' ' 46' ' ' PHE . 4.2 m-85 -129.78 151.02 50.82 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.684 0.278 . . . . 0.0 110.722 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.572 ' CG2' HD11 ' A' ' 66' ' ' ILE . 21.7 t -94.28 77.44 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 CA-C-O 121.01 0.434 . . . . 0.0 111.278 -179.562 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.404 HG23 ' N ' ' A' ' 49' ' ' ARG . 4.9 t -36.36 -54.39 0.83 Allowed 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 -178.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.404 ' N ' HG23 ' A' ' 48' ' ' THR . 3.9 ptt-85 -160.46 163.22 33.15 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.113 0.482 . . . . 0.0 112.242 -179.402 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 16.8 t -118.35 149.69 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.562 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.2 mm-40 -104.97 -68.45 0.04 OUTLIER Pre-proline 0 CA--C 1.538 0.51 0 CA-C-O 119.67 -0.205 . . . . 0.0 111.389 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -78.77 121.47 5.06 Favored 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 121.8 1.667 . . . . 0.0 112.242 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -77.22 65.96 2.92 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 120.911 0.386 . . . . 0.0 111.096 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -156.1 -68.14 0.01 OUTLIER Glycine 0 CA--C 1.528 0.885 0 C-N-CA 120.69 -0.767 . . . . 0.0 113.544 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -58.89 -76.82 0.02 OUTLIER 'Trans proline' 0 C--N 1.356 0.966 0 C-N-CA 122.14 1.893 . . . . 0.0 113.435 -178.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.859 ' HB1' HD12 ' A' ' 60' ' ' LEU . . . -110.14 48.74 0.88 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-O 121.218 0.532 . . . . 0.0 111.5 -179.21 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 34.7 t -105.04 -67.45 0.91 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.999 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.85 -12.74 60.22 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.962 179.176 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 69.1 mt -95.09 -58.91 2.02 Favored 'General case' 0 C--N 1.342 0.276 0 O-C-N 122.137 -0.352 . . . . 0.0 111.506 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.859 HD12 ' HB1' ' A' ' 56' ' ' ALA . 22.2 mt -94.18 148.84 21.8 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.706 -179.519 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.7 pm0 -103.53 150.98 38.61 Favored Pre-proline 0 CA--C 1.538 0.488 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.958 178.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -68.8 73.79 0.94 Allowed 'Trans proline' 0 C--N 1.357 1.007 0 C-N-CA 122.247 1.965 . . . . 0.0 114.108 -178.516 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 140.74 39.2 0.08 OUTLIER Glycine 0 C--N 1.338 0.662 0 C-N-CA 120.549 -0.834 . . . . 0.0 113.943 178.392 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -94.33 -163.3 1.03 Allowed 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 117.286 0.543 . . . . 0.0 111.277 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 27.0 tttm -132.92 121.91 23.54 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 110.275 -0.268 . . . . 0.0 110.275 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.572 HD11 ' CG2' ' A' ' 47' ' ' VAL . 3.7 mm -87.27 109.08 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.802 -178.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 18.1 mm -88.25 -44.45 15.68 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -179.066 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.697 ' HB2' HD12 ' A' ' 96' ' ' ILE . 5.7 mt-30 -150.87 152.44 33.69 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -178.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.427 ' HB3' ' CE1' ' A' ' 74' ' ' PHE . . . -132.52 118.76 19.65 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.637 179.259 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 30.3 m-20 46.47 29.77 0.96 Allowed 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 179.272 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 100.16 -3.26 56.79 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 120.936 -0.649 . . . . 0.0 113.925 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -91.23 145.72 24.43 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 117.901 0.851 . . . . 0.0 110.369 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 80.3 p -88.38 108.42 19.34 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.321 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.427 ' CE1' ' HB3' ' A' ' 69' ' ' ALA . 5.2 m-85 -92.72 8.29 39.91 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 112.376 0.509 . . . . 0.0 112.376 179.621 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.433 HG23 ' O ' ' A' ' 75' ' ' ILE . 6.5 tp -86.49 118.25 32.44 Favored 'Isoleucine or valine' 0 C--N 1.341 0.204 0 CA-C-N 118.124 0.42 . . . . 0.0 110.673 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 62.81 75.77 0.39 Allowed 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 121.206 0.527 . . . . 0.0 111.057 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 8.4 pt -147.71 153.91 11.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.543 179.31 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -66.21 140.46 58.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.512 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -50.3 -51.89 41.29 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -179.215 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -54.6 -25.77 36.53 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 120.978 -0.629 . . . . 0.0 112.963 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -77.28 -38.87 49.95 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.916 0.389 . . . . 0.0 110.453 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -70.05 -39.04 75.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.455 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.541 HG22 HD11 ' A' ' 27' ' ' ILE . 29.1 t -70.67 -43.35 77.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.898 0.38 . . . . 0.0 110.638 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 43.2 m -61.49 -39.18 89.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.221 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.541 ' O ' HG22 ' A' ' 88' ' ' THR . 14.3 mt -64.6 -46.51 82.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.103 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.416 ' HA ' ' CD2' ' A' ' 89' ' ' PHE . 31.9 mt -64.29 -39.83 94.72 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.171 -0.468 . . . . 0.0 112.085 -178.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 19.7 mmtp -65.42 -39.69 92.45 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -178.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.541 HG22 ' O ' ' A' ' 85' ' ' LEU . 9.8 t -70.74 -26.24 63.28 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 -178.058 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.416 ' CD2' ' HA ' ' A' ' 86' ' ' LEU . 6.7 m-85 -46.67 170.85 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -178.471 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 7.1 mp0 -88.56 -142.23 0.13 Allowed 'General case' 0 CA--C 1.55 0.947 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.728 -179.332 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 60.9 m-80 -80.08 -66.91 0.82 Allowed 'General case' 0 C--N 1.348 0.537 0 CA-C-N 119.076 0.853 . . . . 0.0 111.08 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.762 HG23 ' HG3' ' A' ' 18' ' ' GLU . 0.2 OUTLIER -78.8 124.1 27.87 Favored 'General case' 0 C--N 1.334 -0.095 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.412 179.804 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 21.9 t -114.16 112.37 39.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.143 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -90.41 111.37 22.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.889 179.487 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 15.8 mt -112.02 153.49 26.77 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 121.071 0.462 . . . . 0.0 112.166 -178.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.697 HD12 ' HB2' ' A' ' 68' ' ' GLN . 16.5 mt -118.5 130.52 73.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.794 178.681 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.771 HD13 HD23 ' A' ' 60' ' ' LEU . 29.3 pt -136.69 169.66 19.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.997 0.427 . . . . 0.0 111.925 -179.014 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.404 HG12 ' N ' ' A' ' 99' ' ' ARG . 21.3 t -143.65 154.94 16.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.412 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.404 ' N ' HG12 ' A' ' 98' ' ' VAL . 25.3 mmm180 -116.58 114.33 23.97 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.147 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -63.47 121.47 13.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.344 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.632 HG21 ' O ' ' A' ' 9' ' ' ALA . 3.7 m -105.72 93.94 2.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.037 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 29.5 p -98.87 115.11 28.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.952 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 79.5 p . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.24 -0.886 . . . . 0.0 110.79 179.952 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 301' ' ' THR . . . . . . . . . . . . . 5.2 m . . . . . 0 N--CA 1.488 1.458 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 302' ' ' GLY . . . . . . . . . . . . . . . 94.0 68.08 1.06 Allowed Glycine 0 C--N 1.338 0.657 0 C-N-CA 120.717 -0.754 . . . . 0.0 113.29 179.411 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 303' ' ' TRP . . . . . 0.406 ' CZ3' ' HB3' ' B' ' 304' ' ' GLU . 50.8 p-90 -161.68 -43.94 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.767 0.283 . . . . 0.0 111.22 179.125 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 304' ' ' GLU . . . . . 0.406 ' HB3' ' CZ3' ' B' ' 303' ' ' TRP . 7.5 pt-20 -71.86 132.73 44.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.699 0.285 . . . . 0.0 110.844 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 305' ' ' THR . . . . . . . . . . . . . 10.0 m -116.59 131.64 56.89 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.312 -0.404 . . . . 17.879999999999999 110.845 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 306' ' ' TRP . . . . . . . . . . . . . 80.3 m95 -91.09 115.52 28.08 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.847 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 307' ' ' VAL . . . . . 0.546 HG22 ' O ' ' A' ' 25' ' ' PHE . 14.1 m . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.229 -0.891 . . . . 16.109999999999999 111.084 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.205 0 N-CA-C 112.484 -0.246 . . . . 0.0 112.484 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.4 m -87.01 103.43 15.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.793 0.33 . . . . 0.0 110.862 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 7.6 p80 -100.28 176.89 5.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.852 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 3.6 ttt -74.72 -45.8 41.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.9 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 94.49 126.39 4.63 Favored Glycine 0 C--N 1.331 0.286 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.41 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 41.9 m-70 -111.93 -61.54 1.7 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.816 0.341 . . . . 0.0 111.041 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -95.57 166.71 11.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.202 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 15.6 mt -97.39 -63.1 1.16 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.894 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -168.42 150.34 5.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.913 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.4 tppp? -172.78 117.86 0.33 Allowed 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.575 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -107.49 114.04 27.77 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.452 -179.515 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -96.08 106.18 18.32 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.236 -0.438 . . . . 0.0 112.081 -179.316 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 29.6 pt -108.78 166.46 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-O 120.931 0.396 . . . . 0.0 111.843 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 6.2 mtm-85 -114.2 164.26 14.12 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.575 -179.326 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.3 m -148.01 164.67 5.68 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.838 179.111 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 9.2 ttp180 -132.07 119.43 20.98 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.0 t -116.26 130.69 70.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.15 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.83 ' HG2' HG23 ' A' ' 92' ' ' THR . 2.6 mm-40 -105.3 123.79 48.45 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.923 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.538 ' HE2' HD11 ' A' ' 23' ' ' LEU . 11.3 mmtt -70.6 80.01 0.59 Allowed 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 120.805 0.336 . . . . 0.0 111.795 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -137.59 85.68 20.29 Favored Pre-proline 0 CA--C 1.537 0.454 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.068 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -83.57 -24.58 10.79 Favored 'Cis proline' 0 C--N 1.366 1.461 0 CA-C-N 119.55 0.875 . . . . 0.0 113.034 0.421 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -137.46 -177.33 4.74 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 120.799 0.333 . . . . 0.0 111.125 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.538 HD11 ' HE2' ' A' ' 19' ' ' LYS . 4.4 mp -61.94 -57.68 10.81 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.991 179.602 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 99.78 34.25 5.0 Favored Glycine 0 CA--C 1.522 0.513 0 C-N-CA 120.722 -0.751 . . . . 0.0 113.87 179.428 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.419 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 36.3 p90 -160.35 153.06 21.12 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 117.418 0.609 . . . . 0.0 111.184 179.096 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.7 p -105.43 147.95 27.69 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.221 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.659 HD11 HG22 ' A' ' 83' ' ' VAL . 32.4 pt -117.62 148.0 20.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.875 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 65.2 p -140.22 156.57 46.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.745 0.307 . . . . 0.0 111.188 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 109.11 -159.28 14.15 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 121.058 -0.592 . . . . 0.0 112.746 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 108.26 152.75 16.58 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 121.059 -0.591 . . . . 0.0 112.384 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 20.1 t -79.73 106.77 11.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.808 0.337 . . . . 0.0 110.661 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 88.06 -2.1 85.25 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 120.881 -0.675 . . . . 0.0 113.782 -179.525 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -84.44 -155.94 23.58 Favored Glycine 0 C--N 1.341 0.847 0 CA-C-N 117.869 0.835 . . . . 0.0 112.717 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.21 -24.86 65.16 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -179.155 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.61 160.0 35.92 Favored Glycine 0 C--N 1.34 0.793 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.504 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 13.7 p30 -119.59 126.37 26.99 Favored Pre-proline 0 N--CA 1.465 0.301 0 N-CA-C 110.619 -0.141 . . . . 0.0 110.619 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.431 ' HG2' ' CH2' ' B' ' 303' ' ' TRP . 45.9 Cg_endo -88.62 51.87 1.77 Allowed 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 121.901 1.734 . . . . 0.0 112.254 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -133.92 -51.37 0.84 Allowed 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.124 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.403 ' HG3' ' CZ ' ' A' ' 46' ' ' PHE . 1.5 mmp_? -110.52 139.04 21.17 Favored Pre-proline 0 N--CA 1.466 0.33 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.879 -179.541 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -85.58 -46.38 0.04 OUTLIER 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 122.038 1.825 . . . . 0.0 113.198 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -94.62 -8.77 37.08 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 -179.232 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -103.1 116.53 32.68 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 118.157 0.435 . . . . 0.0 110.579 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.7 p30 -104.25 35.3 2.74 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.2 -179.453 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -84.23 -156.77 24.79 Favored Glycine 0 CA--C 1.519 0.316 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.29 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 14.4 mm -111.88 142.57 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-O 120.676 0.274 . . . . 0.0 110.692 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.403 ' CZ ' ' HG3' ' A' ' 39' ' ' ARG . 55.0 m-85 -140.15 154.1 46.87 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.162 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.45 HG21 HD22 ' A' ' 60' ' ' LEU . 17.8 t -97.99 75.75 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-O 120.968 0.413 . . . . 0.0 111.191 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.429 HG23 ' N ' ' A' ' 49' ' ' ARG . 10.0 t -35.66 -51.68 0.66 Allowed 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 -178.554 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.429 ' N ' HG23 ' A' ' 48' ' ' THR . 14.5 ptt180 -160.36 175.4 12.85 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.162 0.506 . . . . 0.0 112.137 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 20.5 t -131.28 151.21 35.33 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.673 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.425 ' HG2' ' CH2' ' B' ' 306' ' ' TRP . 7.5 mm-40 -104.38 -67.82 0.04 OUTLIER Pre-proline 0 CA--C 1.537 0.471 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.676 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -77.4 122.46 6.08 Favored 'Trans proline' 0 C--N 1.357 0.977 0 C-N-CA 121.675 1.584 . . . . 0.0 112.233 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -80.16 64.21 4.91 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.091 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -158.43 -70.56 0.01 OUTLIER Glycine 0 CA--C 1.528 0.886 0 C-N-CA 120.703 -0.76 . . . . 0.0 113.564 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.57 -74.45 0.02 OUTLIER 'Trans proline' 0 C--N 1.358 1.06 0 C-N-CA 122.032 1.821 . . . . 0.0 113.355 -178.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.475 ' HB1' HD12 ' A' ' 60' ' ' LEU . . . -106.9 46.76 0.91 Allowed 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 121.083 0.468 . . . . 0.0 111.643 -179.248 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 91.8 p -108.54 -60.39 1.74 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.109 179.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 5.7 ttpm? -69.42 -15.52 63.3 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.068 179.246 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 64.2 mt -93.23 -63.35 1.22 Allowed 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.869 0.366 . . . . 0.0 111.158 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.612 HD23 HG21 ' A' ' 97' ' ' ILE . 2.9 mt -91.87 144.03 25.9 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.44 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 5.1 pp0? -117.35 155.79 49.64 Favored Pre-proline 0 CA--C 1.534 0.355 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.449 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -59.19 119.28 6.42 Favored 'Trans proline' 0 C--N 1.357 1.01 0 C-N-CA 121.829 1.686 . . . . 0.0 112.49 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 98.68 5.37 56.73 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 121.05 -0.595 . . . . 0.0 113.827 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -71.13 140.35 50.56 Favored 'General case' 0 C--N 1.343 0.32 0 CA-C-N 118.102 0.951 . . . . 0.0 110.791 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 67.0 tttt -92.61 123.45 35.91 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.926 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 20.0 mt -89.15 115.23 28.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.218 -0.447 . . . . 0.0 109.841 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 19.9 mm -89.53 -42.16 14.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 112.249 0.462 . . . . 0.0 112.249 -178.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.879 ' HB3' HD12 ' A' ' 96' ' ' ILE . 22.4 tt0 -152.53 156.97 40.4 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.933 0.397 . . . . 0.0 111.884 -179.148 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -144.67 125.89 14.69 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.194 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.54 ' OD1' HG13 ' A' ' 93' ' ' VAL . 4.3 m-20 45.72 34.45 1.8 Allowed 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 178.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 95.01 -18.03 58.16 Favored Glycine 0 CA--C 1.523 0.593 0 C-N-CA 120.772 -0.728 . . . . 0.0 113.534 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -89.23 126.98 35.72 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 117.353 0.576 . . . . 0.0 110.884 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 8.4 t -72.64 124.52 25.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.937 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -102.75 12.95 35.57 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 6.4 tp -91.0 121.74 41.68 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 CA-C-O 120.944 0.402 . . . . 0.0 110.703 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 5.4 m120 64.24 74.17 0.41 Allowed 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 121.094 0.474 . . . . 0.0 110.721 -179.439 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 13.9 pt -149.77 164.27 3.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.794 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -73.79 144.83 45.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.663 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 6.9 t60 -54.3 -54.35 41.43 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.804 -179.354 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -54.78 -27.46 43.65 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 121.163 -0.541 . . . . 0.0 112.911 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -71.21 -39.29 71.83 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.093 0.473 . . . . 0.0 110.451 179.274 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.19 -52.14 44.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.492 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.659 HG22 HD11 ' A' ' 27' ' ' ILE . 20.8 t -59.68 -43.89 92.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.604 -179.482 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 57.8 m -59.99 -40.9 90.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.534 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 31.2 mt -66.4 -43.93 84.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.53 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.419 HD23 ' CE2' ' A' ' 89' ' ' PHE . 32.6 mt -66.51 -42.6 87.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.796 -179.249 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 42.0 mmtt -65.02 -43.07 93.68 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -178.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 12.1 t -69.43 -25.89 64.34 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -178.39 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.419 ' CE2' HD23 ' A' ' 86' ' ' LEU . 14.7 m-30 -45.56 170.99 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -179.053 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -84.56 -143.01 0.08 Allowed 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.973 -179.224 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 35.9 m120 -83.07 -62.21 1.66 Allowed 'General case' 0 C--N 1.348 0.506 0 CA-C-N 118.992 0.814 . . . . 0.0 111.779 -178.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.83 HG23 ' HG2' ' A' ' 18' ' ' GLU . 0.3 OUTLIER -87.5 129.57 35.02 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.505 -179.65 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.54 HG13 ' OD1' ' A' ' 70' ' ' ASN . 19.1 t -125.41 121.02 59.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.139 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -95.37 105.67 17.65 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.469 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 12.1 mt -99.11 152.55 19.74 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 121.076 0.465 . . . . 0.0 111.673 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.879 HD12 ' HB3' ' A' ' 68' ' ' GLN . 61.1 mt -110.37 126.21 67.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.654 178.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.612 HG21 HD23 ' A' ' 60' ' ' LEU . 43.6 pt -127.95 168.62 20.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.821 0.343 . . . . 0.0 111.622 -178.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.4 t -145.88 151.34 14.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.236 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -114.72 109.68 18.57 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.315 -0.402 . . . . 0.0 109.95 179.292 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -58.56 124.69 20.49 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.891 -179.107 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.4 t -101.96 153.75 5.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.496 179.306 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 71.3 m -160.07 176.5 11.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.892 0.377 . . . . 0.0 111.136 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 22.7 t . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.309 -0.853 . . . . 0.0 110.796 179.912 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 301' ' ' THR . . . . . . . . . . . . . 10.3 t . . . . . 0 N--CA 1.489 1.489 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 302' ' ' GLY . . . . . . . . . . . . . . . -72.25 98.34 0.81 Allowed Glycine 0 CA--C 1.52 0.401 0 C-N-CA 120.904 -0.665 . . . . 0.0 113.111 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 303' ' ' TRP . . . . . 0.431 ' CH2' ' HG2' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -162.52 -158.97 0.54 Allowed 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 116.804 0.302 . . . . 0.0 111.327 -179.952 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.54 -179.64 1.78 Allowed 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -177.73 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 305' ' ' THR . . . . . . . . . . . . . 21.0 m -154.67 100.31 2.23 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 114.942 -1.026 . . . . 17.879999999999999 109.698 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 306' ' ' TRP . . . . . 0.425 ' CH2' ' HG2' ' A' ' 51' ' ' GLN . 83.4 m95 -60.6 123.0 16.11 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.995 0.426 . . . . 0.0 111.684 -179.045 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 307' ' ' VAL . . . . . 0.531 HG12 HG13 ' A' ' 83' ' ' VAL . 16.0 m . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.273 -0.87 . . . . 16.109999999999999 111.174 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.185 0 N-CA-C 112.612 -0.195 . . . . 0.0 112.612 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.4 m -84.82 -175.22 5.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.581 0.229 . . . . 0.0 110.755 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -57.79 108.22 0.55 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.069 0.461 . . . . 0.0 111.366 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 5.2 tpt -79.59 -22.5 43.64 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.034 -0.53 . . . . 0.0 112.163 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -55.7 -169.68 0.08 OUTLIER Glycine 0 C--N 1.338 0.677 0 C-N-CA 120.983 -0.627 . . . . 0.0 113.466 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 13.2 m80 -75.92 166.03 24.11 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.002 0.429 . . . . 0.0 111.405 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -125.56 -159.21 0.88 Allowed 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.907 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.42 109.97 0.7 Allowed 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.986 0.422 . . . . 0.0 111.581 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.557 ' HA ' HG21 ' A' ' 101' ' ' VAL . . . -151.92 -144.28 0.15 Allowed 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.053 -179.541 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -43.88 108.05 0.1 Allowed 'General case' 0 N--CA 1.486 1.345 0 CA-C-N 119.223 0.92 . . . . 0.0 112.471 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.454 ' O ' HG13 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -86.47 121.48 29.08 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.612 -177.373 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -100.86 131.36 46.78 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.885 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.604 HD13 ' N ' ' A' ' 13' ' ' ILE . 0.2 OUTLIER -150.4 163.56 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-O 120.61 0.243 . . . . 0.0 111.571 179.89 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 57.9 mtt180 -116.78 164.72 14.23 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.879 -179.536 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.424 HG21 HD21 ' A' ' 60' ' ' LEU . 15.0 m -146.08 161.15 11.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.027 179.307 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.39 120.83 23.62 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.659 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.7 t -125.71 135.55 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.793 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.406 ' HG3' HG23 ' A' ' 92' ' ' THR . 2.9 mp0 -107.44 127.86 53.97 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.742 0.306 . . . . 0.0 111.418 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.46 112.45 6.75 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.13 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -173.75 83.45 0.38 Allowed Pre-proline 0 CA--C 1.54 0.566 0 CA-C-N 116.488 -0.323 . . . . 0.0 111.31 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -83.84 -23.3 12.93 Favored 'Cis proline' 0 C--N 1.366 1.463 0 CA-C-N 119.359 0.807 . . . . 0.0 112.888 0.24 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -137.41 -177.97 5.01 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.745 0.307 . . . . 0.0 110.955 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.612 HD13 HG23 ' B' ' 307' ' ' VAL . 3.2 mp -65.66 -54.35 28.8 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.963 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.592 ' O ' HG13 ' A' ' 50' ' ' VAL . . . 109.83 32.93 2.74 Favored Glycine 0 C--N 1.334 0.426 0 C-N-CA 120.837 -0.697 . . . . 0.0 113.543 179.17 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.409 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 35.8 p90 -167.21 179.38 5.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 117.008 0.404 . . . . 0.0 111.069 179.478 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.0 p -131.39 162.4 30.24 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.205 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.693 HD11 HG22 ' A' ' 83' ' ' VAL . 37.4 pt -127.38 154.89 38.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.879 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 39.1 t -145.14 166.51 25.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.014 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 101.01 -147.52 17.85 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.635 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 105.47 152.97 21.2 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.932 -0.652 . . . . 0.0 112.446 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.46 HG21 ' HA ' ' A' ' 76' ' ' ASN . 32.2 t -79.81 108.1 12.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.913 0.387 . . . . 0.0 110.587 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 90.28 -1.06 79.16 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 120.946 -0.645 . . . . 0.0 113.844 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -83.82 -149.45 9.54 Favored Glycine 0 C--N 1.342 0.903 0 CA-C-N 117.866 0.833 . . . . 0.0 112.887 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 52.0 mtt85 -81.34 -18.32 46.12 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -179.397 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.06 -177.89 49.41 Favored Glycine 0 C--N 1.338 0.652 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.757 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -136.82 157.78 74.23 Favored Pre-proline 0 CA--C 1.533 0.301 0 O-C-N 123.041 -0.093 . . . . 0.0 110.78 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -87.87 17.71 1.65 Allowed 'Trans proline' 0 C--N 1.358 1.068 0 C-N-CA 122.147 1.898 . . . . 0.0 113.781 -179.409 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -101.77 -41.07 6.66 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.87 0.367 . . . . 0.0 110.626 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 11.2 mmp_? -129.99 132.06 23.88 Favored Pre-proline 0 CA--C 1.533 0.322 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.332 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -83.05 -40.39 0.11 Allowed 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 121.887 1.725 . . . . 0.0 113.089 -179.378 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -99.92 -4.23 30.65 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -179.405 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -90.63 122.67 33.62 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 118.2 0.455 . . . . 0.0 110.912 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -102.18 40.82 1.29 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.132 -179.615 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -98.9 -170.77 31.22 Favored Glycine 0 C--N 1.333 0.387 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.507 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 22.0 mm -110.26 127.69 67.03 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-N 116.569 0.184 . . . . 0.0 110.51 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.44 ' CD1' ' N ' ' A' ' 46' ' ' PHE . 4.0 m-85 -128.29 146.77 50.65 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.762 0.315 . . . . 0.0 111.529 -179.454 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 21.4 t -86.7 79.57 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-O 120.98 0.419 . . . . 0.0 111.077 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.5 t -36.24 -55.22 0.8 Allowed 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 114.849 1.426 . . . . 0.0 114.849 -178.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -160.07 -179.55 7.87 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.218 0.532 . . . . 0.0 112.392 -179.049 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.592 HG13 ' O ' ' A' ' 24' ' ' GLY . 13.7 t -138.48 145.55 28.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.498 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.403 ' HG3' ' CH2' ' B' ' 306' ' ' TRP . 15.3 mt-30 -104.55 -68.71 0.04 OUTLIER Pre-proline 0 CA--C 1.537 0.459 0 N-CA-C 111.59 0.218 . . . . 0.0 111.59 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.401 ' HD3' ' CB ' ' A' ' 51' ' ' GLN . 81.4 Cg_endo -81.16 113.84 2.75 Favored 'Trans proline' 0 C--N 1.357 1.005 0 C-N-CA 121.661 1.574 . . . . 0.0 112.304 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -77.78 70.36 4.14 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.138 0.494 . . . . 0.0 110.936 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -145.37 -71.45 0.02 OUTLIER Glycine 0 CA--C 1.526 0.762 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.643 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -58.59 -71.93 0.03 OUTLIER 'Trans proline' 0 C--N 1.357 0.998 0 C-N-CA 122.021 1.814 . . . . 0.0 112.796 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.559 ' HB1' HD12 ' A' ' 60' ' ' LEU . . . -105.87 47.34 0.88 Allowed 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 121.217 0.532 . . . . 0.0 111.263 -179.517 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 98.1 p -83.2 -59.73 2.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.965 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 37.2 tptt -88.21 4.42 45.79 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.016 178.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.475 ' N ' HD22 ' A' ' 59' ' ' LEU . 3.6 mm? -92.6 -64.87 1.05 Allowed 'General case' 0 C--N 1.343 0.302 0 CA-C-N 118.16 0.436 . . . . 0.0 111.727 -179.619 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.559 HD12 ' HB1' ' A' ' 56' ' ' ALA . 3.1 mt -100.9 145.4 28.67 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.159 0.504 . . . . 0.0 112.223 -178.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -107.28 142.51 25.25 Favored Pre-proline 0 CA--C 1.534 0.358 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.996 179.194 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.02 131.29 45.52 Favored 'Trans proline' 0 C--N 1.357 1.0 0 C-N-CA 121.899 1.733 . . . . 0.0 113.159 -179.18 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 81.72 32.25 30.65 Favored Glycine 0 C--N 1.33 0.235 0 CA-C-N 115.979 -0.555 . . . . 0.0 113.55 179.082 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -88.28 -169.51 2.59 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 117.027 0.414 . . . . 0.0 110.898 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 78.1 tttt -138.44 125.64 21.54 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.975 -179.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 34.3 mt -94.36 122.53 45.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.501 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 26.0 mm -104.5 -36.82 4.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -179.054 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.575 ' HB3' HD12 ' A' ' 96' ' ' ILE . 0.1 OUTLIER -148.87 149.46 31.31 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.974 0.416 . . . . 0.0 111.827 -179.185 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.462 ' HB3' ' CE1' ' A' ' 74' ' ' PHE . . . -145.77 122.46 11.17 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.334 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.3 m120 45.94 38.3 4.44 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 179.059 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 84.42 11.21 78.38 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 121.007 -0.616 . . . . 0.0 113.87 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -113.44 121.8 45.38 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 117.69 0.745 . . . . 0.0 110.238 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 79.9 p -72.74 135.78 45.39 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.661 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.462 ' CE1' ' HB3' ' A' ' 69' ' ' ALA . 5.1 m-85 -104.59 23.51 13.21 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.423 HD13 ' HA ' ' A' ' 75' ' ' ILE . 11.4 mm -97.41 139.77 19.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-O 121.032 0.444 . . . . 0.0 109.921 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.46 ' HA ' HG21 ' A' ' 31' ' ' VAL . 7.9 m120 61.47 16.69 7.77 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.446 HD13 ' HA ' ' A' ' 74' ' ' PHE . 25.9 pt -95.29 163.8 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -179.065 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -91.67 149.69 21.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.173 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 15.3 t60 -46.41 -51.89 14.1 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -179.308 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -56.13 -26.91 50.73 Favored Glycine 0 CA--C 1.523 0.573 0 C-N-CA 120.985 -0.626 . . . . 0.0 113.176 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -74.56 -42.97 57.84 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 120.954 0.407 . . . . 0.0 110.476 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.25 -42.49 99.18 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.374 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.693 HG22 HD11 ' A' ' 27' ' ' ILE . 18.0 t -73.71 -40.99 54.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.753 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 43.7 t -62.19 -46.76 87.47 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.353 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 31.5 mt -61.16 -49.83 75.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.72 -179.456 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.739 HD21 HD21 ' A' ' 95' ' ' LEU . 17.3 mt -64.1 -37.68 88.31 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -178.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 9.2 mmtp -71.04 -39.82 72.06 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -178.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 11.4 t -71.87 -27.31 62.78 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 -178.007 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.411 ' CD2' ' HA ' ' A' ' 86' ' ' LEU . 9.6 m-85 -46.74 170.9 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -178.659 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -83.85 -142.85 0.07 Allowed 'General case' 0 CA--C 1.55 0.968 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.834 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -79.48 -70.3 0.52 Allowed 'General case' 0 C--N 1.348 0.523 0 CA-C-N 119.22 0.918 . . . . 0.0 111.501 -179.501 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.406 HG23 ' HG3' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -75.24 123.45 25.32 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.634 -179.687 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.503 HG12 ' CD1' ' A' ' 95' ' ' LEU . 14.2 t -121.04 120.82 63.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.723 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -99.91 107.17 19.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.54 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.739 HD21 HD21 ' A' ' 86' ' ' LEU . 6.2 mp -107.13 161.76 14.48 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 121.054 0.455 . . . . 0.0 111.788 -179.411 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.575 HD12 ' HB3' ' A' ' 68' ' ' GLN . 21.5 mt -123.64 132.23 71.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.402 178.491 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.421 HD13 HD23 ' A' ' 60' ' ' LEU . 43.9 pt -126.38 175.64 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-O 120.689 0.281 . . . . 0.0 111.625 -178.605 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.454 HG13 ' O ' ' A' ' 11' ' ' GLN . 17.2 t -150.22 143.96 17.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-O 120.934 0.397 . . . . 0.0 112.034 -179.45 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.01 116.91 30.68 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 178.367 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -65.77 154.65 38.45 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.047 0.451 . . . . 0.0 111.811 -178.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.557 HG21 ' HA ' ' A' ' 9' ' ' ALA . 8.3 m -115.49 148.6 18.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.683 179.314 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 59.3 p -77.67 124.17 27.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.106 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 39.2 m . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.142 -0.932 . . . . 0.0 110.815 179.88 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 301' ' ' THR . . . . . . . . . . . . . 6.5 m . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.677 0.275 . . . . 0.0 111.237 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 302' ' ' GLY . . . . . . . . . . . . . . . 172.06 -60.88 0.16 Allowed Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.946 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 303' ' ' TRP . . . . . 0.402 ' CZ3' ' HB3' ' B' ' 304' ' ' GLU . 4.1 p-90 -85.77 -21.56 28.14 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 111.906 0.336 . . . . 0.0 111.906 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 304' ' ' GLU . . . . . 0.402 ' HB3' ' CZ3' ' B' ' 303' ' ' TRP . 7.9 pt-20 -99.41 162.1 13.23 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-O 120.911 0.386 . . . . 0.0 111.082 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 305' ' ' THR . . . . . . . . . . . . . 15.2 m -142.24 132.28 24.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.948 -0.569 . . . . 17.879999999999999 110.368 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 306' ' ' TRP . . . . . 0.403 ' CH2' ' HG3' ' A' ' 51' ' ' GLN . 81.0 m95 -88.39 121.73 31.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.335 -179.373 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 307' ' ' VAL . . . . . 0.612 HG23 HD13 ' A' ' 23' ' ' LEU . 23.8 m . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.314 -0.851 . . . . 16.109999999999999 111.167 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.163 0 N-CA-C 112.486 -0.245 . . . . 0.0 112.486 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 75.2 m -113.61 47.78 1.13 Allowed 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 121.231 0.539 . . . . 0.0 110.758 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -76.38 147.71 37.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.749 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.6 ptp -135.77 156.79 48.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.795 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 157.56 -140.43 7.07 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.715 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 13.1 t-160 -113.45 -28.05 7.68 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 -179.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.42 177.77 0.35 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.978 0.418 . . . . 0.0 111.53 -179.52 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.8 mt -87.32 146.45 25.92 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.047 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -103.34 61.8 0.78 Allowed 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 121.33 0.586 . . . . 0.0 110.325 179.45 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 8.9 mmmt -153.48 124.08 7.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.977 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -89.64 88.58 7.46 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -179.333 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -90.91 124.99 35.62 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.119 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.6 pt -148.21 159.14 7.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -178.019 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.737 ' HG3' HD13 ' A' ' 96' ' ' ILE . 13.3 ttp-105 -119.52 157.01 29.21 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.639 -179.436 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 17.6 m -150.93 152.67 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 2.0 ptp180 -114.92 129.02 56.62 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.025 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.2 t -113.54 119.57 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.789 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -93.54 121.48 35.0 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.648 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.91 116.07 10.79 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.752 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -175.85 81.39 0.29 Allowed Pre-proline 0 CA--C 1.538 0.509 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.753 179.515 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -84.85 -22.97 12.86 Favored 'Cis proline' 0 C--N 1.363 1.294 0 CA-C-N 119.327 0.795 . . . . 0.0 113.333 0.542 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -137.93 -179.18 5.61 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.946 0.403 . . . . 0.0 112.06 -179.364 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.4 mp -61.82 -61.17 2.69 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.293 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.417 ' O ' HG13 ' A' ' 50' ' ' VAL . . . 109.25 20.55 7.81 Favored Glycine 0 CA--C 1.523 0.568 0 C-N-CA 120.788 -0.72 . . . . 0.0 113.796 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -151.0 155.67 39.53 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 117.52 0.66 . . . . 0.0 111.393 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -110.11 151.94 26.62 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.537 -179.187 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.619 HD11 HG22 ' A' ' 83' ' ' VAL . 12.1 pt -121.07 151.67 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.465 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.3 m -150.29 163.12 39.1 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.345 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 120.75 -89.57 0.45 Allowed Glycine 0 C--N 1.337 0.618 0 C-N-CA 121.034 -0.603 . . . . 0.0 113.379 179.127 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.432 ' H ' HD13 ' A' ' 45' ' ' ILE . . . 66.91 -138.45 35.08 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.938 -0.649 . . . . 0.0 112.427 -179.49 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.49 HG12 ' O ' ' A' ' 31' ' ' VAL . 47.0 t -131.42 57.95 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-O 121.145 0.497 . . . . 0.0 111.38 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 92.15 -7.5 78.43 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 115.09 0.796 . . . . 0.0 115.09 178.236 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -97.68 26.88 21.34 Favored Glycine 0 C--N 1.339 0.75 0 CA-C-N 118.092 0.946 . . . . 0.0 113.642 -179.258 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -173.12 -42.22 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 178.585 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.86 146.66 0.74 Allowed Glycine 0 CA--C 1.521 0.419 0 CA-C-N 115.877 -0.602 . . . . 0.0 112.966 179.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -123.94 137.58 29.12 Favored Pre-proline 0 CA--C 1.534 0.332 0 N-CA-C 110.541 -0.17 . . . . 0.0 110.541 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -91.47 24.44 0.55 Allowed 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 122.289 1.992 . . . . 0.0 113.593 -179.108 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -107.94 -52.84 2.71 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.759 0.314 . . . . 0.0 110.813 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -119.58 133.37 23.82 Favored Pre-proline 0 N--CA 1.466 0.372 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.359 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -84.61 -46.59 0.05 OUTLIER 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 121.869 1.713 . . . . 0.0 113.086 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 13.1 p-10 -88.06 -9.48 53.21 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -179.559 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -100.89 118.05 36.16 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 118.056 0.389 . . . . 0.0 110.725 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.8 p30 -106.79 66.7 0.69 Allowed 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 121.15 0.5 . . . . 0.0 110.912 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.478 ' O ' HD13 ' A' ' 45' ' ' ILE . . . -114.98 -143.79 8.21 Favored Glycine 0 CA--C 1.519 0.308 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.366 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.478 HD13 ' O ' ' A' ' 44' ' ' GLY . 21.5 mm -125.68 128.14 72.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.607 0.241 . . . . 0.0 110.735 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -121.6 147.46 45.81 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.075 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 21.7 t -92.07 71.89 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.04 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.421 HG23 ' N ' ' A' ' 49' ' ' ARG . 10.1 t -35.78 -54.13 0.73 Allowed 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 -178.415 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.421 ' N ' HG23 ' A' ' 48' ' ' THR . 0.0 OUTLIER -160.03 168.49 25.47 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.945 0.721 . . . . 0.0 112.945 -178.969 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.417 HG13 ' O ' ' A' ' 24' ' ' GLY . 17.3 t -124.89 150.98 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.401 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.4 ' CB ' ' HD3' ' A' ' 52' ' ' PRO . 4.5 mm-40 -105.54 -68.99 0.03 OUTLIER Pre-proline 0 CA--C 1.539 0.547 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.4 ' HD3' ' CB ' ' A' ' 51' ' ' GLN . 87.8 Cg_endo -80.93 121.68 4.11 Favored 'Trans proline' 0 C--N 1.359 1.091 0 C-N-CA 121.861 1.707 . . . . 0.0 112.818 -179.57 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -74.84 67.66 1.66 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 120.968 0.413 . . . . 0.0 111.328 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -156.81 -67.33 0.01 OUTLIER Glycine 0 CA--C 1.528 0.904 0 C-N-CA 120.803 -0.713 . . . . 0.0 113.476 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -58.63 -78.06 0.02 OUTLIER 'Trans proline' 0 C--N 1.357 0.983 0 C-N-CA 122.081 1.854 . . . . 0.0 113.499 -179.046 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.888 ' HB1' HD12 ' A' ' 60' ' ' LEU . . . -117.06 53.96 0.89 Allowed 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 121.255 0.55 . . . . 0.0 111.929 -179.167 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 77.8 p -108.14 -65.12 1.15 Allowed 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 178.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.14 -14.43 61.8 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.18 178.182 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 65.0 mt -92.66 -57.42 2.67 Favored 'General case' 0 C--N 1.344 0.329 0 O-C-N 122.137 -0.352 . . . . 0.0 110.901 179.429 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.888 HD12 ' HB1' ' A' ' 56' ' ' ALA . 27.9 mt -96.24 146.92 24.29 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.291 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.75 145.7 50.53 Favored Pre-proline 0 N--CA 1.47 0.567 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.97 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_exo -58.32 127.18 23.8 Favored 'Trans proline' 0 C--N 1.362 1.263 0 C-N-CA 122.35 2.034 . . . . 0.0 113.689 -178.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 106.65 8.35 32.64 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 120.906 -0.664 . . . . 0.0 114.435 178.603 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -93.71 146.89 23.52 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 117.821 0.81 . . . . 0.0 111.575 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 51.5 tttt -98.71 133.08 43.54 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.699 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 29.3 mt -89.29 119.74 36.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.467 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 20.5 mm -89.83 -38.68 11.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -178.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -155.36 154.66 32.35 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 121.059 0.457 . . . . 0.0 112.033 -179.246 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -141.93 123.87 15.31 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.966 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 42.91 41.69 2.71 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 179.008 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 84.97 -0.48 89.09 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 120.9 -0.666 . . . . 0.0 114.152 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -108.4 124.47 50.44 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 117.953 0.877 . . . . 0.0 110.914 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 30.6 t -70.9 131.62 44.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.694 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -101.7 19.8 17.44 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -179.135 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 28.7 mm -92.46 121.09 42.77 Favored 'Isoleucine or valine' 0 C--N 1.339 0.12 0 CA-C-O 120.766 0.317 . . . . 0.0 110.664 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 57.1 m-20 61.87 74.88 0.43 Allowed 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.209 0.528 . . . . 0.0 110.743 -179.435 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 10.3 pt -146.57 150.27 15.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.914 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -68.92 136.54 52.74 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.998 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.587 ' O ' HG23 ' A' ' 83' ' ' VAL . 36.7 t60 -43.47 -45.92 6.6 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -179.112 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -59.39 -28.69 65.04 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.457 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 3.7 tp-100 -72.65 -44.47 61.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.918 0.39 . . . . 0.0 110.639 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.87 -37.95 85.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.257 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.619 HG22 HD11 ' A' ' 27' ' ' ILE . 24.2 t -75.06 -42.48 45.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.946 0.403 . . . . 0.0 110.755 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 42.2 t -62.81 -41.65 99.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.142 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' A' ' 85' ' ' LEU . 27.4 mt -65.27 -46.75 79.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.455 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.429 ' HA ' ' CD2' ' A' ' 89' ' ' PHE . 27.2 mt -65.94 -30.87 71.52 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.147 -0.479 . . . . 0.0 112.169 -178.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 30.0 mmtt -77.13 -35.44 56.17 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -179.174 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 9.7 t -75.52 -26.68 58.28 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -178.374 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.429 ' CD2' ' HA ' ' A' ' 86' ' ' LEU . 21.0 m-85 -52.56 149.36 5.97 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.145 0.498 . . . . 0.0 112.134 -179.196 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -65.18 -136.65 0.0 OUTLIER 'General case' 0 CA--C 1.555 1.161 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.557 -179.149 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -80.3 -70.36 0.53 Allowed 'General case' 0 C--N 1.351 0.665 0 CA-C-N 119.588 1.086 . . . . 0.0 112.613 -179.045 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.8 p -78.34 127.53 32.35 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.792 0.329 . . . . 0.0 111.3 -179.038 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.466 ' O ' HD12 ' A' ' 95' ' ' LEU . 21.8 t -117.2 114.08 44.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.719 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -89.67 111.86 22.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.515 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.466 HD12 ' O ' ' A' ' 93' ' ' VAL . 4.0 mp -112.96 151.52 30.47 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.982 0.42 . . . . 0.0 111.781 -179.345 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.737 HD13 ' HG3' ' A' ' 14' ' ' ARG . 17.6 mm -107.6 121.93 61.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.9 178.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.459 HD13 HD23 ' A' ' 60' ' ' LEU . 22.4 pt -129.05 163.1 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-O 120.809 0.338 . . . . 0.0 111.881 -179.147 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.431 HG12 ' N ' ' A' ' 99' ' ' ARG . 14.3 t -150.76 155.72 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.727 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.431 ' N ' HG12 ' A' ' 98' ' ' VAL . 32.9 mmm-85 -110.5 122.43 47.73 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.767 177.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -70.45 104.31 2.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.852 0.358 . . . . 0.0 111.156 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 22.9 t -118.61 123.99 72.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.733 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 17.6 t -113.82 128.11 56.28 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.817 0.342 . . . . 0.0 111.087 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 76.8 p . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.325 -0.845 . . . . 0.0 110.868 179.744 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 301' ' ' THR . . . . . . . . . . . . . 8.2 m . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 121.143 0.497 . . . . 0.0 111.026 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 302' ' ' GLY . . . . . . . . . . . . . . . -179.51 61.28 0.08 OUTLIER Glycine 0 CA--C 1.521 0.427 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.862 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 303' ' ' TRP . . . . . . . . . . . . . 45.0 p-90 -124.8 16.63 8.68 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -139.47 135.26 33.36 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 120.763 0.316 . . . . 0.0 110.988 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 305' ' ' THR . . . . . . . . . . . . . 80.7 m -123.93 122.5 38.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.039 -0.528 . . . . 17.879999999999999 110.669 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 306' ' ' TRP . . . . . . . . . . . . . 86.1 m95 -78.16 107.84 11.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.891 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 307' ' ' VAL . . . . . 0.414 HG12 HG13 ' A' ' 83' ' ' VAL . 17.5 m . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.257 -0.878 . . . . 16.109999999999999 111.153 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.142 0 N-CA-C 112.509 -0.236 . . . . 0.0 112.509 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 62.0 m -152.04 -63.32 0.17 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.784 0.326 . . . . 0.0 110.957 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 27.6 p-80 -124.33 141.35 52.14 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.006 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 6.5 ptp -141.17 -47.55 0.4 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.899 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 139.67 120.34 1.75 Allowed Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.527 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 4.8 m80 -157.99 -48.35 0.06 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.802 0.334 . . . . 0.0 110.84 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -86.07 116.24 24.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.089 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.8 mp -124.08 106.68 10.56 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.55 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.659 ' HA ' HG11 ' A' ' 101' ' ' VAL . . . -169.29 -161.34 0.3 Allowed 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.228 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 35.9 mttt -50.97 115.37 1.49 Allowed 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -179.277 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.868 ' O ' HG13 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -107.28 175.57 5.45 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.856 179.752 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.43 102.83 4.15 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.688 -0.233 . . . . 0.0 111.265 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.9 pt -107.94 162.49 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-N 116.204 -0.453 . . . . 0.0 112.164 -179.324 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.513 ' HG3' HD13 ' A' ' 96' ' ' ILE . 14.5 ttm105 -116.98 152.86 33.7 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.987 -179.278 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.1 m -143.2 144.12 24.1 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.668 179.106 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 11.6 ttp-105 -116.73 130.58 56.81 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.804 0.335 . . . . 0.0 111.293 -179.455 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.0 t -123.49 125.57 71.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.07 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.516 ' HG3' HG22 ' A' ' 92' ' ' THR . 6.1 mp0 -92.21 119.77 32.15 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.892 0.377 . . . . 0.0 111.086 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -71.18 119.75 15.77 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.091 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -174.65 82.72 0.34 Allowed Pre-proline 0 CA--C 1.539 0.556 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.077 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo -86.84 -18.93 19.75 Favored 'Cis proline' 0 C--N 1.365 1.409 0 CA-C-N 119.407 0.824 . . . . 0.0 113.228 0.412 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -133.44 -178.56 5.04 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.829 0.347 . . . . 0.0 111.383 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.417 ' HB3' ' CE2' ' A' ' 25' ' ' PHE . 2.9 mp -65.63 -56.16 13.69 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.707 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.453 ' O ' HG13 ' A' ' 50' ' ' VAL . . . 107.66 32.5 3.36 Favored Glycine 0 CA--C 1.52 0.383 0 C-N-CA 120.932 -0.652 . . . . 0.0 113.7 179.138 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.417 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 42.1 p90 -163.74 152.81 14.12 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 117.163 0.482 . . . . 0.0 111.175 179.232 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.9 p -104.25 150.45 24.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.456 -179.377 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.783 HD11 HG22 ' A' ' 83' ' ' VAL . 22.5 pt -117.67 144.58 25.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.49 179.349 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 77.8 p -131.52 157.34 43.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.767 0.318 . . . . 0.0 110.893 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 107.98 -156.19 15.92 Favored Glycine 0 C--N 1.33 0.234 0 C-N-CA 121.014 -0.613 . . . . 0.0 112.453 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 110.85 148.48 11.49 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.995 -0.621 . . . . 0.0 112.507 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.432 HG21 ' HA ' ' A' ' 76' ' ' ASN . 41.3 t -80.48 100.28 4.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.956 0.408 . . . . 0.0 110.903 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 94.79 2.28 63.01 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 120.99 -0.624 . . . . 0.0 114.139 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.97 -154.84 28.09 Favored Glycine 0 C--N 1.341 0.858 0 CA-C-N 117.827 0.813 . . . . 0.0 112.981 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 1.9 mtt180 -62.66 -22.85 66.77 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.79 160.12 35.49 Favored Glycine 0 C--N 1.336 0.537 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.843 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -114.62 136.15 22.4 Favored Pre-proline 0 CA--C 1.535 0.392 0 N-CA-C 110.556 -0.164 . . . . 0.0 110.556 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -87.91 13.28 2.64 Favored 'Trans proline' 0 C--N 1.357 1.0 0 C-N-CA 122.018 1.812 . . . . 0.0 113.98 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -99.64 -41.55 7.27 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.666 0.269 . . . . 0.0 111.178 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.76 136.15 27.99 Favored Pre-proline 0 N--CA 1.466 0.374 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.714 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -85.63 -44.58 0.05 OUTLIER 'Trans proline' 0 C--N 1.358 1.049 0 C-N-CA 122.052 1.835 . . . . 0.0 113.413 -179.215 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -92.64 -9.0 42.51 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -179.535 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -95.68 117.93 31.41 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-N 118.097 0.408 . . . . 0.0 110.339 179.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -105.09 38.56 1.91 Allowed 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.509 -179.177 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.52 ' O ' HD13 ' A' ' 45' ' ' ILE . . . -92.28 -148.67 23.11 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 120.867 -0.683 . . . . 0.0 111.846 179.198 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.52 HD13 ' O ' ' A' ' 44' ' ' GLY . 20.8 mm -125.52 140.22 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 116.798 0.299 . . . . 0.0 110.842 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -137.81 151.01 47.67 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.12 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 21.7 t -90.56 73.69 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-O 121.126 0.488 . . . . 0.0 111.084 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.43 HG23 ' N ' ' A' ' 49' ' ' ARG . 9.7 t -36.24 -53.17 0.82 Allowed 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 114.745 1.387 . . . . 0.0 114.745 -178.476 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.43 ' N ' HG23 ' A' ' 48' ' ' THR . 11.8 ptm180 -161.24 172.79 16.06 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.213 0.53 . . . . 0.0 112.291 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.453 HG13 ' O ' ' A' ' 24' ' ' GLY . 19.4 t -127.47 147.19 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.445 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.416 ' CG ' ' CH2' ' B' ' 306' ' ' TRP . 4.6 mm-40 -102.1 -69.67 0.04 OUTLIER Pre-proline 0 CA--C 1.537 0.446 0 CA-C-O 119.629 -0.224 . . . . 0.0 110.983 179.509 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.402 ' HD3' ' CB ' ' A' ' 51' ' ' GLN . 95.0 Cg_endo -80.91 114.93 2.97 Favored 'Trans proline' 0 C--N 1.359 1.112 0 C-N-CA 121.653 1.569 . . . . 0.0 112.036 179.389 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -74.89 68.4 1.76 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 121.025 0.44 . . . . 0.0 111.098 -179.611 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -150.94 -71.15 0.01 OUTLIER Glycine 0 CA--C 1.528 0.872 0 C-N-CA 120.668 -0.777 . . . . 0.0 113.714 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -59.7 -77.49 0.02 OUTLIER 'Trans proline' 0 C--N 1.358 1.06 0 C-N-CA 121.928 1.752 . . . . 0.0 113.465 -178.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.797 ' HB1' HD12 ' A' ' 60' ' ' LEU . . . -106.8 49.57 0.8 Allowed 'General case' 0 CA--C 1.529 0.152 0 CA-C-O 121.401 0.619 . . . . 0.0 111.194 -179.39 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.9 t -100.86 -61.41 1.37 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.117 179.514 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.7 ttpt -74.35 -7.68 53.69 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.106 178.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 20.7 mt -92.69 -59.02 2.17 Favored 'General case' 0 C--N 1.344 0.333 0 CA-C-N 118.219 0.463 . . . . 0.0 110.9 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.797 HD12 ' HB1' ' A' ' 56' ' ' ALA . 11.6 mt -93.36 143.29 26.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.299 -179.693 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -112.44 141.27 24.89 Favored Pre-proline 0 CA--C 1.534 0.365 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.258 179.498 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -57.62 122.55 11.96 Favored 'Trans proline' 0 C--N 1.358 1.045 0 C-N-CA 121.784 1.656 . . . . 0.0 112.777 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.57 16.6 21.84 Favored Glycine 0 CA--C 1.522 0.507 0 C-N-CA 120.971 -0.633 . . . . 0.0 113.932 179.068 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -94.29 147.36 23.27 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 117.559 0.68 . . . . 0.0 110.772 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 58.5 tttm -96.74 135.76 38.23 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.153 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 29.3 mt -95.67 123.65 47.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.591 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 23.7 mm -99.39 -42.22 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.824 -178.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -146.76 151.51 37.29 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 121.173 0.511 . . . . 0.0 112.139 -179.058 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.62 ' HB3' ' CE1' ' A' ' 74' ' ' PHE . . . -139.83 122.45 16.3 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.943 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 45.62 28.18 0.5 Allowed 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 179.203 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 95.47 14.19 48.5 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 120.966 -0.635 . . . . 0.0 113.49 -179.613 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -116.8 122.15 43.59 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 117.65 0.725 . . . . 0.0 110.677 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 63.8 p -68.87 124.11 22.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.427 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.62 ' CE1' ' HB3' ' A' ' 69' ' ' ALA . 3.4 m-85 -94.08 19.98 8.51 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 8.5 tp -97.84 138.11 23.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-O 120.633 0.254 . . . . 0.0 111.418 -179.144 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.432 ' HA ' HG21 ' A' ' 31' ' ' VAL . 77.2 m-20 63.18 20.82 12.51 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -179.538 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.487 HD13 ' HA ' ' A' ' 74' ' ' PHE . 26.2 pt -98.15 164.32 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -178.488 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -85.67 146.78 26.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.254 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.47 ' O ' HG23 ' A' ' 83' ' ' VAL . 31.1 t60 -47.34 -50.27 22.38 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 115.857 -0.611 . . . . 0.0 112.602 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -61.01 -29.04 69.84 Favored Glycine 0 CA--C 1.519 0.282 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.174 179.437 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -65.32 -45.79 82.92 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.918 0.389 . . . . 0.0 111.023 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.77 -38.31 86.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.361 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.783 HG22 HD11 ' A' ' 27' ' ' ILE . 25.6 t -73.11 -42.97 58.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.741 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 35.5 t -63.66 -46.0 87.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.087 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 23.8 mt -59.31 -50.97 71.92 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.826 -179.401 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.412 ' HA ' ' CD2' ' A' ' 89' ' ' PHE . 26.0 mt -62.76 -32.45 73.6 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.932 -178.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 44.1 mttm -76.88 -37.62 55.15 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -178.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 10.2 t -73.92 -29.51 62.08 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -178.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.412 ' CD2' ' HA ' ' A' ' 86' ' ' LEU . 15.3 m-85 -47.54 171.38 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -179.07 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -77.53 -145.6 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.98 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.659 -179.194 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 30.5 m120 -79.41 -67.96 0.71 Allowed 'General case' 0 C--N 1.348 0.511 0 CA-C-N 118.831 0.742 . . . . 0.0 110.835 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.516 HG22 ' HG3' ' A' ' 18' ' ' GLU . 0.8 OUTLIER -74.65 120.43 20.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.785 -179.865 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.438 HG12 ' CD1' ' A' ' 95' ' ' LEU . 18.4 t -113.22 115.18 49.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.897 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -95.39 107.0 19.11 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.454 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.438 ' CD1' HG12 ' A' ' 93' ' ' VAL . 6.2 mp -102.82 150.99 22.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.722 -179.351 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.513 HD13 ' HG3' ' A' ' 14' ' ' ARG . 17.2 mm -107.38 122.18 61.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.74 178.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.411 HD13 HD23 ' A' ' 60' ' ' LEU . 41.8 pt -126.03 163.4 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-O 121.148 0.499 . . . . 0.0 112.185 -179.15 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.868 HG13 ' O ' ' A' ' 11' ' ' GLN . 51.1 t -137.89 144.3 31.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.185 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 49.5 mmm-85 -111.98 109.8 19.77 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.968 179.071 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -59.25 145.9 41.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.024 0.44 . . . . 0.0 111.777 -179.08 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.659 HG11 ' HA ' ' A' ' 9' ' ' ALA . 3.3 m -107.51 108.71 25.9 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.605 179.584 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 40.0 t -105.88 35.11 3.01 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.401 -179.343 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 28.3 t . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.196 -0.907 . . . . 0.0 110.761 179.781 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 301' ' ' THR . . . . . . . . . . . . . 64.3 p . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.747 0.308 . . . . 0.0 111.165 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 302' ' ' GLY . . . . . . . . . . . . . . . 170.38 121.34 0.58 Allowed Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.754 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 303' ' ' TRP . . . . . . . . . . . . . 2.3 p-90 -100.43 -18.33 16.76 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 179.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -89.55 162.4 15.7 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.799 0.333 . . . . 0.0 110.991 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 305' ' ' THR . . . . . . . . . . . . . 6.8 m -124.23 115.89 21.8 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.072 -0.513 . . . . 17.879999999999999 110.453 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 306' ' ' TRP . . . . . 0.416 ' CH2' ' CG ' ' A' ' 51' ' ' GLN . 83.7 m95 -79.16 113.84 17.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.031 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 307' ' ' VAL . . . . . 0.425 HG12 HG13 ' A' ' 83' ' ' VAL . 16.1 m . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.223 -0.894 . . . . 16.109999999999999 111.142 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.21 0 N-CA-C 112.515 -0.234 . . . . 0.0 112.515 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 57.4 p -148.86 33.31 0.76 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.897 0.38 . . . . 0.0 110.842 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -82.08 142.68 32.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.633 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -141.56 105.93 4.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.678 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -82.64 -176.56 51.49 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.752 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -86.62 -36.39 18.85 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.794 0.331 . . . . 0.0 110.969 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -68.8 -174.24 0.56 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.034 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 16.6 tp -63.76 159.16 19.96 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.811 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.31 127.29 32.55 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.711 -179.672 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.5 tppt? -174.89 125.46 0.27 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.381 179.587 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -88.67 92.15 9.09 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 112.797 0.665 . . . . 0.0 112.797 -177.22 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -96.15 123.8 39.91 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.737 179.092 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.606 HD13 ' N ' ' A' ' 13' ' ' ILE . 0.2 OUTLIER -151.08 165.86 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -179.712 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.48 158.55 22.4 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.637 179.747 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.9 m -144.16 145.51 21.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.755 179.301 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.03 114.19 27.91 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.177 -179.517 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.4 t -110.62 119.13 58.76 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.839 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.556 ' HG3' HG23 ' A' ' 92' ' ' THR . 1.0 OUTLIER -100.04 128.56 46.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.491 179.581 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.496 ' HD3' HD12 ' A' ' 23' ' ' LEU . 14.0 mtmt -84.02 123.77 30.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.139 0.495 . . . . 0.0 111.608 -179.462 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -172.84 85.7 0.41 Allowed Pre-proline 0 CA--C 1.537 0.448 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.797 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -82.48 -20.19 20.35 Favored 'Cis proline' 0 C--N 1.365 1.401 0 CA-C-N 119.357 0.806 . . . . 0.0 113.15 0.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -136.4 -178.34 5.12 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 120.854 0.359 . . . . 0.0 111.513 -179.479 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.496 HD12 ' HD3' ' A' ' 19' ' ' LYS . 3.4 mp -67.21 -52.41 41.42 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.668 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.423 ' O ' HG13 ' A' ' 50' ' ' VAL . . . 106.75 26.17 5.94 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.898 -0.668 . . . . 0.0 113.833 179.096 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.419 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 42.1 p90 -156.63 171.14 20.86 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 117.461 0.63 . . . . 0.0 111.316 179.429 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.3 p -119.82 153.63 35.48 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.09 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.78 HD11 HG22 ' A' ' 83' ' ' VAL . 26.4 pt -120.39 148.52 23.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.907 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 74.6 p -140.61 158.28 44.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.045 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 106.26 -148.01 16.36 Favored Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.731 179.62 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.79 151.77 26.34 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.374 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 13.7 t -79.82 99.32 3.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.722 0.296 . . . . 0.0 110.463 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 104.28 -7.81 47.88 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 120.922 -0.656 . . . . 0.0 113.522 -179.435 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -73.44 -148.44 1.13 Allowed Glycine 0 C--N 1.344 1.001 0 CA-C-N 117.751 0.776 . . . . 0.0 112.248 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 53.1 mtt-85 -89.21 16.96 6.46 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -179.168 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 63.86 170.72 1.88 Allowed Glycine 0 C--N 1.338 0.693 0 C-N-CA 120.999 -0.62 . . . . 0.0 113.42 179.041 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -139.75 143.8 36.4 Favored Pre-proline 0 CA--C 1.534 0.363 0 N-CA-C 110.518 -0.179 . . . . 0.0 110.518 179.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -92.32 27.28 0.38 Allowed 'Trans proline' 0 C--N 1.358 1.042 0 C-N-CA 122.34 2.027 . . . . 0.0 113.537 -179.143 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -103.43 -51.35 3.23 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.754 0.311 . . . . 0.0 110.945 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 16.2 mtp180 -120.31 137.33 25.95 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.418 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -85.3 -45.74 0.05 OUTLIER 'Trans proline' 0 C--N 1.358 1.078 0 C-N-CA 121.904 1.736 . . . . 0.0 113.59 -179.07 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -89.62 -13.01 38.04 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -179.304 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -106.74 122.69 46.87 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 122.001 -0.437 . . . . 0.0 110.831 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 19.0 p30 -108.69 36.04 2.99 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 121.01 0.433 . . . . 0.0 111.099 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -79.27 -157.93 12.89 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.361 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.7 mm -110.14 132.06 59.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-O 120.697 0.284 . . . . 0.0 111.114 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.435 ' N ' ' CD1' ' A' ' 46' ' ' PHE . 5.4 m-85 -131.39 150.14 52.27 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.346 179.732 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.607 HG23 ' OD1' ' A' ' 64' ' ' ASP . 31.4 t -94.15 75.68 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-O 120.961 0.41 . . . . 0.0 111.466 -179.532 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.406 HG23 ' N ' ' A' ' 49' ' ' ARG . 5.2 t -33.89 -52.99 0.45 Allowed 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 114.939 1.459 . . . . 0.0 114.939 -178.672 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.406 ' N ' HG23 ' A' ' 48' ' ' THR . 13.0 ptm180 -158.13 173.54 16.57 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -179.257 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.423 HG13 ' O ' ' A' ' 24' ' ' GLY . 18.3 t -133.81 150.0 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.464 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.407 ' HG3' ' CH2' ' B' ' 306' ' ' TRP . 8.1 mt-30 -104.99 -67.92 0.04 OUTLIER Pre-proline 0 CA--C 1.539 0.543 0 N-CA-C 111.643 0.238 . . . . 0.0 111.643 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -79.07 121.07 4.79 Favored 'Trans proline' 0 C--N 1.358 1.047 0 C-N-CA 121.645 1.563 . . . . 0.0 112.522 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -78.61 69.55 4.81 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 121.103 0.478 . . . . 0.0 111.016 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -158.37 -68.96 0.01 OUTLIER Glycine 0 CA--C 1.528 0.885 0 C-N-CA 120.794 -0.717 . . . . 0.0 113.358 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -60.98 -75.41 0.02 OUTLIER 'Trans proline' 0 C--N 1.358 1.053 0 C-N-CA 121.94 1.76 . . . . 0.0 113.429 -178.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.742 ' HB1' HD12 ' A' ' 60' ' ' LEU . . . -108.15 47.52 0.9 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 121.24 0.543 . . . . 0.0 111.964 -178.798 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.4 t -111.22 -64.19 1.31 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.727 178.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.14 -16.11 61.17 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.783 178.557 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 27.7 mt -96.51 -52.67 3.86 Favored 'General case' 0 C--N 1.342 0.262 0 CA-C-O 120.616 0.246 . . . . 0.0 111.135 -179.141 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.742 HD12 ' HB1' ' A' ' 56' ' ' ALA . 8.9 mt -103.76 151.12 23.42 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.884 0.373 . . . . 0.0 111.748 -179.474 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 3.5 pp0? -126.45 149.42 67.57 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.641 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -58.57 130.01 35.19 Favored 'Trans proline' 0 C--N 1.361 1.186 0 C-N-CA 122.342 2.028 . . . . 0.0 113.658 -178.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 98.35 9.46 53.28 Favored Glycine 0 CA--C 1.525 0.714 0 CA-C-N 115.673 -0.694 . . . . 0.0 114.075 179.054 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.607 ' OD1' HG23 ' A' ' 47' ' ' VAL . 10.5 p30 -77.82 -174.48 3.52 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 117.841 0.82 . . . . 0.0 111.623 -179.272 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 25.4 tttm -139.2 124.32 18.95 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.008 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 26.5 mt -88.72 115.23 28.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-O 121.106 0.479 . . . . 0.0 110.812 -179.157 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 19.8 mm -89.78 -42.82 14.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -178.22 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.784 ' HB2' HD12 ' A' ' 96' ' ' ILE . 0.0 OUTLIER -150.11 146.33 26.85 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.102 0.477 . . . . 0.0 112.116 -179.006 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.587 ' HB3' ' CE1' ' A' ' 74' ' ' PHE . . . -131.06 120.9 24.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.919 179.464 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 42.76 35.46 0.71 Allowed 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 178.624 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 91.51 -12.59 68.88 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 120.819 -0.705 . . . . 0.0 113.853 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -88.21 125.46 34.64 Favored 'General case' 0 C--O 1.231 0.082 0 CA-C-N 117.648 0.724 . . . . 0.0 109.949 179.518 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 84.4 p -69.67 115.55 9.04 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.754 -179.038 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.587 ' CE1' ' HB3' ' A' ' 69' ' ' ALA . 4.4 m-85 -95.25 9.17 40.75 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.954 178.866 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 7.6 tp -89.38 126.86 42.33 Favored 'Isoleucine or valine' 0 C--N 1.343 0.288 0 CA-C-N 118.181 0.446 . . . . 0.0 110.508 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 57.1 m-80 61.09 70.82 0.59 Allowed 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 121.284 0.564 . . . . 0.0 110.786 -179.634 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.404 HD13 ' HA ' ' A' ' 74' ' ' PHE . 19.9 pt -145.6 168.48 7.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.885 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -82.45 148.14 28.34 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.18 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.423 ' O ' HG23 ' A' ' 83' ' ' VAL . 1.3 t-160 -52.23 -52.5 52.03 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.281 -179.633 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -56.8 -26.05 53.34 Favored Glycine 0 CA--C 1.523 0.552 0 C-N-CA 121.037 -0.601 . . . . 0.0 113.171 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -74.32 -40.25 62.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.068 0.461 . . . . 0.0 110.641 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.3 -34.47 74.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.797 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.78 HG22 HD11 ' A' ' 27' ' ' ILE . 24.0 t -75.08 -44.85 43.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.911 0.386 . . . . 0.0 110.861 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 23.3 t -59.01 -36.97 75.83 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.383 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 85' ' ' LEU . 35.7 mt -71.0 -42.3 69.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.099 0.476 . . . . 0.0 110.588 179.575 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.425 ' HA ' ' CD2' ' A' ' 89' ' ' PHE . 33.2 mt -77.53 -8.27 57.54 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -179.408 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 15.8 mmtp -98.09 -36.65 10.02 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.247 0.546 . . . . 0.0 110.427 178.427 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 9.1 t -70.19 -21.78 63.01 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.494 -0.775 . . . . 0.0 112.142 -178.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.425 ' CD2' ' HA ' ' A' ' 86' ' ' LEU . 12.9 m-85 -55.83 126.8 27.22 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.194 0.521 . . . . 0.0 111.06 -179.06 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 23.1 mp0 -60.29 -64.5 0.93 Allowed 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -177.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 32.4 m120 -134.6 -81.95 0.44 Allowed 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -178.659 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.556 HG23 ' HG3' ' A' ' 18' ' ' GLU . 0.2 OUTLIER -70.76 158.75 35.76 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.033 0.444 . . . . 0.0 111.08 -178.718 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 19.5 t -150.38 113.97 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.888 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -89.36 119.33 29.73 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.202 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.5 mt -122.71 147.41 46.51 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.166 0.508 . . . . 0.0 111.893 -178.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.784 HD12 ' HB2' ' A' ' 68' ' ' GLN . 41.2 mt -112.86 126.46 70.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.536 -0.757 . . . . 0.0 109.719 178.638 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.454 HD13 HD23 ' A' ' 60' ' ' LEU . 30.9 pt -126.0 166.48 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-O 120.837 0.351 . . . . 0.0 111.296 -179.051 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 16.1 t -150.01 149.49 14.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.574 -179.531 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.34 115.63 30.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.258 178.213 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -73.17 133.27 44.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.935 0.398 . . . . 0.0 111.7 -178.532 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 15.8 m -90.87 145.98 6.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.801 179.393 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 22.7 t -134.46 33.97 3.26 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.976 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 56.8 p . . . . . 0 C--O 1.248 0.99 0 CA-C-O 118.282 -0.866 . . . . 0.0 110.836 179.886 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 301' ' ' THR . . . . . . . . . . . . . 4.0 m . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.742 0.306 . . . . 0.0 111.178 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 302' ' ' GLY . . . . . . . . . . . . . . . -165.37 112.23 0.49 Allowed Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.447 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 303' ' ' TRP . . . . . 0.403 ' CZ3' ' HB3' ' B' ' 304' ' ' GLU . 13.2 p-90 -73.29 -5.44 39.57 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 304' ' ' GLU . . . . . 0.403 ' HB3' ' CZ3' ' B' ' 303' ' ' TRP . 1.5 pm0 -107.54 158.5 17.17 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 118.336 0.516 . . . . 0.0 110.716 179.712 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 305' ' ' THR . . . . . . . . . . . . . 4.3 m -124.77 130.94 53.38 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.189 -0.46 . . . . 17.879999999999999 110.731 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 306' ' ' TRP . . . . . 0.407 ' CH2' ' HG3' ' A' ' 51' ' ' GLN . 77.2 m95 -91.05 110.84 22.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.92 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 307' ' ' VAL . . . . . 0.461 HG12 HG13 ' A' ' 83' ' ' VAL . 16.8 m . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.217 -0.897 . . . . 16.109999999999999 111.076 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.204 0 N-CA-C 112.47 -0.252 . . . . 0.0 112.47 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.5 t -156.79 94.33 1.44 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.795 0.331 . . . . 0.0 110.804 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -92.72 167.73 11.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.789 179.751 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.01 -41.16 2.46 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.142 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 152.56 104.8 0.26 Allowed Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.828 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 17.9 t-80 -124.85 147.18 48.91 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.695 0.284 . . . . 0.0 110.568 179.552 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -100.33 147.7 25.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.204 -179.644 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -144.63 35.73 1.17 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.6 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.478 ' HA ' HG11 ' A' ' 101' ' ' VAL . . . -88.98 -146.09 0.16 Allowed 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.562 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 42.3 mmtm -44.2 107.79 0.1 Allowed 'General case' 0 N--CA 1.485 1.301 0 CA-C-N 118.957 0.799 . . . . 0.0 112.819 -179.391 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.421 ' O ' HG13 ' A' ' 98' ' ' VAL . 0.9 OUTLIER -96.62 162.1 13.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.627 -179.77 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -132.43 97.78 4.19 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.901 179.126 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.4 pt -109.3 158.94 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -178.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -116.12 148.65 40.08 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.975 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 20.1 m -138.85 142.41 34.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.011 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 74.9 mtm-85 -105.18 120.31 41.22 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.123 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.1 t -111.01 112.91 42.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.974 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -89.19 119.55 29.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.676 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.47 ' HE2' HD11 ' A' ' 23' ' ' LEU . 20.1 mttt -75.03 118.0 17.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.046 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -169.37 86.89 0.61 Allowed Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.56 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -81.61 -18.45 24.93 Favored 'Cis proline' 0 C--N 1.363 1.294 0 CA-C-N 119.384 0.816 . . . . 0.0 113.408 0.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -136.42 -175.97 4.18 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.695 0.283 . . . . 0.0 111.1 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.47 HD11 ' HE2' ' A' ' 19' ' ' LYS . 3.7 mp -62.36 -56.96 13.33 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.685 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.562 ' O ' HG13 ' A' ' 50' ' ' VAL . . . 100.9 35.53 4.25 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.762 -0.732 . . . . 0.0 114.318 178.566 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.468 ' O ' HG22 ' B' ' 307' ' ' VAL . 36.3 p90 -159.74 153.75 23.27 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 117.283 0.541 . . . . 0.0 110.915 179.019 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.405 ' HB3' ' CD2' ' B' ' 306' ' ' TRP . 2.2 p -105.93 145.12 31.7 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.148 0.499 . . . . 0.0 112.023 -178.802 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.602 HD11 HG22 ' A' ' 83' ' ' VAL . 31.2 pt -122.59 149.92 26.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.357 178.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.7 m -144.67 -176.67 5.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.786 0.326 . . . . 0.0 110.93 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.09 -146.47 22.99 Favored Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.908 -0.663 . . . . 0.0 113.086 179.407 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.41 162.46 31.61 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.102 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.46 HG22 ' HB2' ' A' ' 43' ' ' ASP . 23.6 t -76.54 92.02 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 CA-C-O 121.236 0.541 . . . . 0.0 110.479 -179.208 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 100.4 8.18 50.25 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-N 115.32 -0.854 . . . . 0.0 113.487 -179.24 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -83.51 -161.33 31.4 Favored Glycine 0 C--N 1.343 0.944 0 CA-C-N 117.719 0.76 . . . . 0.0 113.248 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 91.4 mtt-85 -64.24 -27.37 69.0 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -179.28 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.36 167.55 41.97 Favored Glycine 0 C--N 1.337 0.62 0 C-N-CA 120.636 -0.792 . . . . 0.0 113.165 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 12.1 m-80 -125.71 144.8 49.41 Favored Pre-proline 0 CA--C 1.536 0.422 0 C-N-CA 122.131 0.173 . . . . 0.0 110.712 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -83.69 2.57 8.23 Favored 'Trans proline' 0 C--N 1.356 0.968 0 C-N-CA 121.865 1.71 . . . . 0.0 113.615 179.679 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -99.99 -39.5 8.11 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.017 0.437 . . . . 0.0 110.453 179.463 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 5.1 ppt_? -90.92 128.77 46.64 Favored Pre-proline 0 N--CA 1.469 0.513 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.931 -179.115 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -89.02 -22.24 1.1 Allowed 'Trans proline' 0 C--N 1.359 1.111 0 C-N-CA 122.325 2.017 . . . . 0.0 113.408 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -155.41 18.91 0.41 Allowed 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.986 0.735 . . . . 0.0 112.986 -179.323 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -90.24 118.03 29.45 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 122.188 -0.32 . . . . 0.0 110.828 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.46 ' HB2' HG22 ' A' ' 31' ' ' VAL . 3.1 p30 -89.61 40.64 1.0 Allowed 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -179.08 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -109.7 -155.63 15.88 Favored Glycine 0 C--N 1.336 0.57 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.86 179.555 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.6 mm -122.13 137.77 54.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 N-CA-C 110.504 -0.184 . . . . 0.0 110.504 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -129.88 148.74 51.78 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.68 0.276 . . . . 0.0 111.282 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.673 HG22 HD11 ' A' ' 66' ' ' ILE . 19.8 t -94.45 77.13 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-O 121.007 0.432 . . . . 0.0 110.99 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.419 HG23 ' N ' ' A' ' 49' ' ' ARG . 9.4 t -37.85 -53.68 1.29 Allowed 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 -178.5 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.419 ' N ' HG23 ' A' ' 48' ' ' THR . 0.3 OUTLIER -159.11 177.88 10.63 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 118.273 0.488 . . . . 0.0 112.235 -179.826 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.562 HG13 ' O ' ' A' ' 24' ' ' GLY . 7.5 t -130.0 148.06 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.944 -179.412 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.428 ' HG2' ' CH2' ' B' ' 306' ' ' TRP . 8.3 mm-40 -96.02 -68.07 0.07 OUTLIER Pre-proline 0 CA--C 1.536 0.416 0 C-N-CA 121.366 -0.134 . . . . 0.0 111.049 179.536 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -80.39 121.9 4.43 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 121.811 1.674 . . . . 0.0 111.955 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -79.6 64.7 4.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.936 0.398 . . . . 0.0 111.28 -179.611 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -157.83 -67.28 0.01 OUTLIER Glycine 0 CA--C 1.529 0.962 0 C-N-CA 120.668 -0.777 . . . . 0.0 113.547 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -57.96 -73.74 0.03 OUTLIER 'Trans proline' 0 C--N 1.357 0.975 0 C-N-CA 122.183 1.922 . . . . 0.0 113.52 -178.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -112.24 47.95 1.03 Allowed 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.189 0.518 . . . . 0.0 111.393 -179.351 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 95.4 p -107.77 -50.08 3.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.515 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.4 mmtm -80.38 -9.96 59.75 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.487 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.2 mp -96.23 -56.69 2.55 Favored 'General case' 0 C--N 1.342 0.25 0 CA-C-N 118.106 0.412 . . . . 0.0 111.184 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.735 HD23 HG21 ' A' ' 97' ' ' ILE . 1.1 mt -92.66 146.23 23.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.326 -179.702 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -112.49 140.83 24.24 Favored Pre-proline 0 CA--C 1.535 0.373 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.52 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -57.07 125.87 20.34 Favored 'Trans proline' 0 C--N 1.356 0.923 0 C-N-CA 121.716 1.61 . . . . 0.0 112.242 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 92.45 19.82 37.04 Favored Glycine 0 CA--C 1.523 0.539 0 C-N-CA 120.948 -0.644 . . . . 0.0 113.336 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -93.69 155.34 17.31 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-N 117.237 0.518 . . . . 0.0 110.047 179.457 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 58.8 tttp -100.07 125.54 46.16 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.92 0.39 . . . . 0.0 111.753 -179.066 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.673 HD11 HG22 ' A' ' 47' ' ' VAL . 44.4 mt -89.81 120.48 38.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.973 179.325 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 19.3 mm -95.86 -41.34 11.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -178.323 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.751 ' HB3' HD12 ' A' ' 96' ' ' ILE . 0.2 OUTLIER -149.48 153.9 37.97 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 112.2 0.445 . . . . 0.0 112.2 -178.13 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.484 ' HB3' ' CE1' ' A' ' 74' ' ' PHE . . . -142.45 123.27 14.32 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.856 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.419 ' HB2' ' CZ ' ' A' ' 89' ' ' PHE . 28.4 m-20 41.55 37.72 0.75 Allowed 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 178.663 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 96.11 -16.73 60.58 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 120.843 -0.694 . . . . 0.0 113.643 179.152 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 53.8 m-85 -91.35 122.62 34.11 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 117.565 0.683 . . . . 0.0 110.66 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 8.8 m -71.47 131.43 43.3 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.978 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.484 ' CE1' ' HB3' ' A' ' 69' ' ' ALA . 4.6 m-85 -105.6 14.37 28.57 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 112.292 0.478 . . . . 0.0 112.292 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 7.0 tp -92.04 126.13 44.63 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 CA-C-O 120.998 0.428 . . . . 0.0 111.096 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 61.46 70.41 0.6 Allowed 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 121.151 0.5 . . . . 0.0 110.845 -179.279 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 7.1 pt -148.66 164.24 4.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.984 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -81.35 143.14 32.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.458 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -50.99 -52.1 46.14 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -179.438 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -53.47 -27.92 34.98 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 121.248 -0.501 . . . . 0.0 113.05 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 49.7 tp60 -74.37 -38.71 63.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.092 0.473 . . . . 0.0 110.124 179.119 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.43 -53.75 32.05 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.597 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.602 HG22 HD11 ' A' ' 27' ' ' ILE . 20.0 t -58.5 -43.39 86.82 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.417 -179.647 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.7 t -60.46 -41.29 93.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.392 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.468 ' O ' HG22 ' A' ' 88' ' ' THR . 26.8 mt -65.17 -45.97 82.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.518 -179.595 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.514 HD12 HD13 ' A' ' 27' ' ' ILE . 32.9 mt -63.15 -38.45 91.23 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.192 -0.458 . . . . 0.0 112.012 -179.148 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 19.1 mmtt -66.48 -40.3 89.23 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.451 0.538 . . . . 0.0 112.451 -178.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.468 HG22 ' O ' ' A' ' 85' ' ' LEU . 7.8 t -72.18 -27.88 62.85 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -177.895 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.43 ' CD2' ' HA ' ' A' ' 86' ' ' LEU . 12.6 m-85 -49.09 173.66 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -178.416 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -87.84 -140.25 0.11 Allowed 'General case' 0 CA--C 1.552 1.026 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.204 -179.268 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 33.1 m120 -82.58 -61.82 1.78 Allowed 'General case' 0 C--N 1.348 0.538 0 CA-C-N 119.251 0.932 . . . . 0.0 111.526 -179.358 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -84.09 129.03 34.92 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.061 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.3 t -123.29 120.26 59.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.511 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -92.54 91.71 7.72 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.48 -179.503 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 2.5 mt -92.5 155.15 18.02 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.837 0.351 . . . . 0.0 111.419 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.751 HD12 ' HB3' ' A' ' 68' ' ' GLN . 72.9 mt -115.36 127.29 72.99 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.487 178.395 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.735 HG21 HD23 ' A' ' 60' ' ' LEU . 45.3 pt -123.76 162.37 24.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-O 120.902 0.382 . . . . 0.0 111.534 -178.845 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.421 HG13 ' O ' ' A' ' 11' ' ' GLN . 36.7 t -136.73 139.8 44.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.5 -179.287 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -110.47 106.28 15.54 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.665 178.77 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -60.18 130.08 44.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.882 0.373 . . . . 0.0 111.578 -178.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.478 HG11 ' HA ' ' A' ' 9' ' ' ALA . 14.9 m -97.47 156.94 3.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.995 179.718 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 56.7 p -162.42 102.01 1.07 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.948 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 24.0 t . . . . . 0 C--O 1.248 0.993 0 CA-C-O 118.284 -0.865 . . . . 0.0 110.903 179.964 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 301' ' ' THR . . . . . . . . . . . . . 12.8 p . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.748 0.309 . . . . 0.0 111.165 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 302' ' ' GLY . . . . . . . . . . . . . . . -100.67 -70.51 0.91 Allowed Glycine 0 CA--C 1.518 0.254 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.884 -179.739 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 303' ' ' TRP . . . . . . . . . . . . . 11.8 p-90 -147.67 20.73 1.16 Allowed 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -123.26 172.54 8.55 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.069 0.461 . . . . 0.0 111.346 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 305' ' ' THR . . . . . . . . . . . . . 6.4 m -139.32 119.44 13.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.801 -0.636 . . . . 17.879999999999999 110.372 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 306' ' ' TRP . . . . . 0.428 ' CH2' ' HG2' ' A' ' 51' ' ' GLN . 96.5 m95 -85.71 114.6 22.81 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.109 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 307' ' ' VAL . . . . . 0.468 HG22 ' O ' ' A' ' 25' ' ' PHE . 18.0 m . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.285 -0.864 . . . . 16.109999999999999 111.142 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.198 0 N-CA-C 112.544 -0.222 . . . . 0.0 112.544 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.0 p -114.07 33.29 5.33 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.853 0.359 . . . . 0.0 110.951 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 74.0 m80 -99.68 123.09 43.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.821 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.11 177.1 5.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.797 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 158.85 -149.05 18.93 Favored Glycine 0 C--N 1.331 0.304 0 C-N-CA 120.972 -0.632 . . . . 0.0 112.486 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 10.6 m-70 -147.77 -72.33 0.21 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.74 0.305 . . . . 0.0 110.887 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -109.72 154.09 23.39 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.939 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 53.5 mt -143.31 163.56 32.66 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.089 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -130.84 82.18 2.04 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.968 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -162.61 177.8 9.1 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.588 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.427 ' O ' HG13 ' A' ' 98' ' ' VAL . 12.7 pt20 -152.33 143.61 23.27 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.596 -0.275 . . . . 0.0 111.249 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -133.34 105.14 6.79 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.806 0.336 . . . . 0.0 111.205 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 19.7 pt -117.05 156.15 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-N 116.061 -0.518 . . . . 0.0 112.205 -179.6 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 29.7 mtm180 -90.29 167.47 12.64 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -178.529 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.475 HG13 ' HB3' ' A' ' 59' ' ' LEU . 77.6 t -147.43 122.97 2.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.977 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.414 ' HG2' HG22 ' A' ' 92' ' ' THR . 20.8 ttt180 -110.42 112.85 25.05 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.66 179.663 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.2 t -120.21 125.95 74.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.089 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.805 ' CG ' HG23 ' A' ' 92' ' ' THR . 28.9 mt-10 -102.05 128.51 48.48 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.106 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.426 ' HD2' HD12 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -72.81 114.6 11.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.962 179.919 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -174.95 83.35 0.32 Allowed Pre-proline 0 CA--C 1.537 0.471 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.087 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -83.38 -23.82 12.29 Favored 'Cis proline' 0 C--N 1.362 1.283 0 CA-C-N 119.445 0.838 . . . . 0.0 112.868 0.453 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.1 mp0 -130.68 -177.4 4.34 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.755 0.312 . . . . 0.0 111.405 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.426 HD12 ' HD2' ' A' ' 19' ' ' LYS . 3.3 mp -62.93 -59.83 4.29 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.978 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.464 ' O ' HG13 ' A' ' 50' ' ' VAL . . . 115.7 29.91 2.32 Favored Glycine 0 C--N 1.335 0.499 0 C-N-CA 120.925 -0.655 . . . . 0.0 113.771 179.365 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.443 ' O ' HG22 ' B' ' 307' ' ' VAL . 51.2 p90 -169.48 149.21 3.93 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 117.37 0.585 . . . . 0.0 111.521 179.452 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.3 p -100.44 150.44 22.64 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.87 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.681 HD11 HG22 ' A' ' 83' ' ' VAL . 38.3 pt -120.27 148.76 23.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.196 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 78.1 p -142.9 160.25 40.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.859 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 108.14 -152.57 16.95 Favored Glycine 0 C--N 1.332 0.338 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.94 179.617 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 104.0 157.01 24.14 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 121.096 -0.573 . . . . 0.0 112.264 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.5 t -78.18 100.38 3.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 120.925 0.393 . . . . 0.0 110.853 -179.606 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 93.48 7.68 61.66 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 121.047 -0.597 . . . . 0.0 113.709 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -88.63 -156.07 30.68 Favored Glycine 0 C--N 1.34 0.755 0 CA-C-N 117.746 0.773 . . . . 0.0 112.958 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 10.4 mmt180 -61.13 -27.52 68.45 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 111.606 0.224 . . . . 0.0 111.606 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 103.71 154.4 23.83 Favored Glycine 0 C--N 1.335 0.512 0 C-N-CA 120.881 -0.676 . . . . 0.0 113.059 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -112.15 129.96 23.76 Favored Pre-proline 0 N--CA 1.468 0.472 0 C-N-CA 122.074 0.149 . . . . 0.0 110.618 179.738 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -93.42 34.19 0.22 Allowed 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 122.316 2.011 . . . . 0.0 113.101 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -110.34 -51.2 2.89 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.786 0.327 . . . . 0.0 111.156 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 45.3 mtt-85 -127.13 158.29 69.55 Favored Pre-proline 0 CA--C 1.535 0.366 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.741 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -90.71 -57.67 0.02 OUTLIER 'Trans proline' 0 C--N 1.357 1.005 0 C-N-CA 122.219 1.946 . . . . 0.0 113.977 -178.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -79.35 -8.07 58.81 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -179.078 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -101.58 114.1 27.82 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 118.024 0.375 . . . . 0.0 110.418 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -105.73 38.81 1.9 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.379 -179.295 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -85.86 -156.3 27.17 Favored Glycine 0 CA--C 1.52 0.36 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.505 179.687 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.5 mm -110.57 130.81 63.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-O 120.531 0.205 . . . . 0.0 110.852 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -125.99 150.97 47.66 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 120.827 0.346 . . . . 0.0 111.43 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.447 HG21 HD22 ' A' ' 60' ' ' LEU . 21.8 t -89.1 81.73 1.97 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.185 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.422 HG23 ' N ' ' A' ' 49' ' ' ARG . 9.4 t -43.14 -55.41 3.92 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -178.268 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.422 ' N ' HG23 ' A' ' 48' ' ' THR . 11.6 ptm180 -161.49 156.95 24.22 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 118.425 0.557 . . . . 0.0 112.209 -179.588 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.464 HG13 ' O ' ' A' ' 24' ' ' GLY . 18.6 t -109.23 146.62 14.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.576 179.51 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.411 ' CB ' ' HD3' ' A' ' 52' ' ' PRO . 0.8 OUTLIER -102.77 -71.34 0.03 OUTLIER Pre-proline 0 CA--C 1.54 0.573 0 CA-C-O 119.437 -0.316 . . . . 0.0 111.311 179.9 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.411 ' HD3' ' CB ' ' A' ' 51' ' ' GLN . 53.9 Cg_endo -83.45 121.45 3.01 Favored 'Trans proline' 0 C--N 1.36 1.143 0 C-N-CA 121.532 1.488 . . . . 0.0 112.104 179.294 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.74 64.51 3.75 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.165 0.507 . . . . 0.0 110.963 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -139.01 -72.07 0.05 OUTLIER Glycine 0 CA--C 1.528 0.862 0 CA-C-N 115.672 -0.694 . . . . 0.0 112.84 179.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -63.76 -59.59 0.2 Allowed 'Trans proline' 0 C--N 1.357 1.009 0 C-N-CA 122.119 1.879 . . . . 0.0 113.585 -179.243 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.468 ' HB1' HD12 ' A' ' 60' ' ' LEU . . . -108.56 45.25 1.04 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.055 0.455 . . . . 0.0 111.426 -179.159 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 89.3 p -84.71 -60.98 1.9 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.04 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 13.6 mmmt -90.49 0.54 57.28 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -179.471 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.475 ' HB3' HG13 ' A' ' 15' ' ' VAL . 60.7 mt -95.48 -65.34 0.98 Allowed 'General case' 0 C--N 1.341 0.214 0 CA-C-N 118.254 0.479 . . . . 0.0 111.826 -179.691 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.569 HD23 HG21 ' A' ' 97' ' ' ILE . 3.4 mt -95.64 139.84 31.31 Favored 'General case' 0 C--O 1.23 0.048 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 -179.473 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 4.7 pp0? -121.4 151.67 56.68 Favored Pre-proline 0 CA--C 1.535 0.369 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.16 178.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -54.43 114.27 1.75 Allowed 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 121.818 1.679 . . . . 0.0 112.983 -179.404 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 118.12 -2.8 16.66 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 121.096 -0.573 . . . . 0.0 114.367 179.434 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -67.77 -177.66 0.82 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 117.831 0.816 . . . . 0.0 111.873 -179.544 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 38.0 tttt -145.22 126.57 14.88 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.705 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.604 ' N ' HD12 ' A' ' 66' ' ' ILE . 3.7 mp -89.63 117.82 33.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-O 120.832 0.349 . . . . 0.0 110.202 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 35.4 mt -106.63 -26.52 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.846 -179.042 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.678 ' HB3' HD13 ' A' ' 96' ' ' ILE . 17.2 tt0 -154.61 149.43 26.63 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.934 0.397 . . . . 0.0 111.77 -179.652 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -149.33 121.24 8.18 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.486 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 48.1 m-20 48.35 35.66 5.99 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 179.204 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 86.88 10.63 71.95 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 120.973 -0.632 . . . . 0.0 113.626 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -112.16 120.91 43.4 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 117.692 0.746 . . . . 0.0 109.811 179.533 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 18.8 m -71.53 128.78 36.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.418 -179.075 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -106.19 13.89 28.33 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.172 -0.467 . . . . 0.0 112.125 179.61 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 6.4 tp -90.83 124.19 43.3 Favored 'Isoleucine or valine' 0 C--N 1.34 0.169 0 O-C-N 122.047 -0.408 . . . . 0.0 110.743 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 63.18 72.75 0.47 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.929 -179.217 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 20.1 pt -146.95 166.06 6.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.795 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -81.84 154.78 25.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.995 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 16.1 t60 -54.6 -56.8 15.21 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.899 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -53.05 -33.2 44.05 Favored Glycine 0 C--N 1.336 0.532 0 C-N-CA 121.257 -0.497 . . . . 0.0 113.363 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 -65.95 -38.91 89.84 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.036 0.446 . . . . 0.0 110.148 179.286 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.3 -63.63 1.02 Allowed 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.684 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.681 HG22 HD11 ' A' ' 27' ' ' ILE . 11.5 t -55.29 -22.87 12.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 N-CA-C 111.93 0.344 . . . . 0.0 111.93 -179.781 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.461 ' O ' HG22 ' A' ' 88' ' ' THR . 18.0 m -77.4 -42.28 36.88 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.747 0.308 . . . . 0.0 111.101 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 25.5 mt -65.71 -42.06 91.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.665 -179.339 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.422 ' HA ' ' CD2' ' A' ' 89' ' ' PHE . 53.4 mt -66.73 -47.98 70.6 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.638 -179.29 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.412 ' HD2' HG12 ' A' ' 83' ' ' VAL . 70.7 mttt -60.66 -45.9 92.36 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -179.199 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.461 HG22 ' O ' ' A' ' 84' ' ' SER . 11.6 t -68.82 -27.7 66.08 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -177.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.422 ' CD2' ' HA ' ' A' ' 86' ' ' LEU . 6.0 m-85 -46.88 174.7 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -178.073 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -85.79 -143.69 0.1 Allowed 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.79 -179.527 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -81.15 -70.71 0.51 Allowed 'General case' 0 C--N 1.347 0.471 0 CA-C-N 119.016 0.825 . . . . 0.0 111.669 -179.201 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.805 HG23 ' CG ' ' A' ' 18' ' ' GLU . 0.3 OUTLIER -79.2 129.26 34.27 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 120.766 0.317 . . . . 0.0 110.448 -179.874 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.7 t -121.63 120.07 60.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.976 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -98.08 105.46 17.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.934 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.574 ' C ' HD12 ' A' ' 96' ' ' ILE . 4.9 mp -105.29 164.38 11.89 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.977 0.418 . . . . 0.0 111.541 -179.701 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.678 HD13 ' HB3' ' A' ' 68' ' ' GLN . 3.1 mp -120.5 131.77 71.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.089 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.569 HG21 HD23 ' A' ' 60' ' ' LEU . 46.0 pt -126.82 166.45 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-O 120.967 0.413 . . . . 0.0 111.809 -178.835 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.427 HG13 ' O ' ' A' ' 11' ' ' GLN . 98.9 t -143.07 143.78 24.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.276 -179.043 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.1 105.06 14.02 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.566 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -59.19 119.01 6.56 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -178.459 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 19.4 t -97.9 112.16 29.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.75 179.435 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 69.9 p -92.99 83.52 4.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.863 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 51.3 p . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.319 -0.848 . . . . 0.0 110.869 179.994 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 301' ' ' THR . . . . . . . . . . . . . 3.4 m . . . . . 0 N--CA 1.489 1.484 0 N-CA-C 111.688 0.255 . . . . 0.0 111.688 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 302' ' ' GLY . . . . . . . . . . . . . . . 162.56 -108.79 0.36 Allowed Glycine 0 C--N 1.333 0.406 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.417 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 303' ' ' TRP . . . . . . . . . . . . . 20.7 p-90 -165.28 -42.04 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 111.649 0.24 . . . . 0.0 111.649 179.618 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 4.0 pm0 -61.9 148.91 41.98 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.736 0.303 . . . . 0.0 111.343 -179.7 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 305' ' ' THR . . . . . . . . . . . . . 5.6 m -127.41 121.06 29.87 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.201 -0.454 . . . . 17.879999999999999 110.803 179.737 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 306' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -85.28 106.91 17.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.74 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 307' ' ' VAL . . . . . 0.594 HG12 HG13 ' A' ' 83' ' ' VAL . 18.4 m . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.281 -0.866 . . . . 16.109999999999999 111.135 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.159 0 N-CA-C 112.525 -0.23 . . . . 0.0 112.525 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.7 t -148.68 120.96 8.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.83 0.348 . . . . 0.0 110.815 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 24.0 m80 -93.69 140.22 29.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.936 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -111.98 177.48 4.63 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.893 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -65.28 176.13 13.62 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.426 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 51.6 p-80 -87.8 77.44 8.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.969 0.414 . . . . 0.0 110.892 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -141.78 28.6 1.76 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.149 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 11.1 mt -102.17 -44.26 5.49 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.061 0.458 . . . . 0.0 110.152 179.479 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -87.63 92.89 9.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.263 179.193 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -170.99 172.27 5.54 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.681 -179.18 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -145.33 96.33 2.82 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.706 0.288 . . . . 0.0 110.934 -179.748 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -98.63 131.75 44.58 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -179.3 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.629 ' N ' HD13 ' A' ' 13' ' ' ILE . 0.2 OUTLIER -151.75 164.31 2.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.577 179.447 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.75 ' HG3' HD13 ' A' ' 96' ' ' ILE . 1.2 ttm180 -118.8 156.82 28.74 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 111.783 0.29 . . . . 0.0 111.783 -179.548 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.464 HG11 ' HB3' ' A' ' 59' ' ' LEU . 29.4 m -143.51 153.61 16.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -115.06 118.25 32.87 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.858 -179.442 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.7 t -114.65 124.24 71.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.368 178.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.675 ' HG2' HG23 ' A' ' 92' ' ' THR . 43.3 mt-10 -102.83 127.84 49.84 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.03 0.443 . . . . 0.0 111.577 -179.367 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.63 118.23 12.23 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.252 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -175.89 78.12 0.29 Allowed Pre-proline 0 CA--C 1.541 0.603 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.703 179.261 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -86.76 -18.67 20.56 Favored 'Cis proline' 0 C--N 1.363 1.311 0 CA-C-N 119.331 0.797 . . . . 0.0 113.231 0.503 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -136.59 -178.0 4.98 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.794 0.33 . . . . 0.0 111.592 -179.467 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.412 ' HB3' ' CE2' ' A' ' 25' ' ' PHE . 4.2 mp -63.99 -56.95 11.41 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.563 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 107.16 29.38 4.57 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.885 -0.674 . . . . 0.0 113.937 178.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.412 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 45.2 p90 -159.03 145.41 16.82 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 117.464 0.632 . . . . 0.0 111.21 179.259 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 8.6 p -96.1 148.9 22.21 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.647 -179.264 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.591 HD11 HG22 ' A' ' 83' ' ' VAL . 25.1 pt -124.52 150.35 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.109 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.348 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 47.9 t -138.38 155.64 48.34 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.298 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 158.5 -99.18 0.18 Allowed Glycine 0 C--N 1.334 0.439 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.519 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 50.23 110.6 0.01 OUTLIER Glycine 0 CA--C 1.527 0.831 0 N-CA-C 115.38 0.912 . . . . 0.0 115.38 178.118 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 20.4 t -77.8 91.29 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.127 0 O-C-N 122.547 -0.384 . . . . 0.0 110.837 179.089 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 91.69 -4.79 79.54 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 120.821 -0.704 . . . . 0.0 114.149 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -111.26 9.51 28.87 Favored Glycine 0 C--N 1.342 0.908 0 CA-C-N 117.932 0.866 . . . . 0.0 114.282 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -178.35 -77.29 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 117.736 0.768 . . . . 0.0 109.626 178.647 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 113.13 152.81 11.21 Favored Glycine 0 C--N 1.335 0.491 0 CA-C-N 115.919 -0.582 . . . . 0.0 113.124 179.218 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -125.76 136.3 28.19 Favored Pre-proline 0 CA--C 1.535 0.37 0 N-CA-C 110.345 -0.243 . . . . 0.0 110.345 179.551 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -93.75 28.94 0.29 Allowed 'Trans proline' 0 C--N 1.356 0.947 0 C-N-CA 122.422 2.082 . . . . 0.0 113.514 -179.1 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -108.03 -49.75 3.16 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.692 0.282 . . . . 0.0 111.203 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 14.2 mmm180 -117.15 135.31 23.07 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.004 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -83.57 -44.56 0.07 OUTLIER 'Trans proline' 0 C--N 1.359 1.104 0 C-N-CA 121.898 1.732 . . . . 0.0 112.81 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -93.9 -13.4 27.21 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -101.35 118.46 37.02 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 117.864 0.302 . . . . 0.0 110.318 179.553 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -108.44 42.39 1.4 Allowed 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 120.978 0.418 . . . . 0.0 111.364 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -88.83 -156.32 31.25 Favored Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.269 179.57 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 27.7 mm -109.97 135.44 48.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-N 116.678 0.239 . . . . 0.0 110.843 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.429 ' N ' ' CD1' ' A' ' 46' ' ' PHE . 4.5 m-85 -132.7 148.24 52.34 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 120.681 0.277 . . . . 0.0 111.42 -179.396 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.539 HG21 HD22 ' A' ' 60' ' ' LEU . 16.8 t -92.88 73.37 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -179.314 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.439 HG23 ' N ' ' A' ' 49' ' ' ARG . 8.9 t -34.31 -53.13 0.5 Allowed 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -178.706 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.439 ' N ' HG23 ' A' ' 48' ' ' THR . 0.5 OUTLIER -160.31 177.39 10.67 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 121.87 -0.519 . . . . 0.0 112.042 -179.636 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 12.1 t -132.08 151.35 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.991 -179.5 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -105.31 -68.24 0.04 OUTLIER Pre-proline 0 CA--C 1.538 0.517 0 N-CA-C 111.768 0.285 . . . . 0.0 111.768 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -79.02 119.97 4.47 Favored 'Trans proline' 0 C--N 1.357 0.983 0 C-N-CA 121.811 1.674 . . . . 0.0 112.557 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.38 66.81 4.03 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.003 0.43 . . . . 0.0 111.629 -179.672 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -162.19 -66.58 0.02 OUTLIER Glycine 0 CA--C 1.528 0.865 0 C-N-CA 120.718 -0.753 . . . . 0.0 113.522 -179.653 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.67 -74.46 0.02 OUTLIER 'Trans proline' 0 C--N 1.357 0.993 0 C-N-CA 122.043 1.828 . . . . 0.0 113.469 -178.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -117.21 49.32 1.21 Allowed 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 121.054 0.454 . . . . 0.0 112.122 -178.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 16.7 t -109.22 -58.67 2.0 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 178.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 19.4 tptt -68.35 -10.84 57.76 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.743 178.506 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.464 ' HB3' HG11 ' A' ' 15' ' ' VAL . 54.1 mt -91.24 -65.14 1.04 Allowed 'General case' 0 C--N 1.343 0.304 0 CA-C-N 118.022 0.374 . . . . 0.0 110.85 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.762 HD23 HG21 ' A' ' 97' ' ' ILE . 1.5 mp -91.92 148.62 22.08 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.958 179.69 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.4 pm0 -115.18 151.82 46.13 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.985 178.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -57.37 128.53 29.9 Favored 'Trans proline' 0 C--N 1.356 0.962 0 C-N-CA 121.911 1.74 . . . . 0.0 113.041 -179.185 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 93.86 15.63 48.33 Favored Glycine 0 CA--C 1.524 0.653 0 CA-C-N 115.919 -0.582 . . . . 0.0 113.68 179.395 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -76.91 -174.49 3.11 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 117.518 0.659 . . . . 0.0 111.064 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 47.0 tttm -141.89 125.11 16.4 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.567 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 60.9 mt -90.54 113.34 26.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.186 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 24.2 mm -90.91 -36.88 8.6 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-N 115.936 -0.575 . . . . 0.0 112.077 -178.303 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.28 145.99 27.34 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.065 0.46 . . . . 0.0 111.172 -179.245 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.416 ' HB3' ' CE1' ' A' ' 74' ' ' PHE . . . -136.97 119.69 16.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.015 179.732 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.3 m120 45.95 30.04 0.84 Allowed 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 179.156 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 100.78 -14.21 58.99 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 120.693 -0.765 . . . . 0.0 113.563 -179.714 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -88.49 153.7 20.94 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 117.506 0.653 . . . . 0.0 110.09 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 12.5 m -101.25 124.62 47.23 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.428 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.416 ' CE1' ' HB3' ' A' ' 69' ' ' ALA . 3.6 m-85 -101.59 17.77 22.0 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 7.9 tp -92.28 121.17 42.63 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 CA-C-O 120.923 0.392 . . . . 0.0 110.61 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 21.7 m120 62.17 76.47 0.37 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.005 -179.415 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 23.7 pt -150.01 161.61 4.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.802 179.645 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -81.25 140.72 34.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.967 0.413 . . . . 0.0 111.396 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -41.49 -49.96 3.96 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -179.207 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -57.56 -33.36 66.6 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.965 -179.563 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 36.2 tp60 -69.74 -44.73 69.67 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.826 0.346 . . . . 0.0 111.196 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.92 -63.37 1.13 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.859 -179.64 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.591 HG22 HD11 ' A' ' 27' ' ' ILE . 24.4 t -50.81 -42.27 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -179.416 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 37.1 m -62.89 -39.53 94.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.735 0.303 . . . . 0.0 111.306 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 16.6 mt -64.75 -49.5 70.56 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.861 -179.509 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 54.4 mt -65.04 -33.16 75.38 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -178.715 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 60.3 mttm -76.02 -37.32 58.53 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -178.734 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 12.0 t -73.98 -26.12 60.29 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -178.613 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -54.94 155.19 4.61 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.145 0.498 . . . . 0.0 111.911 -178.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -63.29 -139.31 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.128 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.489 -178.86 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -82.01 -66.06 0.93 Allowed 'General case' 0 C--N 1.351 0.658 0 CA-C-N 119.345 0.975 . . . . 0.0 112.251 -178.761 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.675 HG23 ' HG2' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -76.67 123.49 26.23 Favored 'General case' 0 CA--C 1.528 0.11 0 CA-C-O 120.939 0.399 . . . . 0.0 110.958 -179.308 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.528 ' O ' HD12 ' A' ' 95' ' ' LEU . 18.0 t -114.22 112.2 39.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.634 179.342 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -89.7 112.26 23.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.353 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.528 HD12 ' O ' ' A' ' 93' ' ' VAL . 4.6 mp -115.06 154.02 29.63 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 121.115 0.483 . . . . 0.0 112.044 -178.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.75 HD13 ' HG3' ' A' ' 14' ' ' ARG . 17.9 mm -109.38 122.7 64.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.809 178.394 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.762 HG21 HD23 ' A' ' 60' ' ' LEU . 24.6 pt -118.11 157.73 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-O 120.685 0.279 . . . . 0.0 111.047 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.7 t -142.95 146.82 21.29 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-O 121.06 0.457 . . . . 0.0 111.708 -179.296 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.3 mmm-85 -111.69 110.38 20.74 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 178.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -67.05 129.41 39.81 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 120.998 0.428 . . . . 0.0 111.568 -179.509 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 17.1 m -146.39 164.69 8.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.896 179.622 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 78.0 p -138.2 52.32 1.84 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.314 0.578 . . . . 0.0 110.81 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 17.1 m . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.207 -0.901 . . . . 0.0 110.911 179.986 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 301' ' ' THR . . . . . . . . . . . . . 4.7 m . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.68 0.276 . . . . 0.0 111.247 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 302' ' ' GLY . . . . . . . . . . . . . . . 173.39 -64.63 0.12 Allowed Glycine 0 C--N 1.333 0.403 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.692 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 303' ' ' TRP . . . . . . . . . . . . . 47.0 p-90 -76.22 -28.92 57.38 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.49 0.186 . . . . 0.0 111.125 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -91.16 105.53 17.87 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.869 0.366 . . . . 0.0 110.375 179.199 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 305' ' ' THR . . . . . . . . . . . . . 7.9 m -97.84 131.13 44.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.108 -0.497 . . . . 17.879999999999999 111.201 -179.411 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 306' ' ' TRP . . . . . . . . . . . . . 92.4 m95 -89.16 106.4 18.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.866 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 307' ' ' VAL . . . . . 0.508 HG12 HG13 ' A' ' 83' ' ' VAL . 16.5 m . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.176 -0.916 . . . . 16.109999999999999 111.094 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.253 0 N-CA-C 112.56 -0.216 . . . . 0.0 112.56 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.4 t -88.52 -34.32 17.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.781 0.324 . . . . 0.0 110.904 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -68.08 169.46 10.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.581 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 55.9 mtm -90.0 -62.89 1.37 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.943 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 92.77 -91.47 1.55 Allowed Glycine 0 C--N 1.331 0.272 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.304 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 24.2 m80 -83.82 173.8 10.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.728 0.299 . . . . 0.0 110.674 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.5 mp0 -82.04 123.26 28.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.808 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.44 ' N ' HD22 ' A' ' 8' ' ' LEU . 4.0 mm? -74.77 100.74 4.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.071 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -93.92 69.01 3.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.272 0.558 . . . . 0.0 110.812 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -165.64 171.42 13.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.528 -179.712 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -142.77 130.3 21.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.596 -0.275 . . . . 0.0 111.127 -179.697 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -124.2 102.21 7.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.582 179.555 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.606 HD13 ' N ' ' A' ' 13' ' ' ILE . 0.1 OUTLIER -126.91 159.31 36.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-O 121.071 0.462 . . . . 0.0 111.703 -179.888 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 15.4 ttm-85 -109.32 161.67 15.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.413 -179.335 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.55 HG13 HD13 ' A' ' 59' ' ' LEU . 21.4 t -139.76 147.78 23.64 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.967 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 7.0 tpp85 -115.75 106.42 13.84 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.706 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.1 t -111.68 127.43 68.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.289 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.469 ' HG3' HG23 ' A' ' 92' ' ' THR . 3.9 mp0 -90.42 156.94 17.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.513 179.594 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.7 74.95 1.1 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.074 0.464 . . . . 0.0 110.406 179.637 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -141.38 85.84 11.52 Favored Pre-proline 0 CA--C 1.538 0.511 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.593 -179.502 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -85.83 -21.58 15.05 Favored 'Cis proline' 0 C--N 1.363 1.3 0 CA-C-N 119.638 0.906 . . . . 0.0 113.211 0.411 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -138.04 -176.11 4.33 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.733 0.301 . . . . 0.0 111.351 -179.609 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.9 mp -64.74 -57.87 7.8 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.048 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.4 ' O ' HG13 ' A' ' 50' ' ' VAL . . . 108.0 32.9 3.15 Favored Glycine 0 C--N 1.337 0.623 0 C-N-CA 120.86 -0.686 . . . . 0.0 113.621 179.087 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -165.69 145.62 6.58 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 117.206 0.503 . . . . 0.0 111.044 179.353 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.5 p -100.71 153.48 19.4 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.536 -179.224 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 25.6 pt -122.26 150.11 25.77 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.829 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 85.0 p -145.03 161.25 39.86 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 121.222 -0.191 . . . . 0.0 111.427 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 119.3 -91.62 0.51 Allowed Glycine 0 C--N 1.34 0.752 0 C-N-CA 120.911 -0.661 . . . . 0.0 114.191 178.552 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.469 ' H ' HD13 ' A' ' 45' ' ' ILE . . . 67.32 -133.47 30.69 Favored Glycine 0 CA--C 1.521 0.416 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.38 -179.308 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 23.9 t -151.4 81.38 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 CA-C-O 121.141 0.496 . . . . 0.0 109.832 179.298 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.56 15.15 44.57 Favored Glycine 0 CA--C 1.528 0.901 0 CA-C-N 115.753 -0.658 . . . . 0.0 113.161 -178.72 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -93.98 -143.02 12.79 Favored Glycine 0 C--N 1.338 0.691 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.292 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 5.1 mmt85 -54.29 -26.17 27.78 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -179.125 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.47 160.31 32.94 Favored Glycine 0 C--N 1.336 0.582 0 C-N-CA 120.768 -0.73 . . . . 0.0 113.492 179.341 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -121.51 136.9 26.33 Favored Pre-proline 0 N--CA 1.466 0.333 0 N-CA-C 110.491 -0.189 . . . . 0.0 110.491 179.396 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -92.83 26.96 0.37 Allowed 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 122.224 1.949 . . . . 0.0 113.127 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -102.24 -49.78 3.81 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.761 0.315 . . . . 0.0 111.008 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -124.51 140.37 35.16 Favored Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.783 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -83.76 -41.95 0.09 OUTLIER 'Trans proline' 0 C--N 1.359 1.092 0 C-N-CA 122.028 1.819 . . . . 0.0 113.201 -179.466 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -93.97 -13.08 27.42 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -179.239 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -103.54 120.69 41.37 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 117.888 0.313 . . . . 0.0 111.358 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -104.35 16.86 25.27 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -57.77 -167.29 0.12 Allowed Glycine 0 C--N 1.338 0.673 0 C-N-CA 120.637 -0.792 . . . . 0.0 113.033 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.469 HD13 ' H ' ' A' ' 30' ' ' GLY . 20.6 mm -104.28 125.97 59.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 179.043 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -122.66 146.52 47.39 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 120.796 0.332 . . . . 0.0 111.428 -179.38 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.646 ' CG2' HD11 ' A' ' 66' ' ' ILE . 34.2 t -89.89 73.02 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-O 121.25 0.548 . . . . 0.0 110.252 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.0 t -36.14 -53.59 0.8 Allowed 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -178.373 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 7.7 ptm180 -158.64 168.77 25.98 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.198 0.523 . . . . 0.0 112.321 -179.345 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.4 HG13 ' O ' ' A' ' 24' ' ' GLY . 14.4 t -126.39 148.68 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.372 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.419 ' HG2' ' CH2' ' B' ' 306' ' ' TRP . 7.1 mm-40 -105.25 -68.81 0.03 OUTLIER Pre-proline 0 CA--C 1.538 0.514 0 N-CA-C 111.706 0.261 . . . . 0.0 111.706 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -79.26 120.19 4.44 Favored 'Trans proline' 0 C--N 1.357 0.998 0 C-N-CA 121.8 1.667 . . . . 0.0 112.487 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -78.5 66.92 4.16 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 121.03 0.443 . . . . 0.0 111.064 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -160.91 -65.87 0.02 OUTLIER Glycine 0 CA--C 1.527 0.836 0 C-N-CA 120.721 -0.752 . . . . 0.0 113.548 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -56.27 -61.12 0.37 Allowed 'Trans proline' 0 C--N 1.356 0.973 0 C-N-CA 122.229 1.953 . . . . 0.0 113.513 -178.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.842 ' HB1' HD12 ' A' ' 60' ' ' LEU . . . -136.21 58.56 1.74 Allowed 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 121.206 0.527 . . . . 0.0 111.933 -178.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.8 t -119.3 -58.23 1.94 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.898 179.001 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 25.3 tptp -64.56 -16.08 62.05 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.743 178.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.55 HD13 HG13 ' A' ' 15' ' ' VAL . 39.5 mt -98.2 -49.73 4.61 Favored 'General case' 0 C--N 1.341 0.221 0 CA-C-O 120.805 0.336 . . . . 0.0 111.441 -179.729 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.842 HD12 ' HB1' ' A' ' 56' ' ' ALA . 41.9 mt -90.99 148.76 22.18 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.978 0.418 . . . . 0.0 111.802 -179.316 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -116.04 137.25 23.25 Favored Pre-proline 0 CA--C 1.536 0.42 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.235 179.107 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -52.4 126.57 21.06 Favored 'Trans proline' 0 C--N 1.356 0.971 0 C-N-CA 122.011 1.808 . . . . 0.0 113.044 -179.315 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 95.33 18.1 34.58 Favored Glycine 0 CA--C 1.521 0.428 0 C-N-CA 121.045 -0.598 . . . . 0.0 113.807 179.031 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -86.18 144.64 27.37 Favored 'General case' 0 C--N 1.339 0.122 0 CA-C-N 117.625 0.713 . . . . 0.0 110.679 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -92.89 129.57 38.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.566 -179.35 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.646 HD11 ' CG2' ' A' ' 47' ' ' VAL . 2.8 mm -88.08 111.95 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 25.9 mm -90.63 -44.62 14.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -178.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.815 ' HB3' HD12 ' A' ' 96' ' ' ILE . 20.4 tt0 -148.45 150.85 34.18 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.201 0.524 . . . . 0.0 112.403 -178.769 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.526 ' HB3' ' CE1' ' A' ' 74' ' ' PHE . . . -142.46 124.32 15.17 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.079 179.53 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.3 m120 45.13 27.64 0.33 Allowed 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 178.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 99.78 -8.84 59.97 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 120.808 -0.711 . . . . 0.0 114.128 179.759 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -97.81 122.64 41.15 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 117.797 0.798 . . . . 0.0 110.886 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.9 t -69.02 126.25 29.23 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.432 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.526 ' CE1' ' HB3' ' A' ' 69' ' ' ALA . 3.1 m-85 -97.58 17.9 16.69 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -179.027 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 30.5 mm -92.5 119.61 40.35 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-O 120.82 0.343 . . . . 0.0 110.946 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 61.11 76.86 0.35 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.262 0.553 . . . . 0.0 111.143 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 17.4 pt -145.97 150.3 15.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.546 179.575 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -62.27 142.43 57.73 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.165 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.487 ' O ' HG23 ' A' ' 83' ' ' VAL . 12.3 t60 -47.97 -50.81 26.05 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.597 -179.151 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -60.17 -27.58 65.33 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.694 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -69.87 -43.57 71.57 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 120.948 0.404 . . . . 0.0 110.878 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.68 -39.88 76.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.491 -179.477 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 79' ' ' HIS . 26.7 t -71.88 -45.24 65.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.125 -179.669 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.507 ' O ' HG22 ' A' ' 88' ' ' THR . 36.1 t -62.61 -36.79 83.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.548 -179.436 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.438 HD23 ' HA ' ' A' ' 85' ' ' LEU . 18.3 mt -68.0 -45.69 73.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.833 0.349 . . . . 0.0 111.761 -179.402 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.428 HD21 HD21 ' A' ' 95' ' ' LEU . 18.3 mt -68.17 -32.89 73.46 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -178.838 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 3.0 mtmp? -79.6 -37.98 34.99 Favored 'General case' 0 N--CA 1.457 -0.087 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -178.731 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.507 HG22 ' O ' ' A' ' 84' ' ' SER . 9.0 t -70.77 -23.28 62.37 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -178.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -51.06 176.4 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 121.335 0.588 . . . . 0.0 112.398 -178.702 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 87.0 mm-40 -82.08 -144.0 0.06 Allowed 'General case' 0 CA--C 1.551 0.998 0 CA-C-N 115.476 -0.783 . . . . 0.0 111.119 -179.064 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -79.87 -63.48 1.4 Allowed 'General case' 0 C--N 1.347 0.493 0 CA-C-N 118.94 0.791 . . . . 0.0 110.964 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.469 HG23 ' HG3' ' A' ' 18' ' ' GLU . 0.5 OUTLIER -87.19 138.38 31.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.198 179.797 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 18.2 t -127.08 121.65 58.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.047 -179.586 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -93.52 101.46 13.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.337 179.541 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.428 HD21 HD21 ' A' ' 86' ' ' LEU . 5.6 mp -104.07 155.69 18.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.043 0.449 . . . . 0.0 111.797 -179.307 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.815 HD12 ' HB3' ' A' ' 68' ' ' GLN . 41.4 mt -116.01 130.76 70.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.641 178.87 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.568 HD13 HD23 ' A' ' 60' ' ' LEU . 39.3 pt -126.95 160.66 35.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-O 120.992 0.425 . . . . 0.0 111.635 -179.137 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 71.9 t -143.17 149.42 18.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.136 -179.172 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.429 ' O ' HG23 ' A' ' 101' ' ' VAL . 0.7 OUTLIER -112.84 117.51 32.35 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.928 179.092 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 48.2 mm-40 -62.02 127.6 32.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.832 0.349 . . . . 0.0 111.723 -179.23 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 99' ' ' ARG . 14.6 t -140.78 100.79 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.658 179.332 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 11.6 t -155.25 180.0 8.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.903 0.382 . . . . 0.0 111.161 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 79.7 p . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.25 -0.881 . . . . 0.0 110.846 179.951 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 301' ' ' THR . . . . . . . . . . . . . 41.6 p . . . . . 0 N--CA 1.487 1.413 0 CA-C-O 120.79 0.329 . . . . 0.0 111.135 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 302' ' ' GLY . . . . . . . . . . . . . . . 95.24 163.21 34.56 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.571 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 303' ' ' TRP . . . . . . . . . . . . . 18.5 p-90 -104.34 -28.99 11.04 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.616 0.246 . . . . 0.0 111.281 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -70.83 175.44 5.04 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.74 0.305 . . . . 0.0 110.696 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 305' ' ' THR . . . . . . . . . . . . . 5.3 m -141.22 119.34 12.02 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.353 -0.385 . . . . 17.879999999999999 110.607 179.73 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 306' ' ' TRP . . . . . 0.419 ' CH2' ' HG2' ' A' ' 51' ' ' GLN . 83.6 m95 -84.29 117.32 23.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.046 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 307' ' ' VAL . . . . . 0.454 HG12 HG13 ' A' ' 83' ' ' VAL . 16.2 m . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.261 -0.876 . . . . 16.109999999999999 111.159 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.146 0 N-CA-C 112.565 -0.214 . . . . 0.0 112.565 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.1 t -91.97 116.66 29.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.884 0.374 . . . . 0.0 110.991 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -84.34 141.94 30.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.375 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.53 97.37 5.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.629 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 154.18 -33.63 0.72 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.309 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -123.3 86.68 2.62 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.873 0.368 . . . . 0.0 110.587 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -91.0 157.66 17.15 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.968 -179.603 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -170.83 -41.71 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.572 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.559 ' HA ' HG11 ' A' ' 101' ' ' VAL . . . -64.17 -160.05 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.632 -179.413 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.404 ' HG3' HG22 ' A' ' 101' ' ' VAL . 0.2 OUTLIER -51.46 102.86 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -179.178 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.556 ' O ' HD13 ' A' ' 13' ' ' ILE . 4.6 mt-30 -89.73 107.56 19.17 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -179.61 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -89.34 95.19 10.18 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.277 179.259 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.556 HD13 ' O ' ' A' ' 11' ' ' GLN . 0.1 OUTLIER -113.97 164.16 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -179.191 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 82.3 mtt-85 -100.56 168.49 9.68 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.655 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.799 HG13 ' CB ' ' A' ' 59' ' ' LEU . 40.3 t -150.35 139.23 15.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.015 179.518 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 39.7 mtt85 -113.93 108.09 16.58 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.845 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.5 t -111.29 123.66 67.36 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.16 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.677 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -86.18 161.16 18.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.179 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.3 73.28 0.81 Allowed 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.545 179.736 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -138.68 85.13 17.41 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.168 -179.727 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -86.03 -19.93 18.54 Favored 'Cis proline' 0 C--N 1.364 1.372 0 CA-C-N 119.507 0.86 . . . . 0.0 113.129 0.428 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -136.46 -177.64 4.81 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 120.746 0.307 . . . . 0.0 111.276 -179.407 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.415 ' HB3' ' CE1' ' A' ' 25' ' ' PHE . 3.2 mp -65.3 -55.81 16.21 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.263 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 109.48 16.13 11.44 Favored Glycine 0 C--N 1.336 0.528 0 C-N-CA 120.794 -0.717 . . . . 0.0 114.215 178.708 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.494 ' O ' HG22 ' B' ' 307' ' ' VAL . 51.0 p90 -145.79 157.02 43.95 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 117.759 0.78 . . . . 0.0 111.463 179.671 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.4 p -108.52 150.59 27.24 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.171 -179.618 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.55 HD11 HG22 ' A' ' 83' ' ' VAL . 17.7 pt -122.88 151.67 27.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.502 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 98.2 p -149.98 164.07 36.43 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.207 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 112.48 -96.08 0.82 Allowed Glycine 0 C--N 1.337 0.601 0 C-N-CA 120.898 -0.668 . . . . 0.0 113.876 178.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.498 ' H ' HD13 ' A' ' 45' ' ' ILE . . . 74.52 -132.82 14.93 Favored Glycine 0 CA--C 1.519 0.309 0 C-N-CA 121.119 -0.562 . . . . 0.0 112.401 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 24.1 t -149.75 87.16 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.342 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 92.89 5.16 64.56 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 120.983 -0.627 . . . . 0.0 113.693 -178.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -77.47 -134.62 0.71 Allowed Glycine 0 C--N 1.343 0.963 0 CA-C-N 117.741 0.77 . . . . 0.0 112.723 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 1.4 mtt180 -71.17 -19.67 62.38 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.597 0.592 . . . . 0.0 112.597 -179.29 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.92 -156.02 17.0 Favored Glycine 0 C--N 1.342 0.907 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.952 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -173.89 132.86 0.57 Allowed Pre-proline 0 CA--C 1.534 0.358 0 N-CA-C 110.539 -0.171 . . . . 0.0 110.539 179.657 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -90.16 25.6 0.55 Allowed 'Trans proline' 0 C--N 1.358 1.048 0 C-N-CA 122.174 1.916 . . . . 0.0 113.89 -179.155 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -110.25 -56.06 2.38 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.734 0.302 . . . . 0.0 110.921 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -114.16 135.78 22.18 Favored Pre-proline 0 CA--C 1.535 0.389 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.689 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -86.96 -47.58 0.04 OUTLIER 'Trans proline' 0 C--N 1.36 1.14 0 C-N-CA 121.994 1.796 . . . . 0.0 113.623 -179.289 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -95.83 -11.4 26.88 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -179.331 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -94.48 115.91 28.16 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 117.904 0.32 . . . . 0.0 110.27 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.4 p30 -102.3 64.52 0.92 Allowed 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 121.174 0.511 . . . . 0.0 111.408 -179.266 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -116.15 -162.49 13.13 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.316 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.498 HD13 ' H ' ' A' ' 30' ' ' GLY . 15.8 mm -107.53 131.64 57.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 110.348 -0.242 . . . . 0.0 110.348 179.537 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -129.55 149.87 51.13 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.77 0.319 . . . . 0.0 111.107 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.571 HG23 HD11 ' A' ' 66' ' ' ILE . 21.8 t -97.13 73.58 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.331 -179.126 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.6 t -35.34 -53.54 0.64 Allowed 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 114.527 1.306 . . . . 0.0 114.527 -178.691 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 1.8 ptt-85 -158.53 163.84 36.69 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.059 0.457 . . . . 0.0 112.112 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 5.3 t -121.26 154.85 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.56 -179.489 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 3.6 mm-40 -104.73 -68.3 0.04 OUTLIER Pre-proline 0 CA--C 1.538 0.513 0 N-CA-C 111.575 0.213 . . . . 0.0 111.575 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -80.37 120.13 3.96 Favored 'Trans proline' 0 C--N 1.358 1.07 0 C-N-CA 121.836 1.691 . . . . 0.0 112.481 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -77.06 69.2 3.32 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 120.992 0.425 . . . . 0.0 111.337 -179.476 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -165.04 -64.33 0.02 OUTLIER Glycine 0 CA--C 1.529 0.937 0 C-N-CA 120.696 -0.764 . . . . 0.0 113.719 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.57 -72.52 0.03 OUTLIER 'Trans proline' 0 C--N 1.357 1.002 0 C-N-CA 122.072 1.848 . . . . 0.0 113.72 -178.789 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.784 ' HB1' HD12 ' A' ' 60' ' ' LEU . . . -102.68 -10.92 18.8 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 -178.092 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.9 t -75.31 -25.93 58.27 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -178.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.9 tppt? -76.81 -20.94 55.81 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.799 ' CB ' HG13 ' A' ' 15' ' ' VAL . 43.5 mt -123.48 6.43 8.96 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -178.137 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.784 HD12 ' HB1' ' A' ' 56' ' ' ALA . 91.2 mt -136.03 148.9 48.58 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 118.344 0.52 . . . . 0.0 111.729 179.649 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -104.98 141.49 22.66 Favored Pre-proline 0 CA--C 1.536 0.42 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.437 179.317 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -64.15 71.16 0.2 Allowed 'Trans proline' 0 C--N 1.362 1.254 0 C-N-CA 122.297 1.998 . . . . 0.0 113.647 -179.127 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 139.16 40.42 0.09 OUTLIER Glycine 0 CA--C 1.524 0.617 0 C-N-CA 120.903 -0.665 . . . . 0.0 113.299 179.221 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -96.36 -161.67 0.89 Allowed 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 117.034 0.417 . . . . 0.0 110.661 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.6 tttm -138.77 122.0 16.98 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 120.718 0.294 . . . . 0.0 110.818 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.571 HD11 HG23 ' A' ' 47' ' ' VAL . 4.3 mp -89.45 120.97 39.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.534 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 20.1 mm -92.39 -40.39 12.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -178.403 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 -150.38 150.86 31.96 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.12 0.486 . . . . 0.0 111.981 -178.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.422 ' HB3' ' CE1' ' A' ' 74' ' ' PHE . . . -138.23 123.02 18.79 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.684 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 17.0 m120 40.85 33.63 0.22 Allowed 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 178.468 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 99.2 -20.87 48.29 Favored Glycine 0 CA--C 1.522 0.509 0 C-N-CA 120.724 -0.75 . . . . 0.0 113.409 179.576 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -88.46 119.52 28.97 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 117.151 0.475 . . . . 0.0 110.281 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 33.3 t -66.25 122.12 16.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.005 -179.642 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.422 ' CE1' ' HB3' ' A' ' 69' ' ' ALA . 2.9 m-85 -98.07 7.64 45.99 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -178.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.403 ' O ' HG23 ' A' ' 75' ' ' ILE . 6.5 tp -84.55 120.28 34.94 Favored 'Isoleucine or valine' 0 C--N 1.341 0.201 0 CA-C-N 118.392 0.542 . . . . 0.0 110.678 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 62.13 75.93 0.39 Allowed 'General case' 0 C--O 1.232 0.184 0 CA-C-O 121.259 0.552 . . . . 0.0 111.023 -179.439 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 16.0 pt -144.87 152.86 14.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.514 179.479 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -64.61 150.9 46.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.039 0.447 . . . . 0.0 110.992 -179.607 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.408 ' O ' HG23 ' A' ' 83' ' ' VAL . 11.0 t60 -54.73 -55.11 33.37 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.953 -179.301 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -55.55 -25.3 42.09 Favored Glycine 0 CA--C 1.523 0.544 0 C-N-CA 121.058 -0.592 . . . . 0.0 113.309 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.21 -39.85 53.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.056 0.455 . . . . 0.0 110.592 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.66 -35.88 67.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.207 -179.387 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.55 HG22 HD11 ' A' ' 27' ' ' ILE . 22.6 t -76.08 -45.85 35.35 Favored 'Isoleucine or valine' 0 C--O 1.231 0.082 0 CA-C-O 120.83 0.348 . . . . 0.0 111.022 -179.557 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.585 ' O ' HG22 ' A' ' 88' ' ' THR . 45.1 m -61.63 -35.33 77.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.078 -179.712 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.439 HD23 ' HA ' ' A' ' 85' ' ' LEU . 15.3 mt -70.64 -44.02 68.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.171 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.425 ' HA ' ' CD2' ' A' ' 89' ' ' PHE . 13.7 mt -68.45 -31.03 70.05 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -179.067 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 23.7 mtmt -83.79 -36.35 23.62 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 -179.3 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.585 HG22 ' O ' ' A' ' 84' ' ' SER . 9.0 t -72.26 -24.06 61.3 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -178.872 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.425 ' CD2' ' HA ' ' A' ' 86' ' ' LEU . 8.3 m-85 -49.74 177.02 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -178.81 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 50.9 mm-40 -82.17 -144.83 0.06 Allowed 'General case' 0 CA--C 1.549 0.911 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.689 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -78.24 -65.05 1.03 Allowed 'General case' 0 C--N 1.347 0.468 0 CA-C-N 118.977 0.808 . . . . 0.0 111.021 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -83.58 140.35 32.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.356 179.631 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 19.0 t -124.84 120.68 59.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.275 -179.606 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -89.49 107.31 19.0 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.134 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 15.2 mt -107.95 145.29 34.04 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.99 0.424 . . . . 0.0 111.766 -178.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 15.9 mm -108.01 125.91 64.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.174 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.43 HD13 HD23 ' A' ' 60' ' ' LEU . 41.6 pt -131.2 167.99 24.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -178.468 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 18.3 t -149.72 153.94 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.167 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -115.77 116.01 27.3 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.315 179.307 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -67.57 127.52 33.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.371 -179.505 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.559 HG11 ' HA ' ' A' ' 9' ' ' ALA . 13.3 m -108.82 175.56 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.795 179.731 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 21.2 m -79.54 144.46 33.9 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.99 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 77.7 p . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.289 -0.863 . . . . 0.0 110.865 179.962 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 301' ' ' THR . . . . . . . . . . . . . 1.7 m . . . . . 0 N--CA 1.487 1.407 0 CA-C-O 121.191 0.52 . . . . 0.0 111.028 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 302' ' ' GLY . . . . . . . . . . . . . . . -84.03 177.77 52.04 Favored Glycine 0 C--N 1.333 0.364 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.488 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 303' ' ' TRP . . . . . 0.407 ' CZ3' ' HB3' ' B' ' 304' ' ' GLU . 34.7 p-90 -76.33 -28.52 56.91 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.519 0.2 . . . . 0.0 111.377 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 304' ' ' GLU . . . . . 0.407 ' HB3' ' CZ3' ' B' ' 303' ' ' TRP . 7.4 pt-20 -86.69 153.53 21.67 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.737 0.303 . . . . 0.0 110.796 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 305' ' ' THR . . . . . . . . . . . . . 16.9 m -139.76 120.88 14.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.303 -0.408 . . . . 17.879999999999999 110.953 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 306' ' ' TRP . . . . . . . . . . . . . 92.2 m95 -80.64 111.03 16.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.863 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 307' ' ' VAL . . . . . 0.494 HG22 ' O ' ' A' ' 25' ' ' PHE . 15.5 m . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.253 -0.879 . . . . 16.109999999999999 111.122 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.253 0 N-CA-C 112.473 -0.251 . . . . 0.0 112.473 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.8 m -90.85 138.48 31.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.776 0.322 . . . . 0.0 110.845 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 22.9 m-70 -83.12 156.49 23.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.882 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -103.9 -31.84 9.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.922 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 114.6 48.86 0.53 Allowed Glycine 0 C--N 1.332 0.325 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.622 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -100.22 117.98 35.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.764 0.316 . . . . 0.0 110.646 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -70.12 -178.97 1.77 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.004 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.6 mp -64.43 135.55 56.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.937 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -110.82 46.06 1.1 Allowed 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.103 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.3 mmmm -64.74 127.79 33.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.875 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -88.98 90.27 8.34 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.979 -178.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -84.97 99.09 10.76 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.437 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.4 pt -117.48 159.24 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.214 -178.265 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.715 ' HG2' HD13 ' A' ' 96' ' ' ILE . 0.1 OUTLIER -112.95 157.58 21.31 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.099 -179.361 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.5 m -141.66 139.68 31.43 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.707 179.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -106.03 114.27 28.31 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.605 -179.123 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.0 t -114.13 123.26 69.62 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.997 179.544 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.558 ' HG3' HG22 ' A' ' 92' ' ' THR . 4.8 mp0 -98.95 119.08 37.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.704 179.767 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.469 ' HE2' HD11 ' A' ' 23' ' ' LEU . 16.1 mttt -70.02 118.38 12.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.048 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -171.98 85.57 0.45 Allowed Pre-proline 0 CA--C 1.536 0.435 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.655 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -84.0 -17.76 26.09 Favored 'Cis proline' 0 C--N 1.363 1.338 0 CA-C-N 119.383 0.815 . . . . 0.0 113.42 0.624 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 51.7 mm-40 -136.79 -177.04 4.56 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 120.913 0.387 . . . . 0.0 111.689 -179.444 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.469 HD11 ' HE2' ' A' ' 19' ' ' LYS . 4.5 mp -65.67 -56.1 13.93 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.244 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 102.54 39.46 2.77 Favored Glycine 0 CA--C 1.522 0.488 0 C-N-CA 120.754 -0.736 . . . . 0.0 113.926 178.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.426 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 43.3 p90 -169.85 156.91 6.5 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 117.155 0.477 . . . . 0.0 111.202 179.173 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 9.3 p -113.55 154.64 26.78 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.506 -179.414 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.464 HD11 HG22 ' A' ' 83' ' ' VAL . 46.6 pt -121.38 153.35 25.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.799 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 77.6 p -141.21 155.24 46.07 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.865 179.573 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 114.05 -158.26 14.43 Favored Glycine 0 C--N 1.335 0.508 0 C-N-CA 120.934 -0.651 . . . . 0.0 113.369 179.502 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 137.27 -135.51 7.68 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 121.26 -0.495 . . . . 0.0 112.234 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 39.5 t -141.88 75.38 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.225 0.536 . . . . 0.0 109.877 179.345 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 93.59 13.56 55.11 Favored Glycine 0 CA--C 1.529 0.943 0 CA-C-N 115.66 -0.7 . . . . 0.0 113.154 -178.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -86.74 -146.42 10.05 Favored Glycine 0 C--N 1.342 0.908 0 CA-C-N 117.598 0.699 . . . . 0.0 112.695 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 69.6 mtt180 -56.46 -24.56 46.49 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -179.238 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.24 175.46 48.76 Favored Glycine 0 C--N 1.336 0.536 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.629 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -139.53 146.55 48.52 Favored Pre-proline 0 CA--C 1.534 0.337 0 N-CA-C 110.473 -0.195 . . . . 0.0 110.473 179.723 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -92.33 30.32 0.31 Allowed 'Trans proline' 0 C--N 1.358 1.039 0 C-N-CA 122.309 2.006 . . . . 0.0 113.43 -179.315 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -107.48 -56.48 2.21 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.778 0.323 . . . . 0.0 110.647 179.574 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -112.46 139.12 22.27 Favored Pre-proline 0 CA--C 1.534 0.33 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.376 179.41 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -87.58 -50.3 0.03 OUTLIER 'Trans proline' 0 C--N 1.358 1.044 0 C-N-CA 121.964 1.776 . . . . 0.0 113.642 -178.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -95.43 -7.82 37.22 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -179.196 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -90.9 113.75 26.03 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 118.106 0.412 . . . . 0.0 110.766 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 14.1 p30 -98.88 54.82 1.01 Allowed 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 121.1 0.476 . . . . 0.0 111.15 -179.547 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -112.45 -163.75 16.49 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 121.056 -0.592 . . . . 0.0 112.577 179.695 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 13.1 mm -108.74 133.79 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 116.553 0.177 . . . . 0.0 110.591 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.432 ' CD1' ' N ' ' A' ' 46' ' ' PHE . 3.7 m-85 -131.2 151.59 51.32 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 120.542 0.21 . . . . 0.0 110.714 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.582 HG23 ' OD1' ' A' ' 64' ' ' ASP . 29.2 t -91.0 79.79 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-O 121.103 0.478 . . . . 0.0 110.686 179.763 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.408 HG23 ' N ' ' A' ' 49' ' ' ARG . 5.1 t -36.41 -53.78 0.85 Allowed 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 114.824 1.416 . . . . 0.0 114.824 -178.533 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.408 ' N ' HG23 ' A' ' 48' ' ' THR . 0.0 OUTLIER -160.48 179.47 8.59 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.236 0.541 . . . . 0.0 112.372 -178.988 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 20.3 t -137.37 148.62 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.48 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 7.2 mm-40 -105.06 -68.85 0.03 OUTLIER Pre-proline 0 CA--C 1.538 0.488 0 CA-C-O 119.629 -0.224 . . . . 0.0 111.389 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -78.12 118.04 4.28 Favored 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 121.676 1.584 . . . . 0.0 112.045 179.508 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.3 pm0 -75.63 66.95 2.04 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.114 0.483 . . . . 0.0 111.257 -179.434 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -156.03 -69.83 0.01 OUTLIER Glycine 0 CA--C 1.528 0.868 0 C-N-CA 120.791 -0.719 . . . . 0.0 113.335 -179.474 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -60.07 -75.81 0.02 OUTLIER 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 121.968 1.779 . . . . 0.0 113.365 -179.019 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.544 ' HB1' HD12 ' A' ' 60' ' ' LEU . . . -104.05 46.06 0.93 Allowed 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 121.073 0.464 . . . . 0.0 111.77 -179.103 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.9 t -114.4 -65.04 1.23 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.006 179.233 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.1 tppm? -62.46 -21.22 65.27 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.488 178.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 40.2 mt -97.73 -54.9 2.97 Favored 'General case' 0 C--N 1.339 0.128 0 CA-C-O 120.59 0.233 . . . . 0.0 111.558 -179.231 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.551 HD23 HD13 ' A' ' 97' ' ' ILE . 32.6 mt -93.96 146.94 23.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.807 0.337 . . . . 0.0 111.563 -179.478 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -118.84 143.06 32.91 Favored Pre-proline 0 CA--C 1.537 0.472 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.333 179.408 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -62.19 131.69 35.6 Favored 'Trans proline' 0 C--N 1.359 1.092 0 C-N-CA 122.128 1.886 . . . . 0.0 113.761 -179.011 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 93.88 18.7 36.5 Favored Glycine 0 C--N 1.335 0.482 0 CA-C-N 115.934 -0.575 . . . . 0.0 113.89 178.558 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.582 ' OD1' HG23 ' A' ' 47' ' ' VAL . 2.8 p30 -85.16 -171.71 3.78 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 117.33 0.565 . . . . 0.0 111.227 -179.44 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 43.5 tttm -135.11 122.03 21.16 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.773 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.456 ' CG2' HD12 ' A' ' 95' ' ' LEU . 20.6 mt -90.12 117.3 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.017 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 20.2 mm -96.01 -36.77 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -179.179 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.02 150.55 30.09 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.136 0.493 . . . . 0.0 112.07 -178.873 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.619 ' HB3' ' CE1' ' A' ' 74' ' ' PHE . . . -137.25 119.94 16.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.822 179.315 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.414 ' HB2' ' CZ ' ' A' ' 89' ' ' PHE . 62.8 m-20 42.56 28.87 0.13 Allowed 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 179.26 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 99.31 5.69 55.78 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 120.888 -0.672 . . . . 0.0 113.98 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -109.32 121.28 44.82 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 117.911 0.856 . . . . 0.0 110.084 179.437 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.3 t -68.03 121.0 15.18 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.798 0.332 . . . . 0.0 111.235 -179.121 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.619 ' CE1' ' HB3' ' A' ' 69' ' ' ALA . 3.9 m-30 -99.63 15.15 27.62 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 116.173 -0.467 . . . . 0.0 112.069 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 7.7 tp -92.2 123.41 44.3 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-O 120.785 0.326 . . . . 0.0 110.86 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 61.29 73.78 0.47 Allowed 'General case' 0 C--O 1.232 0.167 0 CA-C-O 121.258 0.551 . . . . 0.0 110.773 -179.475 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 11.7 pt -149.21 160.93 5.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.646 179.703 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -73.29 139.47 46.12 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.225 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.418 ' O ' HG23 ' A' ' 83' ' ' VAL . 3.8 t-160 -48.25 -49.74 32.25 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -179.513 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -56.63 -28.26 56.16 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 121.13 -0.557 . . . . 0.0 112.944 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -73.96 -40.91 62.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.888 0.375 . . . . 0.0 110.372 179.652 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.98 -36.41 83.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.032 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.528 HG13 HG12 ' B' ' 307' ' ' VAL . 22.1 t -75.04 -41.4 45.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.821 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 54.3 p -60.45 -45.66 92.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.291 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 54.8 mt -65.84 -44.66 84.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.611 -179.558 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.42 ' HA ' ' CD2' ' A' ' 89' ' ' PHE . 12.6 mt -66.74 -36.54 82.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.23 -0.441 . . . . 0.0 112.105 -178.841 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 54.9 mttm -75.31 -38.56 60.21 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 -178.65 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 11.5 t -70.94 -24.85 62.52 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -178.383 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.42 ' CD2' ' HA ' ' A' ' 86' ' ' LEU . 8.5 m-85 -47.82 173.55 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -178.855 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 6.9 mm-40 -81.38 -145.58 0.06 Allowed 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.517 -179.513 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -79.36 -66.78 0.83 Allowed 'General case' 0 C--N 1.345 0.401 0 CA-C-N 118.911 0.778 . . . . 0.0 110.721 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.558 HG22 ' HG3' ' A' ' 18' ' ' GLU . 0.6 OUTLIER -76.91 126.37 30.86 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.645 179.629 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.693 HG12 ' CD2' ' A' ' 95' ' ' LEU . 21.2 t -119.27 123.23 70.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.97 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -100.68 106.46 17.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.578 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.693 ' CD2' HG12 ' A' ' 93' ' ' VAL . 4.3 mm? -100.36 149.92 23.13 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.47 -179.591 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.715 HD13 ' HG2' ' A' ' 14' ' ' ARG . 17.5 mm -108.54 124.87 65.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.38 178.377 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.551 HD13 HD23 ' A' ' 60' ' ' LEU . 43.4 pt -129.23 165.17 29.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.735 0.302 . . . . 0.0 111.255 -179.161 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.41 HG12 ' N ' ' A' ' 99' ' ' ARG . 14.6 t -150.38 154.57 8.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.009 0.433 . . . . 0.0 111.689 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.41 ' N ' HG12 ' A' ' 98' ' ' VAL . 0.1 OUTLIER -108.49 112.76 25.31 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 177.694 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -55.41 135.89 49.94 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.638 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 101' ' ' VAL . 16.4 m -146.74 114.83 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.016 179.295 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.9 m -100.2 85.06 2.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.867 0.365 . . . . 0.0 110.852 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 57.3 p . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.211 -0.9 . . . . 0.0 110.906 179.981 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 301' ' ' THR . . . . . . . . . . . . . 12.6 m . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 120.886 0.374 . . . . 0.0 111.269 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 302' ' ' GLY . . . . . . . . . . . . . . . 69.02 46.69 58.13 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.847 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 303' ' ' TRP . . . . . . . . . . . . . 27.1 p-90 -90.7 -27.91 18.67 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 121.211 -0.196 . . . . 0.0 111.071 179.576 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 4.9 pm0 -77.53 158.82 29.7 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.674 0.273 . . . . 0.0 110.492 179.521 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 305' ' ' THR . . . . . . . . . . . . . 5.7 m -132.97 121.79 23.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.39 -0.368 . . . . 17.879999999999999 110.888 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 306' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -85.58 118.55 25.16 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.99 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 307' ' ' VAL . . . . . 0.528 HG12 HG13 ' A' ' 83' ' ' VAL . 18.3 m . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.21 -0.9 . . . . 16.109999999999999 111.139 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.226 0 N-CA-C 112.423 -0.271 . . . . 0.0 112.423 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.3 t -160.44 33.08 0.16 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.871 0.367 . . . . 0.0 110.889 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 60.6 m80 -93.56 145.19 24.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.791 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.9 ptp -94.97 150.27 20.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.009 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 70.99 79.37 0.38 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.818 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -165.56 33.7 0.05 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.937 0.399 . . . . 0.0 110.874 179.7 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.6 mp0 -98.65 61.53 1.35 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.269 0.557 . . . . 0.0 110.405 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.6 mt -148.88 136.07 20.09 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.792 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -92.1 75.72 5.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.655 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 60.5 mmtt -143.83 -178.8 6.1 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.697 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -148.69 100.44 3.1 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.914 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -90.15 118.54 29.76 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.097 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.616 ' N ' HD13 ' A' ' 13' ' ' ILE . 0.2 OUTLIER -139.82 155.29 24.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.958 0.409 . . . . 0.0 111.544 -179.893 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.74 167.13 10.08 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.448 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.63 HG13 ' HB3' ' A' ' 59' ' ' LEU . 22.4 t -146.82 153.5 12.6 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.966 179.437 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.497 ' CD ' HG22 ' A' ' 92' ' ' THR . 0.0 OUTLIER -129.05 118.65 22.88 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.278 179.77 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.3 t -125.43 130.63 72.78 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-O 120.924 0.392 . . . . 0.0 111.453 -179.472 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -100.02 146.11 27.11 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.067 179.221 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.64 76.59 9.51 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.863 0.363 . . . . 0.0 110.492 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -140.8 85.65 12.47 Favored Pre-proline 0 CA--C 1.539 0.528 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.706 -179.448 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -82.15 -30.67 4.76 Favored 'Cis proline' 0 C--N 1.363 1.338 0 CA-C-N 119.409 0.825 . . . . 0.0 113.172 0.31 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -138.19 -178.54 5.32 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.872 0.367 . . . . 0.0 111.361 -179.66 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.411 ' HB3' ' CE2' ' A' ' 25' ' ' PHE . 3.2 mp -62.09 -61.89 2.16 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.83 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 103.79 34.87 3.65 Favored Glycine 0 CA--C 1.52 0.38 0 C-N-CA 120.825 -0.702 . . . . 0.0 113.783 179.013 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.411 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 31.1 p90 -163.57 145.95 9.73 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 117.254 0.527 . . . . 0.0 111.137 179.321 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.8 p -100.63 150.4 22.76 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.056 -179.656 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.66 HD11 HG22 ' A' ' 83' ' ' VAL . 25.4 pt -117.23 147.63 20.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.867 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 12.9 p -138.35 153.92 48.96 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.77 0.319 . . . . 0.0 111.293 -179.523 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 113.47 -158.92 13.97 Favored Glycine 0 C--N 1.332 0.323 0 C-N-CA 120.977 -0.63 . . . . 0.0 113.519 179.119 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 109.47 153.38 14.91 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 121.234 -0.507 . . . . 0.0 112.022 -179.437 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 17.9 t -76.82 98.39 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-O 121.081 0.467 . . . . 0.0 110.522 -179.542 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 96.0 10.25 56.42 Favored Glycine 0 CA--C 1.528 0.866 0 CA-C-N 115.657 -0.701 . . . . 0.0 113.349 -179.215 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.6 -158.28 32.66 Favored Glycine 0 C--N 1.342 0.865 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.712 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -59.61 -27.63 66.48 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -179.067 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 117.57 -167.02 12.66 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.662 -179.686 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -145.44 125.92 7.27 Favored Pre-proline 0 CA--C 1.533 0.291 0 O-C-N 122.928 -0.16 . . . . 0.0 110.871 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -92.31 24.7 0.48 Allowed 'Trans proline' 0 C--N 1.355 0.913 0 C-N-CA 122.122 1.881 . . . . 0.0 112.875 179.745 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -124.49 -49.63 1.78 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 120.793 0.33 . . . . 0.0 110.639 179.704 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -114.83 130.98 23.69 Favored Pre-proline 0 CA--C 1.533 0.301 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.455 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -85.0 -44.85 0.05 OUTLIER 'Trans proline' 0 C--N 1.356 0.927 0 C-N-CA 121.965 1.776 . . . . 0.0 113.22 -179.452 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -89.6 -3.95 58.05 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -179.353 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -109.94 125.26 52.66 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 118.156 0.435 . . . . 0.0 110.576 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -109.98 31.29 5.97 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.647 -179.23 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.422 ' O ' HD13 ' A' ' 45' ' ' ILE . . . -76.49 -146.62 2.04 Favored Glycine 0 CA--C 1.519 0.34 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.98 179.401 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.422 HD13 ' O ' ' A' ' 44' ' ' GLY . 14.7 mm -124.13 135.36 63.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-N 116.934 0.367 . . . . 0.0 110.469 179.269 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.427 ' CD1' ' N ' ' A' ' 46' ' ' PHE . 7.7 m-85 -132.99 151.98 52.01 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.16 -179.586 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.528 HG23 ' OD1' ' A' ' 64' ' ' ASP . 21.8 t -97.34 74.23 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 CA-C-O 121.058 0.456 . . . . 0.0 110.797 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.419 HG23 ' N ' ' A' ' 49' ' ' ARG . 8.0 t -31.44 -53.23 0.23 Allowed 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 -178.71 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.419 ' N ' HG23 ' A' ' 48' ' ' THR . 0.0 OUTLIER -160.9 -178.92 7.14 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.155 0.502 . . . . 0.0 111.987 -179.457 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.0 t -134.73 150.75 30.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.61 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -104.86 -68.23 0.04 OUTLIER Pre-proline 0 CA--C 1.538 0.495 0 N-CA-C 111.728 0.269 . . . . 0.0 111.728 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -79.25 119.39 4.2 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 121.781 1.654 . . . . 0.0 112.275 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -75.15 68.33 1.9 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.931 0.396 . . . . 0.0 110.872 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -161.19 -66.64 0.02 OUTLIER Glycine 0 CA--C 1.529 0.936 0 C-N-CA 120.651 -0.785 . . . . 0.0 113.821 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -58.32 -76.44 0.02 OUTLIER 'Trans proline' 0 C--N 1.356 0.949 0 C-N-CA 122.166 1.911 . . . . 0.0 113.452 -178.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.919 ' HB1' HD12 ' A' ' 60' ' ' LEU . . . -115.32 50.95 0.95 Allowed 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.289 0.566 . . . . 0.0 111.298 -179.399 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.4 t -112.85 -63.37 1.45 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.45 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.82 -13.64 61.78 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.569 179.313 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.63 ' HB3' HG13 ' A' ' 15' ' ' VAL . 34.6 mt -96.61 -54.43 3.24 Favored 'General case' 0 C--N 1.345 0.388 0 O-C-N 122.091 -0.381 . . . . 0.0 111.101 179.562 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.919 HD12 ' HB1' ' A' ' 56' ' ' ALA . 56.5 mt -91.93 146.86 23.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.453 -179.681 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -118.25 137.47 24.65 Favored Pre-proline 0 CA--C 1.537 0.48 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.016 178.759 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.82 131.01 43.57 Favored 'Trans proline' 0 C--N 1.361 1.195 0 C-N-CA 122.341 2.027 . . . . 0.0 113.931 -178.665 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 96.73 16.59 35.88 Favored Glycine 0 CA--C 1.523 0.576 0 CA-C-N 115.637 -0.71 . . . . 0.0 113.816 178.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.528 ' OD1' HG23 ' A' ' 47' ' ' VAL . 2.7 p30 -81.65 -169.1 2.16 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 117.379 0.589 . . . . 0.0 111.298 -179.482 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 45.8 tttp -139.31 124.57 19.05 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.28 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 33.9 mt -89.02 115.16 28.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.615 -179.686 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 23.9 mm -94.19 -38.17 9.01 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 116.097 -0.501 . . . . 0.0 112.126 -178.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.729 ' HB3' HD12 ' A' ' 96' ' ' ILE . 1.2 tt0 -151.08 150.89 31.23 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.178 0.514 . . . . 0.0 112.096 -179.025 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -145.56 124.68 12.87 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.942 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.6 m120 43.95 31.7 0.54 Allowed 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 179.097 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 97.6 -6.0 62.64 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 120.78 -0.724 . . . . 0.0 114.068 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -102.03 123.06 45.27 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 117.83 0.815 . . . . 0.0 110.775 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 7.9 m -71.43 126.8 30.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.927 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -99.75 6.64 45.46 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.413 ' O ' HG23 ' A' ' 75' ' ' ILE . 7.3 tp -83.85 120.06 34.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 118.165 0.438 . . . . 0.0 110.896 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 3.1 m120 63.3 76.17 0.37 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.032 0.444 . . . . 0.0 111.072 -179.353 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 9.3 pt -150.19 164.77 3.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.817 179.608 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.7 mp0 -78.75 148.52 32.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.139 0.495 . . . . 0.0 111.454 -179.67 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 23.9 t60 -53.47 -54.13 41.44 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.282 -179.507 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -55.33 -27.43 47.15 Favored Glycine 0 CA--C 1.52 0.373 0 C-N-CA 121.147 -0.549 . . . . 0.0 113.163 -179.481 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.4 tp60 -73.57 -39.02 64.98 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.028 0.442 . . . . 0.0 110.544 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.11 -55.91 12.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.933 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.66 HG22 HD11 ' A' ' 27' ' ' ILE . 17.2 t -58.29 -44.0 87.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.787 -179.29 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.6 t -60.39 -39.24 86.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.596 -179.408 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.544 ' O ' HG22 ' A' ' 88' ' ' THR . 30.2 mt -67.52 -43.61 80.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.825 -179.439 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.43 ' HA ' ' CD2' ' A' ' 89' ' ' PHE . 22.2 mt -66.66 -42.07 87.18 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -179.022 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 15.1 mttm -64.48 -41.47 96.47 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -178.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.544 HG22 ' O ' ' A' ' 85' ' ' LEU . 9.7 t -64.11 -22.61 67.0 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -178.788 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.43 ' CD2' ' HA ' ' A' ' 86' ' ' LEU . 21.4 m-85 -60.81 131.0 49.29 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.951 0.405 . . . . 0.0 110.495 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -65.77 -105.34 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.959 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -178.388 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -88.4 -83.04 0.22 Allowed 'General case' 0 C--N 1.35 0.618 0 CA-C-N 119.422 1.01 . . . . 0.0 113.321 -178.044 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.497 HG22 ' CD ' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -71.22 162.17 29.87 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 121.128 0.489 . . . . 0.0 111.658 -178.652 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 19.9 t -151.41 112.91 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.612 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.1 mp0 -89.01 122.51 32.43 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 179.576 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 14.1 mt -121.56 143.05 49.51 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -178.46 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.729 HD12 ' HB3' ' A' ' 68' ' ' GLN . 42.4 mt -114.07 129.28 70.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 177.765 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.436 HD13 HD23 ' A' ' 60' ' ' LEU . 43.5 pt -134.71 172.99 15.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -178.156 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 20.2 t -147.25 151.66 13.63 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.731 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -123.2 113.51 19.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.53 179.716 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -66.16 117.9 9.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.336 -179.319 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 22.1 t -108.69 117.96 55.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.487 179.562 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 10.5 t -90.73 120.72 32.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.051 -179.667 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 20.2 m . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.182 -0.913 . . . . 0.0 110.761 179.912 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 301' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.394 0 CA-C-O 120.808 0.337 . . . . 0.0 111.071 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 302' ' ' GLY . . . . . . . . . . . . . . . 106.25 86.62 1.9 Allowed Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.255 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 303' ' ' TRP . . . . . . . . . . . . . 61.1 p-90 -94.11 -30.49 14.62 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.662 0.267 . . . . 0.0 111.33 -179.615 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -90.41 132.32 35.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.81 0.338 . . . . 0.0 111.128 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 305' ' ' THR . . . . . . . . . . . . . 7.4 m -109.38 134.69 51.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.009 -0.541 . . . . 17.879999999999999 110.613 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 306' ' ' TRP . . . . . . . . . . . . . 83.4 m95 -97.43 131.71 43.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.885 0.374 . . . . 0.0 111.058 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 307' ' ' VAL . . . . . . . . . . . . . 24.0 m . . . . . 0 C--O 1.25 1.125 0 CA-C-O 118.271 -0.871 . . . . 16.109999999999999 111.153 -179.876 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.162 0 N-CA-C 112.517 -0.233 . . . . 0.0 112.517 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.3 m -133.31 48.51 2.38 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.395 0.617 . . . . 0.0 110.644 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 13.7 m-70 -92.64 149.5 21.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.987 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 8.8 ptm -165.37 123.26 1.58 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.063 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 106.02 -32.01 7.8 Favored Glycine 0 C--N 1.333 0.369 0 C-N-CA 121.001 -0.618 . . . . 0.0 112.883 179.606 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -69.75 -30.64 68.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.596 0.236 . . . . 0.0 111.229 -179.625 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -115.02 72.29 0.79 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 121.117 0.484 . . . . 0.0 110.732 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 14.0 tp -152.85 141.03 20.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.829 -179.732 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.555 ' HB3' HG21 ' A' ' 101' ' ' VAL . . . -167.29 37.85 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 120.93 0.395 . . . . 0.0 111.63 -179.775 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 16.9 mtpt -75.29 116.22 15.78 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.886 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.65 108.22 20.49 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.915 0.388 . . . . 0.0 111.962 -179.258 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -88.05 107.43 18.74 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.5 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.589 ' H ' HD13 ' A' ' 13' ' ' ILE . 0.2 OUTLIER -114.42 154.8 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.934 179.934 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 1.1 ttt85 -93.09 165.45 12.83 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.628 -179.167 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.463 HG11 HD11 ' A' ' 60' ' ' LEU . 53.9 t -141.1 118.59 8.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.241 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -105.48 109.29 21.21 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 178.782 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.451 HG23 HG12 ' A' ' 15' ' ' VAL . 14.0 t -121.37 131.81 72.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-O 120.883 0.373 . . . . 0.0 111.517 -179.245 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.435 ' CG ' HG23 ' A' ' 92' ' ' THR . 34.4 mt-10 -92.04 164.07 13.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.162 179.16 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.32 74.93 1.05 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 121.337 0.589 . . . . 0.0 110.949 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -141.61 84.71 12.06 Favored Pre-proline 0 CA--C 1.54 0.593 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.419 -179.471 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -83.73 -23.92 11.87 Favored 'Cis proline' 0 C--N 1.364 1.352 0 CA-C-N 119.444 0.837 . . . . 0.0 113.009 0.229 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -139.14 -169.07 2.57 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 120.692 0.282 . . . . 0.0 110.986 -179.483 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.509 HD13 HG23 ' B' ' 307' ' ' VAL . 5.2 mp -67.47 -49.43 63.61 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-O 120.807 0.337 . . . . 0.0 110.228 179.43 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.505 ' O ' HG13 ' A' ' 50' ' ' VAL . . . 106.22 24.32 6.9 Favored Glycine 0 C--N 1.333 0.364 0 C-N-CA 120.972 -0.633 . . . . 0.0 113.371 179.205 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.41 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 45.1 p90 -160.52 153.87 21.99 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 117.14 0.47 . . . . 0.0 111.28 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.8 p -104.03 156.77 17.59 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.977 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.47 HD11 HG22 ' A' ' 83' ' ' VAL . 30.9 pt -122.91 149.39 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.1 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.4 m -151.29 169.74 21.22 Favored 'General case' 0 CA--C 1.53 0.212 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.144 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.66 21.49 26.24 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 121.076 -0.583 . . . . 0.0 114.164 178.202 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -60.47 151.96 38.89 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.343 179.328 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 58.5 t -78.37 106.91 9.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.028 0.442 . . . . 0.0 110.281 -179.508 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 94.24 -5.42 71.38 Favored Glycine 0 CA--C 1.53 0.994 0 CA-C-N 115.752 -0.658 . . . . 0.0 113.635 -178.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -85.89 -139.87 5.36 Favored Glycine 0 C--N 1.345 1.075 0 CA-C-N 117.804 0.802 . . . . 0.0 113.236 -179.541 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 8.6 mmt180 -75.75 -17.91 59.73 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -178.106 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 99.25 -150.12 19.15 Favored Glycine 0 C--N 1.339 0.749 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.477 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -166.57 132.95 1.93 Allowed Pre-proline 0 CA--C 1.535 0.393 0 CA-C-N 116.626 0.213 . . . . 0.0 110.99 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -90.41 25.7 0.53 Allowed 'Trans proline' 0 C--N 1.36 1.135 0 C-N-CA 122.193 1.929 . . . . 0.0 113.689 -179.554 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -110.65 -54.69 2.56 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.755 0.312 . . . . 0.0 110.785 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.426 ' HG3' ' CE2' ' A' ' 46' ' ' PHE . 4.9 mmp_? -108.41 144.76 30.14 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.311 179.558 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -89.17 -51.9 0.02 OUTLIER 'Trans proline' 0 C--N 1.357 1.026 0 C-N-CA 121.899 1.733 . . . . 0.0 113.853 -178.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -99.28 -2.47 36.44 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 -178.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -95.07 117.92 31.0 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 118.264 0.484 . . . . 0.0 110.601 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -101.08 37.01 1.84 Allowed 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.958 -179.051 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.4 -168.03 38.52 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.466 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.2 mm -102.83 129.21 54.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 178.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.426 ' CE2' ' HG3' ' A' ' 39' ' ' ARG . 1.2 m-85 -129.99 149.49 51.69 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.839 0.352 . . . . 0.0 110.925 -179.154 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.553 HG23 ' OD1' ' A' ' 64' ' ' ASP . 38.8 t -89.77 79.07 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.306 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.417 HG23 ' N ' ' A' ' 49' ' ' ARG . 9.9 t -37.82 -53.31 1.3 Allowed 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 -178.564 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.417 ' N ' HG23 ' A' ' 48' ' ' THR . 3.5 ptt-85 -160.3 165.49 31.22 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 118.229 0.468 . . . . 0.0 112.111 -179.691 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.505 HG13 ' O ' ' A' ' 24' ' ' GLY . 12.1 t -122.98 148.38 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.805 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.4 ' HG3' ' CH2' ' B' ' 306' ' ' TRP . 8.5 mt-30 -100.21 -68.41 0.04 OUTLIER Pre-proline 0 CA--C 1.538 0.487 0 CA-C-O 119.738 -0.172 . . . . 0.0 111.129 179.687 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -80.78 117.22 3.28 Favored 'Trans proline' 0 C--N 1.358 1.07 0 C-N-CA 121.715 1.61 . . . . 0.0 112.581 179.673 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -75.57 70.55 2.41 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 120.954 0.407 . . . . 0.0 110.784 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -162.8 -65.92 0.02 OUTLIER Glycine 0 CA--C 1.529 0.937 0 C-N-CA 120.789 -0.72 . . . . 0.0 113.354 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -58.27 -78.26 0.02 OUTLIER 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 122.118 1.878 . . . . 0.0 112.924 -179.15 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.687 ' HB1' HD12 ' A' ' 60' ' ' LEU . . . -108.19 46.88 0.93 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.47 0.652 . . . . 0.0 110.582 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 91.7 p -101.95 -61.43 1.39 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.193 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -71.77 -7.12 46.24 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.206 179.115 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.461 ' HB3' HG13 ' A' ' 15' ' ' VAL . 66.3 mt -95.57 -59.61 1.84 Allowed 'General case' 0 C--N 1.344 0.332 0 CA-C-N 118.244 0.474 . . . . 0.0 111.541 -179.516 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.687 HD12 ' HB1' ' A' ' 56' ' ' ALA . 2.7 mt -95.63 144.31 26.18 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.654 0.264 . . . . 0.0 111.452 -179.375 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.1 pm0 -112.35 142.73 27.5 Favored Pre-proline 0 CA--C 1.538 0.488 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.382 178.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -50.93 130.32 30.92 Favored 'Trans proline' 0 C--N 1.359 1.105 0 C-N-CA 122.206 1.937 . . . . 0.0 113.667 -179.089 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 82.59 24.73 52.85 Favored Glycine 0 C--N 1.333 0.386 0 CA-C-N 115.853 -0.612 . . . . 0.0 113.637 178.625 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.553 ' OD1' HG23 ' A' ' 47' ' ' VAL . 20.6 p30 -86.98 -171.79 3.68 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 117.025 0.413 . . . . 0.0 110.793 -179.618 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 66.5 tttt -140.33 128.83 22.76 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ILE . . . . . 0.565 ' N ' HD12 ' A' ' 66' ' ' ILE . 4.0 mp -93.59 118.82 40.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.833 179.308 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 23.7 mm -92.67 -33.97 5.74 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.86 -178.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 -146.88 148.85 32.24 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.95 0.405 . . . . 0.0 111.456 -179.471 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -138.5 114.84 10.36 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.509 -179.614 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 49.32 29.11 2.57 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 179.159 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 101.03 -22.65 38.55 Favored Glycine 0 CA--C 1.521 0.458 0 C-N-CA 120.787 -0.721 . . . . 0.0 113.178 179.711 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -89.16 127.95 35.76 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 117.099 0.449 . . . . 0.0 110.696 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.2 m -65.93 130.35 42.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.974 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -104.65 21.58 16.59 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.662 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 6.6 tp -101.68 140.53 20.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 O-C-N 122.249 -0.282 . . . . 0.0 110.99 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 34.7 m-20 65.54 10.72 6.89 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -178.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 17.3 pt -89.12 156.09 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 121.334 0.588 . . . . 0.0 112.584 -178.287 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -80.84 153.6 27.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.615 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 9.3 t60 -49.8 -55.26 14.78 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 -179.262 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -54.83 -28.0 45.83 Favored Glycine 0 C--N 1.335 0.522 0 C-N-CA 121.039 -0.6 . . . . 0.0 113.351 -179.141 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -72.78 -41.86 64.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.943 0.401 . . . . 0.0 110.484 179.591 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.78 -57.4 8.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.742 -179.319 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.47 HG22 HD11 ' A' ' 27' ' ' ILE . 15.4 t -56.7 -43.95 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-O 120.871 0.367 . . . . 0.0 111.595 -179.377 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 38.0 m -60.79 -43.18 98.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.438 -179.193 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.453 HD23 ' HA ' ' A' ' 85' ' ' LEU . 12.8 mt -65.51 -47.39 76.13 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.577 -179.415 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.425 ' HA ' ' CD2' ' A' ' 89' ' ' PHE . 26.5 mt -64.37 -41.77 96.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.661 -179.033 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 36.8 mmtt -64.23 -41.71 96.88 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -178.548 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 11.3 t -72.02 -25.04 61.66 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -177.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.425 ' CD2' ' HA ' ' A' ' 86' ' ' LEU . 14.8 m-85 -53.81 156.6 2.71 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.53 0.681 . . . . 0.0 112.741 -178.476 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -61.72 -145.55 0.0 OUTLIER 'General case' 0 CA--C 1.556 1.179 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.672 -178.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -81.25 -59.52 2.61 Favored 'General case' 0 C--N 1.35 0.62 0 CA-C-N 118.859 0.754 . . . . 0.0 111.829 -178.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.435 HG23 ' CG ' ' A' ' 18' ' ' GLU . 0.2 OUTLIER -87.15 135.19 33.39 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 -179.644 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 12.0 t -127.6 124.82 64.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.865 0.364 . . . . 0.0 111.484 -179.011 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -101.03 114.87 29.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.25 179.224 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.445 ' N ' HD12 ' A' ' 95' ' ' LEU . 5.7 mp -113.58 160.84 18.11 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.082 0.468 . . . . 0.0 111.929 -179.083 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 22.9 mm -118.67 129.73 74.51 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.263 179.3 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.497 HG21 ' CD2' ' A' ' 60' ' ' LEU . 7.1 pt -134.14 166.79 27.8 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-O 120.577 0.227 . . . . 0.0 111.592 -179.509 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.408 HG12 ' N ' ' A' ' 99' ' ' ARG . 21.3 t -144.88 155.27 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-O 121.203 0.525 . . . . 0.0 111.873 -179.336 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.408 ' N ' HG12 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -112.26 110.15 20.23 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.361 178.798 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -70.54 143.18 51.69 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.025 0.441 . . . . 0.0 112.164 -178.468 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.555 HG21 ' HB3' ' A' ' 9' ' ' ALA . 17.8 m -150.71 108.09 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.955 179.367 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 22.9 t -156.4 135.6 12.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.871 0.367 . . . . 0.0 111.089 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 19.9 m . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.174 -0.917 . . . . 0.0 110.856 179.874 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 301' ' ' THR . . . . . . . . . . . . . 1.8 p . . . . . 0 N--CA 1.487 1.4 0 CA-C-O 120.746 0.308 . . . . 0.0 111.222 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 302' ' ' GLY . . . . . . . . . . . . . . . 147.98 -76.63 0.25 Allowed Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.646 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 303' ' ' TRP . . . . . . . . . . . . . 11.7 p-90 -115.21 -53.09 2.65 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.719 0.295 . . . . 0.0 111.143 -179.722 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.79 143.49 41.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.853 0.359 . . . . 0.0 111.101 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 305' ' ' THR . . . . . . . . . . . . . 11.5 m -119.05 130.66 55.75 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.017 -0.538 . . . . 17.879999999999999 110.611 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 306' ' ' TRP . . . . . 0.4 ' CH2' ' HG3' ' A' ' 51' ' ' GLN . 82.3 m95 -90.68 105.35 17.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.895 0.378 . . . . 0.0 110.904 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 307' ' ' VAL . . . . . 0.509 HG23 HD13 ' A' ' 23' ' ' LEU . 15.9 m . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.248 -0.882 . . . . 16.109999999999999 111.138 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.201 0 N-CA-C 112.504 -0.238 . . . . 0.0 112.504 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.2 m -96.29 167.1 11.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.757 0.313 . . . . 0.0 110.864 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 22.3 m80 -79.92 130.67 35.48 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.781 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 6.2 mtt -85.91 111.06 19.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.975 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -110.87 -108.56 3.08 Favored Glycine 0 C--N 1.33 0.242 0 C-N-CA 121.066 -0.588 . . . . 0.0 112.437 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 40.8 m80 -149.58 142.5 24.79 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.678 0.275 . . . . 0.0 110.784 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -110.46 36.38 3.1 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.814 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.2 mp -129.34 176.99 7.5 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.656 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.722 ' HB3' HG11 ' A' ' 101' ' ' VAL . . . -107.71 49.74 0.8 Allowed 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 121.218 0.533 . . . . 0.0 111.619 -179.454 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -98.97 106.06 18.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.977 179.316 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.521 ' O ' HG13 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -119.38 179.58 4.15 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.511 -178.747 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.59 110.6 5.21 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.048 179.579 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.547 ' H ' HD13 ' A' ' 13' ' ' ILE . 0.1 OUTLIER -105.87 160.64 5.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.377 -179.071 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.72 151.07 26.69 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.129 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.421 HG13 HD13 ' A' ' 59' ' ' LEU . 21.3 t -137.29 137.11 46.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.837 179.433 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.52 111.46 24.18 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.783 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.8 t -105.47 116.83 50.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.812 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.57 ' CG ' HG23 ' A' ' 92' ' ' THR . 34.6 mt-10 -94.61 116.92 29.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.853 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 24.5 mttt -71.57 127.37 32.35 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.479 0.656 . . . . 0.0 110.934 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -172.18 83.09 0.45 Allowed Pre-proline 0 CA--C 1.539 0.555 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.872 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -85.85 -8.78 48.08 Favored 'Cis proline' 0 C--N 1.366 1.448 0 CA-C-N 119.426 0.831 . . . . 0.0 113.786 0.192 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -137.29 -177.53 4.81 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.789 0.328 . . . . 0.0 111.264 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.415 ' HB3' ' CE2' ' A' ' 25' ' ' PHE . 3.5 mp -63.03 -57.15 11.64 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.105 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 102.29 29.02 6.18 Favored Glycine 0 C--N 1.337 0.631 0 C-N-CA 120.82 -0.705 . . . . 0.0 113.675 178.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.415 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 36.0 p90 -157.26 145.31 19.18 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 117.131 0.465 . . . . 0.0 110.825 179.225 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.5 p -98.85 149.7 22.64 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.608 -179.363 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.73 HD11 HG22 ' A' ' 83' ' ' VAL . 21.0 pt -121.7 147.8 25.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.288 179.116 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 34.1 t -143.68 163.38 33.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.839 0.352 . . . . 0.0 111.078 -179.595 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 103.51 -146.67 16.51 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.61 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.12 156.57 29.02 Favored Glycine 0 N--CA 1.452 -0.233 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.228 -179.718 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 17.3 t -78.64 101.61 4.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.872 0.368 . . . . 0.0 110.773 -179.602 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 92.85 1.55 67.67 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 120.979 -0.629 . . . . 0.0 113.746 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -82.13 -155.38 15.82 Favored Glycine 0 C--N 1.341 0.831 0 CA-C-N 117.965 0.882 . . . . 0.0 113.038 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 73.7 mtt180 -63.64 -27.92 69.56 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.638 0.236 . . . . 0.0 111.638 -179.548 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.54 168.32 38.41 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 120.608 -0.805 . . . . 0.0 112.794 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -137.11 139.13 27.42 Favored Pre-proline 0 CA--C 1.534 0.359 0 O-C-N 123.004 -0.115 . . . . 0.0 110.804 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -92.53 27.3 0.37 Allowed 'Trans proline' 0 C--N 1.358 1.078 0 C-N-CA 122.396 2.064 . . . . 0.0 113.291 -179.437 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -100.77 -54.1 2.9 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.71 0.291 . . . . 0.0 110.956 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -114.17 141.45 26.39 Favored Pre-proline 0 CA--C 1.533 0.295 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.606 179.73 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -87.59 -50.32 0.03 OUTLIER 'Trans proline' 0 C--N 1.358 1.049 0 C-N-CA 121.992 1.794 . . . . 0.0 113.66 -178.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -87.44 -11.47 49.0 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 -179.21 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -101.31 115.99 31.77 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 117.984 0.356 . . . . 0.0 110.793 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 30.9 p-10 -104.42 44.63 1.01 Allowed 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 121.211 0.529 . . . . 0.0 110.712 179.347 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -92.42 -159.45 35.19 Favored Glycine 0 C--N 1.332 0.328 0 CA-C-N 115.826 -0.625 . . . . 0.0 112.71 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.1 mm -107.5 131.94 56.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -131.58 148.66 52.63 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.816 0.341 . . . . 0.0 111.307 -179.32 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 24.0 t -89.78 73.95 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-O 121.158 0.504 . . . . 0.0 111.014 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.6 t -38.4 -52.63 1.55 Allowed 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 114.444 1.276 . . . . 0.0 114.444 -178.489 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -158.02 162.37 38.14 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 121.108 0.48 . . . . 0.0 112.116 -179.546 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 15.7 t -120.93 149.55 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.47 179.727 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 18.8 mm-40 -104.35 -67.77 0.04 OUTLIER Pre-proline 0 CA--C 1.538 0.513 0 N-CA-C 111.941 0.348 . . . . 0.0 111.941 -179.53 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -76.87 124.5 7.48 Favored 'Trans proline' 0 C--N 1.357 1.004 0 C-N-CA 121.666 1.577 . . . . 0.0 112.79 -179.694 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.85 63.4 3.56 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.142 -179.718 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -158.35 -66.97 0.01 OUTLIER Glycine 0 CA--C 1.526 0.774 0 C-N-CA 120.57 -0.824 . . . . 0.0 113.643 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -57.58 -77.07 0.02 OUTLIER 'Trans proline' 0 C--N 1.357 1.011 0 C-N-CA 122.195 1.93 . . . . 0.0 113.63 -178.8 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.883 ' HB1' HD12 ' A' ' 60' ' ' LEU . . . -118.34 51.8 1.06 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 121.267 0.556 . . . . 0.0 111.208 -179.036 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 19.8 t -116.56 -60.17 1.88 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.142 179.003 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 40.2 pttt -69.22 -9.99 55.62 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.977 179.007 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.421 HD13 HG13 ' A' ' 15' ' ' VAL . 69.5 mt -102.5 -52.24 3.15 Favored 'General case' 0 C--N 1.345 0.371 0 CA-C-N 118.237 0.471 . . . . 0.0 110.936 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.883 HD12 ' HB1' ' A' ' 56' ' ' ALA . 53.3 mt -91.02 158.42 16.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.36 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -130.65 143.03 47.65 Favored Pre-proline 0 CA--C 1.535 0.377 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.429 179.472 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -50.44 128.1 22.32 Favored 'Trans proline' 0 C--N 1.361 1.219 0 C-N-CA 122.099 1.866 . . . . 0.0 113.389 -179.51 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.06 2.25 48.58 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 120.979 -0.629 . . . . 0.0 113.911 179.617 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -75.95 140.91 42.32 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 118.024 0.912 . . . . 0.0 111.151 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 60.7 tttp -97.54 129.1 44.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.909 179.679 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 28.3 mt -89.06 114.07 26.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.562 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.574 HG23 HD11 ' A' ' 75' ' ' ILE . 21.1 mm -89.72 -44.06 14.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -178.601 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.493 ' HB2' HD12 ' A' ' 96' ' ' ILE . 9.6 mt-30 -148.23 149.53 32.08 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.348 0.594 . . . . 0.0 112.344 -178.573 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.578 ' HB3' ' CE1' ' A' ' 74' ' ' PHE . . . -136.82 121.4 18.39 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.121 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 48.1 m-20 45.67 28.46 0.54 Allowed 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 178.6 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 101.7 -14.09 57.73 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 120.762 -0.732 . . . . 0.0 113.705 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -88.59 127.99 35.57 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-N 117.685 0.742 . . . . 0.0 110.432 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 79.4 p -76.27 127.04 32.1 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.784 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' PHE . . . . . 0.578 ' CE1' ' HB3' ' A' ' 69' ' ' ALA . 6.3 m-85 -101.97 14.2 32.64 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.574 HD11 HG23 ' A' ' 67' ' ' ILE . 31.4 mm -90.65 125.53 43.46 Favored 'Isoleucine or valine' 0 C--N 1.341 0.226 0 O-C-N 122.011 -0.43 . . . . 0.0 110.97 179.386 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 61.64 71.88 0.53 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-O 121.279 0.561 . . . . 0.0 110.838 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 12.7 pt -149.01 165.84 3.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.792 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -80.97 145.21 31.33 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.95 0.405 . . . . 0.0 110.771 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -52.5 -51.73 58.03 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.05 -179.034 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -56.58 -27.46 54.62 Favored Glycine 0 C--N 1.334 0.424 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.938 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 7.1 tm0? -72.72 -40.2 66.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.957 0.408 . . . . 0.0 110.316 179.44 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.48 -36.13 82.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.314 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.73 HG22 HD11 ' A' ' 27' ' ' ILE . 25.4 t -73.4 -44.13 54.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.978 0.418 . . . . 0.0 110.572 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 23.0 t -56.49 -38.07 71.23 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.135 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 89.6 mt -71.78 -39.54 69.86 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.364 179.15 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.421 ' HA ' ' CD2' ' A' ' 89' ' ' PHE . 75.2 mt -78.14 -3.0 40.25 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 179.32 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 11.5 mmtp -99.23 -40.78 7.78 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-O 121.302 0.572 . . . . 0.0 110.303 178.377 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 8.9 t -73.86 -24.53 59.76 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -178.021 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.421 ' CD2' ' HA ' ' A' ' 86' ' ' LEU . 10.2 m-85 -48.52 171.62 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -178.534 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -86.99 -142.47 0.11 Allowed 'General case' 0 CA--C 1.554 1.113 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.214 -179.097 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -78.13 -68.32 0.65 Allowed 'General case' 0 C--N 1.349 0.561 0 CA-C-N 119.027 0.83 . . . . 0.0 111.017 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.57 HG23 ' CG ' ' A' ' 18' ' ' GLU . 0.2 OUTLIER -81.41 134.24 35.52 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.572 179.954 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 21.3 t -120.84 124.67 72.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.138 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -89.78 115.12 26.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.982 179.376 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.0 mt -118.57 148.24 42.87 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.043 0.449 . . . . 0.0 112.041 -178.799 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.493 HD12 ' HB2' ' A' ' 68' ' ' GLN . 48.6 mt -119.56 132.22 69.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.527 178.451 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.478 HD13 ' CD2' ' A' ' 60' ' ' LEU . 35.1 pt -130.67 169.03 22.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.864 0.364 . . . . 0.0 111.762 -179.207 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.521 HG13 ' O ' ' A' ' 11' ' ' GLN . 58.2 t -133.01 143.02 40.67 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.042 -179.186 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.49 102.23 10.11 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.756 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -81.71 133.53 35.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.848 0.356 . . . . 0.0 111.727 -178.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.722 HG11 ' HB3' ' A' ' 9' ' ' ALA . 9.2 m -95.51 179.77 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.628 179.411 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 16.7 t -61.05 112.58 2.15 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.82 0.343 . . . . 0.0 111.149 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 38.6 t . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.816 179.946 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 301' ' ' THR . . . . . . . . . . . . . 4.3 m . . . . . 0 N--CA 1.487 1.424 0 CA-C-O 120.689 0.281 . . . . 0.0 111.466 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 302' ' ' GLY . . . . . . . . . . . . . . . -83.17 60.65 4.87 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.853 -179.771 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 303' ' ' TRP . . . . . . . . . . . . . 9.5 p-90 -145.98 16.54 1.39 Allowed 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 179.621 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -115.58 134.76 54.75 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.842 0.353 . . . . 0.0 110.904 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 305' ' ' THR . . . . . . . . . . . . . 3.5 m -105.1 123.42 47.79 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.109 -0.496 . . . . 17.879999999999999 110.688 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 306' ' ' TRP . . . . . . . . . . . . . 88.5 m95 -89.02 112.2 23.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.951 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 307' ' ' VAL . . . . . 0.488 HG12 HG13 ' A' ' 83' ' ' VAL . 17.8 m . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.241 -0.885 . . . . 16.109999999999999 111.077 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 . . . . . 0 CA--C 1.53 0.184 0 CA-C-O 120.802 0.334 . . . . 0.0 110.962 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.564 ' H ' HD13 ' A' ' 13' ' ' ILE . 0.2 OUTLIER -112.99 159.52 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-O 121.155 0.502 . . . . 0.0 112.202 -179.657 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 11.5 ttp-105 -114.5 155.23 26.81 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.9 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.536 HG21 HD21 ' A' ' 60' ' ' LEU . 15.9 m -136.65 143.73 34.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.217 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.5 mtm180 -108.44 106.85 17.15 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.609 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.8 t -110.31 110.39 31.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.883 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.711 ' HG3' HG23 ' A' ' 92' ' ' THR . 0.9 OUTLIER -88.79 128.76 35.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.899 -179.975 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.494 ' HD3' HD12 ' A' ' 23' ' ' LEU . 10.4 mtmt -80.53 115.04 19.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.937 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -166.98 89.06 0.76 Allowed Pre-proline 0 CA--C 1.535 0.39 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.634 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -79.72 -24.06 13.07 Favored 'Cis proline' 0 C--N 1.363 1.317 0 CA-C-N 119.36 0.807 . . . . 0.0 112.879 0.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 54.4 mm-40 -135.53 -176.8 4.4 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.8 0.333 . . . . 0.0 111.451 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.494 HD12 ' HD3' ' A' ' 19' ' ' LYS . 3.0 mp -63.47 -59.08 5.13 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.02 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.437 ' O ' HG13 ' A' ' 50' ' ' VAL . . . 106.75 31.18 4.02 Favored Glycine 0 CA--C 1.521 0.415 0 C-N-CA 120.867 -0.682 . . . . 0.0 113.585 179.157 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.418 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 28.3 p90 -162.62 155.44 19.52 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 117.066 0.433 . . . . 0.0 111.235 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.1 p -108.12 152.98 23.8 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.4 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.744 HD11 HG22 ' A' ' 83' ' ' VAL . 41.3 pt -120.27 148.71 23.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.632 179.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.5 t -139.45 167.71 21.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.871 0.367 . . . . 0.0 111.05 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.46 -146.4 18.19 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.972 -0.632 . . . . 0.0 112.382 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 101.54 153.32 25.75 Favored Glycine 0 C--N 1.331 0.255 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.491 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 25.9 t -79.53 97.24 2.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.906 0.384 . . . . 0.0 111.003 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 98.81 -2.72 58.58 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 120.999 -0.62 . . . . 0.0 113.937 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -78.64 -155.75 8.83 Favored Glycine 0 C--N 1.34 0.781 0 CA-C-N 117.842 0.821 . . . . 0.0 113.04 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -62.12 -29.41 70.31 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.505 0.193 . . . . 0.0 111.341 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 107.94 153.74 17.75 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.606 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -112.28 129.85 23.91 Favored Pre-proline 0 N--CA 1.468 0.468 0 CA-C-O 119.886 -0.102 . . . . 0.0 110.764 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -92.85 34.9 0.23 Allowed 'Trans proline' 0 C--N 1.357 0.999 0 C-N-CA 122.357 2.038 . . . . 0.0 113.129 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -116.12 -49.21 2.7 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.761 0.315 . . . . 0.0 110.952 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 32.1 mmt180 -116.36 138.93 24.72 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.806 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -83.63 -44.31 0.07 OUTLIER 'Trans proline' 0 C--N 1.357 1.023 0 C-N-CA 121.972 1.782 . . . . 0.0 112.936 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -92.03 -8.58 45.59 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -108.22 123.21 48.41 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 118.08 0.4 . . . . 0.0 110.885 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.2 p30 -110.04 34.67 3.74 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.072 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -78.73 -158.56 12.5 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.485 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 20.5 mm -108.94 131.04 60.76 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 N-CA-C 110.418 -0.215 . . . . 0.0 110.418 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -130.48 146.39 52.02 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.87 0.367 . . . . 0.0 111.545 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 22.0 t -90.38 73.95 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.672 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.2 t -34.47 -54.31 0.53 Allowed 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 114.767 1.395 . . . . 0.0 114.767 -178.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 11.0 ptm180 -160.3 170.87 20.19 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.201 0.524 . . . . 0.0 112.171 -179.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.437 HG13 ' O ' ' A' ' 24' ' ' GLY . 21.2 t -125.23 147.24 29.93 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.355 179.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 8.3 mm-40 -103.91 -68.09 0.04 OUTLIER Pre-proline 0 CA--C 1.535 0.4 0 CA-C-N 116.833 -0.167 . . . . 0.0 111.277 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -79.83 119.33 3.97 Favored 'Trans proline' 0 C--N 1.356 0.951 0 C-N-CA 121.694 1.596 . . . . 0.0 112.173 179.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -79.59 66.27 5.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.276 0.56 . . . . 0.0 110.793 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -143.86 -73.37 0.03 OUTLIER Glycine 0 CA--C 1.526 0.734 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.58 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -60.2 -70.03 0.04 OUTLIER 'Trans proline' 0 C--N 1.358 1.03 0 C-N-CA 121.832 1.688 . . . . 0.0 112.938 -179.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -99.02 43.4 1.06 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-O 120.99 0.424 . . . . 0.0 111.415 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 92.9 p -87.11 -59.41 2.26 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.304 179.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -91.12 -4.0 56.6 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.791 -0.641 . . . . 0.0 112.244 179.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -91.62 -69.52 0.73 Allowed 'General case' 0 C--N 1.341 0.22 0 CA-C-N 118.231 0.469 . . . . 0.0 111.606 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.536 HD21 HG21 ' A' ' 15' ' ' VAL . 5.7 mt -96.82 146.31 25.04 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.896 0.379 . . . . 0.0 111.921 -179.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -112.61 151.17 43.69 Favored Pre-proline 0 N--CA 1.47 0.574 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.478 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -64.22 129.22 23.56 Favored 'Trans proline' 0 C--N 1.355 0.909 0 C-N-CA 121.872 1.714 . . . . 0.0 112.588 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 92.71 18.99 38.87 Favored Glycine 0 CA--C 1.523 0.541 0 C-N-CA 120.929 -0.653 . . . . 0.0 113.689 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -93.54 151.35 19.76 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 117.306 0.553 . . . . 0.0 110.762 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 60.1 tttm -100.1 130.27 46.23 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.212 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 28.0 mt -89.85 117.08 32.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.411 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 22.1 mm -90.48 -43.96 14.63 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -178.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.619 ' HB3' HD12 ' A' ' 96' ' ' ILE . 3.4 tt0 -145.14 150.79 37.39 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.812 0.339 . . . . 0.0 111.652 -178.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.553 ' HB3' ' CE1' ' A' ' 74' ' ' PHE . . . -138.32 119.78 14.91 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.487 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.401 ' HB2' ' CZ ' ' A' ' 89' ' ' PHE . 2.4 m120 46.47 29.0 0.81 Allowed 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 178.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 101.78 -20.25 46.74 Favored Glycine 0 CA--C 1.521 0.468 0 C-N-CA 120.747 -0.739 . . . . 0.0 113.391 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -88.77 126.51 35.37 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 117.212 0.506 . . . . 0.0 110.535 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.5 t -72.53 141.71 48.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.576 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.553 ' CE1' ' HB3' ' A' ' 69' ' ' ALA . 3.7 m-85 -111.43 20.57 17.11 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -179.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 24.7 mm -97.52 137.66 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-O 120.681 0.277 . . . . 0.0 111.446 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 65.31 10.69 6.7 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 9.5 pt -92.88 163.08 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 N-CA-C 113.375 0.879 . . . . 0.0 113.375 -178.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -83.03 144.7 29.76 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.79 179.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 8.8 t-160 -52.35 -51.4 59.01 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -178.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -53.95 -28.39 40.14 Favored Glycine 0 C--N 1.335 0.509 0 C-N-CA 121.104 -0.569 . . . . 0.0 113.127 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.4 tp-100 -75.77 -37.72 59.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.993 0.425 . . . . 0.0 110.309 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.63 -47.92 68.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.373 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.744 HG22 HD11 ' A' ' 27' ' ' ILE . 20.3 t -62.02 -43.37 97.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.271 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 33.2 t -60.77 -38.32 84.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.424 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.45 ' O ' HG22 ' A' ' 88' ' ' THR . 32.7 mt -67.66 -45.54 74.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.454 -179.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.441 ' HA ' ' CD2' ' A' ' 89' ' ' PHE . 15.6 mt -64.21 -36.25 83.44 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -179.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 34.2 mttm -72.19 -37.98 69.17 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 -178.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.45 HG22 ' O ' ' A' ' 85' ' ' LEU . 9.9 t -70.99 -27.02 63.4 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -178.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.441 ' CD2' ' HA ' ' A' ' 86' ' ' LEU . 13.3 m-85 -49.45 148.01 3.0 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -178.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -65.65 -137.75 0.0 OUTLIER 'General case' 0 CA--C 1.551 0.994 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.292 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -81.36 -69.79 0.58 Allowed 'General case' 0 C--N 1.351 0.646 0 CA-C-N 119.488 1.04 . . . . 0.0 112.403 -178.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.711 HG23 ' HG3' ' A' ' 18' ' ' GLU . 0.2 OUTLIER -74.18 121.36 21.09 Favored 'General case' 0 C--O 1.231 0.08 0 CA-C-O 120.839 0.352 . . . . 0.0 111.068 -179.278 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 19.1 t -112.58 111.89 38.08 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.004 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -93.44 126.08 38.39 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 2.0 mt -130.42 159.93 35.55 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.074 0.464 . . . . 0.0 111.867 -178.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.619 HD12 ' HB3' ' A' ' 68' ' ' GLN . 48.2 mt -119.17 129.18 75.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.984 178.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.514 HD13 HD23 ' A' ' 60' ' ' LEU . 33.0 pt -125.55 165.32 23.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-O 120.97 0.414 . . . . 0.0 111.878 -179.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 44.3 t -144.61 149.34 17.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.555 -179.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.51 116.29 28.6 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.091 179.002 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 . . . . . 0 N--CA 1.462 0.137 0 CA-C-O 120.936 0.398 . . . . 0.0 111.647 -178.953 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.786 0.327 . . . . 0.0 110.865 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 305' ' ' THR . . . . . . . . . . . . . 6.9 m -122.78 120.19 32.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.142 -0.481 . . . . 17.879999999999999 110.627 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 306' ' ' TRP . . . . . . . . . . . . . 94.3 m95 -85.03 114.21 22.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.945 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 307' ' ' VAL . . . . . . . . . . . . . 25.2 m . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.14 -0.934 . . . . 16.109999999999999 111.168 -179.849 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.229 0 CA-C-O 120.928 0.394 . . . . 0.0 111.002 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.615 ' H ' HD13 ' A' ' 13' ' ' ILE . 0.2 OUTLIER -126.2 155.79 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.296 179.867 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.642 ' HG3' HD13 ' A' ' 96' ' ' ILE . 24.7 ttm-85 -116.52 152.39 34.19 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.11 -179.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.405 ' HB ' HD22 ' A' ' 59' ' ' LEU . 18.5 m -145.78 147.23 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 N-CA-C 111.623 0.231 . . . . 0.0 111.623 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 14.1 ptp180 -112.54 130.59 55.96 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.813 0.34 . . . . 0.0 111.274 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.7 t -116.07 120.38 64.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.705 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.729 ' HG3' HG22 ' A' ' 92' ' ' THR . 3.5 mp0 -94.2 119.54 33.15 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.831 -179.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.57 113.18 4.02 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.833 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -175.29 84.02 0.31 Allowed Pre-proline 0 CA--C 1.537 0.461 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.119 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -82.68 -24.84 10.8 Favored 'Cis proline' 0 C--N 1.363 1.297 0 CA-C-N 119.508 0.86 . . . . 0.0 112.8 0.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -137.51 -178.06 5.06 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 120.815 0.341 . . . . 0.0 111.441 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.42 ' HB3' ' CE2' ' A' ' 25' ' ' PHE . 3.5 mp -61.1 -59.65 5.01 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.198 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.411 ' O ' HG13 ' A' ' 50' ' ' VAL . . . 104.94 25.53 6.76 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 120.799 -0.715 . . . . 0.0 113.48 179.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.498 ' O ' HG22 ' B' ' 307' ' ' VAL . 37.2 p90 -155.25 144.47 20.98 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 117.252 0.526 . . . . 0.0 111.051 179.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.3 p -98.91 151.82 20.44 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.363 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.872 HD11 HG22 ' A' ' 83' ' ' VAL . 22.5 pt -122.34 153.62 26.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.914 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.8 m -148.06 162.12 40.02 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.78 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 106.58 -149.9 16.71 Favored Glycine 0 C--N 1.332 0.355 0 C-N-CA 120.908 -0.663 . . . . 0.0 113.186 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 103.98 154.91 23.72 Favored Glycine 0 C--N 1.331 0.267 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.178 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 18.7 t -78.75 110.82 14.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 120.934 0.397 . . . . 0.0 110.756 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 88.83 3.71 76.59 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 120.939 -0.648 . . . . 0.0 113.847 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -82.89 -146.77 6.54 Favored Glycine 0 C--N 1.341 0.825 0 CA-C-N 117.841 0.82 . . . . 0.0 112.798 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 48.5 mtt-85 -81.0 -4.36 54.88 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.03 162.35 37.52 Favored Glycine 0 C--N 1.344 0.991 0 C-N-CA 120.609 -0.805 . . . . 0.0 113.099 179.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -105.84 134.87 19.53 Favored Pre-proline 0 CA--C 1.533 0.289 0 CA-C-O 119.899 -0.096 . . . . 0.0 110.921 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -92.87 27.06 0.37 Allowed 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 122.309 2.006 . . . . 0.0 112.819 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -125.25 -46.03 1.81 Allowed 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.731 0.3 . . . . 0.0 110.796 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 64.6 mtt-85 -116.59 150.99 46.56 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.614 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -92.08 -57.58 0.02 OUTLIER 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 122.153 1.902 . . . . 0.0 114.082 -178.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -84.21 -7.18 59.43 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 -178.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -101.69 117.08 34.16 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 118.154 0.433 . . . . 0.0 111.108 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -106.31 34.03 3.57 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.481 -179.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -80.86 -161.56 26.19 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.199 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.8 mm -107.27 131.28 57.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-N 116.782 0.291 . . . . 0.0 110.298 179.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.435 ' N ' ' CD1' ' A' ' 46' ' ' PHE . 6.0 m-85 -130.5 148.35 52.3 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.882 0.372 . . . . 0.0 111.359 -179.332 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.538 HG23 ' OD1' ' A' ' 64' ' ' ASP . 22.0 t -92.2 76.02 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-O 121.158 0.504 . . . . 0.0 110.955 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.424 HG23 ' N ' ' A' ' 49' ' ' ARG . 8.2 t -35.13 -51.72 0.56 Allowed 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 -178.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.424 ' N ' HG23 ' A' ' 48' ' ' THR . 3.6 ptm180 -160.22 176.63 11.52 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.117 0.484 . . . . 0.0 112.28 -179.254 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.411 HG13 ' O ' ' A' ' 24' ' ' GLY . 18.3 t -130.8 148.47 33.08 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.605 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -102.66 -67.89 0.04 OUTLIER Pre-proline 0 CA--C 1.536 0.422 0 CA-C-O 119.753 -0.165 . . . . 0.0 111.392 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -79.4 120.8 4.55 Favored 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 121.796 1.664 . . . . 0.0 112.052 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -77.76 65.63 3.27 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.94 0.4 . . . . 0.0 111.096 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -158.42 -66.54 0.01 OUTLIER Glycine 0 CA--C 1.528 0.85 0 C-N-CA 120.765 -0.731 . . . . 0.0 113.362 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -58.26 -76.43 0.02 OUTLIER 'Trans proline' 0 C--N 1.357 0.99 0 C-N-CA 122.142 1.895 . . . . 0.0 113.36 -179.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.858 ' HB1' HD12 ' A' ' 60' ' ' LEU . . . -111.72 49.77 0.88 Allowed 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.196 0.522 . . . . 0.0 111.437 -179.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 82.4 p -107.35 -67.25 0.97 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.758 179.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.72 -12.13 57.27 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.99 178.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.405 HD22 ' HB ' ' A' ' 15' ' ' VAL . 4.4 mt -93.71 -59.22 2.05 Favored 'General case' 0 C--N 1.342 0.24 0 O-C-N 122.008 -0.433 . . . . 0.0 111.405 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.858 HD12 ' HB1' ' A' ' 56' ' ' ALA . 15.2 mt -93.03 149.26 21.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.547 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.22 144.53 33.13 Favored Pre-proline 0 N--CA 1.471 0.603 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.744 179.2 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.53 133.47 52.05 Favored 'Trans proline' 0 C--N 1.359 1.081 0 C-N-CA 122.165 1.91 . . . . 0.0 113.427 -178.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 87.75 21.75 45.77 Favored Glycine 0 C--N 1.334 0.417 0 CA-C-N 115.716 -0.675 . . . . 0.0 113.632 178.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.538 ' OD1' HG23 ' A' ' 47' ' ' VAL . 2.9 p30 -84.62 -169.55 2.68 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 117.092 0.446 . . . . 0.0 111.005 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 57.8 tttp -141.55 126.44 18.19 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-O 120.874 0.368 . . . . 0.0 111.338 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 27.9 mt -90.31 118.05 34.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.233 179.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.512 HD12 ' CG2' ' A' ' 98' ' ' VAL . 50.3 mt -102.14 -31.79 3.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 N-CA-C 112.419 0.525 . . . . 0.0 112.419 -178.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.61 144.57 27.31 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.005 0.431 . . . . 0.0 111.844 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.47 ' HB3' ' CE1' ' A' ' 74' ' ' PHE . . . -146.25 121.48 10.19 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.783 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 44.73 41.77 5.3 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 178.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 89.21 -17.99 48.07 Favored Glycine 0 CA--C 1.524 0.605 0 C-N-CA 120.856 -0.688 . . . . 0.0 113.634 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -100.92 123.27 44.87 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 117.373 0.586 . . . . 0.0 110.256 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 30.0 m -72.52 151.87 42.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.284 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.47 ' CE1' ' HB3' ' A' ' 69' ' ' ALA . 3.7 m-85 -113.09 19.56 17.08 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.783 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.431 HD11 HG23 ' A' ' 67' ' ' ILE . 30.7 mm -97.03 133.14 39.69 Favored 'Isoleucine or valine' 0 C--O 1.231 0.111 0 CA-C-O 120.751 0.31 . . . . 0.0 110.859 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 61.23 62.36 1.4 Allowed 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 121.185 0.517 . . . . 0.0 110.898 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 18.7 pt -144.43 164.67 13.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.752 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -82.09 145.53 30.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.633 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 -51.2 -53.29 36.37 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 116.167 -0.47 . . . . 0.0 112.162 -179.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -54.65 -25.97 37.62 Favored Glycine 0 CA--C 1.523 0.549 0 C-N-CA 121.079 -0.582 . . . . 0.0 113.02 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -74.46 -39.69 62.37 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.111 0.481 . . . . 0.0 110.404 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -70.5 -37.57 74.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.852 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.872 HG22 HD11 ' A' ' 27' ' ' ILE . 35.2 t -70.49 -44.53 76.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.972 0.415 . . . . 0.0 110.893 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 75.4 m -61.05 -37.32 82.21 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.303 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 19.9 mt -65.65 -46.89 77.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.599 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.415 ' HA ' ' CD2' ' A' ' 89' ' ' PHE . 34.4 mt -65.7 -38.31 88.87 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.897 -178.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 56.1 mttm -71.45 -39.16 71.16 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -178.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 12.0 t -73.77 -27.28 61.07 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -178.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.415 ' CD2' ' HA ' ' A' ' 86' ' ' LEU . 11.8 m-85 -48.98 172.7 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -178.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -84.31 -143.46 0.08 Allowed 'General case' 0 CA--C 1.552 1.054 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.193 -179.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 67.8 m-80 -76.96 -69.95 0.49 Allowed 'General case' 0 C--N 1.349 0.564 0 CA-C-N 119.005 0.821 . . . . 0.0 111.552 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.729 HG22 ' HG3' ' A' ' 18' ' ' GLU . 4.7 p -80.07 125.46 29.82 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.921 0.391 . . . . 0.0 110.788 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 18.8 t -113.41 114.56 47.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.556 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -87.79 112.97 23.0 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 4.2 mt -115.21 152.64 32.3 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-O 121.224 0.535 . . . . 0.0 112.101 -178.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.642 HD13 ' HG3' ' A' ' 14' ' ' ARG . 31.3 mm -112.39 124.6 69.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.065 178.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.535 HD13 HD23 ' A' ' 60' ' ' LEU . 29.3 pt -127.23 158.34 38.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 120.882 0.372 . . . . 0.0 111.208 -178.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.512 ' CG2' HD12 ' A' ' 67' ' ' ILE . 58.3 t -144.24 150.25 16.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.241 -179.133 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.6 mmm180 -112.0 116.8 31.16 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 . . . . . 0 C--N 1.328 -0.339 0 CA-C-O 121.058 0.456 . . . . 0.0 111.703 -178.844 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.692 0.282 . . . . 0.0 110.515 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 305' ' ' THR . . . . . . . . . . . . . 4.7 m -140.42 113.71 8.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.454 -0.339 . . . . 17.879999999999999 111.159 -179.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 306' ' ' TRP . . . . . . . . . . . . . 92.8 m95 -80.77 105.46 12.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.707 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 307' ' ' VAL . . . . . 0.498 HG22 ' O ' ' A' ' 25' ' ' PHE . 16.7 m . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.233 -0.889 . . . . 16.109999999999999 111.134 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 . . . . . 0 C--O 1.232 0.17 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 19.8 pt -147.29 159.17 9.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -178.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 9.7 ttm105 -104.91 153.77 20.96 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.718 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.5 m -146.74 132.74 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.547 178.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.2 ttt180 -107.84 119.94 40.88 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.202 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.4 t -118.97 119.77 61.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.062 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.711 ' CG ' HG23 ' A' ' 92' ' ' THR . 40.0 mt-10 -96.79 132.36 42.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.681 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.484 ' HE2' HD11 ' A' ' 23' ' ' LEU . 21.5 mttt -80.31 122.98 27.58 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.435 0.636 . . . . 0.0 111.856 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -173.97 85.52 0.36 Allowed Pre-proline 0 CA--C 1.537 0.466 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.939 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -81.3 -17.52 27.25 Favored 'Cis proline' 0 C--N 1.365 1.401 0 CA-C-N 119.261 0.772 . . . . 0.0 113.371 0.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 38.1 mm-40 -136.63 -177.17 4.61 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.79 0.329 . . . . 0.0 111.453 -179.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.484 HD11 ' HE2' ' A' ' 19' ' ' LYS . 4.5 mp -59.42 -63.08 1.43 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.211 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.507 ' O ' HG13 ' A' ' 50' ' ' VAL . . . 114.67 28.84 2.83 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 120.877 -0.677 . . . . 0.0 113.485 179.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.444 ' O ' HG22 ' B' ' 307' ' ' VAL . 49.5 p90 -164.14 148.9 10.15 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 117.156 0.478 . . . . 0.0 111.285 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.4 p -102.06 155.1 18.4 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.24 -179.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.837 HD11 HG22 ' A' ' 83' ' ' VAL . 21.1 pt -125.38 153.47 32.95 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.752 179.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.4 m -143.28 165.61 26.99 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.821 0.343 . . . . 0.0 111.139 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.77 -144.45 17.22 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.674 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 102.3 151.52 23.83 Favored Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.378 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.574 HG22 ' OD2' ' A' ' 43' ' ' ASP . 30.3 t -79.99 98.7 3.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.849 0.357 . . . . 0.0 110.781 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 98.94 -3.61 58.71 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 120.958 -0.639 . . . . 0.0 114.07 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -81.17 -150.66 7.53 Favored Glycine 0 C--N 1.342 0.906 0 CA-C-N 117.799 0.8 . . . . 0.0 112.904 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 4.9 ptt-85 -87.18 12.23 12.16 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 51.39 -173.02 0.17 Allowed Glycine 0 C--N 1.342 0.893 0 N-CA-C 114.496 0.559 . . . . 0.0 114.496 178.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 22.7 p30 -142.56 161.51 49.32 Favored Pre-proline 0 CA--C 1.536 0.41 0 CA-C-N 115.553 -0.323 . . . . 0.0 110.545 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -92.75 25.12 0.44 Allowed 'Trans proline' 0 C--N 1.358 1.052 0 C-N-CA 122.386 2.057 . . . . 0.0 113.431 -179.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -103.33 -44.17 5.23 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.699 0.285 . . . . 0.0 111.298 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -124.07 136.16 27.22 Favored Pre-proline 0 CA--C 1.535 0.369 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.503 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -84.98 -46.89 0.04 OUTLIER 'Trans proline' 0 C--N 1.358 1.04 0 C-N-CA 121.908 1.738 . . . . 0.0 113.385 -179.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -97.01 -11.31 24.68 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 112.867 0.691 . . . . 0.0 112.867 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -92.33 121.59 33.97 Favored 'General case' 0 N--CA 1.464 0.254 0 O-C-N 122.064 -0.397 . . . . 0.0 110.465 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.574 ' OD2' HG22 ' A' ' 31' ' ' VAL . 14.0 p-10 -111.03 47.65 0.98 Allowed 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.04 0.448 . . . . 0.0 111.596 -179.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -94.71 -162.83 35.07 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 121.058 -0.592 . . . . 0.0 111.69 179.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 14.6 mm -112.45 124.91 69.59 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-N 117.421 0.611 . . . . 0.0 110.449 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -126.79 146.51 50.22 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.735 0.302 . . . . 0.0 110.959 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.572 HG23 ' OD1' ' A' ' 64' ' ' ASP . 22.7 t -90.99 76.18 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-O 120.89 0.376 . . . . 0.0 111.201 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.402 HG23 ' N ' ' A' ' 49' ' ' ARG . 4.8 t -33.09 -54.53 0.39 Allowed 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 -178.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.402 ' N ' HG23 ' A' ' 48' ' ' THR . 0.6 OUTLIER -160.27 174.17 14.61 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.262 0.553 . . . . 0.0 112.45 -179.271 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.507 HG13 ' O ' ' A' ' 24' ' ' GLY . 20.7 t -124.79 145.36 32.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.459 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.403 ' CB ' ' HD3' ' A' ' 52' ' ' PRO . 1.9 mm-40 -102.86 -69.95 0.04 OUTLIER Pre-proline 0 CA--C 1.539 0.54 0 CA-C-O 119.461 -0.304 . . . . 0.0 111.413 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.403 ' HD3' ' CB ' ' A' ' 51' ' ' GLN . 61.0 Cg_endo -82.57 121.15 3.3 Favored 'Trans proline' 0 C--N 1.359 1.118 0 C-N-CA 121.698 1.599 . . . . 0.0 112.601 179.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -79.8 66.21 5.21 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.303 0.573 . . . . 0.0 110.799 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -142.08 -71.08 0.03 OUTLIER Glycine 0 CA--C 1.527 0.834 0 CA-C-N 115.778 -0.646 . . . . 0.0 113.152 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -63.47 -58.15 0.31 Allowed 'Trans proline' 0 C--N 1.358 1.058 0 C-N-CA 121.948 1.766 . . . . 0.0 113.497 -179.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.494 ' HB1' HD12 ' A' ' 60' ' ' LEU . . . -118.8 48.56 1.44 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 121.08 0.467 . . . . 0.0 111.728 -179.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 82.6 p -79.81 -59.64 2.66 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.852 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 17.3 mttt -97.73 9.89 41.44 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 79.0 mt -92.23 -65.11 1.03 Allowed 'General case' 0 C--N 1.34 0.181 0 O-C-N 122.106 -0.371 . . . . 0.0 111.413 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.515 HD23 HG21 ' A' ' 97' ' ' ILE . 1.1 mt -97.12 147.76 23.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.509 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -113.4 140.04 23.95 Favored Pre-proline 0 N--CA 1.469 0.481 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.67 178.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -53.01 136.04 60.04 Favored 'Trans proline' 0 C--N 1.358 1.068 0 C-N-CA 122.083 1.855 . . . . 0.0 113.291 -178.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 82.03 24.78 54.29 Favored Glycine 0 C--N 1.333 0.374 0 CA-C-N 115.767 -0.651 . . . . 0.0 113.246 179.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.572 ' OD1' HG23 ' A' ' 47' ' ' VAL . 3.0 p30 -86.05 -170.58 3.16 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.89 0.345 . . . . 0.0 110.857 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 60.8 tttp -139.33 122.86 17.32 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.83 0.348 . . . . 0.0 110.891 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 48.8 mt -89.61 121.94 40.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.509 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 19.5 mm -96.03 -43.97 12.81 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 N-CA-C 112.581 0.585 . . . . 0.0 112.581 -178.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -145.81 150.57 36.44 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 121.073 0.463 . . . . 0.0 111.957 -178.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.404 ' HB3' ' CE1' ' A' ' 74' ' ' PHE . . . -137.1 119.46 15.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.94 179.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 42.28 32.3 0.32 Allowed 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 113.642 0.978 . . . . 0.0 113.642 178.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 97.83 4.2 57.94 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 120.986 -0.626 . . . . 0.0 114.083 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -110.09 124.24 51.15 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 117.949 0.875 . . . . 0.0 110.565 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 54.8 p -72.78 139.85 47.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.484 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.412 ' HA ' HD13 ' A' ' 77' ' ' ILE . 4.7 m-85 -110.5 21.55 16.49 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -179.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.439 HG22 ' OD1' ' A' ' 76' ' ' ASN . 21.1 mm -100.29 139.45 21.72 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 O-C-N 122.214 -0.304 . . . . 0.0 111.048 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.504 ' HA ' HG21 ' A' ' 31' ' ' VAL . 19.9 m120 63.81 12.23 6.54 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -179.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.412 HD13 ' HA ' ' A' ' 74' ' ' PHE . 25.3 pt -93.62 158.21 2.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -178.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -81.63 148.83 28.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.479 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.453 ' O ' HG23 ' A' ' 83' ' ' VAL . 35.4 t60 -47.23 -50.32 21.34 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -179.324 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -57.59 -26.15 56.65 Favored Glycine 0 C--N 1.335 0.501 0 C-N-CA 120.874 -0.679 . . . . 0.0 113.082 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.419 ' OE1' HD11 ' A' ' 85' ' ' LEU . 0.0 OUTLIER -76.21 -42.59 45.63 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.897 0.38 . . . . 0.0 110.887 179.839 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.38 -39.57 81.69 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.662 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.837 HG22 HD11 ' A' ' 27' ' ' ILE . 25.4 t -72.57 -43.2 63.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.852 0.358 . . . . 0.0 110.666 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 34.7 t -60.53 -39.95 89.75 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.296 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.419 HD11 ' OE1' ' A' ' 81' ' ' GLN . 53.2 mt -67.56 -44.0 79.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.898 0.38 . . . . 0.0 111.139 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.422 ' HA ' ' CD2' ' A' ' 89' ' ' PHE . 17.5 mt -66.27 -38.57 88.11 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.809 -178.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 48.5 mttm -73.31 -38.09 65.96 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -178.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 9.0 t -70.15 -25.34 63.42 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -178.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.422 ' CD2' ' HA ' ' A' ' 86' ' ' LEU . 14.7 m-85 -53.5 140.49 28.04 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.19 0.519 . . . . 0.0 111.842 -179.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -62.59 -131.4 0.0 OUTLIER 'General case' 0 CA--C 1.558 1.258 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.948 -178.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -82.59 -72.28 0.45 Allowed 'General case' 0 C--N 1.355 0.806 0 CA-C-N 119.718 1.144 . . . . 0.0 112.621 -177.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.711 HG23 ' CG ' ' A' ' 18' ' ' GLU . 0.3 OUTLIER -74.23 123.11 23.91 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.818 0.342 . . . . 0.0 111.011 -179.367 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.49 ' CG1' HD11 ' A' ' 95' ' ' LEU . 16.6 t -109.51 116.08 51.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.953 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.95 104.62 16.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.353 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.49 HD11 ' CG1' ' A' ' 93' ' ' VAL . 3.8 mp -111.76 158.54 19.23 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.239 0.542 . . . . 0.0 112.098 -179.118 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 26.5 mm -118.72 129.59 74.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.822 178.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.515 HG21 HD23 ' A' ' 60' ' ' LEU . 25.8 pt -130.96 167.24 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-O 120.846 0.355 . . . . 0.0 111.663 -178.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 19.0 t -148.29 151.65 13.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.243 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -115.42 131.05 57.05 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.928 179.086 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 . . . . . 0 C--N 1.327 -0.385 0 CA-C-N 116.262 -0.426 . . . . 0.0 112.061 -178.985 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.464 0.255 0 CA-C-O 120.953 0.406 . . . . 0.0 111.068 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 305' ' ' THR . . . . . . . . . . . . . 4.9 m -144.98 118.86 9.29 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.123 -0.489 . . . . 17.879999999999999 111.047 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 306' ' ' TRP . . . . . . . . . . . . . 91.9 m95 -88.79 106.0 18.09 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.664 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 307' ' ' VAL . . . . . 0.444 HG22 ' O ' ' A' ' 25' ' ' PHE . 25.6 m . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.26 -0.876 . . . . 16.109999999999999 111.16 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.465 0.322 0 CA-C-O 120.718 0.294 . . . . 0.0 111.147 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 18.4 pt -115.82 158.11 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -178.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.683 ' HG3' HD13 ' A' ' 96' ' ' ILE . 26.8 ttp180 -116.07 156.19 26.81 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.612 -179.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.7 m -149.45 142.83 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.302 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.17 132.01 54.55 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.949 0.404 . . . . 0.0 111.236 179.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.3 t -114.62 120.03 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.155 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.495 ' HG2' HG23 ' A' ' 92' ' ' THR . 3.0 mm-40 -89.8 111.59 22.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.095 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.526 ' HD2' HD12 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -65.87 116.89 7.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.971 179.87 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -175.1 84.87 0.32 Allowed Pre-proline 0 CA--C 1.54 0.571 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.962 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -84.7 -22.2 14.65 Favored 'Cis proline' 0 C--N 1.366 1.475 0 CA-C-N 119.488 0.853 . . . . 0.0 113.058 0.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 18.2 mp0 -131.42 -178.28 4.78 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.768 0.318 . . . . 0.0 111.142 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.526 HD12 ' HD2' ' A' ' 19' ' ' LYS . 3.2 mp -63.12 -58.16 8.18 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.563 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.612 ' O ' HG13 ' A' ' 50' ' ' VAL . . . 109.92 26.89 4.8 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.888 -0.672 . . . . 0.0 113.377 179.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.447 ' O ' HG22 ' B' ' 307' ' ' VAL . 37.4 p90 -159.84 139.93 11.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 117.133 0.467 . . . . 0.0 111.12 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.9 p -94.06 153.59 18.07 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.823 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.407 HD11 HG22 ' A' ' 83' ' ' VAL . 28.2 pt -122.59 152.77 27.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.084 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 50.9 m -146.14 160.93 41.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.912 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 104.97 -146.77 16.14 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 120.988 -0.625 . . . . 0.0 113.098 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.36 157.62 28.92 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.993 -0.622 . . . . 0.0 111.98 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 18.8 t -78.55 109.65 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 CA-C-O 120.806 0.336 . . . . 0.0 110.953 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 86.8 3.81 83.05 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 121.039 -0.601 . . . . 0.0 113.857 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -82.87 -154.7 16.45 Favored Glycine 0 C--N 1.343 0.954 0 CA-C-N 117.816 0.808 . . . . 0.0 112.928 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 7.4 mtt180 -75.71 -2.51 29.96 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -179.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.26 -151.28 25.52 Favored Glycine 0 C--N 1.342 0.911 0 C-N-CA 120.695 -0.764 . . . . 0.0 113.037 179.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -173.54 142.3 0.94 Allowed Pre-proline 0 CA--C 1.534 0.346 0 N-CA-C 110.611 -0.144 . . . . 0.0 110.611 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -90.42 39.87 0.39 Allowed 'Trans proline' 0 C--N 1.358 1.03 0 C-N-CA 122.274 1.983 . . . . 0.0 113.507 -179.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -125.62 -53.44 1.57 Allowed 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.739 0.304 . . . . 0.0 110.915 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? -116.16 136.28 22.97 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.677 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -85.59 -46.37 0.04 OUTLIER 'Trans proline' 0 C--N 1.358 1.05 0 C-N-CA 121.965 1.777 . . . . 0.0 113.335 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -93.42 -8.68 41.02 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 -179.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -101.03 121.48 41.87 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 118.175 0.443 . . . . 0.0 110.537 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -110.72 39.8 2.15 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 120.819 0.342 . . . . 0.0 111.874 -178.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -87.44 -158.97 33.48 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.085 179.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 13.9 mm -109.43 124.58 66.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 116.996 0.398 . . . . 0.0 110.83 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.418 ' CD1' ' N ' ' A' ' 46' ' ' PHE . 7.3 m-85 -127.12 150.16 49.62 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.628 0.251 . . . . 0.0 110.636 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.457 ' CG2' HD11 ' A' ' 66' ' ' ILE . 22.5 t -95.92 78.98 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.531 -179.202 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.9 t -35.58 -53.6 0.69 Allowed 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 -178.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.402 ' HG3' ' CH2' ' B' ' 306' ' ' TRP . 15.4 ptt180 -160.77 163.95 31.87 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.993 0.425 . . . . 0.0 111.801 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.612 HG13 ' O ' ' A' ' 24' ' ' GLY . 11.8 t -114.29 146.13 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.42 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.404 ' CB ' ' HD3' ' A' ' 52' ' ' PRO . 4.9 mm-40 -97.13 -70.41 0.05 OUTLIER Pre-proline 0 CA--C 1.538 0.496 0 CA-C-O 119.465 -0.302 . . . . 0.0 111.316 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.404 ' HD3' ' CB ' ' A' ' 51' ' ' GLN . 60.2 Cg_endo -83.05 121.13 3.1 Favored 'Trans proline' 0 C--N 1.36 1.133 0 C-N-CA 121.606 1.538 . . . . 0.0 112.292 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -78.62 65.49 3.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.205 0.526 . . . . 0.0 110.737 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -148.19 -70.56 0.01 OUTLIER Glycine 0 CA--C 1.527 0.793 0 C-N-CA 120.965 -0.636 . . . . 0.0 112.871 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -60.37 -63.3 0.12 Allowed 'Trans proline' 0 C--N 1.358 1.062 0 C-N-CA 121.977 1.784 . . . . 0.0 112.893 -179.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.429 ' HB1' HD12 ' A' ' 60' ' ' LEU . . . -110.02 45.65 1.09 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.16 0.505 . . . . 0.0 111.186 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 88.9 p -82.5 -59.06 2.65 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.93 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -93.72 5.28 52.17 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 80.2 mt -92.04 -72.61 0.58 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 118.144 0.429 . . . . 0.0 111.612 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.701 HD23 HG21 ' A' ' 97' ' ' ILE . 1.0 OUTLIER -95.94 143.08 27.44 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.545 0.212 . . . . 0.0 110.764 179.852 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -114.98 153.6 47.08 Favored Pre-proline 0 N--CA 1.471 0.592 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.776 179.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -55.22 123.71 14.49 Favored 'Trans proline' 0 C--N 1.36 1.161 0 C-N-CA 122.335 2.023 . . . . 0.0 113.882 -178.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 92.74 16.02 50.29 Favored Glycine 0 CA--C 1.521 0.467 0 CA-C-N 115.687 -0.688 . . . . 0.0 114.139 178.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.429 ' OD1' HG23 ' A' ' 47' ' ' VAL . 35.1 p-10 -80.27 -171.7 3.13 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 117.541 0.671 . . . . 0.0 111.361 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 32.2 tttp -142.4 125.14 15.94 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 120.774 0.321 . . . . 0.0 111.108 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.559 ' N ' HD12 ' A' ' 66' ' ' ILE . 3.5 mp -90.87 123.86 43.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.023 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 21.0 mm -94.9 -44.55 13.3 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -179.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -148.62 150.42 33.24 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 120.833 0.349 . . . . 0.0 111.668 -178.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.507 ' HB3' ' CE1' ' A' ' 74' ' ' PHE . . . -136.7 123.69 21.49 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.557 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 28.7 m-20 42.44 35.01 0.59 Allowed 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 113.61 0.966 . . . . 0.0 113.61 178.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 99.65 -16.37 58.81 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 120.867 -0.682 . . . . 0.0 113.792 179.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -92.99 123.06 35.97 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 117.534 0.667 . . . . 0.0 111.016 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 14.9 m -71.12 130.49 41.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.077 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.507 ' CE1' ' HB3' ' A' ' 69' ' ' ALA . 5.6 m-85 -103.16 15.64 28.73 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 6.5 tp -89.32 124.24 41.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-O 120.729 0.299 . . . . 0.0 110.546 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 62.54 73.78 0.45 Allowed 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.118 0.485 . . . . 0.0 111.161 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 11.5 pt -144.29 163.12 14.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.886 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -81.12 153.39 27.32 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.256 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 21.1 t60 -52.85 -55.7 21.21 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 116.02 -0.537 . . . . 0.0 112.186 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -56.29 -26.7 51.27 Favored Glycine 0 C--N 1.334 0.45 0 C-N-CA 121.073 -0.584 . . . . 0.0 113.277 -179.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -72.66 -40.56 66.25 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.866 0.365 . . . . 0.0 111.008 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.99 -41.0 95.8 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.423 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.407 HG22 HD11 ' A' ' 27' ' ' ILE . 16.1 t -70.74 -42.0 77.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.199 -179.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 72.5 m -60.53 -45.82 92.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.588 -179.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 31.7 mt -64.14 -45.52 88.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.603 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.426 ' HA ' ' CD2' ' A' ' 89' ' ' PHE . 24.5 mt -65.36 -39.48 92.35 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.956 -179.009 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 8.4 mmtp -68.68 -40.02 80.31 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -178.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 8.8 t -72.22 -27.26 62.42 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -177.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.426 ' CD2' ' HA ' ' A' ' 86' ' ' LEU . 10.5 m-85 -47.87 172.81 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 113.105 0.779 . . . . 0.0 113.105 -177.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -92.5 -138.0 0.18 Allowed 'General case' 0 CA--C 1.554 1.103 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.277 -178.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 54.5 m-80 -78.96 -74.97 0.25 Allowed 'General case' 0 C--N 1.35 0.61 0 CA-C-N 119.454 1.025 . . . . 0.0 111.955 -178.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.495 HG23 ' HG2' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -77.44 123.19 26.21 Favored 'General case' 0 CA--C 1.527 0.081 0 CA-C-O 120.84 0.352 . . . . 0.0 110.307 -179.832 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 20.2 t -111.32 116.69 53.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.498 179.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -86.77 112.66 21.91 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.959 0.409 . . . . 0.0 110.159 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.3 mt -116.51 147.46 41.75 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.679 -0.692 . . . . 0.0 111.896 -178.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.683 HD13 ' HG3' ' A' ' 14' ' ' ARG . 18.8 mm -107.19 121.71 60.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.651 178.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.701 HG21 HD23 ' A' ' 60' ' ' LEU . 41.4 pt -126.5 158.64 36.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.855 0.36 . . . . 0.0 111.119 -179.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 17.2 t -146.78 153.19 12.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.258 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 2.6 mmm180 -109.87 116.9 32.48 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 . . . . . 0 N--CA 1.456 -0.158 0 CA-C-O 120.678 0.275 . . . . 0.0 110.628 -179.994 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 . . . . . 0 C--O 1.232 0.156 0 CA-C-O 120.662 0.268 . . . . 0.0 110.721 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 305' ' ' THR . . . . . . . . . . . . . 4.7 m -122.7 114.88 21.17 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.21 -0.45 . . . . 17.879999999999999 110.923 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 306' ' ' TRP . . . . . 0.402 ' CH2' ' HG3' ' A' ' 49' ' ' ARG . 98.9 m95 -78.75 104.79 9.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.797 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 307' ' ' VAL . . . . . 0.447 HG22 ' O ' ' A' ' 25' ' ' PHE . 17.0 m . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.264 -0.874 . . . . 16.109999999999999 111.135 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.2 tm-20 . . . . . 0 C--O 1.233 0.197 0 CA-C-O 120.783 0.325 . . . . 0.0 110.941 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.1 pt -149.61 159.59 5.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-O 120.824 0.345 . . . . 0.0 111.8 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.434 ' HG3' HD13 ' A' ' 96' ' ' ILE . 10.2 ttm-85 -116.6 153.32 32.46 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.264 -178.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.406 ' HB ' HD22 ' A' ' 59' ' ' LEU . 14.9 m -141.91 144.04 26.02 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.356 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 2.4 ttt-85 -108.09 115.58 30.39 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.5 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.0 t -109.34 121.52 62.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-O 120.896 0.379 . . . . 0.0 111.459 -179.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.555 ' HG3' HG22 ' A' ' 92' ' ' THR . 5.3 mp0 -96.79 114.7 26.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.206 179.252 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.5 ' HD3' HD12 ' A' ' 23' ' ' LEU . 19.2 mtmt -75.23 119.97 20.09 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.929 0.395 . . . . 0.0 111.262 -179.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -163.59 86.87 1.25 Allowed Pre-proline 0 CA--C 1.536 0.425 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.712 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -84.59 -13.43 37.69 Favored 'Cis proline' 0 C--N 1.364 1.345 0 CA-C-N 119.548 0.874 . . . . 0.0 113.595 0.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -136.78 -175.95 4.2 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.892 0.377 . . . . 0.0 111.176 -179.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.5 HD12 ' HD3' ' A' ' 19' ' ' LYS . 1.5 mp -63.44 -52.22 62.39 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.3 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 102.88 29.99 5.63 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 120.862 -0.685 . . . . 0.0 113.586 179.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.418 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 32.1 p90 -162.15 146.53 12.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 117.053 0.426 . . . . 0.0 110.919 179.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.5 p -97.15 155.55 16.78 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.367 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.772 HD11 HG22 ' A' ' 83' ' ' VAL . 29.0 pt -124.21 154.06 30.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.306 179.196 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 48.1 t -145.78 171.94 14.04 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.835 0.35 . . . . 0.0 111.165 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 92.14 -137.72 13.87 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.584 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.45 155.01 29.98 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.25 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.495 HG21 ' HA ' ' A' ' 76' ' ' ASN . 34.8 t -78.69 97.38 2.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.014 0.435 . . . . 0.0 110.705 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 98.86 -1.87 58.16 Favored Glycine 0 CA--C 1.531 1.067 0 CA-C-N 115.844 -0.616 . . . . 0.0 113.723 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -72.34 -154.62 2.29 Favored Glycine 0 C--N 1.343 0.932 0 CA-C-N 117.856 0.828 . . . . 0.0 113.098 -179.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 4.5 mtt85 -72.7 -29.06 63.07 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 111.656 0.243 . . . . 0.0 111.656 -179.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 124.32 -163.49 18.08 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.908 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -170.74 132.69 0.93 Allowed Pre-proline 0 CA--C 1.536 0.428 0 O-C-N 123.026 -0.102 . . . . 0.0 110.744 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -91.52 44.15 0.44 Allowed 'Trans proline' 0 C--N 1.358 1.069 0 C-N-CA 122.178 1.918 . . . . 0.0 113.073 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -122.84 -57.77 1.7 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.226 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 6.1 mmp_? -113.3 145.25 32.84 Favored Pre-proline 0 N--CA 1.467 0.382 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.991 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -88.78 -56.45 0.02 OUTLIER 'Trans proline' 0 C--N 1.36 1.181 0 C-N-CA 122.041 1.827 . . . . 0.0 113.125 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -86.51 -7.63 58.23 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -104.0 121.23 42.73 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 117.967 0.349 . . . . 0.0 111.02 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.7 p30 -110.8 40.34 2.03 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 121.042 0.448 . . . . 0.0 110.834 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -84.37 -157.19 25.95 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.976 -0.631 . . . . 0.0 112.732 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 19.6 mm -110.53 122.4 64.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.522 0.201 . . . . 0.0 110.563 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -122.07 144.76 48.72 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 120.899 0.381 . . . . 0.0 111.392 -179.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 22.7 t -86.37 75.87 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.161 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.408 HG23 ' N ' ' A' ' 49' ' ' ARG . 4.7 t -33.87 -52.88 0.44 Allowed 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 -178.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.408 ' N ' HG23 ' A' ' 48' ' ' THR . 5.8 ptt85 -160.35 179.09 8.95 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.074 0.464 . . . . 0.0 111.737 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 15.8 t -134.48 146.92 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.782 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -104.87 -68.17 0.04 OUTLIER Pre-proline 0 CA--C 1.536 0.441 0 CA-C-N 116.704 -0.225 . . . . 0.0 111.267 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -78.34 112.62 3.23 Favored 'Trans proline' 0 C--N 1.357 1.023 0 C-N-CA 121.654 1.569 . . . . 0.0 112.009 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -72.81 70.92 1.01 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.003 0.43 . . . . 0.0 111.298 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -162.27 -65.77 0.02 OUTLIER Glycine 0 CA--C 1.527 0.787 0 C-N-CA 120.79 -0.719 . . . . 0.0 113.273 -179.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -57.05 -76.11 0.02 OUTLIER 'Trans proline' 0 C--N 1.357 1.017 0 C-N-CA 122.086 1.857 . . . . 0.0 113.098 -179.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.885 ' HB1' HD12 ' A' ' 60' ' ' LEU . . . -116.38 47.37 1.43 Allowed 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 121.265 0.555 . . . . 0.0 111.636 -179.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.7 t -99.73 -63.27 1.14 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.922 179.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 44.2 mttp -74.51 -3.91 33.66 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.1 178.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.406 HD22 ' HB ' ' A' ' 15' ' ' VAL . 9.0 mt -99.13 -50.51 4.13 Favored 'General case' 0 C--N 1.343 0.311 0 CA-C-N 118.265 0.484 . . . . 0.0 111.373 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.885 HD12 ' HB1' ' A' ' 56' ' ' ALA . 19.0 mt -102.56 150.34 23.51 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-O 120.818 0.342 . . . . 0.0 111.492 -179.342 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -97.56 140.69 22.14 Favored Pre-proline 0 CA--C 1.535 0.388 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.873 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -63.79 79.06 0.15 Allowed 'Trans proline' 0 C--N 1.362 1.243 0 C-N-CA 122.068 1.845 . . . . 0.0 112.16 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 129.29 41.32 0.26 Allowed Glycine 0 CA--C 1.525 0.68 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.606 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -96.24 -158.25 0.64 Allowed 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 179.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 59.5 tttp -144.65 127.53 16.37 Favored 'General case' 0 C--O 1.231 0.081 0 CA-C-O 120.679 0.276 . . . . 0.0 110.942 179.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.606 ' N ' HD12 ' A' ' 66' ' ' ILE . 3.3 mp -88.9 115.73 29.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 13.4 mm -91.38 -39.13 11.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.558 -179.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -149.55 150.22 31.93 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.06 0.457 . . . . 0.0 111.365 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.422 ' HB3' ' CE1' ' A' ' 74' ' ' PHE . . . -134.59 115.35 13.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.246 179.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 63.3 m-20 46.72 29.27 0.93 Allowed 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 179.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 100.08 -7.52 58.77 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 120.892 -0.67 . . . . 0.0 113.889 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -95.35 129.22 42.57 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 117.94 0.87 . . . . 0.0 110.028 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.27 125.27 28.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.816 0.341 . . . . 0.0 111.147 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.422 ' CE1' ' HB3' ' A' ' 69' ' ' ALA . 3.4 m-85 -100.71 22.53 11.8 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.461 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 7.0 tp -102.93 141.4 18.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 O-C-N 122.137 -0.352 . . . . 0.0 110.95 -178.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.495 ' HA ' HG21 ' A' ' 31' ' ' VAL . 1.0 OUTLIER 64.71 11.58 6.92 Favored 'General case' 0 CA--C 1.55 0.947 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -178.841 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 18.0 pt -94.2 164.91 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -177.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -85.69 144.99 27.5 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.542 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.494 ' O ' HG23 ' A' ' 83' ' ' VAL . 1.8 t-160 -48.79 -51.12 30.88 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -179.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -55.98 -26.81 49.52 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 120.837 -0.697 . . . . 0.0 113.177 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.7 tp-100 -75.98 -40.97 52.71 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.08 0.467 . . . . 0.0 110.866 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.63 -34.93 77.97 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.539 -179.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.772 HG22 HD11 ' A' ' 27' ' ' ILE . 23.5 t -71.99 -42.54 68.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.927 0.394 . . . . 0.0 110.584 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.2 t -61.23 -41.16 96.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.28 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.432 ' O ' HG22 ' A' ' 88' ' ' THR . 25.5 mt -65.82 -45.97 80.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.459 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.433 ' HA ' ' CD2' ' A' ' 89' ' ' PHE . 39.5 mt -64.61 -37.02 86.14 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.112 -0.495 . . . . 0.0 112.195 -178.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 34.1 mmtt -71.26 -36.68 71.84 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -178.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.432 HG22 ' O ' ' A' ' 85' ' ' LEU . 9.8 t -73.59 -29.08 62.18 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 -178.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.433 ' CD2' ' HA ' ' A' ' 86' ' ' LEU . 16.4 m-85 -50.49 147.22 4.68 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -178.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -66.72 -136.6 0.0 OUTLIER 'General case' 0 CA--C 1.556 1.21 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.053 -179.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -80.57 -67.88 0.73 Allowed 'General case' 0 C--N 1.352 0.68 0 CA-C-N 119.586 1.085 . . . . 0.0 111.883 -178.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.555 HG22 ' HG3' ' A' ' 18' ' ' GLU . 0.9 OUTLIER -81.55 135.35 35.58 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.689 0.281 . . . . 0.0 110.979 -179.553 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.5 t -128.01 122.64 58.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.151 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -89.66 108.33 19.61 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 178.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 12.5 mt -110.12 144.23 39.04 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.011 0.434 . . . . 0.0 111.679 -179.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.434 HD13 ' HG3' ' A' ' 14' ' ' ARG . 21.6 mm -106.21 120.8 57.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.604 178.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.721 HD13 HD23 ' A' ' 60' ' ' LEU . 23.5 pt -126.84 164.14 27.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.818 0.342 . . . . 0.0 111.313 -179.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 22.1 t -149.72 151.87 12.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.245 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -111.97 121.21 44.37 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.268 178.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.973 0.416 . . . . 0.0 111.534 -179.262 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 . . . . . 0 C--O 1.232 0.146 0 CA-C-O 121.004 0.431 . . . . 0.0 111.284 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 305' ' ' THR . . . . . . . . . . . . . 5.8 m -138.95 128.8 24.94 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.91 -0.586 . . . . 17.879999999999999 110.339 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 306' ' ' TRP . . . . . . . . . . . . . 88.7 m95 -94.48 114.63 26.67 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.944 0.402 . . . . 0.0 111.224 -179.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 307' ' ' VAL . . . . . . . . . . . . . 15.4 m . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.244 -0.884 . . . . 16.109999999999999 111.074 -179.971 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 . . . . . 0 C--O 1.232 0.182 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.558 ' H ' HD13 ' A' ' 13' ' ' ILE . 0.2 OUTLIER -110.81 161.49 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -178.66 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 12.6 mtm180 -112.23 155.72 23.55 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.1 -0.954 . . . . 0.0 110.776 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.441 HG21 HD21 ' A' ' 60' ' ' LEU . 15.9 m -143.82 142.77 24.51 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-O 120.79 0.328 . . . . 0.0 110.911 179.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 22.1 ttm180 -107.27 115.02 29.43 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.248 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.9 t -114.53 117.7 56.38 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.972 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.762 ' HG3' HG23 ' A' ' 92' ' ' THR . 1.6 mp0 -93.29 122.75 36.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.635 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.437 ' HD3' HD12 ' A' ' 23' ' ' LEU . 15.3 mtmt -76.68 120.86 22.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.081 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -171.11 88.22 0.47 Allowed Pre-proline 0 CA--C 1.536 0.408 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.726 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -82.69 -18.45 24.91 Favored 'Cis proline' 0 C--N 1.362 1.267 0 CA-C-N 119.477 0.849 . . . . 0.0 113.277 0.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -135.31 -178.29 5.04 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.868 0.366 . . . . 0.0 111.755 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.437 HD12 ' HD3' ' A' ' 19' ' ' LYS . 3.0 mp -64.14 -57.27 10.05 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.03 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 103.35 32.46 4.57 Favored Glycine 0 CA--C 1.522 0.493 0 C-N-CA 120.797 -0.716 . . . . 0.0 113.98 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.546 ' O ' HG22 ' B' ' 307' ' ' VAL . 38.7 p90 -162.36 147.25 12.4 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 117.363 0.582 . . . . 0.0 111.191 179.223 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.3 p -100.65 151.4 21.68 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.474 -179.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.541 HD11 HG22 ' A' ' 83' ' ' VAL . 28.9 pt -121.71 151.15 25.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.911 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 28.7 t -150.33 164.57 35.46 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.548 0.213 . . . . 0.0 111.44 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 115.05 -94.84 0.69 Allowed Glycine 0 C--N 1.338 0.658 0 C-N-CA 120.972 -0.632 . . . . 0.0 113.797 178.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.515 ' H ' HD13 ' A' ' 45' ' ' ILE . . . 72.18 -134.76 21.82 Favored Glycine 0 CA--C 1.524 0.601 0 C-N-CA 121.24 -0.505 . . . . 0.0 112.597 -179.51 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 23.1 t -148.08 84.55 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 CA-C-O 120.953 0.406 . . . . 0.0 109.962 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 92.44 9.34 61.75 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 120.823 -0.703 . . . . 0.0 113.44 -179.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -84.2 -140.68 4.66 Favored Glycine 0 C--N 1.342 0.868 0 CA-C-N 117.705 0.753 . . . . 0.0 112.487 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.22 -28.35 62.81 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 111.745 0.276 . . . . 0.0 111.745 -179.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.34 158.87 30.98 Favored Glycine 0 C--N 1.333 0.362 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.772 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -124.96 133.35 24.73 Favored Pre-proline 0 CA--C 1.535 0.371 0 N-CA-C 110.744 -0.095 . . . . 0.0 110.744 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -91.19 26.61 0.45 Allowed 'Trans proline' 0 C--N 1.358 1.03 0 C-N-CA 122.181 1.921 . . . . 0.0 113.451 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -106.62 -53.85 2.56 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.791 0.329 . . . . 0.0 110.6 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 1.2 mmm180 -118.63 137.4 24.81 Favored Pre-proline 0 CA--C 1.535 0.399 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.566 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -86.33 -48.02 0.04 OUTLIER 'Trans proline' 0 C--N 1.357 0.993 0 C-N-CA 121.954 1.77 . . . . 0.0 113.356 -179.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -91.63 -10.9 38.72 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -96.64 113.63 25.2 Favored 'General case' 0 C--O 1.231 0.083 0 CA-C-N 117.998 0.363 . . . . 0.0 110.533 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.5 p-10 -100.03 64.62 1.23 Allowed 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 121.123 0.487 . . . . 0.0 111.17 -179.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -116.09 -159.02 11.71 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 121.118 -0.563 . . . . 0.0 112.462 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.515 HD13 ' H ' ' A' ' 30' ' ' GLY . 20.8 mm -111.44 133.21 57.79 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-O 120.444 0.164 . . . . 0.0 110.813 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.433 ' N ' ' CD1' ' A' ' 46' ' ' PHE . 4.2 m-85 -129.78 151.02 50.82 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.684 0.278 . . . . 0.0 110.722 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.572 ' CG2' HD11 ' A' ' 66' ' ' ILE . 21.7 t -94.28 77.44 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 CA-C-O 121.01 0.434 . . . . 0.0 111.278 -179.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.404 HG23 ' N ' ' A' ' 49' ' ' ARG . 4.9 t -36.36 -54.39 0.83 Allowed 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 -178.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.404 ' N ' HG23 ' A' ' 48' ' ' THR . 3.9 ptt-85 -160.46 163.22 33.15 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.113 0.482 . . . . 0.0 112.242 -179.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 16.8 t -118.35 149.69 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.562 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.2 mm-40 -104.97 -68.45 0.04 OUTLIER Pre-proline 0 CA--C 1.538 0.51 0 CA-C-O 119.67 -0.205 . . . . 0.0 111.389 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -78.77 121.47 5.06 Favored 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 121.8 1.667 . . . . 0.0 112.242 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -77.22 65.96 2.92 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 120.911 0.386 . . . . 0.0 111.096 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -156.1 -68.14 0.01 OUTLIER Glycine 0 CA--C 1.528 0.885 0 C-N-CA 120.69 -0.767 . . . . 0.0 113.544 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -58.89 -76.82 0.02 OUTLIER 'Trans proline' 0 C--N 1.356 0.966 0 C-N-CA 122.14 1.893 . . . . 0.0 113.435 -178.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.859 ' HB1' HD12 ' A' ' 60' ' ' LEU . . . -110.14 48.74 0.88 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-O 121.218 0.532 . . . . 0.0 111.5 -179.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 34.7 t -105.04 -67.45 0.91 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.999 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.85 -12.74 60.22 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.962 179.176 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 69.1 mt -95.09 -58.91 2.02 Favored 'General case' 0 C--N 1.342 0.276 0 O-C-N 122.137 -0.352 . . . . 0.0 111.506 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.859 HD12 ' HB1' ' A' ' 56' ' ' ALA . 22.2 mt -94.18 148.84 21.8 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.706 -179.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.7 pm0 -103.53 150.98 38.61 Favored Pre-proline 0 CA--C 1.538 0.488 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.958 178.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -68.8 73.79 0.94 Allowed 'Trans proline' 0 C--N 1.357 1.007 0 C-N-CA 122.247 1.965 . . . . 0.0 114.108 -178.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 140.74 39.2 0.08 OUTLIER Glycine 0 C--N 1.338 0.662 0 C-N-CA 120.549 -0.834 . . . . 0.0 113.943 178.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -94.33 -163.3 1.03 Allowed 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 117.286 0.543 . . . . 0.0 111.277 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 27.0 tttm -132.92 121.91 23.54 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 110.275 -0.268 . . . . 0.0 110.275 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.572 HD11 ' CG2' ' A' ' 47' ' ' VAL . 3.7 mm -87.27 109.08 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.802 -178.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 18.1 mm -88.25 -44.45 15.68 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -179.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.697 ' HB2' HD12 ' A' ' 96' ' ' ILE . 5.7 mt-30 -150.87 152.44 33.69 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -178.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.427 ' HB3' ' CE1' ' A' ' 74' ' ' PHE . . . -132.52 118.76 19.65 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.637 179.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 30.3 m-20 46.47 29.77 0.96 Allowed 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 179.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 100.16 -3.26 56.79 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 120.936 -0.649 . . . . 0.0 113.925 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -91.23 145.72 24.43 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 117.901 0.851 . . . . 0.0 110.369 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 80.3 p -88.38 108.42 19.34 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.321 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.427 ' CE1' ' HB3' ' A' ' 69' ' ' ALA . 5.2 m-85 -92.72 8.29 39.91 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 112.376 0.509 . . . . 0.0 112.376 179.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.433 HG23 ' O ' ' A' ' 75' ' ' ILE . 6.5 tp -86.49 118.25 32.44 Favored 'Isoleucine or valine' 0 C--N 1.341 0.204 0 CA-C-N 118.124 0.42 . . . . 0.0 110.673 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 62.81 75.77 0.39 Allowed 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 121.206 0.527 . . . . 0.0 111.057 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 8.4 pt -147.71 153.91 11.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.543 179.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -66.21 140.46 58.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.512 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -50.3 -51.89 41.29 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -179.215 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -54.6 -25.77 36.53 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 120.978 -0.629 . . . . 0.0 112.963 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -77.28 -38.87 49.95 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.916 0.389 . . . . 0.0 110.453 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -70.05 -39.04 75.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.455 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.541 HG22 HD11 ' A' ' 27' ' ' ILE . 29.1 t -70.67 -43.35 77.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.898 0.38 . . . . 0.0 110.638 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 43.2 m -61.49 -39.18 89.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.221 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.541 ' O ' HG22 ' A' ' 88' ' ' THR . 14.3 mt -64.6 -46.51 82.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.103 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.416 ' HA ' ' CD2' ' A' ' 89' ' ' PHE . 31.9 mt -64.29 -39.83 94.72 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.171 -0.468 . . . . 0.0 112.085 -178.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 19.7 mmtp -65.42 -39.69 92.45 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -178.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.541 HG22 ' O ' ' A' ' 85' ' ' LEU . 9.8 t -70.74 -26.24 63.28 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 -178.058 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.416 ' CD2' ' HA ' ' A' ' 86' ' ' LEU . 6.7 m-85 -46.67 170.85 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -178.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 7.1 mp0 -88.56 -142.23 0.13 Allowed 'General case' 0 CA--C 1.55 0.947 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.728 -179.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 60.9 m-80 -80.08 -66.91 0.82 Allowed 'General case' 0 C--N 1.348 0.537 0 CA-C-N 119.076 0.853 . . . . 0.0 111.08 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.762 HG23 ' HG3' ' A' ' 18' ' ' GLU . 0.2 OUTLIER -78.8 124.1 27.87 Favored 'General case' 0 C--N 1.334 -0.095 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.412 179.804 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 21.9 t -114.16 112.37 39.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.143 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -90.41 111.37 22.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.889 179.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 15.8 mt -112.02 153.49 26.77 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 121.071 0.462 . . . . 0.0 112.166 -178.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.697 HD12 ' HB2' ' A' ' 68' ' ' GLN . 16.5 mt -118.5 130.52 73.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.794 178.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.771 HD13 HD23 ' A' ' 60' ' ' LEU . 29.3 pt -136.69 169.66 19.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.997 0.427 . . . . 0.0 111.925 -179.014 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.404 HG12 ' N ' ' A' ' 99' ' ' ARG . 21.3 t -143.65 154.94 16.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.412 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.404 ' N ' HG12 ' A' ' 98' ' ' VAL . 25.3 mmm180 -116.58 114.33 23.97 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.147 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.344 -179.346 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.699 0.285 . . . . 0.0 110.844 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 305' ' ' THR . . . . . . . . . . . . . 10.0 m -116.59 131.64 56.89 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.312 -0.404 . . . . 17.879999999999999 110.845 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 306' ' ' TRP . . . . . . . . . . . . . 80.3 m95 -91.09 115.52 28.08 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.847 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 307' ' ' VAL . . . . . 0.546 HG22 ' O ' ' A' ' 25' ' ' PHE . 14.1 m . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.229 -0.891 . . . . 16.109999999999999 111.084 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 . . . . . 0 CA--C 1.533 0.307 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 29.6 pt -108.78 166.46 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-O 120.931 0.396 . . . . 0.0 111.843 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 6.2 mtm-85 -114.2 164.26 14.12 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.575 -179.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.3 m -148.01 164.67 5.68 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.838 179.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 9.2 ttp180 -132.07 119.43 20.98 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.0 t -116.26 130.69 70.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.15 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.83 ' HG2' HG23 ' A' ' 92' ' ' THR . 2.6 mm-40 -105.3 123.79 48.45 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.923 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.538 ' HE2' HD11 ' A' ' 23' ' ' LEU . 11.3 mmtt -70.6 80.01 0.59 Allowed 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 120.805 0.336 . . . . 0.0 111.795 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -137.59 85.68 20.29 Favored Pre-proline 0 CA--C 1.537 0.454 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.068 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -83.57 -24.58 10.79 Favored 'Cis proline' 0 C--N 1.366 1.461 0 CA-C-N 119.55 0.875 . . . . 0.0 113.034 0.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -137.46 -177.33 4.74 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 120.799 0.333 . . . . 0.0 111.125 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.538 HD11 ' HE2' ' A' ' 19' ' ' LYS . 4.4 mp -61.94 -57.68 10.81 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.991 179.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 99.78 34.25 5.0 Favored Glycine 0 CA--C 1.522 0.513 0 C-N-CA 120.722 -0.751 . . . . 0.0 113.87 179.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.419 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 36.3 p90 -160.35 153.06 21.12 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 117.418 0.609 . . . . 0.0 111.184 179.096 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.7 p -105.43 147.95 27.69 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.221 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.659 HD11 HG22 ' A' ' 83' ' ' VAL . 32.4 pt -117.62 148.0 20.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.875 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 65.2 p -140.22 156.57 46.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.745 0.307 . . . . 0.0 111.188 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 109.11 -159.28 14.15 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 121.058 -0.592 . . . . 0.0 112.746 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 108.26 152.75 16.58 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 121.059 -0.591 . . . . 0.0 112.384 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 20.1 t -79.73 106.77 11.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.808 0.337 . . . . 0.0 110.661 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 88.06 -2.1 85.25 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 120.881 -0.675 . . . . 0.0 113.782 -179.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -84.44 -155.94 23.58 Favored Glycine 0 C--N 1.341 0.847 0 CA-C-N 117.869 0.835 . . . . 0.0 112.717 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.21 -24.86 65.16 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -179.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.61 160.0 35.92 Favored Glycine 0 C--N 1.34 0.793 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.504 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 13.7 p30 -119.59 126.37 26.99 Favored Pre-proline 0 N--CA 1.465 0.301 0 N-CA-C 110.619 -0.141 . . . . 0.0 110.619 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -88.62 51.87 1.77 Allowed 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 121.901 1.734 . . . . 0.0 112.254 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -133.92 -51.37 0.84 Allowed 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.124 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.403 ' HG3' ' CZ ' ' A' ' 46' ' ' PHE . 1.5 mmp_? -110.52 139.04 21.17 Favored Pre-proline 0 N--CA 1.466 0.33 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.879 -179.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -85.58 -46.38 0.04 OUTLIER 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 122.038 1.825 . . . . 0.0 113.198 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -94.62 -8.77 37.08 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 -179.232 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -103.1 116.53 32.68 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 118.157 0.435 . . . . 0.0 110.579 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.7 p30 -104.25 35.3 2.74 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.2 -179.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -84.23 -156.77 24.79 Favored Glycine 0 CA--C 1.519 0.316 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.29 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 14.4 mm -111.88 142.57 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-O 120.676 0.274 . . . . 0.0 110.692 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.403 ' CZ ' ' HG3' ' A' ' 39' ' ' ARG . 55.0 m-85 -140.15 154.1 46.87 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.162 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.45 HG21 HD22 ' A' ' 60' ' ' LEU . 17.8 t -97.99 75.75 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-O 120.968 0.413 . . . . 0.0 111.191 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.429 HG23 ' N ' ' A' ' 49' ' ' ARG . 10.0 t -35.66 -51.68 0.66 Allowed 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 -178.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.429 ' N ' HG23 ' A' ' 48' ' ' THR . 14.5 ptt180 -160.36 175.4 12.85 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.162 0.506 . . . . 0.0 112.137 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 20.5 t -131.28 151.21 35.33 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.673 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.425 ' HG2' ' CH2' ' B' ' 306' ' ' TRP . 7.5 mm-40 -104.38 -67.82 0.04 OUTLIER Pre-proline 0 CA--C 1.537 0.471 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.676 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -77.4 122.46 6.08 Favored 'Trans proline' 0 C--N 1.357 0.977 0 C-N-CA 121.675 1.584 . . . . 0.0 112.233 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -80.16 64.21 4.91 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.091 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -158.43 -70.56 0.01 OUTLIER Glycine 0 CA--C 1.528 0.886 0 C-N-CA 120.703 -0.76 . . . . 0.0 113.564 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.57 -74.45 0.02 OUTLIER 'Trans proline' 0 C--N 1.358 1.06 0 C-N-CA 122.032 1.821 . . . . 0.0 113.355 -178.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.475 ' HB1' HD12 ' A' ' 60' ' ' LEU . . . -106.9 46.76 0.91 Allowed 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 121.083 0.468 . . . . 0.0 111.643 -179.248 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 91.8 p -108.54 -60.39 1.74 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.109 179.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 5.7 ttpm? -69.42 -15.52 63.3 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.068 179.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 64.2 mt -93.23 -63.35 1.22 Allowed 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.869 0.366 . . . . 0.0 111.158 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.612 HD23 HG21 ' A' ' 97' ' ' ILE . 2.9 mt -91.87 144.03 25.9 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.44 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 5.1 pp0? -117.35 155.79 49.64 Favored Pre-proline 0 CA--C 1.534 0.355 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.449 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -59.19 119.28 6.42 Favored 'Trans proline' 0 C--N 1.357 1.01 0 C-N-CA 121.829 1.686 . . . . 0.0 112.49 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 98.68 5.37 56.73 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 121.05 -0.595 . . . . 0.0 113.827 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -71.13 140.35 50.56 Favored 'General case' 0 C--N 1.343 0.32 0 CA-C-N 118.102 0.951 . . . . 0.0 110.791 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 67.0 tttt -92.61 123.45 35.91 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.926 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 20.0 mt -89.15 115.23 28.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.218 -0.447 . . . . 0.0 109.841 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 19.9 mm -89.53 -42.16 14.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 112.249 0.462 . . . . 0.0 112.249 -178.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.879 ' HB3' HD12 ' A' ' 96' ' ' ILE . 22.4 tt0 -152.53 156.97 40.4 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.933 0.397 . . . . 0.0 111.884 -179.148 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -144.67 125.89 14.69 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.194 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.54 ' OD1' HG13 ' A' ' 93' ' ' VAL . 4.3 m-20 45.72 34.45 1.8 Allowed 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 178.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 95.01 -18.03 58.16 Favored Glycine 0 CA--C 1.523 0.593 0 C-N-CA 120.772 -0.728 . . . . 0.0 113.534 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -89.23 126.98 35.72 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 117.353 0.576 . . . . 0.0 110.884 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 8.4 t -72.64 124.52 25.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.937 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -102.75 12.95 35.57 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 6.4 tp -91.0 121.74 41.68 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 CA-C-O 120.944 0.402 . . . . 0.0 110.703 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 5.4 m120 64.24 74.17 0.41 Allowed 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 121.094 0.474 . . . . 0.0 110.721 -179.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 13.9 pt -149.77 164.27 3.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.794 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -73.79 144.83 45.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.663 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 6.9 t60 -54.3 -54.35 41.43 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.804 -179.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -54.78 -27.46 43.65 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 121.163 -0.541 . . . . 0.0 112.911 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -71.21 -39.29 71.83 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.093 0.473 . . . . 0.0 110.451 179.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.19 -52.14 44.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.492 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.659 HG22 HD11 ' A' ' 27' ' ' ILE . 20.8 t -59.68 -43.89 92.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.604 -179.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 57.8 m -59.99 -40.9 90.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.534 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 31.2 mt -66.4 -43.93 84.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.53 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.419 HD23 ' CE2' ' A' ' 89' ' ' PHE . 32.6 mt -66.51 -42.6 87.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.796 -179.249 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 42.0 mmtt -65.02 -43.07 93.68 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -178.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 12.1 t -69.43 -25.89 64.34 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -178.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.419 ' CE2' HD23 ' A' ' 86' ' ' LEU . 14.7 m-30 -45.56 170.99 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -179.053 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -84.56 -143.01 0.08 Allowed 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.973 -179.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 35.9 m120 -83.07 -62.21 1.66 Allowed 'General case' 0 C--N 1.348 0.506 0 CA-C-N 118.992 0.814 . . . . 0.0 111.779 -178.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.83 HG23 ' HG2' ' A' ' 18' ' ' GLU . 0.3 OUTLIER -87.5 129.57 35.02 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.505 -179.65 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.54 HG13 ' OD1' ' A' ' 70' ' ' ASN . 19.1 t -125.41 121.02 59.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.139 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -95.37 105.67 17.65 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.469 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 12.1 mt -99.11 152.55 19.74 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 121.076 0.465 . . . . 0.0 111.673 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.879 HD12 ' HB3' ' A' ' 68' ' ' GLN . 61.1 mt -110.37 126.21 67.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.654 178.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.612 HG21 HD23 ' A' ' 60' ' ' LEU . 43.6 pt -127.95 168.62 20.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.821 0.343 . . . . 0.0 111.622 -178.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.4 t -145.88 151.34 14.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.236 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -114.72 109.68 18.57 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.315 -0.402 . . . . 0.0 109.95 179.292 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.891 -179.107 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.535 0.369 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 305' ' ' THR . . . . . . . . . . . . . 21.0 m -154.67 100.31 2.23 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 114.942 -1.026 . . . . 17.879999999999999 109.698 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 306' ' ' TRP . . . . . 0.425 ' CH2' ' HG2' ' A' ' 51' ' ' GLN . 83.4 m95 -60.6 123.0 16.11 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.995 0.426 . . . . 0.0 111.684 -179.045 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 307' ' ' VAL . . . . . 0.531 HG12 HG13 ' A' ' 83' ' ' VAL . 16.0 m . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.273 -0.87 . . . . 16.109999999999999 111.174 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.535 0.369 0 CA-C-O 120.637 0.256 . . . . 0.0 110.885 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.604 HD13 ' N ' ' A' ' 13' ' ' ILE . 0.2 OUTLIER -150.4 163.56 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-O 120.61 0.243 . . . . 0.0 111.571 179.89 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 57.9 mtt180 -116.78 164.72 14.23 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.879 -179.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.424 HG21 HD21 ' A' ' 60' ' ' LEU . 15.0 m -146.08 161.15 11.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.027 179.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.39 120.83 23.62 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.659 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.7 t -125.71 135.55 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.793 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.406 ' HG3' HG23 ' A' ' 92' ' ' THR . 2.9 mp0 -107.44 127.86 53.97 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.742 0.306 . . . . 0.0 111.418 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.46 112.45 6.75 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.13 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -173.75 83.45 0.38 Allowed Pre-proline 0 CA--C 1.54 0.566 0 CA-C-N 116.488 -0.323 . . . . 0.0 111.31 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -83.84 -23.3 12.93 Favored 'Cis proline' 0 C--N 1.366 1.463 0 CA-C-N 119.359 0.807 . . . . 0.0 112.888 0.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -137.41 -177.97 5.01 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.745 0.307 . . . . 0.0 110.955 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.612 HD13 HG23 ' B' ' 307' ' ' VAL . 3.2 mp -65.66 -54.35 28.8 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.963 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.592 ' O ' HG13 ' A' ' 50' ' ' VAL . . . 109.83 32.93 2.74 Favored Glycine 0 C--N 1.334 0.426 0 C-N-CA 120.837 -0.697 . . . . 0.0 113.543 179.17 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.409 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 35.8 p90 -167.21 179.38 5.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 117.008 0.404 . . . . 0.0 111.069 179.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.0 p -131.39 162.4 30.24 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.205 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.693 HD11 HG22 ' A' ' 83' ' ' VAL . 37.4 pt -127.38 154.89 38.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.879 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 39.1 t -145.14 166.51 25.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.014 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 101.01 -147.52 17.85 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.635 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 105.47 152.97 21.2 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.932 -0.652 . . . . 0.0 112.446 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.46 HG21 ' HA ' ' A' ' 76' ' ' ASN . 32.2 t -79.81 108.1 12.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.913 0.387 . . . . 0.0 110.587 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 90.28 -1.06 79.16 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 120.946 -0.645 . . . . 0.0 113.844 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -83.82 -149.45 9.54 Favored Glycine 0 C--N 1.342 0.903 0 CA-C-N 117.866 0.833 . . . . 0.0 112.887 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 52.0 mtt85 -81.34 -18.32 46.12 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -179.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.06 -177.89 49.41 Favored Glycine 0 C--N 1.338 0.652 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.757 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -136.82 157.78 74.23 Favored Pre-proline 0 CA--C 1.533 0.301 0 O-C-N 123.041 -0.093 . . . . 0.0 110.78 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -87.87 17.71 1.65 Allowed 'Trans proline' 0 C--N 1.358 1.068 0 C-N-CA 122.147 1.898 . . . . 0.0 113.781 -179.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -101.77 -41.07 6.66 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.87 0.367 . . . . 0.0 110.626 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 11.2 mmp_? -129.99 132.06 23.88 Favored Pre-proline 0 CA--C 1.533 0.322 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.332 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -83.05 -40.39 0.11 Allowed 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 121.887 1.725 . . . . 0.0 113.089 -179.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -99.92 -4.23 30.65 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -179.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -90.63 122.67 33.62 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 118.2 0.455 . . . . 0.0 110.912 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -102.18 40.82 1.29 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.132 -179.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -98.9 -170.77 31.22 Favored Glycine 0 C--N 1.333 0.387 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.507 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 22.0 mm -110.26 127.69 67.03 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-N 116.569 0.184 . . . . 0.0 110.51 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.44 ' CD1' ' N ' ' A' ' 46' ' ' PHE . 4.0 m-85 -128.29 146.77 50.65 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.762 0.315 . . . . 0.0 111.529 -179.454 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 21.4 t -86.7 79.57 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-O 120.98 0.419 . . . . 0.0 111.077 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.5 t -36.24 -55.22 0.8 Allowed 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 114.849 1.426 . . . . 0.0 114.849 -178.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -160.07 -179.55 7.87 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.218 0.532 . . . . 0.0 112.392 -179.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.592 HG13 ' O ' ' A' ' 24' ' ' GLY . 13.7 t -138.48 145.55 28.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.498 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.403 ' HG3' ' CH2' ' B' ' 306' ' ' TRP . 15.3 mt-30 -104.55 -68.71 0.04 OUTLIER Pre-proline 0 CA--C 1.537 0.459 0 N-CA-C 111.59 0.218 . . . . 0.0 111.59 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.401 ' HD3' ' CB ' ' A' ' 51' ' ' GLN . 81.4 Cg_endo -81.16 113.84 2.75 Favored 'Trans proline' 0 C--N 1.357 1.005 0 C-N-CA 121.661 1.574 . . . . 0.0 112.304 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -77.78 70.36 4.14 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.138 0.494 . . . . 0.0 110.936 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -145.37 -71.45 0.02 OUTLIER Glycine 0 CA--C 1.526 0.762 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.643 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -58.59 -71.93 0.03 OUTLIER 'Trans proline' 0 C--N 1.357 0.998 0 C-N-CA 122.021 1.814 . . . . 0.0 112.796 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.559 ' HB1' HD12 ' A' ' 60' ' ' LEU . . . -105.87 47.34 0.88 Allowed 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 121.217 0.532 . . . . 0.0 111.263 -179.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 98.1 p -83.2 -59.73 2.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.965 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 37.2 tptt -88.21 4.42 45.79 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.016 178.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.475 ' N ' HD22 ' A' ' 59' ' ' LEU . 3.6 mm? -92.6 -64.87 1.05 Allowed 'General case' 0 C--N 1.343 0.302 0 CA-C-N 118.16 0.436 . . . . 0.0 111.727 -179.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.559 HD12 ' HB1' ' A' ' 56' ' ' ALA . 3.1 mt -100.9 145.4 28.67 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.159 0.504 . . . . 0.0 112.223 -178.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -107.28 142.51 25.25 Favored Pre-proline 0 CA--C 1.534 0.358 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.996 179.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.02 131.29 45.52 Favored 'Trans proline' 0 C--N 1.357 1.0 0 C-N-CA 121.899 1.733 . . . . 0.0 113.159 -179.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 81.72 32.25 30.65 Favored Glycine 0 C--N 1.33 0.235 0 CA-C-N 115.979 -0.555 . . . . 0.0 113.55 179.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -88.28 -169.51 2.59 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 117.027 0.414 . . . . 0.0 110.898 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 78.1 tttt -138.44 125.64 21.54 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.975 -179.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 34.3 mt -94.36 122.53 45.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.501 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 26.0 mm -104.5 -36.82 4.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -179.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.575 ' HB3' HD12 ' A' ' 96' ' ' ILE . 0.1 OUTLIER -148.87 149.46 31.31 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.974 0.416 . . . . 0.0 111.827 -179.185 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.462 ' HB3' ' CE1' ' A' ' 74' ' ' PHE . . . -145.77 122.46 11.17 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.334 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.3 m120 45.94 38.3 4.44 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 179.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 84.42 11.21 78.38 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 121.007 -0.616 . . . . 0.0 113.87 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -113.44 121.8 45.38 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 117.69 0.745 . . . . 0.0 110.238 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 79.9 p -72.74 135.78 45.39 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.661 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.462 ' CE1' ' HB3' ' A' ' 69' ' ' ALA . 5.1 m-85 -104.59 23.51 13.21 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.423 HD13 ' HA ' ' A' ' 75' ' ' ILE . 11.4 mm -97.41 139.77 19.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-O 121.032 0.444 . . . . 0.0 109.921 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.46 ' HA ' HG21 ' A' ' 31' ' ' VAL . 7.9 m120 61.47 16.69 7.77 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.446 HD13 ' HA ' ' A' ' 74' ' ' PHE . 25.9 pt -95.29 163.8 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -179.065 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -91.67 149.69 21.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.173 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 15.3 t60 -46.41 -51.89 14.1 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -179.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -56.13 -26.91 50.73 Favored Glycine 0 CA--C 1.523 0.573 0 C-N-CA 120.985 -0.626 . . . . 0.0 113.176 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -74.56 -42.97 57.84 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 120.954 0.407 . . . . 0.0 110.476 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.25 -42.49 99.18 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.374 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.693 HG22 HD11 ' A' ' 27' ' ' ILE . 18.0 t -73.71 -40.99 54.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.753 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 43.7 t -62.19 -46.76 87.47 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.353 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 31.5 mt -61.16 -49.83 75.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.72 -179.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.739 HD21 HD21 ' A' ' 95' ' ' LEU . 17.3 mt -64.1 -37.68 88.31 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -178.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 9.2 mmtp -71.04 -39.82 72.06 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -178.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 11.4 t -71.87 -27.31 62.78 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 -178.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.411 ' CD2' ' HA ' ' A' ' 86' ' ' LEU . 9.6 m-85 -46.74 170.9 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -178.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -83.85 -142.85 0.07 Allowed 'General case' 0 CA--C 1.55 0.968 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.834 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -79.48 -70.3 0.52 Allowed 'General case' 0 C--N 1.348 0.523 0 CA-C-N 119.22 0.918 . . . . 0.0 111.501 -179.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.406 HG23 ' HG3' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -75.24 123.45 25.32 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.634 -179.687 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.503 HG12 ' CD1' ' A' ' 95' ' ' LEU . 14.2 t -121.04 120.82 63.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.723 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -99.91 107.17 19.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.54 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.739 HD21 HD21 ' A' ' 86' ' ' LEU . 6.2 mp -107.13 161.76 14.48 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 121.054 0.455 . . . . 0.0 111.788 -179.411 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.575 HD12 ' HB3' ' A' ' 68' ' ' GLN . 21.5 mt -123.64 132.23 71.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.402 178.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.421 HD13 HD23 ' A' ' 60' ' ' LEU . 43.9 pt -126.38 175.64 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-O 120.689 0.281 . . . . 0.0 111.625 -178.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 17.2 t -150.22 143.96 17.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-O 120.934 0.397 . . . . 0.0 112.034 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.01 116.91 30.68 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 178.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 . . . . . 0 C--N 1.332 -0.17 0 CA-C-O 121.047 0.451 . . . . 0.0 111.811 -178.787 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 . . . . . 0 N--CA 1.461 0.116 0 CA-C-O 120.911 0.386 . . . . 0.0 111.082 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 305' ' ' THR . . . . . . . . . . . . . 15.2 m -142.24 132.28 24.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.948 -0.569 . . . . 17.879999999999999 110.368 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 306' ' ' TRP . . . . . 0.403 ' CH2' ' HG3' ' A' ' 51' ' ' GLN . 81.0 m95 -88.39 121.73 31.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.335 -179.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 307' ' ' VAL . . . . . 0.612 HG23 HD13 ' A' ' 23' ' ' LEU . 23.8 m . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.314 -0.851 . . . . 16.109999999999999 111.167 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 . . . . . 0 N--CA 1.463 0.211 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.6 pt -148.21 159.14 7.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -178.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.737 ' HG3' HD13 ' A' ' 96' ' ' ILE . 13.3 ttp-105 -119.52 157.01 29.21 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.639 -179.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 17.6 m -150.93 152.67 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 2.0 ptp180 -114.92 129.02 56.62 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.025 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.2 t -113.54 119.57 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.789 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -93.54 121.48 35.0 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.648 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.91 116.07 10.79 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.752 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -175.85 81.39 0.29 Allowed Pre-proline 0 CA--C 1.538 0.509 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.753 179.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -84.85 -22.97 12.86 Favored 'Cis proline' 0 C--N 1.363 1.294 0 CA-C-N 119.327 0.795 . . . . 0.0 113.333 0.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -137.93 -179.18 5.61 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.946 0.403 . . . . 0.0 112.06 -179.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.4 mp -61.82 -61.17 2.69 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.293 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.417 ' O ' HG13 ' A' ' 50' ' ' VAL . . . 109.25 20.55 7.81 Favored Glycine 0 CA--C 1.523 0.568 0 C-N-CA 120.788 -0.72 . . . . 0.0 113.796 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -151.0 155.67 39.53 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 117.52 0.66 . . . . 0.0 111.393 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -110.11 151.94 26.62 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.537 -179.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.619 HD11 HG22 ' A' ' 83' ' ' VAL . 12.1 pt -121.07 151.67 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.465 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.3 m -150.29 163.12 39.1 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.345 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 120.75 -89.57 0.45 Allowed Glycine 0 C--N 1.337 0.618 0 C-N-CA 121.034 -0.603 . . . . 0.0 113.379 179.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.432 ' H ' HD13 ' A' ' 45' ' ' ILE . . . 66.91 -138.45 35.08 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.938 -0.649 . . . . 0.0 112.427 -179.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.49 HG12 ' O ' ' A' ' 31' ' ' VAL . 47.0 t -131.42 57.95 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-O 121.145 0.497 . . . . 0.0 111.38 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 92.15 -7.5 78.43 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 115.09 0.796 . . . . 0.0 115.09 178.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -97.68 26.88 21.34 Favored Glycine 0 C--N 1.339 0.75 0 CA-C-N 118.092 0.946 . . . . 0.0 113.642 -179.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -173.12 -42.22 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 178.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.86 146.66 0.74 Allowed Glycine 0 CA--C 1.521 0.419 0 CA-C-N 115.877 -0.602 . . . . 0.0 112.966 179.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -123.94 137.58 29.12 Favored Pre-proline 0 CA--C 1.534 0.332 0 N-CA-C 110.541 -0.17 . . . . 0.0 110.541 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -91.47 24.44 0.55 Allowed 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 122.289 1.992 . . . . 0.0 113.593 -179.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -107.94 -52.84 2.71 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.759 0.314 . . . . 0.0 110.813 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -119.58 133.37 23.82 Favored Pre-proline 0 N--CA 1.466 0.372 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.359 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -84.61 -46.59 0.05 OUTLIER 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 121.869 1.713 . . . . 0.0 113.086 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 13.1 p-10 -88.06 -9.48 53.21 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -179.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -100.89 118.05 36.16 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 118.056 0.389 . . . . 0.0 110.725 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.8 p30 -106.79 66.7 0.69 Allowed 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 121.15 0.5 . . . . 0.0 110.912 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.478 ' O ' HD13 ' A' ' 45' ' ' ILE . . . -114.98 -143.79 8.21 Favored Glycine 0 CA--C 1.519 0.308 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.366 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.478 HD13 ' O ' ' A' ' 44' ' ' GLY . 21.5 mm -125.68 128.14 72.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.607 0.241 . . . . 0.0 110.735 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -121.6 147.46 45.81 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.075 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 21.7 t -92.07 71.89 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.04 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.421 HG23 ' N ' ' A' ' 49' ' ' ARG . 10.1 t -35.78 -54.13 0.73 Allowed 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 -178.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.421 ' N ' HG23 ' A' ' 48' ' ' THR . 0.0 OUTLIER -160.03 168.49 25.47 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.945 0.721 . . . . 0.0 112.945 -178.969 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.417 HG13 ' O ' ' A' ' 24' ' ' GLY . 17.3 t -124.89 150.98 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.401 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.4 ' CB ' ' HD3' ' A' ' 52' ' ' PRO . 4.5 mm-40 -105.54 -68.99 0.03 OUTLIER Pre-proline 0 CA--C 1.539 0.547 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.4 ' HD3' ' CB ' ' A' ' 51' ' ' GLN . 87.8 Cg_endo -80.93 121.68 4.11 Favored 'Trans proline' 0 C--N 1.359 1.091 0 C-N-CA 121.861 1.707 . . . . 0.0 112.818 -179.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -74.84 67.66 1.66 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 120.968 0.413 . . . . 0.0 111.328 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -156.81 -67.33 0.01 OUTLIER Glycine 0 CA--C 1.528 0.904 0 C-N-CA 120.803 -0.713 . . . . 0.0 113.476 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -58.63 -78.06 0.02 OUTLIER 'Trans proline' 0 C--N 1.357 0.983 0 C-N-CA 122.081 1.854 . . . . 0.0 113.499 -179.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.888 ' HB1' HD12 ' A' ' 60' ' ' LEU . . . -117.06 53.96 0.89 Allowed 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 121.255 0.55 . . . . 0.0 111.929 -179.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 77.8 p -108.14 -65.12 1.15 Allowed 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 178.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.14 -14.43 61.8 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.18 178.182 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 65.0 mt -92.66 -57.42 2.67 Favored 'General case' 0 C--N 1.344 0.329 0 O-C-N 122.137 -0.352 . . . . 0.0 110.901 179.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.888 HD12 ' HB1' ' A' ' 56' ' ' ALA . 27.9 mt -96.24 146.92 24.29 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.291 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -124.75 145.7 50.53 Favored Pre-proline 0 N--CA 1.47 0.567 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.97 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_exo -58.32 127.18 23.8 Favored 'Trans proline' 0 C--N 1.362 1.263 0 C-N-CA 122.35 2.034 . . . . 0.0 113.689 -178.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 106.65 8.35 32.64 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 120.906 -0.664 . . . . 0.0 114.435 178.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -93.71 146.89 23.52 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 117.821 0.81 . . . . 0.0 111.575 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 51.5 tttt -98.71 133.08 43.54 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.699 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 29.3 mt -89.29 119.74 36.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.467 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 20.5 mm -89.83 -38.68 11.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -178.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -155.36 154.66 32.35 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 121.059 0.457 . . . . 0.0 112.033 -179.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -141.93 123.87 15.31 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.966 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 42.91 41.69 2.71 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 179.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 84.97 -0.48 89.09 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 120.9 -0.666 . . . . 0.0 114.152 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -108.4 124.47 50.44 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 117.953 0.877 . . . . 0.0 110.914 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 30.6 t -70.9 131.62 44.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.694 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -101.7 19.8 17.44 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -179.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 28.7 mm -92.46 121.09 42.77 Favored 'Isoleucine or valine' 0 C--N 1.339 0.12 0 CA-C-O 120.766 0.317 . . . . 0.0 110.664 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 57.1 m-20 61.87 74.88 0.43 Allowed 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.209 0.528 . . . . 0.0 110.743 -179.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 10.3 pt -146.57 150.27 15.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.914 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -68.92 136.54 52.74 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.998 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.587 ' O ' HG23 ' A' ' 83' ' ' VAL . 36.7 t60 -43.47 -45.92 6.6 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -179.112 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -59.39 -28.69 65.04 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.457 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 3.7 tp-100 -72.65 -44.47 61.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.918 0.39 . . . . 0.0 110.639 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.87 -37.95 85.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.257 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.619 HG22 HD11 ' A' ' 27' ' ' ILE . 24.2 t -75.06 -42.48 45.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.946 0.403 . . . . 0.0 110.755 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 42.2 t -62.81 -41.65 99.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.142 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' A' ' 85' ' ' LEU . 27.4 mt -65.27 -46.75 79.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.455 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.429 ' HA ' ' CD2' ' A' ' 89' ' ' PHE . 27.2 mt -65.94 -30.87 71.52 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.147 -0.479 . . . . 0.0 112.169 -178.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 30.0 mmtt -77.13 -35.44 56.17 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -179.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 9.7 t -75.52 -26.68 58.28 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -178.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.429 ' CD2' ' HA ' ' A' ' 86' ' ' LEU . 21.0 m-85 -52.56 149.36 5.97 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.145 0.498 . . . . 0.0 112.134 -179.196 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -65.18 -136.65 0.0 OUTLIER 'General case' 0 CA--C 1.555 1.161 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.557 -179.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -80.3 -70.36 0.53 Allowed 'General case' 0 C--N 1.351 0.665 0 CA-C-N 119.588 1.086 . . . . 0.0 112.613 -179.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.8 p -78.34 127.53 32.35 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.792 0.329 . . . . 0.0 111.3 -179.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.466 ' O ' HD12 ' A' ' 95' ' ' LEU . 21.8 t -117.2 114.08 44.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.719 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -89.67 111.86 22.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.515 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.466 HD12 ' O ' ' A' ' 93' ' ' VAL . 4.0 mp -112.96 151.52 30.47 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.982 0.42 . . . . 0.0 111.781 -179.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.737 HD13 ' HG3' ' A' ' 14' ' ' ARG . 17.6 mm -107.6 121.93 61.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.9 178.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.459 HD13 HD23 ' A' ' 60' ' ' LEU . 22.4 pt -129.05 163.1 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-O 120.809 0.338 . . . . 0.0 111.881 -179.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.431 HG12 ' N ' ' A' ' 99' ' ' ARG . 14.3 t -150.76 155.72 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.727 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.431 ' N ' HG12 ' A' ' 98' ' ' VAL . 32.9 mmm-85 -110.5 122.43 47.73 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.767 177.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 . . . . . 0 C--N 1.328 -0.331 0 CA-C-O 120.852 0.358 . . . . 0.0 111.156 -179.598 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.763 0.316 . . . . 0.0 110.988 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 305' ' ' THR . . . . . . . . . . . . . 80.7 m -123.93 122.5 38.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.039 -0.528 . . . . 17.879999999999999 110.669 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 306' ' ' TRP . . . . . . . . . . . . . 86.1 m95 -78.16 107.84 11.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.891 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 307' ' ' VAL . . . . . 0.414 HG12 HG13 ' A' ' 83' ' ' VAL . 17.5 m . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.257 -0.878 . . . . 16.109999999999999 111.153 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.466 0.331 0 CA-C-O 120.58 0.229 . . . . 0.0 111.265 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.9 pt -107.94 162.49 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-N 116.204 -0.453 . . . . 0.0 112.164 -179.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.513 ' HG3' HD13 ' A' ' 96' ' ' ILE . 14.5 ttm105 -116.98 152.86 33.7 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.987 -179.278 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.1 m -143.2 144.12 24.1 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.668 179.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 11.6 ttp-105 -116.73 130.58 56.81 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.804 0.335 . . . . 0.0 111.293 -179.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.0 t -123.49 125.57 71.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.07 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.516 ' HG3' HG22 ' A' ' 92' ' ' THR . 6.1 mp0 -92.21 119.77 32.15 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.892 0.377 . . . . 0.0 111.086 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -71.18 119.75 15.77 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.091 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -174.65 82.72 0.34 Allowed Pre-proline 0 CA--C 1.539 0.556 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.077 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo -86.84 -18.93 19.75 Favored 'Cis proline' 0 C--N 1.365 1.409 0 CA-C-N 119.407 0.824 . . . . 0.0 113.228 0.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -133.44 -178.56 5.04 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.829 0.347 . . . . 0.0 111.383 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.417 ' HB3' ' CE2' ' A' ' 25' ' ' PHE . 2.9 mp -65.63 -56.16 13.69 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.707 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.453 ' O ' HG13 ' A' ' 50' ' ' VAL . . . 107.66 32.5 3.36 Favored Glycine 0 CA--C 1.52 0.383 0 C-N-CA 120.932 -0.652 . . . . 0.0 113.7 179.138 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.417 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 42.1 p90 -163.74 152.81 14.12 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 117.163 0.482 . . . . 0.0 111.175 179.232 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.9 p -104.25 150.45 24.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.456 -179.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.783 HD11 HG22 ' A' ' 83' ' ' VAL . 22.5 pt -117.67 144.58 25.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.49 179.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 77.8 p -131.52 157.34 43.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.767 0.318 . . . . 0.0 110.893 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 107.98 -156.19 15.92 Favored Glycine 0 C--N 1.33 0.234 0 C-N-CA 121.014 -0.613 . . . . 0.0 112.453 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 110.85 148.48 11.49 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.995 -0.621 . . . . 0.0 112.507 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.432 HG21 ' HA ' ' A' ' 76' ' ' ASN . 41.3 t -80.48 100.28 4.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.956 0.408 . . . . 0.0 110.903 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 94.79 2.28 63.01 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 120.99 -0.624 . . . . 0.0 114.139 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.97 -154.84 28.09 Favored Glycine 0 C--N 1.341 0.858 0 CA-C-N 117.827 0.813 . . . . 0.0 112.981 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 1.9 mtt180 -62.66 -22.85 66.77 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.79 160.12 35.49 Favored Glycine 0 C--N 1.336 0.537 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.843 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -114.62 136.15 22.4 Favored Pre-proline 0 CA--C 1.535 0.392 0 N-CA-C 110.556 -0.164 . . . . 0.0 110.556 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -87.91 13.28 2.64 Favored 'Trans proline' 0 C--N 1.357 1.0 0 C-N-CA 122.018 1.812 . . . . 0.0 113.98 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -99.64 -41.55 7.27 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.666 0.269 . . . . 0.0 111.178 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.76 136.15 27.99 Favored Pre-proline 0 N--CA 1.466 0.374 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.714 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -85.63 -44.58 0.05 OUTLIER 'Trans proline' 0 C--N 1.358 1.049 0 C-N-CA 122.052 1.835 . . . . 0.0 113.413 -179.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -92.64 -9.0 42.51 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -179.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -95.68 117.93 31.41 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-N 118.097 0.408 . . . . 0.0 110.339 179.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -105.09 38.56 1.91 Allowed 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.509 -179.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.52 ' O ' HD13 ' A' ' 45' ' ' ILE . . . -92.28 -148.67 23.11 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 120.867 -0.683 . . . . 0.0 111.846 179.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.52 HD13 ' O ' ' A' ' 44' ' ' GLY . 20.8 mm -125.52 140.22 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 116.798 0.299 . . . . 0.0 110.842 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -137.81 151.01 47.67 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.12 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 21.7 t -90.56 73.69 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-O 121.126 0.488 . . . . 0.0 111.084 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.43 HG23 ' N ' ' A' ' 49' ' ' ARG . 9.7 t -36.24 -53.17 0.82 Allowed 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 114.745 1.387 . . . . 0.0 114.745 -178.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.43 ' N ' HG23 ' A' ' 48' ' ' THR . 11.8 ptm180 -161.24 172.79 16.06 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.213 0.53 . . . . 0.0 112.291 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.453 HG13 ' O ' ' A' ' 24' ' ' GLY . 19.4 t -127.47 147.19 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.445 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.416 ' CG ' ' CH2' ' B' ' 306' ' ' TRP . 4.6 mm-40 -102.1 -69.67 0.04 OUTLIER Pre-proline 0 CA--C 1.537 0.446 0 CA-C-O 119.629 -0.224 . . . . 0.0 110.983 179.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.402 ' HD3' ' CB ' ' A' ' 51' ' ' GLN . 95.0 Cg_endo -80.91 114.93 2.97 Favored 'Trans proline' 0 C--N 1.359 1.112 0 C-N-CA 121.653 1.569 . . . . 0.0 112.036 179.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -74.89 68.4 1.76 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 121.025 0.44 . . . . 0.0 111.098 -179.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -150.94 -71.15 0.01 OUTLIER Glycine 0 CA--C 1.528 0.872 0 C-N-CA 120.668 -0.777 . . . . 0.0 113.714 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -59.7 -77.49 0.02 OUTLIER 'Trans proline' 0 C--N 1.358 1.06 0 C-N-CA 121.928 1.752 . . . . 0.0 113.465 -178.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.797 ' HB1' HD12 ' A' ' 60' ' ' LEU . . . -106.8 49.57 0.8 Allowed 'General case' 0 CA--C 1.529 0.152 0 CA-C-O 121.401 0.619 . . . . 0.0 111.194 -179.39 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.9 t -100.86 -61.41 1.37 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.117 179.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.7 ttpt -74.35 -7.68 53.69 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.106 178.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 20.7 mt -92.69 -59.02 2.17 Favored 'General case' 0 C--N 1.344 0.333 0 CA-C-N 118.219 0.463 . . . . 0.0 110.9 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.797 HD12 ' HB1' ' A' ' 56' ' ' ALA . 11.6 mt -93.36 143.29 26.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.299 -179.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -112.44 141.27 24.89 Favored Pre-proline 0 CA--C 1.534 0.365 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.258 179.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -57.62 122.55 11.96 Favored 'Trans proline' 0 C--N 1.358 1.045 0 C-N-CA 121.784 1.656 . . . . 0.0 112.777 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.57 16.6 21.84 Favored Glycine 0 CA--C 1.522 0.507 0 C-N-CA 120.971 -0.633 . . . . 0.0 113.932 179.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -94.29 147.36 23.27 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 117.559 0.68 . . . . 0.0 110.772 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 58.5 tttm -96.74 135.76 38.23 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.153 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 29.3 mt -95.67 123.65 47.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.591 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 23.7 mm -99.39 -42.22 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.824 -178.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -146.76 151.51 37.29 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 121.173 0.511 . . . . 0.0 112.139 -179.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.62 ' HB3' ' CE1' ' A' ' 74' ' ' PHE . . . -139.83 122.45 16.3 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.943 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 45.62 28.18 0.5 Allowed 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 179.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 95.47 14.19 48.5 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 120.966 -0.635 . . . . 0.0 113.49 -179.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -116.8 122.15 43.59 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 117.65 0.725 . . . . 0.0 110.677 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 63.8 p -68.87 124.11 22.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.427 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.62 ' CE1' ' HB3' ' A' ' 69' ' ' ALA . 3.4 m-85 -94.08 19.98 8.51 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 8.5 tp -97.84 138.11 23.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-O 120.633 0.254 . . . . 0.0 111.418 -179.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.432 ' HA ' HG21 ' A' ' 31' ' ' VAL . 77.2 m-20 63.18 20.82 12.51 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -179.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.487 HD13 ' HA ' ' A' ' 74' ' ' PHE . 26.2 pt -98.15 164.32 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -178.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -85.67 146.78 26.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.254 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.47 ' O ' HG23 ' A' ' 83' ' ' VAL . 31.1 t60 -47.34 -50.27 22.38 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 115.857 -0.611 . . . . 0.0 112.602 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -61.01 -29.04 69.84 Favored Glycine 0 CA--C 1.519 0.282 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.174 179.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -65.32 -45.79 82.92 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.918 0.389 . . . . 0.0 111.023 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.77 -38.31 86.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.361 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.783 HG22 HD11 ' A' ' 27' ' ' ILE . 25.6 t -73.11 -42.97 58.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.741 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 35.5 t -63.66 -46.0 87.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.087 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 23.8 mt -59.31 -50.97 71.92 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.826 -179.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.412 ' HA ' ' CD2' ' A' ' 89' ' ' PHE . 26.0 mt -62.76 -32.45 73.6 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.932 -178.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 44.1 mttm -76.88 -37.62 55.15 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -178.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 10.2 t -73.92 -29.51 62.08 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -178.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.412 ' CD2' ' HA ' ' A' ' 86' ' ' LEU . 15.3 m-85 -47.54 171.38 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -179.07 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -77.53 -145.6 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.98 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.659 -179.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 30.5 m120 -79.41 -67.96 0.71 Allowed 'General case' 0 C--N 1.348 0.511 0 CA-C-N 118.831 0.742 . . . . 0.0 110.835 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.516 HG22 ' HG3' ' A' ' 18' ' ' GLU . 0.8 OUTLIER -74.65 120.43 20.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.785 -179.865 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.438 HG12 ' CD1' ' A' ' 95' ' ' LEU . 18.4 t -113.22 115.18 49.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.897 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -95.39 107.0 19.11 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.454 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.438 ' CD1' HG12 ' A' ' 93' ' ' VAL . 6.2 mp -102.82 150.99 22.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.722 -179.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.513 HD13 ' HG3' ' A' ' 14' ' ' ARG . 17.2 mm -107.38 122.18 61.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.74 178.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.411 HD13 HD23 ' A' ' 60' ' ' LEU . 41.8 pt -126.03 163.4 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-O 121.148 0.499 . . . . 0.0 112.185 -179.15 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 51.1 t -137.89 144.3 31.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.185 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 49.5 mmm-85 -111.98 109.8 19.77 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.968 179.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 . . . . . 0 C--N 1.329 -0.309 0 CA-C-O 121.024 0.44 . . . . 0.0 111.777 -179.08 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 . . . . . 0 N--CA 1.463 0.178 0 CA-C-O 120.799 0.333 . . . . 0.0 110.991 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 305' ' ' THR . . . . . . . . . . . . . 6.8 m -124.23 115.89 21.8 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.072 -0.513 . . . . 17.879999999999999 110.453 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 306' ' ' TRP . . . . . 0.416 ' CH2' ' CG ' ' A' ' 51' ' ' GLN . 83.7 m95 -79.16 113.84 17.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.031 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 307' ' ' VAL . . . . . 0.425 HG12 HG13 ' A' ' 83' ' ' VAL . 16.1 m . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.223 -0.894 . . . . 16.109999999999999 111.142 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 . . . . . 0 CA--C 1.531 0.242 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.606 HD13 ' N ' ' A' ' 13' ' ' ILE . 0.2 OUTLIER -151.08 165.86 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -179.712 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.48 158.55 22.4 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.637 179.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.9 m -144.16 145.51 21.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.755 179.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.03 114.19 27.91 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.177 -179.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.4 t -110.62 119.13 58.76 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.839 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.556 ' HG3' HG23 ' A' ' 92' ' ' THR . 1.0 OUTLIER -100.04 128.56 46.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.491 179.581 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.496 ' HD3' HD12 ' A' ' 23' ' ' LEU . 14.0 mtmt -84.02 123.77 30.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.139 0.495 . . . . 0.0 111.608 -179.462 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -172.84 85.7 0.41 Allowed Pre-proline 0 CA--C 1.537 0.448 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.797 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -82.48 -20.19 20.35 Favored 'Cis proline' 0 C--N 1.365 1.401 0 CA-C-N 119.357 0.806 . . . . 0.0 113.15 0.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -136.4 -178.34 5.12 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 120.854 0.359 . . . . 0.0 111.513 -179.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.496 HD12 ' HD3' ' A' ' 19' ' ' LYS . 3.4 mp -67.21 -52.41 41.42 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.668 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.423 ' O ' HG13 ' A' ' 50' ' ' VAL . . . 106.75 26.17 5.94 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.898 -0.668 . . . . 0.0 113.833 179.096 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.419 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 42.1 p90 -156.63 171.14 20.86 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 117.461 0.63 . . . . 0.0 111.316 179.429 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.3 p -119.82 153.63 35.48 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.09 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.78 HD11 HG22 ' A' ' 83' ' ' VAL . 26.4 pt -120.39 148.52 23.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.907 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 74.6 p -140.61 158.28 44.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.045 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 106.26 -148.01 16.36 Favored Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.731 179.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.79 151.77 26.34 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.374 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 13.7 t -79.82 99.32 3.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.722 0.296 . . . . 0.0 110.463 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 104.28 -7.81 47.88 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 120.922 -0.656 . . . . 0.0 113.522 -179.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -73.44 -148.44 1.13 Allowed Glycine 0 C--N 1.344 1.001 0 CA-C-N 117.751 0.776 . . . . 0.0 112.248 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 53.1 mtt-85 -89.21 16.96 6.46 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -179.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 63.86 170.72 1.88 Allowed Glycine 0 C--N 1.338 0.693 0 C-N-CA 120.999 -0.62 . . . . 0.0 113.42 179.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -139.75 143.8 36.4 Favored Pre-proline 0 CA--C 1.534 0.363 0 N-CA-C 110.518 -0.179 . . . . 0.0 110.518 179.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -92.32 27.28 0.38 Allowed 'Trans proline' 0 C--N 1.358 1.042 0 C-N-CA 122.34 2.027 . . . . 0.0 113.537 -179.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -103.43 -51.35 3.23 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.754 0.311 . . . . 0.0 110.945 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 16.2 mtp180 -120.31 137.33 25.95 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.418 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -85.3 -45.74 0.05 OUTLIER 'Trans proline' 0 C--N 1.358 1.078 0 C-N-CA 121.904 1.736 . . . . 0.0 113.59 -179.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -89.62 -13.01 38.04 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -179.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -106.74 122.69 46.87 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 122.001 -0.437 . . . . 0.0 110.831 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 19.0 p30 -108.69 36.04 2.99 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 121.01 0.433 . . . . 0.0 111.099 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -79.27 -157.93 12.89 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.361 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.7 mm -110.14 132.06 59.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-O 120.697 0.284 . . . . 0.0 111.114 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.435 ' N ' ' CD1' ' A' ' 46' ' ' PHE . 5.4 m-85 -131.39 150.14 52.27 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.346 179.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.607 HG23 ' OD1' ' A' ' 64' ' ' ASP . 31.4 t -94.15 75.68 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-O 120.961 0.41 . . . . 0.0 111.466 -179.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.406 HG23 ' N ' ' A' ' 49' ' ' ARG . 5.2 t -33.89 -52.99 0.45 Allowed 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 114.939 1.459 . . . . 0.0 114.939 -178.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.406 ' N ' HG23 ' A' ' 48' ' ' THR . 13.0 ptm180 -158.13 173.54 16.57 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -179.257 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.423 HG13 ' O ' ' A' ' 24' ' ' GLY . 18.3 t -133.81 150.0 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.464 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.407 ' HG3' ' CH2' ' B' ' 306' ' ' TRP . 8.1 mt-30 -104.99 -67.92 0.04 OUTLIER Pre-proline 0 CA--C 1.539 0.543 0 N-CA-C 111.643 0.238 . . . . 0.0 111.643 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -79.07 121.07 4.79 Favored 'Trans proline' 0 C--N 1.358 1.047 0 C-N-CA 121.645 1.563 . . . . 0.0 112.522 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -78.61 69.55 4.81 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 121.103 0.478 . . . . 0.0 111.016 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -158.37 -68.96 0.01 OUTLIER Glycine 0 CA--C 1.528 0.885 0 C-N-CA 120.794 -0.717 . . . . 0.0 113.358 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -60.98 -75.41 0.02 OUTLIER 'Trans proline' 0 C--N 1.358 1.053 0 C-N-CA 121.94 1.76 . . . . 0.0 113.429 -178.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.742 ' HB1' HD12 ' A' ' 60' ' ' LEU . . . -108.15 47.52 0.9 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 121.24 0.543 . . . . 0.0 111.964 -178.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.4 t -111.22 -64.19 1.31 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.727 178.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.14 -16.11 61.17 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.783 178.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 27.7 mt -96.51 -52.67 3.86 Favored 'General case' 0 C--N 1.342 0.262 0 CA-C-O 120.616 0.246 . . . . 0.0 111.135 -179.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.742 HD12 ' HB1' ' A' ' 56' ' ' ALA . 8.9 mt -103.76 151.12 23.42 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.884 0.373 . . . . 0.0 111.748 -179.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 3.5 pp0? -126.45 149.42 67.57 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.641 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -58.57 130.01 35.19 Favored 'Trans proline' 0 C--N 1.361 1.186 0 C-N-CA 122.342 2.028 . . . . 0.0 113.658 -178.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 98.35 9.46 53.28 Favored Glycine 0 CA--C 1.525 0.714 0 CA-C-N 115.673 -0.694 . . . . 0.0 114.075 179.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.607 ' OD1' HG23 ' A' ' 47' ' ' VAL . 10.5 p30 -77.82 -174.48 3.52 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 117.841 0.82 . . . . 0.0 111.623 -179.272 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 25.4 tttm -139.2 124.32 18.95 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.008 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 26.5 mt -88.72 115.23 28.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-O 121.106 0.479 . . . . 0.0 110.812 -179.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 19.8 mm -89.78 -42.82 14.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -178.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.784 ' HB2' HD12 ' A' ' 96' ' ' ILE . 0.0 OUTLIER -150.11 146.33 26.85 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.102 0.477 . . . . 0.0 112.116 -179.006 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.587 ' HB3' ' CE1' ' A' ' 74' ' ' PHE . . . -131.06 120.9 24.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.919 179.464 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 42.76 35.46 0.71 Allowed 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 178.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 91.51 -12.59 68.88 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 120.819 -0.705 . . . . 0.0 113.853 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -88.21 125.46 34.64 Favored 'General case' 0 C--O 1.231 0.082 0 CA-C-N 117.648 0.724 . . . . 0.0 109.949 179.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 84.4 p -69.67 115.55 9.04 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.754 -179.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.587 ' CE1' ' HB3' ' A' ' 69' ' ' ALA . 4.4 m-85 -95.25 9.17 40.75 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.954 178.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 7.6 tp -89.38 126.86 42.33 Favored 'Isoleucine or valine' 0 C--N 1.343 0.288 0 CA-C-N 118.181 0.446 . . . . 0.0 110.508 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 57.1 m-80 61.09 70.82 0.59 Allowed 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 121.284 0.564 . . . . 0.0 110.786 -179.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.404 HD13 ' HA ' ' A' ' 74' ' ' PHE . 19.9 pt -145.6 168.48 7.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.885 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -82.45 148.14 28.34 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.18 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.423 ' O ' HG23 ' A' ' 83' ' ' VAL . 1.3 t-160 -52.23 -52.5 52.03 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.281 -179.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -56.8 -26.05 53.34 Favored Glycine 0 CA--C 1.523 0.552 0 C-N-CA 121.037 -0.601 . . . . 0.0 113.171 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -74.32 -40.25 62.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.068 0.461 . . . . 0.0 110.641 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.3 -34.47 74.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.797 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.78 HG22 HD11 ' A' ' 27' ' ' ILE . 24.0 t -75.08 -44.85 43.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.911 0.386 . . . . 0.0 110.861 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 23.3 t -59.01 -36.97 75.83 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.383 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 85' ' ' LEU . 35.7 mt -71.0 -42.3 69.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.099 0.476 . . . . 0.0 110.588 179.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.425 ' HA ' ' CD2' ' A' ' 89' ' ' PHE . 33.2 mt -77.53 -8.27 57.54 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -179.408 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 15.8 mmtp -98.09 -36.65 10.02 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.247 0.546 . . . . 0.0 110.427 178.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 9.1 t -70.19 -21.78 63.01 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.494 -0.775 . . . . 0.0 112.142 -178.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.425 ' CD2' ' HA ' ' A' ' 86' ' ' LEU . 12.9 m-85 -55.83 126.8 27.22 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.194 0.521 . . . . 0.0 111.06 -179.06 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 23.1 mp0 -60.29 -64.5 0.93 Allowed 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -177.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 32.4 m120 -134.6 -81.95 0.44 Allowed 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -178.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.556 HG23 ' HG3' ' A' ' 18' ' ' GLU . 0.2 OUTLIER -70.76 158.75 35.76 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.033 0.444 . . . . 0.0 111.08 -178.718 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 19.5 t -150.38 113.97 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.888 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -89.36 119.33 29.73 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.202 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.5 mt -122.71 147.41 46.51 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.166 0.508 . . . . 0.0 111.893 -178.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.784 HD12 ' HB2' ' A' ' 68' ' ' GLN . 41.2 mt -112.86 126.46 70.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.536 -0.757 . . . . 0.0 109.719 178.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.454 HD13 HD23 ' A' ' 60' ' ' LEU . 30.9 pt -126.0 166.48 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-O 120.837 0.351 . . . . 0.0 111.296 -179.051 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 16.1 t -150.01 149.49 14.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.574 -179.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.34 115.63 30.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.258 178.213 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 . . . . . 0 C--N 1.329 -0.288 0 CA-C-O 120.935 0.398 . . . . 0.0 111.7 -178.532 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 . . . . . 0 N--CA 1.466 0.352 0 CA-C-O 120.754 0.311 . . . . 0.0 110.716 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 305' ' ' THR . . . . . . . . . . . . . 4.3 m -124.77 130.94 53.38 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.189 -0.46 . . . . 17.879999999999999 110.731 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 306' ' ' TRP . . . . . 0.407 ' CH2' ' HG3' ' A' ' 51' ' ' GLN . 77.2 m95 -91.05 110.84 22.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.92 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 307' ' ' VAL . . . . . 0.461 HG12 HG13 ' A' ' 83' ' ' VAL . 16.8 m . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.217 -0.897 . . . . 16.109999999999999 111.076 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 . . . . . 0 N--CA 1.464 0.233 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.4 pt -109.3 158.94 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -178.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -116.12 148.65 40.08 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.975 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 20.1 m -138.85 142.41 34.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.011 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 74.9 mtm-85 -105.18 120.31 41.22 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.123 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.1 t -111.01 112.91 42.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.974 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -89.19 119.55 29.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.676 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.47 ' HE2' HD11 ' A' ' 23' ' ' LEU . 20.1 mttt -75.03 118.0 17.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.046 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -169.37 86.89 0.61 Allowed Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.56 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -81.61 -18.45 24.93 Favored 'Cis proline' 0 C--N 1.363 1.294 0 CA-C-N 119.384 0.816 . . . . 0.0 113.408 0.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -136.42 -175.97 4.18 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.695 0.283 . . . . 0.0 111.1 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.47 HD11 ' HE2' ' A' ' 19' ' ' LYS . 3.7 mp -62.36 -56.96 13.33 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.685 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.562 ' O ' HG13 ' A' ' 50' ' ' VAL . . . 100.9 35.53 4.25 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.762 -0.732 . . . . 0.0 114.318 178.566 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.468 ' O ' HG22 ' B' ' 307' ' ' VAL . 36.3 p90 -159.74 153.75 23.27 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 117.283 0.541 . . . . 0.0 110.915 179.019 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.405 ' HB3' ' CD2' ' B' ' 306' ' ' TRP . 2.2 p -105.93 145.12 31.7 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.148 0.499 . . . . 0.0 112.023 -178.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.602 HD11 HG22 ' A' ' 83' ' ' VAL . 31.2 pt -122.59 149.92 26.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.357 178.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.7 m -144.67 -176.67 5.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.786 0.326 . . . . 0.0 110.93 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.09 -146.47 22.99 Favored Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.908 -0.663 . . . . 0.0 113.086 179.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.41 162.46 31.61 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.102 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.46 HG22 ' HB2' ' A' ' 43' ' ' ASP . 23.6 t -76.54 92.02 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 CA-C-O 121.236 0.541 . . . . 0.0 110.479 -179.208 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 100.4 8.18 50.25 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-N 115.32 -0.854 . . . . 0.0 113.487 -179.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -83.51 -161.33 31.4 Favored Glycine 0 C--N 1.343 0.944 0 CA-C-N 117.719 0.76 . . . . 0.0 113.248 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 91.4 mtt-85 -64.24 -27.37 69.0 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -179.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.36 167.55 41.97 Favored Glycine 0 C--N 1.337 0.62 0 C-N-CA 120.636 -0.792 . . . . 0.0 113.165 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 12.1 m-80 -125.71 144.8 49.41 Favored Pre-proline 0 CA--C 1.536 0.422 0 C-N-CA 122.131 0.173 . . . . 0.0 110.712 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -83.69 2.57 8.23 Favored 'Trans proline' 0 C--N 1.356 0.968 0 C-N-CA 121.865 1.71 . . . . 0.0 113.615 179.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -99.99 -39.5 8.11 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.017 0.437 . . . . 0.0 110.453 179.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 5.1 ppt_? -90.92 128.77 46.64 Favored Pre-proline 0 N--CA 1.469 0.513 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.931 -179.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -89.02 -22.24 1.1 Allowed 'Trans proline' 0 C--N 1.359 1.111 0 C-N-CA 122.325 2.017 . . . . 0.0 113.408 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -155.41 18.91 0.41 Allowed 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.986 0.735 . . . . 0.0 112.986 -179.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -90.24 118.03 29.45 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 122.188 -0.32 . . . . 0.0 110.828 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.46 ' HB2' HG22 ' A' ' 31' ' ' VAL . 3.1 p30 -89.61 40.64 1.0 Allowed 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -179.08 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -109.7 -155.63 15.88 Favored Glycine 0 C--N 1.336 0.57 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.86 179.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.6 mm -122.13 137.77 54.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 N-CA-C 110.504 -0.184 . . . . 0.0 110.504 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -129.88 148.74 51.78 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.68 0.276 . . . . 0.0 111.282 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.673 HG22 HD11 ' A' ' 66' ' ' ILE . 19.8 t -94.45 77.13 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-O 121.007 0.432 . . . . 0.0 110.99 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.419 HG23 ' N ' ' A' ' 49' ' ' ARG . 9.4 t -37.85 -53.68 1.29 Allowed 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 -178.5 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.419 ' N ' HG23 ' A' ' 48' ' ' THR . 0.3 OUTLIER -159.11 177.88 10.63 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 118.273 0.488 . . . . 0.0 112.235 -179.826 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.562 HG13 ' O ' ' A' ' 24' ' ' GLY . 7.5 t -130.0 148.06 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.944 -179.412 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.428 ' HG2' ' CH2' ' B' ' 306' ' ' TRP . 8.3 mm-40 -96.02 -68.07 0.07 OUTLIER Pre-proline 0 CA--C 1.536 0.416 0 C-N-CA 121.366 -0.134 . . . . 0.0 111.049 179.536 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -80.39 121.9 4.43 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 121.811 1.674 . . . . 0.0 111.955 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -79.6 64.7 4.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.936 0.398 . . . . 0.0 111.28 -179.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -157.83 -67.28 0.01 OUTLIER Glycine 0 CA--C 1.529 0.962 0 C-N-CA 120.668 -0.777 . . . . 0.0 113.547 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -57.96 -73.74 0.03 OUTLIER 'Trans proline' 0 C--N 1.357 0.975 0 C-N-CA 122.183 1.922 . . . . 0.0 113.52 -178.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -112.24 47.95 1.03 Allowed 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.189 0.518 . . . . 0.0 111.393 -179.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 95.4 p -107.77 -50.08 3.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.515 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.4 mmtm -80.38 -9.96 59.75 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.487 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.2 mp -96.23 -56.69 2.55 Favored 'General case' 0 C--N 1.342 0.25 0 CA-C-N 118.106 0.412 . . . . 0.0 111.184 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.735 HD23 HG21 ' A' ' 97' ' ' ILE . 1.1 mt -92.66 146.23 23.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.326 -179.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -112.49 140.83 24.24 Favored Pre-proline 0 CA--C 1.535 0.373 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.52 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -57.07 125.87 20.34 Favored 'Trans proline' 0 C--N 1.356 0.923 0 C-N-CA 121.716 1.61 . . . . 0.0 112.242 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 92.45 19.82 37.04 Favored Glycine 0 CA--C 1.523 0.539 0 C-N-CA 120.948 -0.644 . . . . 0.0 113.336 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -93.69 155.34 17.31 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-N 117.237 0.518 . . . . 0.0 110.047 179.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 58.8 tttp -100.07 125.54 46.16 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.92 0.39 . . . . 0.0 111.753 -179.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.673 HD11 HG22 ' A' ' 47' ' ' VAL . 44.4 mt -89.81 120.48 38.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.973 179.325 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 19.3 mm -95.86 -41.34 11.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -178.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.751 ' HB3' HD12 ' A' ' 96' ' ' ILE . 0.2 OUTLIER -149.48 153.9 37.97 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 112.2 0.445 . . . . 0.0 112.2 -178.13 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.484 ' HB3' ' CE1' ' A' ' 74' ' ' PHE . . . -142.45 123.27 14.32 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.856 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.419 ' HB2' ' CZ ' ' A' ' 89' ' ' PHE . 28.4 m-20 41.55 37.72 0.75 Allowed 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 178.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 96.11 -16.73 60.58 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 120.843 -0.694 . . . . 0.0 113.643 179.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 53.8 m-85 -91.35 122.62 34.11 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 117.565 0.683 . . . . 0.0 110.66 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 8.8 m -71.47 131.43 43.3 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.978 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.484 ' CE1' ' HB3' ' A' ' 69' ' ' ALA . 4.6 m-85 -105.6 14.37 28.57 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 112.292 0.478 . . . . 0.0 112.292 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 7.0 tp -92.04 126.13 44.63 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 CA-C-O 120.998 0.428 . . . . 0.0 111.096 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 61.46 70.41 0.6 Allowed 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 121.151 0.5 . . . . 0.0 110.845 -179.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 7.1 pt -148.66 164.24 4.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.984 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -81.35 143.14 32.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.458 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -50.99 -52.1 46.14 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -179.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -53.47 -27.92 34.98 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 121.248 -0.501 . . . . 0.0 113.05 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 49.7 tp60 -74.37 -38.71 63.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.092 0.473 . . . . 0.0 110.124 179.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.43 -53.75 32.05 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.597 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.602 HG22 HD11 ' A' ' 27' ' ' ILE . 20.0 t -58.5 -43.39 86.82 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.417 -179.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.7 t -60.46 -41.29 93.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.392 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.468 ' O ' HG22 ' A' ' 88' ' ' THR . 26.8 mt -65.17 -45.97 82.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.518 -179.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.514 HD12 HD13 ' A' ' 27' ' ' ILE . 32.9 mt -63.15 -38.45 91.23 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.192 -0.458 . . . . 0.0 112.012 -179.148 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 19.1 mmtt -66.48 -40.3 89.23 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.451 0.538 . . . . 0.0 112.451 -178.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.468 HG22 ' O ' ' A' ' 85' ' ' LEU . 7.8 t -72.18 -27.88 62.85 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -177.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.43 ' CD2' ' HA ' ' A' ' 86' ' ' LEU . 12.6 m-85 -49.09 173.66 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -178.416 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -87.84 -140.25 0.11 Allowed 'General case' 0 CA--C 1.552 1.026 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.204 -179.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 33.1 m120 -82.58 -61.82 1.78 Allowed 'General case' 0 C--N 1.348 0.538 0 CA-C-N 119.251 0.932 . . . . 0.0 111.526 -179.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -84.09 129.03 34.92 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.061 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.3 t -123.29 120.26 59.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.511 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -92.54 91.71 7.72 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.48 -179.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 2.5 mt -92.5 155.15 18.02 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.837 0.351 . . . . 0.0 111.419 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.751 HD12 ' HB3' ' A' ' 68' ' ' GLN . 72.9 mt -115.36 127.29 72.99 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.487 178.395 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.735 HG21 HD23 ' A' ' 60' ' ' LEU . 45.3 pt -123.76 162.37 24.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-O 120.902 0.382 . . . . 0.0 111.534 -178.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 36.7 t -136.73 139.8 44.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.5 -179.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -110.47 106.28 15.54 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.665 178.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 . . . . . 0 C--N 1.329 -0.295 0 CA-C-O 120.882 0.373 . . . . 0.0 111.578 -178.996 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 . . . . . 0 N--CA 1.466 0.373 0 CA-C-O 121.069 0.461 . . . . 0.0 111.346 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 305' ' ' THR . . . . . . . . . . . . . 6.4 m -139.32 119.44 13.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.801 -0.636 . . . . 17.879999999999999 110.372 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 306' ' ' TRP . . . . . 0.428 ' CH2' ' HG2' ' A' ' 51' ' ' GLN . 96.5 m95 -85.71 114.6 22.81 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.109 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 307' ' ' VAL . . . . . 0.468 HG22 ' O ' ' A' ' 25' ' ' PHE . 18.0 m . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.285 -0.864 . . . . 16.109999999999999 111.142 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 . . . . . 0 N--CA 1.464 0.244 0 CA-C-O 120.806 0.336 . . . . 0.0 111.205 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 19.7 pt -117.05 156.15 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-N 116.061 -0.518 . . . . 0.0 112.205 -179.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 29.7 mtm180 -90.29 167.47 12.64 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -178.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.475 HG13 ' HB3' ' A' ' 59' ' ' LEU . 77.6 t -147.43 122.97 2.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.977 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.414 ' HG2' HG22 ' A' ' 92' ' ' THR . 20.8 ttt180 -110.42 112.85 25.05 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.66 179.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.2 t -120.21 125.95 74.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.089 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.805 ' CG ' HG23 ' A' ' 92' ' ' THR . 28.9 mt-10 -102.05 128.51 48.48 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.106 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.426 ' HD2' HD12 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -72.81 114.6 11.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.962 179.919 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -174.95 83.35 0.32 Allowed Pre-proline 0 CA--C 1.537 0.471 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.087 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -83.38 -23.82 12.29 Favored 'Cis proline' 0 C--N 1.362 1.283 0 CA-C-N 119.445 0.838 . . . . 0.0 112.868 0.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.1 mp0 -130.68 -177.4 4.34 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.755 0.312 . . . . 0.0 111.405 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.426 HD12 ' HD2' ' A' ' 19' ' ' LYS . 3.3 mp -62.93 -59.83 4.29 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.978 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.464 ' O ' HG13 ' A' ' 50' ' ' VAL . . . 115.7 29.91 2.32 Favored Glycine 0 C--N 1.335 0.499 0 C-N-CA 120.925 -0.655 . . . . 0.0 113.771 179.365 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.443 ' O ' HG22 ' B' ' 307' ' ' VAL . 51.2 p90 -169.48 149.21 3.93 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 117.37 0.585 . . . . 0.0 111.521 179.452 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.3 p -100.44 150.44 22.64 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.87 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.681 HD11 HG22 ' A' ' 83' ' ' VAL . 38.3 pt -120.27 148.76 23.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.196 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 78.1 p -142.9 160.25 40.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.859 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 108.14 -152.57 16.95 Favored Glycine 0 C--N 1.332 0.338 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.94 179.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 104.0 157.01 24.14 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 121.096 -0.573 . . . . 0.0 112.264 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.5 t -78.18 100.38 3.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 120.925 0.393 . . . . 0.0 110.853 -179.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 93.48 7.68 61.66 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 121.047 -0.597 . . . . 0.0 113.709 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -88.63 -156.07 30.68 Favored Glycine 0 C--N 1.34 0.755 0 CA-C-N 117.746 0.773 . . . . 0.0 112.958 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 10.4 mmt180 -61.13 -27.52 68.45 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 111.606 0.224 . . . . 0.0 111.606 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 103.71 154.4 23.83 Favored Glycine 0 C--N 1.335 0.512 0 C-N-CA 120.881 -0.676 . . . . 0.0 113.059 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -112.15 129.96 23.76 Favored Pre-proline 0 N--CA 1.468 0.472 0 C-N-CA 122.074 0.149 . . . . 0.0 110.618 179.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -93.42 34.19 0.22 Allowed 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 122.316 2.011 . . . . 0.0 113.101 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -110.34 -51.2 2.89 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.786 0.327 . . . . 0.0 111.156 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 45.3 mtt-85 -127.13 158.29 69.55 Favored Pre-proline 0 CA--C 1.535 0.366 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.741 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -90.71 -57.67 0.02 OUTLIER 'Trans proline' 0 C--N 1.357 1.005 0 C-N-CA 122.219 1.946 . . . . 0.0 113.977 -178.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -79.35 -8.07 58.81 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -179.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -101.58 114.1 27.82 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 118.024 0.375 . . . . 0.0 110.418 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -105.73 38.81 1.9 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.379 -179.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -85.86 -156.3 27.17 Favored Glycine 0 CA--C 1.52 0.36 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.505 179.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.5 mm -110.57 130.81 63.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-O 120.531 0.205 . . . . 0.0 110.852 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -125.99 150.97 47.66 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 120.827 0.346 . . . . 0.0 111.43 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.447 HG21 HD22 ' A' ' 60' ' ' LEU . 21.8 t -89.1 81.73 1.97 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.185 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.422 HG23 ' N ' ' A' ' 49' ' ' ARG . 9.4 t -43.14 -55.41 3.92 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -178.268 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.422 ' N ' HG23 ' A' ' 48' ' ' THR . 11.6 ptm180 -161.49 156.95 24.22 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 118.425 0.557 . . . . 0.0 112.209 -179.588 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.464 HG13 ' O ' ' A' ' 24' ' ' GLY . 18.6 t -109.23 146.62 14.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.576 179.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.411 ' CB ' ' HD3' ' A' ' 52' ' ' PRO . 0.8 OUTLIER -102.77 -71.34 0.03 OUTLIER Pre-proline 0 CA--C 1.54 0.573 0 CA-C-O 119.437 -0.316 . . . . 0.0 111.311 179.9 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.411 ' HD3' ' CB ' ' A' ' 51' ' ' GLN . 53.9 Cg_endo -83.45 121.45 3.01 Favored 'Trans proline' 0 C--N 1.36 1.143 0 C-N-CA 121.532 1.488 . . . . 0.0 112.104 179.294 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.74 64.51 3.75 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.165 0.507 . . . . 0.0 110.963 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -139.01 -72.07 0.05 OUTLIER Glycine 0 CA--C 1.528 0.862 0 CA-C-N 115.672 -0.694 . . . . 0.0 112.84 179.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -63.76 -59.59 0.2 Allowed 'Trans proline' 0 C--N 1.357 1.009 0 C-N-CA 122.119 1.879 . . . . 0.0 113.585 -179.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.468 ' HB1' HD12 ' A' ' 60' ' ' LEU . . . -108.56 45.25 1.04 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.055 0.455 . . . . 0.0 111.426 -179.159 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 89.3 p -84.71 -60.98 1.9 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.04 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 13.6 mmmt -90.49 0.54 57.28 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -179.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.475 ' HB3' HG13 ' A' ' 15' ' ' VAL . 60.7 mt -95.48 -65.34 0.98 Allowed 'General case' 0 C--N 1.341 0.214 0 CA-C-N 118.254 0.479 . . . . 0.0 111.826 -179.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.569 HD23 HG21 ' A' ' 97' ' ' ILE . 3.4 mt -95.64 139.84 31.31 Favored 'General case' 0 C--O 1.23 0.048 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 -179.473 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 4.7 pp0? -121.4 151.67 56.68 Favored Pre-proline 0 CA--C 1.535 0.369 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.16 178.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -54.43 114.27 1.75 Allowed 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 121.818 1.679 . . . . 0.0 112.983 -179.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 118.12 -2.8 16.66 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 121.096 -0.573 . . . . 0.0 114.367 179.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -67.77 -177.66 0.82 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 117.831 0.816 . . . . 0.0 111.873 -179.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 38.0 tttt -145.22 126.57 14.88 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.705 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.604 ' N ' HD12 ' A' ' 66' ' ' ILE . 3.7 mp -89.63 117.82 33.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-O 120.832 0.349 . . . . 0.0 110.202 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 35.4 mt -106.63 -26.52 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.846 -179.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.678 ' HB3' HD13 ' A' ' 96' ' ' ILE . 17.2 tt0 -154.61 149.43 26.63 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.934 0.397 . . . . 0.0 111.77 -179.652 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -149.33 121.24 8.18 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.486 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 48.1 m-20 48.35 35.66 5.99 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 179.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 86.88 10.63 71.95 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 120.973 -0.632 . . . . 0.0 113.626 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -112.16 120.91 43.4 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 117.692 0.746 . . . . 0.0 109.811 179.533 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 18.8 m -71.53 128.78 36.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.418 -179.075 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -106.19 13.89 28.33 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.172 -0.467 . . . . 0.0 112.125 179.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 6.4 tp -90.83 124.19 43.3 Favored 'Isoleucine or valine' 0 C--N 1.34 0.169 0 O-C-N 122.047 -0.408 . . . . 0.0 110.743 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 63.18 72.75 0.47 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.929 -179.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 20.1 pt -146.95 166.06 6.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.795 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -81.84 154.78 25.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.995 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 16.1 t60 -54.6 -56.8 15.21 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.899 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -53.05 -33.2 44.05 Favored Glycine 0 C--N 1.336 0.532 0 C-N-CA 121.257 -0.497 . . . . 0.0 113.363 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 -65.95 -38.91 89.84 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.036 0.446 . . . . 0.0 110.148 179.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.3 -63.63 1.02 Allowed 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.684 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.681 HG22 HD11 ' A' ' 27' ' ' ILE . 11.5 t -55.29 -22.87 12.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 N-CA-C 111.93 0.344 . . . . 0.0 111.93 -179.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.461 ' O ' HG22 ' A' ' 88' ' ' THR . 18.0 m -77.4 -42.28 36.88 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.747 0.308 . . . . 0.0 111.101 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 25.5 mt -65.71 -42.06 91.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.665 -179.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.422 ' HA ' ' CD2' ' A' ' 89' ' ' PHE . 53.4 mt -66.73 -47.98 70.6 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.638 -179.29 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.412 ' HD2' HG12 ' A' ' 83' ' ' VAL . 70.7 mttt -60.66 -45.9 92.36 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -179.199 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.461 HG22 ' O ' ' A' ' 84' ' ' SER . 11.6 t -68.82 -27.7 66.08 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -177.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.422 ' CD2' ' HA ' ' A' ' 86' ' ' LEU . 6.0 m-85 -46.88 174.7 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -178.073 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -85.79 -143.69 0.1 Allowed 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.79 -179.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -81.15 -70.71 0.51 Allowed 'General case' 0 C--N 1.347 0.471 0 CA-C-N 119.016 0.825 . . . . 0.0 111.669 -179.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.805 HG23 ' CG ' ' A' ' 18' ' ' GLU . 0.3 OUTLIER -79.2 129.26 34.27 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 120.766 0.317 . . . . 0.0 110.448 -179.874 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.7 t -121.63 120.07 60.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.976 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -98.08 105.46 17.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.934 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.574 ' C ' HD12 ' A' ' 96' ' ' ILE . 4.9 mp -105.29 164.38 11.89 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.977 0.418 . . . . 0.0 111.541 -179.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.678 HD13 ' HB3' ' A' ' 68' ' ' GLN . 3.1 mp -120.5 131.77 71.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.089 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.569 HG21 HD23 ' A' ' 60' ' ' LEU . 46.0 pt -126.82 166.45 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-O 120.967 0.413 . . . . 0.0 111.809 -178.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 98.9 t -143.07 143.78 24.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.276 -179.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.1 105.06 14.02 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 . . . . . 0 C--N 1.33 -0.269 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -178.459 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 4.0 pm0 . . . . . 0 CA--C 1.529 0.163 0 CA-C-O 120.736 0.303 . . . . 0.0 111.343 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 305' ' ' THR . . . . . . . . . . . . . 5.6 m -127.41 121.06 29.87 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.201 -0.454 . . . . 17.879999999999999 110.803 179.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 306' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -85.28 106.91 17.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.74 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 307' ' ' VAL . . . . . 0.594 HG12 HG13 ' A' ' 83' ' ' VAL . 18.4 m . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.281 -0.866 . . . . 16.109999999999999 111.135 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 . . . . . 0 N--CA 1.467 0.398 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.629 ' N ' HD13 ' A' ' 13' ' ' ILE . 0.2 OUTLIER -151.75 164.31 2.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.577 179.447 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.75 ' HG3' HD13 ' A' ' 96' ' ' ILE . 1.2 ttm180 -118.8 156.82 28.74 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 111.783 0.29 . . . . 0.0 111.783 -179.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.464 HG11 ' HB3' ' A' ' 59' ' ' LEU . 29.4 m -143.51 153.61 16.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -115.06 118.25 32.87 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.858 -179.442 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.7 t -114.65 124.24 71.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.368 178.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.675 ' HG2' HG23 ' A' ' 92' ' ' THR . 43.3 mt-10 -102.83 127.84 49.84 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.03 0.443 . . . . 0.0 111.577 -179.367 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.63 118.23 12.23 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.252 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -175.89 78.12 0.29 Allowed Pre-proline 0 CA--C 1.541 0.603 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.703 179.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -86.76 -18.67 20.56 Favored 'Cis proline' 0 C--N 1.363 1.311 0 CA-C-N 119.331 0.797 . . . . 0.0 113.231 0.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -136.59 -178.0 4.98 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.794 0.33 . . . . 0.0 111.592 -179.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.412 ' HB3' ' CE2' ' A' ' 25' ' ' PHE . 4.2 mp -63.99 -56.95 11.41 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.563 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 107.16 29.38 4.57 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.885 -0.674 . . . . 0.0 113.937 178.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.412 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 45.2 p90 -159.03 145.41 16.82 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 117.464 0.632 . . . . 0.0 111.21 179.259 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 8.6 p -96.1 148.9 22.21 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.647 -179.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.591 HD11 HG22 ' A' ' 83' ' ' VAL . 25.1 pt -124.52 150.35 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.109 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.348 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 47.9 t -138.38 155.64 48.34 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.298 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 158.5 -99.18 0.18 Allowed Glycine 0 C--N 1.334 0.439 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.519 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 50.23 110.6 0.01 OUTLIER Glycine 0 CA--C 1.527 0.831 0 N-CA-C 115.38 0.912 . . . . 0.0 115.38 178.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 20.4 t -77.8 91.29 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.127 0 O-C-N 122.547 -0.384 . . . . 0.0 110.837 179.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 91.69 -4.79 79.54 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 120.821 -0.704 . . . . 0.0 114.149 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -111.26 9.51 28.87 Favored Glycine 0 C--N 1.342 0.908 0 CA-C-N 117.932 0.866 . . . . 0.0 114.282 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -178.35 -77.29 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 117.736 0.768 . . . . 0.0 109.626 178.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 113.13 152.81 11.21 Favored Glycine 0 C--N 1.335 0.491 0 CA-C-N 115.919 -0.582 . . . . 0.0 113.124 179.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -125.76 136.3 28.19 Favored Pre-proline 0 CA--C 1.535 0.37 0 N-CA-C 110.345 -0.243 . . . . 0.0 110.345 179.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -93.75 28.94 0.29 Allowed 'Trans proline' 0 C--N 1.356 0.947 0 C-N-CA 122.422 2.082 . . . . 0.0 113.514 -179.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -108.03 -49.75 3.16 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.692 0.282 . . . . 0.0 111.203 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 14.2 mmm180 -117.15 135.31 23.07 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.004 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -83.57 -44.56 0.07 OUTLIER 'Trans proline' 0 C--N 1.359 1.104 0 C-N-CA 121.898 1.732 . . . . 0.0 112.81 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -93.9 -13.4 27.21 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -101.35 118.46 37.02 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 117.864 0.302 . . . . 0.0 110.318 179.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -108.44 42.39 1.4 Allowed 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 120.978 0.418 . . . . 0.0 111.364 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -88.83 -156.32 31.25 Favored Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.269 179.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 27.7 mm -109.97 135.44 48.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-N 116.678 0.239 . . . . 0.0 110.843 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.429 ' N ' ' CD1' ' A' ' 46' ' ' PHE . 4.5 m-85 -132.7 148.24 52.34 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 120.681 0.277 . . . . 0.0 111.42 -179.396 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.539 HG21 HD22 ' A' ' 60' ' ' LEU . 16.8 t -92.88 73.37 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -179.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.439 HG23 ' N ' ' A' ' 49' ' ' ARG . 8.9 t -34.31 -53.13 0.5 Allowed 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -178.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.439 ' N ' HG23 ' A' ' 48' ' ' THR . 0.5 OUTLIER -160.31 177.39 10.67 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 121.87 -0.519 . . . . 0.0 112.042 -179.636 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 12.1 t -132.08 151.35 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.991 -179.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -105.31 -68.24 0.04 OUTLIER Pre-proline 0 CA--C 1.538 0.517 0 N-CA-C 111.768 0.285 . . . . 0.0 111.768 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -79.02 119.97 4.47 Favored 'Trans proline' 0 C--N 1.357 0.983 0 C-N-CA 121.811 1.674 . . . . 0.0 112.557 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.38 66.81 4.03 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.003 0.43 . . . . 0.0 111.629 -179.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -162.19 -66.58 0.02 OUTLIER Glycine 0 CA--C 1.528 0.865 0 C-N-CA 120.718 -0.753 . . . . 0.0 113.522 -179.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.67 -74.46 0.02 OUTLIER 'Trans proline' 0 C--N 1.357 0.993 0 C-N-CA 122.043 1.828 . . . . 0.0 113.469 -178.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -117.21 49.32 1.21 Allowed 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 121.054 0.454 . . . . 0.0 112.122 -178.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 16.7 t -109.22 -58.67 2.0 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 178.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 19.4 tptt -68.35 -10.84 57.76 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.743 178.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.464 ' HB3' HG11 ' A' ' 15' ' ' VAL . 54.1 mt -91.24 -65.14 1.04 Allowed 'General case' 0 C--N 1.343 0.304 0 CA-C-N 118.022 0.374 . . . . 0.0 110.85 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.762 HD23 HG21 ' A' ' 97' ' ' ILE . 1.5 mp -91.92 148.62 22.08 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.958 179.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.4 pm0 -115.18 151.82 46.13 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.985 178.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -57.37 128.53 29.9 Favored 'Trans proline' 0 C--N 1.356 0.962 0 C-N-CA 121.911 1.74 . . . . 0.0 113.041 -179.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 93.86 15.63 48.33 Favored Glycine 0 CA--C 1.524 0.653 0 CA-C-N 115.919 -0.582 . . . . 0.0 113.68 179.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -76.91 -174.49 3.11 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 117.518 0.659 . . . . 0.0 111.064 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 47.0 tttm -141.89 125.11 16.4 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.567 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 60.9 mt -90.54 113.34 26.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.186 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 24.2 mm -90.91 -36.88 8.6 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-N 115.936 -0.575 . . . . 0.0 112.077 -178.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.28 145.99 27.34 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.065 0.46 . . . . 0.0 111.172 -179.245 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.416 ' HB3' ' CE1' ' A' ' 74' ' ' PHE . . . -136.97 119.69 16.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.015 179.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.3 m120 45.95 30.04 0.84 Allowed 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 179.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 100.78 -14.21 58.99 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 120.693 -0.765 . . . . 0.0 113.563 -179.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -88.49 153.7 20.94 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 117.506 0.653 . . . . 0.0 110.09 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 12.5 m -101.25 124.62 47.23 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.428 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.416 ' CE1' ' HB3' ' A' ' 69' ' ' ALA . 3.6 m-85 -101.59 17.77 22.0 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 7.9 tp -92.28 121.17 42.63 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 CA-C-O 120.923 0.392 . . . . 0.0 110.61 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 62.17 76.47 0.37 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.005 -179.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 23.7 pt -150.01 161.61 4.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.802 179.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -81.25 140.72 34.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.967 0.413 . . . . 0.0 111.396 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -41.49 -49.96 3.96 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -179.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -57.56 -33.36 66.6 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.965 -179.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 36.2 tp60 -69.74 -44.73 69.67 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.826 0.346 . . . . 0.0 111.196 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.92 -63.37 1.13 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.859 -179.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.591 HG22 HD11 ' A' ' 27' ' ' ILE . 24.4 t -50.81 -42.27 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -179.416 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 37.1 m -62.89 -39.53 94.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.735 0.303 . . . . 0.0 111.306 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 16.6 mt -64.75 -49.5 70.56 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.861 -179.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 54.4 mt -65.04 -33.16 75.38 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -178.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 60.3 mttm -76.02 -37.32 58.53 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -178.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 12.0 t -73.98 -26.12 60.29 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -178.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -54.94 155.19 4.61 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.145 0.498 . . . . 0.0 111.911 -178.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -63.29 -139.31 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.128 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.489 -178.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -82.01 -66.06 0.93 Allowed 'General case' 0 C--N 1.351 0.658 0 CA-C-N 119.345 0.975 . . . . 0.0 112.251 -178.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.675 HG23 ' HG2' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -76.67 123.49 26.23 Favored 'General case' 0 CA--C 1.528 0.11 0 CA-C-O 120.939 0.399 . . . . 0.0 110.958 -179.308 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.528 ' O ' HD12 ' A' ' 95' ' ' LEU . 18.0 t -114.22 112.2 39.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.634 179.342 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -89.7 112.26 23.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.353 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.528 HD12 ' O ' ' A' ' 93' ' ' VAL . 4.6 mp -115.06 154.02 29.63 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 121.115 0.483 . . . . 0.0 112.044 -178.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.75 HD13 ' HG3' ' A' ' 14' ' ' ARG . 17.9 mm -109.38 122.7 64.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.809 178.394 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.762 HG21 HD23 ' A' ' 60' ' ' LEU . 24.6 pt -118.11 157.73 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-O 120.685 0.279 . . . . 0.0 111.047 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.7 t -142.95 146.82 21.29 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-O 121.06 0.457 . . . . 0.0 111.708 -179.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.3 mmm-85 -111.69 110.38 20.74 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 178.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.998 0.428 . . . . 0.0 111.568 -179.509 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.869 0.366 . . . . 0.0 110.375 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 305' ' ' THR . . . . . . . . . . . . . 7.9 m -97.84 131.13 44.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.108 -0.497 . . . . 17.879999999999999 111.201 -179.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 306' ' ' TRP . . . . . . . . . . . . . 92.4 m95 -89.16 106.4 18.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.866 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 307' ' ' VAL . . . . . 0.508 HG12 HG13 ' A' ' 83' ' ' VAL . 16.5 m . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.176 -0.916 . . . . 16.109999999999999 111.094 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.584 0.23 . . . . 0.0 110.582 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.606 ' N ' HD13 ' A' ' 13' ' ' ILE . 0.1 OUTLIER -126.91 159.31 36.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-O 121.071 0.462 . . . . 0.0 111.703 -179.888 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 15.4 ttm-85 -109.32 161.67 15.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.413 -179.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.55 HG13 HD13 ' A' ' 59' ' ' LEU . 21.4 t -139.76 147.78 23.64 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.967 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 7.0 tpp85 -115.75 106.42 13.84 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.706 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.1 t -111.68 127.43 68.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.289 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.469 ' HG3' HG23 ' A' ' 92' ' ' THR . 3.9 mp0 -90.42 156.94 17.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.513 179.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.7 74.95 1.1 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.074 0.464 . . . . 0.0 110.406 179.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -141.38 85.84 11.52 Favored Pre-proline 0 CA--C 1.538 0.511 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.593 -179.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -85.83 -21.58 15.05 Favored 'Cis proline' 0 C--N 1.363 1.3 0 CA-C-N 119.638 0.906 . . . . 0.0 113.211 0.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -138.04 -176.11 4.33 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.733 0.301 . . . . 0.0 111.351 -179.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.9 mp -64.74 -57.87 7.8 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.048 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.4 ' O ' HG13 ' A' ' 50' ' ' VAL . . . 108.0 32.9 3.15 Favored Glycine 0 C--N 1.337 0.623 0 C-N-CA 120.86 -0.686 . . . . 0.0 113.621 179.087 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -165.69 145.62 6.58 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 117.206 0.503 . . . . 0.0 111.044 179.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.5 p -100.71 153.48 19.4 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.536 -179.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 25.6 pt -122.26 150.11 25.77 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.829 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 85.0 p -145.03 161.25 39.86 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 121.222 -0.191 . . . . 0.0 111.427 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 119.3 -91.62 0.51 Allowed Glycine 0 C--N 1.34 0.752 0 C-N-CA 120.911 -0.661 . . . . 0.0 114.191 178.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.469 ' H ' HD13 ' A' ' 45' ' ' ILE . . . 67.32 -133.47 30.69 Favored Glycine 0 CA--C 1.521 0.416 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.38 -179.308 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 23.9 t -151.4 81.38 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 CA-C-O 121.141 0.496 . . . . 0.0 109.832 179.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.56 15.15 44.57 Favored Glycine 0 CA--C 1.528 0.901 0 CA-C-N 115.753 -0.658 . . . . 0.0 113.161 -178.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -93.98 -143.02 12.79 Favored Glycine 0 C--N 1.338 0.691 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.292 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 5.1 mmt85 -54.29 -26.17 27.78 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -179.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.47 160.31 32.94 Favored Glycine 0 C--N 1.336 0.582 0 C-N-CA 120.768 -0.73 . . . . 0.0 113.492 179.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -121.51 136.9 26.33 Favored Pre-proline 0 N--CA 1.466 0.333 0 N-CA-C 110.491 -0.189 . . . . 0.0 110.491 179.396 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -92.83 26.96 0.37 Allowed 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 122.224 1.949 . . . . 0.0 113.127 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -102.24 -49.78 3.81 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.761 0.315 . . . . 0.0 111.008 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -124.51 140.37 35.16 Favored Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.783 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -83.76 -41.95 0.09 OUTLIER 'Trans proline' 0 C--N 1.359 1.092 0 C-N-CA 122.028 1.819 . . . . 0.0 113.201 -179.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -93.97 -13.08 27.42 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -179.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -103.54 120.69 41.37 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 117.888 0.313 . . . . 0.0 111.358 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -104.35 16.86 25.27 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -57.77 -167.29 0.12 Allowed Glycine 0 C--N 1.338 0.673 0 C-N-CA 120.637 -0.792 . . . . 0.0 113.033 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.469 HD13 ' H ' ' A' ' 30' ' ' GLY . 20.6 mm -104.28 125.97 59.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 179.043 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -122.66 146.52 47.39 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 120.796 0.332 . . . . 0.0 111.428 -179.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.646 ' CG2' HD11 ' A' ' 66' ' ' ILE . 34.2 t -89.89 73.02 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-O 121.25 0.548 . . . . 0.0 110.252 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.0 t -36.14 -53.59 0.8 Allowed 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -178.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 7.7 ptm180 -158.64 168.77 25.98 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.198 0.523 . . . . 0.0 112.321 -179.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.4 HG13 ' O ' ' A' ' 24' ' ' GLY . 14.4 t -126.39 148.68 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.372 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.419 ' HG2' ' CH2' ' B' ' 306' ' ' TRP . 7.1 mm-40 -105.25 -68.81 0.03 OUTLIER Pre-proline 0 CA--C 1.538 0.514 0 N-CA-C 111.706 0.261 . . . . 0.0 111.706 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -79.26 120.19 4.44 Favored 'Trans proline' 0 C--N 1.357 0.998 0 C-N-CA 121.8 1.667 . . . . 0.0 112.487 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -78.5 66.92 4.16 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 121.03 0.443 . . . . 0.0 111.064 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -160.91 -65.87 0.02 OUTLIER Glycine 0 CA--C 1.527 0.836 0 C-N-CA 120.721 -0.752 . . . . 0.0 113.548 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -56.27 -61.12 0.37 Allowed 'Trans proline' 0 C--N 1.356 0.973 0 C-N-CA 122.229 1.953 . . . . 0.0 113.513 -178.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.842 ' HB1' HD12 ' A' ' 60' ' ' LEU . . . -136.21 58.56 1.74 Allowed 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 121.206 0.527 . . . . 0.0 111.933 -178.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.8 t -119.3 -58.23 1.94 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.898 179.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 25.3 tptp -64.56 -16.08 62.05 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.743 178.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.55 HD13 HG13 ' A' ' 15' ' ' VAL . 39.5 mt -98.2 -49.73 4.61 Favored 'General case' 0 C--N 1.341 0.221 0 CA-C-O 120.805 0.336 . . . . 0.0 111.441 -179.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.842 HD12 ' HB1' ' A' ' 56' ' ' ALA . 41.9 mt -90.99 148.76 22.18 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.978 0.418 . . . . 0.0 111.802 -179.316 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -116.04 137.25 23.25 Favored Pre-proline 0 CA--C 1.536 0.42 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.235 179.107 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -52.4 126.57 21.06 Favored 'Trans proline' 0 C--N 1.356 0.971 0 C-N-CA 122.011 1.808 . . . . 0.0 113.044 -179.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 95.33 18.1 34.58 Favored Glycine 0 CA--C 1.521 0.428 0 C-N-CA 121.045 -0.598 . . . . 0.0 113.807 179.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -86.18 144.64 27.37 Favored 'General case' 0 C--N 1.339 0.122 0 CA-C-N 117.625 0.713 . . . . 0.0 110.679 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -92.89 129.57 38.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.566 -179.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.646 HD11 ' CG2' ' A' ' 47' ' ' VAL . 2.8 mm -88.08 111.95 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 25.9 mm -90.63 -44.62 14.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -178.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.815 ' HB3' HD12 ' A' ' 96' ' ' ILE . 20.4 tt0 -148.45 150.85 34.18 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.201 0.524 . . . . 0.0 112.403 -178.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.526 ' HB3' ' CE1' ' A' ' 74' ' ' PHE . . . -142.46 124.32 15.17 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.079 179.53 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.3 m120 45.13 27.64 0.33 Allowed 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 178.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 99.78 -8.84 59.97 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 120.808 -0.711 . . . . 0.0 114.128 179.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -97.81 122.64 41.15 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 117.797 0.798 . . . . 0.0 110.886 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.9 t -69.02 126.25 29.23 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.432 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.526 ' CE1' ' HB3' ' A' ' 69' ' ' ALA . 3.1 m-85 -97.58 17.9 16.69 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -179.027 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 30.5 mm -92.5 119.61 40.35 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-O 120.82 0.343 . . . . 0.0 110.946 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 61.11 76.86 0.35 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.262 0.553 . . . . 0.0 111.143 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 17.4 pt -145.97 150.3 15.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.546 179.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -62.27 142.43 57.73 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.165 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.487 ' O ' HG23 ' A' ' 83' ' ' VAL . 12.3 t60 -47.97 -50.81 26.05 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.597 -179.151 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -60.17 -27.58 65.33 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.694 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -69.87 -43.57 71.57 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 120.948 0.404 . . . . 0.0 110.878 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.68 -39.88 76.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.491 -179.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 79' ' ' HIS . 26.7 t -71.88 -45.24 65.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.125 -179.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.507 ' O ' HG22 ' A' ' 88' ' ' THR . 36.1 t -62.61 -36.79 83.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.548 -179.436 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.438 HD23 ' HA ' ' A' ' 85' ' ' LEU . 18.3 mt -68.0 -45.69 73.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.833 0.349 . . . . 0.0 111.761 -179.402 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.428 HD21 HD21 ' A' ' 95' ' ' LEU . 18.3 mt -68.17 -32.89 73.46 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -178.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 3.0 mtmp? -79.6 -37.98 34.99 Favored 'General case' 0 N--CA 1.457 -0.087 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -178.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.507 HG22 ' O ' ' A' ' 84' ' ' SER . 9.0 t -70.77 -23.28 62.37 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -178.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -51.06 176.4 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 121.335 0.588 . . . . 0.0 112.398 -178.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 87.0 mm-40 -82.08 -144.0 0.06 Allowed 'General case' 0 CA--C 1.551 0.998 0 CA-C-N 115.476 -0.783 . . . . 0.0 111.119 -179.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -79.87 -63.48 1.4 Allowed 'General case' 0 C--N 1.347 0.493 0 CA-C-N 118.94 0.791 . . . . 0.0 110.964 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.469 HG23 ' HG3' ' A' ' 18' ' ' GLU . 0.5 OUTLIER -87.19 138.38 31.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.198 179.797 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 18.2 t -127.08 121.65 58.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.047 -179.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -93.52 101.46 13.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.337 179.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.428 HD21 HD21 ' A' ' 86' ' ' LEU . 5.6 mp -104.07 155.69 18.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.043 0.449 . . . . 0.0 111.797 -179.307 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.815 HD12 ' HB3' ' A' ' 68' ' ' GLN . 41.4 mt -116.01 130.76 70.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.641 178.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.568 HD13 HD23 ' A' ' 60' ' ' LEU . 39.3 pt -126.95 160.66 35.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-O 120.992 0.425 . . . . 0.0 111.635 -179.137 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 71.9 t -143.17 149.42 18.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.136 -179.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -112.84 117.51 32.35 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.928 179.092 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 48.2 mm-40 . . . . . 0 C--N 1.328 -0.335 0 CA-C-O 120.832 0.349 . . . . 0.0 111.723 -179.23 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.74 0.305 . . . . 0.0 110.696 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 305' ' ' THR . . . . . . . . . . . . . 5.3 m -141.22 119.34 12.02 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.353 -0.385 . . . . 17.879999999999999 110.607 179.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 306' ' ' TRP . . . . . 0.419 ' CH2' ' HG2' ' A' ' 51' ' ' GLN . 83.6 m95 -84.29 117.32 23.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.046 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 307' ' ' VAL . . . . . 0.454 HG12 HG13 ' A' ' 83' ' ' VAL . 16.2 m . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.261 -0.876 . . . . 16.109999999999999 111.159 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 . . . . . 0 CA--C 1.532 0.281 0 CA-C-O 120.716 0.293 . . . . 0.0 110.277 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.522 ' H ' HD13 ' A' ' 13' ' ' ILE . 0.1 OUTLIER -113.97 164.16 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -179.191 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 82.3 mtt-85 -100.56 168.49 9.68 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.655 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.799 HG13 ' CB ' ' A' ' 59' ' ' LEU . 40.3 t -150.35 139.23 15.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.015 179.518 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 39.7 mtt85 -113.93 108.09 16.58 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.845 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.5 t -111.29 123.66 67.36 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.16 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.677 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -86.18 161.16 18.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.179 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.3 73.28 0.81 Allowed 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.545 179.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -138.68 85.13 17.41 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.168 -179.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -86.03 -19.93 18.54 Favored 'Cis proline' 0 C--N 1.364 1.372 0 CA-C-N 119.507 0.86 . . . . 0.0 113.129 0.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -136.46 -177.64 4.81 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 120.746 0.307 . . . . 0.0 111.276 -179.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.415 ' HB3' ' CE1' ' A' ' 25' ' ' PHE . 3.2 mp -65.3 -55.81 16.21 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.263 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 109.48 16.13 11.44 Favored Glycine 0 C--N 1.336 0.528 0 C-N-CA 120.794 -0.717 . . . . 0.0 114.215 178.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.494 ' O ' HG22 ' B' ' 307' ' ' VAL . 51.0 p90 -145.79 157.02 43.95 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 117.759 0.78 . . . . 0.0 111.463 179.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.4 p -108.52 150.59 27.24 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.171 -179.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.55 HD11 HG22 ' A' ' 83' ' ' VAL . 17.7 pt -122.88 151.67 27.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.502 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 98.2 p -149.98 164.07 36.43 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.207 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 112.48 -96.08 0.82 Allowed Glycine 0 C--N 1.337 0.601 0 C-N-CA 120.898 -0.668 . . . . 0.0 113.876 178.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.498 ' H ' HD13 ' A' ' 45' ' ' ILE . . . 74.52 -132.82 14.93 Favored Glycine 0 CA--C 1.519 0.309 0 C-N-CA 121.119 -0.562 . . . . 0.0 112.401 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 24.1 t -149.75 87.16 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 92.89 5.16 64.56 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 120.983 -0.627 . . . . 0.0 113.693 -178.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -77.47 -134.62 0.71 Allowed Glycine 0 C--N 1.343 0.963 0 CA-C-N 117.741 0.77 . . . . 0.0 112.723 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 1.4 mtt180 -71.17 -19.67 62.38 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.597 0.592 . . . . 0.0 112.597 -179.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.92 -156.02 17.0 Favored Glycine 0 C--N 1.342 0.907 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.952 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -173.89 132.86 0.57 Allowed Pre-proline 0 CA--C 1.534 0.358 0 N-CA-C 110.539 -0.171 . . . . 0.0 110.539 179.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -90.16 25.6 0.55 Allowed 'Trans proline' 0 C--N 1.358 1.048 0 C-N-CA 122.174 1.916 . . . . 0.0 113.89 -179.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -110.25 -56.06 2.38 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.734 0.302 . . . . 0.0 110.921 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -114.16 135.78 22.18 Favored Pre-proline 0 CA--C 1.535 0.389 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.689 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -86.96 -47.58 0.04 OUTLIER 'Trans proline' 0 C--N 1.36 1.14 0 C-N-CA 121.994 1.796 . . . . 0.0 113.623 -179.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -95.83 -11.4 26.88 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -179.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -94.48 115.91 28.16 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 117.904 0.32 . . . . 0.0 110.27 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.4 p30 -102.3 64.52 0.92 Allowed 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 121.174 0.511 . . . . 0.0 111.408 -179.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -116.15 -162.49 13.13 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.316 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.498 HD13 ' H ' ' A' ' 30' ' ' GLY . 15.8 mm -107.53 131.64 57.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 110.348 -0.242 . . . . 0.0 110.348 179.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -129.55 149.87 51.13 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.77 0.319 . . . . 0.0 111.107 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.571 HG23 HD11 ' A' ' 66' ' ' ILE . 21.8 t -97.13 73.58 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.331 -179.126 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.6 t -35.34 -53.54 0.64 Allowed 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 114.527 1.306 . . . . 0.0 114.527 -178.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 1.8 ptt-85 -158.53 163.84 36.69 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.059 0.457 . . . . 0.0 112.112 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 5.3 t -121.26 154.85 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.56 -179.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 3.6 mm-40 -104.73 -68.3 0.04 OUTLIER Pre-proline 0 CA--C 1.538 0.513 0 N-CA-C 111.575 0.213 . . . . 0.0 111.575 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -80.37 120.13 3.96 Favored 'Trans proline' 0 C--N 1.358 1.07 0 C-N-CA 121.836 1.691 . . . . 0.0 112.481 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -77.06 69.2 3.32 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 120.992 0.425 . . . . 0.0 111.337 -179.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -165.04 -64.33 0.02 OUTLIER Glycine 0 CA--C 1.529 0.937 0 C-N-CA 120.696 -0.764 . . . . 0.0 113.719 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.57 -72.52 0.03 OUTLIER 'Trans proline' 0 C--N 1.357 1.002 0 C-N-CA 122.072 1.848 . . . . 0.0 113.72 -178.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.784 ' HB1' HD12 ' A' ' 60' ' ' LEU . . . -102.68 -10.92 18.8 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 -178.092 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.9 t -75.31 -25.93 58.27 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -178.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.9 tppt? -76.81 -20.94 55.81 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.799 ' CB ' HG13 ' A' ' 15' ' ' VAL . 43.5 mt -123.48 6.43 8.96 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -178.137 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.784 HD12 ' HB1' ' A' ' 56' ' ' ALA . 91.2 mt -136.03 148.9 48.58 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 118.344 0.52 . . . . 0.0 111.729 179.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -104.98 141.49 22.66 Favored Pre-proline 0 CA--C 1.536 0.42 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.437 179.317 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -64.15 71.16 0.2 Allowed 'Trans proline' 0 C--N 1.362 1.254 0 C-N-CA 122.297 1.998 . . . . 0.0 113.647 -179.127 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 139.16 40.42 0.09 OUTLIER Glycine 0 CA--C 1.524 0.617 0 C-N-CA 120.903 -0.665 . . . . 0.0 113.299 179.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -96.36 -161.67 0.89 Allowed 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 117.034 0.417 . . . . 0.0 110.661 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.6 tttm -138.77 122.0 16.98 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 120.718 0.294 . . . . 0.0 110.818 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.571 HD11 HG23 ' A' ' 47' ' ' VAL . 4.3 mp -89.45 120.97 39.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.534 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 20.1 mm -92.39 -40.39 12.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -178.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 -150.38 150.86 31.96 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.12 0.486 . . . . 0.0 111.981 -178.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.422 ' HB3' ' CE1' ' A' ' 74' ' ' PHE . . . -138.23 123.02 18.79 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.684 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.435 ' ND2' HG13 ' A' ' 93' ' ' VAL . 62.8 m-20 40.85 33.63 0.22 Allowed 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 178.468 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 99.2 -20.87 48.29 Favored Glycine 0 CA--C 1.522 0.509 0 C-N-CA 120.724 -0.75 . . . . 0.0 113.409 179.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -88.46 119.52 28.97 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 117.151 0.475 . . . . 0.0 110.281 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 33.3 t -66.25 122.12 16.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.005 -179.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.422 ' CE1' ' HB3' ' A' ' 69' ' ' ALA . 2.9 m-85 -98.07 7.64 45.99 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -178.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.403 ' O ' HG23 ' A' ' 75' ' ' ILE . 6.5 tp -84.55 120.28 34.94 Favored 'Isoleucine or valine' 0 C--N 1.341 0.201 0 CA-C-N 118.392 0.542 . . . . 0.0 110.678 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 62.13 75.93 0.39 Allowed 'General case' 0 C--O 1.232 0.184 0 CA-C-O 121.259 0.552 . . . . 0.0 111.023 -179.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 16.0 pt -144.87 152.86 14.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.514 179.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -64.61 150.9 46.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.039 0.447 . . . . 0.0 110.992 -179.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.408 ' O ' HG23 ' A' ' 83' ' ' VAL . 11.0 t60 -54.73 -55.11 33.37 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.953 -179.301 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -55.55 -25.3 42.09 Favored Glycine 0 CA--C 1.523 0.544 0 C-N-CA 121.058 -0.592 . . . . 0.0 113.309 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.21 -39.85 53.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.056 0.455 . . . . 0.0 110.592 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.66 -35.88 67.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.207 -179.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.55 HG22 HD11 ' A' ' 27' ' ' ILE . 22.6 t -76.08 -45.85 35.35 Favored 'Isoleucine or valine' 0 C--O 1.231 0.082 0 CA-C-O 120.83 0.348 . . . . 0.0 111.022 -179.557 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.585 ' O ' HG22 ' A' ' 88' ' ' THR . 45.1 m -61.63 -35.33 77.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.078 -179.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.439 HD23 ' HA ' ' A' ' 85' ' ' LEU . 15.3 mt -70.64 -44.02 68.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.171 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.425 ' HA ' ' CD2' ' A' ' 89' ' ' PHE . 13.7 mt -68.45 -31.03 70.05 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -179.067 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 23.7 mtmt -83.79 -36.35 23.62 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 -179.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.585 HG22 ' O ' ' A' ' 84' ' ' SER . 9.0 t -72.26 -24.06 61.3 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -178.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.425 ' CD2' ' HA ' ' A' ' 86' ' ' LEU . 8.3 m-85 -49.74 177.02 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -178.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 50.9 mm-40 -82.17 -144.83 0.06 Allowed 'General case' 0 CA--C 1.549 0.911 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.689 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -78.24 -65.05 1.03 Allowed 'General case' 0 C--N 1.347 0.468 0 CA-C-N 118.977 0.808 . . . . 0.0 111.021 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -83.58 140.35 32.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.356 179.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.435 HG13 ' ND2' ' A' ' 70' ' ' ASN . 19.0 t -124.84 120.68 59.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.275 -179.606 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -89.49 107.31 19.0 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.134 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 15.2 mt -107.95 145.29 34.04 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.99 0.424 . . . . 0.0 111.766 -178.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 15.9 mm -108.01 125.91 64.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.174 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.43 HD13 HD23 ' A' ' 60' ' ' LEU . 41.6 pt -131.2 167.99 24.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -178.468 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 18.3 t -149.72 153.94 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.167 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -115.77 116.01 27.3 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.315 179.307 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 . . . . . 0 C--N 1.329 -0.299 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.371 -179.505 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.737 0.303 . . . . 0.0 110.796 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 305' ' ' THR . . . . . . . . . . . . . 16.9 m -139.76 120.88 14.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.303 -0.408 . . . . 17.879999999999999 110.953 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 306' ' ' TRP . . . . . . . . . . . . . 92.2 m95 -80.64 111.03 16.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.863 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 307' ' ' VAL . . . . . 0.494 HG22 ' O ' ' A' ' 25' ' ' PHE . 15.5 m . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.253 -0.879 . . . . 16.109999999999999 111.122 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 . . . . . 0 C--O 1.231 0.126 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.4 pt -117.48 159.24 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.214 -178.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . 0.715 ' HG2' HD13 ' A' ' 96' ' ' ILE . 0.1 OUTLIER -112.95 157.58 21.31 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.099 -179.361 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.5 m -141.66 139.68 31.43 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.707 179.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -106.03 114.27 28.31 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.605 -179.123 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.0 t -114.13 123.26 69.62 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.997 179.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.558 ' HG3' HG22 ' A' ' 92' ' ' THR . 4.8 mp0 -98.95 119.08 37.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.704 179.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.469 ' HE2' HD11 ' A' ' 23' ' ' LEU . 16.1 mttt -70.02 118.38 12.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.048 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -171.98 85.57 0.45 Allowed Pre-proline 0 CA--C 1.536 0.435 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.655 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -84.0 -17.76 26.09 Favored 'Cis proline' 0 C--N 1.363 1.338 0 CA-C-N 119.383 0.815 . . . . 0.0 113.42 0.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 51.7 mm-40 -136.79 -177.04 4.56 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 120.913 0.387 . . . . 0.0 111.689 -179.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.469 HD11 ' HE2' ' A' ' 19' ' ' LYS . 4.5 mp -65.67 -56.1 13.93 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.244 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 102.54 39.46 2.77 Favored Glycine 0 CA--C 1.522 0.488 0 C-N-CA 120.754 -0.736 . . . . 0.0 113.926 178.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.426 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 43.3 p90 -169.85 156.91 6.5 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 117.155 0.477 . . . . 0.0 111.202 179.173 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 9.3 p -113.55 154.64 26.78 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.506 -179.414 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.464 HD11 HG22 ' A' ' 83' ' ' VAL . 46.6 pt -121.38 153.35 25.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.799 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 77.6 p -141.21 155.24 46.07 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.865 179.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 114.05 -158.26 14.43 Favored Glycine 0 C--N 1.335 0.508 0 C-N-CA 120.934 -0.651 . . . . 0.0 113.369 179.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 137.27 -135.51 7.68 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 121.26 -0.495 . . . . 0.0 112.234 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 39.5 t -141.88 75.38 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.225 0.536 . . . . 0.0 109.877 179.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 93.59 13.56 55.11 Favored Glycine 0 CA--C 1.529 0.943 0 CA-C-N 115.66 -0.7 . . . . 0.0 113.154 -178.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -86.74 -146.42 10.05 Favored Glycine 0 C--N 1.342 0.908 0 CA-C-N 117.598 0.699 . . . . 0.0 112.695 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 69.6 mtt180 -56.46 -24.56 46.49 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -179.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.24 175.46 48.76 Favored Glycine 0 C--N 1.336 0.536 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.629 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -139.53 146.55 48.52 Favored Pre-proline 0 CA--C 1.534 0.337 0 N-CA-C 110.473 -0.195 . . . . 0.0 110.473 179.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -92.33 30.32 0.31 Allowed 'Trans proline' 0 C--N 1.358 1.039 0 C-N-CA 122.309 2.006 . . . . 0.0 113.43 -179.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -107.48 -56.48 2.21 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.778 0.323 . . . . 0.0 110.647 179.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -112.46 139.12 22.27 Favored Pre-proline 0 CA--C 1.534 0.33 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.376 179.41 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -87.58 -50.3 0.03 OUTLIER 'Trans proline' 0 C--N 1.358 1.044 0 C-N-CA 121.964 1.776 . . . . 0.0 113.642 -178.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -95.43 -7.82 37.22 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -179.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -90.9 113.75 26.03 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 118.106 0.412 . . . . 0.0 110.766 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 14.1 p30 -98.88 54.82 1.01 Allowed 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 121.1 0.476 . . . . 0.0 111.15 -179.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -112.45 -163.75 16.49 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 121.056 -0.592 . . . . 0.0 112.577 179.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 13.1 mm -108.74 133.79 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 116.553 0.177 . . . . 0.0 110.591 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.432 ' CD1' ' N ' ' A' ' 46' ' ' PHE . 3.7 m-85 -131.2 151.59 51.32 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 120.542 0.21 . . . . 0.0 110.714 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.582 HG23 ' OD1' ' A' ' 64' ' ' ASP . 29.2 t -91.0 79.79 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-O 121.103 0.478 . . . . 0.0 110.686 179.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.408 HG23 ' N ' ' A' ' 49' ' ' ARG . 5.1 t -36.41 -53.78 0.85 Allowed 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 114.824 1.416 . . . . 0.0 114.824 -178.533 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.408 ' N ' HG23 ' A' ' 48' ' ' THR . 0.0 OUTLIER -160.48 179.47 8.59 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.236 0.541 . . . . 0.0 112.372 -178.988 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 20.3 t -137.37 148.62 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.48 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 7.2 mm-40 -105.06 -68.85 0.03 OUTLIER Pre-proline 0 CA--C 1.538 0.488 0 CA-C-O 119.629 -0.224 . . . . 0.0 111.389 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -78.12 118.04 4.28 Favored 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 121.676 1.584 . . . . 0.0 112.045 179.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.3 pm0 -75.63 66.95 2.04 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.114 0.483 . . . . 0.0 111.257 -179.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -156.03 -69.83 0.01 OUTLIER Glycine 0 CA--C 1.528 0.868 0 C-N-CA 120.791 -0.719 . . . . 0.0 113.335 -179.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -60.07 -75.81 0.02 OUTLIER 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 121.968 1.779 . . . . 0.0 113.365 -179.019 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.544 ' HB1' HD12 ' A' ' 60' ' ' LEU . . . -104.05 46.06 0.93 Allowed 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 121.073 0.464 . . . . 0.0 111.77 -179.103 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.9 t -114.4 -65.04 1.23 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.006 179.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.1 tppm? -62.46 -21.22 65.27 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.488 178.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 40.2 mt -97.73 -54.9 2.97 Favored 'General case' 0 C--N 1.339 0.128 0 CA-C-O 120.59 0.233 . . . . 0.0 111.558 -179.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.551 HD23 HD13 ' A' ' 97' ' ' ILE . 32.6 mt -93.96 146.94 23.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.807 0.337 . . . . 0.0 111.563 -179.478 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -118.84 143.06 32.91 Favored Pre-proline 0 CA--C 1.537 0.472 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.333 179.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -62.19 131.69 35.6 Favored 'Trans proline' 0 C--N 1.359 1.092 0 C-N-CA 122.128 1.886 . . . . 0.0 113.761 -179.011 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 93.88 18.7 36.5 Favored Glycine 0 C--N 1.335 0.482 0 CA-C-N 115.934 -0.575 . . . . 0.0 113.89 178.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.582 ' OD1' HG23 ' A' ' 47' ' ' VAL . 2.8 p30 -85.16 -171.71 3.78 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 117.33 0.565 . . . . 0.0 111.227 -179.44 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 43.5 tttm -135.11 122.03 21.16 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.773 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.456 ' CG2' HD12 ' A' ' 95' ' ' LEU . 20.6 mt -90.12 117.3 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.017 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 20.2 mm -96.01 -36.77 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -179.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.02 150.55 30.09 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.136 0.493 . . . . 0.0 112.07 -178.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.619 ' HB3' ' CE1' ' A' ' 74' ' ' PHE . . . -137.25 119.94 16.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.822 179.315 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.414 ' HB2' ' CZ ' ' A' ' 89' ' ' PHE . 62.8 m-20 42.56 28.87 0.13 Allowed 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 179.26 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 99.31 5.69 55.78 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 120.888 -0.672 . . . . 0.0 113.98 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -109.32 121.28 44.82 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 117.911 0.856 . . . . 0.0 110.084 179.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.3 t -68.03 121.0 15.18 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.798 0.332 . . . . 0.0 111.235 -179.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.619 ' CE1' ' HB3' ' A' ' 69' ' ' ALA . 3.9 m-30 -99.63 15.15 27.62 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 116.173 -0.467 . . . . 0.0 112.069 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 7.7 tp -92.2 123.41 44.3 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-O 120.785 0.326 . . . . 0.0 110.86 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 61.29 73.78 0.47 Allowed 'General case' 0 C--O 1.232 0.167 0 CA-C-O 121.258 0.551 . . . . 0.0 110.773 -179.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 11.7 pt -149.21 160.93 5.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.646 179.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -73.29 139.47 46.12 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.225 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.418 ' O ' HG23 ' A' ' 83' ' ' VAL . 3.8 t-160 -48.25 -49.74 32.25 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -179.513 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -56.63 -28.26 56.16 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 121.13 -0.557 . . . . 0.0 112.944 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -73.96 -40.91 62.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.888 0.375 . . . . 0.0 110.372 179.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.98 -36.41 83.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.032 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.528 HG13 HG12 ' B' ' 307' ' ' VAL . 22.1 t -75.04 -41.4 45.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.821 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 54.3 p -60.45 -45.66 92.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.291 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 54.8 mt -65.84 -44.66 84.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.611 -179.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.42 ' HA ' ' CD2' ' A' ' 89' ' ' PHE . 12.6 mt -66.74 -36.54 82.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.23 -0.441 . . . . 0.0 112.105 -178.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 54.9 mttm -75.31 -38.56 60.21 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 -178.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 11.5 t -70.94 -24.85 62.52 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -178.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.42 ' CD2' ' HA ' ' A' ' 86' ' ' LEU . 8.5 m-85 -47.82 173.55 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -178.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 6.9 mm-40 -81.38 -145.58 0.06 Allowed 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.517 -179.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -79.36 -66.78 0.83 Allowed 'General case' 0 C--N 1.345 0.401 0 CA-C-N 118.911 0.778 . . . . 0.0 110.721 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.558 HG22 ' HG3' ' A' ' 18' ' ' GLU . 0.6 OUTLIER -76.91 126.37 30.86 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.645 179.629 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.693 HG12 ' CD2' ' A' ' 95' ' ' LEU . 21.2 t -119.27 123.23 70.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.97 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -100.68 106.46 17.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.578 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.693 ' CD2' HG12 ' A' ' 93' ' ' VAL . 4.3 mm? -100.36 149.92 23.13 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.47 -179.591 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.715 HD13 ' HG2' ' A' ' 14' ' ' ARG . 17.5 mm -108.54 124.87 65.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.38 178.377 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.551 HD13 HD23 ' A' ' 60' ' ' LEU . 43.4 pt -129.23 165.17 29.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.735 0.302 . . . . 0.0 111.255 -179.161 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.41 HG12 ' N ' ' A' ' 99' ' ' ARG . 14.6 t -150.38 154.57 8.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.009 0.433 . . . . 0.0 111.689 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.41 ' N ' HG12 ' A' ' 98' ' ' VAL . 0.1 OUTLIER -108.49 112.76 25.31 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 177.694 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 . . . . . 0 N--CA 1.462 0.157 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.638 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 4.9 pm0 . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.674 0.273 . . . . 0.0 110.492 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 305' ' ' THR . . . . . . . . . . . . . 5.7 m -132.97 121.79 23.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.39 -0.368 . . . . 17.879999999999999 110.888 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 306' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -85.58 118.55 25.16 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.99 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 307' ' ' VAL . . . . . 0.528 HG12 HG13 ' A' ' 83' ' ' VAL . 18.3 m . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.21 -0.9 . . . . 16.109999999999999 111.139 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.529 0.156 0 CA-C-O 120.775 0.322 . . . . 0.0 111.097 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.616 ' N ' HD13 ' A' ' 13' ' ' ILE . 0.2 OUTLIER -139.82 155.29 24.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.958 0.409 . . . . 0.0 111.544 -179.893 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.74 167.13 10.08 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.448 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.63 HG13 ' HB3' ' A' ' 59' ' ' LEU . 22.4 t -146.82 153.5 12.6 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.966 179.437 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.497 ' CD ' HG22 ' A' ' 92' ' ' THR . 0.0 OUTLIER -129.05 118.65 22.88 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.278 179.77 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.3 t -125.43 130.63 72.78 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-O 120.924 0.392 . . . . 0.0 111.453 -179.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -100.02 146.11 27.11 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.067 179.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.64 76.59 9.51 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.863 0.363 . . . . 0.0 110.492 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -140.8 85.65 12.47 Favored Pre-proline 0 CA--C 1.539 0.528 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.706 -179.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -82.15 -30.67 4.76 Favored 'Cis proline' 0 C--N 1.363 1.338 0 CA-C-N 119.409 0.825 . . . . 0.0 113.172 0.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -138.19 -178.54 5.32 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.872 0.367 . . . . 0.0 111.361 -179.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.411 ' HB3' ' CE2' ' A' ' 25' ' ' PHE . 3.2 mp -62.09 -61.89 2.16 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.83 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 103.79 34.87 3.65 Favored Glycine 0 CA--C 1.52 0.38 0 C-N-CA 120.825 -0.702 . . . . 0.0 113.783 179.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.411 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 31.1 p90 -163.57 145.95 9.73 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 117.254 0.527 . . . . 0.0 111.137 179.321 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.8 p -100.63 150.4 22.76 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.056 -179.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.66 HD11 HG22 ' A' ' 83' ' ' VAL . 25.4 pt -117.23 147.63 20.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.867 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 12.9 p -138.35 153.92 48.96 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.77 0.319 . . . . 0.0 111.293 -179.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 113.47 -158.92 13.97 Favored Glycine 0 C--N 1.332 0.323 0 C-N-CA 120.977 -0.63 . . . . 0.0 113.519 179.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 109.47 153.38 14.91 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 121.234 -0.507 . . . . 0.0 112.022 -179.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 17.9 t -76.82 98.39 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-O 121.081 0.467 . . . . 0.0 110.522 -179.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 96.0 10.25 56.42 Favored Glycine 0 CA--C 1.528 0.866 0 CA-C-N 115.657 -0.701 . . . . 0.0 113.349 -179.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.6 -158.28 32.66 Favored Glycine 0 C--N 1.342 0.865 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.712 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -59.61 -27.63 66.48 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -179.067 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 117.57 -167.02 12.66 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.662 -179.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -145.44 125.92 7.27 Favored Pre-proline 0 CA--C 1.533 0.291 0 O-C-N 122.928 -0.16 . . . . 0.0 110.871 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -92.31 24.7 0.48 Allowed 'Trans proline' 0 C--N 1.355 0.913 0 C-N-CA 122.122 1.881 . . . . 0.0 112.875 179.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -124.49 -49.63 1.78 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 120.793 0.33 . . . . 0.0 110.639 179.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -114.83 130.98 23.69 Favored Pre-proline 0 CA--C 1.533 0.301 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.455 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -85.0 -44.85 0.05 OUTLIER 'Trans proline' 0 C--N 1.356 0.927 0 C-N-CA 121.965 1.776 . . . . 0.0 113.22 -179.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -89.6 -3.95 58.05 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -179.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -109.94 125.26 52.66 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 118.156 0.435 . . . . 0.0 110.576 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -109.98 31.29 5.97 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.647 -179.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.422 ' O ' HD13 ' A' ' 45' ' ' ILE . . . -76.49 -146.62 2.04 Favored Glycine 0 CA--C 1.519 0.34 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.98 179.401 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.422 HD13 ' O ' ' A' ' 44' ' ' GLY . 14.7 mm -124.13 135.36 63.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-N 116.934 0.367 . . . . 0.0 110.469 179.269 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.427 ' CD1' ' N ' ' A' ' 46' ' ' PHE . 7.7 m-85 -132.99 151.98 52.01 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.16 -179.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.528 HG23 ' OD1' ' A' ' 64' ' ' ASP . 21.8 t -97.34 74.23 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 CA-C-O 121.058 0.456 . . . . 0.0 110.797 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.419 HG23 ' N ' ' A' ' 49' ' ' ARG . 8.0 t -31.44 -53.23 0.23 Allowed 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 -178.71 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.419 ' N ' HG23 ' A' ' 48' ' ' THR . 0.0 OUTLIER -160.9 -178.92 7.14 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.155 0.502 . . . . 0.0 111.987 -179.457 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.0 t -134.73 150.75 30.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.61 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -104.86 -68.23 0.04 OUTLIER Pre-proline 0 CA--C 1.538 0.495 0 N-CA-C 111.728 0.269 . . . . 0.0 111.728 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -79.25 119.39 4.2 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 121.781 1.654 . . . . 0.0 112.275 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -75.15 68.33 1.9 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.931 0.396 . . . . 0.0 110.872 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -161.19 -66.64 0.02 OUTLIER Glycine 0 CA--C 1.529 0.936 0 C-N-CA 120.651 -0.785 . . . . 0.0 113.821 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -58.32 -76.44 0.02 OUTLIER 'Trans proline' 0 C--N 1.356 0.949 0 C-N-CA 122.166 1.911 . . . . 0.0 113.452 -178.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.919 ' HB1' HD12 ' A' ' 60' ' ' LEU . . . -115.32 50.95 0.95 Allowed 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.289 0.566 . . . . 0.0 111.298 -179.399 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.4 t -112.85 -63.37 1.45 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.45 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.82 -13.64 61.78 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.569 179.313 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.63 ' HB3' HG13 ' A' ' 15' ' ' VAL . 34.6 mt -96.61 -54.43 3.24 Favored 'General case' 0 C--N 1.345 0.388 0 O-C-N 122.091 -0.381 . . . . 0.0 111.101 179.562 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.919 HD12 ' HB1' ' A' ' 56' ' ' ALA . 56.5 mt -91.93 146.86 23.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.453 -179.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -118.25 137.47 24.65 Favored Pre-proline 0 CA--C 1.537 0.48 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.016 178.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.82 131.01 43.57 Favored 'Trans proline' 0 C--N 1.361 1.195 0 C-N-CA 122.341 2.027 . . . . 0.0 113.931 -178.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 96.73 16.59 35.88 Favored Glycine 0 CA--C 1.523 0.576 0 CA-C-N 115.637 -0.71 . . . . 0.0 113.816 178.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.528 ' OD1' HG23 ' A' ' 47' ' ' VAL . 2.7 p30 -81.65 -169.1 2.16 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 117.379 0.589 . . . . 0.0 111.298 -179.482 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 45.8 tttp -139.31 124.57 19.05 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.28 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 33.9 mt -89.02 115.16 28.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.615 -179.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 23.9 mm -94.19 -38.17 9.01 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 116.097 -0.501 . . . . 0.0 112.126 -178.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.729 ' HB3' HD12 ' A' ' 96' ' ' ILE . 0.0 OUTLIER -151.08 150.89 31.23 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.178 0.514 . . . . 0.0 112.096 -179.025 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -145.56 124.68 12.87 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.942 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.6 m120 43.95 31.7 0.54 Allowed 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 179.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 97.6 -6.0 62.64 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 120.78 -0.724 . . . . 0.0 114.068 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -102.03 123.06 45.27 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 117.83 0.815 . . . . 0.0 110.775 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 7.9 m -71.43 126.8 30.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.927 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -99.75 6.64 45.46 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.413 ' O ' HG23 ' A' ' 75' ' ' ILE . 7.3 tp -83.85 120.06 34.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 118.165 0.438 . . . . 0.0 110.896 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 63.3 76.17 0.37 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.032 0.444 . . . . 0.0 111.072 -179.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 9.3 pt -150.19 164.77 3.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.817 179.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.7 mp0 -78.75 148.52 32.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.139 0.495 . . . . 0.0 111.454 -179.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 23.9 t60 -53.47 -54.13 41.44 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.282 -179.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -55.33 -27.43 47.15 Favored Glycine 0 CA--C 1.52 0.373 0 C-N-CA 121.147 -0.549 . . . . 0.0 113.163 -179.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.4 tp60 -73.57 -39.02 64.98 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.028 0.442 . . . . 0.0 110.544 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.11 -55.91 12.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.933 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.66 HG22 HD11 ' A' ' 27' ' ' ILE . 17.2 t -58.29 -44.0 87.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.787 -179.29 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.6 t -60.39 -39.24 86.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.596 -179.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.544 ' O ' HG22 ' A' ' 88' ' ' THR . 30.2 mt -67.52 -43.61 80.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.825 -179.439 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.43 ' HA ' ' CD2' ' A' ' 89' ' ' PHE . 22.2 mt -66.66 -42.07 87.18 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -179.022 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 15.1 mttm -64.48 -41.47 96.47 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -178.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.544 HG22 ' O ' ' A' ' 85' ' ' LEU . 9.7 t -64.11 -22.61 67.0 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -178.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.43 ' CD2' ' HA ' ' A' ' 86' ' ' LEU . 21.4 m-85 -60.81 131.0 49.29 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.951 0.405 . . . . 0.0 110.495 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -65.77 -105.34 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.959 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -178.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -88.4 -83.04 0.22 Allowed 'General case' 0 C--N 1.35 0.618 0 CA-C-N 119.422 1.01 . . . . 0.0 113.321 -178.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.497 HG22 ' CD ' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -71.22 162.17 29.87 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 121.128 0.489 . . . . 0.0 111.658 -178.652 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 19.9 t -151.41 112.91 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.612 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.1 mp0 -89.01 122.51 32.43 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 179.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 14.1 mt -121.56 143.05 49.51 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -178.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.729 HD12 ' HB3' ' A' ' 68' ' ' GLN . 42.4 mt -114.07 129.28 70.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 177.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.436 HD13 HD23 ' A' ' 60' ' ' LEU . 43.5 pt -134.71 172.99 15.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -178.156 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 20.2 t -147.25 151.66 13.63 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.731 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -123.2 113.51 19.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.53 179.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 . . . . . 0 C--N 1.33 -0.263 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.336 -179.319 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.81 0.338 . . . . 0.0 111.128 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 305' ' ' THR . . . . . . . . . . . . . 7.4 m -109.38 134.69 51.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.009 -0.541 . . . . 17.879999999999999 110.613 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 306' ' ' TRP . . . . . . . . . . . . . 83.4 m95 -97.43 131.71 43.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.885 0.374 . . . . 0.0 111.058 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 307' ' ' VAL . . . . . . . . . . . . . 24.0 m . . . . . 0 C--O 1.25 1.125 0 CA-C-O 118.271 -0.871 . . . . 16.109999999999999 111.153 -179.876 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 . . . . . 0 N--CA 1.465 0.284 0 CA-C-O 120.802 0.334 . . . . 0.0 111.5 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.589 ' H ' HD13 ' A' ' 13' ' ' ILE . 0.2 OUTLIER -114.42 154.8 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.934 179.934 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 1.1 ttt85 -93.09 165.45 12.83 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.628 -179.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.463 HG11 HD11 ' A' ' 60' ' ' LEU . 53.9 t -141.1 118.59 8.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.241 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -105.48 109.29 21.21 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 178.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.451 HG23 HG12 ' A' ' 15' ' ' VAL . 14.0 t -121.37 131.81 72.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-O 120.883 0.373 . . . . 0.0 111.517 -179.245 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.435 ' CG ' HG23 ' A' ' 92' ' ' THR . 34.4 mt-10 -92.04 164.07 13.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.162 179.16 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.32 74.93 1.05 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 121.337 0.589 . . . . 0.0 110.949 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -141.61 84.71 12.06 Favored Pre-proline 0 CA--C 1.54 0.593 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.419 -179.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -83.73 -23.92 11.87 Favored 'Cis proline' 0 C--N 1.364 1.352 0 CA-C-N 119.444 0.837 . . . . 0.0 113.009 0.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -139.14 -169.07 2.57 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 120.692 0.282 . . . . 0.0 110.986 -179.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.509 HD13 HG23 ' B' ' 307' ' ' VAL . 5.2 mp -67.47 -49.43 63.61 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-O 120.807 0.337 . . . . 0.0 110.228 179.43 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.505 ' O ' HG13 ' A' ' 50' ' ' VAL . . . 106.22 24.32 6.9 Favored Glycine 0 C--N 1.333 0.364 0 C-N-CA 120.972 -0.633 . . . . 0.0 113.371 179.205 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.41 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 45.1 p90 -160.52 153.87 21.99 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 117.14 0.47 . . . . 0.0 111.28 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.8 p -104.03 156.77 17.59 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.977 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.47 HD11 HG22 ' A' ' 83' ' ' VAL . 30.9 pt -122.91 149.39 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.1 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.4 m -151.29 169.74 21.22 Favored 'General case' 0 CA--C 1.53 0.212 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.144 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.66 21.49 26.24 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 121.076 -0.583 . . . . 0.0 114.164 178.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -60.47 151.96 38.89 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.343 179.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 58.5 t -78.37 106.91 9.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.028 0.442 . . . . 0.0 110.281 -179.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 94.24 -5.42 71.38 Favored Glycine 0 CA--C 1.53 0.994 0 CA-C-N 115.752 -0.658 . . . . 0.0 113.635 -178.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -85.89 -139.87 5.36 Favored Glycine 0 C--N 1.345 1.075 0 CA-C-N 117.804 0.802 . . . . 0.0 113.236 -179.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 8.6 mmt180 -75.75 -17.91 59.73 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -178.106 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 99.25 -150.12 19.15 Favored Glycine 0 C--N 1.339 0.749 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.477 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -166.57 132.95 1.93 Allowed Pre-proline 0 CA--C 1.535 0.393 0 CA-C-N 116.626 0.213 . . . . 0.0 110.99 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -90.41 25.7 0.53 Allowed 'Trans proline' 0 C--N 1.36 1.135 0 C-N-CA 122.193 1.929 . . . . 0.0 113.689 -179.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -110.65 -54.69 2.56 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.755 0.312 . . . . 0.0 110.785 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.426 ' HG3' ' CE2' ' A' ' 46' ' ' PHE . 4.9 mmp_? -108.41 144.76 30.14 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.311 179.558 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -89.17 -51.9 0.02 OUTLIER 'Trans proline' 0 C--N 1.357 1.026 0 C-N-CA 121.899 1.733 . . . . 0.0 113.853 -178.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -99.28 -2.47 36.44 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 -178.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -95.07 117.92 31.0 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 118.264 0.484 . . . . 0.0 110.601 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -101.08 37.01 1.84 Allowed 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.958 -179.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.4 -168.03 38.52 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.466 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.2 mm -102.83 129.21 54.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 178.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.426 ' CE2' ' HG3' ' A' ' 39' ' ' ARG . 1.2 m-85 -129.99 149.49 51.69 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.839 0.352 . . . . 0.0 110.925 -179.154 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.553 HG23 ' OD1' ' A' ' 64' ' ' ASP . 38.8 t -89.77 79.07 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.306 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.417 HG23 ' N ' ' A' ' 49' ' ' ARG . 9.9 t -37.82 -53.31 1.3 Allowed 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 -178.564 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.417 ' N ' HG23 ' A' ' 48' ' ' THR . 3.5 ptt-85 -160.3 165.49 31.22 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 118.229 0.468 . . . . 0.0 112.111 -179.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.505 HG13 ' O ' ' A' ' 24' ' ' GLY . 12.1 t -122.98 148.38 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.805 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.4 ' HG3' ' CH2' ' B' ' 306' ' ' TRP . 8.5 mt-30 -100.21 -68.41 0.04 OUTLIER Pre-proline 0 CA--C 1.538 0.487 0 CA-C-O 119.738 -0.172 . . . . 0.0 111.129 179.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -80.78 117.22 3.28 Favored 'Trans proline' 0 C--N 1.358 1.07 0 C-N-CA 121.715 1.61 . . . . 0.0 112.581 179.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -75.57 70.55 2.41 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 120.954 0.407 . . . . 0.0 110.784 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -162.8 -65.92 0.02 OUTLIER Glycine 0 CA--C 1.529 0.937 0 C-N-CA 120.789 -0.72 . . . . 0.0 113.354 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -58.27 -78.26 0.02 OUTLIER 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 122.118 1.878 . . . . 0.0 112.924 -179.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.687 ' HB1' HD12 ' A' ' 60' ' ' LEU . . . -108.19 46.88 0.93 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.47 0.652 . . . . 0.0 110.582 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 91.7 p -101.95 -61.43 1.39 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.193 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -71.77 -7.12 46.24 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.206 179.115 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.461 ' HB3' HG13 ' A' ' 15' ' ' VAL . 66.3 mt -95.57 -59.61 1.84 Allowed 'General case' 0 C--N 1.344 0.332 0 CA-C-N 118.244 0.474 . . . . 0.0 111.541 -179.516 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.687 HD12 ' HB1' ' A' ' 56' ' ' ALA . 2.7 mt -95.63 144.31 26.18 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.654 0.264 . . . . 0.0 111.452 -179.375 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.1 pm0 -112.35 142.73 27.5 Favored Pre-proline 0 CA--C 1.538 0.488 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.382 178.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -50.93 130.32 30.92 Favored 'Trans proline' 0 C--N 1.359 1.105 0 C-N-CA 122.206 1.937 . . . . 0.0 113.667 -179.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 82.59 24.73 52.85 Favored Glycine 0 C--N 1.333 0.386 0 CA-C-N 115.853 -0.612 . . . . 0.0 113.637 178.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.553 ' OD1' HG23 ' A' ' 47' ' ' VAL . 20.6 p30 -86.98 -171.79 3.68 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 117.025 0.413 . . . . 0.0 110.793 -179.618 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 66.5 tttt -140.33 128.83 22.76 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . 0.565 ' N ' HD12 ' A' ' 66' ' ' ILE . 4.0 mp -93.59 118.82 40.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.833 179.308 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 23.7 mm -92.67 -33.97 5.74 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.86 -178.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 -146.88 148.85 32.24 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.95 0.405 . . . . 0.0 111.456 -179.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -138.5 114.84 10.36 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.509 -179.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 49.32 29.11 2.57 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 179.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 101.03 -22.65 38.55 Favored Glycine 0 CA--C 1.521 0.458 0 C-N-CA 120.787 -0.721 . . . . 0.0 113.178 179.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -89.16 127.95 35.76 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 117.099 0.449 . . . . 0.0 110.696 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.2 m -65.93 130.35 42.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.974 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -104.65 21.58 16.59 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.662 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 6.6 tp -101.68 140.53 20.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 O-C-N 122.249 -0.282 . . . . 0.0 110.99 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 34.7 m-20 65.54 10.72 6.89 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -178.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 17.3 pt -89.12 156.09 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 121.334 0.588 . . . . 0.0 112.584 -178.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -80.84 153.6 27.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.615 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 9.3 t60 -49.8 -55.26 14.78 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 -179.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -54.83 -28.0 45.83 Favored Glycine 0 C--N 1.335 0.522 0 C-N-CA 121.039 -0.6 . . . . 0.0 113.351 -179.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -72.78 -41.86 64.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.943 0.401 . . . . 0.0 110.484 179.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.78 -57.4 8.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.742 -179.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.47 HG22 HD11 ' A' ' 27' ' ' ILE . 15.4 t -56.7 -43.95 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-O 120.871 0.367 . . . . 0.0 111.595 -179.377 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 38.0 m -60.79 -43.18 98.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.438 -179.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.453 HD23 ' HA ' ' A' ' 85' ' ' LEU . 12.8 mt -65.51 -47.39 76.13 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.577 -179.415 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.425 ' HA ' ' CD2' ' A' ' 89' ' ' PHE . 26.5 mt -64.37 -41.77 96.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.661 -179.033 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 36.8 mmtt -64.23 -41.71 96.88 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -178.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 11.3 t -72.02 -25.04 61.66 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -177.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.425 ' CD2' ' HA ' ' A' ' 86' ' ' LEU . 14.8 m-85 -53.81 156.6 2.71 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.53 0.681 . . . . 0.0 112.741 -178.476 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -61.72 -145.55 0.0 OUTLIER 'General case' 0 CA--C 1.556 1.179 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.672 -178.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -81.25 -59.52 2.61 Favored 'General case' 0 C--N 1.35 0.62 0 CA-C-N 118.859 0.754 . . . . 0.0 111.829 -178.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.435 HG23 ' CG ' ' A' ' 18' ' ' GLU . 0.2 OUTLIER -87.15 135.19 33.39 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 -179.644 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 12.0 t -127.6 124.82 64.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.865 0.364 . . . . 0.0 111.484 -179.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -101.03 114.87 29.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.25 179.224 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.445 ' N ' HD12 ' A' ' 95' ' ' LEU . 5.7 mp -113.58 160.84 18.11 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.082 0.468 . . . . 0.0 111.929 -179.083 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 22.9 mm -118.67 129.73 74.51 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.263 179.3 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.497 HG21 ' CD2' ' A' ' 60' ' ' LEU . 7.1 pt -134.14 166.79 27.8 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-O 120.577 0.227 . . . . 0.0 111.592 -179.509 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.408 HG12 ' N ' ' A' ' 99' ' ' ARG . 21.3 t -144.88 155.27 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-O 121.203 0.525 . . . . 0.0 111.873 -179.336 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.408 ' N ' HG12 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -112.26 110.15 20.23 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.361 178.798 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 . . . . . 0 N--CA 1.464 0.229 0 CA-C-O 121.025 0.441 . . . . 0.0 112.164 -178.468 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.853 0.359 . . . . 0.0 111.101 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 305' ' ' THR . . . . . . . . . . . . . 11.5 m -119.05 130.66 55.75 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.017 -0.538 . . . . 17.879999999999999 110.611 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 306' ' ' TRP . . . . . 0.4 ' CH2' ' HG3' ' A' ' 51' ' ' GLN . 82.3 m95 -90.68 105.35 17.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.895 0.378 . . . . 0.0 110.904 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 307' ' ' VAL . . . . . 0.509 HG23 HD13 ' A' ' 23' ' ' LEU . 15.9 m . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.248 -0.882 . . . . 16.109999999999999 111.138 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.534 0.345 0 CA-C-O 120.726 0.298 . . . . 0.0 111.048 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.547 ' H ' HD13 ' A' ' 13' ' ' ILE . 0.1 OUTLIER -105.87 160.64 5.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.377 -179.071 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.72 151.07 26.69 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.129 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.421 HG13 HD13 ' A' ' 59' ' ' LEU . 21.3 t -137.29 137.11 46.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.837 179.433 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.52 111.46 24.18 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.783 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.8 t -105.47 116.83 50.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.812 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.57 ' CG ' HG23 ' A' ' 92' ' ' THR . 34.6 mt-10 -94.61 116.92 29.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.853 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 24.5 mttt -71.57 127.37 32.35 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.479 0.656 . . . . 0.0 110.934 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -172.18 83.09 0.45 Allowed Pre-proline 0 CA--C 1.539 0.555 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.872 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -85.85 -8.78 48.08 Favored 'Cis proline' 0 C--N 1.366 1.448 0 CA-C-N 119.426 0.831 . . . . 0.0 113.786 0.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -137.29 -177.53 4.81 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.789 0.328 . . . . 0.0 111.264 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.415 ' HB3' ' CE2' ' A' ' 25' ' ' PHE . 3.5 mp -63.03 -57.15 11.64 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.105 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 102.29 29.02 6.18 Favored Glycine 0 C--N 1.337 0.631 0 C-N-CA 120.82 -0.705 . . . . 0.0 113.675 178.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.415 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 36.0 p90 -157.26 145.31 19.18 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 117.131 0.465 . . . . 0.0 110.825 179.225 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.5 p -98.85 149.7 22.64 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.608 -179.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.73 HD11 HG22 ' A' ' 83' ' ' VAL . 21.0 pt -121.7 147.8 25.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.288 179.116 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 34.1 t -143.68 163.38 33.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.839 0.352 . . . . 0.0 111.078 -179.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 103.51 -146.67 16.51 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.61 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.12 156.57 29.02 Favored Glycine 0 N--CA 1.452 -0.233 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.228 -179.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 17.3 t -78.64 101.61 4.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.872 0.368 . . . . 0.0 110.773 -179.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 92.85 1.55 67.67 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 120.979 -0.629 . . . . 0.0 113.746 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -82.13 -155.38 15.82 Favored Glycine 0 C--N 1.341 0.831 0 CA-C-N 117.965 0.882 . . . . 0.0 113.038 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 73.7 mtt180 -63.64 -27.92 69.56 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.638 0.236 . . . . 0.0 111.638 -179.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.54 168.32 38.41 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 120.608 -0.805 . . . . 0.0 112.794 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -137.11 139.13 27.42 Favored Pre-proline 0 CA--C 1.534 0.359 0 O-C-N 123.004 -0.115 . . . . 0.0 110.804 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -92.53 27.3 0.37 Allowed 'Trans proline' 0 C--N 1.358 1.078 0 C-N-CA 122.396 2.064 . . . . 0.0 113.291 -179.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -100.77 -54.1 2.9 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.71 0.291 . . . . 0.0 110.956 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -114.17 141.45 26.39 Favored Pre-proline 0 CA--C 1.533 0.295 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.606 179.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -87.59 -50.32 0.03 OUTLIER 'Trans proline' 0 C--N 1.358 1.049 0 C-N-CA 121.992 1.794 . . . . 0.0 113.66 -178.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -87.44 -11.47 49.0 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 -179.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -101.31 115.99 31.77 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 117.984 0.356 . . . . 0.0 110.793 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 30.9 p-10 -104.42 44.63 1.01 Allowed 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 121.211 0.529 . . . . 0.0 110.712 179.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -92.42 -159.45 35.19 Favored Glycine 0 C--N 1.332 0.328 0 CA-C-N 115.826 -0.625 . . . . 0.0 112.71 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.1 mm -107.5 131.94 56.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -131.58 148.66 52.63 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.816 0.341 . . . . 0.0 111.307 -179.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 24.0 t -89.78 73.95 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-O 121.158 0.504 . . . . 0.0 111.014 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.6 t -38.4 -52.63 1.55 Allowed 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 114.444 1.276 . . . . 0.0 114.444 -178.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -158.02 162.37 38.14 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 121.108 0.48 . . . . 0.0 112.116 -179.546 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 15.7 t -120.93 149.55 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.47 179.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 18.8 mm-40 -104.35 -67.77 0.04 OUTLIER Pre-proline 0 CA--C 1.538 0.513 0 N-CA-C 111.941 0.348 . . . . 0.0 111.941 -179.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -76.87 124.5 7.48 Favored 'Trans proline' 0 C--N 1.357 1.004 0 C-N-CA 121.666 1.577 . . . . 0.0 112.79 -179.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.85 63.4 3.56 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.142 -179.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -158.35 -66.97 0.01 OUTLIER Glycine 0 CA--C 1.526 0.774 0 C-N-CA 120.57 -0.824 . . . . 0.0 113.643 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -57.58 -77.07 0.02 OUTLIER 'Trans proline' 0 C--N 1.357 1.011 0 C-N-CA 122.195 1.93 . . . . 0.0 113.63 -178.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.883 ' HB1' HD12 ' A' ' 60' ' ' LEU . . . -118.34 51.8 1.06 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 121.267 0.556 . . . . 0.0 111.208 -179.036 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 19.8 t -116.56 -60.17 1.88 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.142 179.003 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 40.2 pttt -69.22 -9.99 55.62 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.977 179.007 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.421 HD13 HG13 ' A' ' 15' ' ' VAL . 69.5 mt -102.5 -52.24 3.15 Favored 'General case' 0 C--N 1.345 0.371 0 CA-C-N 118.237 0.471 . . . . 0.0 110.936 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.883 HD12 ' HB1' ' A' ' 56' ' ' ALA . 53.3 mt -91.02 158.42 16.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.36 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -130.65 143.03 47.65 Favored Pre-proline 0 CA--C 1.535 0.377 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.429 179.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -50.44 128.1 22.32 Favored 'Trans proline' 0 C--N 1.361 1.219 0 C-N-CA 122.099 1.866 . . . . 0.0 113.389 -179.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.06 2.25 48.58 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 120.979 -0.629 . . . . 0.0 113.911 179.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -75.95 140.91 42.32 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 118.024 0.912 . . . . 0.0 111.151 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 60.7 tttp -97.54 129.1 44.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.909 179.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 28.3 mt -89.06 114.07 26.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.562 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.574 HG23 HD11 ' A' ' 75' ' ' ILE . 21.1 mm -89.72 -44.06 14.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -178.601 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.493 ' HB2' HD12 ' A' ' 96' ' ' ILE . 9.6 mt-30 -148.23 149.53 32.08 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.348 0.594 . . . . 0.0 112.344 -178.573 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.578 ' HB3' ' CE1' ' A' ' 74' ' ' PHE . . . -136.82 121.4 18.39 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.121 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 48.1 m-20 45.67 28.46 0.54 Allowed 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 178.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 101.7 -14.09 57.73 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 120.762 -0.732 . . . . 0.0 113.705 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -88.59 127.99 35.57 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-N 117.685 0.742 . . . . 0.0 110.432 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 79.4 p -76.27 127.04 32.1 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.784 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . 0.578 ' CE1' ' HB3' ' A' ' 69' ' ' ALA . 6.3 m-85 -101.97 14.2 32.64 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.574 HD11 HG23 ' A' ' 67' ' ' ILE . 31.4 mm -90.65 125.53 43.46 Favored 'Isoleucine or valine' 0 C--N 1.341 0.226 0 O-C-N 122.011 -0.43 . . . . 0.0 110.97 179.386 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 61.64 71.88 0.53 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-O 121.279 0.561 . . . . 0.0 110.838 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 12.7 pt -149.01 165.84 3.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.792 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -80.97 145.21 31.33 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.95 0.405 . . . . 0.0 110.771 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -52.5 -51.73 58.03 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.05 -179.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -56.58 -27.46 54.62 Favored Glycine 0 C--N 1.334 0.424 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.938 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 7.1 tm0? -72.72 -40.2 66.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.957 0.408 . . . . 0.0 110.316 179.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.48 -36.13 82.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.314 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.73 HG22 HD11 ' A' ' 27' ' ' ILE . 25.4 t -73.4 -44.13 54.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.978 0.418 . . . . 0.0 110.572 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 23.0 t -56.49 -38.07 71.23 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.135 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 89.6 mt -71.78 -39.54 69.86 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.364 179.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.421 ' HA ' ' CD2' ' A' ' 89' ' ' PHE . 75.2 mt -78.14 -3.0 40.25 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 179.32 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 11.5 mmtp -99.23 -40.78 7.78 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-O 121.302 0.572 . . . . 0.0 110.303 178.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 8.9 t -73.86 -24.53 59.76 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -178.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.421 ' CD2' ' HA ' ' A' ' 86' ' ' LEU . 10.2 m-85 -48.52 171.62 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -178.534 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -86.99 -142.47 0.11 Allowed 'General case' 0 CA--C 1.554 1.113 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.214 -179.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -78.13 -68.32 0.65 Allowed 'General case' 0 C--N 1.349 0.561 0 CA-C-N 119.027 0.83 . . . . 0.0 111.017 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.57 HG23 ' CG ' ' A' ' 18' ' ' GLU . 0.2 OUTLIER -81.41 134.24 35.52 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.572 179.954 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 21.3 t -120.84 124.67 72.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.138 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -89.78 115.12 26.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.982 179.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.0 mt -118.57 148.24 42.87 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.043 0.449 . . . . 0.0 112.041 -178.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.493 HD12 ' HB2' ' A' ' 68' ' ' GLN . 48.6 mt -119.56 132.22 69.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.527 178.451 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.478 HD13 ' CD2' ' A' ' 60' ' ' LEU . 35.1 pt -130.67 169.03 22.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.864 0.364 . . . . 0.0 111.762 -179.207 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.467 HG23 ' CG1' ' A' ' 67' ' ' ILE . 58.2 t -133.01 143.02 40.67 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.042 -179.186 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.49 102.23 10.11 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 . . . . . 0 C--N 1.328 -0.346 0 CA-C-O 120.848 0.356 . . . . 0.0 111.727 -178.895 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 . . . . . 0 N--CA 1.464 0.245 0 CA-C-O 120.842 0.353 . . . . 0.0 110.904 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 305' ' ' THR . . . . . . . . . . . . . 3.5 m -105.1 123.42 47.79 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.109 -0.496 . . . . 17.879999999999999 110.688 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 306' ' ' TRP . . . . . . . . . . . . . 88.5 m95 -89.02 112.2 23.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.951 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 307' ' ' VAL . . . . . 0.488 HG12 HG13 ' A' ' 83' ' ' VAL . 17.8 m . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.241 -0.885 . . . . 16.109999999999999 111.077 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.162 0 N-CA-C 112.489 -0.244 . . . . 0.0 112.489 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 75.6 p -158.01 -179.57 8.25 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.862 0.363 . . . . 0.0 110.942 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 13.4 t-80 -76.41 134.53 39.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.826 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 10.7 mmt -83.77 162.59 20.59 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.895 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -157.49 -78.44 0.02 OUTLIER Glycine 0 CA--C 1.518 0.233 0 C-N-CA 120.825 -0.703 . . . . 0.0 112.44 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 12.1 m-70 -89.64 60.0 4.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.263 0.554 . . . . 0.0 110.646 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -167.82 177.34 5.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.881 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 16.6 tp -72.99 103.84 3.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.065 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.625 ' HA ' HG21 ' A' ' 101' ' ' VAL . . . -171.0 -171.17 0.95 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.374 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 5.2 mtpt -63.88 104.52 0.7 Allowed 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.093 -179.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.711 ' O ' HG13 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -98.8 168.66 9.99 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.936 179.928 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.6 tt0 -132.72 95.57 3.62 Favored 'General case' 0 CA--C 1.53 0.184 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.962 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.564 ' H ' HD13 ' A' ' 13' ' ' ILE . 0.2 OUTLIER -112.99 159.52 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-O 121.155 0.502 . . . . 0.0 112.202 -179.657 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 11.5 ttp-105 -114.5 155.23 26.81 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.9 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.536 HG21 HD21 ' A' ' 60' ' ' LEU . 15.9 m -136.65 143.73 34.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.217 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.5 mtm180 -108.44 106.85 17.15 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.609 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.8 t -110.31 110.39 31.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.883 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.711 ' HG3' HG23 ' A' ' 92' ' ' THR . 0.9 OUTLIER -88.79 128.76 35.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.899 -179.975 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.494 ' HD3' HD12 ' A' ' 23' ' ' LEU . 10.4 mtmt -80.53 115.04 19.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.937 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -166.98 89.06 0.76 Allowed Pre-proline 0 CA--C 1.535 0.39 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.634 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -79.72 -24.06 13.07 Favored 'Cis proline' 0 C--N 1.363 1.317 0 CA-C-N 119.36 0.807 . . . . 0.0 112.879 0.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 54.4 mm-40 -135.53 -176.8 4.4 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.8 0.333 . . . . 0.0 111.451 -179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.494 HD12 ' HD3' ' A' ' 19' ' ' LYS . 3.0 mp -63.47 -59.08 5.13 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.02 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.437 ' O ' HG13 ' A' ' 50' ' ' VAL . . . 106.75 31.18 4.02 Favored Glycine 0 CA--C 1.521 0.415 0 C-N-CA 120.867 -0.682 . . . . 0.0 113.585 179.157 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.418 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 28.3 p90 -162.62 155.44 19.52 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 117.066 0.433 . . . . 0.0 111.235 179.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.1 p -108.12 152.98 23.8 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.4 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.744 HD11 HG22 ' A' ' 83' ' ' VAL . 41.3 pt -120.27 148.71 23.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.632 179.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.5 t -139.45 167.71 21.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.871 0.367 . . . . 0.0 111.05 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.46 -146.4 18.19 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.972 -0.632 . . . . 0.0 112.382 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 101.54 153.32 25.75 Favored Glycine 0 C--N 1.331 0.255 0 C-N-CA 120.848 -0.692 . . . . 0.0 112.491 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 25.9 t -79.53 97.24 2.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.906 0.384 . . . . 0.0 111.003 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 98.81 -2.72 58.58 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 120.999 -0.62 . . . . 0.0 113.937 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -78.64 -155.75 8.83 Favored Glycine 0 C--N 1.34 0.781 0 CA-C-N 117.842 0.821 . . . . 0.0 113.04 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -62.12 -29.41 70.31 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.505 0.193 . . . . 0.0 111.341 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 107.94 153.74 17.75 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.606 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -112.28 129.85 23.91 Favored Pre-proline 0 N--CA 1.468 0.468 0 CA-C-O 119.886 -0.102 . . . . 0.0 110.764 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -92.85 34.9 0.23 Allowed 'Trans proline' 0 C--N 1.357 0.999 0 C-N-CA 122.357 2.038 . . . . 0.0 113.129 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -116.12 -49.21 2.7 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.761 0.315 . . . . 0.0 110.952 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 32.1 mmt180 -116.36 138.93 24.72 Favored Pre-proline 0 CA--C 1.534 0.333 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.806 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -83.63 -44.31 0.07 OUTLIER 'Trans proline' 0 C--N 1.357 1.023 0 C-N-CA 121.972 1.782 . . . . 0.0 112.936 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -92.03 -8.58 45.59 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -108.22 123.21 48.41 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 118.08 0.4 . . . . 0.0 110.885 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.2 p30 -110.04 34.67 3.74 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.072 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -78.73 -158.56 12.5 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.485 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 20.5 mm -108.94 131.04 60.76 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.158 0 N-CA-C 110.418 -0.215 . . . . 0.0 110.418 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -130.48 146.39 52.02 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.87 0.367 . . . . 0.0 111.545 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 22.0 t -90.38 73.95 0.99 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.672 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.2 t -34.47 -54.31 0.53 Allowed 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 114.767 1.395 . . . . 0.0 114.767 -178.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 11.0 ptm180 -160.3 170.87 20.19 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.201 0.524 . . . . 0.0 112.171 -179.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.437 HG13 ' O ' ' A' ' 24' ' ' GLY . 21.2 t -125.23 147.24 29.93 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 CA-C-N 115.485 -0.779 . . . . 0.0 110.355 179.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 8.3 mm-40 -103.91 -68.09 0.04 OUTLIER Pre-proline 0 CA--C 1.535 0.4 0 CA-C-N 116.833 -0.167 . . . . 0.0 111.277 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -79.83 119.33 3.97 Favored 'Trans proline' 0 C--N 1.356 0.951 0 C-N-CA 121.694 1.596 . . . . 0.0 112.173 179.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -79.59 66.27 5.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.276 0.56 . . . . 0.0 110.793 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -143.86 -73.37 0.03 OUTLIER Glycine 0 CA--C 1.526 0.734 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.58 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -60.2 -70.03 0.04 OUTLIER 'Trans proline' 0 C--N 1.358 1.03 0 C-N-CA 121.832 1.688 . . . . 0.0 112.938 -179.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -99.02 43.4 1.06 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-O 120.99 0.424 . . . . 0.0 111.415 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 92.9 p -87.11 -59.41 2.26 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.304 179.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -91.12 -4.0 56.6 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 115.791 -0.641 . . . . 0.0 112.244 179.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -91.62 -69.52 0.73 Allowed 'General case' 0 C--N 1.341 0.22 0 CA-C-N 118.231 0.469 . . . . 0.0 111.606 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.536 HD21 HG21 ' A' ' 15' ' ' VAL . 5.7 mt -96.82 146.31 25.04 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.896 0.379 . . . . 0.0 111.921 -179.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 9.4 pt20 -112.61 151.17 43.69 Favored Pre-proline 0 N--CA 1.47 0.574 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.478 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -64.22 129.22 23.56 Favored 'Trans proline' 0 C--N 1.355 0.909 0 C-N-CA 121.872 1.714 . . . . 0.0 112.588 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 92.71 18.99 38.87 Favored Glycine 0 CA--C 1.523 0.541 0 C-N-CA 120.929 -0.653 . . . . 0.0 113.689 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -93.54 151.35 19.76 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 117.306 0.553 . . . . 0.0 110.762 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 60.1 tttm -100.1 130.27 46.23 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.212 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 28.0 mt -89.85 117.08 32.46 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.411 179.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 22.1 mm -90.48 -43.96 14.63 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -178.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.619 ' HB3' HD12 ' A' ' 96' ' ' ILE . 3.4 tt0 -145.14 150.79 37.39 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.812 0.339 . . . . 0.0 111.652 -178.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.553 ' HB3' ' CE1' ' A' ' 74' ' ' PHE . . . -138.32 119.78 14.91 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.487 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.401 ' HB2' ' CZ ' ' A' ' 89' ' ' PHE . 2.4 m120 46.47 29.0 0.81 Allowed 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 178.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 101.78 -20.25 46.74 Favored Glycine 0 CA--C 1.521 0.468 0 C-N-CA 120.747 -0.739 . . . . 0.0 113.391 179.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -88.77 126.51 35.37 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 117.212 0.506 . . . . 0.0 110.535 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.5 t -72.53 141.71 48.48 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.576 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.553 ' CE1' ' HB3' ' A' ' 69' ' ' ALA . 3.7 m-85 -111.43 20.57 17.11 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -179.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 24.7 mm -97.52 137.66 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-O 120.681 0.277 . . . . 0.0 111.446 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 65.31 10.69 6.7 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 9.5 pt -92.88 163.08 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 N-CA-C 113.375 0.879 . . . . 0.0 113.375 -178.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -83.03 144.7 29.76 Favored 'General case' 0 N--CA 1.454 -0.246 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.79 179.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 8.8 t-160 -52.35 -51.4 59.01 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -178.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -53.95 -28.39 40.14 Favored Glycine 0 C--N 1.335 0.509 0 C-N-CA 121.104 -0.569 . . . . 0.0 113.127 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.4 tp-100 -75.77 -37.72 59.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.993 0.425 . . . . 0.0 110.309 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.63 -47.92 68.22 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.373 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.744 HG22 HD11 ' A' ' 27' ' ' ILE . 20.3 t -62.02 -43.37 97.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.271 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 33.2 t -60.77 -38.32 84.86 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.424 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.45 ' O ' HG22 ' A' ' 88' ' ' THR . 32.7 mt -67.66 -45.54 74.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.454 -179.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.441 ' HA ' ' CD2' ' A' ' 89' ' ' PHE . 15.6 mt -64.21 -36.25 83.44 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -179.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 34.2 mttm -72.19 -37.98 69.17 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 -178.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.45 HG22 ' O ' ' A' ' 85' ' ' LEU . 9.9 t -70.99 -27.02 63.4 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -178.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.441 ' CD2' ' HA ' ' A' ' 86' ' ' LEU . 13.3 m-85 -49.45 148.01 3.0 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -178.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -65.65 -137.75 0.0 OUTLIER 'General case' 0 CA--C 1.551 0.994 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.292 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -81.36 -69.79 0.58 Allowed 'General case' 0 C--N 1.351 0.646 0 CA-C-N 119.488 1.04 . . . . 0.0 112.403 -178.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.711 HG23 ' HG3' ' A' ' 18' ' ' GLU . 0.2 OUTLIER -74.18 121.36 21.09 Favored 'General case' 0 C--O 1.231 0.08 0 CA-C-O 120.839 0.352 . . . . 0.0 111.068 -179.278 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 19.1 t -112.58 111.89 38.08 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.004 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -93.44 126.08 38.39 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 2.0 mt -130.42 159.93 35.55 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.074 0.464 . . . . 0.0 111.867 -178.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.619 HD12 ' HB3' ' A' ' 68' ' ' GLN . 48.2 mt -119.17 129.18 75.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.984 178.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.514 HD13 HD23 ' A' ' 60' ' ' LEU . 33.0 pt -125.55 165.32 23.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-O 120.97 0.414 . . . . 0.0 111.878 -179.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.711 HG13 ' O ' ' A' ' 11' ' ' GLN . 44.3 t -144.61 149.34 17.29 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.555 -179.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.51 116.29 28.6 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.091 179.002 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 24.3 mm-40 -63.12 166.5 5.93 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 120.936 0.398 . . . . 0.0 111.647 -178.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.625 HG21 ' HA ' ' A' ' 9' ' ' ALA . 3.7 m -149.89 108.52 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.973 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 31.5 t -149.45 110.02 4.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.922 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 8.3 t . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.234 -0.888 . . . . 0.0 110.799 179.995 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 301' ' ' THR . . . . . . . . . . . . . 2.8 m . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.813 0.34 . . . . 0.0 111.208 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 302' ' ' GLY . . . . . . . . . . . . . . . 78.12 130.43 0.56 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.572 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 303' ' ' TRP . . . . . . . . . . . . . 20.5 p-90 -169.89 -42.25 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.718 0.294 . . . . 0.0 111.102 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -71.93 131.06 42.45 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.786 0.327 . . . . 0.0 110.865 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 305' ' ' THR . . . . . . . . . . . . . 6.9 m -122.78 120.19 32.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.142 -0.481 . . . . 17.879999999999999 110.627 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 306' ' ' TRP . . . . . . . . . . . . . 94.3 m95 -85.03 114.21 22.02 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.945 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 307' ' ' VAL . . . . . . . . . . . . . 25.2 m . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.14 -0.934 . . . . 16.109999999999999 111.168 -179.849 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.124 0 N-CA-C 112.514 -0.234 . . . . 0.0 112.514 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.6 t -162.44 -47.28 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.831 0.348 . . . . 0.0 110.948 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 16.0 m80 -70.74 109.14 4.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.093 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 11.9 mmm -103.89 -47.17 4.28 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.789 179.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -178.26 -39.42 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.427 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -81.18 99.13 8.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.782 0.325 . . . . 0.0 110.658 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -142.43 163.79 31.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.024 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -81.07 86.91 6.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.663 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -144.48 44.2 1.4 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.111 0.481 . . . . 0.0 110.904 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 6.0 tttt -174.65 -179.27 1.46 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.508 -179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.424 ' O ' HG13 ' A' ' 98' ' ' VAL . 5.2 pt20 -149.95 138.38 20.62 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-O 120.725 0.298 . . . . 0.0 111.345 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -127.6 110.23 12.49 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.002 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.615 ' H ' HD13 ' A' ' 13' ' ' ILE . 0.2 OUTLIER -126.2 155.79 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.296 179.867 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.642 ' HG3' HD13 ' A' ' 96' ' ' ILE . 24.7 ttm-85 -116.52 152.39 34.19 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.11 -179.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.405 ' HB ' HD22 ' A' ' 59' ' ' LEU . 18.5 m -145.78 147.23 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 N-CA-C 111.623 0.231 . . . . 0.0 111.623 -179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 14.1 ptp180 -112.54 130.59 55.96 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.813 0.34 . . . . 0.0 111.274 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.7 t -116.07 120.38 64.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.705 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.729 ' HG3' HG22 ' A' ' 92' ' ' THR . 3.5 mp0 -94.2 119.54 33.15 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.831 -179.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.57 113.18 4.02 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.833 179.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -175.29 84.02 0.31 Allowed Pre-proline 0 CA--C 1.537 0.461 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.119 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -82.68 -24.84 10.8 Favored 'Cis proline' 0 C--N 1.363 1.297 0 CA-C-N 119.508 0.86 . . . . 0.0 112.8 0.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -137.51 -178.06 5.06 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 120.815 0.341 . . . . 0.0 111.441 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.42 ' HB3' ' CE2' ' A' ' 25' ' ' PHE . 3.5 mp -61.1 -59.65 5.01 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.198 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.411 ' O ' HG13 ' A' ' 50' ' ' VAL . . . 104.94 25.53 6.76 Favored Glycine 0 CA--C 1.521 0.421 0 C-N-CA 120.799 -0.715 . . . . 0.0 113.48 179.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.498 ' O ' HG22 ' B' ' 307' ' ' VAL . 37.2 p90 -155.25 144.47 20.98 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 117.252 0.526 . . . . 0.0 111.051 179.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 5.3 p -98.91 151.82 20.44 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.363 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.872 HD11 HG22 ' A' ' 83' ' ' VAL . 22.5 pt -122.34 153.62 26.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.914 179.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.8 m -148.06 162.12 40.02 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.78 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 106.58 -149.9 16.71 Favored Glycine 0 C--N 1.332 0.355 0 C-N-CA 120.908 -0.663 . . . . 0.0 113.186 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 103.98 154.91 23.72 Favored Glycine 0 C--N 1.331 0.267 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.178 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 18.7 t -78.75 110.82 14.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 120.934 0.397 . . . . 0.0 110.756 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 88.83 3.71 76.59 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 120.939 -0.648 . . . . 0.0 113.847 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -82.89 -146.77 6.54 Favored Glycine 0 C--N 1.341 0.825 0 CA-C-N 117.841 0.82 . . . . 0.0 112.798 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 48.5 mtt-85 -81.0 -4.36 54.88 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 87.03 162.35 37.52 Favored Glycine 0 C--N 1.344 0.991 0 C-N-CA 120.609 -0.805 . . . . 0.0 113.099 179.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 69.3 m-80 -105.84 134.87 19.53 Favored Pre-proline 0 CA--C 1.533 0.289 0 CA-C-O 119.899 -0.096 . . . . 0.0 110.921 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -92.87 27.06 0.37 Allowed 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 122.309 2.006 . . . . 0.0 112.819 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -125.25 -46.03 1.81 Allowed 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.731 0.3 . . . . 0.0 110.796 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 64.6 mtt-85 -116.59 150.99 46.56 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.614 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -92.08 -57.58 0.02 OUTLIER 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 122.153 1.902 . . . . 0.0 114.082 -178.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -84.21 -7.18 59.43 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 -178.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -101.69 117.08 34.16 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 118.154 0.433 . . . . 0.0 111.108 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -106.31 34.03 3.57 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.481 -179.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -80.86 -161.56 26.19 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.199 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.8 mm -107.27 131.28 57.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-N 116.782 0.291 . . . . 0.0 110.298 179.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.435 ' N ' ' CD1' ' A' ' 46' ' ' PHE . 6.0 m-85 -130.5 148.35 52.3 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-O 120.882 0.372 . . . . 0.0 111.359 -179.332 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.538 HG23 ' OD1' ' A' ' 64' ' ' ASP . 22.0 t -92.2 76.02 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-O 121.158 0.504 . . . . 0.0 110.955 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.424 HG23 ' N ' ' A' ' 49' ' ' ARG . 8.2 t -35.13 -51.72 0.56 Allowed 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 -178.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.424 ' N ' HG23 ' A' ' 48' ' ' THR . 3.6 ptm180 -160.22 176.63 11.52 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.117 0.484 . . . . 0.0 112.28 -179.254 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.411 HG13 ' O ' ' A' ' 24' ' ' GLY . 18.3 t -130.8 148.47 33.08 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.605 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -102.66 -67.89 0.04 OUTLIER Pre-proline 0 CA--C 1.536 0.422 0 CA-C-O 119.753 -0.165 . . . . 0.0 111.392 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -79.4 120.8 4.55 Favored 'Trans proline' 0 C--N 1.355 0.905 0 C-N-CA 121.796 1.664 . . . . 0.0 112.052 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -77.76 65.63 3.27 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.94 0.4 . . . . 0.0 111.096 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -158.42 -66.54 0.01 OUTLIER Glycine 0 CA--C 1.528 0.85 0 C-N-CA 120.765 -0.731 . . . . 0.0 113.362 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -58.26 -76.43 0.02 OUTLIER 'Trans proline' 0 C--N 1.357 0.99 0 C-N-CA 122.142 1.895 . . . . 0.0 113.36 -179.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.858 ' HB1' HD12 ' A' ' 60' ' ' LEU . . . -111.72 49.77 0.88 Allowed 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.196 0.522 . . . . 0.0 111.437 -179.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 82.4 p -107.35 -67.25 0.97 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.758 179.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.72 -12.13 57.27 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.99 178.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.405 HD22 ' HB ' ' A' ' 15' ' ' VAL . 4.4 mt -93.71 -59.22 2.05 Favored 'General case' 0 C--N 1.342 0.24 0 O-C-N 122.008 -0.433 . . . . 0.0 111.405 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.858 HD12 ' HB1' ' A' ' 56' ' ' ALA . 15.2 mt -93.03 149.26 21.35 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.547 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.22 144.53 33.13 Favored Pre-proline 0 N--CA 1.471 0.603 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.744 179.2 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.53 133.47 52.05 Favored 'Trans proline' 0 C--N 1.359 1.081 0 C-N-CA 122.165 1.91 . . . . 0.0 113.427 -178.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 87.75 21.75 45.77 Favored Glycine 0 C--N 1.334 0.417 0 CA-C-N 115.716 -0.675 . . . . 0.0 113.632 178.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.538 ' OD1' HG23 ' A' ' 47' ' ' VAL . 2.9 p30 -84.62 -169.55 2.68 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 117.092 0.446 . . . . 0.0 111.005 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 57.8 tttp -141.55 126.44 18.19 Favored 'General case' 0 CA--C 1.528 0.111 0 CA-C-O 120.874 0.368 . . . . 0.0 111.338 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 27.9 mt -90.31 118.05 34.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.233 179.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.512 HD12 ' CG2' ' A' ' 98' ' ' VAL . 50.3 mt -102.14 -31.79 3.13 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 N-CA-C 112.419 0.525 . . . . 0.0 112.419 -178.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -148.61 144.57 27.31 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.005 0.431 . . . . 0.0 111.844 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.47 ' HB3' ' CE1' ' A' ' 74' ' ' PHE . . . -146.25 121.48 10.19 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.783 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 44.73 41.77 5.3 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 178.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 89.21 -17.99 48.07 Favored Glycine 0 CA--C 1.524 0.605 0 C-N-CA 120.856 -0.688 . . . . 0.0 113.634 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -100.92 123.27 44.87 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 117.373 0.586 . . . . 0.0 110.256 -179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 30.0 m -72.52 151.87 42.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.284 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.47 ' CE1' ' HB3' ' A' ' 69' ' ' ALA . 3.7 m-85 -113.09 19.56 17.08 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.783 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.431 HD11 HG23 ' A' ' 67' ' ' ILE . 30.7 mm -97.03 133.14 39.69 Favored 'Isoleucine or valine' 0 C--O 1.231 0.111 0 CA-C-O 120.751 0.31 . . . . 0.0 110.859 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 61.23 62.36 1.4 Allowed 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 121.185 0.517 . . . . 0.0 110.898 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 18.7 pt -144.43 164.67 13.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.752 -179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -82.09 145.53 30.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.633 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 -51.2 -53.29 36.37 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 116.167 -0.47 . . . . 0.0 112.162 -179.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -54.65 -25.97 37.62 Favored Glycine 0 CA--C 1.523 0.549 0 C-N-CA 121.079 -0.582 . . . . 0.0 113.02 179.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -74.46 -39.69 62.37 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.111 0.481 . . . . 0.0 110.404 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -70.5 -37.57 74.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.76 -0.654 . . . . 0.0 111.852 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.872 HG22 HD11 ' A' ' 27' ' ' ILE . 35.2 t -70.49 -44.53 76.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 120.972 0.415 . . . . 0.0 110.893 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 75.4 m -61.05 -37.32 82.21 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.303 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 19.9 mt -65.65 -46.89 77.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.599 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.415 ' HA ' ' CD2' ' A' ' 89' ' ' PHE . 34.4 mt -65.7 -38.31 88.87 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.897 -178.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 56.1 mttm -71.45 -39.16 71.16 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -178.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 12.0 t -73.77 -27.28 61.07 Favored 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -178.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.415 ' CD2' ' HA ' ' A' ' 86' ' ' LEU . 11.8 m-85 -48.98 172.7 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 -178.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -84.31 -143.46 0.08 Allowed 'General case' 0 CA--C 1.552 1.054 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.193 -179.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 67.8 m-80 -76.96 -69.95 0.49 Allowed 'General case' 0 C--N 1.349 0.564 0 CA-C-N 119.005 0.821 . . . . 0.0 111.552 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.729 HG22 ' HG3' ' A' ' 18' ' ' GLU . 4.7 p -80.07 125.46 29.82 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 120.921 0.391 . . . . 0.0 110.788 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 18.8 t -113.41 114.56 47.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.556 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -87.79 112.97 23.0 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 4.2 mt -115.21 152.64 32.3 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-O 121.224 0.535 . . . . 0.0 112.101 -178.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.642 HD13 ' HG3' ' A' ' 14' ' ' ARG . 31.3 mm -112.39 124.6 69.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.065 178.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.535 HD13 HD23 ' A' ' 60' ' ' LEU . 29.3 pt -127.23 158.34 38.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 120.882 0.372 . . . . 0.0 111.208 -178.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.512 ' CG2' HD12 ' A' ' 67' ' ' ILE . 58.3 t -144.24 150.25 16.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.241 -179.133 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.6 mmm180 -112.0 116.8 31.16 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -67.54 143.97 55.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.058 0.456 . . . . 0.0 111.703 -178.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 25.5 t -148.07 102.52 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.516 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 69.0 m -151.15 166.04 32.03 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.118 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 20.0 t . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.243 -0.884 . . . . 0.0 110.814 179.879 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 301' ' ' THR . . . . . . . . . . . . . 47.1 p . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.758 0.313 . . . . 0.0 111.231 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 302' ' ' GLY . . . . . . . . . . . . . . . -87.75 147.04 20.26 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.455 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 303' ' ' TRP . . . . . . . . . . . . . 26.9 p-90 -74.98 -30.62 61.22 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 120.657 0.265 . . . . 0.0 111.126 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -83.51 164.75 19.63 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.692 0.282 . . . . 0.0 110.515 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 305' ' ' THR . . . . . . . . . . . . . 4.7 m -140.42 113.71 8.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.454 -0.339 . . . . 17.879999999999999 111.159 -179.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 306' ' ' TRP . . . . . . . . . . . . . 92.8 m95 -80.77 105.46 12.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.707 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 307' ' ' VAL . . . . . 0.498 HG22 ' O ' ' A' ' 25' ' ' PHE . 16.7 m . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.233 -0.889 . . . . 16.109999999999999 111.134 -179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.176 0 N-CA-C 112.534 -0.226 . . . . 0.0 112.534 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.2 t -86.11 174.37 9.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.744 0.307 . . . . 0.0 110.954 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 36.8 t60 -89.99 121.1 31.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.986 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -137.64 90.94 2.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.451 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -163.71 32.16 0.27 Allowed Glycine 0 C--N 1.334 0.434 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.674 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 37.3 m170 -104.21 162.66 13.0 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.761 0.315 . . . . 0.0 110.781 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -86.46 100.06 12.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.799 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.8 tp -160.35 148.38 16.51 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.155 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -102.14 -158.43 0.67 Allowed 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.788 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.3 mmtm -52.7 124.43 13.82 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 121.159 0.504 . . . . 0.0 111.581 -179.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -87.92 94.17 9.69 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.641 -0.709 . . . . 0.0 112.873 -178.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -94.8 126.76 40.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.557 178.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 19.8 pt -147.29 159.17 9.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -178.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 9.7 ttm105 -104.91 153.77 20.96 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.718 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.5 m -146.74 132.74 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.547 178.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.2 ttt180 -107.84 119.94 40.88 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.202 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.4 t -118.97 119.77 61.96 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.062 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.711 ' CG ' HG23 ' A' ' 92' ' ' THR . 40.0 mt-10 -96.79 132.36 42.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.681 179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.484 ' HE2' HD11 ' A' ' 23' ' ' LEU . 21.5 mttt -80.31 122.98 27.58 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.435 0.636 . . . . 0.0 111.856 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -173.97 85.52 0.36 Allowed Pre-proline 0 CA--C 1.537 0.466 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.939 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -81.3 -17.52 27.25 Favored 'Cis proline' 0 C--N 1.365 1.401 0 CA-C-N 119.261 0.772 . . . . 0.0 113.371 0.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 38.1 mm-40 -136.63 -177.17 4.61 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.79 0.329 . . . . 0.0 111.453 -179.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.484 HD11 ' HE2' ' A' ' 19' ' ' LYS . 4.5 mp -59.42 -63.08 1.43 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.211 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.507 ' O ' HG13 ' A' ' 50' ' ' VAL . . . 114.67 28.84 2.83 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 120.877 -0.677 . . . . 0.0 113.485 179.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.444 ' O ' HG22 ' B' ' 307' ' ' VAL . 49.5 p90 -164.14 148.9 10.15 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 117.156 0.478 . . . . 0.0 111.285 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.4 p -102.06 155.1 18.4 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.24 -179.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.837 HD11 HG22 ' A' ' 83' ' ' VAL . 21.1 pt -125.38 153.47 32.95 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.752 179.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.4 m -143.28 165.61 26.99 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.821 0.343 . . . . 0.0 111.139 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.77 -144.45 17.22 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.674 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 102.3 151.52 23.83 Favored Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.378 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.574 HG22 ' OD2' ' A' ' 43' ' ' ASP . 30.3 t -79.99 98.7 3.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.849 0.357 . . . . 0.0 110.781 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 98.94 -3.61 58.71 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 120.958 -0.639 . . . . 0.0 114.07 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -81.17 -150.66 7.53 Favored Glycine 0 C--N 1.342 0.906 0 CA-C-N 117.799 0.8 . . . . 0.0 112.904 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 4.9 ptt-85 -87.18 12.23 12.16 Favored 'General case' 0 CA--C 1.542 0.653 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 51.39 -173.02 0.17 Allowed Glycine 0 C--N 1.342 0.893 0 N-CA-C 114.496 0.559 . . . . 0.0 114.496 178.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 22.7 p30 -142.56 161.51 49.32 Favored Pre-proline 0 CA--C 1.536 0.41 0 CA-C-N 115.553 -0.323 . . . . 0.0 110.545 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -92.75 25.12 0.44 Allowed 'Trans proline' 0 C--N 1.358 1.052 0 C-N-CA 122.386 2.057 . . . . 0.0 113.431 -179.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -103.33 -44.17 5.23 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.699 0.285 . . . . 0.0 111.298 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -124.07 136.16 27.22 Favored Pre-proline 0 CA--C 1.535 0.369 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.503 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -84.98 -46.89 0.04 OUTLIER 'Trans proline' 0 C--N 1.358 1.04 0 C-N-CA 121.908 1.738 . . . . 0.0 113.385 -179.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -97.01 -11.31 24.68 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 112.867 0.691 . . . . 0.0 112.867 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -92.33 121.59 33.97 Favored 'General case' 0 N--CA 1.464 0.254 0 O-C-N 122.064 -0.397 . . . . 0.0 110.465 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.574 ' OD2' HG22 ' A' ' 31' ' ' VAL . 14.0 p-10 -111.03 47.65 0.98 Allowed 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.04 0.448 . . . . 0.0 111.596 -179.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -94.71 -162.83 35.07 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 121.058 -0.592 . . . . 0.0 111.69 179.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 14.6 mm -112.45 124.91 69.59 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.187 0 CA-C-N 117.421 0.611 . . . . 0.0 110.449 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -126.79 146.51 50.22 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 120.735 0.302 . . . . 0.0 110.959 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.572 HG23 ' OD1' ' A' ' 64' ' ' ASP . 22.7 t -90.99 76.18 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-O 120.89 0.376 . . . . 0.0 111.201 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.402 HG23 ' N ' ' A' ' 49' ' ' ARG . 4.8 t -33.09 -54.53 0.39 Allowed 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 -178.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.402 ' N ' HG23 ' A' ' 48' ' ' THR . 0.6 OUTLIER -160.27 174.17 14.61 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-O 121.262 0.553 . . . . 0.0 112.45 -179.271 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.507 HG13 ' O ' ' A' ' 24' ' ' GLY . 20.7 t -124.79 145.36 32.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-N 115.349 -0.841 . . . . 0.0 110.459 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.403 ' CB ' ' HD3' ' A' ' 52' ' ' PRO . 1.9 mm-40 -102.86 -69.95 0.04 OUTLIER Pre-proline 0 CA--C 1.539 0.54 0 CA-C-O 119.461 -0.304 . . . . 0.0 111.413 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.403 ' HD3' ' CB ' ' A' ' 51' ' ' GLN . 61.0 Cg_endo -82.57 121.15 3.3 Favored 'Trans proline' 0 C--N 1.359 1.118 0 C-N-CA 121.698 1.599 . . . . 0.0 112.601 179.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -79.8 66.21 5.21 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.303 0.573 . . . . 0.0 110.799 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -142.08 -71.08 0.03 OUTLIER Glycine 0 CA--C 1.527 0.834 0 CA-C-N 115.778 -0.646 . . . . 0.0 113.152 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -63.47 -58.15 0.31 Allowed 'Trans proline' 0 C--N 1.358 1.058 0 C-N-CA 121.948 1.766 . . . . 0.0 113.497 -179.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.494 ' HB1' HD12 ' A' ' 60' ' ' LEU . . . -118.8 48.56 1.44 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 121.08 0.467 . . . . 0.0 111.728 -179.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 82.6 p -79.81 -59.64 2.66 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.852 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 17.3 mttt -97.73 9.89 41.44 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 79.0 mt -92.23 -65.11 1.03 Allowed 'General case' 0 C--N 1.34 0.181 0 O-C-N 122.106 -0.371 . . . . 0.0 111.413 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.515 HD23 HG21 ' A' ' 97' ' ' ILE . 1.1 mt -97.12 147.76 23.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.509 -179.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -113.4 140.04 23.95 Favored Pre-proline 0 N--CA 1.469 0.481 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.67 178.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -53.01 136.04 60.04 Favored 'Trans proline' 0 C--N 1.358 1.068 0 C-N-CA 122.083 1.855 . . . . 0.0 113.291 -178.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 82.03 24.78 54.29 Favored Glycine 0 C--N 1.333 0.374 0 CA-C-N 115.767 -0.651 . . . . 0.0 113.246 179.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.572 ' OD1' HG23 ' A' ' 47' ' ' VAL . 3.0 p30 -86.05 -170.58 3.16 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.89 0.345 . . . . 0.0 110.857 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 60.8 tttp -139.33 122.86 17.32 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.83 0.348 . . . . 0.0 110.891 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 48.8 mt -89.61 121.94 40.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.509 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 19.5 mm -96.03 -43.97 12.81 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 N-CA-C 112.581 0.585 . . . . 0.0 112.581 -178.441 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -145.81 150.57 36.44 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 121.073 0.463 . . . . 0.0 111.957 -178.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.404 ' HB3' ' CE1' ' A' ' 74' ' ' PHE . . . -137.1 119.46 15.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.94 179.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 42.28 32.3 0.32 Allowed 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 113.642 0.978 . . . . 0.0 113.642 178.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 97.83 4.2 57.94 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 120.986 -0.626 . . . . 0.0 114.083 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -110.09 124.24 51.15 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 117.949 0.875 . . . . 0.0 110.565 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 54.8 p -72.78 139.85 47.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.484 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.412 ' HA ' HD13 ' A' ' 77' ' ' ILE . 4.7 m-85 -110.5 21.55 16.49 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 112.097 0.406 . . . . 0.0 112.097 -179.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.439 HG22 ' OD1' ' A' ' 76' ' ' ASN . 21.1 mm -100.29 139.45 21.72 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 O-C-N 122.214 -0.304 . . . . 0.0 111.048 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.504 ' HA ' HG21 ' A' ' 31' ' ' VAL . 19.9 m120 63.81 12.23 6.54 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -179.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.412 HD13 ' HA ' ' A' ' 74' ' ' PHE . 25.3 pt -93.62 158.21 2.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 -178.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -81.63 148.83 28.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.479 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.453 ' O ' HG23 ' A' ' 83' ' ' VAL . 35.4 t60 -47.23 -50.32 21.34 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -179.324 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -57.59 -26.15 56.65 Favored Glycine 0 C--N 1.335 0.501 0 C-N-CA 120.874 -0.679 . . . . 0.0 113.082 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.419 ' OE1' HD11 ' A' ' 85' ' ' LEU . 0.0 OUTLIER -76.21 -42.59 45.63 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.897 0.38 . . . . 0.0 110.887 179.839 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.38 -39.57 81.69 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.662 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.837 HG22 HD11 ' A' ' 27' ' ' ILE . 25.4 t -72.57 -43.2 63.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 120.852 0.358 . . . . 0.0 110.666 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 34.7 t -60.53 -39.95 89.75 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.296 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.419 HD11 ' OE1' ' A' ' 81' ' ' GLN . 53.2 mt -67.56 -44.0 79.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.898 0.38 . . . . 0.0 111.139 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.422 ' HA ' ' CD2' ' A' ' 89' ' ' PHE . 17.5 mt -66.27 -38.57 88.11 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.809 -178.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 48.5 mttm -73.31 -38.09 65.96 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -178.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 9.0 t -70.15 -25.34 63.42 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -178.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.422 ' CD2' ' HA ' ' A' ' 86' ' ' LEU . 14.7 m-85 -53.5 140.49 28.04 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.19 0.519 . . . . 0.0 111.842 -179.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -62.59 -131.4 0.0 OUTLIER 'General case' 0 CA--C 1.558 1.258 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.948 -178.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -82.59 -72.28 0.45 Allowed 'General case' 0 C--N 1.355 0.806 0 CA-C-N 119.718 1.144 . . . . 0.0 112.621 -177.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.711 HG23 ' CG ' ' A' ' 18' ' ' GLU . 0.3 OUTLIER -74.23 123.11 23.91 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.818 0.342 . . . . 0.0 111.011 -179.367 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.49 ' CG1' HD11 ' A' ' 95' ' ' LEU . 16.6 t -109.51 116.08 51.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.953 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.95 104.62 16.67 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.353 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.49 HD11 ' CG1' ' A' ' 93' ' ' VAL . 3.8 mp -111.76 158.54 19.23 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 121.239 0.542 . . . . 0.0 112.098 -179.118 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 26.5 mm -118.72 129.59 74.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.822 178.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.515 HG21 HD23 ' A' ' 60' ' ' LEU . 25.8 pt -130.96 167.24 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-O 120.846 0.355 . . . . 0.0 111.663 -178.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 19.0 t -148.29 151.65 13.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.243 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -115.42 131.05 57.05 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.928 179.086 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -64.56 113.72 3.9 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.262 -0.426 . . . . 0.0 112.061 -178.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 20.7 t -121.88 124.83 72.26 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.137 178.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 63.6 p -142.11 135.57 29.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.844 0.354 . . . . 0.0 111.233 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 62.2 m . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.302 -0.856 . . . . 0.0 110.746 179.726 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 301' ' ' THR . . . . . . . . . . . . . 5.9 t . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 121.244 0.545 . . . . 0.0 111.079 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 302' ' ' GLY . . . . . . . . . . . . . . . -90.9 121.06 6.12 Favored Glycine 0 C--N 1.333 0.371 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.307 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 303' ' ' TRP . . . . . . . . . . . . . 55.3 p-90 -99.94 -17.1 17.73 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -98.54 173.43 6.94 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.953 0.406 . . . . 0.0 111.068 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 305' ' ' THR . . . . . . . . . . . . . 4.9 m -144.98 118.86 9.29 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.123 -0.489 . . . . 17.879999999999999 111.047 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 306' ' ' TRP . . . . . . . . . . . . . 91.9 m95 -88.79 106.0 18.09 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.664 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 307' ' ' VAL . . . . . 0.444 HG22 ' O ' ' A' ' 25' ' ' PHE . 25.6 m . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.26 -0.876 . . . . 16.109999999999999 111.16 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.246 0 N-CA-C 112.473 -0.251 . . . . 0.0 112.473 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.8 t -93.43 -178.6 4.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.688 0.28 . . . . 0.0 110.815 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 15.7 p80 -71.09 115.82 10.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.738 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.75 161.97 7.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.184 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -176.15 45.37 0.11 Allowed Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.507 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 15.6 m170 -90.83 132.8 35.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.713 0.292 . . . . 0.0 110.928 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -113.9 66.8 0.67 Allowed 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 121.314 0.578 . . . . 0.0 110.754 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -90.31 135.71 33.51 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.39 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -102.25 47.88 0.89 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 121.15 0.5 . . . . 0.0 111.359 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -64.87 113.76 4.05 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.873 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -90.07 112.56 24.05 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.18 -0.463 . . . . 0.0 112.021 -179.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -87.83 98.29 11.39 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.147 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 18.4 pt -115.82 158.11 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -178.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.683 ' HG3' HD13 ' A' ' 96' ' ' ILE . 26.8 ttp180 -116.07 156.19 26.81 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.612 -179.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.7 m -149.45 142.83 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.302 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.17 132.01 54.55 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.949 0.404 . . . . 0.0 111.236 179.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.3 t -114.62 120.03 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.155 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.495 ' HG2' HG23 ' A' ' 92' ' ' THR . 3.0 mm-40 -89.8 111.59 22.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.095 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.526 ' HD2' HD12 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -65.87 116.89 7.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.971 179.87 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -175.1 84.87 0.32 Allowed Pre-proline 0 CA--C 1.54 0.571 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.962 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -84.7 -22.2 14.65 Favored 'Cis proline' 0 C--N 1.366 1.475 0 CA-C-N 119.488 0.853 . . . . 0.0 113.058 0.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 18.2 mp0 -131.42 -178.28 4.78 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.768 0.318 . . . . 0.0 111.142 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.526 HD12 ' HD2' ' A' ' 19' ' ' LYS . 3.2 mp -63.12 -58.16 8.18 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.563 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.612 ' O ' HG13 ' A' ' 50' ' ' VAL . . . 109.92 26.89 4.8 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.888 -0.672 . . . . 0.0 113.377 179.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.447 ' O ' HG22 ' B' ' 307' ' ' VAL . 37.4 p90 -159.84 139.93 11.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 117.133 0.467 . . . . 0.0 111.12 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.9 p -94.06 153.59 18.07 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.823 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.407 HD11 HG22 ' A' ' 83' ' ' VAL . 28.2 pt -122.59 152.77 27.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.084 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 50.9 m -146.14 160.93 41.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.912 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 104.97 -146.77 16.14 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 120.988 -0.625 . . . . 0.0 113.098 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.36 157.62 28.92 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.993 -0.622 . . . . 0.0 111.98 -179.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 18.8 t -78.55 109.65 13.43 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 CA-C-O 120.806 0.336 . . . . 0.0 110.953 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 86.8 3.81 83.05 Favored Glycine 0 CA--C 1.53 0.988 0 C-N-CA 121.039 -0.601 . . . . 0.0 113.857 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -82.87 -154.7 16.45 Favored Glycine 0 C--N 1.343 0.954 0 CA-C-N 117.816 0.808 . . . . 0.0 112.928 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 7.4 mtt180 -75.71 -2.51 29.96 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -179.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.26 -151.28 25.52 Favored Glycine 0 C--N 1.342 0.911 0 C-N-CA 120.695 -0.764 . . . . 0.0 113.037 179.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -173.54 142.3 0.94 Allowed Pre-proline 0 CA--C 1.534 0.346 0 N-CA-C 110.611 -0.144 . . . . 0.0 110.611 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -90.42 39.87 0.39 Allowed 'Trans proline' 0 C--N 1.358 1.03 0 C-N-CA 122.274 1.983 . . . . 0.0 113.507 -179.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 28.3 m-85 -125.62 -53.44 1.57 Allowed 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.739 0.304 . . . . 0.0 110.915 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 2.3 mmp_? -116.16 136.28 22.97 Favored Pre-proline 0 CA--C 1.534 0.328 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.677 179.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -85.59 -46.37 0.04 OUTLIER 'Trans proline' 0 C--N 1.358 1.05 0 C-N-CA 121.965 1.777 . . . . 0.0 113.335 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -93.42 -8.68 41.02 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 112.91 0.707 . . . . 0.0 112.91 -179.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -101.03 121.48 41.87 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 118.175 0.443 . . . . 0.0 110.537 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -110.72 39.8 2.15 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 120.819 0.342 . . . . 0.0 111.874 -178.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -87.44 -158.97 33.48 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.085 179.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 13.9 mm -109.43 124.58 66.24 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 116.996 0.398 . . . . 0.0 110.83 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.418 ' CD1' ' N ' ' A' ' 46' ' ' PHE . 7.3 m-85 -127.12 150.16 49.62 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.628 0.251 . . . . 0.0 110.636 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.457 ' CG2' HD11 ' A' ' 66' ' ' ILE . 22.5 t -95.92 78.98 1.03 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.531 -179.202 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.9 t -35.58 -53.6 0.69 Allowed 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 -178.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.402 ' HG3' ' CH2' ' B' ' 306' ' ' TRP . 15.4 ptt180 -160.77 163.95 31.87 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-O 120.993 0.425 . . . . 0.0 111.801 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.612 HG13 ' O ' ' A' ' 24' ' ' GLY . 11.8 t -114.29 146.13 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.42 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.404 ' CB ' ' HD3' ' A' ' 52' ' ' PRO . 4.9 mm-40 -97.13 -70.41 0.05 OUTLIER Pre-proline 0 CA--C 1.538 0.496 0 CA-C-O 119.465 -0.302 . . . . 0.0 111.316 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.404 ' HD3' ' CB ' ' A' ' 51' ' ' GLN . 60.2 Cg_endo -83.05 121.13 3.1 Favored 'Trans proline' 0 C--N 1.36 1.133 0 C-N-CA 121.606 1.538 . . . . 0.0 112.292 179.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -78.62 65.49 3.9 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.205 0.526 . . . . 0.0 110.737 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -148.19 -70.56 0.01 OUTLIER Glycine 0 CA--C 1.527 0.793 0 C-N-CA 120.965 -0.636 . . . . 0.0 112.871 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -60.37 -63.3 0.12 Allowed 'Trans proline' 0 C--N 1.358 1.062 0 C-N-CA 121.977 1.784 . . . . 0.0 112.893 -179.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.429 ' HB1' HD12 ' A' ' 60' ' ' LEU . . . -110.02 45.65 1.09 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.16 0.505 . . . . 0.0 111.186 -179.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 88.9 p -82.5 -59.06 2.65 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.93 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -93.72 5.28 52.17 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 80.2 mt -92.04 -72.61 0.58 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 118.144 0.429 . . . . 0.0 111.612 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.701 HD23 HG21 ' A' ' 97' ' ' ILE . 1.0 OUTLIER -95.94 143.08 27.44 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.545 0.212 . . . . 0.0 110.764 179.852 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.3 pp0? -114.98 153.6 47.08 Favored Pre-proline 0 N--CA 1.471 0.592 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.776 179.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -55.22 123.71 14.49 Favored 'Trans proline' 0 C--N 1.36 1.161 0 C-N-CA 122.335 2.023 . . . . 0.0 113.882 -178.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 92.74 16.02 50.29 Favored Glycine 0 CA--C 1.521 0.467 0 CA-C-N 115.687 -0.688 . . . . 0.0 114.139 178.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.429 ' OD1' HG23 ' A' ' 47' ' ' VAL . 35.1 p-10 -80.27 -171.7 3.13 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 117.541 0.671 . . . . 0.0 111.361 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 32.2 tttp -142.4 125.14 15.94 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 120.774 0.321 . . . . 0.0 111.108 -179.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.559 ' N ' HD12 ' A' ' 66' ' ' ILE . 3.5 mp -90.87 123.86 43.2 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.023 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 21.0 mm -94.9 -44.55 13.3 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -179.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -148.62 150.42 33.24 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 120.833 0.349 . . . . 0.0 111.668 -178.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.507 ' HB3' ' CE1' ' A' ' 74' ' ' PHE . . . -136.7 123.69 21.49 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.557 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 28.7 m-20 42.44 35.01 0.59 Allowed 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 113.61 0.966 . . . . 0.0 113.61 178.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 99.65 -16.37 58.81 Favored Glycine 0 CA--C 1.524 0.655 0 C-N-CA 120.867 -0.682 . . . . 0.0 113.792 179.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 -92.99 123.06 35.97 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 117.534 0.667 . . . . 0.0 111.016 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 14.9 m -71.12 130.49 41.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.077 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.507 ' CE1' ' HB3' ' A' ' 69' ' ' ALA . 5.6 m-85 -103.16 15.64 28.73 Favored 'General case' 0 CA--C 1.537 0.455 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 6.5 tp -89.32 124.24 41.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-O 120.729 0.299 . . . . 0.0 110.546 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 77.6 m-20 62.54 73.78 0.45 Allowed 'General case' 0 C--O 1.234 0.238 0 CA-C-O 121.118 0.485 . . . . 0.0 111.161 -179.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 11.5 pt -144.29 163.12 14.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.886 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -81.12 153.39 27.32 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.256 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 21.1 t60 -52.85 -55.7 21.21 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 116.02 -0.537 . . . . 0.0 112.186 -179.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -56.29 -26.7 51.27 Favored Glycine 0 C--N 1.334 0.45 0 C-N-CA 121.073 -0.584 . . . . 0.0 113.277 -179.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -72.66 -40.56 66.25 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.866 0.365 . . . . 0.0 111.008 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.99 -41.0 95.8 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.423 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.407 HG22 HD11 ' A' ' 27' ' ' ILE . 16.1 t -70.74 -42.0 77.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.199 -179.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 72.5 m -60.53 -45.82 92.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.588 -179.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 31.7 mt -64.14 -45.52 88.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.603 -179.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.426 ' HA ' ' CD2' ' A' ' 89' ' ' PHE . 24.5 mt -65.36 -39.48 92.35 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.956 -179.009 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 8.4 mmtp -68.68 -40.02 80.31 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.595 0.591 . . . . 0.0 112.595 -178.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 8.8 t -72.22 -27.26 62.42 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -177.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.426 ' CD2' ' HA ' ' A' ' 86' ' ' LEU . 10.5 m-85 -47.87 172.81 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 113.105 0.779 . . . . 0.0 113.105 -177.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -92.5 -138.0 0.18 Allowed 'General case' 0 CA--C 1.554 1.103 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.277 -178.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 54.5 m-80 -78.96 -74.97 0.25 Allowed 'General case' 0 C--N 1.35 0.61 0 CA-C-N 119.454 1.025 . . . . 0.0 111.955 -178.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.495 HG23 ' HG2' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -77.44 123.19 26.21 Favored 'General case' 0 CA--C 1.527 0.081 0 CA-C-O 120.84 0.352 . . . . 0.0 110.307 -179.832 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 20.2 t -111.32 116.69 53.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.498 179.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -86.77 112.66 21.91 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.959 0.409 . . . . 0.0 110.159 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.3 mt -116.51 147.46 41.75 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.679 -0.692 . . . . 0.0 111.896 -178.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.683 HD13 ' HG3' ' A' ' 14' ' ' ARG . 18.8 mm -107.19 121.71 60.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.651 178.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.701 HG21 HD23 ' A' ' 60' ' ' LEU . 41.4 pt -126.5 158.64 36.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.855 0.36 . . . . 0.0 111.119 -179.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 17.2 t -146.78 153.19 12.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.258 -179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 2.6 mmm180 -109.87 116.9 32.48 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 178.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -69.83 143.08 52.99 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 120.678 0.275 . . . . 0.0 110.628 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -119.14 150.74 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.212 -179.155 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -153.02 -171.5 3.95 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.809 0.338 . . . . 0.0 110.867 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 5.3 m . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.324 -0.846 . . . . 0.0 110.869 -179.939 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 301' ' ' THR . . . . . . . . . . . . . 40.5 p . . . . . 0 N--CA 1.487 1.396 0 CA-C-O 120.757 0.313 . . . . 0.0 111.279 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 302' ' ' GLY . . . . . . . . . . . . . . . 78.47 81.41 0.68 Allowed Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.877 -0.677 . . . . 0.0 112.304 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 303' ' ' TRP . . . . . 0.412 ' CZ3' ' HB3' ' B' ' 304' ' ' GLU . 51.4 p-90 -69.13 -28.78 66.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.534 0.207 . . . . 0.0 111.437 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 304' ' ' GLU . . . . . 0.412 ' HB3' ' CZ3' ' B' ' 303' ' ' TRP . 9.4 pt-20 -97.45 132.81 42.8 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.662 0.268 . . . . 0.0 110.721 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 305' ' ' THR . . . . . . . . . . . . . 4.7 m -122.7 114.88 21.17 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.21 -0.45 . . . . 17.879999999999999 110.923 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 306' ' ' TRP . . . . . 0.402 ' CH2' ' HG3' ' A' ' 49' ' ' ARG . 98.9 m95 -78.75 104.79 9.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.797 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 307' ' ' VAL . . . . . 0.447 HG22 ' O ' ' A' ' 25' ' ' PHE . 17.0 m . . . . . 0 C--O 1.249 1.062 0 CA-C-O 118.264 -0.874 . . . . 16.109999999999999 111.135 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.175 0 N-CA-C 112.502 -0.239 . . . . 0.0 112.502 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.3 t -117.29 146.79 43.09 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.857 0.361 . . . . 0.0 110.798 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 9.0 t60 -92.45 161.81 14.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.776 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 20.9 tpp -71.29 132.78 45.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.612 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 97.66 62.07 0.9 Allowed Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.064 -179.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 2.5 t-160 -98.0 -28.81 13.62 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 111.554 0.205 . . . . 0.0 111.554 -179.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -59.57 118.94 6.66 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.678 0.275 . . . . 0.0 111.202 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 42.1 tp -106.79 -84.74 0.51 Allowed 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.486 -0.325 . . . . 0.0 111.2 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -174.96 35.58 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 O-C-N 122.132 -0.355 . . . . 0.0 111.843 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 36.7 mttp -91.92 -178.46 5.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.651 0.262 . . . . 0.0 111.071 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.55 93.43 3.14 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.362 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.2 tm-20 -95.95 129.8 43.11 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.941 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.1 pt -149.61 159.59 5.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-O 120.824 0.345 . . . . 0.0 111.8 -179.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.434 ' HG3' HD13 ' A' ' 96' ' ' ILE . 10.2 ttm-85 -116.6 153.32 32.46 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.264 -178.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.406 ' HB ' HD22 ' A' ' 59' ' ' LEU . 14.9 m -141.91 144.04 26.02 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.356 179.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 2.4 ttt-85 -108.09 115.58 30.39 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.5 179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.0 t -109.34 121.52 62.51 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-O 120.896 0.379 . . . . 0.0 111.459 -179.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.555 ' HG3' HG22 ' A' ' 92' ' ' THR . 5.3 mp0 -96.79 114.7 26.35 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.206 179.252 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.5 ' HD3' HD12 ' A' ' 23' ' ' LEU . 19.2 mtmt -75.23 119.97 20.09 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.929 0.395 . . . . 0.0 111.262 -179.473 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -163.59 86.87 1.25 Allowed Pre-proline 0 CA--C 1.536 0.425 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.712 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -84.59 -13.43 37.69 Favored 'Cis proline' 0 C--N 1.364 1.345 0 CA-C-N 119.548 0.874 . . . . 0.0 113.595 0.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -136.78 -175.95 4.2 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.892 0.377 . . . . 0.0 111.176 -179.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.5 HD12 ' HD3' ' A' ' 19' ' ' LYS . 1.5 mp -63.44 -52.22 62.39 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.524 -0.307 . . . . 0.0 110.3 179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 102.88 29.99 5.63 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 120.862 -0.685 . . . . 0.0 113.586 179.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.418 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 32.1 p90 -162.15 146.53 12.37 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 117.053 0.426 . . . . 0.0 110.919 179.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.5 p -97.15 155.55 16.78 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.367 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.772 HD11 HG22 ' A' ' 83' ' ' VAL . 29.0 pt -124.21 154.06 30.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.306 179.196 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 48.1 t -145.78 171.94 14.04 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.835 0.35 . . . . 0.0 111.165 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 92.14 -137.72 13.87 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.584 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.45 155.01 29.98 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.962 -0.637 . . . . 0.0 112.25 -179.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.495 HG21 ' HA ' ' A' ' 76' ' ' ASN . 34.8 t -78.69 97.38 2.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.014 0.435 . . . . 0.0 110.705 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 98.86 -1.87 58.16 Favored Glycine 0 CA--C 1.531 1.067 0 CA-C-N 115.844 -0.616 . . . . 0.0 113.723 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -72.34 -154.62 2.29 Favored Glycine 0 C--N 1.343 0.932 0 CA-C-N 117.856 0.828 . . . . 0.0 113.098 -179.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 4.5 mtt85 -72.7 -29.06 63.07 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 111.656 0.243 . . . . 0.0 111.656 -179.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 124.32 -163.49 18.08 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.908 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -170.74 132.69 0.93 Allowed Pre-proline 0 CA--C 1.536 0.428 0 O-C-N 123.026 -0.102 . . . . 0.0 110.744 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -91.52 44.15 0.44 Allowed 'Trans proline' 0 C--N 1.358 1.069 0 C-N-CA 122.178 1.918 . . . . 0.0 113.073 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -122.84 -57.77 1.7 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.226 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 6.1 mmp_? -113.3 145.25 32.84 Favored Pre-proline 0 N--CA 1.467 0.382 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.991 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -88.78 -56.45 0.02 OUTLIER 'Trans proline' 0 C--N 1.36 1.181 0 C-N-CA 122.041 1.827 . . . . 0.0 113.125 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -86.51 -7.63 58.23 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -104.0 121.23 42.73 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 117.967 0.349 . . . . 0.0 111.02 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.7 p30 -110.8 40.34 2.03 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 121.042 0.448 . . . . 0.0 110.834 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -84.37 -157.19 25.95 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.976 -0.631 . . . . 0.0 112.732 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 19.6 mm -110.53 122.4 64.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.522 0.201 . . . . 0.0 110.563 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -122.07 144.76 48.72 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-O 120.899 0.381 . . . . 0.0 111.392 -179.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 22.7 t -86.37 75.87 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.161 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.408 HG23 ' N ' ' A' ' 49' ' ' ARG . 4.7 t -33.87 -52.88 0.44 Allowed 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 -178.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.408 ' N ' HG23 ' A' ' 48' ' ' THR . 5.8 ptt85 -160.35 179.09 8.95 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.074 0.464 . . . . 0.0 111.737 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 15.8 t -134.48 146.92 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.782 -179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -104.87 -68.17 0.04 OUTLIER Pre-proline 0 CA--C 1.536 0.441 0 CA-C-N 116.704 -0.225 . . . . 0.0 111.267 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -78.34 112.62 3.23 Favored 'Trans proline' 0 C--N 1.357 1.023 0 C-N-CA 121.654 1.569 . . . . 0.0 112.009 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -72.81 70.92 1.01 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.003 0.43 . . . . 0.0 111.298 -179.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -162.27 -65.77 0.02 OUTLIER Glycine 0 CA--C 1.527 0.787 0 C-N-CA 120.79 -0.719 . . . . 0.0 113.273 -179.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -57.05 -76.11 0.02 OUTLIER 'Trans proline' 0 C--N 1.357 1.017 0 C-N-CA 122.086 1.857 . . . . 0.0 113.098 -179.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.885 ' HB1' HD12 ' A' ' 60' ' ' LEU . . . -116.38 47.37 1.43 Allowed 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 121.265 0.555 . . . . 0.0 111.636 -179.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.7 t -99.73 -63.27 1.14 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.048 -0.524 . . . . 0.0 109.922 179.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 44.2 mttp -74.51 -3.91 33.66 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.1 178.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.406 HD22 ' HB ' ' A' ' 15' ' ' VAL . 9.0 mt -99.13 -50.51 4.13 Favored 'General case' 0 C--N 1.343 0.311 0 CA-C-N 118.265 0.484 . . . . 0.0 111.373 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.885 HD12 ' HB1' ' A' ' 56' ' ' ALA . 19.0 mt -102.56 150.34 23.51 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-O 120.818 0.342 . . . . 0.0 111.492 -179.342 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -97.56 140.69 22.14 Favored Pre-proline 0 CA--C 1.535 0.388 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.873 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -63.79 79.06 0.15 Allowed 'Trans proline' 0 C--N 1.362 1.243 0 C-N-CA 122.068 1.845 . . . . 0.0 112.16 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 129.29 41.32 0.26 Allowed Glycine 0 CA--C 1.525 0.68 0 CA-C-N 115.787 -0.642 . . . . 0.0 112.606 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -96.24 -158.25 0.64 Allowed 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 110.306 -0.257 . . . . 0.0 110.306 179.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 59.5 tttp -144.65 127.53 16.37 Favored 'General case' 0 C--O 1.231 0.081 0 CA-C-O 120.679 0.276 . . . . 0.0 110.942 179.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.606 ' N ' HD12 ' A' ' 66' ' ' ILE . 3.3 mp -88.9 115.73 29.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 13.4 mm -91.38 -39.13 11.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.558 -179.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -149.55 150.22 31.93 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.06 0.457 . . . . 0.0 111.365 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.422 ' HB3' ' CE1' ' A' ' 74' ' ' PHE . . . -134.59 115.35 13.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.246 179.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 63.3 m-20 46.72 29.27 0.93 Allowed 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 179.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 100.08 -7.52 58.77 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 120.892 -0.67 . . . . 0.0 113.889 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -95.35 129.22 42.57 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 117.94 0.87 . . . . 0.0 110.028 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.27 125.27 28.06 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.816 0.341 . . . . 0.0 111.147 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.422 ' CE1' ' HB3' ' A' ' 69' ' ' ALA . 3.4 m-85 -100.71 22.53 11.8 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.461 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 7.0 tp -102.93 141.4 18.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 O-C-N 122.137 -0.352 . . . . 0.0 110.95 -178.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.495 ' HA ' HG21 ' A' ' 31' ' ' VAL . 1.0 OUTLIER 64.71 11.58 6.92 Favored 'General case' 0 CA--C 1.55 0.947 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -178.841 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 18.0 pt -94.2 164.91 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 N-CA-C 112.983 0.734 . . . . 0.0 112.983 -177.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -85.69 144.99 27.5 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.542 179.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.494 ' O ' HG23 ' A' ' 83' ' ' VAL . 1.8 t-160 -48.79 -51.12 30.88 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -179.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -55.98 -26.81 49.52 Favored Glycine 0 CA--C 1.525 0.672 0 C-N-CA 120.837 -0.697 . . . . 0.0 113.177 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.7 tp-100 -75.98 -40.97 52.71 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.08 0.467 . . . . 0.0 110.866 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.63 -34.93 77.97 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.539 -179.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.772 HG22 HD11 ' A' ' 27' ' ' ILE . 23.5 t -71.99 -42.54 68.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.927 0.394 . . . . 0.0 110.584 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.2 t -61.23 -41.16 96.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.28 -179.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.432 ' O ' HG22 ' A' ' 88' ' ' THR . 25.5 mt -65.82 -45.97 80.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.459 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.433 ' HA ' ' CD2' ' A' ' 89' ' ' PHE . 39.5 mt -64.61 -37.02 86.14 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.112 -0.495 . . . . 0.0 112.195 -178.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 34.1 mmtt -71.26 -36.68 71.84 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -178.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.432 HG22 ' O ' ' A' ' 85' ' ' LEU . 9.8 t -73.59 -29.08 62.18 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 -178.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.433 ' CD2' ' HA ' ' A' ' 86' ' ' LEU . 16.4 m-85 -50.49 147.22 4.68 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -178.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 27.0 mm-40 -66.72 -136.6 0.0 OUTLIER 'General case' 0 CA--C 1.556 1.21 0 CA-C-N 115.442 -0.799 . . . . 0.0 111.053 -179.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -80.57 -67.88 0.73 Allowed 'General case' 0 C--N 1.352 0.68 0 CA-C-N 119.586 1.085 . . . . 0.0 111.883 -178.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.555 HG22 ' HG3' ' A' ' 18' ' ' GLU . 0.9 OUTLIER -81.55 135.35 35.58 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.689 0.281 . . . . 0.0 110.979 -179.553 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.5 t -128.01 122.64 58.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.151 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -89.66 108.33 19.61 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 178.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 12.5 mt -110.12 144.23 39.04 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.011 0.434 . . . . 0.0 111.679 -179.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.434 HD13 ' HG3' ' A' ' 14' ' ' ARG . 21.6 mm -106.21 120.8 57.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.604 178.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.721 HD13 HD23 ' A' ' 60' ' ' LEU . 23.5 pt -126.84 164.14 27.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.818 0.342 . . . . 0.0 111.313 -179.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 22.1 t -149.72 151.87 12.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.245 -179.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -111.97 121.21 44.37 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.268 178.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -61.59 118.01 6.51 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-O 120.973 0.416 . . . . 0.0 111.534 -179.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 30.2 t -104.91 96.79 4.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.415 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 24.4 m -113.1 160.97 17.64 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.902 0.382 . . . . 0.0 111.153 -179.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 43.2 m . . . . . 0 C--O 1.25 1.102 0 CA-C-O 118.21 -0.9 . . . . 0.0 110.779 179.941 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 301' ' ' THR . . . . . . . . . . . . . 41.8 p . . . . . 0 N--CA 1.488 1.43 0 CA-C-O 120.822 0.344 . . . . 0.0 111.225 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 302' ' ' GLY . . . . . . . . . . . . . . . 160.33 -159.22 30.63 Favored Glycine 0 C--N 1.331 0.287 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.265 -179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 303' ' ' TRP . . . . . . . . . . . . . 23.1 p-90 -123.26 -40.16 2.41 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.561 0.219 . . . . 0.0 111.531 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -73.73 153.38 40.07 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.004 0.431 . . . . 0.0 111.284 -179.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 305' ' ' THR . . . . . . . . . . . . . 5.8 m -138.95 128.8 24.94 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.91 -0.586 . . . . 17.879999999999999 110.339 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 306' ' ' TRP . . . . . . . . . . . . . 88.7 m95 -94.48 114.63 26.67 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.944 0.402 . . . . 0.0 111.224 -179.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 307' ' ' VAL . . . . . . . . . . . . . 15.4 m . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.244 -0.884 . . . . 16.109999999999999 111.074 -179.971 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.17 0 N-CA-C 112.459 -0.256 . . . . 0.0 112.459 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.7 t -111.83 -57.93 2.19 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.901 0.381 . . . . 0.0 110.824 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 44.5 t60 -92.65 115.78 28.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.874 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 14.2 ttt -92.61 -56.14 3.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.949 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -162.0 -139.57 2.67 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.67 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 -153.92 100.2 2.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.591 0.234 . . . . 0.0 110.649 -179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 11.2 mp0 -122.77 32.3 5.78 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.099 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.9 mp -128.17 146.33 50.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.867 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.632 ' O ' HG21 ' A' ' 101' ' ' VAL . . . -97.64 89.53 4.68 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.21 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -92.98 125.35 37.53 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.717 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.439 ' O ' HD13 ' A' ' 13' ' ' ILE . 34.2 mt-30 -89.72 89.66 7.88 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.117 -0.492 . . . . 0.0 112.145 -178.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -88.95 92.14 9.11 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 178.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.558 ' H ' HD13 ' A' ' 13' ' ' ILE . 0.2 OUTLIER -110.81 161.49 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -178.66 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 12.6 mtm180 -112.23 155.72 23.55 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.1 -0.954 . . . . 0.0 110.776 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.441 HG21 HD21 ' A' ' 60' ' ' LEU . 15.9 m -143.82 142.77 24.51 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-O 120.79 0.328 . . . . 0.0 110.911 179.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 22.1 ttm180 -107.27 115.02 29.43 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.248 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.9 t -114.53 117.7 56.38 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.972 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.762 ' HG3' HG23 ' A' ' 92' ' ' THR . 1.6 mp0 -93.29 122.75 36.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.635 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.437 ' HD3' HD12 ' A' ' 23' ' ' LEU . 15.3 mtmt -76.68 120.86 22.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.081 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -171.11 88.22 0.47 Allowed Pre-proline 0 CA--C 1.536 0.408 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.726 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -82.69 -18.45 24.91 Favored 'Cis proline' 0 C--N 1.362 1.267 0 CA-C-N 119.477 0.849 . . . . 0.0 113.277 0.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 67.1 mm-40 -135.31 -178.29 5.04 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 120.868 0.366 . . . . 0.0 111.755 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.437 HD12 ' HD3' ' A' ' 19' ' ' LYS . 3.0 mp -64.14 -57.27 10.05 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.03 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 103.35 32.46 4.57 Favored Glycine 0 CA--C 1.522 0.493 0 C-N-CA 120.797 -0.716 . . . . 0.0 113.98 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.546 ' O ' HG22 ' B' ' 307' ' ' VAL . 38.7 p90 -162.36 147.25 12.4 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 117.363 0.582 . . . . 0.0 111.191 179.223 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.3 p -100.65 151.4 21.68 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.474 -179.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.541 HD11 HG22 ' A' ' 83' ' ' VAL . 28.9 pt -121.71 151.15 25.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.911 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 28.7 t -150.33 164.57 35.46 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.548 0.213 . . . . 0.0 111.44 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 115.05 -94.84 0.69 Allowed Glycine 0 C--N 1.338 0.658 0 C-N-CA 120.972 -0.632 . . . . 0.0 113.797 178.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.515 ' H ' HD13 ' A' ' 45' ' ' ILE . . . 72.18 -134.76 21.82 Favored Glycine 0 CA--C 1.524 0.601 0 C-N-CA 121.24 -0.505 . . . . 0.0 112.597 -179.51 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 23.1 t -148.08 84.55 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.136 0 CA-C-O 120.953 0.406 . . . . 0.0 109.962 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 92.44 9.34 61.75 Favored Glycine 0 CA--C 1.528 0.859 0 C-N-CA 120.823 -0.703 . . . . 0.0 113.44 -179.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -84.2 -140.68 4.66 Favored Glycine 0 C--N 1.342 0.868 0 CA-C-N 117.705 0.753 . . . . 0.0 112.487 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -57.22 -28.35 62.81 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 111.745 0.276 . . . . 0.0 111.745 -179.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 97.34 158.87 30.98 Favored Glycine 0 C--N 1.333 0.362 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.772 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -124.96 133.35 24.73 Favored Pre-proline 0 CA--C 1.535 0.371 0 N-CA-C 110.744 -0.095 . . . . 0.0 110.744 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -91.19 26.61 0.45 Allowed 'Trans proline' 0 C--N 1.358 1.03 0 C-N-CA 122.181 1.921 . . . . 0.0 113.451 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -106.62 -53.85 2.56 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.791 0.329 . . . . 0.0 110.6 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 1.2 mmm180 -118.63 137.4 24.81 Favored Pre-proline 0 CA--C 1.535 0.399 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.566 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -86.33 -48.02 0.04 OUTLIER 'Trans proline' 0 C--N 1.357 0.993 0 C-N-CA 121.954 1.77 . . . . 0.0 113.356 -179.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -91.63 -10.9 38.72 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -96.64 113.63 25.2 Favored 'General case' 0 C--O 1.231 0.083 0 CA-C-N 117.998 0.363 . . . . 0.0 110.533 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.5 p-10 -100.03 64.62 1.23 Allowed 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 121.123 0.487 . . . . 0.0 111.17 -179.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -116.09 -159.02 11.71 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 121.118 -0.563 . . . . 0.0 112.462 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.515 HD13 ' H ' ' A' ' 30' ' ' GLY . 20.8 mm -111.44 133.21 57.79 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-O 120.444 0.164 . . . . 0.0 110.813 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.433 ' N ' ' CD1' ' A' ' 46' ' ' PHE . 4.2 m-85 -129.78 151.02 50.82 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.684 0.278 . . . . 0.0 110.722 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.572 ' CG2' HD11 ' A' ' 66' ' ' ILE . 21.7 t -94.28 77.44 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 CA-C-O 121.01 0.434 . . . . 0.0 111.278 -179.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.404 HG23 ' N ' ' A' ' 49' ' ' ARG . 4.9 t -36.36 -54.39 0.83 Allowed 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 -178.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.404 ' N ' HG23 ' A' ' 48' ' ' THR . 3.9 ptt-85 -160.46 163.22 33.15 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.113 0.482 . . . . 0.0 112.242 -179.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 16.8 t -118.35 149.69 20.71 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.562 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 9.2 mm-40 -104.97 -68.45 0.04 OUTLIER Pre-proline 0 CA--C 1.538 0.51 0 CA-C-O 119.67 -0.205 . . . . 0.0 111.389 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -78.77 121.47 5.06 Favored 'Trans proline' 0 C--N 1.355 0.895 0 C-N-CA 121.8 1.667 . . . . 0.0 112.242 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -77.22 65.96 2.92 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 120.911 0.386 . . . . 0.0 111.096 -179.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -156.1 -68.14 0.01 OUTLIER Glycine 0 CA--C 1.528 0.885 0 C-N-CA 120.69 -0.767 . . . . 0.0 113.544 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -58.89 -76.82 0.02 OUTLIER 'Trans proline' 0 C--N 1.356 0.966 0 C-N-CA 122.14 1.893 . . . . 0.0 113.435 -178.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.859 ' HB1' HD12 ' A' ' 60' ' ' LEU . . . -110.14 48.74 0.88 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-O 121.218 0.532 . . . . 0.0 111.5 -179.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 34.7 t -105.04 -67.45 0.91 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.999 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.85 -12.74 60.22 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.962 179.176 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 69.1 mt -95.09 -58.91 2.02 Favored 'General case' 0 C--N 1.342 0.276 0 O-C-N 122.137 -0.352 . . . . 0.0 111.506 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.859 HD12 ' HB1' ' A' ' 56' ' ' ALA . 22.2 mt -94.18 148.84 21.8 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.706 -179.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.7 pm0 -103.53 150.98 38.61 Favored Pre-proline 0 CA--C 1.538 0.488 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.958 178.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 16.2 Cg_exo -68.8 73.79 0.94 Allowed 'Trans proline' 0 C--N 1.357 1.007 0 C-N-CA 122.247 1.965 . . . . 0.0 114.108 -178.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 140.74 39.2 0.08 OUTLIER Glycine 0 C--N 1.338 0.662 0 C-N-CA 120.549 -0.834 . . . . 0.0 113.943 178.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -94.33 -163.3 1.03 Allowed 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 117.286 0.543 . . . . 0.0 111.277 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 27.0 tttm -132.92 121.91 23.54 Favored 'General case' 0 C--O 1.232 0.18 0 N-CA-C 110.275 -0.268 . . . . 0.0 110.275 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.572 HD11 ' CG2' ' A' ' 47' ' ' VAL . 3.7 mm -87.27 109.08 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-N 116.634 -0.257 . . . . 0.0 110.802 -178.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 18.1 mm -88.25 -44.45 15.68 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -179.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.697 ' HB2' HD12 ' A' ' 96' ' ' ILE . 5.7 mt-30 -150.87 152.44 33.69 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -178.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.427 ' HB3' ' CE1' ' A' ' 74' ' ' PHE . . . -132.52 118.76 19.65 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.637 179.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 30.3 m-20 46.47 29.77 0.96 Allowed 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 179.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 100.16 -3.26 56.79 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 120.936 -0.649 . . . . 0.0 113.925 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -91.23 145.72 24.43 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 117.901 0.851 . . . . 0.0 110.369 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 80.3 p -88.38 108.42 19.34 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.321 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.427 ' CE1' ' HB3' ' A' ' 69' ' ' ALA . 5.2 m-85 -92.72 8.29 39.91 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 112.376 0.509 . . . . 0.0 112.376 179.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.433 HG23 ' O ' ' A' ' 75' ' ' ILE . 6.5 tp -86.49 118.25 32.44 Favored 'Isoleucine or valine' 0 C--N 1.341 0.204 0 CA-C-N 118.124 0.42 . . . . 0.0 110.673 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 62.81 75.77 0.39 Allowed 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 121.206 0.527 . . . . 0.0 111.057 -179.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 8.4 pt -147.71 153.91 11.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.543 179.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -66.21 140.46 58.17 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.512 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -50.3 -51.89 41.29 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -179.215 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -54.6 -25.77 36.53 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 120.978 -0.629 . . . . 0.0 112.963 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -77.28 -38.87 49.95 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.916 0.389 . . . . 0.0 110.453 179.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -70.05 -39.04 75.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.455 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.541 HG22 HD11 ' A' ' 27' ' ' ILE . 29.1 t -70.67 -43.35 77.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.898 0.38 . . . . 0.0 110.638 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 43.2 m -61.49 -39.18 89.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.221 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.541 ' O ' HG22 ' A' ' 88' ' ' THR . 14.3 mt -64.6 -46.51 82.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.103 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.416 ' HA ' ' CD2' ' A' ' 89' ' ' PHE . 31.9 mt -64.29 -39.83 94.72 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.171 -0.468 . . . . 0.0 112.085 -178.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 19.7 mmtp -65.42 -39.69 92.45 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -178.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.541 HG22 ' O ' ' A' ' 85' ' ' LEU . 9.8 t -70.74 -26.24 63.28 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 113.52 0.933 . . . . 0.0 113.52 -178.058 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.416 ' CD2' ' HA ' ' A' ' 86' ' ' LEU . 6.7 m-85 -46.67 170.85 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -178.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 7.1 mp0 -88.56 -142.23 0.13 Allowed 'General case' 0 CA--C 1.55 0.947 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.728 -179.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 60.9 m-80 -80.08 -66.91 0.82 Allowed 'General case' 0 C--N 1.348 0.537 0 CA-C-N 119.076 0.853 . . . . 0.0 111.08 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.762 HG23 ' HG3' ' A' ' 18' ' ' GLU . 0.2 OUTLIER -78.8 124.1 27.87 Favored 'General case' 0 C--N 1.334 -0.095 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.412 179.804 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 21.9 t -114.16 112.37 39.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.143 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -90.41 111.37 22.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.889 179.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 15.8 mt -112.02 153.49 26.77 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 121.071 0.462 . . . . 0.0 112.166 -178.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.697 HD12 ' HB2' ' A' ' 68' ' ' GLN . 16.5 mt -118.5 130.52 73.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.794 178.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.771 HD13 HD23 ' A' ' 60' ' ' LEU . 29.3 pt -136.69 169.66 19.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.997 0.427 . . . . 0.0 111.925 -179.014 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.404 HG12 ' N ' ' A' ' 99' ' ' ARG . 21.3 t -143.65 154.94 16.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.412 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.404 ' N ' HG12 ' A' ' 98' ' ' VAL . 25.3 mmm180 -116.58 114.33 23.97 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.147 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -63.47 121.47 13.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.344 -179.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.632 HG21 ' O ' ' A' ' 9' ' ' ALA . 3.7 m -105.72 93.94 2.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.037 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 29.5 p -98.87 115.11 28.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.952 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 79.5 p . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.24 -0.886 . . . . 0.0 110.79 179.952 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 301' ' ' THR . . . . . . . . . . . . . 5.2 m . . . . . 0 N--CA 1.488 1.458 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 302' ' ' GLY . . . . . . . . . . . . . . . 94.0 68.08 1.06 Allowed Glycine 0 C--N 1.338 0.657 0 C-N-CA 120.717 -0.754 . . . . 0.0 113.29 179.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 303' ' ' TRP . . . . . 0.406 ' CZ3' ' HB3' ' B' ' 304' ' ' GLU . 50.8 p-90 -161.68 -43.94 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.767 0.283 . . . . 0.0 111.22 179.125 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 304' ' ' GLU . . . . . 0.406 ' HB3' ' CZ3' ' B' ' 303' ' ' TRP . 7.5 pt-20 -71.86 132.73 44.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.699 0.285 . . . . 0.0 110.844 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 305' ' ' THR . . . . . . . . . . . . . 10.0 m -116.59 131.64 56.89 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.312 -0.404 . . . . 17.879999999999999 110.845 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 306' ' ' TRP . . . . . . . . . . . . . 80.3 m95 -91.09 115.52 28.08 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.847 179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 307' ' ' VAL . . . . . 0.546 HG22 ' O ' ' A' ' 25' ' ' PHE . 14.1 m . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.229 -0.891 . . . . 16.109999999999999 111.084 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.205 0 N-CA-C 112.484 -0.246 . . . . 0.0 112.484 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.4 m -87.01 103.43 15.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.793 0.33 . . . . 0.0 110.862 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 7.6 p80 -100.28 176.89 5.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.852 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 3.6 ttt -74.72 -45.8 41.75 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.9 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 94.49 126.39 4.63 Favored Glycine 0 C--N 1.331 0.286 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.41 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 41.9 m-70 -111.93 -61.54 1.7 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.816 0.341 . . . . 0.0 111.041 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -95.57 166.71 11.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.202 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 15.6 mt -97.39 -63.1 1.16 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.894 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -168.42 150.34 5.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.913 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.4 tppp? -172.78 117.86 0.33 Allowed 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.55 -0.295 . . . . 0.0 111.575 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -107.49 114.04 27.77 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.452 -179.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -96.08 106.18 18.32 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.236 -0.438 . . . . 0.0 112.081 -179.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 29.6 pt -108.78 166.46 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-O 120.931 0.396 . . . . 0.0 111.843 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 6.2 mtm-85 -114.2 164.26 14.12 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.575 -179.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.3 m -148.01 164.67 5.68 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.838 179.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 9.2 ttp180 -132.07 119.43 20.98 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 -179.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.0 t -116.26 130.69 70.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.15 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.83 ' HG2' HG23 ' A' ' 92' ' ' THR . 2.6 mm-40 -105.3 123.79 48.45 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.923 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.538 ' HE2' HD11 ' A' ' 23' ' ' LEU . 11.3 mmtt -70.6 80.01 0.59 Allowed 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 120.805 0.336 . . . . 0.0 111.795 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -137.59 85.68 20.29 Favored Pre-proline 0 CA--C 1.537 0.454 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.068 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -83.57 -24.58 10.79 Favored 'Cis proline' 0 C--N 1.366 1.461 0 CA-C-N 119.55 0.875 . . . . 0.0 113.034 0.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 60.4 mm-40 -137.46 -177.33 4.74 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 120.799 0.333 . . . . 0.0 111.125 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.538 HD11 ' HE2' ' A' ' 19' ' ' LYS . 4.4 mp -61.94 -57.68 10.81 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.991 179.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 99.78 34.25 5.0 Favored Glycine 0 CA--C 1.522 0.513 0 C-N-CA 120.722 -0.751 . . . . 0.0 113.87 179.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.419 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 36.3 p90 -160.35 153.06 21.12 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 117.418 0.609 . . . . 0.0 111.184 179.096 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.7 p -105.43 147.95 27.69 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.221 -179.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.659 HD11 HG22 ' A' ' 83' ' ' VAL . 32.4 pt -117.62 148.0 20.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.875 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 65.2 p -140.22 156.57 46.45 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.745 0.307 . . . . 0.0 111.188 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 109.11 -159.28 14.15 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 121.058 -0.592 . . . . 0.0 112.746 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 108.26 152.75 16.58 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 121.059 -0.591 . . . . 0.0 112.384 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 20.1 t -79.73 106.77 11.3 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-O 120.808 0.337 . . . . 0.0 110.661 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 88.06 -2.1 85.25 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 120.881 -0.675 . . . . 0.0 113.782 -179.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -84.44 -155.94 23.58 Favored Glycine 0 C--N 1.341 0.847 0 CA-C-N 117.869 0.835 . . . . 0.0 112.717 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.21 -24.86 65.16 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -179.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 91.61 160.0 35.92 Favored Glycine 0 C--N 1.34 0.793 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.504 -179.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 13.7 p30 -119.59 126.37 26.99 Favored Pre-proline 0 N--CA 1.465 0.301 0 N-CA-C 110.619 -0.141 . . . . 0.0 110.619 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.431 ' HG2' ' CH2' ' B' ' 303' ' ' TRP . 45.9 Cg_endo -88.62 51.87 1.77 Allowed 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 121.901 1.734 . . . . 0.0 112.254 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -133.92 -51.37 0.84 Allowed 'General case' 0 CA--C 1.529 0.154 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.124 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.403 ' HG3' ' CZ ' ' A' ' 46' ' ' PHE . 1.5 mmp_? -110.52 139.04 21.17 Favored Pre-proline 0 N--CA 1.466 0.33 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.879 -179.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -85.58 -46.38 0.04 OUTLIER 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 122.038 1.825 . . . . 0.0 113.198 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -94.62 -8.77 37.08 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 -179.232 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -103.1 116.53 32.68 Favored 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 118.157 0.435 . . . . 0.0 110.579 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.7 p30 -104.25 35.3 2.74 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.2 -179.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -84.23 -156.77 24.79 Favored Glycine 0 CA--C 1.519 0.316 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.29 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 14.4 mm -111.88 142.57 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-O 120.676 0.274 . . . . 0.0 110.692 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.403 ' CZ ' ' HG3' ' A' ' 39' ' ' ARG . 55.0 m-85 -140.15 154.1 46.87 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.162 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.45 HG21 HD22 ' A' ' 60' ' ' LEU . 17.8 t -97.99 75.75 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 CA-C-O 120.968 0.413 . . . . 0.0 111.191 -179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.429 HG23 ' N ' ' A' ' 49' ' ' ARG . 10.0 t -35.66 -51.68 0.66 Allowed 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 -178.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.429 ' N ' HG23 ' A' ' 48' ' ' THR . 14.5 ptt180 -160.36 175.4 12.85 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.162 0.506 . . . . 0.0 112.137 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 20.5 t -131.28 151.21 35.33 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.673 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.425 ' HG2' ' CH2' ' B' ' 306' ' ' TRP . 7.5 mm-40 -104.38 -67.82 0.04 OUTLIER Pre-proline 0 CA--C 1.537 0.471 0 CA-C-N 116.634 -0.257 . . . . 0.0 111.676 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_endo -77.4 122.46 6.08 Favored 'Trans proline' 0 C--N 1.357 0.977 0 C-N-CA 121.675 1.584 . . . . 0.0 112.233 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -80.16 64.21 4.91 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.091 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -158.43 -70.56 0.01 OUTLIER Glycine 0 CA--C 1.528 0.886 0 C-N-CA 120.703 -0.76 . . . . 0.0 113.564 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -59.57 -74.45 0.02 OUTLIER 'Trans proline' 0 C--N 1.358 1.06 0 C-N-CA 122.032 1.821 . . . . 0.0 113.355 -178.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.475 ' HB1' HD12 ' A' ' 60' ' ' LEU . . . -106.9 46.76 0.91 Allowed 'General case' 0 CA--C 1.53 0.2 0 CA-C-O 121.083 0.468 . . . . 0.0 111.643 -179.248 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 91.8 p -108.54 -60.39 1.74 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.109 179.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 5.7 ttpm? -69.42 -15.52 63.3 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.068 179.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 64.2 mt -93.23 -63.35 1.22 Allowed 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.869 0.366 . . . . 0.0 111.158 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.612 HD23 HG21 ' A' ' 97' ' ' ILE . 2.9 mt -91.87 144.03 25.9 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.44 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 5.1 pp0? -117.35 155.79 49.64 Favored Pre-proline 0 CA--C 1.534 0.355 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.449 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -59.19 119.28 6.42 Favored 'Trans proline' 0 C--N 1.357 1.01 0 C-N-CA 121.829 1.686 . . . . 0.0 112.49 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 98.68 5.37 56.73 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 121.05 -0.595 . . . . 0.0 113.827 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -71.13 140.35 50.56 Favored 'General case' 0 C--N 1.343 0.32 0 CA-C-N 118.102 0.951 . . . . 0.0 110.791 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 67.0 tttt -92.61 123.45 35.91 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.926 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 20.0 mt -89.15 115.23 28.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.218 -0.447 . . . . 0.0 109.841 179.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 19.9 mm -89.53 -42.16 14.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 112.249 0.462 . . . . 0.0 112.249 -178.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.879 ' HB3' HD12 ' A' ' 96' ' ' ILE . 22.4 tt0 -152.53 156.97 40.4 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.933 0.397 . . . . 0.0 111.884 -179.148 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -144.67 125.89 14.69 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.846 -0.616 . . . . 0.0 111.194 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.54 ' OD1' HG13 ' A' ' 93' ' ' VAL . 4.3 m-20 45.72 34.45 1.8 Allowed 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 178.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 95.01 -18.03 58.16 Favored Glycine 0 CA--C 1.523 0.593 0 C-N-CA 120.772 -0.728 . . . . 0.0 113.534 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -89.23 126.98 35.72 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-N 117.353 0.576 . . . . 0.0 110.884 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 8.4 t -72.64 124.52 25.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.937 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -102.75 12.95 35.57 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 6.4 tp -91.0 121.74 41.68 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 CA-C-O 120.944 0.402 . . . . 0.0 110.703 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 5.4 m120 64.24 74.17 0.41 Allowed 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 121.094 0.474 . . . . 0.0 110.721 -179.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 13.9 pt -149.77 164.27 3.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.794 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -73.79 144.83 45.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.663 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 6.9 t60 -54.3 -54.35 41.43 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.804 -179.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -54.78 -27.46 43.65 Favored Glycine 0 CA--C 1.524 0.595 0 C-N-CA 121.163 -0.541 . . . . 0.0 112.911 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -71.21 -39.29 71.83 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.093 0.473 . . . . 0.0 110.451 179.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.19 -52.14 44.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.492 -179.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.659 HG22 HD11 ' A' ' 27' ' ' ILE . 20.8 t -59.68 -43.89 92.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.604 -179.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 57.8 m -59.99 -40.9 90.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.534 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 31.2 mt -66.4 -43.93 84.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.53 -179.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.419 HD23 ' CE2' ' A' ' 89' ' ' PHE . 32.6 mt -66.51 -42.6 87.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.796 -179.249 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 42.0 mmtt -65.02 -43.07 93.68 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 -178.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 12.1 t -69.43 -25.89 64.34 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -178.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.419 ' CE2' HD23 ' A' ' 86' ' ' LEU . 14.7 m-30 -45.56 170.99 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -179.053 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -84.56 -143.01 0.08 Allowed 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.973 -179.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 35.9 m120 -83.07 -62.21 1.66 Allowed 'General case' 0 C--N 1.348 0.506 0 CA-C-N 118.992 0.814 . . . . 0.0 111.779 -178.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.83 HG23 ' HG2' ' A' ' 18' ' ' GLU . 0.3 OUTLIER -87.5 129.57 35.02 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.505 -179.65 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.54 HG13 ' OD1' ' A' ' 70' ' ' ASN . 19.1 t -125.41 121.02 59.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.139 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -95.37 105.67 17.65 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.469 179.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 12.1 mt -99.11 152.55 19.74 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 121.076 0.465 . . . . 0.0 111.673 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.879 HD12 ' HB3' ' A' ' 68' ' ' GLN . 61.1 mt -110.37 126.21 67.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.654 178.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.612 HG21 HD23 ' A' ' 60' ' ' LEU . 43.6 pt -127.95 168.62 20.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.821 0.343 . . . . 0.0 111.622 -178.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.4 t -145.88 151.34 14.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.236 -179.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -114.72 109.68 18.57 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 116.315 -0.402 . . . . 0.0 109.95 179.292 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -58.56 124.69 20.49 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.891 -179.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 21.4 t -101.96 153.75 5.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.496 179.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 71.3 m -160.07 176.5 11.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.892 0.377 . . . . 0.0 111.136 -179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 22.7 t . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.309 -0.853 . . . . 0.0 110.796 179.912 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 301' ' ' THR . . . . . . . . . . . . . 10.3 t . . . . . 0 N--CA 1.489 1.489 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 302' ' ' GLY . . . . . . . . . . . . . . . -72.25 98.34 0.81 Allowed Glycine 0 CA--C 1.52 0.401 0 C-N-CA 120.904 -0.665 . . . . 0.0 113.111 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 303' ' ' TRP . . . . . 0.431 ' CH2' ' HG2' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -162.52 -158.97 0.54 Allowed 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 116.804 0.302 . . . . 0.0 111.327 -179.952 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -69.54 -179.64 1.78 Allowed 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -177.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 305' ' ' THR . . . . . . . . . . . . . 21.0 m -154.67 100.31 2.23 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 114.942 -1.026 . . . . 17.879999999999999 109.698 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 306' ' ' TRP . . . . . 0.425 ' CH2' ' HG2' ' A' ' 51' ' ' GLN . 83.4 m95 -60.6 123.0 16.11 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.995 0.426 . . . . 0.0 111.684 -179.045 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 307' ' ' VAL . . . . . 0.531 HG12 HG13 ' A' ' 83' ' ' VAL . 16.0 m . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.273 -0.87 . . . . 16.109999999999999 111.174 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.185 0 N-CA-C 112.612 -0.195 . . . . 0.0 112.612 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.4 m -84.82 -175.22 5.68 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.581 0.229 . . . . 0.0 110.755 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -57.79 108.22 0.55 Allowed 'General case' 0 N--CA 1.463 0.2 0 CA-C-O 121.069 0.461 . . . . 0.0 111.366 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 5.2 tpt -79.59 -22.5 43.64 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 116.034 -0.53 . . . . 0.0 112.163 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -55.7 -169.68 0.08 OUTLIER Glycine 0 C--N 1.338 0.677 0 C-N-CA 120.983 -0.627 . . . . 0.0 113.466 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 13.2 m80 -75.92 166.03 24.11 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.002 0.429 . . . . 0.0 111.405 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -125.56 -159.21 0.88 Allowed 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.907 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.42 109.97 0.7 Allowed 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.986 0.422 . . . . 0.0 111.581 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.557 ' HA ' HG21 ' A' ' 101' ' ' VAL . . . -151.92 -144.28 0.15 Allowed 'General case' 0 CA--C 1.547 0.835 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.053 -179.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -43.88 108.05 0.1 Allowed 'General case' 0 N--CA 1.486 1.345 0 CA-C-N 119.223 0.92 . . . . 0.0 112.471 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.454 ' O ' HG13 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -86.47 121.48 29.08 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.858 -0.61 . . . . 0.0 112.612 -177.373 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -100.86 131.36 46.78 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.885 179.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.604 HD13 ' N ' ' A' ' 13' ' ' ILE . 0.2 OUTLIER -150.4 163.56 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-O 120.61 0.243 . . . . 0.0 111.571 179.89 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 57.9 mtt180 -116.78 164.72 14.23 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.879 -179.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.424 HG21 HD21 ' A' ' 60' ' ' LEU . 15.0 m -146.08 161.15 11.07 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.027 179.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.39 120.83 23.62 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.659 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.7 t -125.71 135.55 63.59 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.793 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.406 ' HG3' HG23 ' A' ' 92' ' ' THR . 2.9 mp0 -107.44 127.86 53.97 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.742 0.306 . . . . 0.0 111.418 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.46 112.45 6.75 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.13 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -173.75 83.45 0.38 Allowed Pre-proline 0 CA--C 1.54 0.566 0 CA-C-N 116.488 -0.323 . . . . 0.0 111.31 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -83.84 -23.3 12.93 Favored 'Cis proline' 0 C--N 1.366 1.463 0 CA-C-N 119.359 0.807 . . . . 0.0 112.888 0.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -137.41 -177.97 5.01 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.745 0.307 . . . . 0.0 110.955 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.612 HD13 HG23 ' B' ' 307' ' ' VAL . 3.2 mp -65.66 -54.35 28.8 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.963 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.592 ' O ' HG13 ' A' ' 50' ' ' VAL . . . 109.83 32.93 2.74 Favored Glycine 0 C--N 1.334 0.426 0 C-N-CA 120.837 -0.697 . . . . 0.0 113.543 179.17 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.409 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 35.8 p90 -167.21 179.38 5.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 117.008 0.404 . . . . 0.0 111.069 179.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.0 p -131.39 162.4 30.24 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.205 -179.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.693 HD11 HG22 ' A' ' 83' ' ' VAL . 37.4 pt -127.38 154.89 38.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.879 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 39.1 t -145.14 166.51 25.2 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.014 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 101.01 -147.52 17.85 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.635 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 105.47 152.97 21.2 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.932 -0.652 . . . . 0.0 112.446 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.46 HG21 ' HA ' ' A' ' 76' ' ' ASN . 32.2 t -79.81 108.1 12.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.913 0.387 . . . . 0.0 110.587 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 90.28 -1.06 79.16 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 120.946 -0.645 . . . . 0.0 113.844 -179.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -83.82 -149.45 9.54 Favored Glycine 0 C--N 1.342 0.903 0 CA-C-N 117.866 0.833 . . . . 0.0 112.887 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 52.0 mtt85 -81.34 -18.32 46.12 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -179.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 86.06 -177.89 49.41 Favored Glycine 0 C--N 1.338 0.652 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.757 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -136.82 157.78 74.23 Favored Pre-proline 0 CA--C 1.533 0.301 0 O-C-N 123.041 -0.093 . . . . 0.0 110.78 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -87.87 17.71 1.65 Allowed 'Trans proline' 0 C--N 1.358 1.068 0 C-N-CA 122.147 1.898 . . . . 0.0 113.781 -179.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -101.77 -41.07 6.66 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.87 0.367 . . . . 0.0 110.626 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 11.2 mmp_? -129.99 132.06 23.88 Favored Pre-proline 0 CA--C 1.533 0.322 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.332 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -83.05 -40.39 0.11 Allowed 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 121.887 1.725 . . . . 0.0 113.089 -179.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -99.92 -4.23 30.65 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -179.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -90.63 122.67 33.62 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 118.2 0.455 . . . . 0.0 110.912 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -102.18 40.82 1.29 Allowed 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.132 -179.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -98.9 -170.77 31.22 Favored Glycine 0 C--N 1.333 0.387 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.507 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 22.0 mm -110.26 127.69 67.03 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 CA-C-N 116.569 0.184 . . . . 0.0 110.51 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.44 ' CD1' ' N ' ' A' ' 46' ' ' PHE . 4.0 m-85 -128.29 146.77 50.65 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.762 0.315 . . . . 0.0 111.529 -179.454 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 21.4 t -86.7 79.57 1.7 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-O 120.98 0.419 . . . . 0.0 111.077 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.5 t -36.24 -55.22 0.8 Allowed 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 114.849 1.426 . . . . 0.0 114.849 -178.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -160.07 -179.55 7.87 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.218 0.532 . . . . 0.0 112.392 -179.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.592 HG13 ' O ' ' A' ' 24' ' ' GLY . 13.7 t -138.48 145.55 28.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.498 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.403 ' HG3' ' CH2' ' B' ' 306' ' ' TRP . 15.3 mt-30 -104.55 -68.71 0.04 OUTLIER Pre-proline 0 CA--C 1.537 0.459 0 N-CA-C 111.59 0.218 . . . . 0.0 111.59 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.401 ' HD3' ' CB ' ' A' ' 51' ' ' GLN . 81.4 Cg_endo -81.16 113.84 2.75 Favored 'Trans proline' 0 C--N 1.357 1.005 0 C-N-CA 121.661 1.574 . . . . 0.0 112.304 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -77.78 70.36 4.14 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.138 0.494 . . . . 0.0 110.936 -179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -145.37 -71.45 0.02 OUTLIER Glycine 0 CA--C 1.526 0.762 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.643 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -58.59 -71.93 0.03 OUTLIER 'Trans proline' 0 C--N 1.357 0.998 0 C-N-CA 122.021 1.814 . . . . 0.0 112.796 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.559 ' HB1' HD12 ' A' ' 60' ' ' LEU . . . -105.87 47.34 0.88 Allowed 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 121.217 0.532 . . . . 0.0 111.263 -179.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 98.1 p -83.2 -59.73 2.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.965 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 37.2 tptt -88.21 4.42 45.79 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 115.697 -0.683 . . . . 0.0 112.016 178.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.475 ' N ' HD22 ' A' ' 59' ' ' LEU . 3.6 mm? -92.6 -64.87 1.05 Allowed 'General case' 0 C--N 1.343 0.302 0 CA-C-N 118.16 0.436 . . . . 0.0 111.727 -179.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.559 HD12 ' HB1' ' A' ' 56' ' ' ALA . 3.1 mt -100.9 145.4 28.67 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.159 0.504 . . . . 0.0 112.223 -178.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -107.28 142.51 25.25 Favored Pre-proline 0 CA--C 1.534 0.358 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.996 179.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.02 131.29 45.52 Favored 'Trans proline' 0 C--N 1.357 1.0 0 C-N-CA 121.899 1.733 . . . . 0.0 113.159 -179.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 81.72 32.25 30.65 Favored Glycine 0 C--N 1.33 0.235 0 CA-C-N 115.979 -0.555 . . . . 0.0 113.55 179.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -88.28 -169.51 2.59 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 117.027 0.414 . . . . 0.0 110.898 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 78.1 tttt -138.44 125.64 21.54 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.975 -179.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 34.3 mt -94.36 122.53 45.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.501 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 26.0 mm -104.5 -36.82 4.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -179.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.575 ' HB3' HD12 ' A' ' 96' ' ' ILE . 0.1 OUTLIER -148.87 149.46 31.31 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.974 0.416 . . . . 0.0 111.827 -179.185 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.462 ' HB3' ' CE1' ' A' ' 74' ' ' PHE . . . -145.77 122.46 11.17 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.334 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.3 m120 45.94 38.3 4.44 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 179.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 84.42 11.21 78.38 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 121.007 -0.616 . . . . 0.0 113.87 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -113.44 121.8 45.38 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 117.69 0.745 . . . . 0.0 110.238 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 79.9 p -72.74 135.78 45.39 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.661 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.462 ' CE1' ' HB3' ' A' ' 69' ' ' ALA . 5.1 m-85 -104.59 23.51 13.21 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.423 HD13 ' HA ' ' A' ' 75' ' ' ILE . 11.4 mm -97.41 139.77 19.12 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-O 121.032 0.444 . . . . 0.0 109.921 179.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.46 ' HA ' HG21 ' A' ' 31' ' ' VAL . 7.9 m120 61.47 16.69 7.77 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.446 HD13 ' HA ' ' A' ' 74' ' ' PHE . 25.9 pt -95.29 163.8 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 N-CA-C 112.732 0.642 . . . . 0.0 112.732 -179.065 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -91.67 149.69 21.51 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.141 -0.936 . . . . 0.0 111.173 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 15.3 t60 -46.41 -51.89 14.1 Favored 'General case' 0 N--CA 1.476 0.838 0 N-CA-C 112.803 0.668 . . . . 0.0 112.803 -179.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -56.13 -26.91 50.73 Favored Glycine 0 CA--C 1.523 0.573 0 C-N-CA 120.985 -0.626 . . . . 0.0 113.176 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -74.56 -42.97 57.84 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-O 120.954 0.407 . . . . 0.0 110.476 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.25 -42.49 99.18 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.374 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.693 HG22 HD11 ' A' ' 27' ' ' ILE . 18.0 t -73.71 -40.99 54.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.753 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 43.7 t -62.19 -46.76 87.47 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.353 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 31.5 mt -61.16 -49.83 75.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.72 -179.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.739 HD21 HD21 ' A' ' 95' ' ' LEU . 17.3 mt -64.1 -37.68 88.31 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -178.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 9.2 mmtp -71.04 -39.82 72.06 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 112.634 0.605 . . . . 0.0 112.634 -178.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 11.4 t -71.87 -27.31 62.78 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 -178.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.411 ' CD2' ' HA ' ' A' ' 86' ' ' LEU . 9.6 m-85 -46.74 170.9 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -178.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -83.85 -142.85 0.07 Allowed 'General case' 0 CA--C 1.55 0.968 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.834 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -79.48 -70.3 0.52 Allowed 'General case' 0 C--N 1.348 0.523 0 CA-C-N 119.22 0.918 . . . . 0.0 111.501 -179.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.406 HG23 ' HG3' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -75.24 123.45 25.32 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.634 -179.687 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.503 HG12 ' CD1' ' A' ' 95' ' ' LEU . 14.2 t -121.04 120.82 63.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.723 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -99.91 107.17 19.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.54 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.739 HD21 HD21 ' A' ' 86' ' ' LEU . 6.2 mp -107.13 161.76 14.48 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 121.054 0.455 . . . . 0.0 111.788 -179.411 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.575 HD12 ' HB3' ' A' ' 68' ' ' GLN . 21.5 mt -123.64 132.23 71.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.402 178.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.421 HD13 HD23 ' A' ' 60' ' ' LEU . 43.9 pt -126.38 175.64 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-O 120.689 0.281 . . . . 0.0 111.625 -178.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.454 HG13 ' O ' ' A' ' 11' ' ' GLN . 17.2 t -150.22 143.96 17.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-O 120.934 0.397 . . . . 0.0 112.034 -179.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.01 116.91 30.68 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 178.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -65.77 154.65 38.45 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.047 0.451 . . . . 0.0 111.811 -178.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.557 HG21 ' HA ' ' A' ' 9' ' ' ALA . 8.3 m -115.49 148.6 18.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.683 179.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 59.3 p -77.67 124.17 27.6 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.106 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 39.2 m . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.142 -0.932 . . . . 0.0 110.815 179.88 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 301' ' ' THR . . . . . . . . . . . . . 6.5 m . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.677 0.275 . . . . 0.0 111.237 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 302' ' ' GLY . . . . . . . . . . . . . . . 172.06 -60.88 0.16 Allowed Glycine 0 C--N 1.334 0.448 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.946 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 303' ' ' TRP . . . . . 0.402 ' CZ3' ' HB3' ' B' ' 304' ' ' GLU . 4.1 p-90 -85.77 -21.56 28.14 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 111.906 0.336 . . . . 0.0 111.906 -179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 304' ' ' GLU . . . . . 0.402 ' HB3' ' CZ3' ' B' ' 303' ' ' TRP . 7.9 pt-20 -99.41 162.1 13.23 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-O 120.911 0.386 . . . . 0.0 111.082 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 305' ' ' THR . . . . . . . . . . . . . 15.2 m -142.24 132.28 24.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.948 -0.569 . . . . 17.879999999999999 110.368 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 306' ' ' TRP . . . . . 0.403 ' CH2' ' HG3' ' A' ' 51' ' ' GLN . 81.0 m95 -88.39 121.73 31.11 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.335 -179.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 307' ' ' VAL . . . . . 0.612 HG23 HD13 ' A' ' 23' ' ' LEU . 23.8 m . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.314 -0.851 . . . . 16.109999999999999 111.167 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.163 0 N-CA-C 112.486 -0.245 . . . . 0.0 112.486 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 75.2 m -113.61 47.78 1.13 Allowed 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 121.231 0.539 . . . . 0.0 110.758 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 3.7 t-160 -76.38 147.71 37.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.749 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.6 ptp -135.77 156.79 48.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.795 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 157.56 -140.43 7.07 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.715 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 13.1 t-160 -113.45 -28.05 7.68 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 111.711 0.263 . . . . 0.0 111.711 -179.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.42 177.77 0.35 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.978 0.418 . . . . 0.0 111.53 -179.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.8 mt -87.32 146.45 25.92 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.047 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -103.34 61.8 0.78 Allowed 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 121.33 0.586 . . . . 0.0 110.325 179.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 8.9 mmmt -153.48 124.08 7.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.977 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -89.64 88.58 7.46 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -179.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -90.91 124.99 35.62 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 179.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 5.6 pt -148.21 159.14 7.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -178.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.737 ' HG3' HD13 ' A' ' 96' ' ' ILE . 13.3 ttp-105 -119.52 157.01 29.21 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.639 -179.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 17.6 m -150.93 152.67 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 2.0 ptp180 -114.92 129.02 56.62 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.025 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.2 t -113.54 119.57 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.789 179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -93.54 121.48 35.0 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.648 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.91 116.07 10.79 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.752 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -175.85 81.39 0.29 Allowed Pre-proline 0 CA--C 1.538 0.509 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.753 179.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -84.85 -22.97 12.86 Favored 'Cis proline' 0 C--N 1.363 1.294 0 CA-C-N 119.327 0.795 . . . . 0.0 113.333 0.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -137.93 -179.18 5.61 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.946 0.403 . . . . 0.0 112.06 -179.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.4 mp -61.82 -61.17 2.69 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.293 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.417 ' O ' HG13 ' A' ' 50' ' ' VAL . . . 109.25 20.55 7.81 Favored Glycine 0 CA--C 1.523 0.568 0 C-N-CA 120.788 -0.72 . . . . 0.0 113.796 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -151.0 155.67 39.53 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 117.52 0.66 . . . . 0.0 111.393 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -110.11 151.94 26.62 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.537 -179.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.619 HD11 HG22 ' A' ' 83' ' ' VAL . 12.1 pt -121.07 151.67 24.18 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.197 0 CA-C-N 115.921 -0.582 . . . . 0.0 111.465 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 14.3 m -150.29 163.12 39.1 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.345 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 120.75 -89.57 0.45 Allowed Glycine 0 C--N 1.337 0.618 0 C-N-CA 121.034 -0.603 . . . . 0.0 113.379 179.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.432 ' H ' HD13 ' A' ' 45' ' ' ILE . . . 66.91 -138.45 35.08 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.938 -0.649 . . . . 0.0 112.427 -179.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.49 HG12 ' O ' ' A' ' 31' ' ' VAL . 47.0 t -131.42 57.95 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-O 121.145 0.497 . . . . 0.0 111.38 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 92.15 -7.5 78.43 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 115.09 0.796 . . . . 0.0 115.09 178.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -97.68 26.88 21.34 Favored Glycine 0 C--N 1.339 0.75 0 CA-C-N 118.092 0.946 . . . . 0.0 113.642 -179.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -173.12 -42.22 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 178.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.86 146.66 0.74 Allowed Glycine 0 CA--C 1.521 0.419 0 CA-C-N 115.877 -0.602 . . . . 0.0 112.966 179.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.2 p30 -123.94 137.58 29.12 Favored Pre-proline 0 CA--C 1.534 0.332 0 N-CA-C 110.541 -0.17 . . . . 0.0 110.541 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -91.47 24.44 0.55 Allowed 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 122.289 1.992 . . . . 0.0 113.593 -179.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -107.94 -52.84 2.71 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.759 0.314 . . . . 0.0 110.813 179.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -119.58 133.37 23.82 Favored Pre-proline 0 N--CA 1.466 0.372 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.359 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -84.61 -46.59 0.05 OUTLIER 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 121.869 1.713 . . . . 0.0 113.086 -179.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 13.1 p-10 -88.06 -9.48 53.21 Favored 'General case' 0 CA--C 1.538 0.508 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -179.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -100.89 118.05 36.16 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 118.056 0.389 . . . . 0.0 110.725 179.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.8 p30 -106.79 66.7 0.69 Allowed 'General case' 0 CA--C 1.533 0.315 0 CA-C-O 121.15 0.5 . . . . 0.0 110.912 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.478 ' O ' HD13 ' A' ' 45' ' ' ILE . . . -114.98 -143.79 8.21 Favored Glycine 0 CA--C 1.519 0.308 0 CA-C-N 115.924 -0.58 . . . . 0.0 112.366 179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.478 HD13 ' O ' ' A' ' 44' ' ' GLY . 21.5 mm -125.68 128.14 72.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.607 0.241 . . . . 0.0 110.735 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -121.6 147.46 45.81 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.075 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 21.7 t -92.07 71.89 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.04 -179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.421 HG23 ' N ' ' A' ' 49' ' ' ARG . 10.1 t -35.78 -54.13 0.73 Allowed 'General case' 0 N--CA 1.478 0.941 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 -178.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.421 ' N ' HG23 ' A' ' 48' ' ' THR . 0.0 OUTLIER -160.03 168.49 25.47 Favored 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 112.945 0.721 . . . . 0.0 112.945 -178.969 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.417 HG13 ' O ' ' A' ' 24' ' ' GLY . 17.3 t -124.89 150.98 30.13 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.401 179.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.4 ' CB ' ' HD3' ' A' ' 52' ' ' PRO . 4.5 mm-40 -105.54 -68.99 0.03 OUTLIER Pre-proline 0 CA--C 1.539 0.547 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.4 ' HD3' ' CB ' ' A' ' 51' ' ' GLN . 87.8 Cg_endo -80.93 121.68 4.11 Favored 'Trans proline' 0 C--N 1.359 1.091 0 C-N-CA 121.861 1.707 . . . . 0.0 112.818 -179.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -74.84 67.66 1.66 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 120.968 0.413 . . . . 0.0 111.328 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -156.81 -67.33 0.01 OUTLIER Glycine 0 CA--C 1.528 0.904 0 C-N-CA 120.803 -0.713 . . . . 0.0 113.476 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -58.63 -78.06 0.02 OUTLIER 'Trans proline' 0 C--N 1.357 0.983 0 C-N-CA 122.081 1.854 . . . . 0.0 113.499 -179.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.888 ' HB1' HD12 ' A' ' 60' ' ' LEU . . . -117.06 53.96 0.89 Allowed 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 121.255 0.55 . . . . 0.0 111.929 -179.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 77.8 p -108.14 -65.12 1.15 Allowed 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 178.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.14 -14.43 61.8 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.18 178.182 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 65.0 mt -92.66 -57.42 2.67 Favored 'General case' 0 C--N 1.344 0.329 0 O-C-N 122.137 -0.352 . . . . 0.0 110.901 179.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.888 HD12 ' HB1' ' A' ' 56' ' ' ALA . 27.9 mt -96.24 146.92 24.29 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.291 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -124.75 145.7 50.53 Favored Pre-proline 0 N--CA 1.47 0.567 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.97 179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_exo -58.32 127.18 23.8 Favored 'Trans proline' 0 C--N 1.362 1.263 0 C-N-CA 122.35 2.034 . . . . 0.0 113.689 -178.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 106.65 8.35 32.64 Favored Glycine 0 CA--C 1.524 0.621 0 C-N-CA 120.906 -0.664 . . . . 0.0 114.435 178.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -93.71 146.89 23.52 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 117.821 0.81 . . . . 0.0 111.575 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 51.5 tttt -98.71 133.08 43.54 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.699 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 29.3 mt -89.29 119.74 36.88 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.467 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 20.5 mm -89.83 -38.68 11.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -178.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 12.8 tt0 -155.36 154.66 32.35 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 121.059 0.457 . . . . 0.0 112.033 -179.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -141.93 123.87 15.31 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.966 179.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 42.91 41.69 2.71 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 179.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 84.97 -0.48 89.09 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 120.9 -0.666 . . . . 0.0 114.152 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -108.4 124.47 50.44 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 117.953 0.877 . . . . 0.0 110.914 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 30.6 t -70.9 131.62 44.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.694 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -101.7 19.8 17.44 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -179.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 28.7 mm -92.46 121.09 42.77 Favored 'Isoleucine or valine' 0 C--N 1.339 0.12 0 CA-C-O 120.766 0.317 . . . . 0.0 110.664 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 57.1 m-20 61.87 74.88 0.43 Allowed 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.209 0.528 . . . . 0.0 110.743 -179.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 10.3 pt -146.57 150.27 15.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.914 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -68.92 136.54 52.74 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.998 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.587 ' O ' HG23 ' A' ' 83' ' ' VAL . 36.7 t60 -43.47 -45.92 6.6 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 -179.112 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -59.39 -28.69 65.04 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.457 179.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 3.7 tp-100 -72.65 -44.47 61.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.918 0.39 . . . . 0.0 110.639 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.87 -37.95 85.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.257 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.619 HG22 HD11 ' A' ' 27' ' ' ILE . 24.2 t -75.06 -42.48 45.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.946 0.403 . . . . 0.0 110.755 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 42.2 t -62.81 -41.65 99.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.142 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' A' ' 85' ' ' LEU . 27.4 mt -65.27 -46.75 79.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.455 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.429 ' HA ' ' CD2' ' A' ' 89' ' ' PHE . 27.2 mt -65.94 -30.87 71.52 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.147 -0.479 . . . . 0.0 112.169 -178.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 30.0 mmtt -77.13 -35.44 56.17 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.039 0.385 . . . . 0.0 112.039 -179.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 9.7 t -75.52 -26.68 58.28 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -178.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.429 ' CD2' ' HA ' ' A' ' 86' ' ' LEU . 21.0 m-85 -52.56 149.36 5.97 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-O 121.145 0.498 . . . . 0.0 112.134 -179.196 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -65.18 -136.65 0.0 OUTLIER 'General case' 0 CA--C 1.555 1.161 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.557 -179.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -80.3 -70.36 0.53 Allowed 'General case' 0 C--N 1.351 0.665 0 CA-C-N 119.588 1.086 . . . . 0.0 112.613 -179.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.8 p -78.34 127.53 32.35 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.792 0.329 . . . . 0.0 111.3 -179.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.466 ' O ' HD12 ' A' ' 95' ' ' LEU . 21.8 t -117.2 114.08 44.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.719 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -89.67 111.86 22.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.515 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.466 HD12 ' O ' ' A' ' 93' ' ' VAL . 4.0 mp -112.96 151.52 30.47 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 120.982 0.42 . . . . 0.0 111.781 -179.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.737 HD13 ' HG3' ' A' ' 14' ' ' ARG . 17.6 mm -107.6 121.93 61.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.9 178.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.459 HD13 HD23 ' A' ' 60' ' ' LEU . 22.4 pt -129.05 163.1 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-O 120.809 0.338 . . . . 0.0 111.881 -179.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.431 HG12 ' N ' ' A' ' 99' ' ' ARG . 14.3 t -150.76 155.72 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.208 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.727 -179.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.431 ' N ' HG12 ' A' ' 98' ' ' VAL . 32.9 mmm-85 -110.5 122.43 47.73 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.094 -0.503 . . . . 0.0 109.767 177.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -70.45 104.31 2.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.852 0.358 . . . . 0.0 111.156 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 22.9 t -118.61 123.99 72.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.733 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 17.6 t -113.82 128.11 56.28 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-O 120.817 0.342 . . . . 0.0 111.087 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 76.8 p . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.325 -0.845 . . . . 0.0 110.868 179.744 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 301' ' ' THR . . . . . . . . . . . . . 8.2 m . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 121.143 0.497 . . . . 0.0 111.026 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 302' ' ' GLY . . . . . . . . . . . . . . . -179.51 61.28 0.08 OUTLIER Glycine 0 CA--C 1.521 0.427 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.862 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 303' ' ' TRP . . . . . . . . . . . . . 45.0 p-90 -124.8 16.63 8.68 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 112.043 0.386 . . . . 0.0 112.043 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -139.47 135.26 33.36 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 120.763 0.316 . . . . 0.0 110.988 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 305' ' ' THR . . . . . . . . . . . . . 80.7 m -123.93 122.5 38.12 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.039 -0.528 . . . . 17.879999999999999 110.669 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 306' ' ' TRP . . . . . . . . . . . . . 86.1 m95 -78.16 107.84 11.03 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.891 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 307' ' ' VAL . . . . . 0.414 HG12 HG13 ' A' ' 83' ' ' VAL . 17.5 m . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.257 -0.878 . . . . 16.109999999999999 111.153 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.142 0 N-CA-C 112.509 -0.236 . . . . 0.0 112.509 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 62.0 m -152.04 -63.32 0.17 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.784 0.326 . . . . 0.0 110.957 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -124.33 141.35 52.14 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.006 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 6.5 ptp -141.17 -47.55 0.4 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.899 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 139.67 120.34 1.75 Allowed Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.527 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 4.8 m80 -157.99 -48.35 0.06 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.802 0.334 . . . . 0.0 110.84 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -86.07 116.24 24.15 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.089 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.8 mp -124.08 106.68 10.56 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.55 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.659 ' HA ' HG11 ' A' ' 101' ' ' VAL . . . -169.29 -161.34 0.3 Allowed 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 116.455 -0.338 . . . . 0.0 111.228 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 35.9 mttt -50.97 115.37 1.49 Allowed 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -179.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.868 ' O ' HG13 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -107.28 175.57 5.45 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.856 179.752 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.43 102.83 4.15 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.688 -0.233 . . . . 0.0 111.265 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 23.9 pt -107.94 162.49 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-N 116.204 -0.453 . . . . 0.0 112.164 -179.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.513 ' HG3' HD13 ' A' ' 96' ' ' ILE . 14.5 ttm105 -116.98 152.86 33.7 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.987 -179.278 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.1 m -143.2 144.12 24.1 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.668 179.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 11.6 ttp-105 -116.73 130.58 56.81 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 120.804 0.335 . . . . 0.0 111.293 -179.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.0 t -123.49 125.57 71.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.07 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.516 ' HG3' HG22 ' A' ' 92' ' ' THR . 6.1 mp0 -92.21 119.77 32.15 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.892 0.377 . . . . 0.0 111.086 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -71.18 119.75 15.77 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.091 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -174.65 82.72 0.34 Allowed Pre-proline 0 CA--C 1.539 0.556 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.077 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_endo -86.84 -18.93 19.75 Favored 'Cis proline' 0 C--N 1.365 1.409 0 CA-C-N 119.407 0.824 . . . . 0.0 113.228 0.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -133.44 -178.56 5.04 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.829 0.347 . . . . 0.0 111.383 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.417 ' HB3' ' CE2' ' A' ' 25' ' ' PHE . 2.9 mp -65.63 -56.16 13.69 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.707 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.453 ' O ' HG13 ' A' ' 50' ' ' VAL . . . 107.66 32.5 3.36 Favored Glycine 0 CA--C 1.52 0.383 0 C-N-CA 120.932 -0.652 . . . . 0.0 113.7 179.138 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.417 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 42.1 p90 -163.74 152.81 14.12 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 117.163 0.482 . . . . 0.0 111.175 179.232 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.9 p -104.25 150.45 24.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.456 -179.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.783 HD11 HG22 ' A' ' 83' ' ' VAL . 22.5 pt -117.67 144.58 25.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.49 179.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 77.8 p -131.52 157.34 43.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.767 0.318 . . . . 0.0 110.893 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 107.98 -156.19 15.92 Favored Glycine 0 C--N 1.33 0.234 0 C-N-CA 121.014 -0.613 . . . . 0.0 112.453 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 110.85 148.48 11.49 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.995 -0.621 . . . . 0.0 112.507 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.432 HG21 ' HA ' ' A' ' 76' ' ' ASN . 41.3 t -80.48 100.28 4.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.956 0.408 . . . . 0.0 110.903 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 94.79 2.28 63.01 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 120.99 -0.624 . . . . 0.0 114.139 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.97 -154.84 28.09 Favored Glycine 0 C--N 1.341 0.858 0 CA-C-N 117.827 0.813 . . . . 0.0 112.981 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 1.9 mtt180 -62.66 -22.85 66.77 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 92.79 160.12 35.49 Favored Glycine 0 C--N 1.336 0.537 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.843 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 3.5 p30 -114.62 136.15 22.4 Favored Pre-proline 0 CA--C 1.535 0.392 0 N-CA-C 110.556 -0.164 . . . . 0.0 110.556 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -87.91 13.28 2.64 Favored 'Trans proline' 0 C--N 1.357 1.0 0 C-N-CA 122.018 1.812 . . . . 0.0 113.98 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -99.64 -41.55 7.27 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 120.666 0.269 . . . . 0.0 111.178 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.76 136.15 27.99 Favored Pre-proline 0 N--CA 1.466 0.374 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.714 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -85.63 -44.58 0.05 OUTLIER 'Trans proline' 0 C--N 1.358 1.049 0 C-N-CA 122.052 1.835 . . . . 0.0 113.413 -179.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -92.64 -9.0 42.51 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -179.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -95.68 117.93 31.41 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-N 118.097 0.408 . . . . 0.0 110.339 179.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -105.09 38.56 1.91 Allowed 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.509 -179.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.52 ' O ' HD13 ' A' ' 45' ' ' ILE . . . -92.28 -148.67 23.11 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 120.867 -0.683 . . . . 0.0 111.846 179.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.52 HD13 ' O ' ' A' ' 44' ' ' GLY . 20.8 mm -125.52 140.22 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 116.798 0.299 . . . . 0.0 110.842 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -137.81 151.01 47.67 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.12 -179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 21.7 t -90.56 73.69 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-O 121.126 0.488 . . . . 0.0 111.084 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.43 HG23 ' N ' ' A' ' 49' ' ' ARG . 9.7 t -36.24 -53.17 0.82 Allowed 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 114.745 1.387 . . . . 0.0 114.745 -178.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.43 ' N ' HG23 ' A' ' 48' ' ' THR . 11.8 ptm180 -161.24 172.79 16.06 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.213 0.53 . . . . 0.0 112.291 -179.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.453 HG13 ' O ' ' A' ' 24' ' ' GLY . 19.4 t -127.47 147.19 32.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.445 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.416 ' CG ' ' CH2' ' B' ' 306' ' ' TRP . 4.6 mm-40 -102.1 -69.67 0.04 OUTLIER Pre-proline 0 CA--C 1.537 0.446 0 CA-C-O 119.629 -0.224 . . . . 0.0 110.983 179.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.402 ' HD3' ' CB ' ' A' ' 51' ' ' GLN . 95.0 Cg_endo -80.91 114.93 2.97 Favored 'Trans proline' 0 C--N 1.359 1.112 0 C-N-CA 121.653 1.569 . . . . 0.0 112.036 179.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -74.89 68.4 1.76 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 121.025 0.44 . . . . 0.0 111.098 -179.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -150.94 -71.15 0.01 OUTLIER Glycine 0 CA--C 1.528 0.872 0 C-N-CA 120.668 -0.777 . . . . 0.0 113.714 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -59.7 -77.49 0.02 OUTLIER 'Trans proline' 0 C--N 1.358 1.06 0 C-N-CA 121.928 1.752 . . . . 0.0 113.465 -178.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.797 ' HB1' HD12 ' A' ' 60' ' ' LEU . . . -106.8 49.57 0.8 Allowed 'General case' 0 CA--C 1.529 0.152 0 CA-C-O 121.401 0.619 . . . . 0.0 111.194 -179.39 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 7.9 t -100.86 -61.41 1.37 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.117 179.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.7 ttpt -74.35 -7.68 53.69 Favored 'General case' 0 CA--C 1.542 0.645 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.106 178.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 20.7 mt -92.69 -59.02 2.17 Favored 'General case' 0 C--N 1.344 0.333 0 CA-C-N 118.219 0.463 . . . . 0.0 110.9 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.797 HD12 ' HB1' ' A' ' 56' ' ' ALA . 11.6 mt -93.36 143.29 26.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.299 -179.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -112.44 141.27 24.89 Favored Pre-proline 0 CA--C 1.534 0.365 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.258 179.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -57.62 122.55 11.96 Favored 'Trans proline' 0 C--N 1.358 1.045 0 C-N-CA 121.784 1.656 . . . . 0.0 112.777 -179.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.57 16.6 21.84 Favored Glycine 0 CA--C 1.522 0.507 0 C-N-CA 120.971 -0.633 . . . . 0.0 113.932 179.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -94.29 147.36 23.27 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 117.559 0.68 . . . . 0.0 110.772 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 58.5 tttm -96.74 135.76 38.23 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.153 -179.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 29.3 mt -95.67 123.65 47.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.591 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 23.7 mm -99.39 -42.22 10.45 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.824 -178.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -146.76 151.51 37.29 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 121.173 0.511 . . . . 0.0 112.139 -179.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.62 ' HB3' ' CE1' ' A' ' 74' ' ' PHE . . . -139.83 122.45 16.3 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.943 179.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 45.62 28.18 0.5 Allowed 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 113.01 0.744 . . . . 0.0 113.01 179.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 95.47 14.19 48.5 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 120.966 -0.635 . . . . 0.0 113.49 -179.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -116.8 122.15 43.59 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 117.65 0.725 . . . . 0.0 110.677 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 63.8 p -68.87 124.11 22.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.427 179.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.62 ' CE1' ' HB3' ' A' ' 69' ' ' ALA . 3.4 m-85 -94.08 19.98 8.51 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 8.5 tp -97.84 138.11 23.53 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-O 120.633 0.254 . . . . 0.0 111.418 -179.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.432 ' HA ' HG21 ' A' ' 31' ' ' VAL . 77.2 m-20 63.18 20.82 12.51 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -179.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.487 HD13 ' HA ' ' A' ' 74' ' ' PHE . 26.2 pt -98.15 164.32 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -178.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -85.67 146.78 26.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.254 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.47 ' O ' HG23 ' A' ' 83' ' ' VAL . 31.1 t60 -47.34 -50.27 22.38 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 115.857 -0.611 . . . . 0.0 112.602 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -61.01 -29.04 69.84 Favored Glycine 0 CA--C 1.519 0.282 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.174 179.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -65.32 -45.79 82.92 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.918 0.389 . . . . 0.0 111.023 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.77 -38.31 86.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.361 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.783 HG22 HD11 ' A' ' 27' ' ' ILE . 25.6 t -73.11 -42.97 58.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.741 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 35.5 t -63.66 -46.0 87.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.087 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 23.8 mt -59.31 -50.97 71.92 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.826 -179.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.412 ' HA ' ' CD2' ' A' ' 89' ' ' PHE . 26.0 mt -62.76 -32.45 73.6 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.932 -178.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 44.1 mttm -76.88 -37.62 55.15 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.437 0.532 . . . . 0.0 112.437 -178.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 10.2 t -73.92 -29.51 62.08 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -178.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.412 ' CD2' ' HA ' ' A' ' 86' ' ' LEU . 15.3 m-85 -47.54 171.38 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 -179.07 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -77.53 -145.6 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.98 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.659 -179.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 30.5 m120 -79.41 -67.96 0.71 Allowed 'General case' 0 C--N 1.348 0.511 0 CA-C-N 118.831 0.742 . . . . 0.0 110.835 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.516 HG22 ' HG3' ' A' ' 18' ' ' GLU . 0.8 OUTLIER -74.65 120.43 20.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.785 -179.865 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.438 HG12 ' CD1' ' A' ' 95' ' ' LEU . 18.4 t -113.22 115.18 49.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.897 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.8 mp0 -95.39 107.0 19.11 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.454 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.438 ' CD1' HG12 ' A' ' 93' ' ' VAL . 6.2 mp -102.82 150.99 22.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.722 -179.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.513 HD13 ' HG3' ' A' ' 14' ' ' ARG . 17.2 mm -107.38 122.18 61.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.74 178.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.411 HD13 HD23 ' A' ' 60' ' ' LEU . 41.8 pt -126.03 163.4 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-O 121.148 0.499 . . . . 0.0 112.185 -179.15 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.868 HG13 ' O ' ' A' ' 11' ' ' GLN . 51.1 t -137.89 144.3 31.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.185 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 49.5 mmm-85 -111.98 109.8 19.77 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.968 179.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -59.25 145.9 41.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.024 0.44 . . . . 0.0 111.777 -179.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.659 HG11 ' HA ' ' A' ' 9' ' ' ALA . 3.3 m -107.51 108.71 25.9 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.605 179.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 40.0 t -105.88 35.11 3.01 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.401 -179.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 28.3 t . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.196 -0.907 . . . . 0.0 110.761 179.781 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 301' ' ' THR . . . . . . . . . . . . . 64.3 p . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.747 0.308 . . . . 0.0 111.165 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 302' ' ' GLY . . . . . . . . . . . . . . . 170.38 121.34 0.58 Allowed Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.754 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 303' ' ' TRP . . . . . . . . . . . . . 2.3 p-90 -100.43 -18.33 16.76 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 179.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -89.55 162.4 15.7 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.799 0.333 . . . . 0.0 110.991 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 305' ' ' THR . . . . . . . . . . . . . 6.8 m -124.23 115.89 21.8 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.072 -0.513 . . . . 17.879999999999999 110.453 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 306' ' ' TRP . . . . . 0.416 ' CH2' ' CG ' ' A' ' 51' ' ' GLN . 83.7 m95 -79.16 113.84 17.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.031 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 307' ' ' VAL . . . . . 0.425 HG12 HG13 ' A' ' 83' ' ' VAL . 16.1 m . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.223 -0.894 . . . . 16.109999999999999 111.142 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.21 0 N-CA-C 112.515 -0.234 . . . . 0.0 112.515 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 57.4 p -148.86 33.31 0.76 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.897 0.38 . . . . 0.0 110.842 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -82.08 142.68 32.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.633 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -141.56 105.93 4.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.678 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -82.64 -176.56 51.49 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.752 -179.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 2.8 m-70 -86.62 -36.39 18.85 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.794 0.331 . . . . 0.0 110.969 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -68.8 -174.24 0.56 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.034 -179.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 16.6 tp -63.76 159.16 19.96 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.811 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -69.31 127.29 32.55 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.711 -179.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.5 tppt? -174.89 125.46 0.27 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.381 179.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -88.67 92.15 9.09 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 112.797 0.665 . . . . 0.0 112.797 -177.22 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -96.15 123.8 39.91 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.737 179.092 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.606 HD13 ' N ' ' A' ' 13' ' ' ILE . 0.2 OUTLIER -151.08 165.86 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -179.712 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.48 158.55 22.4 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.637 179.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.9 m -144.16 145.51 21.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.755 179.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.03 114.19 27.91 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.177 -179.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.4 t -110.62 119.13 58.76 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.839 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.556 ' HG3' HG23 ' A' ' 92' ' ' THR . 1.0 OUTLIER -100.04 128.56 46.11 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.491 179.581 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.496 ' HD3' HD12 ' A' ' 23' ' ' LEU . 14.0 mtmt -84.02 123.77 30.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.139 0.495 . . . . 0.0 111.608 -179.462 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -172.84 85.7 0.41 Allowed Pre-proline 0 CA--C 1.537 0.448 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.797 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -82.48 -20.19 20.35 Favored 'Cis proline' 0 C--N 1.365 1.401 0 CA-C-N 119.357 0.806 . . . . 0.0 113.15 0.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -136.4 -178.34 5.12 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 120.854 0.359 . . . . 0.0 111.513 -179.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.496 HD12 ' HD3' ' A' ' 19' ' ' LYS . 3.4 mp -67.21 -52.41 41.42 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.668 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.423 ' O ' HG13 ' A' ' 50' ' ' VAL . . . 106.75 26.17 5.94 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.898 -0.668 . . . . 0.0 113.833 179.096 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.419 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 42.1 p90 -156.63 171.14 20.86 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 117.461 0.63 . . . . 0.0 111.316 179.429 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.3 p -119.82 153.63 35.48 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.09 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.78 HD11 HG22 ' A' ' 83' ' ' VAL . 26.4 pt -120.39 148.52 23.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.907 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 74.6 p -140.61 158.28 44.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.045 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 106.26 -148.01 16.36 Favored Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.968 -0.634 . . . . 0.0 112.731 179.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.79 151.77 26.34 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.374 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 13.7 t -79.82 99.32 3.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.722 0.296 . . . . 0.0 110.463 179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 104.28 -7.81 47.88 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 120.922 -0.656 . . . . 0.0 113.522 -179.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -73.44 -148.44 1.13 Allowed Glycine 0 C--N 1.344 1.001 0 CA-C-N 117.751 0.776 . . . . 0.0 112.248 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 53.1 mtt-85 -89.21 16.96 6.46 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -179.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 63.86 170.72 1.88 Allowed Glycine 0 C--N 1.338 0.693 0 C-N-CA 120.999 -0.62 . . . . 0.0 113.42 179.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -139.75 143.8 36.4 Favored Pre-proline 0 CA--C 1.534 0.363 0 N-CA-C 110.518 -0.179 . . . . 0.0 110.518 179.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -92.32 27.28 0.38 Allowed 'Trans proline' 0 C--N 1.358 1.042 0 C-N-CA 122.34 2.027 . . . . 0.0 113.537 -179.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -103.43 -51.35 3.23 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.754 0.311 . . . . 0.0 110.945 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 16.2 mtp180 -120.31 137.33 25.95 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.418 179.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -85.3 -45.74 0.05 OUTLIER 'Trans proline' 0 C--N 1.358 1.078 0 C-N-CA 121.904 1.736 . . . . 0.0 113.59 -179.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -89.62 -13.01 38.04 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 112.858 0.688 . . . . 0.0 112.858 -179.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -106.74 122.69 46.87 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 122.001 -0.437 . . . . 0.0 110.831 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 19.0 p30 -108.69 36.04 2.99 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 121.01 0.433 . . . . 0.0 111.099 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -79.27 -157.93 12.89 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 120.937 -0.649 . . . . 0.0 112.361 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.7 mm -110.14 132.06 59.47 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-O 120.697 0.284 . . . . 0.0 111.114 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.435 ' N ' ' CD1' ' A' ' 46' ' ' PHE . 5.4 m-85 -131.39 150.14 52.27 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.346 179.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.607 HG23 ' OD1' ' A' ' 64' ' ' ASP . 31.4 t -94.15 75.68 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-O 120.961 0.41 . . . . 0.0 111.466 -179.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.406 HG23 ' N ' ' A' ' 49' ' ' ARG . 5.2 t -33.89 -52.99 0.45 Allowed 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 114.939 1.459 . . . . 0.0 114.939 -178.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.406 ' N ' HG23 ' A' ' 48' ' ' THR . 13.0 ptm180 -158.13 173.54 16.57 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -179.257 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.423 HG13 ' O ' ' A' ' 24' ' ' GLY . 18.3 t -133.81 150.0 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.304 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.464 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.407 ' HG3' ' CH2' ' B' ' 306' ' ' TRP . 8.1 mt-30 -104.99 -67.92 0.04 OUTLIER Pre-proline 0 CA--C 1.539 0.543 0 N-CA-C 111.643 0.238 . . . . 0.0 111.643 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -79.07 121.07 4.79 Favored 'Trans proline' 0 C--N 1.358 1.047 0 C-N-CA 121.645 1.563 . . . . 0.0 112.522 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -78.61 69.55 4.81 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 121.103 0.478 . . . . 0.0 111.016 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -158.37 -68.96 0.01 OUTLIER Glycine 0 CA--C 1.528 0.885 0 C-N-CA 120.794 -0.717 . . . . 0.0 113.358 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -60.98 -75.41 0.02 OUTLIER 'Trans proline' 0 C--N 1.358 1.053 0 C-N-CA 121.94 1.76 . . . . 0.0 113.429 -178.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.742 ' HB1' HD12 ' A' ' 60' ' ' LEU . . . -108.15 47.52 0.9 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 121.24 0.543 . . . . 0.0 111.964 -178.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 8.4 t -111.22 -64.19 1.31 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.089 -0.505 . . . . 0.0 109.727 178.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.14 -16.11 61.17 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.783 178.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 27.7 mt -96.51 -52.67 3.86 Favored 'General case' 0 C--N 1.342 0.262 0 CA-C-O 120.616 0.246 . . . . 0.0 111.135 -179.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.742 HD12 ' HB1' ' A' ' 56' ' ' ALA . 8.9 mt -103.76 151.12 23.42 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 120.884 0.373 . . . . 0.0 111.748 -179.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 3.5 pp0? -126.45 149.42 67.57 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.641 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -58.57 130.01 35.19 Favored 'Trans proline' 0 C--N 1.361 1.186 0 C-N-CA 122.342 2.028 . . . . 0.0 113.658 -178.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 98.35 9.46 53.28 Favored Glycine 0 CA--C 1.525 0.714 0 CA-C-N 115.673 -0.694 . . . . 0.0 114.075 179.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.607 ' OD1' HG23 ' A' ' 47' ' ' VAL . 10.5 p30 -77.82 -174.48 3.52 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 117.841 0.82 . . . . 0.0 111.623 -179.272 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 25.4 tttm -139.2 124.32 18.95 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.008 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 26.5 mt -88.72 115.23 28.31 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-O 121.106 0.479 . . . . 0.0 110.812 -179.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 19.8 mm -89.78 -42.82 14.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -178.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.784 ' HB2' HD12 ' A' ' 96' ' ' ILE . 0.0 OUTLIER -150.11 146.33 26.85 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.102 0.477 . . . . 0.0 112.116 -179.006 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.587 ' HB3' ' CE1' ' A' ' 74' ' ' PHE . . . -131.06 120.9 24.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.919 179.464 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 42.76 35.46 0.71 Allowed 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 178.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 91.51 -12.59 68.88 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 120.819 -0.705 . . . . 0.0 113.853 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -88.21 125.46 34.64 Favored 'General case' 0 C--O 1.231 0.082 0 CA-C-N 117.648 0.724 . . . . 0.0 109.949 179.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 84.4 p -69.67 115.55 9.04 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.754 -179.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.587 ' CE1' ' HB3' ' A' ' 69' ' ' ALA . 4.4 m-85 -95.25 9.17 40.75 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.954 178.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 7.6 tp -89.38 126.86 42.33 Favored 'Isoleucine or valine' 0 C--N 1.343 0.288 0 CA-C-N 118.181 0.446 . . . . 0.0 110.508 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 57.1 m-80 61.09 70.82 0.59 Allowed 'General case' 0 CA--C 1.531 0.235 0 CA-C-O 121.284 0.564 . . . . 0.0 110.786 -179.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.404 HD13 ' HA ' ' A' ' 74' ' ' PHE . 19.9 pt -145.6 168.48 7.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.885 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -82.45 148.14 28.34 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.18 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.423 ' O ' HG23 ' A' ' 83' ' ' VAL . 1.3 t-160 -52.23 -52.5 52.03 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.893 -0.594 . . . . 0.0 112.281 -179.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -56.8 -26.05 53.34 Favored Glycine 0 CA--C 1.523 0.552 0 C-N-CA 121.037 -0.601 . . . . 0.0 113.171 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -74.32 -40.25 62.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.068 0.461 . . . . 0.0 110.641 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.3 -34.47 74.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.797 -179.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.78 HG22 HD11 ' A' ' 27' ' ' ILE . 24.0 t -75.08 -44.85 43.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.911 0.386 . . . . 0.0 110.861 -179.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 23.3 t -59.01 -36.97 75.83 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.383 -179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 85' ' ' LEU . 35.7 mt -71.0 -42.3 69.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.099 0.476 . . . . 0.0 110.588 179.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.425 ' HA ' ' CD2' ' A' ' 89' ' ' PHE . 33.2 mt -77.53 -8.27 57.54 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -179.408 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 15.8 mmtp -98.09 -36.65 10.02 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.247 0.546 . . . . 0.0 110.427 178.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 9.1 t -70.19 -21.78 63.01 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.494 -0.775 . . . . 0.0 112.142 -178.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.425 ' CD2' ' HA ' ' A' ' 86' ' ' LEU . 12.9 m-85 -55.83 126.8 27.22 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 121.194 0.521 . . . . 0.0 111.06 -179.06 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 23.1 mp0 -60.29 -64.5 0.93 Allowed 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 113.727 1.01 . . . . 0.0 113.727 -177.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 32.4 m120 -134.6 -81.95 0.44 Allowed 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 112.649 0.611 . . . . 0.0 112.649 -178.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.556 HG23 ' HG3' ' A' ' 18' ' ' GLU . 0.2 OUTLIER -70.76 158.75 35.76 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.033 0.444 . . . . 0.0 111.08 -178.718 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 19.5 t -150.38 113.97 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.888 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -89.36 119.33 29.73 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.202 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.5 mt -122.71 147.41 46.51 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.166 0.508 . . . . 0.0 111.893 -178.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.784 HD12 ' HB2' ' A' ' 68' ' ' GLN . 41.2 mt -112.86 126.46 70.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.536 -0.757 . . . . 0.0 109.719 178.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.454 HD13 HD23 ' A' ' 60' ' ' LEU . 30.9 pt -126.0 166.48 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-O 120.837 0.351 . . . . 0.0 111.296 -179.051 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 16.1 t -150.01 149.49 14.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.574 -179.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.34 115.63 30.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.258 178.213 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -73.17 133.27 44.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.935 0.398 . . . . 0.0 111.7 -178.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 15.8 m -90.87 145.98 6.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.801 179.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 22.7 t -134.46 33.97 3.26 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.976 -179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 56.8 p . . . . . 0 C--O 1.248 0.99 0 CA-C-O 118.282 -0.866 . . . . 0.0 110.836 179.886 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 301' ' ' THR . . . . . . . . . . . . . 4.0 m . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.742 0.306 . . . . 0.0 111.178 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 302' ' ' GLY . . . . . . . . . . . . . . . -165.37 112.23 0.49 Allowed Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.909 -0.662 . . . . 0.0 112.447 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 303' ' ' TRP . . . . . 0.403 ' CZ3' ' HB3' ' B' ' 304' ' ' GLU . 13.2 p-90 -73.29 -5.44 39.57 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 112.836 0.68 . . . . 0.0 112.836 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 304' ' ' GLU . . . . . 0.403 ' HB3' ' CZ3' ' B' ' 303' ' ' TRP . 1.5 pm0 -107.54 158.5 17.17 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 118.336 0.516 . . . . 0.0 110.716 179.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 305' ' ' THR . . . . . . . . . . . . . 4.3 m -124.77 130.94 53.38 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.189 -0.46 . . . . 17.879999999999999 110.731 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 306' ' ' TRP . . . . . 0.407 ' CH2' ' HG3' ' A' ' 51' ' ' GLN . 77.2 m95 -91.05 110.84 22.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.92 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 307' ' ' VAL . . . . . 0.461 HG12 HG13 ' A' ' 83' ' ' VAL . 16.8 m . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.217 -0.897 . . . . 16.109999999999999 111.076 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.204 0 N-CA-C 112.47 -0.252 . . . . 0.0 112.47 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.5 t -156.79 94.33 1.44 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.795 0.331 . . . . 0.0 110.804 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -92.72 167.73 11.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.789 179.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.01 -41.16 2.46 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.142 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 152.56 104.8 0.26 Allowed Glycine 0 C--N 1.332 0.361 0 C-N-CA 120.751 -0.737 . . . . 0.0 112.828 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 17.9 t-80 -124.85 147.18 48.91 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.695 0.284 . . . . 0.0 110.568 179.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -100.33 147.7 25.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.204 -179.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -144.63 35.73 1.17 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.6 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.478 ' HA ' HG11 ' A' ' 101' ' ' VAL . . . -88.98 -146.09 0.16 Allowed 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.562 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 42.3 mmtm -44.2 107.79 0.1 Allowed 'General case' 0 N--CA 1.485 1.301 0 CA-C-N 118.957 0.799 . . . . 0.0 112.819 -179.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.421 ' O ' HG13 ' A' ' 98' ' ' VAL . 0.9 OUTLIER -96.62 162.1 13.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.627 -179.77 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -132.43 97.78 4.19 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.901 179.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.4 pt -109.3 158.94 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -178.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -116.12 148.65 40.08 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.975 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 20.1 m -138.85 142.41 34.36 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.011 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 74.9 mtm-85 -105.18 120.31 41.22 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.123 -179.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.1 t -111.01 112.91 42.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.974 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -89.19 119.55 29.78 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.676 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.47 ' HE2' HD11 ' A' ' 23' ' ' LEU . 20.1 mttt -75.03 118.0 17.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.046 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -169.37 86.89 0.61 Allowed Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.56 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -81.61 -18.45 24.93 Favored 'Cis proline' 0 C--N 1.363 1.294 0 CA-C-N 119.384 0.816 . . . . 0.0 113.408 0.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -136.42 -175.97 4.18 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 120.695 0.283 . . . . 0.0 111.1 -179.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.47 HD11 ' HE2' ' A' ' 19' ' ' LYS . 3.7 mp -62.36 -56.96 13.33 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.685 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.562 ' O ' HG13 ' A' ' 50' ' ' VAL . . . 100.9 35.53 4.25 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.762 -0.732 . . . . 0.0 114.318 178.566 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.468 ' O ' HG22 ' B' ' 307' ' ' VAL . 36.3 p90 -159.74 153.75 23.27 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 117.283 0.541 . . . . 0.0 110.915 179.019 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.405 ' HB3' ' CD2' ' B' ' 306' ' ' TRP . 2.2 p -105.93 145.12 31.7 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.148 0.499 . . . . 0.0 112.023 -178.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.602 HD11 HG22 ' A' ' 83' ' ' VAL . 31.2 pt -122.59 149.92 26.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.357 178.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.7 m -144.67 -176.67 5.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.786 0.326 . . . . 0.0 110.93 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.09 -146.47 22.99 Favored Glycine 0 C--N 1.332 0.319 0 C-N-CA 120.908 -0.663 . . . . 0.0 113.086 179.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.41 162.46 31.61 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.102 -179.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.46 HG22 ' HB2' ' A' ' 43' ' ' ASP . 23.6 t -76.54 92.02 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 CA-C-O 121.236 0.541 . . . . 0.0 110.479 -179.208 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 100.4 8.18 50.25 Favored Glycine 0 CA--C 1.531 1.052 0 CA-C-N 115.32 -0.854 . . . . 0.0 113.487 -179.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -83.51 -161.33 31.4 Favored Glycine 0 C--N 1.343 0.944 0 CA-C-N 117.719 0.76 . . . . 0.0 113.248 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 91.4 mtt-85 -64.24 -27.37 69.0 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -179.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 90.36 167.55 41.97 Favored Glycine 0 C--N 1.337 0.62 0 C-N-CA 120.636 -0.792 . . . . 0.0 113.165 179.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 12.1 m-80 -125.71 144.8 49.41 Favored Pre-proline 0 CA--C 1.536 0.422 0 C-N-CA 122.131 0.173 . . . . 0.0 110.712 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_endo -83.69 2.57 8.23 Favored 'Trans proline' 0 C--N 1.356 0.968 0 C-N-CA 121.865 1.71 . . . . 0.0 113.615 179.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -99.99 -39.5 8.11 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.017 0.437 . . . . 0.0 110.453 179.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 5.1 ppt_? -90.92 128.77 46.64 Favored Pre-proline 0 N--CA 1.469 0.513 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.931 -179.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -89.02 -22.24 1.1 Allowed 'Trans proline' 0 C--N 1.359 1.111 0 C-N-CA 122.325 2.017 . . . . 0.0 113.408 179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -155.41 18.91 0.41 Allowed 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.986 0.735 . . . . 0.0 112.986 -179.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -90.24 118.03 29.45 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 122.188 -0.32 . . . . 0.0 110.828 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.46 ' HB2' HG22 ' A' ' 31' ' ' VAL . 3.1 p30 -89.61 40.64 1.0 Allowed 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -179.08 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -109.7 -155.63 15.88 Favored Glycine 0 C--N 1.336 0.57 0 C-N-CA 120.998 -0.62 . . . . 0.0 112.86 179.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.6 mm -122.13 137.77 54.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 N-CA-C 110.504 -0.184 . . . . 0.0 110.504 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -129.88 148.74 51.78 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.68 0.276 . . . . 0.0 111.282 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.673 HG22 HD11 ' A' ' 66' ' ' ILE . 19.8 t -94.45 77.13 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-O 121.007 0.432 . . . . 0.0 110.99 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.419 HG23 ' N ' ' A' ' 49' ' ' ARG . 9.4 t -37.85 -53.68 1.29 Allowed 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 -178.5 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.419 ' N ' HG23 ' A' ' 48' ' ' THR . 0.3 OUTLIER -159.11 177.88 10.63 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 118.273 0.488 . . . . 0.0 112.235 -179.826 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.562 HG13 ' O ' ' A' ' 24' ' ' GLY . 7.5 t -130.0 148.06 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.944 -179.412 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.428 ' HG2' ' CH2' ' B' ' 306' ' ' TRP . 8.3 mm-40 -96.02 -68.07 0.07 OUTLIER Pre-proline 0 CA--C 1.536 0.416 0 C-N-CA 121.366 -0.134 . . . . 0.0 111.049 179.536 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -80.39 121.9 4.43 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 121.811 1.674 . . . . 0.0 111.955 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -79.6 64.7 4.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.936 0.398 . . . . 0.0 111.28 -179.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -157.83 -67.28 0.01 OUTLIER Glycine 0 CA--C 1.529 0.962 0 C-N-CA 120.668 -0.777 . . . . 0.0 113.547 -179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -57.96 -73.74 0.03 OUTLIER 'Trans proline' 0 C--N 1.357 0.975 0 C-N-CA 122.183 1.922 . . . . 0.0 113.52 -178.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -112.24 47.95 1.03 Allowed 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.189 0.518 . . . . 0.0 111.393 -179.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 95.4 p -107.77 -50.08 3.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.515 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 10.4 mmtm -80.38 -9.96 59.75 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.831 -0.622 . . . . 0.0 112.487 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.2 mp -96.23 -56.69 2.55 Favored 'General case' 0 C--N 1.342 0.25 0 CA-C-N 118.106 0.412 . . . . 0.0 111.184 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.735 HD23 HG21 ' A' ' 97' ' ' ILE . 1.1 mt -92.66 146.23 23.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.326 -179.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -112.49 140.83 24.24 Favored Pre-proline 0 CA--C 1.535 0.373 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.52 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -57.07 125.87 20.34 Favored 'Trans proline' 0 C--N 1.356 0.923 0 C-N-CA 121.716 1.61 . . . . 0.0 112.242 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 92.45 19.82 37.04 Favored Glycine 0 CA--C 1.523 0.539 0 C-N-CA 120.948 -0.644 . . . . 0.0 113.336 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 47.8 m-20 -93.69 155.34 17.31 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-N 117.237 0.518 . . . . 0.0 110.047 179.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 58.8 tttp -100.07 125.54 46.16 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.92 0.39 . . . . 0.0 111.753 -179.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.673 HD11 HG22 ' A' ' 47' ' ' VAL . 44.4 mt -89.81 120.48 38.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.077 -0.51 . . . . 0.0 109.973 179.325 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 19.3 mm -95.86 -41.34 11.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -178.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.751 ' HB3' HD12 ' A' ' 96' ' ' ILE . 0.2 OUTLIER -149.48 153.9 37.97 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 112.2 0.445 . . . . 0.0 112.2 -178.13 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.484 ' HB3' ' CE1' ' A' ' 74' ' ' PHE . . . -142.45 123.27 14.32 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.856 -179.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.419 ' HB2' ' CZ ' ' A' ' 89' ' ' PHE . 28.4 m-20 41.55 37.72 0.75 Allowed 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 178.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 96.11 -16.73 60.58 Favored Glycine 0 CA--C 1.525 0.662 0 C-N-CA 120.843 -0.694 . . . . 0.0 113.643 179.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 53.8 m-85 -91.35 122.62 34.11 Favored 'General case' 0 C--O 1.231 0.108 0 CA-C-N 117.565 0.683 . . . . 0.0 110.66 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 8.8 m -71.47 131.43 43.3 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.978 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.484 ' CE1' ' HB3' ' A' ' 69' ' ' ALA . 4.6 m-85 -105.6 14.37 28.57 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 112.292 0.478 . . . . 0.0 112.292 -179.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 7.0 tp -92.04 126.13 44.63 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 CA-C-O 120.998 0.428 . . . . 0.0 111.096 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 61.46 70.41 0.6 Allowed 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 121.151 0.5 . . . . 0.0 110.845 -179.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 7.1 pt -148.66 164.24 4.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.984 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -81.35 143.14 32.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.458 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -50.99 -52.1 46.14 Favored 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -179.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -53.47 -27.92 34.98 Favored Glycine 0 CA--C 1.526 0.733 0 C-N-CA 121.248 -0.501 . . . . 0.0 113.05 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 49.7 tp60 -74.37 -38.71 63.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.092 0.473 . . . . 0.0 110.124 179.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.43 -53.75 32.05 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.597 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.602 HG22 HD11 ' A' ' 27' ' ' ILE . 20.0 t -58.5 -43.39 86.82 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.417 -179.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.7 t -60.46 -41.29 93.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.392 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.468 ' O ' HG22 ' A' ' 88' ' ' THR . 26.8 mt -65.17 -45.97 82.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.518 -179.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.514 HD12 HD13 ' A' ' 27' ' ' ILE . 32.9 mt -63.15 -38.45 91.23 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.192 -0.458 . . . . 0.0 112.012 -179.148 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 19.1 mmtt -66.48 -40.3 89.23 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.451 0.538 . . . . 0.0 112.451 -178.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.468 HG22 ' O ' ' A' ' 85' ' ' LEU . 7.8 t -72.18 -27.88 62.85 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.674 0.99 . . . . 0.0 113.674 -177.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.43 ' CD2' ' HA ' ' A' ' 86' ' ' LEU . 12.6 m-85 -49.09 173.66 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -178.416 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -87.84 -140.25 0.11 Allowed 'General case' 0 CA--C 1.552 1.026 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.204 -179.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 33.1 m120 -82.58 -61.82 1.78 Allowed 'General case' 0 C--N 1.348 0.538 0 CA-C-N 119.251 0.932 . . . . 0.0 111.526 -179.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -84.09 129.03 34.92 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.061 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.3 t -123.29 120.26 59.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.511 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -92.54 91.71 7.72 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.48 -179.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 2.5 mt -92.5 155.15 18.02 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.837 0.351 . . . . 0.0 111.419 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.751 HD12 ' HB3' ' A' ' 68' ' ' GLN . 72.9 mt -115.36 127.29 72.99 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.487 178.395 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.735 HG21 HD23 ' A' ' 60' ' ' LEU . 45.3 pt -123.76 162.37 24.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-O 120.902 0.382 . . . . 0.0 111.534 -178.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.421 HG13 ' O ' ' A' ' 11' ' ' GLN . 36.7 t -136.73 139.8 44.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.5 -179.287 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -110.47 106.28 15.54 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.665 178.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -60.18 130.08 44.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.882 0.373 . . . . 0.0 111.578 -178.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.478 HG11 ' HA ' ' A' ' 9' ' ' ALA . 14.9 m -97.47 156.94 3.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.995 179.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 56.7 p -162.42 102.01 1.07 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.948 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 24.0 t . . . . . 0 C--O 1.248 0.993 0 CA-C-O 118.284 -0.865 . . . . 0.0 110.903 179.964 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 301' ' ' THR . . . . . . . . . . . . . 12.8 p . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.748 0.309 . . . . 0.0 111.165 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 302' ' ' GLY . . . . . . . . . . . . . . . -100.67 -70.51 0.91 Allowed Glycine 0 CA--C 1.518 0.254 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.884 -179.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 303' ' ' TRP . . . . . . . . . . . . . 11.8 p-90 -147.67 20.73 1.16 Allowed 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -123.26 172.54 8.55 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 121.069 0.461 . . . . 0.0 111.346 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 305' ' ' THR . . . . . . . . . . . . . 6.4 m -139.32 119.44 13.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.801 -0.636 . . . . 17.879999999999999 110.372 179.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 306' ' ' TRP . . . . . 0.428 ' CH2' ' HG2' ' A' ' 51' ' ' GLN . 96.5 m95 -85.71 114.6 22.81 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.109 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 307' ' ' VAL . . . . . 0.468 HG22 ' O ' ' A' ' 25' ' ' PHE . 18.0 m . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.285 -0.864 . . . . 16.109999999999999 111.142 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.198 0 N-CA-C 112.544 -0.222 . . . . 0.0 112.544 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.0 p -114.07 33.29 5.33 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.853 0.359 . . . . 0.0 110.951 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 74.0 m80 -99.68 123.09 43.6 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.821 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.11 177.1 5.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.797 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 158.85 -149.05 18.93 Favored Glycine 0 C--N 1.331 0.304 0 C-N-CA 120.972 -0.632 . . . . 0.0 112.486 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 10.6 m-70 -147.77 -72.33 0.21 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.74 0.305 . . . . 0.0 110.887 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -109.72 154.09 23.39 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.939 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 53.5 mt -143.31 163.56 32.66 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.089 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -130.84 82.18 2.04 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.968 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -162.61 177.8 9.1 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.588 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.427 ' O ' HG13 ' A' ' 98' ' ' VAL . 10.5 pt20 -152.33 143.61 23.27 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.596 -0.275 . . . . 0.0 111.249 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -133.34 105.14 6.79 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.806 0.336 . . . . 0.0 111.205 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 19.7 pt -117.05 156.15 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 CA-C-N 116.061 -0.518 . . . . 0.0 112.205 -179.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 29.7 mtm180 -90.29 167.47 12.64 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -178.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.475 HG13 ' HB3' ' A' ' 59' ' ' LEU . 77.6 t -147.43 122.97 2.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.977 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.414 ' HG2' HG22 ' A' ' 92' ' ' THR . 20.8 ttt180 -110.42 112.85 25.05 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.66 179.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.2 t -120.21 125.95 74.75 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.089 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.805 ' CG ' HG23 ' A' ' 92' ' ' THR . 28.9 mt-10 -102.05 128.51 48.48 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.106 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.426 ' HD2' HD12 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -72.81 114.6 11.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.962 179.919 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -174.95 83.35 0.32 Allowed Pre-proline 0 CA--C 1.537 0.471 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.087 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -83.38 -23.82 12.29 Favored 'Cis proline' 0 C--N 1.362 1.283 0 CA-C-N 119.445 0.838 . . . . 0.0 112.868 0.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.1 mp0 -130.68 -177.4 4.34 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.755 0.312 . . . . 0.0 111.405 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.426 HD12 ' HD2' ' A' ' 19' ' ' LYS . 3.3 mp -62.93 -59.83 4.29 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.978 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.464 ' O ' HG13 ' A' ' 50' ' ' VAL . . . 115.7 29.91 2.32 Favored Glycine 0 C--N 1.335 0.499 0 C-N-CA 120.925 -0.655 . . . . 0.0 113.771 179.365 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.443 ' O ' HG22 ' B' ' 307' ' ' VAL . 51.2 p90 -169.48 149.21 3.93 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 117.37 0.585 . . . . 0.0 111.521 179.452 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.3 p -100.44 150.44 22.64 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.87 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.681 HD11 HG22 ' A' ' 83' ' ' VAL . 38.3 pt -120.27 148.76 23.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.196 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 78.1 p -142.9 160.25 40.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.859 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 108.14 -152.57 16.95 Favored Glycine 0 C--N 1.332 0.338 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.94 179.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 104.0 157.01 24.14 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 121.096 -0.573 . . . . 0.0 112.264 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.5 t -78.18 100.38 3.25 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-O 120.925 0.393 . . . . 0.0 110.853 -179.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 93.48 7.68 61.66 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 121.047 -0.597 . . . . 0.0 113.709 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -88.63 -156.07 30.68 Favored Glycine 0 C--N 1.34 0.755 0 CA-C-N 117.746 0.773 . . . . 0.0 112.958 -179.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 10.4 mmt180 -61.13 -27.52 68.45 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 111.606 0.224 . . . . 0.0 111.606 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 103.71 154.4 23.83 Favored Glycine 0 C--N 1.335 0.512 0 C-N-CA 120.881 -0.676 . . . . 0.0 113.059 179.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -112.15 129.96 23.76 Favored Pre-proline 0 N--CA 1.468 0.472 0 C-N-CA 122.074 0.149 . . . . 0.0 110.618 179.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -93.42 34.19 0.22 Allowed 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 122.316 2.011 . . . . 0.0 113.101 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -110.34 -51.2 2.89 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.786 0.327 . . . . 0.0 111.156 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 45.3 mtt-85 -127.13 158.29 69.55 Favored Pre-proline 0 CA--C 1.535 0.366 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.741 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -90.71 -57.67 0.02 OUTLIER 'Trans proline' 0 C--N 1.357 1.005 0 C-N-CA 122.219 1.946 . . . . 0.0 113.977 -178.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -79.35 -8.07 58.81 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -179.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -101.58 114.1 27.82 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 118.024 0.375 . . . . 0.0 110.418 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -105.73 38.81 1.9 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.379 -179.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -85.86 -156.3 27.17 Favored Glycine 0 CA--C 1.52 0.36 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.505 179.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.5 mm -110.57 130.81 63.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 CA-C-O 120.531 0.205 . . . . 0.0 110.852 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -125.99 150.97 47.66 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 120.827 0.346 . . . . 0.0 111.43 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.447 HG21 HD22 ' A' ' 60' ' ' LEU . 21.8 t -89.1 81.73 1.97 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.185 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.422 HG23 ' N ' ' A' ' 49' ' ' ARG . 9.4 t -43.14 -55.41 3.92 Favored 'General case' 0 CA--C 1.546 0.806 0 N-CA-C 114.035 1.124 . . . . 0.0 114.035 -178.268 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.422 ' N ' HG23 ' A' ' 48' ' ' THR . 11.6 ptm180 -161.49 156.95 24.22 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 118.425 0.557 . . . . 0.0 112.209 -179.588 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.464 HG13 ' O ' ' A' ' 24' ' ' GLY . 18.6 t -109.23 146.62 14.53 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.576 179.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.411 ' CB ' ' HD3' ' A' ' 52' ' ' PRO . 0.8 OUTLIER -102.77 -71.34 0.03 OUTLIER Pre-proline 0 CA--C 1.54 0.573 0 CA-C-O 119.437 -0.316 . . . . 0.0 111.311 179.9 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.411 ' HD3' ' CB ' ' A' ' 51' ' ' GLN . 53.9 Cg_endo -83.45 121.45 3.01 Favored 'Trans proline' 0 C--N 1.36 1.143 0 C-N-CA 121.532 1.488 . . . . 0.0 112.104 179.294 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.74 64.51 3.75 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.165 0.507 . . . . 0.0 110.963 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -139.01 -72.07 0.05 OUTLIER Glycine 0 CA--C 1.528 0.862 0 CA-C-N 115.672 -0.694 . . . . 0.0 112.84 179.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -63.76 -59.59 0.2 Allowed 'Trans proline' 0 C--N 1.357 1.009 0 C-N-CA 122.119 1.879 . . . . 0.0 113.585 -179.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.468 ' HB1' HD12 ' A' ' 60' ' ' LEU . . . -108.56 45.25 1.04 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.055 0.455 . . . . 0.0 111.426 -179.159 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 89.3 p -84.71 -60.98 1.9 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.04 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 13.6 mmmt -90.49 0.54 57.28 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -179.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.475 ' HB3' HG13 ' A' ' 15' ' ' VAL . 60.7 mt -95.48 -65.34 0.98 Allowed 'General case' 0 C--N 1.341 0.214 0 CA-C-N 118.254 0.479 . . . . 0.0 111.826 -179.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.569 HD23 HG21 ' A' ' 97' ' ' ILE . 3.4 mt -95.64 139.84 31.31 Favored 'General case' 0 C--O 1.23 0.048 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 -179.473 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 4.7 pp0? -121.4 151.67 56.68 Favored Pre-proline 0 CA--C 1.535 0.369 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.16 178.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -54.43 114.27 1.75 Allowed 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 121.818 1.679 . . . . 0.0 112.983 -179.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 118.12 -2.8 16.66 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 121.096 -0.573 . . . . 0.0 114.367 179.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -67.77 -177.66 0.82 Allowed 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 117.831 0.816 . . . . 0.0 111.873 -179.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 38.0 tttt -145.22 126.57 14.88 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.705 179.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.604 ' N ' HD12 ' A' ' 66' ' ' ILE . 3.7 mp -89.63 117.82 33.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 CA-C-O 120.832 0.349 . . . . 0.0 110.202 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 35.4 mt -106.63 -26.52 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.846 -179.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.678 ' HB3' HD13 ' A' ' 96' ' ' ILE . 17.2 tt0 -154.61 149.43 26.63 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.934 0.397 . . . . 0.0 111.77 -179.652 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -149.33 121.24 8.18 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.486 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 48.1 m-20 48.35 35.66 5.99 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 179.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 86.88 10.63 71.95 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 120.973 -0.632 . . . . 0.0 113.626 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -112.16 120.91 43.4 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 117.692 0.746 . . . . 0.0 109.811 179.533 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 18.8 m -71.53 128.78 36.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.418 -179.075 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -106.19 13.89 28.33 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 116.172 -0.467 . . . . 0.0 112.125 179.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 6.4 tp -90.83 124.19 43.3 Favored 'Isoleucine or valine' 0 C--N 1.34 0.169 0 O-C-N 122.047 -0.408 . . . . 0.0 110.743 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 63.18 72.75 0.47 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.929 -179.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 20.1 pt -146.95 166.06 6.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.795 179.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -81.84 154.78 25.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.4 -0.363 . . . . 0.0 110.995 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 16.1 t60 -54.6 -56.8 15.21 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.899 -179.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -53.05 -33.2 44.05 Favored Glycine 0 C--N 1.336 0.532 0 C-N-CA 121.257 -0.497 . . . . 0.0 113.363 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 6.2 tp60 -65.95 -38.91 89.84 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.036 0.446 . . . . 0.0 110.148 179.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.3 -63.63 1.02 Allowed 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.684 179.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.681 HG22 HD11 ' A' ' 27' ' ' ILE . 11.5 t -55.29 -22.87 12.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 N-CA-C 111.93 0.344 . . . . 0.0 111.93 -179.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.461 ' O ' HG22 ' A' ' 88' ' ' THR . 18.0 m -77.4 -42.28 36.88 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.747 0.308 . . . . 0.0 111.101 -179.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 25.5 mt -65.71 -42.06 91.58 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.665 -179.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.422 ' HA ' ' CD2' ' A' ' 89' ' ' PHE . 53.4 mt -66.73 -47.98 70.6 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.638 -179.29 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.412 ' HD2' HG12 ' A' ' 83' ' ' VAL . 70.7 mttt -60.66 -45.9 92.36 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -179.199 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.461 HG22 ' O ' ' A' ' 84' ' ' SER . 11.6 t -68.82 -27.7 66.08 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -177.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.422 ' CD2' ' HA ' ' A' ' 86' ' ' LEU . 6.0 m-85 -46.88 174.7 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 113.61 0.967 . . . . 0.0 113.61 -178.073 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -85.79 -143.69 0.1 Allowed 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.79 -179.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -81.15 -70.71 0.51 Allowed 'General case' 0 C--N 1.347 0.471 0 CA-C-N 119.016 0.825 . . . . 0.0 111.669 -179.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.805 HG23 ' CG ' ' A' ' 18' ' ' GLU . 0.3 OUTLIER -79.2 129.26 34.27 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 120.766 0.317 . . . . 0.0 110.448 -179.874 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.7 t -121.63 120.07 60.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.976 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -98.08 105.46 17.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.934 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.574 ' C ' HD12 ' A' ' 96' ' ' ILE . 4.9 mp -105.29 164.38 11.89 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 120.977 0.418 . . . . 0.0 111.541 -179.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.678 HD13 ' HB3' ' A' ' 68' ' ' GLN . 3.1 mp -120.5 131.77 71.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.089 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.569 HG21 HD23 ' A' ' 60' ' ' LEU . 46.0 pt -126.82 166.45 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.196 0 CA-C-O 120.967 0.413 . . . . 0.0 111.809 -178.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.427 HG13 ' O ' ' A' ' 11' ' ' GLN . 98.9 t -143.07 143.78 24.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.276 -179.043 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.1 105.06 14.02 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -59.19 119.01 6.56 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 -178.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 19.4 t -97.9 112.16 29.34 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.75 179.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 69.9 p -92.99 83.52 4.73 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.863 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 51.3 p . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.319 -0.848 . . . . 0.0 110.869 179.994 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 301' ' ' THR . . . . . . . . . . . . . 3.4 m . . . . . 0 N--CA 1.489 1.484 0 N-CA-C 111.688 0.255 . . . . 0.0 111.688 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 302' ' ' GLY . . . . . . . . . . . . . . . 162.56 -108.79 0.36 Allowed Glycine 0 C--N 1.333 0.406 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.417 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 303' ' ' TRP . . . . . . . . . . . . . 20.7 p-90 -165.28 -42.04 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 111.649 0.24 . . . . 0.0 111.649 179.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 4.0 pm0 -61.9 148.91 41.98 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.736 0.303 . . . . 0.0 111.343 -179.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 305' ' ' THR . . . . . . . . . . . . . 5.6 m -127.41 121.06 29.87 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.201 -0.454 . . . . 17.879999999999999 110.803 179.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 306' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -85.28 106.91 17.03 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.74 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 307' ' ' VAL . . . . . 0.594 HG12 HG13 ' A' ' 83' ' ' VAL . 18.4 m . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.281 -0.866 . . . . 16.109999999999999 111.135 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.159 0 N-CA-C 112.525 -0.23 . . . . 0.0 112.525 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.7 t -148.68 120.96 8.39 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.83 0.348 . . . . 0.0 110.815 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 24.0 m80 -93.69 140.22 29.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.936 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -111.98 177.48 4.63 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.893 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -65.28 176.13 13.62 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.426 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 51.6 p-80 -87.8 77.44 8.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.969 0.414 . . . . 0.0 110.892 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -141.78 28.6 1.76 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.149 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 11.1 mt -102.17 -44.26 5.49 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.061 0.458 . . . . 0.0 110.152 179.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -87.63 92.89 9.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.263 179.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -170.99 172.27 5.54 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.681 -179.18 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -145.33 96.33 2.82 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.706 0.288 . . . . 0.0 110.934 -179.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -98.63 131.75 44.58 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -179.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.629 ' N ' HD13 ' A' ' 13' ' ' ILE . 0.2 OUTLIER -151.75 164.31 2.33 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.577 179.447 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.75 ' HG3' HD13 ' A' ' 96' ' ' ILE . 1.2 ttm180 -118.8 156.82 28.74 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 111.783 0.29 . . . . 0.0 111.783 -179.548 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.464 HG11 ' HB3' ' A' ' 59' ' ' LEU . 29.4 m -143.51 153.61 16.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -115.06 118.25 32.87 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.858 -179.442 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.7 t -114.65 124.24 71.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.368 178.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.675 ' HG2' HG23 ' A' ' 92' ' ' THR . 43.3 mt-10 -102.83 127.84 49.84 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.03 0.443 . . . . 0.0 111.577 -179.367 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.63 118.23 12.23 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.252 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -175.89 78.12 0.29 Allowed Pre-proline 0 CA--C 1.541 0.603 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.703 179.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -86.76 -18.67 20.56 Favored 'Cis proline' 0 C--N 1.363 1.311 0 CA-C-N 119.331 0.797 . . . . 0.0 113.231 0.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -136.59 -178.0 4.98 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.794 0.33 . . . . 0.0 111.592 -179.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.412 ' HB3' ' CE2' ' A' ' 25' ' ' PHE . 4.2 mp -63.99 -56.95 11.41 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.563 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 107.16 29.38 4.57 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 120.885 -0.674 . . . . 0.0 113.937 178.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.412 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 45.2 p90 -159.03 145.41 16.82 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 117.464 0.632 . . . . 0.0 111.21 179.259 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 8.6 p -96.1 148.9 22.21 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.647 -179.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.591 HD11 HG22 ' A' ' 83' ' ' VAL . 25.1 pt -124.52 150.35 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.109 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.348 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 47.9 t -138.38 155.64 48.34 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.298 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 158.5 -99.18 0.18 Allowed Glycine 0 C--N 1.334 0.439 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.519 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 50.23 110.6 0.01 OUTLIER Glycine 0 CA--C 1.527 0.831 0 N-CA-C 115.38 0.912 . . . . 0.0 115.38 178.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 20.4 t -77.8 91.29 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.127 0 O-C-N 122.547 -0.384 . . . . 0.0 110.837 179.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 91.69 -4.79 79.54 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 120.821 -0.704 . . . . 0.0 114.149 179.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -111.26 9.51 28.87 Favored Glycine 0 C--N 1.342 0.908 0 CA-C-N 117.932 0.866 . . . . 0.0 114.282 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -178.35 -77.29 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 117.736 0.768 . . . . 0.0 109.626 178.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 113.13 152.81 11.21 Favored Glycine 0 C--N 1.335 0.491 0 CA-C-N 115.919 -0.582 . . . . 0.0 113.124 179.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -125.76 136.3 28.19 Favored Pre-proline 0 CA--C 1.535 0.37 0 N-CA-C 110.345 -0.243 . . . . 0.0 110.345 179.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -93.75 28.94 0.29 Allowed 'Trans proline' 0 C--N 1.356 0.947 0 C-N-CA 122.422 2.082 . . . . 0.0 113.514 -179.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -108.03 -49.75 3.16 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.692 0.282 . . . . 0.0 111.203 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 14.2 mmm180 -117.15 135.31 23.07 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.004 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -83.57 -44.56 0.07 OUTLIER 'Trans proline' 0 C--N 1.359 1.104 0 C-N-CA 121.898 1.732 . . . . 0.0 112.81 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -93.9 -13.4 27.21 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -101.35 118.46 37.02 Favored 'General case' 0 N--CA 1.462 0.139 0 CA-C-N 117.864 0.302 . . . . 0.0 110.318 179.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -108.44 42.39 1.4 Allowed 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 120.978 0.418 . . . . 0.0 111.364 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -88.83 -156.32 31.25 Favored Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.269 179.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 27.7 mm -109.97 135.44 48.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-N 116.678 0.239 . . . . 0.0 110.843 179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.429 ' N ' ' CD1' ' A' ' 46' ' ' PHE . 4.5 m-85 -132.7 148.24 52.34 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 120.681 0.277 . . . . 0.0 111.42 -179.396 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.539 HG21 HD22 ' A' ' 60' ' ' LEU . 16.8 t -92.88 73.37 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.668 0 N-CA-C 112.324 0.49 . . . . 0.0 112.324 -179.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.439 HG23 ' N ' ' A' ' 49' ' ' ARG . 8.9 t -34.31 -53.13 0.5 Allowed 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 -178.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.439 ' N ' HG23 ' A' ' 48' ' ' THR . 0.5 OUTLIER -160.31 177.39 10.67 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 121.87 -0.519 . . . . 0.0 112.042 -179.636 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 12.1 t -132.08 151.35 34.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.991 -179.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -105.31 -68.24 0.04 OUTLIER Pre-proline 0 CA--C 1.538 0.517 0 N-CA-C 111.768 0.285 . . . . 0.0 111.768 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -79.02 119.97 4.47 Favored 'Trans proline' 0 C--N 1.357 0.983 0 C-N-CA 121.811 1.674 . . . . 0.0 112.557 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -78.38 66.81 4.03 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.003 0.43 . . . . 0.0 111.629 -179.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -162.19 -66.58 0.02 OUTLIER Glycine 0 CA--C 1.528 0.865 0 C-N-CA 120.718 -0.753 . . . . 0.0 113.522 -179.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.67 -74.46 0.02 OUTLIER 'Trans proline' 0 C--N 1.357 0.993 0 C-N-CA 122.043 1.828 . . . . 0.0 113.469 -178.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -117.21 49.32 1.21 Allowed 'General case' 0 CA--C 1.533 0.29 0 CA-C-O 121.054 0.454 . . . . 0.0 112.122 -178.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 16.7 t -109.22 -58.67 2.0 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 178.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 19.4 tptt -68.35 -10.84 57.76 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.743 178.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.464 ' HB3' HG11 ' A' ' 15' ' ' VAL . 54.1 mt -91.24 -65.14 1.04 Allowed 'General case' 0 C--N 1.343 0.304 0 CA-C-N 118.022 0.374 . . . . 0.0 110.85 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.762 HD23 HG21 ' A' ' 97' ' ' ILE . 1.5 mp -91.92 148.62 22.08 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.958 179.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.4 pm0 -115.18 151.82 46.13 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.985 178.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -57.37 128.53 29.9 Favored 'Trans proline' 0 C--N 1.356 0.962 0 C-N-CA 121.911 1.74 . . . . 0.0 113.041 -179.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 93.86 15.63 48.33 Favored Glycine 0 CA--C 1.524 0.653 0 CA-C-N 115.919 -0.582 . . . . 0.0 113.68 179.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -76.91 -174.49 3.11 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 117.518 0.659 . . . . 0.0 111.064 -179.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 47.0 tttm -141.89 125.11 16.4 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.567 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 60.9 mt -90.54 113.34 26.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.186 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 24.2 mm -90.91 -36.88 8.6 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 CA-C-N 115.936 -0.575 . . . . 0.0 112.077 -178.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.28 145.99 27.34 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.065 0.46 . . . . 0.0 111.172 -179.245 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.416 ' HB3' ' CE1' ' A' ' 74' ' ' PHE . . . -136.97 119.69 16.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.015 179.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.3 m120 45.95 30.04 0.84 Allowed 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 179.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 100.78 -14.21 58.99 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 120.693 -0.765 . . . . 0.0 113.563 -179.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -88.49 153.7 20.94 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 117.506 0.653 . . . . 0.0 110.09 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 12.5 m -101.25 124.62 47.23 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.428 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.416 ' CE1' ' HB3' ' A' ' 69' ' ' ALA . 3.6 m-85 -101.59 17.77 22.0 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -179.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 7.9 tp -92.28 121.17 42.63 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 CA-C-O 120.923 0.392 . . . . 0.0 110.61 179.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 88.4 m-20 62.17 76.47 0.37 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.005 -179.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 23.7 pt -150.01 161.61 4.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.802 179.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -81.25 140.72 34.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.967 0.413 . . . . 0.0 111.396 -179.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -41.49 -49.96 3.96 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -179.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -57.56 -33.36 66.6 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.965 -179.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 36.2 tp60 -69.74 -44.73 69.67 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.826 0.346 . . . . 0.0 111.196 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.92 -63.37 1.13 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.859 -179.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.591 HG22 HD11 ' A' ' 27' ' ' ILE . 24.4 t -50.81 -42.27 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -179.416 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 37.1 m -62.89 -39.53 94.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.735 0.303 . . . . 0.0 111.306 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 16.6 mt -64.75 -49.5 70.56 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.861 -179.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 54.4 mt -65.04 -33.16 75.38 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -178.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 60.3 mttm -76.02 -37.32 58.53 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.188 0.44 . . . . 0.0 112.188 -178.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 12.0 t -73.98 -26.12 60.29 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -178.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -54.94 155.19 4.61 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.145 0.498 . . . . 0.0 111.911 -178.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -63.29 -139.31 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.128 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.489 -178.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -82.01 -66.06 0.93 Allowed 'General case' 0 C--N 1.351 0.658 0 CA-C-N 119.345 0.975 . . . . 0.0 112.251 -178.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.675 HG23 ' HG2' ' A' ' 18' ' ' GLU . 0.0 OUTLIER -76.67 123.49 26.23 Favored 'General case' 0 CA--C 1.528 0.11 0 CA-C-O 120.939 0.399 . . . . 0.0 110.958 -179.308 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.528 ' O ' HD12 ' A' ' 95' ' ' LEU . 18.0 t -114.22 112.2 39.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.634 179.342 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -89.7 112.26 23.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.353 179.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.528 HD12 ' O ' ' A' ' 93' ' ' VAL . 4.6 mp -115.06 154.02 29.63 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 121.115 0.483 . . . . 0.0 112.044 -178.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.75 HD13 ' HG3' ' A' ' 14' ' ' ARG . 17.9 mm -109.38 122.7 64.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.809 178.394 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.762 HG21 HD23 ' A' ' 60' ' ' LEU . 24.6 pt -118.11 157.73 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 CA-C-O 120.685 0.279 . . . . 0.0 111.047 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 21.7 t -142.95 146.82 21.29 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-O 121.06 0.457 . . . . 0.0 111.708 -179.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.3 mmm-85 -111.69 110.38 20.74 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 178.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -67.05 129.41 39.81 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 120.998 0.428 . . . . 0.0 111.568 -179.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 17.1 m -146.39 164.69 8.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.896 179.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 78.0 p -138.2 52.32 1.84 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.314 0.578 . . . . 0.0 110.81 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 17.1 m . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.207 -0.901 . . . . 0.0 110.911 179.986 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 301' ' ' THR . . . . . . . . . . . . . 4.7 m . . . . . 0 N--CA 1.487 1.381 0 CA-C-O 120.68 0.276 . . . . 0.0 111.247 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 302' ' ' GLY . . . . . . . . . . . . . . . 173.39 -64.63 0.12 Allowed Glycine 0 C--N 1.333 0.403 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.692 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 303' ' ' TRP . . . . . . . . . . . . . 47.0 p-90 -76.22 -28.92 57.38 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.49 0.186 . . . . 0.0 111.125 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -91.16 105.53 17.87 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.869 0.366 . . . . 0.0 110.375 179.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 305' ' ' THR . . . . . . . . . . . . . 7.9 m -97.84 131.13 44.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.108 -0.497 . . . . 17.879999999999999 111.201 -179.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 306' ' ' TRP . . . . . . . . . . . . . 92.4 m95 -89.16 106.4 18.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.866 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 307' ' ' VAL . . . . . 0.508 HG12 HG13 ' A' ' 83' ' ' VAL . 16.5 m . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.176 -0.916 . . . . 16.109999999999999 111.094 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.253 0 N-CA-C 112.56 -0.216 . . . . 0.0 112.56 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.4 t -88.52 -34.32 17.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.781 0.324 . . . . 0.0 110.904 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -68.08 169.46 10.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.581 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 55.9 mtm -90.0 -62.89 1.37 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.943 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 92.77 -91.47 1.55 Allowed Glycine 0 C--N 1.331 0.272 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.304 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 24.2 m80 -83.82 173.8 10.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.728 0.299 . . . . 0.0 110.674 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.5 mp0 -82.04 123.26 28.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.808 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.44 ' N ' HD22 ' A' ' 8' ' ' LEU . 4.0 mm? -74.77 100.74 4.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.071 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -93.92 69.01 3.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.272 0.558 . . . . 0.0 110.812 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -165.64 171.42 13.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.528 -179.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -142.77 130.3 21.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.596 -0.275 . . . . 0.0 111.127 -179.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -124.2 102.21 7.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.582 179.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.606 HD13 ' N ' ' A' ' 13' ' ' ILE . 0.1 OUTLIER -126.91 159.31 36.98 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-O 121.071 0.462 . . . . 0.0 111.703 -179.888 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 15.4 ttm-85 -109.32 161.67 15.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.413 -179.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.55 HG13 HD13 ' A' ' 59' ' ' LEU . 21.4 t -139.76 147.78 23.64 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.967 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 7.0 tpp85 -115.75 106.42 13.84 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.706 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.1 t -111.68 127.43 68.85 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.289 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.469 ' HG3' HG23 ' A' ' 92' ' ' THR . 3.9 mp0 -90.42 156.94 17.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.513 179.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -105.7 74.95 1.1 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.074 0.464 . . . . 0.0 110.406 179.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -141.38 85.84 11.52 Favored Pre-proline 0 CA--C 1.538 0.511 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.593 -179.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -85.83 -21.58 15.05 Favored 'Cis proline' 0 C--N 1.363 1.3 0 CA-C-N 119.638 0.906 . . . . 0.0 113.211 0.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -138.04 -176.11 4.33 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.733 0.301 . . . . 0.0 111.351 -179.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.9 mp -64.74 -57.87 7.8 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.048 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.4 ' O ' HG13 ' A' ' 50' ' ' VAL . . . 108.0 32.9 3.15 Favored Glycine 0 C--N 1.337 0.623 0 C-N-CA 120.86 -0.686 . . . . 0.0 113.621 179.087 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 39.9 p90 -165.69 145.62 6.58 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 117.206 0.503 . . . . 0.0 111.044 179.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.5 p -100.71 153.48 19.4 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.536 -179.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 25.6 pt -122.26 150.11 25.77 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.829 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 85.0 p -145.03 161.25 39.86 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 121.222 -0.191 . . . . 0.0 111.427 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 119.3 -91.62 0.51 Allowed Glycine 0 C--N 1.34 0.752 0 C-N-CA 120.911 -0.661 . . . . 0.0 114.191 178.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.469 ' H ' HD13 ' A' ' 45' ' ' ILE . . . 67.32 -133.47 30.69 Favored Glycine 0 CA--C 1.521 0.416 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.38 -179.308 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 23.9 t -151.4 81.38 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 CA-C-O 121.141 0.496 . . . . 0.0 109.832 179.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.56 15.15 44.57 Favored Glycine 0 CA--C 1.528 0.901 0 CA-C-N 115.753 -0.658 . . . . 0.0 113.161 -178.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -93.98 -143.02 12.79 Favored Glycine 0 C--N 1.338 0.691 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.292 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 5.1 mmt85 -54.29 -26.17 27.78 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 112.497 0.554 . . . . 0.0 112.497 -179.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 85.47 160.31 32.94 Favored Glycine 0 C--N 1.336 0.582 0 C-N-CA 120.768 -0.73 . . . . 0.0 113.492 179.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -121.51 136.9 26.33 Favored Pre-proline 0 N--CA 1.466 0.333 0 N-CA-C 110.491 -0.189 . . . . 0.0 110.491 179.396 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -92.83 26.96 0.37 Allowed 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 122.224 1.949 . . . . 0.0 113.127 -179.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 62.2 m-85 -102.24 -49.78 3.81 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.761 0.315 . . . . 0.0 111.008 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -124.51 140.37 35.16 Favored Pre-proline 0 CA--C 1.534 0.364 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.783 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -83.76 -41.95 0.09 OUTLIER 'Trans proline' 0 C--N 1.359 1.092 0 C-N-CA 122.028 1.819 . . . . 0.0 113.201 -179.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -93.97 -13.08 27.42 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -179.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -103.54 120.69 41.37 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 117.888 0.313 . . . . 0.0 111.358 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -104.35 16.86 25.27 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -57.77 -167.29 0.12 Allowed Glycine 0 C--N 1.338 0.673 0 C-N-CA 120.637 -0.792 . . . . 0.0 113.033 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.469 HD13 ' H ' ' A' ' 30' ' ' GLY . 20.6 mm -104.28 125.97 59.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 179.043 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -122.66 146.52 47.39 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 120.796 0.332 . . . . 0.0 111.428 -179.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.646 ' CG2' HD11 ' A' ' 66' ' ' ILE . 34.2 t -89.89 73.02 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-O 121.25 0.548 . . . . 0.0 110.252 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.0 t -36.14 -53.59 0.8 Allowed 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 114.674 1.361 . . . . 0.0 114.674 -178.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 7.7 ptm180 -158.64 168.77 25.98 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.198 0.523 . . . . 0.0 112.321 -179.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.4 HG13 ' O ' ' A' ' 24' ' ' GLY . 14.4 t -126.39 148.68 31.08 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.372 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.419 ' HG2' ' CH2' ' B' ' 306' ' ' TRP . 7.1 mm-40 -105.25 -68.81 0.03 OUTLIER Pre-proline 0 CA--C 1.538 0.514 0 N-CA-C 111.706 0.261 . . . . 0.0 111.706 -179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -79.26 120.19 4.44 Favored 'Trans proline' 0 C--N 1.357 0.998 0 C-N-CA 121.8 1.667 . . . . 0.0 112.487 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -78.5 66.92 4.16 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-O 121.03 0.443 . . . . 0.0 111.064 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -160.91 -65.87 0.02 OUTLIER Glycine 0 CA--C 1.527 0.836 0 C-N-CA 120.721 -0.752 . . . . 0.0 113.548 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -56.27 -61.12 0.37 Allowed 'Trans proline' 0 C--N 1.356 0.973 0 C-N-CA 122.229 1.953 . . . . 0.0 113.513 -178.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.842 ' HB1' HD12 ' A' ' 60' ' ' LEU . . . -136.21 58.56 1.74 Allowed 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 121.206 0.527 . . . . 0.0 111.933 -178.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.8 t -119.3 -58.23 1.94 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.898 179.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 25.3 tptp -64.56 -16.08 62.05 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.743 178.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.55 HD13 HG13 ' A' ' 15' ' ' VAL . 39.5 mt -98.2 -49.73 4.61 Favored 'General case' 0 C--N 1.341 0.221 0 CA-C-O 120.805 0.336 . . . . 0.0 111.441 -179.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.842 HD12 ' HB1' ' A' ' 56' ' ' ALA . 41.9 mt -90.99 148.76 22.18 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.978 0.418 . . . . 0.0 111.802 -179.316 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -116.04 137.25 23.25 Favored Pre-proline 0 CA--C 1.536 0.42 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.235 179.107 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -52.4 126.57 21.06 Favored 'Trans proline' 0 C--N 1.356 0.971 0 C-N-CA 122.011 1.808 . . . . 0.0 113.044 -179.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 95.33 18.1 34.58 Favored Glycine 0 CA--C 1.521 0.428 0 C-N-CA 121.045 -0.598 . . . . 0.0 113.807 179.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -86.18 144.64 27.37 Favored 'General case' 0 C--N 1.339 0.122 0 CA-C-N 117.625 0.713 . . . . 0.0 110.679 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -92.89 129.57 38.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.566 -179.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.646 HD11 ' CG2' ' A' ' 47' ' ' VAL . 2.8 mm -88.08 111.95 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 25.9 mm -90.63 -44.62 14.76 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -178.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.815 ' HB3' HD12 ' A' ' 96' ' ' ILE . 20.4 tt0 -148.45 150.85 34.18 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.201 0.524 . . . . 0.0 112.403 -178.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.526 ' HB3' ' CE1' ' A' ' 74' ' ' PHE . . . -142.46 124.32 15.17 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.079 179.53 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.3 m120 45.13 27.64 0.33 Allowed 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 178.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 99.78 -8.84 59.97 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 120.808 -0.711 . . . . 0.0 114.128 179.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -97.81 122.64 41.15 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 117.797 0.798 . . . . 0.0 110.886 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.9 t -69.02 126.25 29.23 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.432 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.526 ' CE1' ' HB3' ' A' ' 69' ' ' ALA . 3.1 m-85 -97.58 17.9 16.69 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -179.027 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 30.5 mm -92.5 119.61 40.35 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 CA-C-O 120.82 0.343 . . . . 0.0 110.946 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 61.11 76.86 0.35 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.262 0.553 . . . . 0.0 111.143 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 17.4 pt -145.97 150.3 15.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.546 179.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -62.27 142.43 57.73 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.165 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.487 ' O ' HG23 ' A' ' 83' ' ' VAL . 12.3 t60 -47.97 -50.81 26.05 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.597 -179.151 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -60.17 -27.58 65.33 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.694 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -69.87 -43.57 71.57 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 120.948 0.404 . . . . 0.0 110.878 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.68 -39.88 76.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.491 -179.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 79' ' ' HIS . 26.7 t -71.88 -45.24 65.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.125 -179.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.507 ' O ' HG22 ' A' ' 88' ' ' THR . 36.1 t -62.61 -36.79 83.91 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.548 -179.436 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.438 HD23 ' HA ' ' A' ' 85' ' ' LEU . 18.3 mt -68.0 -45.69 73.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.833 0.349 . . . . 0.0 111.761 -179.402 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.428 HD21 HD21 ' A' ' 95' ' ' LEU . 18.3 mt -68.17 -32.89 73.46 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.237 0.458 . . . . 0.0 112.237 -178.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 3.0 mtmp? -79.6 -37.98 34.99 Favored 'General case' 0 N--CA 1.457 -0.087 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -178.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.507 HG22 ' O ' ' A' ' 84' ' ' SER . 9.0 t -70.77 -23.28 62.37 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -178.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -51.06 176.4 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 121.335 0.588 . . . . 0.0 112.398 -178.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 87.0 mm-40 -82.08 -144.0 0.06 Allowed 'General case' 0 CA--C 1.551 0.998 0 CA-C-N 115.476 -0.783 . . . . 0.0 111.119 -179.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -79.87 -63.48 1.4 Allowed 'General case' 0 C--N 1.347 0.493 0 CA-C-N 118.94 0.791 . . . . 0.0 110.964 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.469 HG23 ' HG3' ' A' ' 18' ' ' GLU . 0.5 OUTLIER -87.19 138.38 31.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.198 179.797 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 18.2 t -127.08 121.65 58.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.047 -179.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -93.52 101.46 13.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.337 179.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.428 HD21 HD21 ' A' ' 86' ' ' LEU . 5.6 mp -104.07 155.69 18.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.043 0.449 . . . . 0.0 111.797 -179.307 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.815 HD12 ' HB3' ' A' ' 68' ' ' GLN . 41.4 mt -116.01 130.76 70.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.641 178.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.568 HD13 HD23 ' A' ' 60' ' ' LEU . 39.3 pt -126.95 160.66 35.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-O 120.992 0.425 . . . . 0.0 111.635 -179.137 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 71.9 t -143.17 149.42 18.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.136 -179.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.429 ' O ' HG23 ' A' ' 101' ' ' VAL . 0.7 OUTLIER -112.84 117.51 32.35 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.928 179.092 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 48.2 mm-40 -62.02 127.6 32.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.832 0.349 . . . . 0.0 111.723 -179.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 99' ' ' ARG . 14.6 t -140.78 100.79 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.658 179.332 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 11.6 t -155.25 180.0 8.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.903 0.382 . . . . 0.0 111.161 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 79.7 p . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.25 -0.881 . . . . 0.0 110.846 179.951 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 301' ' ' THR . . . . . . . . . . . . . 41.6 p . . . . . 0 N--CA 1.487 1.413 0 CA-C-O 120.79 0.329 . . . . 0.0 111.135 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 302' ' ' GLY . . . . . . . . . . . . . . . 95.24 163.21 34.56 Favored Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.571 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 303' ' ' TRP . . . . . . . . . . . . . 18.5 p-90 -104.34 -28.99 11.04 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 120.616 0.246 . . . . 0.0 111.281 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -70.83 175.44 5.04 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.74 0.305 . . . . 0.0 110.696 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 305' ' ' THR . . . . . . . . . . . . . 5.3 m -141.22 119.34 12.02 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.353 -0.385 . . . . 17.879999999999999 110.607 179.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 306' ' ' TRP . . . . . 0.419 ' CH2' ' HG2' ' A' ' 51' ' ' GLN . 83.6 m95 -84.29 117.32 23.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.046 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 307' ' ' VAL . . . . . 0.454 HG12 HG13 ' A' ' 83' ' ' VAL . 16.2 m . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.261 -0.876 . . . . 16.109999999999999 111.159 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.146 0 N-CA-C 112.565 -0.214 . . . . 0.0 112.565 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.1 t -91.97 116.66 29.1 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.884 0.374 . . . . 0.0 110.991 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -84.34 141.94 30.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.375 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.53 97.37 5.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.629 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 154.18 -33.63 0.72 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 121.0 -0.619 . . . . 0.0 112.309 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -123.3 86.68 2.62 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.873 0.368 . . . . 0.0 110.587 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -91.0 157.66 17.15 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.968 -179.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -170.83 -41.71 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.572 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.559 ' HA ' HG11 ' A' ' 101' ' ' VAL . . . -64.17 -160.05 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.632 -179.413 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.404 ' HG3' HG22 ' A' ' 101' ' ' VAL . 0.2 OUTLIER -51.46 102.86 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -179.178 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.556 ' O ' HD13 ' A' ' 13' ' ' ILE . 4.6 mt-30 -89.73 107.56 19.17 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -179.61 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -89.34 95.19 10.18 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.277 179.259 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.556 HD13 ' O ' ' A' ' 11' ' ' GLN . 0.1 OUTLIER -113.97 164.16 10.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -179.191 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 82.3 mtt-85 -100.56 168.49 9.68 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.655 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.799 HG13 ' CB ' ' A' ' 59' ' ' LEU . 40.3 t -150.35 139.23 15.08 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.015 179.518 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 39.7 mtt85 -113.93 108.09 16.58 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.845 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 18.5 t -111.29 123.66 67.36 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.16 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.677 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -86.18 161.16 18.98 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.179 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.3 73.28 0.81 Allowed 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.545 179.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -138.68 85.13 17.41 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.168 -179.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -86.03 -19.93 18.54 Favored 'Cis proline' 0 C--N 1.364 1.372 0 CA-C-N 119.507 0.86 . . . . 0.0 113.129 0.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -136.46 -177.64 4.81 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 120.746 0.307 . . . . 0.0 111.276 -179.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.415 ' HB3' ' CE1' ' A' ' 25' ' ' PHE . 3.2 mp -65.3 -55.81 16.21 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.263 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 109.48 16.13 11.44 Favored Glycine 0 C--N 1.336 0.528 0 C-N-CA 120.794 -0.717 . . . . 0.0 114.215 178.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.494 ' O ' HG22 ' B' ' 307' ' ' VAL . 51.0 p90 -145.79 157.02 43.95 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 117.759 0.78 . . . . 0.0 111.463 179.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.4 p -108.52 150.59 27.24 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.171 -179.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.55 HD11 HG22 ' A' ' 83' ' ' VAL . 17.7 pt -122.88 151.67 27.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.502 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 98.2 p -149.98 164.07 36.43 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.207 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 112.48 -96.08 0.82 Allowed Glycine 0 C--N 1.337 0.601 0 C-N-CA 120.898 -0.668 . . . . 0.0 113.876 178.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.498 ' H ' HD13 ' A' ' 45' ' ' ILE . . . 74.52 -132.82 14.93 Favored Glycine 0 CA--C 1.519 0.309 0 C-N-CA 121.119 -0.562 . . . . 0.0 112.401 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 24.1 t -149.75 87.16 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 92.89 5.16 64.56 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 120.983 -0.627 . . . . 0.0 113.693 -178.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -77.47 -134.62 0.71 Allowed Glycine 0 C--N 1.343 0.963 0 CA-C-N 117.741 0.77 . . . . 0.0 112.723 -179.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 1.4 mtt180 -71.17 -19.67 62.38 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 112.597 0.592 . . . . 0.0 112.597 -179.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 104.92 -156.02 17.0 Favored Glycine 0 C--N 1.342 0.907 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.952 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -173.89 132.86 0.57 Allowed Pre-proline 0 CA--C 1.534 0.358 0 N-CA-C 110.539 -0.171 . . . . 0.0 110.539 179.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -90.16 25.6 0.55 Allowed 'Trans proline' 0 C--N 1.358 1.048 0 C-N-CA 122.174 1.916 . . . . 0.0 113.89 -179.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -110.25 -56.06 2.38 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.734 0.302 . . . . 0.0 110.921 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -114.16 135.78 22.18 Favored Pre-proline 0 CA--C 1.535 0.389 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.689 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -86.96 -47.58 0.04 OUTLIER 'Trans proline' 0 C--N 1.36 1.14 0 C-N-CA 121.994 1.796 . . . . 0.0 113.623 -179.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -95.83 -11.4 26.88 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -179.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -94.48 115.91 28.16 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 117.904 0.32 . . . . 0.0 110.27 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 20.4 p30 -102.3 64.52 0.92 Allowed 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 121.174 0.511 . . . . 0.0 111.408 -179.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -116.15 -162.49 13.13 Favored Glycine 0 C--N 1.333 0.411 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.316 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.498 HD13 ' H ' ' A' ' 30' ' ' GLY . 15.8 mm -107.53 131.64 57.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 N-CA-C 110.348 -0.242 . . . . 0.0 110.348 179.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -129.55 149.87 51.13 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.77 0.319 . . . . 0.0 111.107 -179.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.571 HG23 HD11 ' A' ' 66' ' ' ILE . 21.8 t -97.13 73.58 0.63 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.331 -179.126 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.6 t -35.34 -53.54 0.64 Allowed 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 114.527 1.306 . . . . 0.0 114.527 -178.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 1.8 ptt-85 -158.53 163.84 36.69 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.059 0.457 . . . . 0.0 112.112 -179.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 5.3 t -121.26 154.85 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.56 -179.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 3.6 mm-40 -104.73 -68.3 0.04 OUTLIER Pre-proline 0 CA--C 1.538 0.513 0 N-CA-C 111.575 0.213 . . . . 0.0 111.575 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -80.37 120.13 3.96 Favored 'Trans proline' 0 C--N 1.358 1.07 0 C-N-CA 121.836 1.691 . . . . 0.0 112.481 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -77.06 69.2 3.32 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 120.992 0.425 . . . . 0.0 111.337 -179.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -165.04 -64.33 0.02 OUTLIER Glycine 0 CA--C 1.529 0.937 0 C-N-CA 120.696 -0.764 . . . . 0.0 113.719 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -58.57 -72.52 0.03 OUTLIER 'Trans proline' 0 C--N 1.357 1.002 0 C-N-CA 122.072 1.848 . . . . 0.0 113.72 -178.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.784 ' HB1' HD12 ' A' ' 60' ' ' LEU . . . -102.68 -10.92 18.8 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 113.796 1.036 . . . . 0.0 113.796 -178.092 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.9 t -75.31 -25.93 58.27 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 112.131 0.419 . . . . 0.0 112.131 -178.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.9 tppt? -76.81 -20.94 55.81 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 111.925 0.343 . . . . 0.0 111.925 179.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.799 ' CB ' HG13 ' A' ' 15' ' ' VAL . 43.5 mt -123.48 6.43 8.96 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -178.137 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.784 HD12 ' HB1' ' A' ' 56' ' ' ALA . 91.2 mt -136.03 148.9 48.58 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 118.344 0.52 . . . . 0.0 111.729 179.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -104.98 141.49 22.66 Favored Pre-proline 0 CA--C 1.536 0.42 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.437 179.317 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo -64.15 71.16 0.2 Allowed 'Trans proline' 0 C--N 1.362 1.254 0 C-N-CA 122.297 1.998 . . . . 0.0 113.647 -179.127 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 139.16 40.42 0.09 OUTLIER Glycine 0 CA--C 1.524 0.617 0 C-N-CA 120.903 -0.665 . . . . 0.0 113.299 179.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -96.36 -161.67 0.89 Allowed 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 117.034 0.417 . . . . 0.0 110.661 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.6 tttm -138.77 122.0 16.98 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 120.718 0.294 . . . . 0.0 110.818 179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.571 HD11 HG23 ' A' ' 47' ' ' VAL . 4.3 mp -89.45 120.97 39.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.534 -179.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 20.1 mm -92.39 -40.39 12.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -178.403 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 9.4 mt-30 -150.38 150.86 31.96 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.12 0.486 . . . . 0.0 111.981 -178.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.422 ' HB3' ' CE1' ' A' ' 74' ' ' PHE . . . -138.23 123.02 18.79 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.684 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.435 ' ND2' HG13 ' A' ' 93' ' ' VAL . 62.8 m-20 40.85 33.63 0.22 Allowed 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 178.468 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 99.2 -20.87 48.29 Favored Glycine 0 CA--C 1.522 0.509 0 C-N-CA 120.724 -0.75 . . . . 0.0 113.409 179.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -88.46 119.52 28.97 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 117.151 0.475 . . . . 0.0 110.281 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 33.3 t -66.25 122.12 16.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.005 -179.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.422 ' CE1' ' HB3' ' A' ' 69' ' ' ALA . 2.9 m-85 -98.07 7.64 45.99 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 113.121 0.786 . . . . 0.0 113.121 -178.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.403 ' O ' HG23 ' A' ' 75' ' ' ILE . 6.5 tp -84.55 120.28 34.94 Favored 'Isoleucine or valine' 0 C--N 1.341 0.201 0 CA-C-N 118.392 0.542 . . . . 0.0 110.678 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 62.13 75.93 0.39 Allowed 'General case' 0 C--O 1.232 0.184 0 CA-C-O 121.259 0.552 . . . . 0.0 111.023 -179.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 16.0 pt -144.87 152.86 14.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.514 179.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 7.0 mt-10 -64.61 150.9 46.09 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.039 0.447 . . . . 0.0 110.992 -179.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.408 ' O ' HG23 ' A' ' 83' ' ' VAL . 11.0 t60 -54.73 -55.11 33.37 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.953 -179.301 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -55.55 -25.3 42.09 Favored Glycine 0 CA--C 1.523 0.544 0 C-N-CA 121.058 -0.592 . . . . 0.0 113.309 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.21 -39.85 53.64 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.056 0.455 . . . . 0.0 110.592 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -72.66 -35.88 67.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.207 -179.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.55 HG22 HD11 ' A' ' 27' ' ' ILE . 22.6 t -76.08 -45.85 35.35 Favored 'Isoleucine or valine' 0 C--O 1.231 0.082 0 CA-C-O 120.83 0.348 . . . . 0.0 111.022 -179.557 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.585 ' O ' HG22 ' A' ' 88' ' ' THR . 45.1 m -61.63 -35.33 77.6 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.078 -179.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.439 HD23 ' HA ' ' A' ' 85' ' ' LEU . 15.3 mt -70.64 -44.02 68.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.171 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.425 ' HA ' ' CD2' ' A' ' 89' ' ' PHE . 13.7 mt -68.45 -31.03 70.05 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.283 0.475 . . . . 0.0 112.283 -179.067 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 23.7 mtmt -83.79 -36.35 23.62 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 -179.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.585 HG22 ' O ' ' A' ' 84' ' ' SER . 9.0 t -72.26 -24.06 61.3 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -178.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.425 ' CD2' ' HA ' ' A' ' 86' ' ' LEU . 8.3 m-85 -49.74 177.02 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -178.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 50.9 mm-40 -82.17 -144.83 0.06 Allowed 'General case' 0 CA--C 1.549 0.911 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.689 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 -78.24 -65.05 1.03 Allowed 'General case' 0 C--N 1.347 0.468 0 CA-C-N 118.977 0.808 . . . . 0.0 111.021 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -83.58 140.35 32.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.356 179.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.435 HG13 ' ND2' ' A' ' 70' ' ' ASN . 19.0 t -124.84 120.68 59.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.275 -179.606 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -89.49 107.31 19.0 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.134 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 15.2 mt -107.95 145.29 34.04 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.99 0.424 . . . . 0.0 111.766 -178.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 15.9 mm -108.01 125.91 64.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 178.174 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.43 HD13 HD23 ' A' ' 60' ' ' LEU . 41.6 pt -131.2 167.99 24.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -178.468 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 18.3 t -149.72 153.94 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.167 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -115.77 116.01 27.3 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.315 179.307 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -67.57 127.52 33.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.371 -179.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.559 HG11 ' HA ' ' A' ' 9' ' ' ALA . 13.3 m -108.82 175.56 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.795 179.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 21.2 m -79.54 144.46 33.9 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.99 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 77.7 p . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.289 -0.863 . . . . 0.0 110.865 179.962 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 301' ' ' THR . . . . . . . . . . . . . 1.7 m . . . . . 0 N--CA 1.487 1.407 0 CA-C-O 121.191 0.52 . . . . 0.0 111.028 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 302' ' ' GLY . . . . . . . . . . . . . . . -84.03 177.77 52.04 Favored Glycine 0 C--N 1.333 0.364 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.488 -179.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 303' ' ' TRP . . . . . 0.407 ' CZ3' ' HB3' ' B' ' 304' ' ' GLU . 34.7 p-90 -76.33 -28.52 56.91 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.519 0.2 . . . . 0.0 111.377 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 304' ' ' GLU . . . . . 0.407 ' HB3' ' CZ3' ' B' ' 303' ' ' TRP . 7.4 pt-20 -86.69 153.53 21.67 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.737 0.303 . . . . 0.0 110.796 179.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 305' ' ' THR . . . . . . . . . . . . . 16.9 m -139.76 120.88 14.73 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.303 -0.408 . . . . 17.879999999999999 110.953 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 306' ' ' TRP . . . . . . . . . . . . . 92.2 m95 -80.64 111.03 16.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.863 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 307' ' ' VAL . . . . . 0.494 HG22 ' O ' ' A' ' 25' ' ' PHE . 15.5 m . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.253 -0.879 . . . . 16.109999999999999 111.122 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.253 0 N-CA-C 112.473 -0.251 . . . . 0.0 112.473 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.8 m -90.85 138.48 31.56 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.776 0.322 . . . . 0.0 110.845 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 22.9 m-70 -83.12 156.49 23.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.882 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -103.9 -31.84 9.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.922 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 114.6 48.86 0.53 Allowed Glycine 0 C--N 1.332 0.325 0 C-N-CA 121.076 -0.583 . . . . 0.0 112.622 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 1.9 t-160 -100.22 117.98 35.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.764 0.316 . . . . 0.0 110.646 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -70.12 -178.97 1.77 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.004 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.6 mp -64.43 135.55 56.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.937 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -110.82 46.06 1.1 Allowed 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.103 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.3 mmmm -64.74 127.79 33.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.875 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.4 mp0 -88.98 90.27 8.34 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.979 -178.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -84.97 99.09 10.76 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 178.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 14.4 pt -117.48 159.24 17.76 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.214 -178.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.715 ' HG2' HD13 ' A' ' 96' ' ' ILE . 0.1 OUTLIER -112.95 157.58 21.31 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.099 -179.361 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.5 m -141.66 139.68 31.43 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.707 179.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -106.03 114.27 28.31 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.605 -179.123 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.0 t -114.13 123.26 69.62 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.997 179.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.558 ' HG3' HG22 ' A' ' 92' ' ' THR . 4.8 mp0 -98.95 119.08 37.13 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.704 179.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.469 ' HE2' HD11 ' A' ' 23' ' ' LEU . 16.1 mttt -70.02 118.38 12.79 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.048 -179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -171.98 85.57 0.45 Allowed Pre-proline 0 CA--C 1.536 0.435 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.655 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -84.0 -17.76 26.09 Favored 'Cis proline' 0 C--N 1.363 1.338 0 CA-C-N 119.383 0.815 . . . . 0.0 113.42 0.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 51.7 mm-40 -136.79 -177.04 4.56 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 120.913 0.387 . . . . 0.0 111.689 -179.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.469 HD11 ' HE2' ' A' ' 19' ' ' LYS . 4.5 mp -65.67 -56.1 13.93 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.244 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 102.54 39.46 2.77 Favored Glycine 0 CA--C 1.522 0.488 0 C-N-CA 120.754 -0.736 . . . . 0.0 113.926 178.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.426 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 43.3 p90 -169.85 156.91 6.5 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 117.155 0.477 . . . . 0.0 111.202 179.173 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 9.3 p -113.55 154.64 26.78 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.506 -179.414 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.464 HD11 HG22 ' A' ' 83' ' ' VAL . 46.6 pt -121.38 153.35 25.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.799 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 77.6 p -141.21 155.24 46.07 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.865 179.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 114.05 -158.26 14.43 Favored Glycine 0 C--N 1.335 0.508 0 C-N-CA 120.934 -0.651 . . . . 0.0 113.369 179.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 137.27 -135.51 7.68 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 121.26 -0.495 . . . . 0.0 112.234 -179.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 39.5 t -141.88 75.38 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.225 0.536 . . . . 0.0 109.877 179.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 93.59 13.56 55.11 Favored Glycine 0 CA--C 1.529 0.943 0 CA-C-N 115.66 -0.7 . . . . 0.0 113.154 -178.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -86.74 -146.42 10.05 Favored Glycine 0 C--N 1.342 0.908 0 CA-C-N 117.598 0.699 . . . . 0.0 112.695 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 69.6 mtt180 -56.46 -24.56 46.49 Favored 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -179.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 80.24 175.46 48.76 Favored Glycine 0 C--N 1.336 0.536 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.629 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -139.53 146.55 48.52 Favored Pre-proline 0 CA--C 1.534 0.337 0 N-CA-C 110.473 -0.195 . . . . 0.0 110.473 179.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -92.33 30.32 0.31 Allowed 'Trans proline' 0 C--N 1.358 1.039 0 C-N-CA 122.309 2.006 . . . . 0.0 113.43 -179.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -107.48 -56.48 2.21 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.778 0.323 . . . . 0.0 110.647 179.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -112.46 139.12 22.27 Favored Pre-proline 0 CA--C 1.534 0.33 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.376 179.41 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -87.58 -50.3 0.03 OUTLIER 'Trans proline' 0 C--N 1.358 1.044 0 C-N-CA 121.964 1.776 . . . . 0.0 113.642 -178.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -95.43 -7.82 37.22 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -179.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -90.9 113.75 26.03 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 118.106 0.412 . . . . 0.0 110.766 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 14.1 p30 -98.88 54.82 1.01 Allowed 'General case' 0 CA--C 1.535 0.393 0 CA-C-O 121.1 0.476 . . . . 0.0 111.15 -179.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -112.45 -163.75 16.49 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 121.056 -0.592 . . . . 0.0 112.577 179.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 13.1 mm -108.74 133.79 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 116.553 0.177 . . . . 0.0 110.591 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.432 ' CD1' ' N ' ' A' ' 46' ' ' PHE . 3.7 m-85 -131.2 151.59 51.32 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 120.542 0.21 . . . . 0.0 110.714 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.582 HG23 ' OD1' ' A' ' 64' ' ' ASP . 29.2 t -91.0 79.79 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-O 121.103 0.478 . . . . 0.0 110.686 179.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.408 HG23 ' N ' ' A' ' 49' ' ' ARG . 5.1 t -36.41 -53.78 0.85 Allowed 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 114.824 1.416 . . . . 0.0 114.824 -178.533 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.408 ' N ' HG23 ' A' ' 48' ' ' THR . 0.0 OUTLIER -160.48 179.47 8.59 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 121.236 0.541 . . . . 0.0 112.372 -178.988 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 20.3 t -137.37 148.62 25.9 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.48 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 7.2 mm-40 -105.06 -68.85 0.03 OUTLIER Pre-proline 0 CA--C 1.538 0.488 0 CA-C-O 119.629 -0.224 . . . . 0.0 111.389 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -78.12 118.04 4.28 Favored 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 121.676 1.584 . . . . 0.0 112.045 179.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 4.3 pm0 -75.63 66.95 2.04 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.114 0.483 . . . . 0.0 111.257 -179.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -156.03 -69.83 0.01 OUTLIER Glycine 0 CA--C 1.528 0.868 0 C-N-CA 120.791 -0.719 . . . . 0.0 113.335 -179.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -60.07 -75.81 0.02 OUTLIER 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 121.968 1.779 . . . . 0.0 113.365 -179.019 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.544 ' HB1' HD12 ' A' ' 60' ' ' LEU . . . -104.05 46.06 0.93 Allowed 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 121.073 0.464 . . . . 0.0 111.77 -179.103 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 12.9 t -114.4 -65.04 1.23 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.006 179.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.1 tppm? -62.46 -21.22 65.27 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.488 178.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 40.2 mt -97.73 -54.9 2.97 Favored 'General case' 0 C--N 1.339 0.128 0 CA-C-O 120.59 0.233 . . . . 0.0 111.558 -179.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.551 HD23 HD13 ' A' ' 97' ' ' ILE . 32.6 mt -93.96 146.94 23.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.807 0.337 . . . . 0.0 111.563 -179.478 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -118.84 143.06 32.91 Favored Pre-proline 0 CA--C 1.537 0.472 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.333 179.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -62.19 131.69 35.6 Favored 'Trans proline' 0 C--N 1.359 1.092 0 C-N-CA 122.128 1.886 . . . . 0.0 113.761 -179.011 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 93.88 18.7 36.5 Favored Glycine 0 C--N 1.335 0.482 0 CA-C-N 115.934 -0.575 . . . . 0.0 113.89 178.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.582 ' OD1' HG23 ' A' ' 47' ' ' VAL . 2.8 p30 -85.16 -171.71 3.78 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 117.33 0.565 . . . . 0.0 111.227 -179.44 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 43.5 tttm -135.11 122.03 21.16 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.773 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.456 ' CG2' HD12 ' A' ' 95' ' ' LEU . 20.6 mt -90.12 117.3 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.017 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 20.2 mm -96.01 -36.77 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -179.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -152.02 150.55 30.09 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 121.136 0.493 . . . . 0.0 112.07 -178.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.619 ' HB3' ' CE1' ' A' ' 74' ' ' PHE . . . -137.25 119.94 16.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.822 179.315 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.414 ' HB2' ' CZ ' ' A' ' 89' ' ' PHE . 62.8 m-20 42.56 28.87 0.13 Allowed 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 179.26 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 99.31 5.69 55.78 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 120.888 -0.672 . . . . 0.0 113.98 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -109.32 121.28 44.82 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 117.911 0.856 . . . . 0.0 110.084 179.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.3 t -68.03 121.0 15.18 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.798 0.332 . . . . 0.0 111.235 -179.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.619 ' CE1' ' HB3' ' A' ' 69' ' ' ALA . 3.9 m-30 -99.63 15.15 27.62 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 116.173 -0.467 . . . . 0.0 112.069 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 7.7 tp -92.2 123.41 44.3 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-O 120.785 0.326 . . . . 0.0 110.86 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 61.29 73.78 0.47 Allowed 'General case' 0 C--O 1.232 0.167 0 CA-C-O 121.258 0.551 . . . . 0.0 110.773 -179.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 11.7 pt -149.21 160.93 5.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.646 179.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -73.29 139.47 46.12 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.225 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.418 ' O ' HG23 ' A' ' 83' ' ' VAL . 3.8 t-160 -48.25 -49.74 32.25 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -179.513 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -56.63 -28.26 56.16 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 121.13 -0.557 . . . . 0.0 112.944 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -73.96 -40.91 62.71 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.888 0.375 . . . . 0.0 110.372 179.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.98 -36.41 83.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.032 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.528 HG13 HG12 ' B' ' 307' ' ' VAL . 22.1 t -75.04 -41.4 45.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.821 179.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 54.3 p -60.45 -45.66 92.86 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.291 -179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 54.8 mt -65.84 -44.66 84.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.611 -179.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.42 ' HA ' ' CD2' ' A' ' 89' ' ' PHE . 12.6 mt -66.74 -36.54 82.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.23 -0.441 . . . . 0.0 112.105 -178.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 54.9 mttm -75.31 -38.56 60.21 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 -178.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 11.5 t -70.94 -24.85 62.52 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -178.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.42 ' CD2' ' HA ' ' A' ' 86' ' ' LEU . 8.5 m-85 -47.82 173.55 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -178.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 6.9 mm-40 -81.38 -145.58 0.06 Allowed 'General case' 0 CA--C 1.548 0.882 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.517 -179.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -79.36 -66.78 0.83 Allowed 'General case' 0 C--N 1.345 0.401 0 CA-C-N 118.911 0.778 . . . . 0.0 110.721 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.558 HG22 ' HG3' ' A' ' 18' ' ' GLU . 0.6 OUTLIER -76.91 126.37 30.86 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.645 179.629 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.693 HG12 ' CD2' ' A' ' 95' ' ' LEU . 21.2 t -119.27 123.23 70.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.97 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -100.68 106.46 17.92 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.578 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.693 ' CD2' HG12 ' A' ' 93' ' ' VAL . 4.3 mm? -100.36 149.92 23.13 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.47 -179.591 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.715 HD13 ' HG2' ' A' ' 14' ' ' ARG . 17.5 mm -108.54 124.87 65.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.38 178.377 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.551 HD13 HD23 ' A' ' 60' ' ' LEU . 43.4 pt -129.23 165.17 29.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.735 0.302 . . . . 0.0 111.255 -179.161 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.41 HG12 ' N ' ' A' ' 99' ' ' ARG . 14.6 t -150.38 154.57 8.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 121.009 0.433 . . . . 0.0 111.689 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.41 ' N ' HG12 ' A' ' 98' ' ' VAL . 0.1 OUTLIER -108.49 112.76 25.31 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 177.694 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -55.41 135.89 49.94 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 101' ' ' VAL . 16.4 m -146.74 114.83 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.122 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.016 179.295 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 1.9 m -100.2 85.06 2.93 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.867 0.365 . . . . 0.0 110.852 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 57.3 p . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.211 -0.9 . . . . 0.0 110.906 179.981 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 301' ' ' THR . . . . . . . . . . . . . 12.6 m . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 120.886 0.374 . . . . 0.0 111.269 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 302' ' ' GLY . . . . . . . . . . . . . . . 69.02 46.69 58.13 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.847 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 303' ' ' TRP . . . . . . . . . . . . . 27.1 p-90 -90.7 -27.91 18.67 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 121.211 -0.196 . . . . 0.0 111.071 179.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 4.9 pm0 -77.53 158.82 29.7 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.674 0.273 . . . . 0.0 110.492 179.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 305' ' ' THR . . . . . . . . . . . . . 5.7 m -132.97 121.79 23.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.39 -0.368 . . . . 17.879999999999999 110.888 -179.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 306' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -85.58 118.55 25.16 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.99 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 307' ' ' VAL . . . . . 0.528 HG12 HG13 ' A' ' 83' ' ' VAL . 18.3 m . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.21 -0.9 . . . . 16.109999999999999 111.139 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.226 0 N-CA-C 112.423 -0.271 . . . . 0.0 112.423 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.3 t -160.44 33.08 0.16 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.871 0.367 . . . . 0.0 110.889 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 60.6 m80 -93.56 145.19 24.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.791 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.9 ptp -94.97 150.27 20.35 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.009 -179.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 70.99 79.37 0.38 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.964 -0.636 . . . . 0.0 112.818 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -165.56 33.7 0.05 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.937 0.399 . . . . 0.0 110.874 179.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.6 mp0 -98.65 61.53 1.35 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.269 0.557 . . . . 0.0 110.405 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.6 mt -148.88 136.07 20.09 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.792 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -92.1 75.72 5.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.655 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 60.5 mmtt -143.83 -178.8 6.1 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.697 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -148.69 100.44 3.1 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.914 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -90.15 118.54 29.76 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.097 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.616 ' N ' HD13 ' A' ' 13' ' ' ILE . 0.2 OUTLIER -139.82 155.29 24.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.958 0.409 . . . . 0.0 111.544 -179.893 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.74 167.13 10.08 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.448 -179.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.63 HG13 ' HB3' ' A' ' 59' ' ' LEU . 22.4 t -146.82 153.5 12.6 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.966 179.437 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.497 ' CD ' HG22 ' A' ' 92' ' ' THR . 0.0 OUTLIER -129.05 118.65 22.88 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.278 179.77 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.3 t -125.43 130.63 72.78 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-O 120.924 0.392 . . . . 0.0 111.453 -179.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.9 mt-10 -100.02 146.11 27.11 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.067 179.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.64 76.59 9.51 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.863 0.363 . . . . 0.0 110.492 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -140.8 85.65 12.47 Favored Pre-proline 0 CA--C 1.539 0.528 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.706 -179.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -82.15 -30.67 4.76 Favored 'Cis proline' 0 C--N 1.363 1.338 0 CA-C-N 119.409 0.825 . . . . 0.0 113.172 0.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -138.19 -178.54 5.32 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.872 0.367 . . . . 0.0 111.361 -179.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.411 ' HB3' ' CE2' ' A' ' 25' ' ' PHE . 3.2 mp -62.09 -61.89 2.16 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.83 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 103.79 34.87 3.65 Favored Glycine 0 CA--C 1.52 0.38 0 C-N-CA 120.825 -0.702 . . . . 0.0 113.783 179.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.411 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 31.1 p90 -163.57 145.95 9.73 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 117.254 0.527 . . . . 0.0 111.137 179.321 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.8 p -100.63 150.4 22.76 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.056 -179.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.66 HD11 HG22 ' A' ' 83' ' ' VAL . 25.4 pt -117.23 147.63 20.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.867 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 12.9 p -138.35 153.92 48.96 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.77 0.319 . . . . 0.0 111.293 -179.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 113.47 -158.92 13.97 Favored Glycine 0 C--N 1.332 0.323 0 C-N-CA 120.977 -0.63 . . . . 0.0 113.519 179.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 109.47 153.38 14.91 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 121.234 -0.507 . . . . 0.0 112.022 -179.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 17.9 t -76.82 98.39 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 CA-C-O 121.081 0.467 . . . . 0.0 110.522 -179.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 96.0 10.25 56.42 Favored Glycine 0 CA--C 1.528 0.866 0 CA-C-N 115.657 -0.701 . . . . 0.0 113.349 -179.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.6 -158.28 32.66 Favored Glycine 0 C--N 1.342 0.865 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.712 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -59.61 -27.63 66.48 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -179.067 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 117.57 -167.02 12.66 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.662 -179.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -145.44 125.92 7.27 Favored Pre-proline 0 CA--C 1.533 0.291 0 O-C-N 122.928 -0.16 . . . . 0.0 110.871 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -92.31 24.7 0.48 Allowed 'Trans proline' 0 C--N 1.355 0.913 0 C-N-CA 122.122 1.881 . . . . 0.0 112.875 179.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -124.49 -49.63 1.78 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 120.793 0.33 . . . . 0.0 110.639 179.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -114.83 130.98 23.69 Favored Pre-proline 0 CA--C 1.533 0.301 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.455 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -85.0 -44.85 0.05 OUTLIER 'Trans proline' 0 C--N 1.356 0.927 0 C-N-CA 121.965 1.776 . . . . 0.0 113.22 -179.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -89.6 -3.95 58.05 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -179.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -109.94 125.26 52.66 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 118.156 0.435 . . . . 0.0 110.576 179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -109.98 31.29 5.97 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.647 -179.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.422 ' O ' HD13 ' A' ' 45' ' ' ILE . . . -76.49 -146.62 2.04 Favored Glycine 0 CA--C 1.519 0.34 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.98 179.401 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.422 HD13 ' O ' ' A' ' 44' ' ' GLY . 14.7 mm -124.13 135.36 63.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-N 116.934 0.367 . . . . 0.0 110.469 179.269 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.427 ' CD1' ' N ' ' A' ' 46' ' ' PHE . 7.7 m-85 -132.99 151.98 52.01 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.16 -179.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.528 HG23 ' OD1' ' A' ' 64' ' ' ASP . 21.8 t -97.34 74.23 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 CA-C-O 121.058 0.456 . . . . 0.0 110.797 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.419 HG23 ' N ' ' A' ' 49' ' ' ARG . 8.0 t -31.44 -53.23 0.23 Allowed 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 -178.71 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.419 ' N ' HG23 ' A' ' 48' ' ' THR . 0.0 OUTLIER -160.9 -178.92 7.14 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.155 0.502 . . . . 0.0 111.987 -179.457 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.0 t -134.73 150.75 30.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.61 179.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -104.86 -68.23 0.04 OUTLIER Pre-proline 0 CA--C 1.538 0.495 0 N-CA-C 111.728 0.269 . . . . 0.0 111.728 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -79.25 119.39 4.2 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 121.781 1.654 . . . . 0.0 112.275 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -75.15 68.33 1.9 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.931 0.396 . . . . 0.0 110.872 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -161.19 -66.64 0.02 OUTLIER Glycine 0 CA--C 1.529 0.936 0 C-N-CA 120.651 -0.785 . . . . 0.0 113.821 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -58.32 -76.44 0.02 OUTLIER 'Trans proline' 0 C--N 1.356 0.949 0 C-N-CA 122.166 1.911 . . . . 0.0 113.452 -178.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.919 ' HB1' HD12 ' A' ' 60' ' ' LEU . . . -115.32 50.95 0.95 Allowed 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.289 0.566 . . . . 0.0 111.298 -179.399 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 13.4 t -112.85 -63.37 1.45 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.45 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.82 -13.64 61.78 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.569 179.313 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.63 ' HB3' HG13 ' A' ' 15' ' ' VAL . 34.6 mt -96.61 -54.43 3.24 Favored 'General case' 0 C--N 1.345 0.388 0 O-C-N 122.091 -0.381 . . . . 0.0 111.101 179.562 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.919 HD12 ' HB1' ' A' ' 56' ' ' ALA . 56.5 mt -91.93 146.86 23.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.453 -179.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -118.25 137.47 24.65 Favored Pre-proline 0 CA--C 1.537 0.48 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.016 178.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -54.82 131.01 43.57 Favored 'Trans proline' 0 C--N 1.361 1.195 0 C-N-CA 122.341 2.027 . . . . 0.0 113.931 -178.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 96.73 16.59 35.88 Favored Glycine 0 CA--C 1.523 0.576 0 CA-C-N 115.637 -0.71 . . . . 0.0 113.816 178.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.528 ' OD1' HG23 ' A' ' 47' ' ' VAL . 2.7 p30 -81.65 -169.1 2.16 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 117.379 0.589 . . . . 0.0 111.298 -179.482 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 45.8 tttp -139.31 124.57 19.05 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.28 179.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 33.9 mt -89.02 115.16 28.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.615 -179.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 23.9 mm -94.19 -38.17 9.01 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 116.097 -0.501 . . . . 0.0 112.126 -178.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.729 ' HB3' HD12 ' A' ' 96' ' ' ILE . 0.0 OUTLIER -151.08 150.89 31.23 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.178 0.514 . . . . 0.0 112.096 -179.025 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -145.56 124.68 12.87 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.942 179.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.6 m120 43.95 31.7 0.54 Allowed 'General case' 0 N--CA 1.475 0.786 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 179.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 97.6 -6.0 62.64 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 120.78 -0.724 . . . . 0.0 114.068 179.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -102.03 123.06 45.27 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 117.83 0.815 . . . . 0.0 110.775 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 7.9 m -71.43 126.8 30.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.927 179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 4.4 m-85 -99.75 6.64 45.46 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 112.697 0.629 . . . . 0.0 112.697 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.413 ' O ' HG23 ' A' ' 75' ' ' ILE . 7.3 tp -83.85 120.06 34.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 118.165 0.438 . . . . 0.0 110.896 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 63.3 76.17 0.37 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.032 0.444 . . . . 0.0 111.072 -179.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 9.3 pt -150.19 164.77 3.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.817 179.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 10.7 mp0 -78.75 148.52 32.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.139 0.495 . . . . 0.0 111.454 -179.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 23.9 t60 -53.47 -54.13 41.44 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.645 -0.707 . . . . 0.0 112.282 -179.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -55.33 -27.43 47.15 Favored Glycine 0 CA--C 1.52 0.373 0 C-N-CA 121.147 -0.549 . . . . 0.0 113.163 -179.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.4 tp60 -73.57 -39.02 64.98 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.028 0.442 . . . . 0.0 110.544 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.11 -55.91 12.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.933 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.66 HG22 HD11 ' A' ' 27' ' ' ILE . 17.2 t -58.29 -44.0 87.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.787 -179.29 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.6 t -60.39 -39.24 86.61 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.596 -179.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.544 ' O ' HG22 ' A' ' 88' ' ' THR . 30.2 mt -67.52 -43.61 80.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.825 -179.439 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.43 ' HA ' ' CD2' ' A' ' 89' ' ' PHE . 22.2 mt -66.66 -42.07 87.18 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -179.022 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 15.1 mttm -64.48 -41.47 96.47 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -178.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.544 HG22 ' O ' ' A' ' 85' ' ' LEU . 9.7 t -64.11 -22.61 67.0 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -178.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.43 ' CD2' ' HA ' ' A' ' 86' ' ' LEU . 21.4 m-85 -60.81 131.0 49.29 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 120.951 0.405 . . . . 0.0 110.495 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -65.77 -105.34 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.959 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -178.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -88.4 -83.04 0.22 Allowed 'General case' 0 C--N 1.35 0.618 0 CA-C-N 119.422 1.01 . . . . 0.0 113.321 -178.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.497 HG22 ' CD ' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -71.22 162.17 29.87 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-O 121.128 0.489 . . . . 0.0 111.658 -178.652 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 19.9 t -151.41 112.91 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.612 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 12.1 mp0 -89.01 122.51 32.43 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 179.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 14.1 mt -121.56 143.05 49.51 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -178.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.729 HD12 ' HB3' ' A' ' 68' ' ' GLN . 42.4 mt -114.07 129.28 70.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 177.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.436 HD13 HD23 ' A' ' 60' ' ' LEU . 43.5 pt -134.71 172.99 15.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -178.156 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 20.2 t -147.25 151.66 13.63 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.731 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -123.2 113.51 19.03 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.53 179.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -66.16 117.9 9.12 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.336 -179.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 22.1 t -108.69 117.96 55.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.487 179.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 10.5 t -90.73 120.72 32.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.051 -179.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 20.2 m . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.182 -0.913 . . . . 0.0 110.761 179.912 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 301' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.487 1.394 0 CA-C-O 120.808 0.337 . . . . 0.0 111.071 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 302' ' ' GLY . . . . . . . . . . . . . . . 106.25 86.62 1.9 Allowed Glycine 0 C--N 1.332 0.315 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.255 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 303' ' ' TRP . . . . . . . . . . . . . 61.1 p-90 -94.11 -30.49 14.62 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.662 0.267 . . . . 0.0 111.33 -179.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -90.41 132.32 35.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.81 0.338 . . . . 0.0 111.128 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 305' ' ' THR . . . . . . . . . . . . . 7.4 m -109.38 134.69 51.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.009 -0.541 . . . . 17.879999999999999 110.613 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 306' ' ' TRP . . . . . . . . . . . . . 83.4 m95 -97.43 131.71 43.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.885 0.374 . . . . 0.0 111.058 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 307' ' ' VAL . . . . . . . . . . . . . 24.0 m . . . . . 0 C--O 1.25 1.125 0 CA-C-O 118.271 -0.871 . . . . 16.109999999999999 111.153 -179.876 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.162 0 N-CA-C 112.517 -0.233 . . . . 0.0 112.517 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.3 m -133.31 48.51 2.38 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.395 0.617 . . . . 0.0 110.644 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 13.7 m-70 -92.64 149.5 21.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.987 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 8.8 ptm -165.37 123.26 1.58 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.063 179.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 106.02 -32.01 7.8 Favored Glycine 0 C--N 1.333 0.369 0 C-N-CA 121.001 -0.618 . . . . 0.0 112.883 179.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -69.75 -30.64 68.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.596 0.236 . . . . 0.0 111.229 -179.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -115.02 72.29 0.79 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 121.117 0.484 . . . . 0.0 110.732 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 14.0 tp -152.85 141.03 20.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.829 -179.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.555 ' HB3' HG21 ' A' ' 101' ' ' VAL . . . -167.29 37.85 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 120.93 0.395 . . . . 0.0 111.63 -179.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 16.9 mtpt -75.29 116.22 15.78 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.886 179.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.65 108.22 20.49 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 120.915 0.388 . . . . 0.0 111.962 -179.258 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -88.05 107.43 18.74 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.5 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.589 ' H ' HD13 ' A' ' 13' ' ' ILE . 0.2 OUTLIER -114.42 154.8 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.934 179.934 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 1.1 ttt85 -93.09 165.45 12.83 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.628 -179.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.463 HG11 HD11 ' A' ' 60' ' ' LEU . 53.9 t -141.1 118.59 8.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.241 -179.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -105.48 109.29 21.21 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 178.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.451 HG23 HG12 ' A' ' 15' ' ' VAL . 14.0 t -121.37 131.81 72.15 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-O 120.883 0.373 . . . . 0.0 111.517 -179.245 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.435 ' CG ' HG23 ' A' ' 92' ' ' THR . 34.4 mt-10 -92.04 164.07 13.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.162 179.16 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.32 74.93 1.05 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 121.337 0.589 . . . . 0.0 110.949 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -141.61 84.71 12.06 Favored Pre-proline 0 CA--C 1.54 0.593 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.419 -179.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -83.73 -23.92 11.87 Favored 'Cis proline' 0 C--N 1.364 1.352 0 CA-C-N 119.444 0.837 . . . . 0.0 113.009 0.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 20.7 mt-10 -139.14 -169.07 2.57 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 120.692 0.282 . . . . 0.0 110.986 -179.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.509 HD13 HG23 ' B' ' 307' ' ' VAL . 5.2 mp -67.47 -49.43 63.61 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-O 120.807 0.337 . . . . 0.0 110.228 179.43 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.505 ' O ' HG13 ' A' ' 50' ' ' VAL . . . 106.22 24.32 6.9 Favored Glycine 0 C--N 1.333 0.364 0 C-N-CA 120.972 -0.633 . . . . 0.0 113.371 179.205 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.41 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 45.1 p90 -160.52 153.87 21.99 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 117.14 0.47 . . . . 0.0 111.28 179.613 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.8 p -104.03 156.77 17.59 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.977 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.47 HD11 HG22 ' A' ' 83' ' ' VAL . 30.9 pt -122.91 149.39 26.58 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.1 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.4 m -151.29 169.74 21.22 Favored 'General case' 0 CA--C 1.53 0.212 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.144 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 94.66 21.49 26.24 Favored Glycine 0 CA--C 1.523 0.536 0 C-N-CA 121.076 -0.583 . . . . 0.0 114.164 178.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -60.47 151.96 38.89 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.343 179.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 58.5 t -78.37 106.91 9.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 121.028 0.442 . . . . 0.0 110.281 -179.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 94.24 -5.42 71.38 Favored Glycine 0 CA--C 1.53 0.994 0 CA-C-N 115.752 -0.658 . . . . 0.0 113.635 -178.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -85.89 -139.87 5.36 Favored Glycine 0 C--N 1.345 1.075 0 CA-C-N 117.804 0.802 . . . . 0.0 113.236 -179.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 8.6 mmt180 -75.75 -17.91 59.73 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -178.106 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 99.25 -150.12 19.15 Favored Glycine 0 C--N 1.339 0.749 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.477 -179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -166.57 132.95 1.93 Allowed Pre-proline 0 CA--C 1.535 0.393 0 CA-C-N 116.626 0.213 . . . . 0.0 110.99 179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -90.41 25.7 0.53 Allowed 'Trans proline' 0 C--N 1.36 1.135 0 C-N-CA 122.193 1.929 . . . . 0.0 113.689 -179.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 -110.65 -54.69 2.56 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.755 0.312 . . . . 0.0 110.785 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.426 ' HG3' ' CE2' ' A' ' 46' ' ' PHE . 4.9 mmp_? -108.41 144.76 30.14 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.311 179.558 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -89.17 -51.9 0.02 OUTLIER 'Trans proline' 0 C--N 1.357 1.026 0 C-N-CA 121.899 1.733 . . . . 0.0 113.853 -178.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -99.28 -2.47 36.44 Favored 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 -178.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -95.07 117.92 31.0 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 118.264 0.484 . . . . 0.0 110.601 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -101.08 37.01 1.84 Allowed 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.958 -179.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -93.4 -168.03 38.52 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.466 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.2 mm -102.83 129.21 54.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 178.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.426 ' CE2' ' HG3' ' A' ' 39' ' ' ARG . 1.2 m-85 -129.99 149.49 51.69 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.839 0.352 . . . . 0.0 110.925 -179.154 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.553 HG23 ' OD1' ' A' ' 64' ' ' ASP . 38.8 t -89.77 79.07 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.306 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.417 HG23 ' N ' ' A' ' 49' ' ' ARG . 9.9 t -37.82 -53.31 1.3 Allowed 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 -178.564 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.417 ' N ' HG23 ' A' ' 48' ' ' THR . 3.5 ptt-85 -160.3 165.49 31.22 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 118.229 0.468 . . . . 0.0 112.111 -179.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.505 HG13 ' O ' ' A' ' 24' ' ' GLY . 12.1 t -122.98 148.38 26.85 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.805 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.4 ' HG3' ' CH2' ' B' ' 306' ' ' TRP . 8.5 mt-30 -100.21 -68.41 0.04 OUTLIER Pre-proline 0 CA--C 1.538 0.487 0 CA-C-O 119.738 -0.172 . . . . 0.0 111.129 179.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -80.78 117.22 3.28 Favored 'Trans proline' 0 C--N 1.358 1.07 0 C-N-CA 121.715 1.61 . . . . 0.0 112.581 179.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -75.57 70.55 2.41 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 120.954 0.407 . . . . 0.0 110.784 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -162.8 -65.92 0.02 OUTLIER Glycine 0 CA--C 1.529 0.937 0 C-N-CA 120.789 -0.72 . . . . 0.0 113.354 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -58.27 -78.26 0.02 OUTLIER 'Trans proline' 0 C--N 1.358 1.041 0 C-N-CA 122.118 1.878 . . . . 0.0 112.924 -179.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.687 ' HB1' HD12 ' A' ' 60' ' ' LEU . . . -108.19 46.88 0.93 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.47 0.652 . . . . 0.0 110.582 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 91.7 p -101.95 -61.43 1.39 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.193 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -71.77 -7.12 46.24 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.206 179.115 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.461 ' HB3' HG13 ' A' ' 15' ' ' VAL . 66.3 mt -95.57 -59.61 1.84 Allowed 'General case' 0 C--N 1.344 0.332 0 CA-C-N 118.244 0.474 . . . . 0.0 111.541 -179.516 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.687 HD12 ' HB1' ' A' ' 56' ' ' ALA . 2.7 mt -95.63 144.31 26.18 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.654 0.264 . . . . 0.0 111.452 -179.375 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.1 pm0 -112.35 142.73 27.5 Favored Pre-proline 0 CA--C 1.538 0.488 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.382 178.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -50.93 130.32 30.92 Favored 'Trans proline' 0 C--N 1.359 1.105 0 C-N-CA 122.206 1.937 . . . . 0.0 113.667 -179.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 82.59 24.73 52.85 Favored Glycine 0 C--N 1.333 0.386 0 CA-C-N 115.853 -0.612 . . . . 0.0 113.637 178.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.553 ' OD1' HG23 ' A' ' 47' ' ' VAL . 20.6 p30 -86.98 -171.79 3.68 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 117.025 0.413 . . . . 0.0 110.793 -179.618 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 66.5 tttt -140.33 128.83 22.76 Favored 'General case' 0 N--CA 1.466 0.365 0 N-CA-C 112.109 0.411 . . . . 0.0 112.109 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . 0.565 ' N ' HD12 ' A' ' 66' ' ' ILE . 4.0 mp -93.59 118.82 40.29 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.833 179.308 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 23.7 mm -92.67 -33.97 5.74 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.86 -178.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 -146.88 148.85 32.24 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.95 0.405 . . . . 0.0 111.456 -179.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -138.5 114.84 10.36 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.509 -179.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 49.32 29.11 2.57 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 113.11 0.781 . . . . 0.0 113.11 179.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 101.03 -22.65 38.55 Favored Glycine 0 CA--C 1.521 0.458 0 C-N-CA 120.787 -0.721 . . . . 0.0 113.178 179.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 64.4 m-85 -89.16 127.95 35.76 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 117.099 0.449 . . . . 0.0 110.696 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.2 m -65.93 130.35 42.94 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.974 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -104.65 21.58 16.59 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.662 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 6.6 tp -101.68 140.53 20.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 O-C-N 122.249 -0.282 . . . . 0.0 110.99 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 34.7 m-20 65.54 10.72 6.89 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -178.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 17.3 pt -89.12 156.09 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 121.334 0.588 . . . . 0.0 112.584 -178.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 20.8 mt-10 -80.84 153.6 27.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.615 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 9.3 t60 -49.8 -55.26 14.78 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 112.284 0.476 . . . . 0.0 112.284 -179.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -54.83 -28.0 45.83 Favored Glycine 0 C--N 1.335 0.522 0 C-N-CA 121.039 -0.6 . . . . 0.0 113.351 -179.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -72.78 -41.86 64.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.943 0.401 . . . . 0.0 110.484 179.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.78 -57.4 8.07 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.742 -179.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.47 HG22 HD11 ' A' ' 27' ' ' ILE . 15.4 t -56.7 -43.95 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-O 120.871 0.367 . . . . 0.0 111.595 -179.377 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 38.0 m -60.79 -43.18 98.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.438 -179.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.453 HD23 ' HA ' ' A' ' 85' ' ' LEU . 12.8 mt -65.51 -47.39 76.13 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.577 -179.415 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.425 ' HA ' ' CD2' ' A' ' 89' ' ' PHE . 26.5 mt -64.37 -41.77 96.53 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.661 -179.033 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 36.8 mmtt -64.23 -41.71 96.88 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -178.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 11.3 t -72.02 -25.04 61.66 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -177.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.425 ' CD2' ' HA ' ' A' ' 86' ' ' LEU . 14.8 m-85 -53.81 156.6 2.71 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.53 0.681 . . . . 0.0 112.741 -178.476 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -61.72 -145.55 0.0 OUTLIER 'General case' 0 CA--C 1.556 1.179 0 CA-C-N 115.127 -0.942 . . . . 0.0 111.672 -178.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 -81.25 -59.52 2.61 Favored 'General case' 0 C--N 1.35 0.62 0 CA-C-N 118.859 0.754 . . . . 0.0 111.829 -178.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.435 HG23 ' CG ' ' A' ' 18' ' ' GLU . 0.2 OUTLIER -87.15 135.19 33.39 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 -179.644 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 12.0 t -127.6 124.82 64.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.865 0.364 . . . . 0.0 111.484 -179.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -101.03 114.87 29.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.25 179.224 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.445 ' N ' HD12 ' A' ' 95' ' ' LEU . 5.7 mp -113.58 160.84 18.11 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.082 0.468 . . . . 0.0 111.929 -179.083 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 22.9 mm -118.67 129.73 74.51 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.263 179.3 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.497 HG21 ' CD2' ' A' ' 60' ' ' LEU . 7.1 pt -134.14 166.79 27.8 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-O 120.577 0.227 . . . . 0.0 111.592 -179.509 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.408 HG12 ' N ' ' A' ' 99' ' ' ARG . 21.3 t -144.88 155.27 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 CA-C-O 121.203 0.525 . . . . 0.0 111.873 -179.336 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.408 ' N ' HG12 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -112.26 110.15 20.23 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.361 178.798 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -70.54 143.18 51.69 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 121.025 0.441 . . . . 0.0 112.164 -178.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.555 HG21 ' HB3' ' A' ' 9' ' ' ALA . 17.8 m -150.71 108.09 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.955 179.367 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 22.9 t -156.4 135.6 12.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.871 0.367 . . . . 0.0 111.089 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 19.9 m . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.174 -0.917 . . . . 0.0 110.856 179.874 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 301' ' ' THR . . . . . . . . . . . . . 1.8 p . . . . . 0 N--CA 1.487 1.4 0 CA-C-O 120.746 0.308 . . . . 0.0 111.222 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 302' ' ' GLY . . . . . . . . . . . . . . . 147.98 -76.63 0.25 Allowed Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.646 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 303' ' ' TRP . . . . . . . . . . . . . 11.7 p-90 -115.21 -53.09 2.65 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 120.719 0.295 . . . . 0.0 111.143 -179.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.79 143.49 41.89 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.853 0.359 . . . . 0.0 111.101 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 305' ' ' THR . . . . . . . . . . . . . 11.5 m -119.05 130.66 55.75 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.017 -0.538 . . . . 17.879999999999999 110.611 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 306' ' ' TRP . . . . . 0.4 ' CH2' ' HG3' ' A' ' 51' ' ' GLN . 82.3 m95 -90.68 105.35 17.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.895 0.378 . . . . 0.0 110.904 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 307' ' ' VAL . . . . . 0.509 HG23 HD13 ' A' ' 23' ' ' LEU . 15.9 m . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.248 -0.882 . . . . 16.109999999999999 111.138 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.201 0 N-CA-C 112.504 -0.238 . . . . 0.0 112.504 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.2 m -96.29 167.1 11.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.757 0.313 . . . . 0.0 110.864 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 22.3 m80 -79.92 130.67 35.48 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.781 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 6.2 mtt -85.91 111.06 19.88 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.975 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -110.87 -108.56 3.08 Favored Glycine 0 C--N 1.33 0.242 0 C-N-CA 121.066 -0.588 . . . . 0.0 112.437 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 40.8 m80 -149.58 142.5 24.79 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.678 0.275 . . . . 0.0 110.784 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -110.46 36.38 3.1 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.814 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.2 mp -129.34 176.99 7.5 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.656 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.722 ' HB3' HG11 ' A' ' 101' ' ' VAL . . . -107.71 49.74 0.8 Allowed 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 121.218 0.533 . . . . 0.0 111.619 -179.454 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -98.97 106.06 18.28 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.977 179.316 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.521 ' O ' HG13 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -119.38 179.58 4.15 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.511 -178.747 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.59 110.6 5.21 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.048 179.579 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.547 ' H ' HD13 ' A' ' 13' ' ' ILE . 0.1 OUTLIER -105.87 160.64 5.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.377 -179.071 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.72 151.07 26.69 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 115.815 -0.629 . . . . 0.0 111.129 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.421 HG13 HD13 ' A' ' 59' ' ' LEU . 21.3 t -137.29 137.11 46.55 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.837 179.433 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.52 111.46 24.18 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.783 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 19.8 t -105.47 116.83 50.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.812 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.57 ' CG ' HG23 ' A' ' 92' ' ' THR . 34.6 mt-10 -94.61 116.92 29.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.853 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 24.5 mttt -71.57 127.37 32.35 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-O 121.479 0.656 . . . . 0.0 110.934 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -172.18 83.09 0.45 Allowed Pre-proline 0 CA--C 1.539 0.555 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.872 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -85.85 -8.78 48.08 Favored 'Cis proline' 0 C--N 1.366 1.448 0 CA-C-N 119.426 0.831 . . . . 0.0 113.786 0.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -137.29 -177.53 4.81 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.789 0.328 . . . . 0.0 111.264 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.415 ' HB3' ' CE2' ' A' ' 25' ' ' PHE . 3.5 mp -63.03 -57.15 11.64 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.105 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 102.29 29.02 6.18 Favored Glycine 0 C--N 1.337 0.631 0 C-N-CA 120.82 -0.705 . . . . 0.0 113.675 178.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.415 ' CE2' ' HB3' ' A' ' 23' ' ' LEU . 36.0 p90 -157.26 145.31 19.18 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 117.131 0.465 . . . . 0.0 110.825 179.225 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.5 p -98.85 149.7 22.64 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.608 -179.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.73 HD11 HG22 ' A' ' 83' ' ' VAL . 21.0 pt -121.7 147.8 25.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.288 179.116 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 34.1 t -143.68 163.38 33.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.839 0.352 . . . . 0.0 111.078 -179.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 103.51 -146.67 16.51 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.61 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.12 156.57 29.02 Favored Glycine 0 N--CA 1.452 -0.233 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.228 -179.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 17.3 t -78.64 101.61 4.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.872 0.368 . . . . 0.0 110.773 -179.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 92.85 1.55 67.67 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 120.979 -0.629 . . . . 0.0 113.746 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -82.13 -155.38 15.82 Favored Glycine 0 C--N 1.341 0.831 0 CA-C-N 117.965 0.882 . . . . 0.0 113.038 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 73.7 mtt180 -63.64 -27.92 69.56 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.638 0.236 . . . . 0.0 111.638 -179.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 93.54 168.32 38.41 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 120.608 -0.805 . . . . 0.0 112.794 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -137.11 139.13 27.42 Favored Pre-proline 0 CA--C 1.534 0.359 0 O-C-N 123.004 -0.115 . . . . 0.0 110.804 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -92.53 27.3 0.37 Allowed 'Trans proline' 0 C--N 1.358 1.078 0 C-N-CA 122.396 2.064 . . . . 0.0 113.291 -179.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -100.77 -54.1 2.9 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.71 0.291 . . . . 0.0 110.956 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -114.17 141.45 26.39 Favored Pre-proline 0 CA--C 1.533 0.295 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.606 179.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -87.59 -50.32 0.03 OUTLIER 'Trans proline' 0 C--N 1.358 1.049 0 C-N-CA 121.992 1.794 . . . . 0.0 113.66 -178.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -87.44 -11.47 49.0 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 -179.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -101.31 115.99 31.77 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 117.984 0.356 . . . . 0.0 110.793 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 30.9 p-10 -104.42 44.63 1.01 Allowed 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 121.211 0.529 . . . . 0.0 110.712 179.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -92.42 -159.45 35.19 Favored Glycine 0 C--N 1.332 0.328 0 CA-C-N 115.826 -0.625 . . . . 0.0 112.71 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.1 mm -107.5 131.94 56.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 110.312 -0.255 . . . . 0.0 110.312 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -131.58 148.66 52.63 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 120.816 0.341 . . . . 0.0 111.307 -179.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 24.0 t -89.78 73.95 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-O 121.158 0.504 . . . . 0.0 111.014 179.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 5.6 t -38.4 -52.63 1.55 Allowed 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 114.444 1.276 . . . . 0.0 114.444 -178.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -158.02 162.37 38.14 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 121.108 0.48 . . . . 0.0 112.116 -179.546 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 15.7 t -120.93 149.55 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.47 179.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 18.8 mm-40 -104.35 -67.77 0.04 OUTLIER Pre-proline 0 CA--C 1.538 0.513 0 N-CA-C 111.941 0.348 . . . . 0.0 111.941 -179.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -76.87 124.5 7.48 Favored 'Trans proline' 0 C--N 1.357 1.004 0 C-N-CA 121.666 1.577 . . . . 0.0 112.79 -179.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.85 63.4 3.56 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.142 -179.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -158.35 -66.97 0.01 OUTLIER Glycine 0 CA--C 1.526 0.774 0 C-N-CA 120.57 -0.824 . . . . 0.0 113.643 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -57.58 -77.07 0.02 OUTLIER 'Trans proline' 0 C--N 1.357 1.011 0 C-N-CA 122.195 1.93 . . . . 0.0 113.63 -178.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.883 ' HB1' HD12 ' A' ' 60' ' ' LEU . . . -118.34 51.8 1.06 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 121.267 0.556 . . . . 0.0 111.208 -179.036 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 19.8 t -116.56 -60.17 1.88 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.142 179.003 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 40.2 pttt -69.22 -9.99 55.62 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.977 179.007 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.421 HD13 HG13 ' A' ' 15' ' ' VAL . 69.5 mt -102.5 -52.24 3.15 Favored 'General case' 0 C--N 1.345 0.371 0 CA-C-N 118.237 0.471 . . . . 0.0 110.936 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.883 HD12 ' HB1' ' A' ' 56' ' ' ALA . 53.3 mt -91.02 158.42 16.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.36 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -130.65 143.03 47.65 Favored Pre-proline 0 CA--C 1.535 0.377 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.429 179.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 74.8 Cg_exo -50.44 128.1 22.32 Favored 'Trans proline' 0 C--N 1.361 1.219 0 C-N-CA 122.099 1.866 . . . . 0.0 113.389 -179.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.06 2.25 48.58 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 120.979 -0.629 . . . . 0.0 113.911 179.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 65.9 m-20 -75.95 140.91 42.32 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 118.024 0.912 . . . . 0.0 111.151 -179.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 60.7 tttp -97.54 129.1 44.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.909 179.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ILE . . . . . . . . . . . . . 28.3 mt -89.06 114.07 26.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.534 -0.303 . . . . 0.0 110.562 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.574 HG23 HD11 ' A' ' 75' ' ' ILE . 21.1 mm -89.72 -44.06 14.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 112.934 0.716 . . . . 0.0 112.934 -178.601 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.493 ' HB2' HD12 ' A' ' 96' ' ' ILE . 9.6 mt-30 -148.23 149.53 32.08 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.348 0.594 . . . . 0.0 112.344 -178.573 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.578 ' HB3' ' CE1' ' A' ' 74' ' ' PHE . . . -136.82 121.4 18.39 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.121 179.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 48.1 m-20 45.67 28.46 0.54 Allowed 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 178.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 101.7 -14.09 57.73 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 120.762 -0.732 . . . . 0.0 113.705 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 28.8 m-85 -88.59 127.99 35.57 Favored 'General case' 0 C--O 1.231 0.1 0 CA-C-N 117.685 0.742 . . . . 0.0 110.432 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 79.4 p -76.27 127.04 32.1 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.784 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . 0.578 ' CE1' ' HB3' ' A' ' 69' ' ' ALA . 6.3 m-85 -101.97 14.2 32.64 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.574 HD11 HG23 ' A' ' 67' ' ' ILE . 31.4 mm -90.65 125.53 43.46 Favored 'Isoleucine or valine' 0 C--N 1.341 0.226 0 O-C-N 122.011 -0.43 . . . . 0.0 110.97 179.386 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 61.64 71.88 0.53 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-O 121.279 0.561 . . . . 0.0 110.838 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 12.7 pt -149.01 165.84 3.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.792 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -80.97 145.21 31.33 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.95 0.405 . . . . 0.0 110.771 179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -52.5 -51.73 58.03 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.05 -179.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -56.58 -27.46 54.62 Favored Glycine 0 C--N 1.334 0.424 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.938 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 7.1 tm0? -72.72 -40.2 66.31 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.957 0.408 . . . . 0.0 110.316 179.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.48 -36.13 82.0 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.314 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.73 HG22 HD11 ' A' ' 27' ' ' ILE . 25.4 t -73.4 -44.13 54.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.978 0.418 . . . . 0.0 110.572 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 23.0 t -56.49 -38.07 71.23 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.135 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 89.6 mt -71.78 -39.54 69.86 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.364 179.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.421 ' HA ' ' CD2' ' A' ' 89' ' ' PHE . 75.2 mt -78.14 -3.0 40.25 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 179.32 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 11.5 mmtp -99.23 -40.78 7.78 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-O 121.302 0.572 . . . . 0.0 110.303 178.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 8.9 t -73.86 -24.53 59.76 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -178.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.421 ' CD2' ' HA ' ' A' ' 86' ' ' LEU . 10.2 m-85 -48.52 171.62 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 -178.534 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -86.99 -142.47 0.11 Allowed 'General case' 0 CA--C 1.554 1.113 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.214 -179.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -78.13 -68.32 0.65 Allowed 'General case' 0 C--N 1.349 0.561 0 CA-C-N 119.027 0.83 . . . . 0.0 111.017 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.57 HG23 ' CG ' ' A' ' 18' ' ' GLU . 0.2 OUTLIER -81.41 134.24 35.52 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.572 179.954 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 21.3 t -120.84 124.67 72.83 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.138 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -89.78 115.12 26.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.982 179.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 8.0 mt -118.57 148.24 42.87 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.043 0.449 . . . . 0.0 112.041 -178.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.493 HD12 ' HB2' ' A' ' 68' ' ' GLN . 48.6 mt -119.56 132.22 69.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.527 178.451 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.478 HD13 ' CD2' ' A' ' 60' ' ' LEU . 35.1 pt -130.67 169.03 22.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.864 0.364 . . . . 0.0 111.762 -179.207 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.521 HG13 ' O ' ' A' ' 11' ' ' GLN . 58.2 t -133.01 143.02 40.67 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.042 -179.186 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.49 102.23 10.11 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -81.71 133.53 35.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.848 0.356 . . . . 0.0 111.727 -178.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.722 HG11 ' HB3' ' A' ' 9' ' ' ALA . 9.2 m -95.51 179.77 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.628 179.411 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' SER . . . . . . . . . . . . . 16.7 t -61.05 112.58 2.15 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.82 0.343 . . . . 0.0 111.149 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 38.6 t . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.237 -0.887 . . . . 0.0 110.816 179.946 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 301' ' ' THR . . . . . . . . . . . . . 4.3 m . . . . . 0 N--CA 1.487 1.424 0 CA-C-O 120.689 0.281 . . . . 0.0 111.466 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 302' ' ' GLY . . . . . . . . . . . . . . . -83.17 60.65 4.87 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.853 -179.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 303' ' ' TRP . . . . . . . . . . . . . 9.5 p-90 -145.98 16.54 1.39 Allowed 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 179.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 304' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -115.58 134.76 54.75 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 120.842 0.353 . . . . 0.0 110.904 179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 305' ' ' THR . . . . . . . . . . . . . 3.5 m -105.1 123.42 47.79 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.109 -0.496 . . . . 17.879999999999999 110.688 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 306' ' ' TRP . . . . . . . . . . . . . 88.5 m95 -89.02 112.2 23.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.951 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 307' ' ' VAL . . . . . 0.488 HG12 HG13 ' A' ' 83' ' ' VAL . 17.8 m . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.241 -0.885 . . . . 16.109999999999999 111.077 -179.994 . . . . . . . . 1 1 . 1 stop_ save_